Citrus Sinensis ID: 025244
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 255 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.760 | 0.497 | 0.431 | 1e-40 | |
| Q55A09 | 1331 | Probable serine/threonine | yes | no | 0.701 | 0.134 | 0.412 | 5e-31 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.701 | 0.195 | 0.389 | 7e-31 | |
| P18161 | 1155 | Dual specificity protein | no | no | 0.690 | 0.152 | 0.388 | 2e-29 | |
| Q54I36 | 1338 | Dual specificity protein | no | no | 0.686 | 0.130 | 0.402 | 4e-28 | |
| Q54L00 | 650 | Probable LIM domain-conta | no | no | 0.686 | 0.269 | 0.385 | 4e-28 | |
| Q95UN8 | 1161 | Mitogen-activated protein | yes | no | 0.690 | 0.151 | 0.365 | 8e-28 | |
| Q66HA1 | 850 | Mitogen-activated protein | no | no | 0.694 | 0.208 | 0.37 | 1e-27 | |
| P80192 | 1104 | Mitogen-activated protein | yes | no | 0.694 | 0.160 | 0.355 | 1e-27 | |
| Q3U1V8 | 1077 | Mitogen-activated protein | yes | no | 0.694 | 0.164 | 0.355 | 1e-27 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 166 bits (420), Expect = 1e-40, Method: Compositional matrix adjust.
Identities = 88/204 (43%), Positives = 121/204 (59%), Gaps = 10/204 (4%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I+TE +S G LR YL P L + + ALDI+R ME LHS G+IHRDLK NLLL
Sbjct: 162 IITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN 221
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 122
++++ +K+ADFG + E+ GTYRWMAPE+ ++K Y KVD YSF
Sbjct: 222 DEMR-VKVADFGTSCLETQCREAKGNMGTYRWMAPEMI--------KEKPYTRKVDVYSF 272
Query: 123 AIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-AENVPEELSIILTSCWKEDPNARPN 181
IVLWEL LPF+GM+ +QAA+A A KN RP + L+ ++ CW E+P+ RP+
Sbjct: 273 GIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQPALAHLIKRCWSENPSKRPD 332
Query: 182 FTQIIQMLLNYLSAIAPPEPMIPH 205
F+ I+ +L Y + P+ H
Sbjct: 333 FSNIVAVLEKYDECVKEGLPLTSH 356
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 134 bits (338), Expect = 5e-31, Method: Composition-based stats.
Identities = 83/201 (41%), Positives = 112/201 (55%), Gaps = 22/201 (10%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPR------CLDVCVAIGFALDIARAMECLHSHGIIHRDL 54
M IV E L G L + L++ +P LD + + A DIAR M+ LH+ IIHRDL
Sbjct: 1143 MCIVMEFLPSGNLFE-LIHSKPSEQQQSIKLDSTLILAIAFDIARGMQHLHTRNIIHRDL 1201
Query: 55 KPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 114
K NLL+ + IK+AD G+ARE S T+ MT GT W APE+ LR + YN
Sbjct: 1202 KSSNLLMDKHF-NIKIADLGIARETSFTQTMTT-IGTVAWTAPEI-----LRH---ESYN 1251
Query: 115 HKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-AENVPEELSIILTSCWK 173
K D YS+AIVL+ELL + P++G+ + A A K +RP +N ++ CW
Sbjct: 1252 QKADVYSYAIVLYELLTGEEPYQGIPPMNAGILVASKGLRPELPDNCDPNWKKLVVWCWS 1311
Query: 174 EDPNARPNFTQIIQMLLNYLS 194
EDPN RP+F +I NYL+
Sbjct: 1312 EDPNKRPSFEEIT----NYLT 1328
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 134 bits (336), Expect = 7e-31, Method: Compositional matrix adjust.
Identities = 74/190 (38%), Positives = 115/190 (60%), Gaps = 11/190 (5%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +TE L GG+L L + + + +++ + A+ IA+ M LH G+IHRD+K NLL
Sbjct: 733 LCFITEYLPGGSLYDALHSKKIK-MNMQLYKKLAIQIAQGMNYLHLSGVIHRDIKSLNLL 791
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
L E + +K+ DFGL++ +S + MT G+ WM+PEL GE Y KVD Y
Sbjct: 792 LDEHM-NVKICDFGLSKLKSKSTEMTKSIGSPIWMSPELL------MGED--YTEKVDVY 842
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV-PEELSIILTSCWKEDPNAR 179
+F I+LWEL +LP+ G+ ++Q A A K++RP N P +LS ++ +CW +DP R
Sbjct: 843 AFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACWHQDPLKR 902
Query: 180 PNFTQIIQML 189
P+FT+I+ +L
Sbjct: 903 PSFTEILNLL 912
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18161|SPLB_DICDI Dual specificity protein kinase splB OS=Dictyostelium discoideum GN=splB PE=2 SV=2 | Back alignment and function description |
|---|
Score = 129 bits (324), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 77/198 (38%), Positives = 109/198 (55%), Gaps = 22/198 (11%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVC----VAIGFALDIARAMECLHSHGIIHRDLKPEN 58
I+TE ++GG+L L N V + + A D+A + LHS I+HRDL +N
Sbjct: 923 IITEYMAGGSLYNILHNPNSSTPKVKYSFPLVLKMATDMALGLLHLHSITIVHRDLTSQN 982
Query: 59 LLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNH 115
+LL E L IK++DFGL+RE+S MT G RW PEL + HY+
Sbjct: 983 ILLDE-LGNIKISDFGLSREKSREGSMTMTNGGICNPRWRPPELTKNL-------GHYSE 1034
Query: 116 KVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE----ELSIILTSC 171
KVD Y F++V+WE+L ++PF + QA+ A+ +RP +PE EL ++LT C
Sbjct: 1035 KVDVYCFSLVVWEILTGEIPFSDLDGSQASAQVAYAGLRPP---IPEYCDPELKLLLTQC 1091
Query: 172 WKEDPNARPNFTQIIQML 189
W+ DPN RP FT I+ L
Sbjct: 1092 WEADPNDRPPFTYIVNKL 1109
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q54I36|PYK3_DICDI Dual specificity protein kinase pyk3 OS=Dictyostelium discoideum GN=pyk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 125 bits (313), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 76/189 (40%), Positives = 111/189 (58%), Gaps = 14/189 (7%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I TE L GG+L +L+++ L+ + D++ ME LHS ++HRDL +N+LL
Sbjct: 1125 IFTEYLQGGSLYD-VLHIQKIKLNPLMMYKMIHDLSLGMEHLHSIQMLHRDLTSKNILLD 1183
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTY-RWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
E K IK+ADFGLA +L++ MT T RW +PEL + YN KVD YS
Sbjct: 1184 E-FKNIKIADFGLAT--TLSDDMTLSGITNPRWRSPELTKGLV--------YNEKVDVYS 1232
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSIILTSCWKEDPNARP 180
F +V++E+ K+PFEG+ +A AAF+N RP+ + P L ++T CW DP+ RP
Sbjct: 1233 FGLVVYEIYTGKIPFEGLDGTASAAKAAFENYRPAIPPDCPVSLRKLITKCWASDPSQRP 1292
Query: 181 NFTQIIQML 189
+FT+I+ L
Sbjct: 1293 SFTEILTEL 1301
|
Involved in the development. Negatively regulates tyrosine phosphorylation and activation state of dstC/STATc, probably by activating a dstC/STATc phosphatase. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q54L00|LIMKA_DICDI Probable LIM domain-containing serine/threonine-protein kinase DDB_G0287001 OS=Dictyostelium discoideum GN=DDB_G0287001 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 125 bits (313), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 72/187 (38%), Positives = 106/187 (56%), Gaps = 12/187 (6%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
V+EL+ G+LR LL+ + + L + A DIA AM+ LHS G+IHRDLK N+L+TE
Sbjct: 461 VSELVKSGSLRDLLLD-KEKPLAYFTQLSIASDIANAMKHLHSIGVIHRDLKSLNVLITE 519
Query: 64 DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFA 123
D T K+ DFG +R L + MT GT +M+PEL+ + Y+ D Y+F
Sbjct: 520 DF-TAKVIDFGTSRNVDLAKQMTLNLGTSCYMSPELF--------KGNGYDETCDVYAFG 570
Query: 124 IVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSIILTSCWKEDPNARPNF 182
IVLWE++ K P+E +++ A K RP+ + P E S ++ +CW + P RP+F
Sbjct: 571 IVLWEIIARKEPYENINSWSIPVLVA-KGERPTIPADCPSEYSKLIKACWTDKPKKRPSF 629
Query: 183 TQIIQML 189
+I L
Sbjct: 630 KEICDTL 636
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q95UN8|M3KSL_DROME Mitogen-activated protein kinase kinase kinase OS=Drosophila melanogaster GN=slpr PE=1 SV=1 | Back alignment and function description |
|---|
Score = 124 bits (310), Expect = 8e-28, Method: Compositional matrix adjust.
Identities = 73/200 (36%), Positives = 107/200 (53%), Gaps = 24/200 (12%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG---IIHRDLKPE 57
+ +V E GG+L + L P V + +A+ IAR M LH+ IIHRDLK
Sbjct: 213 LCLVMEYARGGSLNRILAGKIP----PDVLVNWAIQIARGMNYLHNEAPMSIIHRDLKSS 268
Query: 58 NLLLTEDL-------KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 110
N+L+ E + KT+K+ DFGLARE T+ M+A GTY WM PE+ S T
Sbjct: 269 NVLIYEAIEGNHLQQKTLKITDFGLAREMYNTQRMSA-AGTYAWMPPEVISVST------ 321
Query: 111 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILT 169
Y+ D +S+ ++LWEL+ + P++G L AY A + P + PE ++
Sbjct: 322 --YSKFSDVWSYGVLLWELITGETPYKGFDPLSVAYGVAVNTLTLPIPKTCPETWGALMK 379
Query: 170 SCWKEDPNARPNFTQIIQML 189
SCW+ DP+ RP F +I++ L
Sbjct: 380 SCWQTDPHKRPGFKEILKQL 399
|
Activates the JUN N-terminal pathway during dorsal closure. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q66HA1|M3K11_RAT Mitogen-activated protein kinase kinase kinase 11 OS=Rattus norvegicus GN=Map3k11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 123 bits (309), Expect = 1e-27, Method: Composition-based stats.
Identities = 74/200 (37%), Positives = 106/200 (53%), Gaps = 23/200 (11%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG---IIHRDLKPE 57
+ +V E +GG L + L R + V + +A+ IAR M LH +IHRDLK
Sbjct: 190 LCLVMEYAAGGPLSRALAGRR---VPPHVLVNWAVQIARGMHYLHCEALVPVIHRDLKSN 246
Query: 58 NLLLTEDL-------KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 110
N+LL + + KT+K+ DFGLARE T M+A GTY WMAPE+ T +G
Sbjct: 247 NILLLQPIEGDDMEHKTLKITDFGLAREWHKTTQMSA-AGTYAWMAPEVIKASTFSKGS- 304
Query: 111 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILT 169
D +SF ++LWELL ++P+ G+ L AY A + P PE + ++
Sbjct: 305 -------DVWSFGVLLWELLTGEVPYRGIDCLAVAYGVAVNKLTLPIPSTCPEPFAQLMA 357
Query: 170 SCWKEDPNARPNFTQIIQML 189
CW +DP+ RP+F I+Q L
Sbjct: 358 DCWAQDPHRRPDFASILQQL 377
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|P80192|M3K9_HUMAN Mitogen-activated protein kinase kinase kinase 9 OS=Homo sapiens GN=MAP3K9 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 123 bits (309), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 71/200 (35%), Positives = 103/200 (51%), Gaps = 23/200 (11%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI---IHRDLKPE 57
+ +V E GG L + L R + + + +A+ IAR M LH I IHRDLK
Sbjct: 216 LCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS 272
Query: 58 NLLLTEDL-------KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 110
N+L+ + + K +K+ DFGLARE T M+A GTY WMAPE+ +G
Sbjct: 273 NILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGTYAWMAPEVIRASMFSKGS- 330
Query: 111 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILT 169
D +S+ ++LWELL ++PF G+ L AY A + P PE + ++
Sbjct: 331 -------DVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLME 383
Query: 170 SCWKEDPNARPNFTQIIQML 189
CW DP++RP+FT I+ L
Sbjct: 384 DCWNPDPHSRPSFTNILDQL 403
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade through the phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7 which in turn activate the JNKs. The MKK/JNK signaling pathway regulates stress response via activator protein-1 (JUN) and GATA4 transcription factors. Plays also a role in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q3U1V8|M3K9_MOUSE Mitogen-activated protein kinase kinase kinase 9 OS=Mus musculus GN=Map3k9 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 123 bits (309), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 71/200 (35%), Positives = 103/200 (51%), Gaps = 23/200 (11%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI---IHRDLKPE 57
+ +V E GG L + L R + + + +A+ IAR M LH I IHRDLK
Sbjct: 209 LCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS 265
Query: 58 NLLLTEDL-------KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 110
N+L+ + + K +K+ DFGLARE T M+A GTY WMAPE+ +G
Sbjct: 266 NILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGTYAWMAPEVIRASMFSKGS- 323
Query: 111 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILT 169
D +S+ ++LWELL ++PF G+ L AY A + P PE + ++
Sbjct: 324 -------DVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLME 376
Query: 170 SCWKEDPNARPNFTQIIQML 189
CW DP++RP+FT I+ L
Sbjct: 377 DCWNPDPHSRPSFTSILDQL 396
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade through the phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7 which in turn activate the JNKs. The MKK/JNK signaling pathway regulates stress response via activator protein-1 (JUN) and GATA4 transcription factors. Plays also a role in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 255 | ||||||
| 225456892 | 352 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.724 | 0.874 | 1e-131 | |
| 255540509 | 351 | protein kinase atn1, putative [Ricinus c | 0.996 | 0.723 | 0.890 | 1e-131 | |
| 449440628 | 353 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.722 | 0.874 | 1e-131 | |
| 224140853 | 351 | predicted protein [Populus trichocarpa] | 1.0 | 0.726 | 0.854 | 1e-130 | |
| 224055579 | 351 | predicted protein [Populus trichocarpa] | 1.0 | 0.726 | 0.847 | 1e-129 | |
| 356516635 | 352 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.724 | 0.858 | 1e-128 | |
| 255560936 | 353 | protein kinase atn1, putative [Ricinus c | 1.0 | 0.722 | 0.847 | 1e-128 | |
| 363808050 | 352 | uncharacterized protein LOC100804884 [Gl | 1.0 | 0.724 | 0.847 | 1e-126 | |
| 225452312 | 352 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.724 | 0.831 | 1e-126 | |
| 357461809 | 352 | Serine/threonine protein kinase TNNI3K [ | 1.0 | 0.724 | 0.827 | 1e-124 |
| >gi|225456892|ref|XP_002280504.1| PREDICTED: serine/threonine-protein kinase HT1 [Vitis vinifera] gi|147839295|emb|CAN63533.1| hypothetical protein VITISV_011081 [Vitis vinifera] gi|297733702|emb|CBI14949.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 474 bits (1221), Expect = e-131, Method: Compositional matrix adjust.
Identities = 223/255 (87%), Positives = 237/255 (92%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
MVIVTELL GGTLRKYLLNMRPRCLD +A+GFALDIARAMECLHSHGIIHRDLKPENL+
Sbjct: 98 MVIVTELLLGGTLRKYLLNMRPRCLDARIAVGFALDIARAMECLHSHGIIHRDLKPENLI 157
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
LT D KT+KL DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR GEKKHYN+KVD+Y
Sbjct: 158 LTADHKTVKLVDFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRHGEKKHYNNKVDAY 217
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN+PEEL+IILTSCWKEDPNARP
Sbjct: 218 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENLPEELAIILTSCWKEDPNARP 277
Query: 181 NFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKM 240
NF+QI+QMLL+YLS I+PPEP IP R+F SENTILPPESPGTSSLM VRDD GETPK KM
Sbjct: 278 NFSQIVQMLLHYLSTISPPEPAIPSRVFASENTILPPESPGTSSLMAVRDDSGETPKVKM 337
Query: 241 GDKPKSLFFCFNLCY 255
+KPK FFCFN CY
Sbjct: 338 ENKPKGFFFCFNQCY 352
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255540509|ref|XP_002511319.1| protein kinase atn1, putative [Ricinus communis] gi|223550434|gb|EEF51921.1| protein kinase atn1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 474 bits (1221), Expect = e-131, Method: Compositional matrix adjust.
Identities = 227/255 (89%), Positives = 237/255 (92%), Gaps = 1/255 (0%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
MVIVTELLSGGTLRKYLLNMRPRCL+ VAIGFALDIARAMECLHSHGIIHRDLKPENLL
Sbjct: 98 MVIVTELLSGGTLRKYLLNMRPRCLETRVAIGFALDIARAMECLHSHGIIHRDLKPENLL 157
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
LT D KT+KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD+Y
Sbjct: 158 LTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDAY 217
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE++PEELSIILTSCWKEDPN RP
Sbjct: 218 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEDLPEELSIILTSCWKEDPNTRP 277
Query: 181 NFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKM 240
NF+QII MLLN+L+ IAPPEP IPHRIF SENT LPPESPGTSSLM V D GETPKAKM
Sbjct: 278 NFSQIIHMLLNHLAVIAPPEPAIPHRIFTSENTFLPPESPGTSSLMAVH-DTGETPKAKM 336
Query: 241 GDKPKSLFFCFNLCY 255
++PK LFFCF CY
Sbjct: 337 ENQPKGLFFCFKQCY 351
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440628|ref|XP_004138086.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] gi|449524138|ref|XP_004169080.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 473 bits (1216), Expect = e-131, Method: Compositional matrix adjust.
Identities = 223/255 (87%), Positives = 236/255 (92%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
MVIVTELL GGTLRKYLLNMRPRCLD VA+GFALDIARAMECLHSHGIIHRDLKPENLL
Sbjct: 99 MVIVTELLLGGTLRKYLLNMRPRCLDTRVAVGFALDIARAMECLHSHGIIHRDLKPENLL 158
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
LT D KT+KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD+Y
Sbjct: 159 LTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDAY 218
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN+PEEL+IILTSCW+ED NARP
Sbjct: 219 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENLPEELAIILTSCWQEDANARP 278
Query: 181 NFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKM 240
NF+QIIQMLLNYL I+PPEP+IP RIF SENT+ PPESPGTSSLM VRDD G+TPKAKM
Sbjct: 279 NFSQIIQMLLNYLYTISPPEPVIPSRIFTSENTVFPPESPGTSSLMAVRDDSGDTPKAKM 338
Query: 241 GDKPKSLFFCFNLCY 255
+ P+ FFC N CY
Sbjct: 339 ENNPRGCFFCSNDCY 353
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224140853|ref|XP_002323793.1| predicted protein [Populus trichocarpa] gi|222866795|gb|EEF03926.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1212), Expect = e-130, Method: Compositional matrix adjust.
Identities = 218/255 (85%), Positives = 240/255 (94%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
MVIVTELL GGTLRKYLLNMRPRCLD+ +A+GFALDIARAMECLHSHGIIHRDLKPENL+
Sbjct: 97 MVIVTELLLGGTLRKYLLNMRPRCLDMRLAVGFALDIARAMECLHSHGIIHRDLKPENLI 156
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
LT D KT+KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR GEKKHYNHKVD+Y
Sbjct: 157 LTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRHGEKKHYNHKVDAY 216
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
SFAIVLWEL+HNKLPFEGMSNLQAAYAAAFKNVRPSAEN+PE+L++I+TSCWKEDPNARP
Sbjct: 217 SFAIVLWELIHNKLPFEGMSNLQAAYAAAFKNVRPSAENLPEDLALIVTSCWKEDPNARP 276
Query: 181 NFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKM 240
NF+QIIQMLL+YLS I+ P+P+IP RIF SEN +LPPESPGTSSLM VRDD+GETP+ ++
Sbjct: 277 NFSQIIQMLLHYLSTISAPKPVIPARIFTSENAVLPPESPGTSSLMAVRDDLGETPRTQI 336
Query: 241 GDKPKSLFFCFNLCY 255
DKPKS FFCFN CY
Sbjct: 337 EDKPKSFFFCFNQCY 351
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224055579|ref|XP_002298549.1| predicted protein [Populus trichocarpa] gi|222845807|gb|EEE83354.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 466 bits (1198), Expect = e-129, Method: Compositional matrix adjust.
Identities = 216/255 (84%), Positives = 235/255 (92%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
MVIVTELL GGTLRKYLLNMRPRCL++ VA GFALDIARAMECLHSHGIIHRDLKPENL+
Sbjct: 97 MVIVTELLLGGTLRKYLLNMRPRCLEMRVAFGFALDIARAMECLHSHGIIHRDLKPENLI 156
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
LT D KT+KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR GEKKHYNHKVD+Y
Sbjct: 157 LTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRHGEKKHYNHKVDAY 216
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
SFAIVLWEL+HNKLPFEGMSNLQAAYAAAFKNVRPSAEN+PE+L++I+TSCWKEDPNARP
Sbjct: 217 SFAIVLWELIHNKLPFEGMSNLQAAYAAAFKNVRPSAENLPEDLALIVTSCWKEDPNARP 276
Query: 181 NFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKM 240
NF+QIIQMLL+YLS I+ PEP IP RIF SEN + PPESPGTSSLM VRDD GETP+ ++
Sbjct: 277 NFSQIIQMLLHYLSTISAPEPAIPARIFTSENAVFPPESPGTSSLMAVRDDSGETPRTQI 336
Query: 241 GDKPKSLFFCFNLCY 255
DKP+ FFCFN CY
Sbjct: 337 EDKPRGFFFCFNQCY 351
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516635|ref|XP_003526999.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 465 bits (1196), Expect = e-128, Method: Compositional matrix adjust.
Identities = 219/255 (85%), Positives = 235/255 (92%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
MVIVTELL GGTLRKYL +MRP+CLD VAIGFALDIARAMECLHSHGIIHRDLKP+NLL
Sbjct: 98 MVIVTELLLGGTLRKYLFSMRPKCLDRHVAIGFALDIARAMECLHSHGIIHRDLKPDNLL 157
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
LTED KT+KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD+Y
Sbjct: 158 LTEDQKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDAY 217
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
SFAIVLWELLHNK+PFEGMSNLQAAYAAAFKNVRPSAEN+PEEL++ILTSCW+EDPNARP
Sbjct: 218 SFAIVLWELLHNKVPFEGMSNLQAAYAAAFKNVRPSAENLPEELAVILTSCWQEDPNARP 277
Query: 181 NFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKM 240
NFTQIIQMLLNYL +APPEPMIP RIF+SENT+LPPESPGTSSLM RDD G+TP+AK
Sbjct: 278 NFTQIIQMLLNYLYTVAPPEPMIPSRIFSSENTVLPPESPGTSSLMAKRDDTGDTPRAKD 337
Query: 241 GDKPKSLFFCFNLCY 255
KP CF+ CY
Sbjct: 338 EIKPNGFLCCFSQCY 352
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255560936|ref|XP_002521481.1| protein kinase atn1, putative [Ricinus communis] gi|223539380|gb|EEF40971.1| protein kinase atn1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 462 bits (1190), Expect = e-128, Method: Compositional matrix adjust.
Identities = 217/256 (84%), Positives = 238/256 (92%), Gaps = 1/256 (0%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
MVIVTELL GGTLRKYLLN+RPR L++ VAIGFALDIARAMECLHSHGIIHRDLKPENL+
Sbjct: 98 MVIVTELLLGGTLRKYLLNLRPRSLELHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 157
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
LT D KT+KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR GEKKHYNHKVD+Y
Sbjct: 158 LTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRHGEKKHYNHKVDAY 217
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
SFAIVLWEL+HNKLPFEGMSNLQAAYAAAFKNVRPSA+++PEE+++I+TSCW+EDPNARP
Sbjct: 218 SFAIVLWELIHNKLPFEGMSNLQAAYAAAFKNVRPSADDLPEEMAMIVTSCWQEDPNARP 277
Query: 181 NFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKM 240
NFTQIIQMLL +LS I+PPEP+IP RIF SEN +LPPESPGTSSLM VRDD GETPK+KM
Sbjct: 278 NFTQIIQMLLRFLSTISPPEPVIPARIFTSENAVLPPESPGTSSLMAVRDDSGETPKSKM 337
Query: 241 GD-KPKSLFFCFNLCY 255
D KP+ FFCFN CY
Sbjct: 338 EDNKPRGFFFCFNQCY 353
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363808050|ref|NP_001241956.1| uncharacterized protein LOC100804884 [Glycine max] gi|255636187|gb|ACU18435.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 457 bits (1176), Expect = e-126, Method: Compositional matrix adjust.
Identities = 216/255 (84%), Positives = 232/255 (90%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
MVIVTELL GGTLRKYLL+MRP+CLD VAIG+ALDIARAMECLHSHGIIHRDLKP+NLL
Sbjct: 98 MVIVTELLLGGTLRKYLLSMRPKCLDRHVAIGYALDIARAMECLHSHGIIHRDLKPDNLL 157
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
LTED KT+KL DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD+Y
Sbjct: 158 LTEDQKTVKLVDFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDAY 217
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
SFAIVLWELLHNK+PFEGMSNLQAAYAAAFKNVRPSAEN+PEEL++ILTSCW+ED NARP
Sbjct: 218 SFAIVLWELLHNKVPFEGMSNLQAAYAAAFKNVRPSAENLPEELAVILTSCWQEDSNARP 277
Query: 181 NFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKM 240
NFTQIIQMLLNYL +APPEPM P RIFNSENT+LPPESPGTSSLM RD G+TP+AK
Sbjct: 278 NFTQIIQMLLNYLYTVAPPEPMTPSRIFNSENTVLPPESPGTSSLMAKRDGTGDTPRAKD 337
Query: 241 GDKPKSLFFCFNLCY 255
KP CF+ CY
Sbjct: 338 EIKPNGFLCCFSQCY 352
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452312|ref|XP_002272486.1| PREDICTED: serine/threonine-protein kinase HT1 [Vitis vinifera] gi|296087594|emb|CBI34850.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 455 bits (1171), Expect = e-126, Method: Compositional matrix adjust.
Identities = 212/255 (83%), Positives = 232/255 (90%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
MVIVTELL GGTLRKYLLN+RPRCLD VA+GFALDIARAMECLHSHGIIHRDLKPENL+
Sbjct: 98 MVIVTELLLGGTLRKYLLNLRPRCLDTKVAVGFALDIARAMECLHSHGIIHRDLKPENLI 157
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
LT D KT+KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR GEKKHYNHKVD+Y
Sbjct: 158 LTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRHGEKKHYNHKVDAY 217
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
SFAIVLWEL+HNKLPFEGMSNLQAAYAAAFKN+RPSAE++PE+L++I+TSCWKEDPN RP
Sbjct: 218 SFAIVLWELVHNKLPFEGMSNLQAAYAAAFKNMRPSAEDLPEDLALIVTSCWKEDPNTRP 277
Query: 181 NFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKM 240
NF+QIIQMLL+YLS I+PPEPM+P R+F SEN +LPPESPGTSSLM VRD GETPK M
Sbjct: 278 NFSQIIQMLLHYLSTISPPEPMVPPRVFTSENAVLPPESPGTSSLMAVRDGSGETPKTSM 337
Query: 241 GDKPKSLFFCFNLCY 255
P+ F CFN CY
Sbjct: 338 ETNPRGCFSCFNHCY 352
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357461809|ref|XP_003601186.1| Serine/threonine protein kinase TNNI3K [Medicago truncatula] gi|355490234|gb|AES71437.1| Serine/threonine protein kinase TNNI3K [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 450 bits (1158), Expect = e-124, Method: Compositional matrix adjust.
Identities = 211/255 (82%), Positives = 230/255 (90%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
MVIVTELLSGGTLRKYLLNMRP+CLD VAIGFALDI+RAMECLHSHGIIHRDLKP+NLL
Sbjct: 98 MVIVTELLSGGTLRKYLLNMRPKCLDTHVAIGFALDISRAMECLHSHGIIHRDLKPDNLL 157
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
LTED T+KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD+Y
Sbjct: 158 LTEDHGTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDAY 217
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
SFAIV WELLHNK+PFEGMSNLQAAYAAAFKNVRP+A+++PEEL++ILTSCW+ED NARP
Sbjct: 218 SFAIVFWELLHNKVPFEGMSNLQAAYAAAFKNVRPNADHLPEELAVILTSCWQEDANARP 277
Query: 181 NFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKM 240
NFTQIIQMLLNYL ++PP P IP RIF SENT+LPPESPGTSSLM RDD G+TP+ K
Sbjct: 278 NFTQIIQMLLNYLYTVSPPTPAIPSRIFTSENTLLPPESPGTSSLMAKRDDTGDTPRVKD 337
Query: 241 GDKPKSLFFCFNLCY 255
KP CF+ CY
Sbjct: 338 EIKPNGFLCCFSQCY 352
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 255 | ||||||
| TAIR|locus:2157717 | 346 | AT5G50180 [Arabidopsis thalian | 1.0 | 0.736 | 0.827 | 2.2e-112 | |
| TAIR|locus:2168778 | 353 | AT5G40540 [Arabidopsis thalian | 0.984 | 0.711 | 0.755 | 5.6e-100 | |
| TAIR|locus:2091423 | 356 | ATN1 [Arabidopsis thaliana (ta | 0.976 | 0.699 | 0.749 | 2.8e-98 | |
| TAIR|locus:2180992 | 333 | AT5G01850 [Arabidopsis thalian | 0.831 | 0.636 | 0.686 | 2.1e-75 | |
| TAIR|locus:2173674 | 405 | AT5G66710 [Arabidopsis thalian | 0.933 | 0.587 | 0.546 | 4.3e-61 | |
| TAIR|locus:2101689 | 377 | AT3G50720 [Arabidopsis thalian | 0.717 | 0.485 | 0.545 | 2.5e-49 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.694 | 0.430 | 0.476 | 1.6e-40 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.694 | 0.429 | 0.470 | 2.3e-39 | |
| TAIR|locus:2154573 | 525 | AT5G58950 [Arabidopsis thalian | 0.698 | 0.339 | 0.425 | 1.1e-37 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.741 | 0.331 | 0.415 | 7.5e-36 |
| TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1109 (395.4 bits), Expect = 2.2e-112, P = 2.2e-112
Identities = 211/255 (82%), Positives = 225/255 (88%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
MVIVTELL GGTLRKYLLN+RP CL+ VAIGFALDIAR MECLHSHGIIHRDLKPENLL
Sbjct: 92 MVIVTELLQGGTLRKYLLNLRPACLETRVAIGFALDIARGMECLHSHGIIHRDLKPENLL 151
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
LT D KT+KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR GEKKHYNHKVD+Y
Sbjct: 152 LTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRLGEKKHYNHKVDAY 211
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE++PEEL I+TSCW EDPNARP
Sbjct: 212 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAESLPEELGDIVTSCWNEDPNARP 271
Query: 181 NFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKM 240
NFT II++LLNYLS + P IP RI S+NT+LPP+SPGTSSLM D+ GETPKAK
Sbjct: 272 NFTHIIELLLNYLSKVGSPISAIPQRILASKNTLLPPDSPGTSSLMAKLDECGETPKAKS 331
Query: 241 GDKPKSLFFCFNLCY 255
DK K LFFCFN CY
Sbjct: 332 EDKRKGLFFCFNQCY 346
|
|
| TAIR|locus:2168778 AT5G40540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 992 (354.3 bits), Expect = 5.6e-100, P = 5.6e-100
Identities = 192/254 (75%), Positives = 221/254 (87%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
MVIVTELL GGTLRKYL+++RP LD+ VA+G+ALDIARAMECLHSHG+IHRDLKPE+L+
Sbjct: 98 MVIVTELLLGGTLRKYLVSLRPGSLDIRVAVGYALDIARAMECLHSHGVIHRDLKPESLI 157
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
LT D KT+KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR GEKKHYNHKVD+Y
Sbjct: 158 LTADYKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRHGEKKHYNHKVDAY 217
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
SFAIVLWEL+HNKLPFEGMSNLQAAYAAAFKNVRPSA+++P++L++I+TSCWKEDPN RP
Sbjct: 218 SFAIVLWELIHNKLPFEGMSNLQAAYAAAFKNVRPSADDLPKDLAMIVTSCWKEDPNDRP 277
Query: 181 NFTQIIQMLLNYLSAIAPPEPMIP--HRIFNSENTILPPESPGTSSLMTVRD-DIGETPK 237
NFT+IIQMLL LS I+ E + P R+F+SENT+LPPESPGT SLMTVRD D T
Sbjct: 278 NFTEIIQMLLRCLSTISSTELVPPAIKRVFSSENTVLPPESPGTCSLMTVRDKDQIPTDA 337
Query: 238 AKMGDKPKSLFFCF 251
++ + FF F
Sbjct: 338 NSAQNEVRGSFFFF 351
|
|
| TAIR|locus:2091423 ATN1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 976 (348.6 bits), Expect = 2.8e-98, P = 2.8e-98
Identities = 191/255 (74%), Positives = 222/255 (87%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
MVIVTELL GGTLRKYL+++RP+ LD+ +A+GFALDIARAMECLHSHGIIHRDLKPENL+
Sbjct: 98 MVIVTELLLGGTLRKYLVSLRPKRLDIRLAVGFALDIARAMECLHSHGIIHRDLKPENLI 157
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
L+ D KT+KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD+Y
Sbjct: 158 LSADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDAY 217
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
SFAIVLWEL+ NKLPFEGMSNLQAAYAAAFKN+RPSAE++P +L +I+TSCWKEDPN RP
Sbjct: 218 SFAIVLWELILNKLPFEGMSNLQAAYAAAFKNLRPSAEDLPGDLEMIVTSCWKEDPNERP 277
Query: 181 NFTQIIQMLLNYLSAIAPPEPMIP--HRIFNSENTILPPESPGTSSLMTVRD-DIG-ETP 236
NFT+IIQMLL YL+ ++ P+ + P R+F+SEN +L PESPGT SLM+VRD D+ +T
Sbjct: 278 NFTEIIQMLLRYLTTVSAPQIIPPPNRRVFSSENIVLSPESPGTCSLMSVRDGDVSRQTV 337
Query: 237 K-AKMGDKP-KSLFF 249
A +K K FF
Sbjct: 338 NTADSSEKQTKGSFF 352
|
|
| TAIR|locus:2180992 AT5G01850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 760 (272.6 bits), Expect = 2.1e-75, P = 2.1e-75
Identities = 147/214 (68%), Positives = 175/214 (81%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
MVIVTELL G +LRKYL ++RP+ L + +A+ FALDIARA+ CLH++GIIHRDLKP+NLL
Sbjct: 90 MVIVTELLPGMSLRKYLTSIRPQLLHLPLALSFALDIARALHCLHANGIIHRDLKPDNLL 149
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
LTE+ K++KLADFGLAREES+TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN+KVD Y
Sbjct: 150 LTENHKSVKLADFGLAREESVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 209
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-SAENVPEELSIILTSCWKEDPNAR 179
SF IVLWELL N++PFEGMSNLQAAYAAAFK RP E + L+ I+ SCW EDPN R
Sbjct: 210 SFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPVMPEGISPSLAFIVQSCWVEDPNMR 269
Query: 180 PNFTQIIQMLLNYLSAIAPPEPM-IPHRIFNSEN 212
P+F+QII++L +L + PP P +P N N
Sbjct: 270 PSFSQIIRLLNEFLLTLTPPPPQPLPETATNRTN 303
|
|
| TAIR|locus:2173674 AT5G66710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 625 (225.1 bits), Expect = 4.3e-61, P = 4.3e-61
Identities = 135/247 (54%), Positives = 173/247 (70%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
++I+TEL+ G TL+K++L++RP+ LD+ ++I FALDIAR ME L+++GIIHRDLKP N+L
Sbjct: 144 LMIITELMEGNTLQKFMLSVRPKPLDLKLSISFALDIARGMEFLNANGIIHRDLKPSNML 203
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
LT D K +KLADFGLAREE+ MT E GTYRWMAPEL+S TL GEKKHY+HKVD Y
Sbjct: 204 LTGDQKHVKLADFGLAREET-KGFMTFEAGTYRWMAPELFSYDTLEIGEKKHYDHKVDVY 262
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
SFAIV WELL NK PF+G +N+ AYAA+ KN RPS EN+PE + IL SCW E+P+ARP
Sbjct: 263 SFAIVFWELLTNKTPFKGKNNIFVAYAAS-KNQRPSVENLPEGVVSILQSCWAENPDARP 321
Query: 181 NFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKM 240
F +I L N L +++ NS+ I +S TSSL+ R + + P KM
Sbjct: 322 EFKEITYSLTNLLRSLSSDTDATSS---NSKANIATEDS--TSSLVQERV-VCDCPGLKM 375
Query: 241 GDKPKSL 247
K K L
Sbjct: 376 S-KTKKL 381
|
|
| TAIR|locus:2101689 AT3G50720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 514 (186.0 bits), Expect = 2.5e-49, P = 2.5e-49
Identities = 101/185 (54%), Positives = 130/185 (70%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
++IVTEL+ GGTL++++LN RP LD+ V++ FALDI+RAME LHS GIIHRDL P N+L
Sbjct: 121 LMIVTELVRGGTLQRFMLNSRPSPLDLKVSLSFALDISRAMEYLHSKGIIHRDLNPRNVL 180
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
+T D+K +KLADFGLARE++L M T E GTYRWMAPE+ S LR GEKKHY+ K+D Y
Sbjct: 181 VTGDMKHVKLADFGLAREKTLGGM-TCEAGTYRWMAPEVCSREPLRIGEKKHYDQKIDVY 239
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
SFA++ W LL NK PF + ++ Y + RPS N+P+E+ IL CW D R
Sbjct: 240 SFALIFWSLLTNKTPFSEIPSISIPYFVN-QGKRPSLSNIPDEVVPILECCWAADSKTRL 298
Query: 181 NFTQI 185
F I
Sbjct: 299 EFKDI 303
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 431 (156.8 bits), Expect = 1.6e-40, P = 1.6e-40
Identities = 90/189 (47%), Positives = 125/189 (66%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IVTE GG++R++L + R + + +A+ ALD+AR M +H IHRDLK +NLL++
Sbjct: 206 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGRNFIHRDLKSDNLLIS 265
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 122
D K+IK+ADFG+AR E TE MT ETGTYRWMAPE+ + + YN KVD YSF
Sbjct: 266 AD-KSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMI--------QHRAYNQKVDVYSF 316
Query: 123 AIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN--VPEELSIILTSCWKEDPNARP 180
IVLWEL+ LPF+ M+ +QAA+A + VRP+ N +P LS I+T CW +P RP
Sbjct: 317 GIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPNDCLPV-LSDIMTRCWDANPEVRP 375
Query: 181 NFTQIIQML 189
F +++++L
Sbjct: 376 CFVEVVKLL 384
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 420 (152.9 bits), Expect = 2.3e-39, P = 2.3e-39
Identities = 89/189 (47%), Positives = 123/189 (65%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IVTE GG++R++L + R + + +A+ ALD+AR M +H IHRDLK +NLL++
Sbjct: 207 IVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQALDVARGMAYVHERNFIHRDLKSDNLLIS 266
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 122
D ++IK+ADFG+AR E TE MT ETGTYRWMAPE+ + + Y KVD YSF
Sbjct: 267 AD-RSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMI--------QHRPYTQKVDVYSF 317
Query: 123 AIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--AENVPEELSIILTSCWKEDPNARP 180
IVLWEL+ LPF+ M+ +QAA+A + VRP+ A+ +P L I+T CW DP RP
Sbjct: 318 GIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPADCLPV-LGEIMTRCWDADPEVRP 376
Query: 181 NFTQIIQML 189
F +I+ +L
Sbjct: 377 CFAEIVNLL 385
|
|
| TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 404 (147.3 bits), Expect = 1.1e-37, P = 1.1e-37
Identities = 80/188 (42%), Positives = 119/188 (63%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
++T+ L G+LR +L R L + I FA+DIAR ME +HS IIHRDLKPEN+L+
Sbjct: 285 VLTQYLPEGSLRSFLHKPENRSLPLKKLIEFAIDIARGMEYIHSRRIIHRDLKPENVLID 344
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 122
E+ +K+ADFG+A EE +M+ + GTYRWMAPE+ ++K + K D YSF
Sbjct: 345 EEFH-LKIADFGIACEEEYCDMLADDPGTYRWMAPEMI--------KRKPHGRKADVYSF 395
Query: 123 AIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE-NVPEELSIILTSCWKEDPNARPN 181
+VLWE++ +P+E M+ +QAA+A KN+RP+ + P + ++ CW P+ RP
Sbjct: 396 GLVLWEMVAGAIPYEDMNPIQAAFAVVHKNIRPAIPGDCPVAMKALIEQCWSVAPDKRPE 455
Query: 182 FTQIIQML 189
F QI+++L
Sbjct: 456 FWQIVKVL 463
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 388 (141.6 bits), Expect = 7.5e-36, P = 7.5e-36
Identities = 84/202 (41%), Positives = 125/202 (61%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ IVTE ++ G++ +L + + + ALD+++ M LH + IIHRDLK NLL
Sbjct: 362 LCIVTEFMTRGSIYDFL-HKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLL 420
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
+ E + +K+ADFG+AR ++ + +MTAETGTYRWMAPE+ E K Y+H+ D +
Sbjct: 421 MDEH-EVVKVADFGVARVQTESGVMTAETGTYRWMAPEVI--------EHKPYDHRADVF 471
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA--ENVPEELSIILTSCWKEDPNA 178
S+AIVLWELL +LP+ ++ LQAA K +RP E P+ L+ +L CW++DP
Sbjct: 472 SYAIVLWELLTGELPYSYLTPLQAAVGVVQKGLRPKIPKETHPK-LTELLEKCWQQDPAL 530
Query: 179 RPNFTQIIQMLLNYLSAIAPPE 200
RPNF +II+ML + + E
Sbjct: 531 RPNFAEIIEMLNQLIREVGDDE 552
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 255 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-54 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-53 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-49 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-49 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-31 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-27 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-27 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-26 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-26 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-24 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-24 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-24 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-24 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-23 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-23 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-23 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-23 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-22 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-22 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-22 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-21 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-21 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-20 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-20 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-19 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-19 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-19 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-18 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-18 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-18 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-17 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-17 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-16 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-16 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-15 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-09 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 1e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-07 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 3e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 8e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-06 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 3e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-05 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 6e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.003 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.003 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 5e-54
Identities = 70/192 (36%), Positives = 105/192 (54%), Gaps = 12/192 (6%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
++IV E + GG L YL RP+ L + + FAL IAR ME L S IHRDL N L
Sbjct: 76 LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCL 135
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETG--TYRWMAPELYSTVTLRQGEKKHYNHKVD 118
+ E+ +K++DFGL+R+ + + G RWMAPE +L++G+ + K D
Sbjct: 136 VGEN-LVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPE-----SLKEGK---FTSKSD 186
Query: 119 SYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPN 177
+SF ++LWE+ + P+ GMSN + P N P EL ++ CW EDP
Sbjct: 187 VWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPE 246
Query: 178 ARPNFTQIIQML 189
RP F++++++L
Sbjct: 247 DRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 1e-53
Identities = 69/194 (35%), Positives = 104/194 (53%), Gaps = 17/194 (8%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVA--IGFALDIARAMECLHSHGIIHRDLKPEN 58
+ IV E + GG L YL RP+ + ++ + FAL IAR ME L S IHRDL N
Sbjct: 76 LYIVMEYMEGGDLLSYLRKNRPK---LSLSDLLSFALQIARGMEYLESKNFIHRDLAARN 132
Query: 59 LLLTEDLKTIKLADFGLAREESLTEMMTAETG--TYRWMAPELYSTVTLRQGEKKHYNHK 116
L+ E+ +K++DFGL+R+ + G RWMAPE +L++G+ + K
Sbjct: 133 CLVGEN-LVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE-----SLKEGK---FTSK 183
Query: 117 VDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKED 175
D +SF ++LWE+ + P+ GMSN + P N P EL ++ CW ED
Sbjct: 184 SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAED 243
Query: 176 PNARPNFTQIIQML 189
P RP F++++++L
Sbjct: 244 PEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 3e-49
Identities = 66/189 (34%), Positives = 88/189 (46%), Gaps = 14/189 (7%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E GG L L L A + I A+E LHS GI+HRDLKPEN+LL
Sbjct: 74 LVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLD 131
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 122
ED +KLADFGLAR+ E +T GT +MAPE+ K Y VD +S
Sbjct: 132 ED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL--------GKGYGKAVDIWSL 182
Query: 123 AIVLWELLHNKLPFEGMSNLQAAYAAAFK---NVRPSAENVPEELSIILTSCWKEDPNAR 179
++L+ELL K PF G L + K P ++ E ++ +DP R
Sbjct: 183 GVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKR 242
Query: 180 PNFTQIIQM 188
+ +Q
Sbjct: 243 LTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 5e-49
Identities = 66/192 (34%), Positives = 99/192 (51%), Gaps = 16/192 (8%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IVTE + GG L +L L + + AL IA+ ME L S +HRDL N L+T
Sbjct: 78 IVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVT 136
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNHKVDS 119
E+L +K++DFGL+R+ + G +WMAPE L+ G+ + K D
Sbjct: 137 ENL-VVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPES-----LKDGK---FTSKSDV 187
Query: 120 YSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSIILTSCWKEDPN 177
+SF ++LWE+ + P+ GMSN + R EN P+EL ++ CW DP
Sbjct: 188 WSFGVLLWEIFTLGEQPYPGMSNEEV-LELLEDGYRLPRPENCPDELYELMLQCWAYDPE 246
Query: 178 ARPNFTQIIQML 189
RP F+++++ L
Sbjct: 247 DRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 5e-47
Identities = 67/200 (33%), Positives = 104/200 (52%), Gaps = 24/200 (12%)
Query: 3 IVTELLSGGTLRKYLLNMRP-------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLK 55
+V E + GG L YL RP L + + FA+ IA+ ME L S +HRDL
Sbjct: 73 LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLA 132
Query: 56 PENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTVTLRQGEKKH 112
N L+ ED +K++DFGL+R+ + +TG RWMAPE +L+ G
Sbjct: 133 ARNCLVGED-LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE-----SLKDG---I 183
Query: 113 YNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQ--AAYAAAFKNVRPSAENVPEELSIILT 169
+ K D +SF ++LWE+ P+ G+SN + ++ +P E P+EL ++
Sbjct: 184 FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKP--EYCPDELYELML 241
Query: 170 SCWKEDPNARPNFTQIIQML 189
SCW+ DP RP F+++++ L
Sbjct: 242 SCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 4e-43
Identities = 73/195 (37%), Positives = 101/195 (51%), Gaps = 19/195 (9%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V E GG L YL R L A AL I R +E LHS+GIIHRDLKPEN+L
Sbjct: 73 LYLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENIL 130
Query: 61 LTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
L E+ +K+ADFGLA++ + +T GT +MAPE+ L G Y KVD
Sbjct: 131 LDENG-VVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEV-----LLGG--NGYGPKVDV 182
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE-------NVPEELSIILTSCW 172
+S ++L+ELL K PF G N+ + + P E + EE ++ C
Sbjct: 183 WSLGVILYELLTGKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCL 241
Query: 173 KEDPNARPNFTQIIQ 187
+DP+ RP +I+Q
Sbjct: 242 NKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-42
Identities = 57/190 (30%), Positives = 86/190 (45%), Gaps = 41/190 (21%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V E GG+L+ L L + L I +E LHS+GIIHRDLKPEN+L
Sbjct: 66 LYLVMEYCEGGSLKDLLKE-NEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENIL 124
Query: 61 LTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
L D +KLADFGL++ S ++ GT +MAPE+ K +Y+ K D
Sbjct: 125 LDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLL-------GKGYYSEKSDI 177
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 179
+S ++L+EL EL ++ ++DP R
Sbjct: 178 WSLGVILYEL--------------------------------PELKDLIRKMLQKDPEKR 205
Query: 180 PNFTQIIQML 189
P+ +I++ L
Sbjct: 206 PSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-31
Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 16/190 (8%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I E +SGG+L LL + L V + I + LHS+GI+HRD+K N+L+
Sbjct: 78 IFLEYVSGGSLSS-LLKKFGK-LPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD 135
Query: 63 EDLKTIKLADFGLAREESLTEMMTAET---GTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
D +KLADFG A+ E GT WMAPE+ +R E Y D
Sbjct: 136 SD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV-----IRGEE---YGRAADI 186
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAA-YAAAFKNVRPS-AENVPEELSIILTSCWKEDPN 177
+S + E+ K P+ + N AA Y P E++ EE L C + DP
Sbjct: 187 WSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPK 246
Query: 178 ARPNFTQIIQ 187
RP +++Q
Sbjct: 247 KRPTADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-31
Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 2 VIVTELLSGGTLRKYLLNMRPRCLDVCV--------AIGFALDIARAMECLHSHGIIHRD 53
++V EL++ G L+ YL + RP + I A +IA M L + +HRD
Sbjct: 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRD 144
Query: 54 LKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTVTLRQGEK 110
L N ++ EDL T+K+ DFG+ R+ T+ RWMAPE +L+ G
Sbjct: 145 LAARNCMVAEDL-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE-----SLKDG-- 196
Query: 111 KHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILT 169
+ K D +SF +VLWE+ + P++G+SN + EN P++L ++
Sbjct: 197 -VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMR 255
Query: 170 SCWKEDPNARPNFTQIIQMLLN 191
CW+ +P RP F +I+ L +
Sbjct: 256 MCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-30
Identities = 62/195 (31%), Positives = 93/195 (47%), Gaps = 24/195 (12%)
Query: 3 IVTELLSGGTLRKYLLNMRPRC--------LDVCVAIGFALDIARAMECLHSHGIIHRDL 54
IV E GG L + + + LD V + AL LHS I+HRD+
Sbjct: 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK------YLHSRKILHRDI 129
Query: 55 KPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 113
KP+N+ LT + +KL DFG+++ S ++ GT +++PEL + K Y
Sbjct: 130 KPQNIFLTSN-GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC--------QNKPY 180
Query: 114 NHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWK 173
N+K D +S VL+EL K PFEG + L+ A P EL +++S +
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQ 240
Query: 174 EDPNARPNFTQIIQM 188
+DP RP+ QI+Q
Sbjct: 241 KDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-30
Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 29/199 (14%)
Query: 3 IVTELLSGGTLRKYLLNMRPR-----CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 57
IVTE ++ G L YL + + LD+C D+ AME L S+G IHRDL
Sbjct: 76 IVTEYMANGCLLNYLRERKGKLGTEWLLDMC------SDVCEAMEYLESNGFIHRDLAAR 129
Query: 58 NLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYN 114
N L+ ED +K++DFGLAR L + T+ GT +W PE++ ++
Sbjct: 130 NCLVGED-NVVKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFD--------YSRFS 179
Query: 115 HKVDSYSFAIVLWELL-HNKLPFEGMSNLQAA--YAAAFKNVRPSAENVPEELSIILTSC 171
K D +SF +++WE+ K+P+E SN + +A ++ RP P E+ I+ SC
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKL--APTEVYTIMYSC 237
Query: 172 WKEDPNARPNFTQIIQMLL 190
W E P RP F +++ L
Sbjct: 238 WHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-30
Identities = 61/183 (33%), Positives = 92/183 (50%), Gaps = 13/183 (7%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I+TEL+ G+L +L + + L V I A +A M L IHRDL N+L+
Sbjct: 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG 138
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGT-YRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
EDL K+ADFGLAR ++++ Y+W APE S ++ K D +S
Sbjct: 139 EDL-VCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAAS--------HGTFSTKSDVWS 189
Query: 122 FAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNAR 179
F I+L+E+ + ++P+ GM+N Y R P P+E+ I+ CW +P R
Sbjct: 190 FGILLYEMFTYGQVPYPGMNN-HEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDR 248
Query: 180 PNF 182
P+F
Sbjct: 249 PSF 251
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 7e-30
Identities = 66/188 (35%), Positives = 97/188 (51%), Gaps = 18/188 (9%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ IVTEL+ G+L +YL R L + I A +A M L + IHRDL N+L
Sbjct: 76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVL 135
Query: 61 LTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPE--LYSTVTLRQGEKKHYNHK 116
+ E+ K+ADFGLAR +E + E +W APE LY+ ++ K
Sbjct: 136 VGENN-ICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSI----------K 184
Query: 117 VDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKE 174
D +SF I+L E++ + ++P+ GM+N + + R P P+EL I+ CWKE
Sbjct: 185 SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKELYDIMLDCWKE 243
Query: 175 DPNARPNF 182
DP+ RP F
Sbjct: 244 DPDDRPTF 251
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-28
Identities = 68/194 (35%), Positives = 102/194 (52%), Gaps = 24/194 (12%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVA---IGFALDIARAMECLHSHGIIHRDLKPENL 59
IVTE ++ G+L YL R R V +GFALD+ ME L +HRDL N+
Sbjct: 77 IVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNV 133
Query: 60 LLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPELYSTVTLRQGEKKHYNHKV 117
L++EDL K++DFGLA+E S + ++G +W APE LR +K ++ K
Sbjct: 134 LVSEDL-VAKVSDFGLAKEASQGQ----DSGKLPVKWTAPE-----ALR---EKKFSTKS 180
Query: 118 DSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKED 175
D +SF I+LWE+ ++P+ + L+ K R + E P E+ ++ CW+ D
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIP-LKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELD 239
Query: 176 PNARPNFTQIIQML 189
P RP F Q+ + L
Sbjct: 240 PAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 5e-28
Identities = 63/179 (35%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
V E GG L +L + A +A +I A+E LHS GII+RDLKPEN+LL
Sbjct: 71 VLEYAPGGELFSHL--SKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDA 128
Query: 64 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
D IKL DFGLA+E S +E T GT ++APE V L +G Y VD +S
Sbjct: 129 D-GHIKLTDFGLAKELS-SEGSRTNTFCGTPEYLAPE----VLLGKG----YGKAVDWWS 178
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSIILTSCWKEDPNAR 179
++L+E+L K PF + + Y E + E +++ ++DP R
Sbjct: 179 LGVLLYEMLTGKPPFYA-EDRKEIY-EKILKDPLRFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 7e-28
Identities = 67/192 (34%), Positives = 95/192 (49%), Gaps = 16/192 (8%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IV EL+ GG+L +L + R L V + +LD A ME L S IHRDL N L+
Sbjct: 69 IVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG 127
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGT----YRWMAPELYSTVTLRQGEKKHYNHKVD 118
E+ +K++DFG++REE + T G +W APE L G Y + D
Sbjct: 128 EN-NVLKISDFGMSREEE-GGIYTVSDGLKQIPIKWTAPE-----ALNYGR---YTSESD 177
Query: 119 SYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPN 177
+S+ I+LWE P+ GMSN Q P+ + PEE+ ++ CW DP
Sbjct: 178 VWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPE 237
Query: 178 ARPNFTQIIQML 189
RP+F++I L
Sbjct: 238 NRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-28
Identities = 67/188 (35%), Positives = 95/188 (50%), Gaps = 22/188 (11%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IVTE +S G+L +L + + L + + A IA M L S IHRDL N+L+
Sbjct: 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG 137
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNHKV 117
E+L K+ADFGLAR E TA G +W APE Y T+ K
Sbjct: 138 ENL-VCKIADFGLARLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTI----------KS 185
Query: 118 DSYSFAIVLWELL-HNKLPFEGMSNLQ--AAYAAAFKNVRPSAENVPEELSIILTSCWKE 174
D +SF I+L E++ + ++P+ GM+N + ++ RP N PEEL ++ CW +
Sbjct: 186 DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPP--NCPEELYDLMLQCWDK 243
Query: 175 DPNARPNF 182
DP RP F
Sbjct: 244 DPEERPTF 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-27
Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 28/204 (13%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
++I+TE + G+L K+L + V +G IA M+ L +HRDL N+L
Sbjct: 80 VMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNIL 138
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTY---------RWMAPELYSTVTLRQGEKK 111
+ +L K++DFGL+R +E TY RW APE + R
Sbjct: 139 VNSNL-VCKVSDFGLSRRLEDSE------ATYTTKGGKIPIRWTAPE---AIAYR----- 183
Query: 112 HYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILT 169
+ D +SF IV+WE++ + + P+ MSN Q A R P + P L ++
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDGYRLPPPMDCPSALYQLML 242
Query: 170 SCWKEDPNARPNFTQIIQMLLNYL 193
CW++D N RP F+QI+ L +
Sbjct: 243 DCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-27
Identities = 69/195 (35%), Positives = 97/195 (49%), Gaps = 20/195 (10%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IV EL+ GG +L PR L V I + A ME L S IHRDL N L+T
Sbjct: 70 IVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT 128
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTYR-----WMAPELYSTVTLRQGEKKHYNHKV 117
E +K++DFG++REE + + A TG + W APE L G Y+ +
Sbjct: 129 EK-NVLKISDFGMSREEE--DGVYASTGGMKQIPVKWTAPE-----ALNYGR---YSSES 177
Query: 118 DSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKED 175
D +SF I+LWE +P+ +SN Q A + VR P E P+ + ++ CW+ D
Sbjct: 178 DVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWEYD 236
Query: 176 PNARPNFTQIIQMLL 190
P RP+F+ + Q L
Sbjct: 237 PGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-27
Identities = 68/212 (32%), Positives = 98/212 (46%), Gaps = 41/212 (19%)
Query: 3 IVTELLSGGTLRKYLLNMRPR----CLDVCVAIG----------FALDIARAMECLHSHG 48
+V E + G LR +L RP D FA +AR ME L S
Sbjct: 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK 152
Query: 49 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG---TYRWMAPE-LYSTVT 104
IHRDL N+L+TED +K+ADFGLAR+ + T +WMAPE L+ V
Sbjct: 153 CIHRDLAARNVLVTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV- 210
Query: 105 LRQGEKKHYNHKVDSYSFAIVLWELL------HNKLPFEGM-SNLQAAYAAAFKNVRPSA 157
Y H+ D +SF ++LWE+ + +P E + L+ Y + +P
Sbjct: 211 --------YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGY----RMEKPQ- 257
Query: 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 189
N +EL ++ CW E P+ RP F Q+++ L
Sbjct: 258 -NCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-26
Identities = 64/189 (33%), Positives = 98/189 (51%), Gaps = 16/189 (8%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-ALDIARAMECLHSHGIIHRDLKPENLLL 61
IV E SGG+L+ LL + L I + ++ + +E LHS+GIIHRD+K N+LL
Sbjct: 74 IVMEFCSGGSLKD-LLKSTNQTLTES-QIAYVCKELLKGLEYLHSNGIIHRDIKAANILL 131
Query: 62 TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
T D + +KL DFGL+ + S T+ GT WMAPE+ + K Y++K D +S
Sbjct: 132 TSDGE-VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN--------GKPYDYKADIWS 182
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---SAENVPEELSIILTSCWKEDPNA 178
I EL K P+ + ++A + A N P + E +E L C +++P
Sbjct: 183 LGITAIELAEGKPPYSELPPMKALFKIA-TNGPPGLRNPEKWSDEFKDFLKKCLQKNPEK 241
Query: 179 RPNFTQIIQ 187
RP Q+++
Sbjct: 242 RPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-26
Identities = 52/181 (28%), Positives = 82/181 (45%), Gaps = 13/181 (7%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
M +V +LL GG LR +L + +I A+E LHS GIIHRD+KP+N+L
Sbjct: 75 MYLVVDLLLGGDLRYHLSQKVK--FSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNIL 132
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
L E + + DF +A + + + T+ +GT +MAPE+ + Y+ VD +
Sbjct: 133 LDEQ-GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR--------QGYSVAVDWW 183
Query: 121 SFAIVLWELLHNKLPFEGMSN-LQAAYAAAFK-NVRPSAENVPEELSIILTSCWKEDPNA 178
S + +E L K P+ G S ++ A + E + + DP
Sbjct: 184 SLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQK 243
Query: 179 R 179
R
Sbjct: 244 R 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 105 bits (261), Expect = 3e-26
Identities = 60/200 (30%), Positives = 87/200 (43%), Gaps = 19/200 (9%)
Query: 1 MVIVTELLSGGTLRKYL-LNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 59
+ +V E + GG+L L R L A+ I A+E LHS GIIHRD+KPEN+
Sbjct: 73 LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENI 132
Query: 60 LLTEDLKTIKLADFGLARE-------ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 112
LL D + +KL DFGLA+ S+ + + GT +MAPE+ L +
Sbjct: 133 LLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV-----LLGLSLAY 187
Query: 113 YNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCW 172
+ D +S I L+ELL PFEG N A + ++ LS
Sbjct: 188 ASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS------P 241
Query: 173 KEDPNARPNFTQIIQMLLNY 192
+ +++ LL
Sbjct: 242 SNPELISKAASDLLKKLLAK 261
|
Length = 384 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-26
Identities = 64/195 (32%), Positives = 99/195 (50%), Gaps = 16/195 (8%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I+TE ++ G+L +L + + + I F+ IA M + IHRDL+ N+L++
Sbjct: 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS 137
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPEL--YSTVTLRQGEKKHYNHKVD 118
E L K+ADFGLAR E E + +W APE + + T+ K D
Sbjct: 138 ESL-MCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI----------KSD 186
Query: 119 SYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPN 177
+SF I+L+E++ + K+P+ GMSN A P EN P+EL I+ +CWKE
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAE 246
Query: 178 ARPNFTQIIQMLLNY 192
RP F + +L ++
Sbjct: 247 ERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-24
Identities = 64/194 (32%), Positives = 95/194 (48%), Gaps = 17/194 (8%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I+TE + G+L +L L + I A IA M + IHRDL+ N+L++
Sbjct: 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS 136
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPEL--YSTVTLRQGEKKHYNHKVD 118
E L K+ADFGLAR E E + +W APE Y T T+ K D
Sbjct: 137 ETL-CCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI----------KSD 185
Query: 119 SYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPN 177
+SF I+L E++ + ++P+ GM+N + P +N PEEL ++ CWKE P
Sbjct: 186 VWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPE 245
Query: 178 ARPNFTQIIQMLLN 191
RP F + ++ +L
Sbjct: 246 ERPTF-EYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-24
Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 34/201 (16%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ IVTE ++ G+L YL + L + F+LD+ AME L ++ +HRDL N+L
Sbjct: 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVL 134
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPELYSTVTLRQGEKKHYNHKVD 118
++ED K++DFGL +E S T+ +TG +W APE LR+ K ++ K D
Sbjct: 135 VSED-NVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPE-----ALRE---KKFSTKSD 181
Query: 119 SYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAEN---------VPEELSIIL 168
+SF I+LWE+ ++P+ + K+V P E P + ++
Sbjct: 182 VWSFGILLWEIYSFGRVPYPRI---------PLKDVVPRVEKGYKMDAPDGCPPVVYDVM 232
Query: 169 TSCWKEDPNARPNFTQIIQML 189
CW D RP+F Q+ + L
Sbjct: 233 KQCWHLDAATRPSFLQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 2e-24
Identities = 56/190 (29%), Positives = 94/190 (49%), Gaps = 17/190 (8%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E + GG+L ++ ++ ++ + +E LHS +IHRD+K +N+LL+
Sbjct: 92 VVMEYMDGGSL-TDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS 150
Query: 63 EDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
+D ++KLADFG A + LT+ + GT WMAPE+ +K Y KVD
Sbjct: 151 KD-GSVKLADFGFAAQ--LTKEKSKRNSVVGTPYWMAPEVIK--------RKDYGPKVDI 199
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--SAENVPEELSIILTSCWKEDPN 177
+S I+ E+ + P+ L+A + K + P + E E L C +DP
Sbjct: 200 WSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPE 259
Query: 178 ARPNFTQIIQ 187
RP+ +++Q
Sbjct: 260 KRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-24
Identities = 58/192 (30%), Positives = 89/192 (46%), Gaps = 13/192 (6%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ IV EL G LR YL + LD+ I ++ ++ A+ L S +HRD+ N+L
Sbjct: 81 VWIVMELAPLGELRSYLQVNKYS-LDLASLILYSYQLSTALAYLESKRFVHRDIAARNVL 139
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPELYSTVTLRQGEKKHYNHKVD 118
++ +KL DFGL+R A G +WMAPE ++ R+ + D
Sbjct: 140 VS-SPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE---SINFRR-----FTSASD 190
Query: 119 SYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPN 177
+ F + +WE+L PF+G+ N P N P L ++T CW DP+
Sbjct: 191 VWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPS 250
Query: 178 ARPNFTQIIQML 189
RP FT++ L
Sbjct: 251 KRPRFTELKAQL 262
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 4e-24
Identities = 58/205 (28%), Positives = 87/205 (42%), Gaps = 33/205 (16%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLD---VCVAIGFALDIARAMECLHSHGIIHRDLKPE 57
+++VTEL G+L L +R L + +A+ IA M L S IHRDL
Sbjct: 70 LMMVTELAPLGSL---LDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAAR 126
Query: 58 NLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR----------WMAPELYSTVTLRQ 107
N+LL D +K+ DFGL R E Y W APE T T
Sbjct: 127 NILLASD-DKVKIGDFGLMRALPQNEDH------YVMEEHLKVPFAWCAPESLRTRT--- 176
Query: 108 GEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELS 165
++H D + F + LWE+ + + P+ G+S Q + R E P+++
Sbjct: 177 -----FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIY 231
Query: 166 IILTSCWKEDPNARPNFTQIIQMLL 190
++ CW +P RP F + + L
Sbjct: 232 NVMLQCWAHNPADRPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 4e-24
Identities = 62/191 (32%), Positives = 101/191 (52%), Gaps = 18/191 (9%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IV EL+S G L +L + V + F+LD+A ME L S ++HRDL N+L++
Sbjct: 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS 134
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPELYSTVTLRQGEKKHYNHKVDSY 120
ED K++DFGLAR S M + +W APE L+ + ++ K D +
Sbjct: 135 EDG-VAKVSDFGLARVGS----MGVDNSKLPVKWTAPE-----ALKHKK---FSSKSDVW 181
Query: 121 SFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNA 178
S+ ++LWE+ + + P+ MS L+ K R E P ++ +++TSCW+ +P
Sbjct: 182 SYGVLLWEVFSYGRAPYPKMS-LKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKK 240
Query: 179 RPNFTQIIQML 189
RP+F ++ + L
Sbjct: 241 RPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 4e-24
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 35/207 (16%)
Query: 2 VIVTELLSGGTLRKYLLNMRPRCLD--------VCVAIGFALDIARAMECLHSHGIIHRD 53
++V EL++ G L+ YL ++RP + + I A +IA M L++ +HRD
Sbjct: 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRD 144
Query: 54 LKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR----------WMAPELYSTV 103
L N ++ D T+K+ DFG+ R+ ET YR WMAPE
Sbjct: 145 LAARNCMVAHDF-TVKIGDFGMTRD-------IYETDYYRKGGKGLLPVRWMAPE----- 191
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPE 162
+L+ G + D +SF +VLWE+ + P++G+SN Q +N PE
Sbjct: 192 SLKDGVFTTSS---DMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPE 248
Query: 163 ELSIILTSCWKEDPNARPNFTQIIQML 189
++ ++ CW+ +P RP F +I+ +L
Sbjct: 249 RVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 5e-24
Identities = 55/193 (28%), Positives = 93/193 (48%), Gaps = 19/193 (9%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IVTE + G L YL + + L + + D+ ME L + IHRDL N L++
Sbjct: 76 IVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS 134
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNHKVDS 119
+K++DFG+ R L + T+ +G +W PE+++ Y+ K D
Sbjct: 135 -STGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNF--------SKYSSKSDV 184
Query: 120 YSFAIVLWELL-HNKLPFEGMSNLQA--AYAAAFKNVRPSAENVPEELSIILTSCWKEDP 176
+SF +++WE+ K+PFE SN + + F+ RP + ++ SCW E P
Sbjct: 185 WSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKL--ASMTVYEVMYSCWHEKP 242
Query: 177 NARPNFTQIIQML 189
RP F ++++ +
Sbjct: 243 EGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 6e-24
Identities = 60/197 (30%), Positives = 93/197 (47%), Gaps = 33/197 (16%)
Query: 3 IVTELLSGGTLRKYLLNMRPR-----CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 57
IVTE +S G L YL R L++C D+ M L S IHRDL
Sbjct: 76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK------DVCEGMAYLESKQFIHRDLAAR 129
Query: 58 NLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKH 112
N L+ + +K++DFGL+R L + T+ G+ RW PE LYS
Sbjct: 130 NCLVDDQG-CVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSK---------- 177
Query: 113 YNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAA--YAAAFKNVRPSAENVPEELSIILT 169
++ K D ++F +++WE+ K+P+E +N + + + RP + E++ I+
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLAS--EKVYAIMY 235
Query: 170 SCWKEDPNARPNFTQII 186
SCW E RP F Q++
Sbjct: 236 SCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 8e-24
Identities = 60/199 (30%), Positives = 92/199 (46%), Gaps = 24/199 (12%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ I E SGGTL + L + R LD V + L + + LHSHGI+HRD+KP N+
Sbjct: 74 VYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIF 131
Query: 61 LTEDLKTIKLADFGLA-----REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 115
L IKL DFG A ++ E + + GT +MAPE+ G+ K +
Sbjct: 132 LD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI-----TGGKGKGHGR 185
Query: 116 KVDSYSFAIVLWELLHNKLPFEGMSN-LQAAYAAAFKNVRPSAENVPEELSI------IL 168
D +S V+ E+ K P+ + N Q + + +P P+ L + L
Sbjct: 186 AADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-KPPI---PDSLQLSPEGKDFL 241
Query: 169 TSCWKEDPNARPNFTQIIQ 187
C + DP RP ++++Q
Sbjct: 242 DRCLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 2e-23
Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 30/205 (14%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVA--IGFALDIARAMECLHSHGIIHRDLKPEN 58
+++V EL G L KYL R ++ V+ A +A M L S +HRDL N
Sbjct: 70 LMLVMELAPLGPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARN 125
Query: 59 LLLTEDLKTIKLADFGLAREESL---TEMMTAETG---TYRWMAPEL--YSTVTLRQGEK 110
+LL K++DFG++R +L ++ A T +W APE Y
Sbjct: 126 VLLVNR-HQAKISDFGMSR--ALGAGSDYYRATTAGRWPLKWYAPECINYGK-------- 174
Query: 111 KHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIIL 168
++ K D +S+ + LWE + P+ M + A R P E P+E+ I+
Sbjct: 175 --FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI-AMLESGERLPRPEECPQEIYSIM 231
Query: 169 TSCWKEDPNARPNFTQIIQMLLNYL 193
SCWK P RP F+++
Sbjct: 232 LSCWKYRPEDRPTFSELESTFRRDP 256
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-23
Identities = 61/195 (31%), Positives = 94/195 (48%), Gaps = 20/195 (10%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
++TE G L +L R L + + F+ +A+ M L S IHRDL N+LLT
Sbjct: 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT 175
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPE-LYSTVTLRQGEKKHYNHKVD 118
K +K+ DFGLAR+ + +WMAPE +++ V Y + D
Sbjct: 176 HG-KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV---------YTFESD 225
Query: 119 SYSFAIVLWELLHNKL-PFEGM---SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKE 174
+S+ I+LWE+ P+ GM S ++ +P E+ P E+ I+ +CW
Sbjct: 226 VWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP--EHAPAEIYDIMKTCWDA 283
Query: 175 DPNARPNFTQIIQML 189
DP RP F QI+Q++
Sbjct: 284 DPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-23
Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 33/215 (15%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCV--------------AIGFALDIARAMECLHS 46
+ ++ E S G LR+YL RP ++ C + A +AR ME L S
Sbjct: 99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS 158
Query: 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG---TYRWMAPE-LYST 102
IHRDL N+L+TED +K+ADFGLAR+ + T +WMAPE L+
Sbjct: 159 KKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 217
Query: 103 VTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEG--MSNLQAAYAAAFKNVRPSAEN 159
+ Y H+ D +SF ++LWE+ P+ G + L + +PS N
Sbjct: 218 I---------YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS--N 266
Query: 160 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194
EL +++ CW P+ RP F Q+++ L L+
Sbjct: 267 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 4e-23
Identities = 63/200 (31%), Positives = 86/200 (43%), Gaps = 41/200 (20%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E L GG L L N+ LD VA + +I A+E LHS+GIIHRDLKP+N+L+
Sbjct: 70 LVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID 127
Query: 63 EDLKTIKLADFGLAREESLTEMMTAE---------TGTYRWMAPELYSTVTLRQGEKKHY 113
+ +KL DFGL++ + + GT ++APE V L QG +
Sbjct: 128 SN-GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE----VILGQG----H 178
Query: 114 NHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS--C 171
+ VD +S +L+E L PF G E E IL
Sbjct: 179 SKTVDWWSLGCILYEFLVGIPPFHG-------------------ETPEEIFQNILNGKIE 219
Query: 172 WKEDPNARPNFTQIIQMLLN 191
W ED +I LL
Sbjct: 220 WPEDVEVSDEAIDLISKLLV 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 5e-23
Identities = 47/200 (23%), Positives = 95/200 (47%), Gaps = 24/200 (12%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDV---------CVAIGFALDIARAMECLHSHGIIHRD 53
++ E G L+++L + + + VA+ IA M+ L + +HRD
Sbjct: 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL--CTQIALGMDHLSNARFVHRD 142
Query: 54 LKPENLLLTEDLKTIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKK 111
L N L++ + +K++ L+++ +E + RW+APE +++ +
Sbjct: 143 LAARNCLVSSQRE-VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE-----AVQEDD-- 194
Query: 112 HYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILT 169
++ K D +SF +++WE+ +LPF G+S+ + + P E P L ++T
Sbjct: 195 -FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMT 253
Query: 170 SCWKEDPNARPNFTQIIQML 189
CW +P RP+F++++ L
Sbjct: 254 RCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-22
Identities = 58/187 (31%), Positives = 91/187 (48%), Gaps = 10/187 (5%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
++IV E GGTL +Y+ LD + F + I A+ +H+ I+HRDLK +N+L
Sbjct: 74 LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNIL 133
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
L + +K+ DFG+++ S GT +++PEL E K YN K D +
Sbjct: 134 LDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC--------EGKPYNQKSDIW 185
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNAR 179
+ VL+EL K FE +NL A P ++ +L ++ S DP+ R
Sbjct: 186 ALGCVLYELASLKRAFEA-ANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKR 244
Query: 180 PNFTQII 186
P +QI+
Sbjct: 245 PQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-22
Identities = 67/221 (30%), Positives = 101/221 (45%), Gaps = 39/221 (17%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAI--------------GFALDIARAMECLHS 46
+ ++ E + G LR++L RP D I A +AR ME L S
Sbjct: 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES 152
Query: 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG---TYRWMAPE-LYST 102
IHRDL N+L+TED +K+ADFGLAR + + +WMAPE L+
Sbjct: 153 RRCIHRDLAARNVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR 211
Query: 103 VTLRQGEKKHYNHKVDSYSFAIVLWELL------HNKLPFEGMSNLQAAYAAAFKNVRPS 156
V Y H+ D +SF I++WE+ + +P E + L + +PS
Sbjct: 212 V---------YTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL---LREGHRMDKPS 259
Query: 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 197
N EL +++ CW P RP F Q+++ L L+A++
Sbjct: 260 --NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-22
Identities = 63/195 (32%), Positives = 93/195 (47%), Gaps = 16/195 (8%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IVTE + G+L +L + L + + A IA M + IHRDL+ N+L+
Sbjct: 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG 136
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPE--LYSTVTLRQGEKKHYNHKVD 118
++L K+ADFGLAR E + + +W APE LY T+ K D
Sbjct: 137 DNL-VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI----------KSD 185
Query: 119 SYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPN 177
+SF I+L EL+ ++P+ GM N + P + PE L ++ CWK+DP+
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPD 245
Query: 178 ARPNFTQIIQMLLNY 192
RP F I L +Y
Sbjct: 246 ERPTFEYIQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 4e-22
Identities = 59/193 (30%), Positives = 96/193 (49%), Gaps = 19/193 (9%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E + G L YL R + +G LD+ M L S +IHRDL N L+
Sbjct: 76 LVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG 134
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNHKVDS 119
E+ + +K++DFG+ R L + T+ TGT +W +PE++S Y+ K D
Sbjct: 135 EN-QVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSF--------SKYSSKSDV 184
Query: 120 YSFAIVLWELL-HNKLPFEGMSNLQAA--YAAAFKNVRPSAENVPEELSIILTSCWKEDP 176
+SF +++WE+ K P+E SN + A F+ +P + + ++ CWKE P
Sbjct: 185 WSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRL--ASQSVYELMQHCWKERP 242
Query: 177 NARPNFTQIIQML 189
RP+F+ ++ L
Sbjct: 243 EDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 4e-22
Identities = 74/248 (29%), Positives = 113/248 (45%), Gaps = 40/248 (16%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCV--------------AIGFALDIARAMECLHS 46
+ ++ E S G LR+YL RP +D + A +AR ME L S
Sbjct: 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS 152
Query: 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG---TYRWMAPE-LYST 102
IHRDL N+L+TED +K+ADFGLAR+ + T +WMAPE L+
Sbjct: 153 QKCIHRDLAARNVLVTED-NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR 211
Query: 103 VTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGM--SNLQAAYAAAFKNVRPSAEN 159
V Y H+ D +SF ++LWE+ P+ G+ L + +P+ N
Sbjct: 212 V---------YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA--N 260
Query: 160 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPM---IPHRIFNSENTILP 216
EL +I+ CW P+ RP F Q+++ L L+ + E + +P ++
Sbjct: 261 CTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSVPFEQYSPGC---- 316
Query: 217 PESPGTSS 224
P+SP + S
Sbjct: 317 PDSPSSCS 324
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-22
Identities = 60/189 (31%), Positives = 93/189 (49%), Gaps = 19/189 (10%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IV EL+ GG +L + L + FALD A M L S IHRDL N L+
Sbjct: 69 IVMELVPGGDFLSFLRKKKDE-LKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG 127
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETG----TYRWMAPELYSTVTLRQGEKKHYNHKVD 118
E+ +K++DFG++R+E + + + +G +W APE L G Y+ + D
Sbjct: 128 EN-NVLKISDFGMSRQED--DGIYSSSGLKQIPIKWTAPE-----ALNYGR---YSSESD 176
Query: 119 SYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSIILTSCWKEDP 176
+S+ I+LWE P+ GM+N QA K R S + P+++ ++ CW P
Sbjct: 177 VWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKP 235
Query: 177 NARPNFTQI 185
RP F+++
Sbjct: 236 ENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 6e-22
Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 21/202 (10%)
Query: 3 IVTELLSGGTLRKYLLNMR-----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 57
I+ EL+ GG L YL + R P L + + LD+A+ L IHRDL
Sbjct: 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAAR 135
Query: 58 NLLLTEDL----KTIKLADFGLAREESLTEMMTAETG---TYRWMAPELYSTVTLRQGEK 110
N L++E + +K+ DFGLAR+ ++ E RWMAPE +L G+
Sbjct: 136 NCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPE-----SLLDGK- 189
Query: 111 KHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILT 169
+ + D +SF +++WE+L + P+ ++N + EN P+++ ++T
Sbjct: 190 --FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMT 247
Query: 170 SCWKEDPNARPNFTQIIQMLLN 191
+CW +DP+ RP F +I ++L N
Sbjct: 248 NCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 6e-22
Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 28/200 (14%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I+TE ++ G L YL + ++ V + A I+ AME L IHRDL N L+
Sbjct: 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 138
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGT--------YRWMAPELYSTVTLRQGEKKHYN 114
E+ +K+ADFGL+R +MT +T T +W APE + ++
Sbjct: 139 EN-HLVKVADFGLSR------LMTGDTYTAHAGAKFPIKWTAPESLAYNK--------FS 183
Query: 115 HKVDSYSFAIVLWEL-LHNKLPFEG--MSNLQAAYAAAFKNVRPSAENVPEELSIILTSC 171
K D ++F ++LWE+ + P+ G +S + ++ RP E P ++ ++ +C
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERP--EGCPPKVYELMRAC 241
Query: 172 WKEDPNARPNFTQIIQMLLN 191
W+ +P+ RP+F +I Q
Sbjct: 242 WQWNPSDRPSFAEIHQAFET 261
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 8e-22
Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 35/204 (17%)
Query: 2 VIVTELLSGGTLRKYLLNMRPRCLDVCV--------AIGFALDIARAMECLHSHGIIHRD 53
+++ EL++ G L+ YL ++RP + V I A +IA M L+++ +HRD
Sbjct: 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRD 144
Query: 54 LKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR----------WMAPELYSTV 103
L N ++ ED T+K+ DFG+ R+ ET YR WM+PE
Sbjct: 145 LAARNCMVAEDF-TVKIGDFGMTRD-------IYETDYYRKGGKGLLPVRWMSPE----- 191
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPE 162
+L+ G Y+ D +SF +VLWE+ + P++GMSN Q + +N P+
Sbjct: 192 SLKDGVFTTYS---DVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPD 248
Query: 163 ELSIILTSCWKEDPNARPNFTQII 186
L ++ CW+ +P RP+F +II
Sbjct: 249 MLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-21
Identities = 64/195 (32%), Positives = 96/195 (49%), Gaps = 16/195 (8%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I+TE ++ G+L +L + + I F+ IA M + IHRDL+ N+L++
Sbjct: 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS 136
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPEL--YSTVTLRQGEKKHYNHKVD 118
L K+ADFGLAR E E + +W APE + + T+ K D
Sbjct: 137 ASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI----------KSD 185
Query: 119 SYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPN 177
+SF I+L E++ + ++P+ GMSN + A P EN PEEL I+ CWK P
Sbjct: 186 VWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPE 245
Query: 178 ARPNFTQIIQMLLNY 192
RP F I +L ++
Sbjct: 246 ERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-21
Identities = 65/196 (33%), Positives = 95/196 (48%), Gaps = 18/196 (9%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IVTE +S G+L +L + R L + + A +A M + IHRDL+ N+L+
Sbjct: 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG 136
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNHKV 117
+ L K+ADFGLAR E TA G +W APE LY T+ K
Sbjct: 137 DGL-VCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI----------KS 184
Query: 118 DSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDP 176
D +SF I+L EL+ ++P+ GM+N + P ++ P L ++ CWK+DP
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDP 244
Query: 177 NARPNFTQIIQMLLNY 192
RP F + L +Y
Sbjct: 245 EERPTFEYLQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-21
Identities = 56/187 (29%), Positives = 86/187 (45%), Gaps = 19/187 (10%)
Query: 9 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 68
S + RK LN P + I A +A M L +HRDL N L+ E++ +
Sbjct: 113 STSSARKCGLNPLPLSCTEQLCI--AKQVAAGMAYLSERKFVHRDLATRNCLVGENMV-V 169
Query: 69 KLADFGLAREESLTEMMTAETGTY---RWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFA 123
K+ADFGL+R + A RWM PE Y+ T D +++
Sbjct: 170 KIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTES----------DVWAYG 219
Query: 124 IVLWELLHNKL-PFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF 182
+VLWE+ + P+ GM++ + Y NV +N P EL ++ CW + P+ RP+F
Sbjct: 220 VVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSF 279
Query: 183 TQIIQML 189
I ++L
Sbjct: 280 ASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-21
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 37/205 (18%)
Query: 11 GTLRKYLLNMR------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 64
G L+ +L R P+ L + A+ IA M LH G+IH+D+ N ++ E+
Sbjct: 94 GNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE 153
Query: 65 LKTIKLADFGLARE------ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
L+ +K+ D L+R+ L + E +WMA E +L K Y+ D
Sbjct: 154 LQ-VKITDNALSRDLFPMDYHCLGD---NENRPVKWMALE-----SL---VNKEYSSASD 201
Query: 119 SYSFAIVLWELL------HNKL-PFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSC 171
+SF ++LWEL+ + ++ PFE + L+ Y A N P+EL ++ C
Sbjct: 202 VWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPI------NCPDELFAVMACC 255
Query: 172 WKEDPNARPNFTQIIQMLLNYLSAI 196
W DP RP+F+Q++Q L ++ + +
Sbjct: 256 WALDPEERPSFSQLVQCLTDFHAQL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-21
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 2 VIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 57
+++ + G L +LL R P L + + F +DIA ME L + IHRDL
Sbjct: 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAAR 142
Query: 58 NLLLTEDLKTIKLADFGLARE---ESLTEMMTAETGTYRWMAPE-LYSTVTLRQGEKKHY 113
N +L ED+ T+ +ADFGL+++ +W+A E L V Y
Sbjct: 143 NCMLREDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV---------Y 192
Query: 114 NHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSC 171
K D ++F + +WE+ + P+ G+ N + Y R E+ +EL ++ SC
Sbjct: 193 TSKSDVWAFGVTMWEIATRGQTPYPGVENHE-IYDYLRHGNRLKQPEDCLDELYDLMYSC 251
Query: 172 WKEDPNARPNFTQIIQMLLNYL 193
W+ DP RP FT++ ++L N L
Sbjct: 252 WRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 2e-21
Identities = 52/202 (25%), Positives = 80/202 (39%), Gaps = 41/202 (20%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
V E G L +Y+ LD +A +I A+E LHS GIIHRDLKPEN+LL +
Sbjct: 80 VLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDK 137
Query: 64 DLKTIKLADFGLAREESLTEMMTAET---------------------GTYRWMAPELYST 102
D IK+ DFG A+ + GT +++PEL +
Sbjct: 138 D-MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN- 195
Query: 103 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA----E 158
+K D ++ +++++L K PF G + F+ +
Sbjct: 196 -------EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL-----TFQKILKLEYSFPP 243
Query: 159 NVPEELSIILTSCWKEDPNARP 180
N P + ++ DP R
Sbjct: 244 NFPPDAKDLIEKLLVLDPQDRL 265
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-21
Identities = 51/157 (32%), Positives = 81/157 (51%), Gaps = 13/157 (8%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 92
A+ IA ME L SH +H+DL N+L+ E L +K++D GL+RE + + +
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH-VKISDLGLSREIYSADYYRVQPKSL 187
Query: 93 ---RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKL-PFEGMSNLQAAYAA 148
RWM PE + G+ ++ D +SF +VLWE+ L P+ G SN +
Sbjct: 188 LPIRWMPPE-----AIMYGK---FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239
Query: 149 AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQI 185
+ + P +E+ P + ++T CW+E P+ RP F I
Sbjct: 240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-21
Identities = 54/187 (28%), Positives = 83/187 (44%), Gaps = 12/187 (6%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IV E G L K L R R L F + I + LHS I+HRD+K NL L
Sbjct: 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD 135
Query: 63 EDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
+K+ D G+A+ S A T GT +++PEL E K YN K D +
Sbjct: 136 AYDN-VKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELC--------EDKPYNEKSDVW 185
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
+ +VL+E K PF+ + P ++ ++L+ ++ C +D RP
Sbjct: 186 ALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245
Query: 181 NFTQIIQ 187
+ Q+++
Sbjct: 246 DTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-21
Identities = 62/200 (31%), Positives = 88/200 (44%), Gaps = 31/200 (15%)
Query: 6 ELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIH 51
E L+ G L ++L+ P LD + A+ IA ME L SH +H
Sbjct: 88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVH 147
Query: 52 RDLKPENLLLTEDLKTIKLADFGLARE---ESLTEMMTAETGTYRWMAPE--LYSTVTLR 106
RDL N L+ E L T+K++DFGL+R+ + + RWM PE LY T
Sbjct: 148 RDLAARNCLVGEGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE 206
Query: 107 QGEKKHYNHKVDSYSFAIVLWELLHNKL-PFEGMSNLQAAYAAAFKNVRPSAENVPEELS 165
D +SF +VLWE+ L P+ G SN + + + P E+ P +
Sbjct: 207 S----------DIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVY 256
Query: 166 IILTSCWKEDPNARPNFTQI 185
++ CW E P RP F I
Sbjct: 257 ALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 3e-21
Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 41/209 (19%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
++ E L G+LR YL R + +++ + F+ I + M+ L S IHRDL N+L+
Sbjct: 85 LIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE 143
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTY----------RWMAPELYSTVTLRQGEKKH 112
+ +K++DFGLA+ ++ + Y W APE T
Sbjct: 144 SE-DLVKISDFGLAK------VLPEDKDYYYVKEPGESPIFWYAPECLRTSK-------- 188
Query: 113 YNHKVDSYSFAIVLWELL----HNKLP---FEGMSNLQAAYAAAFKNVR--------PSA 157
++ D +SF + L+EL ++ P F M + + + P
Sbjct: 189 FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRP 248
Query: 158 ENVPEELSIILTSCWKEDPNARPNFTQII 186
+ P+E+ ++ CW+ +P RP+F +I
Sbjct: 249 PSCPDEVYDLMKLCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 5e-21
Identities = 59/192 (30%), Positives = 94/192 (48%), Gaps = 12/192 (6%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
++I E +GGTL ++ + + + + + + I A+ +H GI+HRD+K N+
Sbjct: 74 LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIF 133
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
LT+ IKL DFG+++ +E AET GT +M+PEL QG K YN K D
Sbjct: 134 LTKA-GLIKLGDFGISKILG-SEYSMAETVVGTPYYMSPELC------QGVK--YNFKSD 183
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNA 178
++ VL+ELL K F+ + L N P EL ++ S ++DP
Sbjct: 184 IWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEK 243
Query: 179 RPNFTQIIQMLL 190
RP +++ L
Sbjct: 244 RPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 9e-21
Identities = 59/172 (34%), Positives = 83/172 (48%), Gaps = 18/172 (10%)
Query: 25 LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 84
LD + F+ +A+ M L S IHRDL N+LLT + K+ DFGLAR+ +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG-RITKICDFGLARDIR-NDS 268
Query: 85 MTAETGTYR----WMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEG 138
G R WMAPE +++ V Y + D +S+ I+LWE+ P+ G
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCV---------YTFESDVWSYGILLWEIFSLGSSPYPG 319
Query: 139 MSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189
M Y + R S E P E+ I+ SCW DP RP F QI+Q++
Sbjct: 320 MPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-20
Identities = 61/197 (30%), Positives = 92/197 (46%), Gaps = 16/197 (8%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IVTE +S G+L +L + L + + A IA M + +HRDL+ N+L+
Sbjct: 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 136
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPE--LYSTVTLRQGEKKHYNHKVD 118
E+L K+ADFGLAR E + + +W APE LY T+ K D
Sbjct: 137 ENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI----------KSD 185
Query: 119 SYSFAIVLWEL-LHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPN 177
+SF I+L EL ++P+ GM N + P PE L ++ CW+++P
Sbjct: 186 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE 245
Query: 178 ARPNFTQIIQMLLNYLS 194
RP F + L +Y +
Sbjct: 246 ERPTFEYLQAFLEDYFT 262
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-20
Identities = 62/195 (31%), Positives = 98/195 (50%), Gaps = 17/195 (8%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
++IVTE + G+L +L + V +G IA M+ L G +HRDL N+L
Sbjct: 80 VMIVTEYMENGSLDAFLRKHDGQ-FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNIL 138
Query: 61 LTEDLKTIKLADFGLAR--EESLTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHK 116
+ +L K++DFGL+R E+ T G RW APE + R+ +
Sbjct: 139 VNSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE---AIAYRK-----FTSA 189
Query: 117 VDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKE 174
D +S+ IV+WE++ + + P+ MSN Q A + R P+ + P L ++ CW++
Sbjct: 190 SDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQK 248
Query: 175 DPNARPNFTQIIQML 189
D N RP F QI+ +L
Sbjct: 249 DRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-20
Identities = 56/190 (29%), Positives = 86/190 (45%), Gaps = 19/190 (10%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I EL+ GG+L K L V + I +E LH +HRD+K N+L+
Sbjct: 79 IFLELVPGGSLAKLLKKYGS--FPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD 136
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 122
+ +KLADFG+A++ + G+ WMAPE V +QG Y D +S
Sbjct: 137 TN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPE----VIAQQGG---YGLAADIWSL 188
Query: 123 AIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSI----ILTSCWKEDPN 177
+ E+ K P+ S L+ AA FK R +P+ LS + C + DP+
Sbjct: 189 GCTVLEMATGKPPW---SQLE-GVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPS 244
Query: 178 ARPNFTQIIQ 187
RP ++++
Sbjct: 245 LRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-20
Identities = 57/183 (31%), Positives = 91/183 (49%), Gaps = 19/183 (10%)
Query: 10 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 69
G YL N R L + I FA I+R M+ L ++HRDL N+L+ E + +K
Sbjct: 109 GNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEG-RKMK 167
Query: 70 LADFGLAR---EESLTEMMTAETGTYRWMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIV 125
++DFGL+R EE + +WMA E L+ + Y + D +SF ++
Sbjct: 168 ISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI---------YTTQSDVWSFGVL 218
Query: 126 LWELLH-NKLPFEGMS--NLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF 182
LWE++ P+ G++ L ++ RP EN EE+ ++ +CWK++P+ RP F
Sbjct: 219 LWEIVTLGGNPYPGIAPERLFNLLKTGYRMERP--ENCSEEMYNLMLTCWKQEPDKRPTF 276
Query: 183 TQI 185
I
Sbjct: 277 ADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 3e-20
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 45/219 (20%)
Query: 3 IVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 59
+V E L GG L + + R + VC+A+ +A+ LH+ G+IHRD+K +++
Sbjct: 93 VVMEFLEGGALTDIVTHTRMNEEQIATVCLAV------LKALSFLHAQGVIHRDIKSDSI 146
Query: 60 LLTEDLKTIKLADFG--------LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 111
LLT D +KL+DFG + R +SL GT WMAPE+ S +
Sbjct: 147 LLTSD-GRVKLSDFGFCAQVSKEVPRRKSL-------VGTPYWMAPEVIS--------RL 190
Query: 112 HYNHKVDSYSFAIVLWELLH------NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELS 165
Y +VD +S I++ E++ N+ P + M ++ KN V L
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKN----LHKVSPRLR 246
Query: 166 IILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 204
L DP R +++ +L+ PP ++P
Sbjct: 247 SFLDRMLVRDPAQRATAAELLNH--PFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-20
Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 33/210 (15%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD--------------IARAMECLHS 46
+ ++ E S G LR+YL RP ++ I D +AR ME L S
Sbjct: 96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS 155
Query: 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG---TYRWMAPE-LYST 102
IHRDL N+L+TE+ +K+ADFGLAR+ + + T +WMAPE L+
Sbjct: 156 QKCIHRDLAARNVLVTEN-NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR 214
Query: 103 VTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGM--SNLQAAYAAAFKNVRPSAEN 159
V Y H+ D +SF +++WE+ P+ G+ L + +P+ N
Sbjct: 215 V---------YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA--N 263
Query: 160 VPEELSIILTSCWKEDPNARPNFTQIIQML 189
EL +++ CW P+ RP F Q+++ L
Sbjct: 264 CTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 4e-20
Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 29/203 (14%)
Query: 3 IVTELLSGGTLRKYLLNMRPR-----CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 57
I+ EL++GG L+ +L RPR L + + A D+A+ + L + IHRD+
Sbjct: 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAAR 145
Query: 58 NLLLTED--LKTIKLADFGLAREESLTE--------MMTAETGTYRWMAPELYSTVTLRQ 107
N LLT + K+ADFG+AR+ M+ +WM PE +
Sbjct: 146 NCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI-----KWMPPEAFLDGI--- 197
Query: 108 GEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI 166
+ K D +SF ++LWE+ +P+ G +N + + P +
Sbjct: 198 -----FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYR 252
Query: 167 ILTSCWKEDPNARPNFTQIIQML 189
I+T CW+ P RPNF I++ +
Sbjct: 253 IMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 5e-20
Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 14/190 (7%)
Query: 1 MVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 58
+ IV E G L K + + + + + + R ++ LH I+HRDLK N
Sbjct: 74 LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSAN 133
Query: 59 LLLTEDLKTIKLADFGLAREESLTEMMT-AETGTYRWMAPELYSTVTLRQGEKKHYNHKV 117
+LL + +K+ D G+++ L + M + GT +MAPE++ + Y++K
Sbjct: 134 ILLVAN-DLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWK--------GRPYSYKS 182
Query: 118 DSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPN 177
D +S +L+E+ PFE S Y P ++L + S + P
Sbjct: 183 DIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPK 242
Query: 178 ARPNFTQIIQ 187
RPN +I+
Sbjct: 243 LRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 7e-20
Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 9/188 (4%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ IV E GG L K + R + + + I+ ++ +H I+HRD+K +N+
Sbjct: 74 LFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIF 133
Query: 61 LTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
L+++ KL DFG+AR+ E+ GT +++PE+ + + YN+K D
Sbjct: 134 LSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC--------QNRPYNNKTDI 185
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 179
+S VL+EL K PFEG + Q P + N +L +++ +K P R
Sbjct: 186 WSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDR 245
Query: 180 PNFTQIIQ 187
P+ T I++
Sbjct: 246 PSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 7e-20
Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 28/198 (14%)
Query: 3 IVTELLSGGTLRKYLLNM---------RPRCLDVCVAIGFALDIARAMECLHSHGIIHRD 53
I+ E GG L +L + R C + A+ F LHSH +IHRD
Sbjct: 79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF----------LHSHKVIHRD 128
Query: 54 LKPENLLLTEDLKTIKLADFGL-AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 112
LK N+LLT D +KLADFG+ A+ +S + GT WMAPE+ + T +
Sbjct: 129 LKAGNILLTLD-GDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKD---NP 184
Query: 113 YNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV---PEELSIILT 169
Y++K D +S I L EL + P ++ ++ K+ P+ + + L
Sbjct: 185 YDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL-KSEPPTLDQPSKWSSSFNDFLK 243
Query: 170 SCWKEDPNARPNFTQIIQ 187
SC +DP+ RP ++++
Sbjct: 244 SCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 7e-20
Identities = 54/173 (31%), Positives = 85/173 (49%), Gaps = 20/173 (11%)
Query: 31 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 90
I ++ +AR ME L S IHRDL N+LL+E+ +K+ DFGLAR + + G
Sbjct: 176 ISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLAR-DIYKDPDYVRKG 233
Query: 91 TYR----WMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 144
R WMAPE ++ V Y + D +SF ++LWE+ P+ G+ +
Sbjct: 234 DARLPLKWMAPESIFDKV---------YTTQSDVWSFGVLLWEIFSLGASPYPGV-QIDE 283
Query: 145 AYAAAFKN-VRPSA-ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195
+ K R A E E+ I+ CW +P RP F++++++L + L
Sbjct: 284 EFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 7e-20
Identities = 42/134 (31%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V L++GG L+ ++ N+ AI +A I +E LH I++RDLKPEN+LL
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL- 128
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 122
+D ++++D GLA E + + GT +MAPE+ + + Y+ VD ++
Sbjct: 129 DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVL--------QGEVYDFSVDWFAL 180
Query: 123 AIVLWELLHNKLPF 136
L+E++ + PF
Sbjct: 181 GCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 9e-20
Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 32/199 (16%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ ++T+L+ G L Y+ N + + + + + IA+ M L ++HRDL N+L
Sbjct: 83 VQLITQLMPLGCLLDYVRNHKDN-IGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVL 141
Query: 61 LTEDLKT---IKLADFGLARE-ESLTEMMTAETGTY--RWMAPELYSTVTLRQGEKKHYN 114
+KT +K+ DFGLA+ + + AE G +WMA E ++ Y
Sbjct: 142 ----VKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE-----SILHRI---YT 189
Query: 115 HKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE------ELSII 167
HK D +S+ + +WEL+ P+EG+ A ++ E +P+ ++ ++
Sbjct: 190 HKSDVWSYGVTVWELMTFGAKPYEGIP------AVEIPDLLEKGERLPQPPICTIDVYMV 243
Query: 168 LTSCWKEDPNARPNFTQII 186
L CW D +RP F ++I
Sbjct: 244 LVKCWMIDAESRPTFKELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 1e-19
Identities = 59/192 (30%), Positives = 94/192 (48%), Gaps = 20/192 (10%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIARAMECLHSHGIIHRDLKPENL 59
+ I+ E GG+ L +P LD I F L ++ +E LH G IHRD+K N+
Sbjct: 74 LWIIMEYCGGGSCLDLL---KPGKLDE-TYIAFILREVLLGLEYLHEEGKIHRDIKAANI 129
Query: 60 LLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKV 117
LL+E+ +KLADFG++ + + T M T GT WMAPE+ ++Q Y+ K
Sbjct: 130 LLSEE-GDVKLADFGVSGQLTST-MSKRNTFVGTPFWMAPEV-----IKQSG---YDEKA 179
Query: 118 DSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE--NVPEELSIILTSCWKED 175
D +S I EL + P + ++ + KN PS E + ++ C +D
Sbjct: 180 DIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-KNNPPSLEGNKFSKPFKDFVSLCLNKD 238
Query: 176 PNARPNFTQIIQ 187
P RP+ ++++
Sbjct: 239 PKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-19
Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 19/197 (9%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
++I+TE + G L +L V +G IA M+ L +HRDL N+L
Sbjct: 80 VMIITEFMENGALDSFL-RQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNIL 138
Query: 61 LTEDLKTIKLADFGLAR---EESLTEMMTAETG---TYRWMAPELYSTVTLRQGEKKHYN 114
+ +L K++DFGL+R +++ T+ G RW APE + R+ +
Sbjct: 139 VNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE---AIAYRK-----FT 189
Query: 115 HKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCW 172
D +S+ IV+WE++ + + P+ MSN Q A ++ R P + P L ++ CW
Sbjct: 190 SASDVWSYGIVMWEVMSYGERPYWDMSN-QDVINAIEQDYRLPPPMDCPTALHQLMLDCW 248
Query: 173 KEDPNARPNFTQIIQML 189
++D NARP F QI+ L
Sbjct: 249 QKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-19
Identities = 56/171 (32%), Positives = 89/171 (52%), Gaps = 20/171 (11%)
Query: 31 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 90
I ++ +AR ME L S IHRDL N+LL+E+ +K+ DFGLAR + + G
Sbjct: 177 ICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLAR-DIYKDPDYVRKG 234
Query: 91 TYR----WMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 144
+ R WMAPE ++ V Y + D +SF ++LWE+ P+ G+ +
Sbjct: 235 SARLPLKWMAPESIFDKV---------YTTQSDVWSFGVLLWEIFSLGASPYPGV-QINE 284
Query: 145 AYAAAFKN-VRPSA-ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 193
+ K+ R A EN E+ I+ +CW+ DP RP F+ ++++L + L
Sbjct: 285 EFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 6e-19
Identities = 57/168 (33%), Positives = 82/168 (48%), Gaps = 18/168 (10%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 92
FA D+A M+ L IHRDL N+L+ E+L + K+ADFGL+R E + T
Sbjct: 124 FASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS-KIADFGLSRGEEVYVKKTMGRLPV 182
Query: 93 RWMAPEL--YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMS--NLQAAYA 147
RWMA E YS Y K D +SF ++LWE++ P+ GM+ L
Sbjct: 183 RWMAIESLNYSV----------YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP 232
Query: 148 AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195
++ +P N +E+ ++ CW++ P RP F QI L L A
Sbjct: 233 QGYRMEKP--RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 6e-19
Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 31/198 (15%)
Query: 3 IVTELLSGGTL---RKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPEN 58
IV E + GG+L K + + L A I + ++ LH+ IIHRD+KP N
Sbjct: 76 IVLEYMDGGSLADLLKKVGKIPEPVLAY-----IARQILKGLDYLHTKRHIIHRDIKPSN 130
Query: 59 LLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPELYSTVTLR-QGEKKHYNH 115
LL+ +K+ADFG+++ E +L + T GT +M+PE R QGE Y++
Sbjct: 131 LLINSK-GEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPE-------RIQGE--SYSY 179
Query: 116 KVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV------RPSAENVPEELSIILT 169
D +S + L E K PF Q ++ + + AE E ++
Sbjct: 180 AADIWSLGLTLLECALGKFPFL--PPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS 237
Query: 170 SCWKEDPNARPNFTQIIQ 187
+C ++DP RP+ +++Q
Sbjct: 238 ACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 8e-19
Identities = 68/246 (27%), Positives = 103/246 (41%), Gaps = 45/246 (18%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
V E ++GG L ++ R D A +A +I ++ LH GII+RDLK +N+LL
Sbjct: 74 VMEYVNGGDLMFHIQ--RSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDS 131
Query: 64 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
+ IK+ADFG+ + E + +T T GT ++APE+ + Y VD ++
Sbjct: 132 E-GHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPEIL------SYQP--YGPAVDWWA 181
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI----ILTSCWKEDPN 177
++L+E+L + PFEG + + VR P LS IL S ++P
Sbjct: 182 LGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR-----YPRWLSKEAKSILKSFLTKNPE 236
Query: 178 AR--------------PNFTQIIQMLLNYLSAIAPPEPMIPHRI--------FNSENTIL 215
R P F +I L P +P I R F E +L
Sbjct: 237 KRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPVL 296
Query: 216 PPESPG 221
P
Sbjct: 297 TPPDEA 302
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-18
Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 31/175 (17%)
Query: 31 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 90
+ F +AR ME L S +HRDL N+LL + K +K+ DFGLAR+ ++
Sbjct: 240 LSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG-KIVKICDFGLARDIMHDSNYVSKGS 298
Query: 91 TY---RWMAPE-----LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGM-- 139
T+ +WMAPE LY+T++ D +S+ I+LWE+ P+ GM
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLS-------------DVWSYGILLWEIFSLGGTPYPGMIV 345
Query: 140 -SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF---TQIIQMLL 190
S + ++ +P ++ +E+ I+ CW +P RP+F + I++ LL
Sbjct: 346 DSTFYNKIKSGYRMAKP--DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-18
Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 15/194 (7%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+I+TE + G L KYL + +G IA M+ L +HRDL N+L
Sbjct: 81 AMIITEYMENGALDKYLRDHDGE-FSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNIL 139
Query: 61 LTEDLKTIKLADFGLARE-ESLTEMMTAETG---TYRWMAPELYSTVTLRQGEKKHYNHK 116
+ +L+ K++DFGL+R E E +G RW APE + + +
Sbjct: 140 VNSNLEC-KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY--------RKFTSA 190
Query: 117 VDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKED 175
D +SF IV+WE++ + P+ MSN + A P+ + P + ++ CW++D
Sbjct: 191 SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQD 250
Query: 176 PNARPNFTQIIQML 189
RP F I+ +L
Sbjct: 251 RARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-18
Identities = 52/162 (32%), Positives = 75/162 (46%), Gaps = 15/162 (9%)
Query: 31 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 90
IGF L +A+ ME L S +HRDL N +L E T+K+ADFGLAR+ E +
Sbjct: 101 IGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVHNH 159
Query: 91 T-----YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 145
T +WMA E T + K D +SF ++LWEL+ P +
Sbjct: 160 TGAKLPVKWMALESLQTQK--------FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI 211
Query: 146 YAAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQII 186
+ R E P+ L ++ SCW P RP F++++
Sbjct: 212 TVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELV 253
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 58/194 (29%), Positives = 95/194 (48%), Gaps = 25/194 (12%)
Query: 10 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 69
T R L+N P L +GF+ +A ME L S +HRDL N+L+ E K +K
Sbjct: 222 ERTRRDTLINESP-ALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEG-KLVK 279
Query: 70 LADFGLAREESLTEMMTAETGTY---RWMAPE-----LYSTVTLRQGEKKHYNHKVDSYS 121
+ DFGLAR+ ++ T+ +WMAPE LY+T++ D +S
Sbjct: 280 ICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLS-------------DVWS 326
Query: 122 FAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSIILTSCWKEDPNAR 179
F I+LWE+ P+ + + Y A + R + + +E+ I+ CW+E R
Sbjct: 327 FGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIR 386
Query: 180 PNFTQIIQMLLNYL 193
P+F+Q++ ++ + L
Sbjct: 387 PDFSQLVHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-18
Identities = 50/136 (36%), Positives = 77/136 (56%), Gaps = 12/136 (8%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
V E L+GG L ++ + D A +A +I ++ LH GII+RDLK +N+LL +
Sbjct: 74 VMEYLNGGDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK 131
Query: 64 DLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 122
D IK+ADFG+ +E E + GT ++APE+ +G+K YN VD +SF
Sbjct: 132 D-GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL------KGQK--YNESVDWWSF 182
Query: 123 AIVLWELLHNKLPFEG 138
++L+E+L + PF G
Sbjct: 183 GVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-18
Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 51/206 (24%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIARAMECLHSHGIIHRDLKPENLLL 61
+V LSGG+L + + PR I L ++ + +E LHS+G IHRD+K N+LL
Sbjct: 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL 135
Query: 62 TEDLKTIKLADFGLAREESLTEMMTAET-------GTYRWMAPELYSTVTLRQGEKKHYN 114
ED ++K+ADFG++ SL + GT WMAPE+ + Y+
Sbjct: 136 GED-GSVKIADFGVS--ASLADGGDRTRKVRKTFVGTPCWMAPEVME-------QVHGYD 185
Query: 115 HKVDSYSFAIVLWELLHNKLPFEG-------MSNLQAA------------YAAAFKNVRP 155
K D +SF I EL P+ M LQ Y+ +F+
Sbjct: 186 FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRK--- 242
Query: 156 SAENVPEELSIILTSCWKEDPNARPN 181
+++ C ++DP+ RP
Sbjct: 243 -----------MISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 3e-18
Identities = 60/192 (31%), Positives = 91/192 (47%), Gaps = 21/192 (10%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIARAMECLHSHGIIHRDLKPENLLL 61
IV E G++ ++ + + L I L + +E LHS+ IHRD+K N+LL
Sbjct: 75 IVMEYCGAGSVSD-IMKITNKTLTE-EEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL 132
Query: 62 TEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
E+ KLADFG++ + + T M T GT WMAPE V G YN+K D
Sbjct: 133 NEE-GQAKLADFGVSGQLTDT-MAKRNTVIGTPFWMAPE----VIQEIG----YNNKADI 182
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE----ELSIILTSCWKED 175
+S I E+ K P+ + ++A + N P + PE E + + C +D
Sbjct: 183 WSLGITAIEMAEGKPPYSDIHPMRAIF--MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKD 240
Query: 176 PNARPNFTQIIQ 187
P RP+ Q++Q
Sbjct: 241 PEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-18
Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 20/198 (10%)
Query: 1 MVIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 56
MVI+ + G L +LL R P L + + F +DIA ME L S IHRDL
Sbjct: 83 MVILP-FMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAA 141
Query: 57 ENLLLTEDLKTIKLADFGLARE---ESLTEMMTAETGTYRWMAPE-LYSTVTLRQGEKKH 112
N +L E++ T+ +ADFGL+++ A +W+A E L V
Sbjct: 142 RNCMLNENM-TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNV--------- 191
Query: 113 YNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSC 171
Y D ++F + +WE++ + P+ G+ N + N + E++ ++ C
Sbjct: 192 YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQC 251
Query: 172 WKEDPNARPNFTQIIQML 189
W +P RP+F + L
Sbjct: 252 WSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-18
Identities = 52/162 (32%), Positives = 73/162 (45%), Gaps = 17/162 (10%)
Query: 34 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY- 92
A+ IA M L S +HRDL N L+ DL +K+ DFG++R+ T+ T
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLVGYDL-VVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 93 --RWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYA 147
RWM PE +Y T D +SF +VLWE+ + K P+ G+SN +
Sbjct: 187 PIRWMPPESIMYRKFTTES----------DVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236
Query: 148 AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189
+ P E+ I+ CWK DP R N I + L
Sbjct: 237 ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-18
Identities = 45/104 (43%), Positives = 64/104 (61%), Gaps = 10/104 (9%)
Query: 36 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRW 94
++A A++ LHS GII+RDLKPEN+LL E+ IKL DFGL++E E GT +
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVEY 164
Query: 95 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
MAPE V R+G + D +SF ++++E+L LPF+G
Sbjct: 165 MAPE----VVNRRG----HTQSADWWSFGVLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-18
Identities = 55/150 (36%), Positives = 76/150 (50%), Gaps = 12/150 (8%)
Query: 40 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 99
+ LHSH IHRD+K N+LLTE T+KLADFG A SL + GT WMAPE
Sbjct: 127 GLAYLHSHERIHRDIKAGNILLTEP-GTVKLADFGSA---SLVSPANSFVGTPYWMAPE- 181
Query: 100 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159
V L E Y+ KVD +S I EL K P M+ + A Y A +N P+ +
Sbjct: 182 ---VILAMDE-GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNDSPTLSS 236
Query: 160 V--PEELSIILTSCWKEDPNARPNFTQIIQ 187
+ + SC ++ P RP+ ++++
Sbjct: 237 NDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-18
Identities = 53/164 (32%), Positives = 81/164 (49%), Gaps = 18/164 (10%)
Query: 31 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 90
+ FA D+AR M+ L IHRDL N+L+ E+ K+ADFGL+R + + T
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRL 185
Query: 91 TYRWMAPEL--YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMS--NLQAA 145
RWMA E YS Y D +S+ ++LWE++ P+ GM+ L
Sbjct: 186 PVRWMAIESLNYSV----------YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 235
Query: 146 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189
++ +P N +E+ ++ CW+E P RP+F QI+ L
Sbjct: 236 LPQGYRLEKPL--NCDDEVYDLMRQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 3e-18
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E L+GG+L + C+D + +A+E LHS+ +IHRD+K +N+LL
Sbjct: 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150
Query: 63 EDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
D ++KL DFG + + + + GT WMAPE+ + +K Y KVD +S
Sbjct: 151 MD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT--------RKAYGPKVDIWS 201
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII----LTSCWKEDPN 177
I+ E++ + P+ + L+A Y A N P +N PE+LS I L C D
Sbjct: 202 LGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQN-PEKLSAIFRDFLNRCLDMDVE 259
Query: 178 ARPNFTQIIQMLLNYLSAIAPPEPMIP 204
R + +++Q +L P + P
Sbjct: 260 KRGSAKELLQH--QFLKIAKPLSSLTP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 5e-18
Identities = 50/182 (27%), Positives = 82/182 (45%), Gaps = 19/182 (10%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLD---VCVAIGFALDIARAMECLHSHGIIHRDLKPENL 59
I+ E GG++R M+ + + V I L A++ +H G+IHRD+K N+
Sbjct: 79 IIMEYAEGGSVRTL---MKAGPIAEKYISVIIREVL---VALKYIHKVGVIHRDIKAANI 132
Query: 60 LLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
L+T +KL DFG+A + + GT WMAPE+ + E K+Y+ K D
Sbjct: 133 LVTNTGN-VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT-------EGKYYDTKAD 184
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAY-AAAFKNVRPSAENVPEELSIILTSCWKEDPN 177
+S I ++E+ P+ + +A K R + L + +C E+P
Sbjct: 185 IWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPK 244
Query: 178 AR 179
R
Sbjct: 245 ER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (200), Expect = 6e-18
Identities = 50/133 (37%), Positives = 68/133 (51%), Gaps = 14/133 (10%)
Query: 13 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 72
L+KYL + RP L + + R + HSH I+HRDLKP+N+L+ D +KLAD
Sbjct: 84 LKKYL-DKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD-GVLKLAD 141
Query: 73 FGLAREESLTEM-MTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 129
FGLAR + T E T YR APE+ G KHY+ VD +S + E+
Sbjct: 142 FGLARAFGIPLRTYTHEVVTLWYR--APEIL------LGS-KHYSTAVDIWSVGCIFAEM 192
Query: 130 LHNKLPFEGMSNL 142
+ K F G S +
Sbjct: 193 ITGKPLFPGDSEI 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 7e-18
Identities = 43/147 (29%), Positives = 70/147 (47%), Gaps = 12/147 (8%)
Query: 46 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTV 103
+ ++HRDLKP N+ L + +KL DFGLA+ + A+T GT +M+PE +
Sbjct: 128 GNTVLHRDLKPANIFLDAN-NNVKLGDFGLAKILG-HDSSFAKTYVGTPYYMSPEQLN-- 183
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 163
Y+ K D +S +++EL PF + LQ A R E
Sbjct: 184 ------HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSE 237
Query: 164 LSIILTSCWKEDPNARPNFTQIIQMLL 190
L+ ++ S DP+ RP+ +++Q+ L
Sbjct: 238 LNEVIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 8e-18
Identities = 52/158 (32%), Positives = 78/158 (49%), Gaps = 18/158 (11%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 92
FA D+AR M+ L IHRDL N+L+ E+ K+ADFGL+R + + T
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRLPV 175
Query: 93 RWMAPEL--YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMS--NLQAAYA 147
RWMA E YS Y D +S+ ++LWE++ P+ GM+ L
Sbjct: 176 RWMAIESLNYSV----------YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 225
Query: 148 AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQI 185
++ +P N +E+ ++ CW+E P RP+F QI
Sbjct: 226 QGYRLEKP--LNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 1e-17
Identities = 57/184 (30%), Positives = 90/184 (48%), Gaps = 20/184 (10%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I+ E G+LR+ ++ + VA+ + + + + LH G+IHRD+K N+L T
Sbjct: 76 IILEYAENGSLRQ-IIKKFGPFPESLVAV-YVYQVLQGLAYLHEQGVIHRDIKAANILTT 133
Query: 63 EDLKTIKLADFGLA-REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
+D +KLADFG+A + +++ + GT WMAPE V G + D +S
Sbjct: 134 KD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPE----VIEMSG----ASTASDIWS 184
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR----PSAENVPEELSIILTSCWKEDPN 177
+ ELL P+ +L AA F+ V+ P E + EL L C+++DPN
Sbjct: 185 LGCTVIELLTGNPPY---YDLNPM-AALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPN 240
Query: 178 ARPN 181
RP
Sbjct: 241 LRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 1e-17
Identities = 62/213 (29%), Positives = 88/213 (41%), Gaps = 40/213 (18%)
Query: 17 LLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 76
L+ R R L + + + + + HSHGI+HRDLKPENLL+ + +KLADFGLA
Sbjct: 87 LIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE-GVLKLADFGLA 145
Query: 77 RE-ESLTEMMTAETGTYRWM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKL 134
R S T T RW APEL + + Y+ VD +S + ELL +
Sbjct: 146 RSFGSPVRPYTHYVVT-RWYRAPEL--LLGDKG-----YSTPVDIWSVGCIFAELLSRRP 197
Query: 135 PFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194
F G S + ++L I + DP P FT + NY
Sbjct: 198 LFPGKSEI-------------------DQLFKIFRTLGTPDPEVWPKFT---SLARNYKF 235
Query: 195 AIAPPEPMIPHRIFNSENTILPPESPGTSSLMT 227
+ M ++F P SP L++
Sbjct: 236 SFPKKAGMPLPKLF-------PNASPQALDLLS 261
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-17
Identities = 42/137 (30%), Positives = 79/137 (57%), Gaps = 9/137 (6%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V L++GG L+ ++ N+ R L++ I ++ I + LHS I++RD+KPEN+L
Sbjct: 68 LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVL 127
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
L +D +L+D GLA E + +T GT +MAPE+ +++ Y++ VD +
Sbjct: 128 L-DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEIL--------KEEPYSYPVDWF 178
Query: 121 SFAIVLWELLHNKLPFE 137
+ ++E++ + PF+
Sbjct: 179 AMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-17
Identities = 63/193 (32%), Positives = 98/193 (50%), Gaps = 25/193 (12%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E L+GG+L + C+D + +A+E LHS+ +IHRD+K +N+LL
Sbjct: 93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 149
Query: 63 EDLKTIKLADFG----LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
D ++KL DFG + E+S M GT WMAPE+ + +K Y KVD
Sbjct: 150 MD-GSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVVT--------RKAYGPKVD 197
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII----LTSCWKE 174
+S I+ E++ + P+ + L+A Y A N P +N PE+LS I L C +
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQN-PEKLSAIFRDFLNRCLEM 255
Query: 175 DPNARPNFTQIIQ 187
D R + +++Q
Sbjct: 256 DVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 1e-17
Identities = 50/188 (26%), Positives = 75/188 (39%), Gaps = 51/188 (27%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ES---LTEMMTAETGTY 92
I + + +H HG HRDLKPENLL++ +K+ADFGLARE S T+ ++ T Y
Sbjct: 108 ILQGLAHIHKHGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVS--TRWY 164
Query: 93 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS------------ 140
R APE + LR Y+ VD ++ ++ EL + F G S
Sbjct: 165 R--APE----ILLRST---SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVL 215
Query: 141 --------------------NLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
+ + P+A E ++ + DP RP
Sbjct: 216 GTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNA---SPEAIDLIKDMLRWDPKKRP 272
Query: 181 NFTQIIQM 188
+Q +Q
Sbjct: 273 TASQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 54/154 (35%), Positives = 81/154 (52%), Gaps = 27/154 (17%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V E + GG L N+ +D+ + FA + A+E LH++GI+HRDLKP+NLL
Sbjct: 76 LCMVMEYVEGGDCATLLKNIGALPVDM-ARMYFA-ETVLALEYLHNYGIVHRDLKPDNLL 133
Query: 61 LTEDLKTIKLADFGLAR---------------EESLTEMMTAET-GTYRWMAPELYSTVT 104
+T + IKL DFGL++ E+ E + + GT ++APE V
Sbjct: 134 ITS-MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE----VI 188
Query: 105 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
LRQG Y VD ++ I+L+E L +PF G
Sbjct: 189 LRQG----YGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-17
Identities = 46/133 (34%), Positives = 70/133 (52%), Gaps = 13/133 (9%)
Query: 6 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 65
E + GG L YL N + +A +I A+E LHS I++RDLKPEN+LL ++
Sbjct: 81 EYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE- 137
Query: 66 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIV 125
IKL DFG A++ L + GT ++APE+ + K +N VD ++ I+
Sbjct: 138 GHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVI--------QSKGHNKAVDWWALGIL 187
Query: 126 LWELLHNKLPFEG 138
++E+L PF
Sbjct: 188 IYEMLVGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-17
Identities = 57/180 (31%), Positives = 89/180 (49%), Gaps = 24/180 (13%)
Query: 19 NMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78
+ P LD+ + F+ +A+ M+ L S IHRD+ N+LLT D + K+ DFGLAR+
Sbjct: 205 DSWP--LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT-DGRVAKICDFGLARD 261
Query: 79 ESLTEMMTAETGTYR----WMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-N 132
+ + G R WMAPE ++ V Y + D +S+ I+LWE+
Sbjct: 262 -IMNDSNYVVKGNARLPVKWMAPESIFDCV---------YTVQSDVWSYGILLWEIFSLG 311
Query: 133 KLPFEGM---SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189
K P+ G+ S ++ RP + P E+ I+ CW +P RP F+QI Q++
Sbjct: 312 KSPYPGILVNSKFYKMVKRGYQMSRP--DFAPPEIYSIMKMCWNLEPTERPTFSQISQLI 369
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-17
Identities = 58/196 (29%), Positives = 88/196 (44%), Gaps = 30/196 (15%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I E + GG+++ L L V + I +E LHS+ I+HRD+K N +L
Sbjct: 81 IFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGAN-ILR 137
Query: 63 EDLKTIKLADFGLARE----ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
+ +KL DFG ++ S M + TGT WM+PE+ S GE Y K D
Sbjct: 138 DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS------GEG--YGRKAD 189
Query: 119 SYSFAIVLWELLHNKLP---FEGMSNLQAAYAAAFK-NVRPSAENVPEELSII----LTS 170
+S + E+L K P FE M AA FK +P+ +P +S L
Sbjct: 190 VWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQPTNPQLPSHVSPDARNFLRR 242
Query: 171 CWKEDPNARPNFTQII 186
+ E+ RP+ +++
Sbjct: 243 TFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-17
Identities = 44/156 (28%), Positives = 79/156 (50%), Gaps = 23/156 (14%)
Query: 44 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE----SLTEMMTAETGTYRWMAPEL 99
LHS GI+HRDLK +NLL+ D K++DFG++++ + M+ + G+ WMAPE+
Sbjct: 124 LHSKGILHRDLKADNLLVDAD-GICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPEV 181
Query: 100 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159
+ + Y+ KVD +S V+ E+ + P+ + A + K P
Sbjct: 182 IHS------YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP--- 232
Query: 160 VPEELSIILTS--------CWKEDPNARPNFTQIIQ 187
+P ++S+ L+ C+ +P+ RP +++Q
Sbjct: 233 IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 3e-17
Identities = 49/135 (36%), Positives = 71/135 (52%), Gaps = 15/135 (11%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E + GG L +L + VA +A + A+E LHS I++RDLKPENLLL
Sbjct: 78 LVMEYVPGGELFSHL--RKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD 135
Query: 63 EDLKTIKLADFGLA-REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
D IK+ DFG A R + T + GT ++APE + L +G Y VD ++
Sbjct: 136 SD-GYIKITDFGFAKRVKGRTYTL---CGTPEYLAPE----IILSKG----YGKAVDWWA 183
Query: 122 FAIVLWELLHNKLPF 136
I+++E+L PF
Sbjct: 184 LGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-17
Identities = 51/139 (36%), Positives = 79/139 (56%), Gaps = 12/139 (8%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ V E L+GG L ++ + D+ A +A +I ++ LHS GI++RDLK +N+L
Sbjct: 71 LFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNIL 128
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
L D IK+ADFG+ +E L + T GT ++APE+ G+K YN VD
Sbjct: 129 LDTD-GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL------LGQK--YNTSVDW 179
Query: 120 YSFAIVLWELLHNKLPFEG 138
+SF ++L+E+L + PF G
Sbjct: 180 WSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-17
Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 15/193 (7%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
M+IVTE +S G L +L + L +G +A M+ L G +H+ L +L
Sbjct: 81 MMIVTEYMSNGALDSFLRKHEGQ-LVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVL 139
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETG--TYRWMAPELYSTVTLRQGEKKHYNHKVD 118
+ DL K++ F +E+ + T +G W APE ++ H++ D
Sbjct: 140 VNSDL-VCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPE-----AIQYH---HFSSASD 190
Query: 119 SYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDP 176
+SF IV+WE++ + + P+ MS Q A R P+ N P L ++ CW+++
Sbjct: 191 VWSFGIVMWEVMSYGERPYWDMSG-QDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKER 249
Query: 177 NARPNFTQIIQML 189
RP F+QI +L
Sbjct: 250 GERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 5e-17
Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E L+GG+L + C+D + +A++ LHS+ +IHRD+K +N+LL
Sbjct: 93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG 149
Query: 63 EDLKTIKLADFG----LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
D ++KL DFG + E+S M GT WMAPE+ + +K Y KVD
Sbjct: 150 MD-GSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVVT--------RKAYGPKVD 197
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII----LTSCWKE 174
+S I+ E++ + P+ + L+A Y A N P +N PE LS + L C +
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQN-PERLSAVFRDFLNRCLEM 255
Query: 175 DPNARPNFTQIIQ----MLLNYLSAIAP 198
D + R + +++Q L LS++ P
Sbjct: 256 DVDRRGSAKELLQHPFLKLAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 8e-17
Identities = 48/155 (30%), Positives = 75/155 (48%), Gaps = 17/155 (10%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE---ESLTEMMTAETGTYR 93
IA ME L SH ++H+DL N+L+ + L +K++D GL RE ++M R
Sbjct: 133 IAAGMEFLSSHHVVHKDLATRNVLVFDKL-NVKISDLGLFREVYAADYYKLMGNSLLPIR 191
Query: 94 WMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKL-PFEGMSNLQAAYAAAF 150
WM+PE +Y ++ D +S+ +VLWE+ L P+ G SN
Sbjct: 192 WMSPEAIMYGKFSIDS----------DIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241
Query: 151 KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQI 185
+ V P ++ P + ++ CW E P+ RP F I
Sbjct: 242 RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 8e-17
Identities = 41/100 (41%), Positives = 55/100 (55%), Gaps = 11/100 (11%)
Query: 40 AMECLHSHGIIHRDLKPENLLLTEDLKT-IKLADFGLAREESLTEMMTAETGTYRWMAPE 98
A E LH+ GII+RDLKPENLLL D +KL DFG A++ + GT ++APE
Sbjct: 105 AFEYLHNRGIIYRDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPE 162
Query: 99 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
+ K Y+ VD +S I+L+ELL + PF
Sbjct: 163 II--------LNKGYDFSVDYWSLGILLYELLTGRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 43/113 (38%), Positives = 60/113 (53%), Gaps = 10/113 (8%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE--MMTAETG 90
F I R ++ LHS GI+HRD+KP NLL+ + +K+ DFGLAR E E MT E
Sbjct: 108 FLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDESKHMTQEVV 166
Query: 91 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 143
T + APE+ +HY VD +S + ELL ++ F+ S +Q
Sbjct: 167 TQYYRAPEILMG-------SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-16
Identities = 54/174 (31%), Positives = 85/174 (48%), Gaps = 22/174 (12%)
Query: 31 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 90
I ++ +A+ ME L S IHRDL N+LL+E+ +K+ DFGLAR + + G
Sbjct: 182 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLAR-DIYKDPDYVRKG 239
Query: 91 TYR----WMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 144
R WMAPE ++ V Y + D +SF ++LWE+ P+ G+ +
Sbjct: 240 DARLPLKWMAPETIFDRV---------YTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDE 289
Query: 145 AYAAAFKN---VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195
+ K +R PE +L CW +P+ RP F+++++ L N L A
Sbjct: 290 EFCRRLKEGTRMRAPDYTTPEMYQTML-DCWHGEPSQRPTFSELVEHLGNLLQA 342
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-16
Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 32/207 (15%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V E L G+LR YL R R D + +A I + ME L S +HRDL N+L
Sbjct: 82 LRLVMEYLPYGSLRDYLQKHRERL-DHRKLLLYASQICKGMEYLGSKRYVHRDLATRNIL 140
Query: 61 LTEDLKTIKLADFGLAR-----EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 115
+ E +K+ DFGL + +E E+ + W APE + E K ++
Sbjct: 141 V-ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF-WYAPESLT-------ESK-FSV 190
Query: 116 KVDSYSFAIVLWELL----HNKLP----FEGMSNLQAAYAAAF-------KNVR-PSAEN 159
D +SF +VL+EL + P M N + + N R P+
Sbjct: 191 ASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPG 250
Query: 160 VPEELSIILTSCWKEDPNARPNFTQII 186
P E+ I+ CW DP+ RP+F+++
Sbjct: 251 CPAEIYAIMKECWNNDPSQRPSFSELA 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-16
Identities = 58/192 (30%), Positives = 93/192 (48%), Gaps = 22/192 (11%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IV + GG L K + R + + + I A++ +H I+HRD+K +N+ LT
Sbjct: 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT 135
Query: 63 EDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
+D TIKL DFG+AR S E+ GT +++PE+ E + YN+K D ++
Sbjct: 136 KD-GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEIC--------ENRPYNNKSDIWA 186
Query: 122 FAIVLWELLHNKLPFEG--MSNLQAAYAAAFKNVRPSAENVP----EELSIILTSCWKED 175
VL+E+ K FE M NL K +R S V +L +++ +K +
Sbjct: 187 LGCVLYEMCTLKHAFEAGNMKNL------VLKIIRGSYPPVSSHYSYDLRNLVSQLFKRN 240
Query: 176 PNARPNFTQIIQ 187
P RP+ I++
Sbjct: 241 PRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-16
Identities = 53/200 (26%), Positives = 86/200 (43%), Gaps = 30/200 (15%)
Query: 2 VIVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENL 59
I E + GG+L K L ++ R + I A + + + LH H IIHRD+KP N+
Sbjct: 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVA--VLKGLTYLHEKHKIIHRDVKPSNI 132
Query: 60 LLTEDLKTIKLADFGLAREESLTEMMT-AETGTYRWMAPELYSTVTLR-QGEKKHYNHKV 117
L+ IKL DFG++ + L + GT +MAPE R QG Y+ K
Sbjct: 133 LVNS-RGQIKLCDFGVSGQ--LVNSLAKTFVGTSSYMAPE-------RIQGN--DYSVKS 180
Query: 118 DSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV---------RPSAENVPEELSIIL 168
D +S + L EL + P+ F+ + R + + +
Sbjct: 181 DIWSLGLSLIELATGRFPY---PPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFV 237
Query: 169 TSCWKEDPNARPNFTQIIQM 188
C +DP RP++ ++++
Sbjct: 238 NLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 2e-16
Identities = 66/210 (31%), Positives = 105/210 (50%), Gaps = 29/210 (13%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V E L+GG+L + C+D + +A+E LH++ +IHRD+K +N+L
Sbjct: 91 LFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVL 147
Query: 61 LTEDLKTIKLADFG----LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 116
L D ++KL DFG + E+S M GT WMAPE+ + +K Y K
Sbjct: 148 LGMD-GSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVVT--------RKAYGPK 195
Query: 117 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII----LTSCW 172
VD +S I+ E++ + P+ + L+A Y A N P +N PE+LS I L C
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQN-PEKLSPIFRDFLNRCL 253
Query: 173 KEDPNARPNFTQIIQ----MLLNYLSAIAP 198
+ D R + +++Q L LS++ P
Sbjct: 254 EMDVEKRGSAKELLQHPFLKLAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-16
Identities = 44/138 (31%), Positives = 73/138 (52%), Gaps = 9/138 (6%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V L++GG L+ ++ NM D A+ +A +I +E LH I++RDLKPEN+L
Sbjct: 75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENIL 134
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
L +D I+++D GLA E E + GT +MAPE+ + + Y D +
Sbjct: 135 L-DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV--------KNERYTFSPDWW 185
Query: 121 SFAIVLWELLHNKLPFEG 138
+++E++ K PF
Sbjct: 186 GLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-16
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 35/213 (16%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPR-CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 59
+ ++ E + G+LR YL P+ L++ + FA I M LHS IHRDL N+
Sbjct: 83 LQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNV 138
Query: 60 LLTEDLKTIKLADFGLAR-----EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 114
LL D + +K+ DFGLA+ E ++ + W A E E K
Sbjct: 139 LLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-WYAVECLK-------ENKFS- 188
Query: 115 HKVDSYSFAIVLWELLHNKLP-------FEGMSNLQAAYAAAFKNVR--------PSAEN 159
+ D +SF + L+ELL + FE M + + + P +N
Sbjct: 189 YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKN 248
Query: 160 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192
P+E+ I++ +CW+ + RP F +I +L
Sbjct: 249 CPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 5e-16
Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 9/155 (5%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT-AETGTYRWM 95
R + LH + +IHRD+K +N+LLT++ + +KL DFG++ + T GT WM
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAE-VKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180
Query: 96 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 155
APE+ + + Y+ + D +S I EL K P M ++A + +N P
Sbjct: 181 APEV---IACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP-RNPPP 236
Query: 156 ---SAENVPEELSIILTSCWKEDPNARPNFTQIIQ 187
S EN ++ + ++ C ++ RP ++++
Sbjct: 237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-16
Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 34 ALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM--TAETG 90
A+ I +A+E LHS +IHRD+KP N+L+ + + +KL DFG++ L + + T + G
Sbjct: 109 AVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ-VKLCDFGISGY--LVDSVAKTIDAG 165
Query: 91 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF 150
+MAPE + + +K Y+ K D +S I + EL + P++
Sbjct: 166 CKPYMAPERINP----ELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV 221
Query: 151 KNVRPS--AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188
+ P AE E + C K++ RPN+ +++Q
Sbjct: 222 EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-16
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 31/212 (14%)
Query: 3 IVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 59
+V E L GG L + + R + VC+A+ +A+ LH+ G+IHRD+K +++
Sbjct: 94 VVMEFLEGGALTDIVTHTRMNEEQIAAVCLAV------LKALSVLHAQGVIHRDIKSDSI 147
Query: 60 LLTEDLKTIKLADFGL-AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
LLT D + +KL+DFG A+ + GT WMAPEL S + Y +VD
Sbjct: 148 LLTHDGR-VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP--------YGPEVD 198
Query: 119 SYSFAIVLWELLH------NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCW 172
+S I++ E++ N+ P + M ++ KN V L L
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKN----LHKVSPSLKGFLDRLL 254
Query: 173 KEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 204
DP R ++++ +L+ PP ++P
Sbjct: 255 VRDPAQRATAAELLKH--PFLAKAGPPSCIVP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-16
Identities = 47/164 (28%), Positives = 82/164 (50%), Gaps = 13/164 (7%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYR 93
I A++ +HS ++HRDLK N+ L IKL DFG +++ S + ++ ++ GT
Sbjct: 178 IVLALDEVHSRKMMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236
Query: 94 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 153
++APEL+ E+K Y+ K D +S ++L+ELL PF+G S + +
Sbjct: 237 YLAPELW--------ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY 288
Query: 154 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM-LLNYLSAI 196
P V + +L ++P RP Q++ L Y++ +
Sbjct: 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANL 332
|
Length = 478 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 8e-16
Identities = 48/145 (33%), Positives = 75/145 (51%), Gaps = 24/145 (16%)
Query: 1 MVIVTELLSGGTLRKYLLNM--------RPRCLDVCVAIGFALDIARAMECLHSHGIIHR 52
+ +V +++GG LR ++ N+ PR A + I +E LH II+R
Sbjct: 68 LCLVMTIMNGGDLRYHIYNVDEENPGFPEPR------ACFYTAQIISGLEHLHQRRIIYR 121
Query: 53 DLKPENLLLTEDLKTIKLADFGLAREESLTEMMT-AETGTYRWMAPELYSTVTLRQGEKK 111
DLKPEN+LL D ++++D GLA E + T GT +MAPEL QGE+
Sbjct: 122 DLKPENVLLDND-GNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELL------QGEE- 173
Query: 112 HYNHKVDSYSFAIVLWELLHNKLPF 136
Y+ VD ++ + L+E++ + PF
Sbjct: 174 -YDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 9e-16
Identities = 52/156 (33%), Positives = 74/156 (47%), Gaps = 22/156 (14%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGTY 92
+ R ++ LHSH I+HRDLKP+N+L+T D +K+ADFGLAR E +LT ++ T Y
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDG-QVKIADFGLARIYSFEMALTSVVV--TLWY 172
Query: 93 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 152
R APE V L+ Y VD +S + EL + F G S F
Sbjct: 173 R--APE----VLLQS----SYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDV 221
Query: 153 V-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 187
+ PS E P +S+ +S +F +
Sbjct: 222 IGLPSEEEWPRNVSLPRSSF---PSYTPRSFKSFVP 254
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 1e-15
Identities = 45/107 (42%), Positives = 57/107 (53%), Gaps = 13/107 (12%)
Query: 39 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWM-A 96
R +E LHS+ I+HRDLKP NLL+ D +KLADFGLAR S MT + T RW A
Sbjct: 113 RGLEYLHSNWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRKMTHQVVT-RWYRA 170
Query: 97 PEL-YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 142
PEL + +HY VD +S + ELL G S++
Sbjct: 171 PELLFGA--------RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-15
Identities = 42/113 (37%), Positives = 63/113 (55%), Gaps = 11/113 (9%)
Query: 36 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYR 93
+I A++ LH GII+RD+K EN+LL + + L DFGL++E E A + GT
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIE 171
Query: 94 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF--EGMSNLQA 144
+MAPE+ +R G H + VD +S ++ +ELL PF +G N Q+
Sbjct: 172 YMAPEV-----IRGGSGGH-DKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-15
Identities = 66/242 (27%), Positives = 107/242 (44%), Gaps = 42/242 (17%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ V E +GG L +L R R A + +I A+E LHS +++RD+K ENL+
Sbjct: 70 LCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 127
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
L +D IK+ DFGL + E +++ T +T GT ++APE+ E Y VD
Sbjct: 128 LDKD-GHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVL--------EDNDYGRAVD 177
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNA 178
+ +V++E++ +LPF + + + +R PE S +L K+DP
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS-LLAGLLKKDPKQ 236
Query: 179 R----PNFTQIIQMLLNYLSAIAPPEPMIPHRIFNS-------ENTILPPESPGTSSLMT 227
R P+ + + HR F S + +LPP P +S +
Sbjct: 237 RLGGGPSDAKEVME----------------HRFFLSINWQDVVQKKLLPPFKPQVTSEVD 280
Query: 228 VR 229
R
Sbjct: 281 TR 282
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 1e-15
Identities = 46/113 (40%), Positives = 58/113 (51%), Gaps = 20/113 (17%)
Query: 39 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR------EESLTEMMTAETGTY 92
+A++ +HS +IHRDLKP N+LL D +KLADFGLAR E ++T T
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDC-RVKLADFGLARSLSELEENPENPVLTDYVAT- 175
Query: 93 RWM-APE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 142
RW APE L ST Y VD +S +L E+L K F G S L
Sbjct: 176 RWYRAPEILLGST---------RYTKGVDMWSVGCILGEMLLGKPLFPGTSTL 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 2e-15
Identities = 51/149 (34%), Positives = 79/149 (53%), Gaps = 12/149 (8%)
Query: 44 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 103
LHSH +IHRD+K N+LLTE +KLADFG A S+ + GT WMAPE+ +
Sbjct: 141 LHSHNMIHRDIKAGNILLTEP-GQVKLADFGSA---SIASPANSFVGTPYWMAPEV--IL 194
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV--P 161
+ +G+ Y+ KVD +S I EL K P M+ + A Y A +N P+ ++
Sbjct: 195 AMDEGQ---YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPTLQSNEWS 250
Query: 162 EELSIILTSCWKEDPNARPNFTQIIQMLL 190
+ + SC ++ P RP ++++ +
Sbjct: 251 DYFRNFVDSCLQKIPQDRPTSEELLKHMF 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-15
Identities = 59/184 (32%), Positives = 95/184 (51%), Gaps = 21/184 (11%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ V E L+GG L + + + R D+ A +A +I ++ LHS GII+RDLK +N++
Sbjct: 71 LFFVMEFLNGGDL-MFHIQDKGR-FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVM 128
Query: 61 LTEDLKTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
L D IK+ADFG+ +E + + GT ++APE+ QG K Y VD
Sbjct: 129 LDRD-GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL------QGLK--YTFSVDW 179
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP----EELSIILTSCWKED 175
+SF ++L+E+L + PF G + F+++R + P +E IL ++ D
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDE-----LFESIRVDTPHYPRWITKESKDILEKLFERD 234
Query: 176 PNAR 179
P R
Sbjct: 235 PTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-15
Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 24/210 (11%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRC-----------LDVCVAIGFALDIARAMECLHSHGI 49
+++V E + G L K+L P L + A IA M L S
Sbjct: 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHF 141
Query: 50 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTVTLR 106
+HRDL N L+ E+L +K+ DFG++R+ T+ T RWM PE ++ R
Sbjct: 142 VHRDLATRNCLVGENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE---SIMYR 197
Query: 107 QGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELS 165
+ + + D +S +VLWE+ + K P+ +SN + V P+E+
Sbjct: 198 K-----FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVY 252
Query: 166 IILTSCWKEDPNARPNFTQIIQMLLNYLSA 195
++ CW+ +P+ R N +I +L N A
Sbjct: 253 DLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-15
Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 46/220 (20%)
Query: 1 MVIVTELLSGGTLRKYL---------LNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 51
+ ++ E + G L ++L L + L + A IA M L S +H
Sbjct: 94 LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVH 153
Query: 52 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY-----------RWMAPELY 100
RDL N L+ ++ TIK+ADFG++R + Y RWMA E
Sbjct: 154 RDLATRNCLVGKNY-TIKIADFGMSRN--------LYSSDYYRVQGRAPLPIRWMAWE-- 202
Query: 101 STVTLRQGEKKHYNHKVDSYSFAIVLWEL--LHNKLPFEGMSNLQAAYAAAFKNVR---- 154
++ G+ + K D ++F + LWE+ L + P+E +++ Q A
Sbjct: 203 ---SVLLGK---FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQ 256
Query: 155 ---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191
P N P+++ ++ CW+ D RP F +I L
Sbjct: 257 IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-15
Identities = 50/219 (22%), Positives = 80/219 (36%), Gaps = 46/219 (21%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E + GG L L+ A + ++ A++ +H G IHRD+KP+N+L+
Sbjct: 78 LVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID 135
Query: 63 EDLKTIKLADFGLA-------------REESLTEMMTAET-----------------GTY 92
D IKLADFGL + GT
Sbjct: 136 AD-GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTP 194
Query: 93 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA--AAF 150
++APE V Y + D +S ++L+E+L+ PF LQ Y +
Sbjct: 195 DYIAPE----VLRGTP----YGLECDWWSLGVILYEMLYGFPPFYS-DTLQETYNKIINW 245
Query: 151 KN--VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 187
K P V E ++ + + +F +I
Sbjct: 246 KESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKS 284
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 52/213 (24%)
Query: 4 VTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
V + GG L + LL +P +CL VA +A ++ A+E LH GI++RDLKPEN+LL
Sbjct: 79 VMDYCPGGELFR-LLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH 137
Query: 63 EDLKTIKLADFGLA----------------------REESLTEMMTAET--------GTY 92
E I L+DF L+ +E + E GT
Sbjct: 138 ES-GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTE 196
Query: 93 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 152
++APE+ S + VD ++ I+L+E+L+ PF+G SN F N
Sbjct: 197 EYIAPEVIS--------GDGHGSAVDWWTLGILLYEMLYGTTPFKG-SNRD----ETFSN 243
Query: 153 VR------PSAENVPEELSIILTSCWKEDPNAR 179
+ P + V ++ +DP+ R
Sbjct: 244 ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-15
Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 17/194 (8%)
Query: 1 MVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 58
+ IV EL G L + + + + R + + + + A+E +HS I+HRD+KP N
Sbjct: 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPAN 136
Query: 59 LLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHK 116
+ +T +KL D GL R S ++ A + GT +M+PE + YN K
Sbjct: 137 VFITAT-GVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI--------HENGYNFK 186
Query: 117 VDSYSFAIVLWELLHNKLPFEG-MSNLQAAYAAAFKNVRP--SAENVPEELSIILTSCWK 173
D +S +L+E+ + PF G NL + K P A++ EEL +++ C
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCIN 246
Query: 174 EDPNARPNFTQIIQ 187
DP RP+ + ++Q
Sbjct: 247 PDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-15
Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 25/197 (12%)
Query: 3 IVTELLSGGTLRKYLLNMRP--------RCLDVCVAIGFALDIARAMECLHSHG-IIHRD 53
IV +L+ G L ++ +++ R ++ V + AL LH I+HRD
Sbjct: 86 IVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL------RYLHKEKRIVHRD 139
Query: 54 LKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 113
L P N++L ED K + + DFGLA+++ +T+ GT + PE+ + E Y
Sbjct: 140 LTPNNIMLGEDDK-VTITDFGLAKQKQPESKLTSVVGTILYSCPEIV------KNEP--Y 190
Query: 114 NHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV-PEELSIILTSCW 172
K D ++F +L+++ + PF + L A P E + E+++ ++TSC
Sbjct: 191 GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCL 250
Query: 173 KEDPNARPNFTQIIQML 189
D ARP+ Q+ M+
Sbjct: 251 TPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-15
Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 29/206 (14%)
Query: 2 VIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 57
V++ + G L +LL R P+ L + + F DIA ME L S IHRDL
Sbjct: 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAAR 141
Query: 58 NLLLTEDLKTIKLADFGLA---------REESLTEMMTAETGTYRWMAPELYSTVTLRQG 108
N +L E++ + +ADFGL+ R+ + +M +W+A E +
Sbjct: 142 NCMLNENM-NVCVADFGLSKKIYNGDYYRQGRIAKM------PVKWIAIESLA------- 187
Query: 109 EKKHYNHKVDSYSFAIVLWEL-LHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII 167
+ Y K D +SF + +WE+ + P+ G+ N + N + + L +
Sbjct: 188 -DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSL 246
Query: 168 LTSCWKEDPNARPNFTQIIQMLLNYL 193
++SCW +P RP+F + L L
Sbjct: 247 MSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-15
Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 10/188 (5%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ IV GG L L + + L + + + IA A++ LH I+HRDLK +N+
Sbjct: 75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVF 134
Query: 61 LTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
LT IK+ D G+AR E+ +M + GT +M+PEL+S K YN+K D
Sbjct: 135 LTRT-NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN--------KPYNYKSDV 185
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 179
++ ++E+ K F Y + P ++ EL ++ + + P R
Sbjct: 186 WALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKR 245
Query: 180 PNFTQIIQ 187
P+ I++
Sbjct: 246 PSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 4e-15
Identities = 39/113 (34%), Positives = 53/113 (46%), Gaps = 16/113 (14%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGT- 91
I R ++ LHS +IHRDLKP N+L+ + +K+ DFGLAR +E +T T
Sbjct: 112 ILRGLKYLHSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 92 -YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 143
YR APEL Y +D +S + ELL K F G +
Sbjct: 171 WYR--APELL-------LSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-15
Identities = 50/134 (37%), Positives = 72/134 (53%), Gaps = 12/134 (8%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
V + ++GG L +L R R A +A +IA A+ LHS II+RDLKPEN+LL +
Sbjct: 74 VLDYVNGGELFFHL--QRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL-D 130
Query: 64 DLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 122
+ L DFGL +E T+ GT ++APE+ LR K+ Y+ VD +
Sbjct: 131 SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV-----LR---KQPYDRTVDWWCL 182
Query: 123 AIVLWELLHNKLPF 136
VL+E+L+ PF
Sbjct: 183 GAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-15
Identities = 47/163 (28%), Positives = 78/163 (47%), Gaps = 20/163 (12%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 92
F I + + LH+ GIIHRD+K N+L+ ++ IK++DFG++++ + T T
Sbjct: 111 FVRQILKGLNYLHNRGIIHRDIKGANILV-DNKGGIKISDFGISKKLEANSLSTK-TNGA 168
Query: 93 R--------WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 144
R WMAPE+ ++ Y K D +S ++ E+L K PF + LQA
Sbjct: 169 RPSLQGSVFWMAPEVV--------KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA 220
Query: 145 AYAAAFKNVRPS-AENVPEELSIILTSCWKEDPNARPNFTQII 186
+ +N P N+ E L ++ D N RP +++
Sbjct: 221 IFKIG-ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 6e-15
Identities = 44/103 (42%), Positives = 57/103 (55%), Gaps = 12/103 (11%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW-M 95
I R ++ +HS GIIHRDLKP N+ + ED + +K+ DFGLAR + MT T RW
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCE-LKILDFGLAR--HTDDEMTGYVAT-RWYR 182
Query: 96 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
APE + L HYN VD +S ++ ELL K F G
Sbjct: 183 APE----IML---NWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-15
Identities = 50/136 (36%), Positives = 70/136 (51%), Gaps = 14/136 (10%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
VTELL GT LL RP L+ F I R ++ +HS G++HRDLKP N+L+
Sbjct: 87 FVTELL--GTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN 142
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 122
E+ +K+ DFGLAR + MT T + APE+ T + Y+ +VD +S
Sbjct: 143 ENCD-LKICDFGLARIQD--PQMTGYVSTRYYRAPEIMLTW-------QKYDVEVDIWSA 192
Query: 123 AIVLWELLHNKLPFEG 138
+ E+L K F G
Sbjct: 193 GCIFAEMLEGKPLFPG 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 53/191 (27%), Positives = 82/191 (42%), Gaps = 22/191 (11%)
Query: 6 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 65
E + GG R L N+ L A + ++ A++ LH G IHRDLKPEN L+
Sbjct: 81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS- 137
Query: 66 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIV 125
IKL DFGL++ + + G+ +MAPE+ +G+ Y+ VD +S +
Sbjct: 138 GHIKLTDFGLSKG--IVTYANSVVGSPDYMAPEVL------RGKG--YDFTVDYWSLGCM 187
Query: 126 LWELLHNKLPFEGMSNLQAAYAAA--FKNV--RPSAENVPEELSI----ILTSCWKEDPN 177
L+E L PF G S + +K RP ++ LS ++T +
Sbjct: 188 LYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSR 246
Query: 178 ARPNFTQIIQM 188
+ I
Sbjct: 247 RFGSLEDIKNH 257
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-14
Identities = 50/146 (34%), Positives = 77/146 (52%), Gaps = 12/146 (8%)
Query: 44 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 103
LHSH +IHRD+K N+LLTE +KLADFG A S + + GT WMAPE+ +
Sbjct: 137 LHSHNMIHRDIKAGNILLTEP-GQVKLADFGSA---SKSSPANSFVGTPYWMAPEV--IL 190
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN--VP 161
+ +G+ Y+ KVD +S I EL K P M+ + A Y A +N P+ ++
Sbjct: 191 AMDEGQ---YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNDSPTLQSNEWT 246
Query: 162 EELSIILTSCWKEDPNARPNFTQIIQ 187
+ + C ++ P RP ++++
Sbjct: 247 DSFRGFVDYCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-14
Identities = 50/205 (24%), Positives = 94/205 (45%), Gaps = 48/205 (23%)
Query: 3 IVTELLSGGTLRKYLLNMRPRC-----LDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 57
++T+L+ G L Y+ + L+ CV IA+ M L ++HRDL
Sbjct: 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLEERRLVHRDLAAR 138
Query: 58 NLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---------RWMAPELYSTVTLRQG 108
N+L+ + + +K+ DFGLA+ ++ A+ Y +WMA L
Sbjct: 139 NVLV-KTPQHVKITDFGLAK------LLGADEKEYHAEGGKVPIKWMA--------LESI 183
Query: 109 EKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE----- 162
+ Y H+ D +S+ + +WEL+ P++G+ A+ ++ E +P+
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP------ASEISSILEKGERLPQPPICT 237
Query: 163 -ELSIILTSCWKEDPNARPNFTQII 186
++ +I+ CW D ++RP F ++I
Sbjct: 238 IDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-14
Identities = 40/138 (28%), Positives = 73/138 (52%), Gaps = 9/138 (6%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V +++GG L+ ++ NM + A+ +A +I +E LH ++RDLKPEN+L
Sbjct: 75 LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENIL 134
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
L +D I+++D GLA + E + GT +MAPE+ + + Y D +
Sbjct: 135 L-DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN--------QRYTLSPDYW 185
Query: 121 SFAIVLWELLHNKLPFEG 138
+++E++ + PF G
Sbjct: 186 GLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-14
Identities = 59/185 (31%), Positives = 98/185 (52%), Gaps = 20/185 (10%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
++ + ++GG L +L + R R + V I ++ +I A+E LH GII+RD+K EN+LL
Sbjct: 82 LILDYINGGELFTHL-SQRERFKEQEVQI-YSGEIVLALEHLHKLGIIYRDIKLENILLD 139
Query: 63 EDLKTIKLADFGLARE--ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
+ + L DFGL++E E E + GT +MAP++ +R G+ H + VD +
Sbjct: 140 SN-GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI-----VRGGDGGH-DKAVDWW 192
Query: 121 SFAIVLWELLHNKLPF--EGMSNLQAAYAAAFKNVRPSAENVPEELSI----ILTSCWKE 174
S ++++ELL PF +G N QA + + + S P+E+S I+ +
Sbjct: 193 SMGVLMYELLTGASPFTVDGEKNSQAEIS---RRILKSEPPYPQEMSALAKDIIQRLLMK 249
Query: 175 DPNAR 179
DP R
Sbjct: 250 DPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-14
Identities = 55/195 (28%), Positives = 89/195 (45%), Gaps = 22/195 (11%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-ALDIARAMECLHSHGIIHRDLKPENLLL 61
I E + GG+L L + D I F I ++ LH + I+HRD+K +N+L+
Sbjct: 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLV 141
Query: 62 TEDLKTIKLADFG----LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKV 117
+K++DFG LA TE TGT ++MAPE+ + +G + Y
Sbjct: 142 NTYSGVVKISDFGTSKRLAGINPCTETF---TGTLQYMAPEV-----IDKGPRG-YGAPA 192
Query: 118 DSYSFAIVLWELLHNKLPFEGMSNLQAA-YAAAFKNVRPSAENVPEELSI----ILTSCW 172
D +S + E+ K PF + QAA + + P +PE LS + C+
Sbjct: 193 DIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP---EIPESLSAEAKNFILRCF 249
Query: 173 KEDPNARPNFTQIIQ 187
+ DP+ R + ++Q
Sbjct: 250 EPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-14
Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 38/220 (17%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE-SLTEMMTAETGT 91
+ +I A+ LHS +++RDLK ENL+L +D IK+ DFGL +E S M GT
Sbjct: 100 YGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGT 158
Query: 92 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 151
++APE+ E Y VD + +V++E++ +LPF + + +
Sbjct: 159 PEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 210
Query: 152 NVR-PSAENVPEELSIILTSCWKEDPNAR--------------PNFTQIIQMLLNYLSAI 196
+R P + E +L K+DP R F I + +
Sbjct: 211 EIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDV-VQKKL 267
Query: 197 APP-EPMIPH----RIFNSENT-----ILPPESPGTSSLM 226
PP +P + R F+ E T I PP+ + L+
Sbjct: 268 EPPFKPQVTSETDTRYFDEEFTAQSITITPPDRYDSLGLL 307
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-14
Identities = 56/197 (28%), Positives = 87/197 (44%), Gaps = 25/197 (12%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+ E ++GG++ L V I + + R + LH + IIHRD+K NLL+
Sbjct: 80 LFVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID 137
Query: 63 EDLKTIKLADFGLAREESLTEMMTAE-----TGTYRWMAPELYSTVTLRQGEKKHYNHKV 117
+ +++ADFG A + E GT +MAPE+ LR GE+ Y
Sbjct: 138 STGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV-----LR-GEQ--YGRSC 189
Query: 118 DSYSFAIVLWELLHNKLPF--EGMSN-LQAAYAAAFKNVRPSAENVPEELSI----ILTS 170
D +S V+ E+ K P+ E SN L + A PS +PE LS +
Sbjct: 190 DVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS---IPEHLSPGLRDVTLR 246
Query: 171 CWKEDPNARPNFTQIIQ 187
C + P RP ++++
Sbjct: 247 CLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-14
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 26/225 (11%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E GG L LLN D +A + ++ A+ +H G +HRD+KPEN+L+
Sbjct: 78 LVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI- 135
Query: 63 EDLKTIKLADFGLAREESLTEMMTAE--TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
+ IKLADFG A + +M+ ++ GT ++APE+ + T+ K Y + D +
Sbjct: 136 DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT--TMNGDGKGTYGVECDWW 193
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
S ++ +E+++ + PF + A + N+ N L + EDP
Sbjct: 194 SLGVIAYEMIYGRSPFH-----EGTSAKTYNNIM----NFQRFLK------FPEDPKVSS 238
Query: 181 NFTQIIQMLLNYLSAIAPPEPMIPHRIF-----NSENTILPPESP 220
+F +IQ LL E + H F N+ LPP P
Sbjct: 239 DFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVP 283
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-14
Identities = 44/152 (28%), Positives = 80/152 (52%), Gaps = 12/152 (7%)
Query: 40 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMA 96
A+ +HS +IHRD+K N+LL + +KL DFG ++ + T ++ GT ++A
Sbjct: 155 AVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213
Query: 97 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 156
PE++ +K Y+ K D +S ++L+ELL K PF+G + + + P
Sbjct: 214 PEIW--------RRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL 265
Query: 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188
++ E+ I+T+ DP RP+ ++++ M
Sbjct: 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-14
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 27/207 (13%)
Query: 1 MVIVTELLSGGTLRKYL----------LNMRPRC----LDVCVAIGFALDIARAMECLHS 46
+++V E + G L K+L ++ +PR L + + A IA M L S
Sbjct: 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS 141
Query: 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTV 103
+HRDL N L+ +L +K+ DFG++R+ T+ T RWM PE ++
Sbjct: 142 QHFVHRDLATRNCLVGANL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE---SI 197
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE 162
R+ + + D +SF ++LWE+ + K P+ +SN + V P+
Sbjct: 198 MYRK-----FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPK 252
Query: 163 ELSIILTSCWKEDPNARPNFTQIIQML 189
E+ I+ CW+ +P R N +I ++L
Sbjct: 253 EVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-14
Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 22/187 (11%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V L++GG L+ ++ +M + A+ +A +I +E LH I++RDLKPEN+L
Sbjct: 75 LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENIL 134
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
L +D I+++D GLA + + GT +MAPE+ + + Y D +
Sbjct: 135 L-DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--------KNERYTFSPDWW 185
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWK------- 173
+ +L+E++ + PF+ Q + V + V EE S + +
Sbjct: 186 ALGCLLYEMIAGQSPFQ-----QRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLL 240
Query: 174 -EDPNAR 179
+DP R
Sbjct: 241 CKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-14
Identities = 51/134 (38%), Positives = 73/134 (54%), Gaps = 12/134 (8%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
V + ++GG L +L R RC A +A ++A A+ LHS II+RDLKPEN+LL
Sbjct: 74 VLDYVNGGELFFHL--QRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDS 131
Query: 64 DLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 122
+ L DFGL +E E T+ GT ++APE+ LR K+ Y+ VD +
Sbjct: 132 QGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPEV-----LR---KEPYDRTVDWWCL 182
Query: 123 AIVLWELLHNKLPF 136
VL+E+L+ PF
Sbjct: 183 GAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-14
Identities = 55/187 (29%), Positives = 91/187 (48%), Gaps = 15/187 (8%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I+ E L GG+ L P LD +I + ++ LHS IHRD+K N+LL+
Sbjct: 79 IIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS 135
Query: 63 EDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
E +KLADFG+A + + T++ GT WMAPE+ ++ Y+ K D +S
Sbjct: 136 EH-GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--------KQSAYDSKADIWS 186
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE-NVPEELSIILTSCWKEDPNARP 180
I EL + P + ++ + KN P+ E N + L + +C ++P+ RP
Sbjct: 187 LGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 245
Query: 181 NFTQIIQ 187
++++
Sbjct: 246 TAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-14
Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 13/150 (8%)
Query: 34 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY- 92
A IA M L S +HRDL N L+ + L +K+ DFG++R+ T+ T
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 93 --RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAA 149
RWM PE ++ R+ + + D +SF +VLWE+ + K P+ +SN +A
Sbjct: 187 PIRWMPPE---SILYRK-----FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238
Query: 150 FKNVRPSAENVPEELSIILTSCWKEDPNAR 179
P E+ I+ CW+ +P R
Sbjct: 239 QGRELERPRTCPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-14
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 31/212 (14%)
Query: 3 IVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 59
+V E L GG L + + R + VC L + RA+ LH+ G+IHRD+K +++
Sbjct: 96 VVMEFLEGGALTDIVTHTRMNEEQIATVC------LSVLRALSYLHNQGVIHRDIKSDSI 149
Query: 60 LLTEDLKTIKLADFGL-AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
LLT D + IKL+DFG A+ + GT WMAPE+ S + Y +VD
Sbjct: 150 LLTSDGR-IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP--------YGTEVD 200
Query: 119 SYSFAIVLWELLH------NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCW 172
+S I++ E++ N+ P + M ++ K+ + + L ++L
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLV--- 257
Query: 173 KEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 204
+P+ R +++Q +L PP ++P
Sbjct: 258 -REPSQRATAQELLQH--PFLKLAGPPSCIVP 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-14
Identities = 52/151 (34%), Positives = 76/151 (50%), Gaps = 16/151 (10%)
Query: 44 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 103
LHSH +IHRD+K N+LL+E +KL DFG A S+ GT WMAPE+ +
Sbjct: 131 LHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSA---SIMAPANXFVGTPYWMAPEV--IL 184
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--SAENVP 161
+ +G+ Y+ KVD +S I EL K P M+ + A Y A +N P + +
Sbjct: 185 AMDEGQ---YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPALQSGHWS 240
Query: 162 EELSIILTSCWKEDPNARPNFTQIIQMLLNY 192
E + SC ++ P RP ++LL +
Sbjct: 241 EYFRNFVDSCLQKIPQDRPT----SEVLLKH 267
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 5e-14
Identities = 43/141 (30%), Positives = 69/141 (48%), Gaps = 14/141 (9%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
V+V E + L + L + R L + + + + +H++GI+HRDLKP NLL
Sbjct: 74 FVLVMEYM-PSDLSEVLRD-EERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLL 131
Query: 61 LTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPE-LYSTVTLRQGEKKHYNHKV 117
++ D +K+ADFGLAR E + + + T + APE LY + Y+ V
Sbjct: 132 ISAD-GVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG--------ARKYDPGV 182
Query: 118 DSYSFAIVLWELLHNKLPFEG 138
D ++ + ELL+ F G
Sbjct: 183 DLWAVGCIFAELLNGSPLFPG 203
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-14
Identities = 42/136 (30%), Positives = 72/136 (52%), Gaps = 9/136 (6%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V +++GG L+ ++ NM D AI +A ++ +E L I++RDLKPEN+L
Sbjct: 75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENIL 134
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
L +D I+++D GLA + E + GT +MAPE+ EK Y D +
Sbjct: 135 L-DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI------NNEK--YTFSPDWW 185
Query: 121 SFAIVLWELLHNKLPF 136
+++E++ + PF
Sbjct: 186 GLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-14
Identities = 40/112 (35%), Positives = 67/112 (59%), Gaps = 12/112 (10%)
Query: 29 VAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE 88
A+ +A +IA + LHS GII+RDLK +N++L + IK+ADFG+ + E++ T
Sbjct: 102 HAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCK-ENIFGGKTTR 159
Query: 89 T--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
T GT ++APE+ + + Y VD ++F ++L+E+L + PF+G
Sbjct: 160 TFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 6e-14
Identities = 50/151 (33%), Positives = 76/151 (50%), Gaps = 15/151 (9%)
Query: 44 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GTYRWMAPELY 100
LH G IHRD+K N+LLTED +KLADFG++ + LT + GT WMAPE+
Sbjct: 117 LHETGKIHRDIKGANILLTED-GDVKLADFGVSAQ--LTATIAKRKSFIGTPYWMAPEVA 173
Query: 101 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160
+ V + G Y+ K D ++ I EL + P + ++A + + N P
Sbjct: 174 A-VERKGG----YDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKD 228
Query: 161 PEELSII----LTSCWKEDPNARPNFTQIIQ 187
E+ S + + C +DP RP T+++Q
Sbjct: 229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-14
Identities = 39/95 (41%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 44 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 103
LHS GIIHRDLKP N+++ D T+K+ DFGLAR + MMT T + APE V
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPE----V 188
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
L G Y VD +S ++ E++ + F G
Sbjct: 189 ILGMG----YKENVDIWSVGCIMGEMIRGTVLFPG 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 8e-14
Identities = 51/188 (27%), Positives = 91/188 (48%), Gaps = 12/188 (6%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ IV E GG L + + R + + + + + ++ +H ++HRD+K +N+
Sbjct: 73 LYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIF 132
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
LT++ K +KL DFG AR + + A T GT ++ PE++ E YN+K D
Sbjct: 133 LTQNGK-VKLGDFGSARLLT-SPGAYACTYVGTPYYVPPEIW--------ENMPYNNKSD 182
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNA 178
+S +L+EL K PF+ S + +P + EL ++ +K +P +
Sbjct: 183 IWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRS 242
Query: 179 RPNFTQII 186
RP+ T I+
Sbjct: 243 RPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-14
Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 15/187 (8%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I+ E L GG+ L +P L+ +I + ++ LHS IHRD+K N+LL+
Sbjct: 79 IIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS 135
Query: 63 EDLKTIKLADFGLAREESLTEMM-TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
E +KLADFG+A + + T++ GT WMAPE+ ++ Y+ K D +S
Sbjct: 136 EQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--------KQSAYDFKADIWS 186
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE-NVPEELSIILTSCWKEDPNARP 180
I EL + P + ++ + KN P+ E + + +C +DP RP
Sbjct: 187 LGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYSKPFKEFVEACLNKDPRFRP 245
Query: 181 NFTQIIQ 187
++++
Sbjct: 246 TAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-13
Identities = 45/145 (31%), Positives = 69/145 (47%), Gaps = 12/145 (8%)
Query: 3 IVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 59
+V E L L+K++ + R L F + + + H HG++HRDLKP+NL
Sbjct: 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNL 141
Query: 60 LLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
L+ + +K+AD GL R S+ + T E T + APE+ T HY+ VD
Sbjct: 142 LVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST-------HYSTPVD 194
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQ 143
+S + E+ + F G S LQ
Sbjct: 195 IWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 65/242 (26%), Positives = 104/242 (42%), Gaps = 38/242 (15%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ V E ++GG L ++ + R D A +A +I A+ LH GII+RDLK +N+L
Sbjct: 71 LFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVL 128
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
L + KLADFG+ +E T+ GT ++APE+ ++ Y VD
Sbjct: 129 LDHE-GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL--------QEMLYGPSVDW 179
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 179
++ ++L+E+L PFE N + A + + ++ IL + ++P R
Sbjct: 180 WAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMR 238
Query: 180 ---------------PNFTQIIQMLLNYLSAIAPP-EPMIPHR--------IFNSENTIL 215
P F ++ LN I PP P I R F E+ +L
Sbjct: 239 LGSLTLGGEEAILRHPFFKELDWEKLNR-RQIEPPFRPRIKSREDVSNFDPDFIKEDPVL 297
Query: 216 PP 217
P
Sbjct: 298 TP 299
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 39/100 (39%), Positives = 55/100 (55%), Gaps = 10/100 (10%)
Query: 39 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 98
R ++ +HS GIIHRDLKP N+ + ED + +++ DFGLAR+ + MT T + APE
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNVAVNEDCE-LRILDFGLARQAD--DEMTGYVATRWYRAPE 185
Query: 99 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
+ HYN VD +S ++ ELL K F G
Sbjct: 186 IMLNWM-------HYNQTVDIWSVGCIMAELLKGKALFPG 218
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-13
Identities = 46/188 (24%), Positives = 84/188 (44%), Gaps = 14/188 (7%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+VT+L+ G L Y+ + R + + + + IA+ M L ++HRDL N+L+
Sbjct: 85 LVTQLMPYGCLLDYVRENKDR-IGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV- 142
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETG---TYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
+ +K+ DFGLAR + E G +WMA L + + H+ D
Sbjct: 143 KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA--------LESILHRRFTHQSDV 194
Query: 120 YSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNA 178
+S+ + +WEL+ P++G+ + P ++ +I+ CW D
Sbjct: 195 WSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSEC 254
Query: 179 RPNFTQII 186
RP F +++
Sbjct: 255 RPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-13
Identities = 51/187 (27%), Positives = 75/187 (40%), Gaps = 45/187 (24%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---R 93
+ +A+ HSH IIHRD+KPEN+L++E +KL DFG AR +L + Y R
Sbjct: 109 LLQAIAYCHSHNIIHRDIKPENILVSESG-VLKLCDFGFAR--ALRARPASPLTDYVATR 165
Query: 94 WM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY------ 146
W APEL T +Y VD ++ ++ ELL + F G S++ Y
Sbjct: 166 WYRAPELLVGDT-------NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCL 218
Query: 147 --------AAAFKNVRPSAENVPEELSII-----------------LTSCWKEDPNARPN 181
N R + PE L +C + DP R
Sbjct: 219 GPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278
Query: 182 FTQIIQM 188
+++Q
Sbjct: 279 CDELLQH 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-13
Identities = 52/181 (28%), Positives = 90/181 (49%), Gaps = 15/181 (8%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ V E ++GG L +L R R + +I A++ LHS I++RDLK ENL+
Sbjct: 70 LCFVMEYVNGGELFFHL--SRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLM 127
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
L +D IK+ DFGL + E +T+ T +T GT ++APE+ E Y VD
Sbjct: 128 LDKD-GHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVL--------EDNDYGRAVD 177
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNA 178
+ +V++E++ +LPF + + ++++ + + +L+ +DPN
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK-FPRTLSADAKSLLSGLLIKDPNK 236
Query: 179 R 179
R
Sbjct: 237 R 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-13
Identities = 50/138 (36%), Positives = 71/138 (51%), Gaps = 14/138 (10%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
++ E LSGG L +L R A + +I+ A+E LH GII+RDLKPEN+LL
Sbjct: 77 LILEYLSGGELFMHL--EREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD 134
Query: 63 EDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
+KL DFGL + ES+ E T GT +MAPE+ R G + VD +
Sbjct: 135 AQ-GHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMAPEILM----RSG----HGKAVDWW 184
Query: 121 SFAIVLWELLHNKLPFEG 138
S +++++L PF
Sbjct: 185 SLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-13
Identities = 43/135 (31%), Positives = 73/135 (54%), Gaps = 12/135 (8%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
V E ++GG L + R R D + +A ++ A+ LH HG+I+RDLK +N+LL
Sbjct: 74 VMEYVNGGDLMFQI--QRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDA 131
Query: 64 DLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 122
+ KLADFG+ +E L + T GT ++APE+ ++ Y VD ++
Sbjct: 132 E-GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL--------QELEYGPSVDWWAL 182
Query: 123 AIVLWELLHNKLPFE 137
++++E++ + PFE
Sbjct: 183 GVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-13
Identities = 40/106 (37%), Positives = 56/106 (52%), Gaps = 10/106 (9%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMA 96
I R ++ +HS IIHRDLKP NL + ED + +K+ DFGLAR + MT T + A
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTD--DEMTGYVATRWYRA 185
Query: 97 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 142
PE+ HYN VD +S ++ ELL + F G ++
Sbjct: 186 PEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 224
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-13
Identities = 39/111 (35%), Positives = 57/111 (51%), Gaps = 8/111 (7%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT 91
+ I R + HSH ++HRDLKP+NLL+ +KLADFGLAR + T E T
Sbjct: 107 YLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVT 166
Query: 92 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 142
+ APE+ +HY+ VD +S + E+++ K F G S +
Sbjct: 167 LWYRAPEILLG-------SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI 210
|
Length = 294 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-13
Identities = 40/110 (36%), Positives = 65/110 (59%), Gaps = 10/110 (9%)
Query: 30 AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE- 88
A+ +A +IA + LHS GII+RDLK +N++L + IK+ADFG+ +E + T
Sbjct: 103 AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGVTTKTF 161
Query: 89 TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
GT ++APE+ + + Y VD ++F ++L+E+L + PFEG
Sbjct: 162 CGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-13
Identities = 37/109 (33%), Positives = 60/109 (55%), Gaps = 7/109 (6%)
Query: 30 AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET 89
A + ++ A++ +HS G IHRD+KP+N+LL + +KLADFG + M+ +T
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANGMVRCDT 202
Query: 90 --GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 136
GT +++PE V QG +Y + D +S + L+E+L PF
Sbjct: 203 AVGTPDYISPE----VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-13
Identities = 48/138 (34%), Positives = 67/138 (48%), Gaps = 14/138 (10%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVC--VAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
I E GG+L ++ R + V A + + + LHS IIHRD+KP N+L
Sbjct: 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNIL 137
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR-QGEKKHYNHKVDS 119
LT +KL DFG++ E + T TGT +MAPE R QG K Y+ D
Sbjct: 138 LTRK-GQVKLCDFGVSGELVNSLAGTF-TGTSFYMAPE-------RIQG--KPYSITSDV 186
Query: 120 YSFAIVLWELLHNKLPFE 137
+S + L E+ N+ PF
Sbjct: 187 WSLGLTLLEVAQNRFPFP 204
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-13
Identities = 43/144 (29%), Positives = 80/144 (55%), Gaps = 22/144 (15%)
Query: 1 MVIVTELLSGGTLRKYLLNM----RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 56
+ V E ++GG L ++ + P+ A+ +A +I+ + LH GII+RDLK
Sbjct: 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQ------AVFYAAEISVGLFFLHRRGIIYRDLKL 129
Query: 57 ENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYN 114
+N++L + IK+ADFG+ + E + + +T T GT ++APE+ + + Y
Sbjct: 130 DNVMLDSE-GHIKIADFGMCK-EHMVDGVTTRTFCGTPDYIAPEIIAY--------QPYG 179
Query: 115 HKVDSYSFAIVLWELLHNKLPFEG 138
VD +++ ++L+E+L + PF+G
Sbjct: 180 KSVDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-13
Identities = 48/161 (29%), Positives = 69/161 (42%), Gaps = 19/161 (11%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E L+GG + + L A + ++ +E LH GIIHRD+KPENLL+
Sbjct: 74 LVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID 131
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 122
+ +KL DFGL+R GT ++APE + D +S
Sbjct: 132 QT-GHLKLTDFGLSR---NGLENKKFVGTPDYLAPETI--------LGVGDDKMSDWWSL 179
Query: 123 AIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 163
V++E L PF + A F N+ N PEE
Sbjct: 180 GCVIFEFLFGYPPFHAETP-----DAVFDNILSRRINWPEE 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-13
Identities = 56/195 (28%), Positives = 92/195 (47%), Gaps = 22/195 (11%)
Query: 3 IVTELLSGGTLRKYLLNM-----RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 57
I+ E GG + +L + P+ +C + A++ LHS IIHRDLK
Sbjct: 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVIC------RQMLEALQYLHSMKIIHRDLKAG 139
Query: 58 NLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 116
N+LLT D IKLADFG++ + T + + GT WMAPE+ T++ Y++K
Sbjct: 140 NVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP---YDYK 195
Query: 117 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI----ILTSCW 172
D +S I L E+ + P ++ ++ A P + P + S+ L +
Sbjct: 196 ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA--KSEPPTLSQPSKWSMEFRDFLKTAL 253
Query: 173 KEDPNARPNFTQIIQ 187
+ P RP+ Q+++
Sbjct: 254 DKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-13
Identities = 47/137 (34%), Positives = 74/137 (54%), Gaps = 12/137 (8%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ V + ++GG L +L R R A +A +IA A+ LHS I++RDLKPEN+L
Sbjct: 71 LYFVLDFVNGGELFFHL--QRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENIL 128
Query: 61 LTEDLKTIKLADFGLAREE-SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
L + + L DFGL +E + ++ T GT ++APE+ K+ Y++ VD
Sbjct: 129 L-DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI--------RKQPYDNTVDW 179
Query: 120 YSFAIVLWELLHNKLPF 136
+ VL+E+L+ PF
Sbjct: 180 WCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 5e-13
Identities = 43/113 (38%), Positives = 56/113 (49%), Gaps = 18/113 (15%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTE--DLKTIKLADFGLAR----EESLTEMMT 86
F I R ++ +HS ++HRDLKP NLLL DL K+ DFGLAR E T +T
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDL---KICDFGLARIADPEHDHTGFLT 167
Query: 87 AETGTYRWM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
T RW APE+ K Y +D +S +L E+L N+ F G
Sbjct: 168 EYVAT-RWYRAPEIMLN-------SKGYTKAIDIWSVGCILAEMLSNRPLFPG 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 6e-13
Identities = 40/108 (37%), Positives = 57/108 (52%), Gaps = 18/108 (16%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE------TG 90
+ ++ LHS+GI+HRD+K N+L+ D +KLADFGLAR T+ +A+ T
Sbjct: 109 LLEGLQYLHSNGILHRDIKGSNILINND-GVLKLADFGLAR--PYTKRNSADYTNRVITL 165
Query: 91 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
YR PEL G + Y +VD +S +L EL K F+G
Sbjct: 166 WYR--PPELL------LGATR-YGPEVDMWSVGCILAELFLGKPIFQG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-13
Identities = 49/137 (35%), Positives = 72/137 (52%), Gaps = 12/137 (8%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ V + ++GG L +L R RC A +A +IA A+ LHS I++RDLKPEN+L
Sbjct: 71 LYFVLDYINGGELFYHL--QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL 128
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
L + I L DFGL +E T+ GT ++APE+ K+ Y+ VD
Sbjct: 129 L-DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL--------HKQPYDRTVDW 179
Query: 120 YSFAIVLWELLHNKLPF 136
+ VL+E+L+ PF
Sbjct: 180 WCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-13
Identities = 44/133 (33%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 35 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW 94
+ R ++ LHSH ++HRDLKP+N+L+T IKLADFGLAR S +T+ T +
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWY 175
Query: 95 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 154
APE+ L Q Y VD +S + E+ K F G S++ +
Sbjct: 176 RAPEV-----LLQSS---YATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIG 226
Query: 155 -PSAENVPEELSI 166
P E+ P ++++
Sbjct: 227 LPGEEDWPRDVAL 239
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-13
Identities = 52/170 (30%), Positives = 88/170 (51%), Gaps = 17/170 (10%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCV--AIGFALDIARAMECLHSHGIIHRDLKPEN 58
+ +V E + GG L + N DV A + ++ A++ +HS G+IHRD+KP+N
Sbjct: 118 LYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDN 172
Query: 59 LLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHK 116
+LL + +KLADFG + T M+ +T GT +++PE+ + QG +Y +
Sbjct: 173 MLL-DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS----QGGDGYYGRE 227
Query: 117 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI 166
D +S + L+E+L PF S L Y+ + ++ N PE++ I
Sbjct: 228 CDWWSVGVFLFEMLVGDTPFYADS-LVGTYSKIMDH--KNSLNFPEDVEI 274
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-13
Identities = 46/123 (37%), Positives = 61/123 (49%), Gaps = 19/123 (15%)
Query: 26 DVCVAIGFALDIAR------AMEC----LHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 75
++C I LD R M C LHS GIIHRDLKP N+++ D T+K+ DFGL
Sbjct: 114 NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGL 172
Query: 76 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP 135
AR + MMT T + APE V L G Y VD +S ++ E++ +
Sbjct: 173 ARTAGTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMIKGGVL 224
Query: 136 FEG 138
F G
Sbjct: 225 FPG 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 8e-13
Identities = 48/197 (24%), Positives = 92/197 (46%), Gaps = 34/197 (17%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+VT+L G+L ++ R LD + + + IA+ M L H ++HR+L N+LL
Sbjct: 85 LVTQLSPLGSLLDHVRQHRDS-LDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK 143
Query: 63 EDLKTIKLADFGLA-------REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 115
D +++ADFG+A ++ +E T +WMA E ++ + Y H
Sbjct: 144 SDSI-VQIADFGVADLLYPDDKKYFYSEHKTP----IKWMALE---SILFGR-----YTH 190
Query: 116 KVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE------ELSIIL 168
+ D +S+ + +WE++ + P+ GM ++ E + + ++ +++
Sbjct: 191 QSDVWSYGVTVWEMMSYGAEPYAGM------RPHEVPDLLEKGERLAQPQICTIDVYMVM 244
Query: 169 TSCWKEDPNARPNFTQI 185
CW D N RP F ++
Sbjct: 245 VKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 33/213 (15%)
Query: 3 IVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 59
++ E L GG L + R + VC ++ +A+ LHS G+IHRD+K +++
Sbjct: 95 VLMEFLQGGALTDIVSQTRLNEEQIATVCESV------LQALCYLHSQGVIHRDIKSDSI 148
Query: 60 LLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
LLT D + +KL+DFG + S + GT WMAPE+ S + Y +VD
Sbjct: 149 LLTLDGR-VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS--------RTPYGTEVD 199
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR----PSAEN---VPEELSIILTSC 171
+S I++ E++ + P+ S +Q A K +R P +N + L L
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSPVQ-----AMKRLRDSPPPKLKNAHKISPVLRDFLERM 254
Query: 172 WKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 204
+P R +++ +L PE ++P
Sbjct: 255 LTREPQERATAQELLDH--PFLLQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-12
Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 11/108 (10%)
Query: 29 VAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE 88
VA + ++ A E LHS II+RDLKPENLLL +K+ DFG A++ + +
Sbjct: 119 VAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK-GHVKVTDFGFAKK--VPDRTFTL 175
Query: 89 TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 136
GT ++APE+ + K + VD ++ ++L+E + PF
Sbjct: 176 CGTPEYLAPEVI--------QSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-12
Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 13/186 (6%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I+ E L GG+ L R D +I + ++ LHS IHRD+K N+LL+
Sbjct: 79 IIMEYLGGGSALDLL---RAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS 135
Query: 63 EDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
E +KLADFG+A + + T++ GT WMAPE+ ++ Y+ K D +S
Sbjct: 136 EQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--------QQSAYDSKADIWS 186
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN 181
I EL + P M ++ + N + + +C +DP+ RP
Sbjct: 187 LGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPT 246
Query: 182 FTQIIQ 187
++++
Sbjct: 247 AKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-12
Identities = 38/107 (35%), Positives = 53/107 (49%), Gaps = 9/107 (8%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGT 91
F + R ++ +HS ++HRDLKP NLLL + +K+ DFGLAR S + MT T
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSEKGDFMTEYVVT 171
Query: 92 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
+ APEL + Y +D +S + ELL K F G
Sbjct: 172 RWYRAPELLLNCS-------EYTTAIDVWSVGCIFAELLGRKPLFPG 211
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 40/99 (40%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 44 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 103
LHS GIIHRDLKP N+++ D T+K+ DFGLAR MMT T + APE V
Sbjct: 139 LHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPE----V 193
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 142
L G Y VD +S ++ EL+ + F+G ++
Sbjct: 194 ILGMG----YKENVDIWSVGCIMGELVKGSVIFQGTDHI 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 53/192 (27%), Positives = 89/192 (46%), Gaps = 15/192 (7%)
Query: 3 IVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
IV EL G L + + + + R + + + + A+E +HS ++HRD+KP N+
Sbjct: 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVF 138
Query: 61 LTEDLKTIKLADFGLAR-EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
+T +KL D GL R S T + GT +M+PE + + YN K D
Sbjct: 139 ITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE--------RIHENGYNFKSDI 189
Query: 120 YSFAIVLWELLHNKLPFEG-MSNLQAAYAAAFKNVRP--SAENVPEELSIILTSCWKEDP 176
+S +L+E+ + PF G NL + + P +++ EEL ++ C DP
Sbjct: 190 WSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDP 249
Query: 177 NARPNFTQIIQM 188
RP+ T + +
Sbjct: 250 EKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 39/136 (28%), Positives = 70/136 (51%), Gaps = 13/136 (9%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
V E +GG L ++++ A+ +A + ++ LH + I++RDLK +NLLL
Sbjct: 80 VMEYAAGGDL---MMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDT 136
Query: 64 DLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 122
+ +K+ADFGL +E T+ GT ++APE+ + + Y VD +
Sbjct: 137 E-GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT--------ETSYTRAVDWWGL 187
Query: 123 AIVLWELLHNKLPFEG 138
++++E+L + PF G
Sbjct: 188 GVLIYEMLVGESPFPG 203
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-12
Identities = 49/188 (26%), Positives = 87/188 (46%), Gaps = 8/188 (4%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E G++ + N + L +I R + LH H +IHRD+K +N+LLT
Sbjct: 86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 145
Query: 63 EDLKTIKLADFGL-AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
E+ + +KL DFG+ A+ + GT WMAPE+ + + Y+ K D +S
Sbjct: 146 ENAE-VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV---IACDENPDATYDFKSDLWS 201
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--SAENVPEELSIILTSCWKEDPNAR 179
I E+ P M ++A + +N P ++ ++ + SC ++ + R
Sbjct: 202 LGITAIEMAEGAPPLCDMHPMRALFLIP-RNPAPRLKSKKWSKKFQSFIESCLVKNHSQR 260
Query: 180 PNFTQIIQ 187
P Q+++
Sbjct: 261 PTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 55/182 (30%), Positives = 89/182 (48%), Gaps = 16/182 (8%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENL 59
+ V E +GG L +L R R A + +I A++ LHS +++RDLK ENL
Sbjct: 70 LCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 127
Query: 60 LLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKV 117
+L +D IK+ DFGL + E + + T +T GT ++APE+ E Y V
Sbjct: 128 MLDKD-GHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVL--------EDNDYGRAV 177
Query: 118 DSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPN 177
D + +V++E++ +LPF + + + +R PE S +L+ K+DP
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKS-LLSGLLKKDPK 236
Query: 178 AR 179
R
Sbjct: 237 QR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-12
Identities = 47/123 (38%), Positives = 63/123 (51%), Gaps = 19/123 (15%)
Query: 26 DVCVAIGFALDIAR------AMEC----LHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 75
++C I LD R M C LHS GIIHRDLKP N+++ D T+K+ DFGL
Sbjct: 107 NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGL 165
Query: 76 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP 135
AR + MMT T + APE V L G Y VD +S ++ E++ +K+
Sbjct: 166 ARTAGTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMVRHKIL 217
Query: 136 FEG 138
F G
Sbjct: 218 FPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-12
Identities = 44/117 (37%), Positives = 62/117 (52%), Gaps = 11/117 (9%)
Query: 40 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAP 97
A+E LH + I++RDLKPEN+LL I L DFGL++ LT+ T T GT ++AP
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDAT-GHIALCDFGLSKAN-LTDNKTTNTFCGTTEYLAP 165
Query: 98 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 154
E V L ++K Y VD +S ++++E+ PF Q AF VR
Sbjct: 166 E----VLL---DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR 215
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-12
Identities = 42/114 (36%), Positives = 58/114 (50%), Gaps = 9/114 (7%)
Query: 32 GFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETG 90
L + R ++ LH + IIHRDLK NLLLT D +K+ADFGLAR + MT +
Sbjct: 112 CLMLQLLRGLQYLHENFIIHRDLKVSNLLLT-DKGCLKIADFGLARTYGLPAKPMTPKVV 170
Query: 91 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 144
T + APEL T Y +D ++ +L ELL +K G S ++
Sbjct: 171 TLWYRAPELLLGCT-------TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-12
Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 20/194 (10%)
Query: 3 IVTELLSGGTLRKYLLNMR-----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 57
I+ E +GG + +L + P+ VC A+ LH + IIHRDLK
Sbjct: 79 ILIEFCAGGAVDAVMLELERPLTEPQIRVVCK------QTLEALNYLHENKIIHRDLKAG 132
Query: 58 NLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 116
N+L T D IKLADFG++ + + T + + GT WMAPE+ V + + Y++K
Sbjct: 133 NILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV---VMCETSKDRPYDYK 188
Query: 117 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE---ELSIILTSCWK 173
D +S I L E+ + P ++ ++ A K+ P+ E L C +
Sbjct: 189 ADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTLAQPSRWSSEFKDFLKKCLE 247
Query: 174 EDPNARPNFTQIIQ 187
++ +AR TQ++Q
Sbjct: 248 KNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-12
Identities = 46/196 (23%), Positives = 83/196 (42%), Gaps = 16/196 (8%)
Query: 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 61
++V EL G L K+L + + + ++ M+ L +HRDL N+LL
Sbjct: 71 MLVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL 128
Query: 62 TEDLKTIKLADFGLAR----EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKV 117
K++DFGL++ +E+ + T +W APE + ++ K
Sbjct: 129 VTQ-HYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK--------FSSKS 179
Query: 118 DSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDP 176
D +SF +++WE + + P++GM + + P E+ ++ CW
Sbjct: 180 DVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGV 239
Query: 177 NARPNFTQIIQMLLNY 192
+ RP F + L NY
Sbjct: 240 DERPGFAVVELRLRNY 255
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-12
Identities = 48/180 (26%), Positives = 77/180 (42%), Gaps = 13/180 (7%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V ++GG L +L R D+ A + ++ A+E LH +I+RDLKPEN+L
Sbjct: 68 LYLVLAFINGGELFHHL--QREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENIL 125
Query: 61 LTEDLKTIKLADFGLAR-EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
L + I L DFGL + + GT ++APEL Y VD
Sbjct: 126 L-DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG--------YTKAVDW 176
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 179
++ ++L+E+L PF N+ Y + + + +L DP R
Sbjct: 177 WTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-12
Identities = 42/113 (37%), Positives = 62/113 (54%), Gaps = 12/113 (10%)
Query: 36 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE--ESLTEMMTAETGTYR 93
+I A+E LH GI++RD+K EN+LL + + L DFGL++E E + GT
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSE-GHVVLTDFGLSKEFLSEEKERTYSFCGTIE 171
Query: 94 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF--EGMSNLQA 144
+MAPE+ +G+ H VD +S I+++ELL PF EG N Q+
Sbjct: 172 YMAPEII------RGKGGH-GKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-12
Identities = 50/145 (34%), Positives = 81/145 (55%), Gaps = 16/145 (11%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ V E +SGG L ++ R R L A ++ +I+ A+ LH GII+RDLK +N+L
Sbjct: 71 LFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVL 128
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
L + IKL D+G+ + E + T T GT ++APE+ LR GE Y VD
Sbjct: 129 LDAE-GHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEI-----LR-GED--YGFSVD 178
Query: 119 SYSFAIVLWELLHNKLPFE--GMSN 141
++ ++++E++ + PF+ GMS+
Sbjct: 179 WWALGVLMFEMMAGRSPFDIVGMSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 6e-12
Identities = 41/95 (43%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 44 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 103
+HS GIIHRDLKP NL + ED + +K+ DFGLAR MT T + APE V
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCE-LKILDFGLAR--HADAEMTGYVVTRWYRAPE----V 185
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
L HYN VD +S ++ E+L K F+G
Sbjct: 186 ILNW---MHYNQTVDIWSVGCIMAEMLTGKTLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-12
Identities = 42/146 (28%), Positives = 73/146 (50%), Gaps = 7/146 (4%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCL-DVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 61
+V E G++ + N + L + +A +I R + LH+H +IHRD+K +N+LL
Sbjct: 96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAY-ICREILRGLAHLHAHKVIHRDIKGQNVLL 154
Query: 62 TEDLKTIKLADFGL-AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
TE+ + +KL DFG+ A+ + GT WMAPE+ + + Y+++ D +
Sbjct: 155 TENAE-VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV---IACDENPDATYDYRSDIW 210
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAY 146
S I E+ P M ++A +
Sbjct: 211 SLGITAIEMAEGAPPLCDMHPMRALF 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-12
Identities = 35/106 (33%), Positives = 61/106 (57%), Gaps = 7/106 (6%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--G 90
+ ++ A++ +HS G IHRD+KP+N+LL + +KLADFG + + M+ +T G
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRCDTAVG 205
Query: 91 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 136
T +++PE+ + QG +Y + D +S + L+E+L PF
Sbjct: 206 TPDYISPEVLKS----QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-12
Identities = 56/193 (29%), Positives = 92/193 (47%), Gaps = 15/193 (7%)
Query: 3 IVTELLSGGT---LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 59
+V EL +GG+ L K LL R LD + ++ LH++ IIHRD+K N+
Sbjct: 101 LVLELCNGGSVTELVKGLLICGQR-LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNI 159
Query: 60 LLTEDLKTIKLADFGLAREESLTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
LLT + +KL DFG++ + + T + GT WMAPE+ + Q Y+ + D
Sbjct: 160 LLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV---IACEQQYDYSYDARCD 215
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE----ELSIILTSCWKE 174
+S I EL P M ++ + +N P+ + PE + ++ C +
Sbjct: 216 VWSLGITAIELGDGDPPLFDMHPVKTLFKIP-RNPPPTLLH-PEKWCRSFNHFISQCLIK 273
Query: 175 DPNARPNFTQIIQ 187
D ARP+ T +++
Sbjct: 274 DFEARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 7e-12
Identities = 41/129 (31%), Positives = 66/129 (51%), Gaps = 9/129 (6%)
Query: 13 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 72
L+KY+ + LD + + + + + HSH ++HRDLKP+NLL+ + +KLAD
Sbjct: 84 LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE-GALKLAD 142
Query: 73 FGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH 131
FGLAR + T E T + APE + L + Y+ VD +S + E+++
Sbjct: 143 FGLARAFGVPVRTYTHEVVTLWYRAPE----ILLGS---RQYSTPVDIWSIGCIFAEMVN 195
Query: 132 NKLPFEGMS 140
+ F G S
Sbjct: 196 RRPLFPGDS 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-12
Identities = 35/113 (30%), Positives = 53/113 (46%), Gaps = 9/113 (7%)
Query: 18 LNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 77
L R R L + A+ I + LH+ IIHRD+K EN+ + D+ + + D G A+
Sbjct: 147 LTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI-NDVDQVCIGDLGAAQ 205
Query: 78 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 130
+ GT APE+ + + YN K D +S IVL+E+L
Sbjct: 206 FPVVAPAFLGLAGTVETNAPEVLA--------RDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 9e-12
Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 26/197 (13%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I E + GG++ L P L V + I + LH++ ++HRD+K N++L
Sbjct: 79 IFMEFVPGGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM 136
Query: 63 EDLKTIKLADFGLARE-------ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 115
+ IKL DFG AR + + M+ + GT WMAPE+ + + Y
Sbjct: 137 PN-GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN--------ESGYGR 187
Query: 116 KVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA-AAFKNVRPSAENVPEELSI----ILTS 170
K D +S ++E+ K P M L A + A + + P +P+ S +TS
Sbjct: 188 KSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR---LPDSFSAAAIDFVTS 244
Query: 171 CWKEDPNARPNFTQIIQ 187
C D + RP+ Q+++
Sbjct: 245 CLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-11
Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 13/146 (8%)
Query: 44 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-EESLTEMMTAETGTYRWMAPELYST 102
+H I+HRDLK +N+ L +L +K+ DFG++R ++ T TGT +M+PE
Sbjct: 122 MHQRRILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK- 178
Query: 103 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-AENVP 161
QG Y+ K D +S +L+E+ FEG N + + PS E
Sbjct: 179 ---HQG----YDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGPTPSLPETYS 230
Query: 162 EELSIILTSCWKEDPNARPNFTQIIQ 187
+L+ I+ S +DP+ RP+ +I++
Sbjct: 231 RQLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-11
Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 25/173 (14%)
Query: 31 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 90
+ AL IA M+ L S +HRDL N L+ E+L TIK+ADFG++R + +
Sbjct: 141 LHVALQIASGMKYLSSLNFVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGR 199
Query: 91 TY---RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH--NKLPFEGMSNLQAA 145
RWMA E + G+ + D ++F + LWE+L + P+ +++ Q
Sbjct: 200 AVLPIRWMAWE-----CILMGK---FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVI 251
Query: 146 YAAA--FKN-------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189
A F++ RP P+ L ++ CW D RP+F+ I L
Sbjct: 252 ENAGEFFRDQGRQVYLFRPPP--CPQGLYELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-11
Identities = 37/112 (33%), Positives = 54/112 (48%), Gaps = 15/112 (13%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-----ESLTEMMTA 87
F + R ++ +HS +IHRDLKP NLL+ ED +++ DFG+AR MT
Sbjct: 112 FLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTE 170
Query: 88 ETGTYRWM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
T RW APEL ++ Y +D +S + E+L + F G
Sbjct: 171 YVAT-RWYRAPELLLSL-------PEYTTAIDMWSVGCIFAEMLGRRQLFPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-11
Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 15/192 (7%)
Query: 3 IVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
IV EL G L + + + R + + + + A+E +HS ++HRD+KP N+
Sbjct: 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVF 138
Query: 61 LTEDLKTIKLADFGLAR-EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
+T +KL D GL R S T + GT +M+PE + + YN K D
Sbjct: 139 ITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE--------RIHENGYNFKSDI 189
Query: 120 YSFAIVLWELLHNKLPFEG--MSNLQAAYAAAFKNVRP-SAENVPEELSIILTSCWKEDP 176
+S +L+E+ + PF G M+ + P E+ E+L +++ C DP
Sbjct: 190 WSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDP 249
Query: 177 NARPNFTQIIQM 188
+ RP+ + Q+
Sbjct: 250 DQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-11
Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 17/194 (8%)
Query: 3 IVTELLSGGT---LRKYLLNMRPRCLDVCVAIGFALDIA-RAMECLHSHGIIHRDLKPEN 58
+V EL +GG+ L K L R + +A + L A ++ LH + IHRD+K N
Sbjct: 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIA--YILHEALMGLQHLHVNKTIHRDVKGNN 154
Query: 59 LLLTEDLKTIKLADFGLAREESLTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKV 117
+LLT + +KL DFG++ + + T + GT WMAPE+ + Q Y+ +
Sbjct: 155 ILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV---IACEQQLDSTYDARC 210
Query: 118 DSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE----ELSIILTSCWK 173
D +S I EL P + ++A + +N P+ PE E + + C
Sbjct: 211 DVWSLGITAIELGDGDPPLADLHPMRALFKIP-RNPPPTLHQ-PELWSNEFNDFIRKCLT 268
Query: 174 EDPNARPNFTQIIQ 187
+D RP + ++Q
Sbjct: 269 KDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 41/107 (38%), Positives = 53/107 (49%), Gaps = 13/107 (12%)
Query: 39 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGT--YRWM 95
+ LH + I+HRDLK NLLL +K+ DFGLARE S + T T YR
Sbjct: 117 SGVAHLHDNWILHRDLKTSNLLLNNR-GILKICDFGLAREYGSPLKPYTQLVVTLWYR-- 173
Query: 96 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 142
APEL G K+ Y+ +D +S + ELL K F G S +
Sbjct: 174 APELL------LGAKE-YSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-11
Identities = 46/193 (23%), Positives = 91/193 (47%), Gaps = 26/193 (13%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+VT+L+ G L Y+ + + + + + + IA+ M L ++HRDL N+L+
Sbjct: 85 LVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK 143
Query: 63 EDLKTIKLADFGLAR-EESLTEMMTAETGTY--RWMAPELYSTVTLRQGEKKHYNHKVDS 119
+K+ DFGLAR E + A+ G +WMA E + + H+ D
Sbjct: 144 SP-NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI--------HYRKFTHQSDV 194
Query: 120 YSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE------ELSIILTSCW 172
+S+ + +WEL+ P++G+ + ++ E +P+ ++ +++ CW
Sbjct: 195 WSYGVTIWELMTFGGKPYDGIPTRE------IPDLLEKGERLPQPPICTIDVYMVMVKCW 248
Query: 173 KEDPNARPNFTQI 185
D ++RP F ++
Sbjct: 249 MIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-11
Identities = 37/99 (37%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 45 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTV 103
HSH ++HRDLKP+NLL+ + IKLADFGLAR + T E T + APE+
Sbjct: 117 HSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 175
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 142
K+Y+ VD +S + E++ + F G S +
Sbjct: 176 -------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-11
Identities = 49/198 (24%), Positives = 94/198 (47%), Gaps = 17/198 (8%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+++V E+ SGG L K+L + + V + ++ M+ L +HRDL N+L
Sbjct: 69 LMLVMEMASGGPLNKFLSGKKDE-ITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVL 127
Query: 61 LTEDLKTIKLADFGLAR----EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 116
L K++DFGL++ ++S + +A +W APE + R+ ++ +
Sbjct: 128 LVNQ-HYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE---CINFRK-----FSSR 178
Query: 117 VDSYSFAIVLWELL-HNKLPFEGMSNLQA-AYAAAFKNVRPSAENVPEELSIILTSCWKE 174
D +S+ I +WE + + P++ M + ++ K + AE P E+ ++ CW
Sbjct: 179 SDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAE-CPPEMYALMKDCWIY 237
Query: 175 DPNARPNFTQIIQMLLNY 192
RPNF ++ + + Y
Sbjct: 238 KWEDRPNFAKVEERMRTY 255
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-11
Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 11/95 (11%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM- 95
+ ++++ +H +GI HRD+KPEN+L+ +D +KLADFG R T T RW
Sbjct: 109 LLKSLDHMHRNGIFHRDIKPENILIKDD--ILKLADFGSCRGIYSKPPYTEYIST-RWYR 165
Query: 96 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 130
APE L G +Y K+D ++ V +E+L
Sbjct: 166 APE----CLLTDG---YYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-11
Identities = 47/139 (33%), Positives = 77/139 (55%), Gaps = 14/139 (10%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V E ++GG L ++ R R L A +A +I A+ LH GII+RDLK +N+L
Sbjct: 71 LFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVL 128
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
L D IKL D+G+ + E L T T GT ++APE+ +GE+ Y VD
Sbjct: 129 LDAD-GHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEIL------RGEE--YGFSVD 178
Query: 119 SYSFAIVLWELLHNKLPFE 137
++ ++++E++ + PF+
Sbjct: 179 WWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 38/146 (26%), Positives = 63/146 (43%), Gaps = 12/146 (8%)
Query: 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM--TAETGTYRWMAPELYSTVT 104
HG+IHRD+KP N+LL + +KL DFG++ L + T G +MAPE
Sbjct: 134 HGVIHRDVKPSNILL-DASGNVKLCDFGISGR--LVDSKAKTRSAGCAAYMAPERIDP-- 188
Query: 105 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM-SNLQAAYAAAFKN--VRPSAENVP 161
Y+ + D +S I L EL + P++ + + + P E
Sbjct: 189 --PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFS 246
Query: 162 EELSIILTSCWKEDPNARPNFTQIIQ 187
+ + C +D RP + +++Q
Sbjct: 247 PDFCSFVDLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 40/106 (37%), Positives = 58/106 (54%), Gaps = 10/106 (9%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMA 96
+ + ++ +H+ GIIHRDLKP NL + ED + +K+ DFGLAR+ MT T + A
Sbjct: 127 MLKGLKYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQTD--SEMTGYVVTRWYRA 183
Query: 97 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 142
PE V L HY VD +S ++ E+L K F+G +L
Sbjct: 184 PE----VILNW---MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL 222
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-11
Identities = 54/182 (29%), Positives = 83/182 (45%), Gaps = 39/182 (21%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWM 95
I R +E HSH IIHRD+KPEN+L+++ +KL DFG AR + E+ T T +
Sbjct: 109 ILRGIEFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYTDYVATRWYR 167
Query: 96 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY--------- 146
APEL G+ K Y VD ++ ++ E+L + F G S++ Y
Sbjct: 168 APELLV------GDTK-YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNL 220
Query: 147 ----------AAAFKNVR-PSAENV-PEE-----LSII----LTSCWKEDPNARPNFTQI 185
F +R P + + P E LS + C + DP+ RP+ +Q+
Sbjct: 221 IPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL 280
Query: 186 IQ 187
+
Sbjct: 281 LH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-11
Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 31/205 (15%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
++ E L G+L++YL + + +++ + +A+ I + M+ L S +HRDL N+L+
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV- 142
Query: 63 EDLKTIKLADFGLAR-----EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKV 117
E +K+ DFGL + +E T ++ + W APE + K Y
Sbjct: 143 ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF-WYAPECLI-------QSKFYIAS- 193
Query: 118 DSYSFAIVLWELL----------HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPE 162
D +SF + L+ELL L G ++ Q + + P N PE
Sbjct: 194 DVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPE 253
Query: 163 ELSIILTSCWKEDPNARPNFTQIIQ 187
E+ ++ CW+ P+ R F +I+
Sbjct: 254 EVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-11
Identities = 55/188 (29%), Positives = 94/188 (50%), Gaps = 20/188 (10%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ V E ++GG L ++ R R L A ++ +I+ A+ LH GII+RDLK +N+L
Sbjct: 71 LFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 128
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
L + IKL D+G+ +E T+ GT ++APE+ +GE Y VD
Sbjct: 129 LDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL------RGED--YGFSVDW 179
Query: 120 YSFAIVLWELLHNKLPFE--GMSNL--QAAYAAAFKNVRPSAENVPEELSI----ILTSC 171
++ ++++E++ + PF+ G S+ Q F+ + +P LS+ +L S
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 239
Query: 172 WKEDPNAR 179
+DP R
Sbjct: 240 LNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-11
Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 25/201 (12%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENL 59
+ + E + G+L + P +++ I A+ + + L++ H I+HRD+KP N+
Sbjct: 78 ICMCMEFMDCGSLDRIYKKGGPIPVEILGKI--AVAVVEGLTYLYNVHRIMHRDIKPSNI 135
Query: 60 LLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
L+ IKL DFG++ E + + GT +M+PE QG K Y K D
Sbjct: 136 LVNSR-GQIKLCDFGVS-GELINSIADTFVGTSTYMSPERI------QGGK--YTVKSDV 185
Query: 120 YSFAIVLWELLHNKLPF---EGMSNLQAAYAAAFKNV---------RPSAENVPEELSII 167
+S I + EL K PF + Q + R + + PE+L
Sbjct: 186 WSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDF 245
Query: 168 LTSCWKEDPNARPNFTQIIQM 188
+ +C +DP RP Q+ M
Sbjct: 246 VDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-11
Identities = 36/118 (30%), Positives = 59/118 (50%), Gaps = 10/118 (8%)
Query: 13 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 72
L+KY + +D + F + + + HSH ++HRDLKP+NLL+ ++ +KLAD
Sbjct: 85 LKKYFDSCNGD-IDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN-GELKLAD 142
Query: 73 FGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 129
FGLAR + +AE T + P++ L Y+ +D +S + EL
Sbjct: 143 FGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL-------YSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-11
Identities = 45/128 (35%), Positives = 60/128 (46%), Gaps = 9/128 (7%)
Query: 13 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 72
LR YL + P L R ++ LH++ I+HRDLKPEN+L+T +KLAD
Sbjct: 93 LRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GQVKLAD 151
Query: 73 FGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN 132
FGLAR S +T T + APE+ T Y VD +S + E+
Sbjct: 152 FGLARIYSCQMALTPVVVTLWYRAPEVLLQST--------YATPVDMWSVGCIFAEMFRR 203
Query: 133 KLPFEGMS 140
K F G S
Sbjct: 204 KPLFCGNS 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-11
Identities = 42/164 (25%), Positives = 71/164 (43%), Gaps = 18/164 (10%)
Query: 34 ALDIARAMECL-HSHGIIHRDLKPENLLLTEDLK-TIKLADFGLA--REESLTEMMTAET 89
A+ +A+ L IIHRD+KP N+LL D IKL DFG++ +S+ + T +
Sbjct: 113 AVATVKALNYLKEELKIIHRDVKPSNILL--DRNGNIKLCDFGISGQLVDSIAK--TRDA 168
Query: 90 GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL-----QA 144
G +MAPE R G Y+ + D +S I L+E+ K P+ +++ Q
Sbjct: 169 GCRPYMAPERIDPSA-RDG----YDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV 223
Query: 145 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188
+ C +D + RP + ++++
Sbjct: 224 VKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-11
Identities = 41/130 (31%), Positives = 57/130 (43%), Gaps = 9/130 (6%)
Query: 18 LNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 77
L PR + + +A+ H H IHRD+KPEN+L+T+ IKL DFG AR
Sbjct: 90 LEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ-GQIKLCDFGFAR 148
Query: 78 EESLTEMMTAETGTYRWM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 136
+ + RW APEL T Y VD ++ V ELL + +
Sbjct: 149 ILTGPGDDYTDYVATRWYRAPELLVGDT-------QYGPPVDVWAIGCVFAELLTGQPLW 201
Query: 137 EGMSNLQAAY 146
G S++ Y
Sbjct: 202 PGKSDVDQLY 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-10
Identities = 39/119 (32%), Positives = 50/119 (42%), Gaps = 23/119 (19%)
Query: 35 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---------------EE 79
L I + LH +HRDL P N+ + K+ADFGLAR
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
E MT++ T + APEL L EK Y+ VD +S + ELL K F G
Sbjct: 185 QRREEMTSKVVTLWYRAPEL-----LMGAEK--YHFAVDMWSVGCIFAELLTGKPLFPG 236
|
Length = 335 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-10
Identities = 64/284 (22%), Positives = 96/284 (33%), Gaps = 76/284 (26%)
Query: 33 FALDIAR--------AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL--------- 75
F D+AR A+E +H G IHRD+KP+N+L+ D IKL DFGL
Sbjct: 98 FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHD 156
Query: 76 ---------AREESL-----------TEMMTAE---------------TGTYRWMAPELY 100
R++S+ + E GT ++APE
Sbjct: 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPE-- 214
Query: 101 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA----AFKNVRPS 156
V LR G Y D +S ++L+E+L + PF + + ++
Sbjct: 215 --VLLRTG----YTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQ 268
Query: 157 AENVPEELSIILTSCWKEDPNARPN---------FTQIIQMLLNYLSAIAPPEPMIPHRI 207
A+ E +IL C + N F + I AP P I H
Sbjct: 269 AKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKAPYIPKITHPT 328
Query: 208 FNSENTILPPESPGTSSLMTVRDDIGETPKAKMGDKPKSLFFCF 251
S + PE + D P + + F+ F
Sbjct: 329 DTSNFDPVDPEKLRSDDSGESSPDRNVKPNN--RKRTEHAFYEF 370
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-10
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 46/219 (21%)
Query: 1 MVIVTELLSGGTLRKYLLNMRP---------RCLDVCVAIGFALDIARAMECLHSHGIIH 51
+ ++TE + G L ++L P + I A IA M+ L S +H
Sbjct: 94 LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVH 153
Query: 52 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY-----------RWMAPELY 100
RDL N L+ ++ TIK+ADFG++R +G Y RWM+ E
Sbjct: 154 RDLATRNCLVGKNY-TIKIADFGMSR--------NLYSGDYYRIQGRAVLPIRWMSWE-- 202
Query: 101 STVTLRQGEKKHYNHKVDSYSFAIVLWELLH--NKLPFEGMSNLQAAYAAA--FKNVR-- 154
++ L + + D ++F + LWE+L + P+ +S+ Q F++
Sbjct: 203 -SILLGK-----FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQ 256
Query: 155 ---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190
P P+ L ++ SCW+ + RP+F +I LL
Sbjct: 257 VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-10
Identities = 39/112 (34%), Positives = 55/112 (49%), Gaps = 15/112 (13%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-----EESLTEMMTA 87
F I ++ +HS ++HRDLKP NLL+ D + +K+ DFGLAR MT
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE-LKICDFGLARGFSENPGENAGFMTE 168
Query: 88 ETGTYRWM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
T RW APE+ + + Y +D +S +L ELL K F+G
Sbjct: 169 YVAT-RWYRAPEIMLSF-------QSYTKAIDVWSVGCILAELLGRKPVFKG 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-10
Identities = 44/195 (22%), Positives = 81/195 (41%), Gaps = 15/195 (7%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-SHGIIHRDLKPENL 59
+ ++ E + G LR+ L + + L + A+D + + L+ +++L +
Sbjct: 97 LSLILEYCTRGYLREVL--DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSF 154
Query: 60 LLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
L+TE+ K K+ GL + S Y + ++ + + Y K D
Sbjct: 155 LVTENYKL-KIICHGLEKILSSPPFKNVNFMVYF--SYKMLNDIF------SEYTIKDDI 205
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSAENVPEELSIILTSCWKEDPN 177
YS +VLWE+ K+PFE ++ + Y + P E+ I+ +C D
Sbjct: 206 YSLGVVLWEIFTGKIPFENLT-TKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSI 264
Query: 178 ARPNFTQIIQMLLNY 192
RPN +I+ L Y
Sbjct: 265 KRPNIKEILYNLSLY 279
|
Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-10
Identities = 51/170 (30%), Positives = 77/170 (45%), Gaps = 20/170 (11%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ I E + GG+++ L L V + I M LHS+ I+HRD+K N +
Sbjct: 81 LTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGAN-I 137
Query: 61 LTEDLKTIKLADFGLAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 116
L + +KL DFG ++ M + + TGT WM+PE+ S GE Y K
Sbjct: 138 LRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS------GEG--YGRK 189
Query: 117 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK-NVRPSAENVPEELS 165
D +S + E+L K P+ A AA FK +P+ +P +S
Sbjct: 190 ADVWSLGCTVVEMLTEKPPWAEYE----AMAAIFKIATQPTNPQLPSHIS 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 52/191 (27%), Positives = 83/191 (43%), Gaps = 18/191 (9%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
++ E + GG+L + DV A I + LH I+HRD+KP NLL+
Sbjct: 149 VLLEFMDGGSLEGTHIADEQFLADV------ARQILSGIAYLHRRHIVHRDIKPSNLLI- 201
Query: 63 EDLKTIKLADFGLAREESLTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
K +K+ADFG++R L + M + GT +M+PE +T L G Y D
Sbjct: 202 NSAKNVKIADFGVSR--ILAQTMDPCNSSVGTIAYMSPERINT-DLNHGAYDGYAG--DI 256
Query: 120 YSFAIVLWELLHNKLPFE-GMSNLQAAYAAAFKNVRPSAE--NVPEELSIILTSCWKEDP 176
+S + + E + PF G A+ A +P E ++ C + +P
Sbjct: 257 WSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREP 316
Query: 177 NARPNFTQIIQ 187
R + Q++Q
Sbjct: 317 AKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-10
Identities = 35/111 (31%), Positives = 61/111 (54%), Gaps = 9/111 (8%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT 91
F + R + +H I+HRDLKP+NLL++ L +KLADFGLAR +S+ ++ ++E T
Sbjct: 108 FMFQLLRGLAYIHGQHILHRDLKPQNLLISY-LGELKLADFGLARAKSIPSQTYSSEVVT 166
Query: 92 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 142
+ P++ T Y+ +D + + E+L + F G+S++
Sbjct: 167 LWYRPPDVLLGAT-------DYSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-10
Identities = 45/130 (34%), Positives = 68/130 (52%), Gaps = 10/130 (7%)
Query: 13 LRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 71
L+KYL ++ + +D + + I + + HS ++HRDLKP+NLL+ ++ IKLA
Sbjct: 85 LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI-DNKGVIKLA 143
Query: 72 DFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 130
DFGLAR + + T E T + APE V L G + Y+ VD +S + E+
Sbjct: 144 DFGLARAFGIPVRVYTHEVVTLWYRAPE----VLL--GSPR-YSTPVDIWSIGTIFAEMA 196
Query: 131 HNKLPFEGMS 140
K F G S
Sbjct: 197 TKKPLFHGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-10
Identities = 35/106 (33%), Positives = 60/106 (56%), Gaps = 9/106 (8%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 92
+A +I +E +H+ +++RDLKP N+LL E ++++D GLA + S + A GT+
Sbjct: 102 YAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFS-KKKPHASVGTH 159
Query: 93 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
+MAPE+ L++G Y+ D +S +L++LL PF
Sbjct: 160 GYMAPEV-----LQKGVA--YDSSADWFSLGCMLFKLLRGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-10
Identities = 33/75 (44%), Positives = 51/75 (68%), Gaps = 3/75 (4%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E L GG + K LL++ D +A+ + ++A A++ LH HGIIHRDLKP+N+L++
Sbjct: 81 LVMEYLIGGDV-KSLLHIYGY-FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS 138
Query: 63 EDLKTIKLADFGLAR 77
+ IKL DFGL++
Sbjct: 139 NE-GHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-10
Identities = 52/173 (30%), Positives = 81/173 (46%), Gaps = 26/173 (15%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ I E + GG+++ L L V + I + + LHS+ I+HRD+K N +
Sbjct: 81 LSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGAN-I 137
Query: 61 LTEDLKTIKLADFGLAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 116
L + +KL DFG ++ M + + TGT WM+PE+ S GE Y K
Sbjct: 138 LRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS------GEG--YGRK 189
Query: 117 VDSYSFAIVLWELLHNKLP---FEGMSNLQAAYAAAFK-NVRPSAENVPEELS 165
D +S A + E+L K P +E M AA FK +P+ +P+ +S
Sbjct: 190 ADVWSVACTVVEMLTEKPPWAEYEAM-------AAIFKIATQPTKPMLPDGVS 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-10
Identities = 47/206 (22%), Positives = 87/206 (42%), Gaps = 41/206 (19%)
Query: 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI----ARAMECLHSHGIIHRDLKPE 57
++V E + G L +L + V++ + LD+ A A+ L ++H ++ +
Sbjct: 76 IMVEEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGK 130
Query: 58 NLLLT-EDLKT-----IKLADFGLAREESLTEMMTAETGTYR-----WMAPELYSTVTLR 106
N+L+ L IKL+D G+ +T + R W+APE
Sbjct: 131 NILVARYGLNEGYVPFIKLSDPGIP--------ITVLSREERVERIPWIAPECI------ 176
Query: 107 QGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSAENVPE--E 163
+ + D +SF L E+ N + P +S+ + ++ P +P+ E
Sbjct: 177 RNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP----MPDCAE 232
Query: 164 LSIILTSCWKEDPNARPNFTQIIQML 189
L+ ++ CW DP RP+F I++ L
Sbjct: 233 LANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-10
Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 16/203 (7%)
Query: 2 VIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 58
++V E G L+ YL + R + V A ++A + LH IH DL N
Sbjct: 71 LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRN 130
Query: 59 LLLTEDLKTIKLADFGLAREESLTE-MMTAETGTY--RWMAPELYSTVTLRQGEKKHYNH 115
LT DL ++K+ D+GLA E+ + +T + RW+APEL K
Sbjct: 131 CQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQ-TK 188
Query: 116 KVDSYSFAIVLWELLHN-KLPFEGMSNLQA-AYAAAFKNVRPSAENVPEELSI----ILT 169
K + +S + +WEL P+ +S+ Q ++++ + + S ++
Sbjct: 189 KSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQ 248
Query: 170 SCWKEDPNARPNFTQIIQMLLNY 192
CW DP RP + + LL Y
Sbjct: 249 FCWL-DPETRPTAEE-VHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-10
Identities = 43/165 (26%), Positives = 66/165 (40%), Gaps = 21/165 (12%)
Query: 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR 106
H I+HRD+KP N+L+ IKL DFG++ + + M + GT +M+PE
Sbjct: 119 HKIMHRDVKPSNILVNSR-GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERL------ 170
Query: 107 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI 166
QG HY + D +S + L E+ + P A F E
Sbjct: 171 QGT--HYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMF-----GRPVSEGEAKE 221
Query: 167 ILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSE 211
P++ I LL+Y+ + P P +P F+ E
Sbjct: 222 SHRPVSGHPPDSPRPMA--IFELLDYI--VNEPPPKLPSGAFSDE 262
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-10
Identities = 54/174 (31%), Positives = 81/174 (46%), Gaps = 28/174 (16%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ I E + GG+++ L + L V + I + LHS+ I+HRD+K N +
Sbjct: 81 LSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGAN-I 137
Query: 61 LTEDLKTIKLADFGLARE-----ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 115
L + + +KL DFG ++ S T M + TGT WM+PE+ S GE Y
Sbjct: 138 LRDSVGNVKLGDFGASKRLQTICLSGTGMKSV-TGTPYWMSPEVIS------GEG--YGR 188
Query: 116 KVDSYSFAIVLWELLHNKLP---FEGMSNLQAAYAAAFK-NVRPSAENVPEELS 165
K D +S + E+L K P FE M AA FK +P+ +P +S
Sbjct: 189 KADIWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQPTNPVLPPHVS 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 6e-10
Identities = 36/111 (32%), Positives = 55/111 (49%), Gaps = 7/111 (6%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 92
F + R + +H I+HRDLKP+NLL++ D +KLADFGLAR +S+ +
Sbjct: 108 FLFQLLRGLSYIHQRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVT 166
Query: 93 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 143
W P V L E Y+ +D + + E++ F GM ++Q
Sbjct: 167 LWYRP---PDVLLGSTE---YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-10
Identities = 41/153 (26%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 2 VIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 59
++V E G L+ YL + R + + A +IA + +H H +H DL N
Sbjct: 71 LLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNC 130
Query: 60 LLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTVTLRQG-----EKK 111
LT DL T+K+ D+G+ + + E RW+APEL V G E+
Sbjct: 131 FLTSDL-TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPEL---VGEFHGGLITAEQT 186
Query: 112 HYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQ 143
+ + ++ + LWEL N P+ +S+ +
Sbjct: 187 KPS---NVWALGVTLWELFENAAQPYSHLSDRE 216
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-10
Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 21/120 (17%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLL-TEDLKTIKLADFGLAR--------EESLTE 83
F + R ++ +HS ++HRDLKP N+ + TEDL +K+ DFGLAR + L+E
Sbjct: 119 FMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDFGLARIVDPHYSHKGYLSE 177
Query: 84 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 143
+ T YR +P L + +Y +D ++ + E+L K F G L+
Sbjct: 178 GLV--TKWYR--SPRLLLSPN-------NYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 9e-10
Identities = 41/169 (24%), Positives = 75/169 (44%), Gaps = 28/169 (16%)
Query: 49 IIHRDLKPENLLLTEDLKTI----------------KLADFGLAREESLTEMMTAETGTY 92
++HRDLKP+N+ L+ ++ I K+ DFGL++ + M + GT
Sbjct: 146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTP 205
Query: 93 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 152
+ +PEL E K Y+ K D ++ +++EL K PF +N + +
Sbjct: 206 YYWSPELLLH------ETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG 259
Query: 153 VRPSAENVPEELSIILTSCWKEDPNARPNFTQII--QMLLNYLSAIAPP 199
+ +EL+I++ + RP+ Q + Q++ N + PP
Sbjct: 260 PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN----VGPP 304
|
Length = 1021 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 51/191 (26%), Positives = 80/191 (41%), Gaps = 29/191 (15%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL-- 61
V E + G TLR+ L L L + A+ C H+ GI+HRDLKP+N+++
Sbjct: 57 VFEYVPGRTLREVLAADGA--LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQ 114
Query: 62 TEDLKTIKLADFGLAR-----EESLTEMMTAET---GTYRWMAPELYSTVTLRQGEKKHY 113
T K+ DFG+ ++ +T T GT + APE LR GE
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-----QLR-GEPV-- 166
Query: 114 NHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE-----ELSIIL 168
D Y++ ++ E L + +G S + Y + + P ++P L +L
Sbjct: 167 TPNSDLYAWGLIFLECLTGQRVVQGASVAEILY----QQLSPVDVSLPPWIAGHPLGQVL 222
Query: 169 TSCWKEDPNAR 179
+DP R
Sbjct: 223 RKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 33/104 (31%), Positives = 50/104 (48%), Gaps = 18/104 (17%)
Query: 44 LHSHGIIHRDLKPENLLLTEDLK---TIKLADFGLAR--EESLTEMMTAE----TGTYRW 94
LHS+ ++HRDLKP N+L+ + +K+ D GLAR L + + T YR
Sbjct: 124 LHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYR- 182
Query: 95 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
APEL +HY +D ++ + ELL + F+G
Sbjct: 183 -APELLLGA-------RHYTKAIDIWAIGCIFAELLTLEPIFKG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 40/113 (35%), Positives = 59/113 (52%), Gaps = 7/113 (6%)
Query: 44 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYST 102
LHS G +HRD+K N+LLT D +KLADFG+A + + T + GT WMAPE+ +
Sbjct: 122 LHSKGKMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV-AA 179
Query: 103 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 155
V G YN D ++ I EL + P + ++A + + N +P
Sbjct: 180 VEKNGG----YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQP 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 19/153 (12%)
Query: 44 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYST 102
LHS G +HRD+K N+LLT++ +KLADFG++ + + T + GT WMAPE+ +
Sbjct: 122 LHSKGKMHRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 103 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS------ 156
K YN D ++ I EL + P + ++A + N +P
Sbjct: 181 -----ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKM 235
Query: 157 --AENVPEELSIILTSCWKEDPNARPNFTQIIQ 187
+ + + + LT ++P RP +++Q
Sbjct: 236 KWSNSFHHFVKMALT----KNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-09
Identities = 40/144 (27%), Positives = 71/144 (49%), Gaps = 13/144 (9%)
Query: 1 MVIVTELLSGGTLRKYL-LNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 59
+++V E + L+KY+ + LD F + + + H + ++HRDLKP+NL
Sbjct: 73 LMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNL 131
Query: 60 LLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPE-LYSTVTLRQGEKKHYNHKV 117
L+ + +KLADFGLAR + + E T + AP+ L + T Y+ +
Sbjct: 132 LINKR-GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT--------YSTSI 182
Query: 118 DSYSFAIVLWELLHNKLPFEGMSN 141
D +S ++ E++ + F G +N
Sbjct: 183 DIWSVGCIMAEMITGRPLFPGTNN 206
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 3e-09
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 11/94 (11%)
Query: 44 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 103
LH H IIH D+K EN+L I L D+GL + GT + +PE
Sbjct: 125 LHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY---DGTLDYFSPE----- 176
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 137
+ + +Y+ D ++ ++ +ELL K PF+
Sbjct: 177 ---KIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207
|
Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-09
Identities = 35/104 (33%), Positives = 60/104 (57%), Gaps = 9/104 (8%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 92
+A +I +E +H+ +++RDLKP N+LL E ++++D GLA + S + A GT+
Sbjct: 102 YATEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFS-KKKPHASVGTH 159
Query: 93 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 136
+MAPE+ L++G Y+ D +S +L++LL PF
Sbjct: 160 GYMAPEV-----LQKGTA--YDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-09
Identities = 49/212 (23%), Positives = 88/212 (41%), Gaps = 31/212 (14%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPR----------CLDVCVAIGFALDIARAMECLHSHGII 50
+ ++TE + G L ++L + + + A+ IA M+ L S +
Sbjct: 92 LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFV 151
Query: 51 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTVTLRQ 107
HRDL N L+ TIK+ADFG++R + + RWMA + ++ L +
Sbjct: 152 HRDLATRNCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMA---WESILLGK 207
Query: 108 GEKKHYNHKVDSYSFAIVLWEL--LHNKLPFEGMSNLQAA------YAAAFKNVRPSAEN 159
+ D ++F + LWE+ L + P+ +S+ Q + + + S
Sbjct: 208 -----FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTP 262
Query: 160 V-PEELSIILTSCWKEDPNARPNFTQIIQMLL 190
+ P + ++ CW D RP F +I L
Sbjct: 263 LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-09
Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 25/209 (11%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT 91
F I R + H ++HRDLKP+NLL+ E +KLADFGLAR +S+ T+ + E T
Sbjct: 109 FLYQILRGLAYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSVPTKTYSNEVVT 167
Query: 92 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 151
+ P+ V L E Y+ ++D + + +E+ + F G S ++ F+
Sbjct: 168 LWYRPPD----VLLGSSE---YSTQIDMWGVGCIFFEMASGRPLFPG-STVEDELHLIFR 219
Query: 152 NV-RPSAENVP-----EELSIILTSCWKEDP--NARPNF-TQIIQMLLNYL----SAIAP 198
+ P+ E P +E +K P N P T+ I++L +L
Sbjct: 220 LLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS 279
Query: 199 PEPMIPHRIFNSENTILP--PESPGTSSL 225
E + H F S T + PES SL
Sbjct: 280 AEEAMKHAYFRSLGTRIHSLPESISIFSL 308
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-09
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 2 VIVTELLSGGTLRKYLLNMRPRCL---DVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 58
++V E G L+ YL + R L D A +IA + LH + IH DL N
Sbjct: 71 LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRN 130
Query: 59 LLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTV---TLRQGEKKH 112
LLT DL T+K+ D+GL+ + + + RW+APEL V L + K
Sbjct: 131 CLLTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKE 189
Query: 113 YNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA-AYAAAFKNVRPSAENVPEELSI---- 166
N +S + +WEL P+ +S+ Q Y + ++ + LS
Sbjct: 190 SN----VWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYE 245
Query: 167 ILTSCWKEDPNARPNFTQIIQMLLNY 192
++ CW + P RP+ + + +LL+Y
Sbjct: 246 VMQFCWLQ-PEQRPSAEE-VHLLLSY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 9e-09
Identities = 31/99 (31%), Positives = 55/99 (55%), Gaps = 6/99 (6%)
Query: 40 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG--LAREESLTEMMTAETGTYRWMAP 97
A++ +H G +HRD+KP+N+LL ++ I+LADFG L T GT +++P
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISP 172
Query: 98 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 136
E+ + + K Y + D +S + ++E+L+ + PF
Sbjct: 173 EILQAM---EDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 9e-09
Identities = 23/49 (46%), Positives = 33/49 (67%), Gaps = 1/49 (2%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81
F + R + H ++HRDLKP+NLL++E +KLADFGLAR +S+
Sbjct: 108 FLFQLLRGLAYCHQRRVLHRDLKPQNLLISE-RGELKLADFGLARAKSV 155
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-09
Identities = 35/107 (32%), Positives = 55/107 (51%), Gaps = 9/107 (8%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT 91
F + R + H I+HRDLKP+NLL+ E +KLADFGLAR +S+ T+ + E T
Sbjct: 108 FMFQLLRGLSYCHKRKILHRDLKPQNLLINEK-GELKLADFGLARAKSVPTKTYSNEVVT 166
Query: 92 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
+ P++ T Y+ +D + +L+E+ + F G
Sbjct: 167 LWYRPPDVLLGST-------EYSTPIDMWGVGCILYEMATGRPMFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 1e-08
Identities = 26/77 (33%), Positives = 38/77 (49%), Gaps = 8/77 (10%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+IV E + G L+ + + L++ IG + + LHS GIIH DL N++
Sbjct: 74 FIIVMEYIEGEPLKDLINSNGMEELELSREIGRL--VGK----LHSAGIIHGDLTTSNMI 127
Query: 61 LTEDLKTIKLADFGLAR 77
L+ I L DFGLA
Sbjct: 128 LSGG--KIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 37/116 (31%), Positives = 55/116 (47%), Gaps = 23/116 (19%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT- 91
F + RA++ +H+ + HRDLKP+N+L D K +K+ DFGLAR + +T T
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANADCK-LKICDFGLAR------VAFNDTPTA 160
Query: 92 --------YRWM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
RW APEL + + Y +D +S + E+L K F G
Sbjct: 161 IFWTDYVATRWYRAPELCGSFFSK------YTPAIDIWSIGCIFAEVLTGKPLFPG 210
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 9/107 (8%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT 91
F + R + H ++HRDLKP+NLL+ E +KLADFGLAR +S+ T+ + E T
Sbjct: 109 FLFQLLRGLNYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYSNEVVT 167
Query: 92 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
+ P++ T Y+ ++D + + +E+ + F G
Sbjct: 168 LWYRPPDILLGST-------DYSTQIDMWGVGCIFYEMSTGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 33/110 (30%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 92
++ + RA+ +HS I HRDLKP+NLL+ + T+KL DFG A+ + + +
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR 234
Query: 93 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 142
+ APEL T +Y +D +S ++ E++ F G S++
Sbjct: 235 FYRAPELMLGAT-------NYTTHIDLWSLGCIIAEMILGYPIFSGQSSV 277
|
Length = 440 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 26/61 (42%), Positives = 37/61 (60%), Gaps = 6/61 (9%)
Query: 44 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-----MMTAETGTYRWMAPE 98
+H + I+HRD+K N+L+T+D +KLADFGLAR SL++ T T + PE
Sbjct: 135 IHRNKILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193
Query: 99 L 99
L
Sbjct: 194 L 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 39/142 (27%), Positives = 71/142 (50%), Gaps = 7/142 (4%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V + GG L L R L +A + ++ A++ +H +HRD+KP+N+L
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 134
Query: 61 LTEDLKTIKLADFG--LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
+ + I+LADFG L E T + GT +++PE+ + + K Y + D
Sbjct: 135 MDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM---EDGKGKYGPECD 190
Query: 119 SYSFAIVLWELLHNKLPFEGMS 140
+S + ++E+L+ + PF S
Sbjct: 191 WWSLGVCMYEMLYGETPFYAES 212
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-08
Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 38/202 (18%)
Query: 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGF--ALDIARAMECLHSHGIIHRDLKPENL 59
++V E + G L L M + + F A +A A+ L ++H ++ +N+
Sbjct: 80 IMVEEFVEFGPLD---LFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNI 136
Query: 60 LL------TEDLKTIKLADFG-----LAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 108
LL E IKL+D G L+R+E + + W+APE
Sbjct: 137 LLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI--------PWIAPECVE------- 181
Query: 109 EKKHYNHKVDSYSFAIVLWELLHN-KLPFEG--MSNLQAAYAAAFKNVRPSAENVPEELS 165
+ K+ + D +SF LWE+ +N ++P + ++ + Y V PS + EL+
Sbjct: 182 DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPSCK----ELA 237
Query: 166 IILTSCWKEDPNARPNFTQIIQ 187
++T C DPN RP F I++
Sbjct: 238 DLMTHCMNYDPNQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-08
Identities = 45/137 (32%), Positives = 66/137 (48%), Gaps = 15/137 (10%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V E + GG +L R + V +A I E L S I++RDLKPENLL
Sbjct: 106 LYLVLEFVIGGEFFTFL--RRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLL 163
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
L +D IK+ DFG A+ + + T GT ++APE + L G K D
Sbjct: 164 LDKD-GFIKMTDFGFAK---VVDTRTYTLCGTPEYIAPE----ILLNVGHGK----AADW 211
Query: 120 YSFAIVLWELLHNKLPF 136
++ I ++E+L PF
Sbjct: 212 WTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-08
Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 33 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 92
+ + +A+ H + I+HRD+KPENLL++ + +KL DFG AR +L+E A Y
Sbjct: 105 YIYQLIKAIHWCHKNDIVHRDIKPENLLISHN-DVLKLCDFGFAR--NLSEGSNANYTEY 161
Query: 93 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 142
+A Y + L G Y VD +S +L EL + F G S +
Sbjct: 162 --VATRWYRSPELLLGAP--YGKAVDMWSVGCILGELSDGQPLFPGESEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 7e-08
Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 18/160 (11%)
Query: 37 IARAMECL-HSHGIIHRDLKPENLLLTEDLKTIKLADFGLA--REESLTEMMTAETGTYR 93
+ + ++ L H IIHRD+KP N+L+ + +KL DFG++ SL + G
Sbjct: 111 VVKGLKFLKEEHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASLAK---TNIGCQS 166
Query: 94 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF--EGMSNLQAAYAAAFK 151
+MAPE + Q Y + D +S + + E+ + P+ E +N+ A +A
Sbjct: 167 YMAPERIKSGGPNQ--NPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD 224
Query: 152 NVRPSAENVPEELSI----ILTSCWKEDPNARPNFTQIIQ 187
P+ +P S + C + PN RP + Q+++
Sbjct: 225 GDPPT---LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-08
Identities = 30/99 (30%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 40 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG--LAREESLTEMMTAETGTYRWMAP 97
A+ +H +HRD+KP+N+LL + I+LADFG L + T + GT +++P
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISP 172
Query: 98 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 136
E+ + G+ Y + D +S + ++E+L+ + PF
Sbjct: 173 EILQAMEDGMGK---YGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 9e-08
Identities = 36/136 (26%), Positives = 58/136 (42%), Gaps = 48/136 (35%)
Query: 40 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL------AREESLTEMMT------- 86
A++ +H G IHRD+KP+NLLL IKL+DFGL + +++
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 87 -------------AET-------------GTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
AET GT ++APE++ + YN + D +
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL--------QTGYNKECDWW 223
Query: 121 SFAIVLWELLHNKLPF 136
S ++++E+L PF
Sbjct: 224 SLGVIMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 33/114 (28%), Positives = 52/114 (45%), Gaps = 20/114 (17%)
Query: 41 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGT---Y--- 92
+ LH + I+HRD+K N+L+ ++ +K+ADFGLAR + G Y
Sbjct: 128 INYLHENHILHRDIKAANILI-DNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 93 ---RWM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 142
RW PEL GE++ Y VD + V E+ + +G S++
Sbjct: 187 VVTRWYRPPELLL------GERR-YTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-07
Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 31/201 (15%)
Query: 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 61
++V E + G+L YL +++ + A +A A+ L G+ H ++ +N+LL
Sbjct: 75 IMVQEYVKFGSLDTYL-KKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLL 133
Query: 62 T--EDLKT-----IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 114
ED KT IKL+D G++ E++ W+ PE ++ +
Sbjct: 134 IREEDRKTGNPPFIKLSDPGISITVLPKEILLERI---PWVPPECIE-------NPQNLS 183
Query: 115 HKVDSYSFAIVLWELLHNKLPFEG----MSNLQAAYAAAFKNVRPSAENVPE--ELSIIL 168
D +SF LWE+ F G +S L + F R P+ EL+ ++
Sbjct: 184 LAADKWSFGTTLWEI------FSGGDKPLSALDSQKKLQFYEDRHQLP-APKWTELANLI 236
Query: 169 TSCWKEDPNARPNFTQIIQML 189
C +P+ RP+F II+ L
Sbjct: 237 NQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-07
Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 16/134 (11%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I TE + GG+L Y R + V A+ + + + L S I+HRD+KP N+L+
Sbjct: 76 ICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN 129
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 122
+KL DFG++ + + + GT +MAPE S GE+ Y D +S
Sbjct: 130 TR-GQVKLCDFGVST-QLVNSIAKTYVGTNAYMAPERIS------GEQ--YGIHSDVWSL 179
Query: 123 AIVLWELLHNKLPF 136
I EL + P+
Sbjct: 180 GISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 34/220 (15%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL-HSHGIIHRDLKPENLLL 61
I E + GG+L + L + ++ + A + R + L H I+HRD+KP N+L+
Sbjct: 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKHQIMHRDVKPSNILV 137
Query: 62 TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
IKL DFG++ + + M + GT +M+PE + + HY+ + D +S
Sbjct: 138 NSR-GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPE--------RLQGTHYSVQSDIWS 187
Query: 122 FAIVLWELLHNKLPF--EGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 179
+ L EL + P L+A + + V E P +S + P R
Sbjct: 188 MGLSLVELAIGRYPIPPPDAKELEAIFG---RPVVDGEEGEPHSISP------RPRPPGR 238
Query: 180 P--------NFTQIIQMLLNYLSAIAPPEPMIPHRIFNSE 211
P I LL+Y+ + P P +P+ +F +
Sbjct: 239 PVSGHGMDSRPAMAIFELLDYI--VNEPPPKLPNGVFTPD 276
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 3e-07
Identities = 21/77 (27%), Positives = 35/77 (45%), Gaps = 11/77 (14%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
IV E + G L+ + ++ IG + + LH GI+H DL N++
Sbjct: 72 KTIVMEYIEGKPLKDV---IEEGNDELLREIGRL--VGK----LHKAGIVHGDLTTSNII 122
Query: 61 LTEDLKTIKLADFGLAR 77
+ +D + L DFGL +
Sbjct: 123 VRDD--KLYLIDFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 68/284 (23%), Positives = 110/284 (38%), Gaps = 78/284 (27%)
Query: 1 MVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 58
+ V + + GG + L+ M P L A + ++ A+E +H G IHRD+KP+N
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMEVFPEVL----ARFYIAELTLAIESVHKMGFIHRDIKPDN 131
Query: 59 LLLTEDLKTIKLADFGLA------------------REESLT---------------EMM 85
+L+ D IKL DFGL R++S+ +
Sbjct: 132 ILIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLK 190
Query: 86 TAE---------------TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 130
T E GT ++APE V LR+G Y D +S ++L+E+L
Sbjct: 191 TLEQRATKQHQRCLAHSLVGTPNYIAPE----VLLRKG----YTQLCDWWSVGVILFEML 242
Query: 131 HNKLPF----EGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWK----------EDP 176
+ PF + L+ ++ P + PE + +I C +D
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302
Query: 177 NARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESP 220
A P F++ + + + AP P I H + S + ESP
Sbjct: 303 KAHPFFSE-VDFSSDIRTQPAPYVPKISHPMDTSNFDPVEEESP 345
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 8e-07
Identities = 18/40 (45%), Positives = 28/40 (70%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 76
I A++ LHS GI+HRD+KP+N++ +E + K+ D G A
Sbjct: 264 ILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 44/167 (26%), Positives = 73/167 (43%), Gaps = 17/167 (10%)
Query: 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR 106
H I+HRD+KP N+L+ IKL DFG++ + + M + GT +M+PE
Sbjct: 123 HKIMHRDVKPSNILVNSR-GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERL------ 174
Query: 107 QGEKKHYNHKVDSYSFAIVLWELLHNKLPF--EGMSNLQAAYAAAFKNVRPSAENVPEEL 164
QG HY+ + D +S + L E+ + P L+ + + P+
Sbjct: 175 QG--THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEG-DPAESETSPRP 231
Query: 165 SIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSE 211
P++RP I LL+Y+ + P P +P +F +E
Sbjct: 232 RPPGRPLSSYGPDSRPPMA--IFELLDYI--VNEPPPKLPSGVFGAE 274
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 53/223 (23%), Positives = 86/223 (38%), Gaps = 63/223 (28%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ V + + GG + L+ M D+ A + ++ A+E +H G IHRD+KP+N+L
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMGIFPEDL--ARFYIAELTCAVESVHKMGFIHRDIKPDNIL 133
Query: 61 LTEDLKTIKLADFGLA------------------REESLTEMMTAE-------------- 88
+ D IKL DFGL R++S+
Sbjct: 134 IDRD-GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPL 192
Query: 89 ----------------TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN 132
GT ++APE V LR G Y D +S ++L+E+L
Sbjct: 193 ERRAARQHQRCLAHSLVGTPNYIAPE----VLLRTG----YTQLCDWWSVGVILYEMLVG 244
Query: 133 KLPFEGMSNLQAAYAA----AFKNVRPSAENVPEELSIILTSC 171
+ PF + L+ ++ P A+ PE +I+ C
Sbjct: 245 QPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC 287
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 19/82 (23%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR--------AMECLHSHGIIHRDL 54
++ E L GG L L+ F+ D+ R A+E +H G IHRD+
Sbjct: 78 LIMEFLPGGDLMTMLIKYDT----------FSEDVTRFYMAECVLAIEAVHKLGFIHRDI 127
Query: 55 KPENLLLTEDLKTIKLADFGLA 76
KP+N+L+ IKL+DFGL+
Sbjct: 128 KPDNILIDRG-GHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 3e-06
Identities = 45/172 (26%), Positives = 74/172 (43%), Gaps = 47/172 (27%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ ++ E L GG + L M+ L + + A++ +H G IHRD+KP+NLL
Sbjct: 76 LYLIMEFLPGGDMMTLL--MKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLL 133
Query: 61 LTEDLKTIKLADFGLA-------REE----------------SLTEMMTAET-------- 89
L + +KL+DFGL R E ++ AET
Sbjct: 134 L-DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQL 192
Query: 90 -----GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 136
GT ++APE++ ++ G YN D +S ++++E+L PF
Sbjct: 193 AFSTVGTPDYIAPEVF----MQTG----YNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 3e-06
Identities = 23/85 (27%), Positives = 34/85 (40%), Gaps = 11/85 (12%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+IV E + G L+ L D+ +G + + LH GI+H DL N++
Sbjct: 74 GLIVMEYIEGELLKDAL---EEARPDLLREVG--RLVGK----LHKAGIVHGDLTTSNII 124
Query: 61 LTEDLKTIKLADFGLAREESLTEMM 85
L+ I DFGL E
Sbjct: 125 LSGG--RIYFIDFGLGEFSDEVEDK 147
|
Length = 204 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-06
Identities = 32/108 (29%), Positives = 45/108 (41%), Gaps = 18/108 (16%)
Query: 40 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM---- 95
A+ LH GIIHRD+K EN+ L E + L DFG A + + Y W
Sbjct: 197 ALAYLHGRGIIHRDVKTENIFLDEPENAV-LGDFGAACK---LDAHPDTPQCYGWSGTLE 252
Query: 96 --APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 141
+PEL + Y K D +S +VL+E+ + G
Sbjct: 253 TNSPELLALDP--------YCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292
|
Length = 392 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 39/152 (25%), Positives = 65/152 (42%), Gaps = 21/152 (13%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+++ ++ G+ L P + + R + LH +G IHR++K ++L++
Sbjct: 76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS 135
Query: 63 ED-LKTIKLADFGLAREESLT----------EMMTAETGTYRWMAPELYSTVTLRQGEKK 111
D L ++ GL+ SL + T W++PEL LRQ +
Sbjct: 136 GDGLVSLS----GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL-----LRQ-DLY 185
Query: 112 HYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 143
YN K D YS I EL ++PF+ M Q
Sbjct: 186 GYNVKSDIYSVGITACELATGRVPFQDMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 45/172 (26%), Positives = 74/172 (43%), Gaps = 47/172 (27%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ ++ E L GG + L M+ L + + A++ +H G IHRD+KP+NLL
Sbjct: 76 LYLIMEFLPGGDMMTLL--MKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLL 133
Query: 61 LTEDLKTIKLADFGLA-------REE----------------SLTEMMTAET-------- 89
L + +KL+DFGL R E ++ AET
Sbjct: 134 L-DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQL 192
Query: 90 -----GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 136
GT ++APE++ ++ G YN D +S ++++E+L PF
Sbjct: 193 AYSTVGTPDYIAPEVF----MQTG----YNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 23/51 (45%), Positives = 31/51 (60%), Gaps = 1/51 (1%)
Query: 26 DVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 76
D+ V G + + LH GI+HRD+KPENLL+T D +K+ DFG A
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-GQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 39/116 (33%), Positives = 54/116 (46%), Gaps = 16/116 (13%)
Query: 18 LNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFG- 74
L R R L + A + A++ +H GIIHRD+K EN+L+ ED I L DFG
Sbjct: 250 LGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGA 306
Query: 75 --LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWE 128
AR T GT APE+ + G+ Y VD +S +V++E
Sbjct: 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLA------GDP--YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 31/118 (26%), Positives = 49/118 (41%), Gaps = 26/118 (22%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLL---------------TEDLKTIKLADFGLAREESL 81
I +E +HS G++HRDLKP+N+LL + L+ L D +
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 82 TEMMTAE---TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 136
MT GT +MAPE L + D Y+ ++L+++L P+
Sbjct: 182 YSSMTIPGKIVGTPDYMAPE-----RLLGVPA---SESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-05
Identities = 37/134 (27%), Positives = 59/134 (44%), Gaps = 19/134 (14%)
Query: 3 IVTELLSGGTLRKYL---LNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 59
+V + GG L ++ LN+ C+ +A ++ A++ LH GI+ RDL P N+
Sbjct: 62 LVLQHAEGGKLWSHISKFLNIPEECVKR-----WAAEMVVALDALHREGIVCRDLNPNNI 116
Query: 60 LLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
LL +D I+L F E + + E + APE+ G D
Sbjct: 117 LL-DDRGHIQLTYFSRWSE--VEDSCDGEAVENMYCAPEV--------GGISEETEACDW 165
Query: 120 YSFAIVLWELLHNK 133
+S +L+ELL K
Sbjct: 166 WSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 5e-05
Identities = 37/119 (31%), Positives = 55/119 (46%), Gaps = 14/119 (11%)
Query: 23 RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA--REES 80
R + +C + + RA++ LH + IIHRD+K EN+ + + L DFG A +
Sbjct: 177 RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP-GDVCLGDFGAACFPVDI 235
Query: 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL--HNKLPFE 137
GT APEL + + Y VD +S IVL+E+ H+ L FE
Sbjct: 236 NANKYYGWAGTIATNAPELLA--------RDPYGPAVDIWSAGIVLFEMATCHDSL-FE 285
|
Length = 391 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 6e-05
Identities = 26/83 (31%), Positives = 39/83 (46%), Gaps = 12/83 (14%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
IV E + GG K +L P ++ +G +A+ LH GI+H DL N +
Sbjct: 411 KTIVMEYI-GGKDLKDVLEGNP---ELVRKVG--EIVAK----LHKAGIVHGDLTTSNFI 460
Query: 61 LTEDLKTIKLADFGLAREESLTE 83
+ +D + L DFGL + L E
Sbjct: 461 VRDD--RLYLIDFGLGKYSDLIE 481
|
Length = 535 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 7e-05
Identities = 33/96 (34%), Positives = 46/96 (47%), Gaps = 10/96 (10%)
Query: 45 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPELYST 102
H +HRD+K N+LL + IKLADFGLAR + T + T + PEL
Sbjct: 133 HKKNFLHRDIKCSNILLNNKGQ-IKLADFGLARLYNSEESRPYTNKVITLWYRPPELL-- 189
Query: 103 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
GE++ Y +D +S +L EL K F+
Sbjct: 190 ----LGEER-YGPAIDVWSCGCILGELFTKKPIFQA 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 33/125 (26%), Positives = 56/125 (44%), Gaps = 14/125 (11%)
Query: 19 NMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT---EDLKTIKLADFGL 75
N +P L + I + LH++ ++HRDLKP N+L+ + +K+AD G
Sbjct: 99 NKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158
Query: 76 AR--EESLTEMMTAE--TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH 131
AR L + + T+ + APEL +HY +D ++ + ELL
Sbjct: 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-------RHYTKAIDIWAIGCIFAELLT 211
Query: 132 NKLPF 136
++ F
Sbjct: 212 SEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 3e-04
Identities = 33/125 (26%), Positives = 56/125 (44%), Gaps = 14/125 (11%)
Query: 19 NMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT---EDLKTIKLADFGL 75
N +P L + I + LH++ ++HRDLKP N+L+ + +K+AD G
Sbjct: 99 NKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158
Query: 76 AR--EESLTEMMTAE--TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH 131
AR L + + T+ + APEL +HY +D ++ + ELL
Sbjct: 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-------RHYTKAIDIWAIGCIFAELLT 211
Query: 132 NKLPF 136
++ F
Sbjct: 212 SEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 36/120 (30%), Positives = 60/120 (50%), Gaps = 16/120 (13%)
Query: 29 VAIGFAL-DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA--------REE 79
+AI F L D+ A++ +HS G IHR +K ++LL+ D K + L+ + R+
Sbjct: 101 LAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQR 159
Query: 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM 139
+ + + W++PE+ L+Q + YN K D YS I EL + +PF+ M
Sbjct: 160 VVHDFPKSSVKNLPWLSPEV-----LQQ-NLQGYNEKSDIYSVGITACELANGHVPFKDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 9e-04
Identities = 48/203 (23%), Positives = 82/203 (40%), Gaps = 36/203 (17%)
Query: 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 61
++V E + G L L + R + V I A +A A+ L ++H ++ +N+LL
Sbjct: 92 IMVEEFVEHGPLDVCLRKEKGR-VPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILL 150
Query: 62 TE------DLKTIKLADFG-----LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 110
IKL+D G L+REE + + W+APE
Sbjct: 151 ARLGLAEGTSPFIKLSDPGVSFTALSREERVERI--------PWIAPECVPGGN------ 196
Query: 111 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE----ELSI 166
+ D +SF L E+ F+G L+ + + +PE EL+
Sbjct: 197 -SLSTAADKWSFGTTLLEIC-----FDGEVPLKERTPSEKERFYEKKHRLPEPSCKELAT 250
Query: 167 ILTSCWKEDPNARPNFTQIIQML 189
+++ C +P RP+F I++ L
Sbjct: 251 LISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 37.0 bits (86), Expect = 0.003
Identities = 33/150 (22%), Positives = 50/150 (33%), Gaps = 24/150 (16%)
Query: 51 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 110
HR K N+LLT D L G + + Y +MAPE+ +
Sbjct: 34 HRQAKSGNILLTWDGL---LKLDGSV---AFKTPEQSRPDPY-FMAPEVIQGQS------ 80
Query: 111 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 170
Y K D YS I L+E L +LP+ L A + P +
Sbjct: 81 --YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN---GMPADDPRD------R 129
Query: 171 CWKEDPNARPNFTQIIQMLLNYLSAIAPPE 200
E +A +F +++ + L
Sbjct: 130 SNLEGVSAARSFEDFMRLCASRLPQRREAA 159
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 31/103 (30%), Positives = 45/103 (43%), Gaps = 14/103 (13%)
Query: 40 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 99
A+E +H +IHRD+K EN+ L D K + L DFG A + E Y W+
Sbjct: 279 AVEYIHDKKLIHRDIKLENIFLNCDGKIV-LGDFGTA----MPFEKEREAFDYGWVG--- 330
Query: 100 YSTVTLRQGE---KKHYNHKVDSYSFAIVLWELL-HNKLPFEG 138
TV E Y D +S ++L ++L H+ P
Sbjct: 331 --TVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD 371
|
Length = 501 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 255 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.76 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.7 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.68 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.48 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.47 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.46 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.45 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.44 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.41 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.4 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.37 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.21 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.21 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.19 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.14 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.14 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.14 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.13 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.05 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.04 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.03 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.88 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.87 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.79 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.72 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.6 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.43 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.42 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.32 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.06 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.97 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.93 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.79 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.72 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.7 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.52 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.4 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.35 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.23 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.92 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.73 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.63 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.01 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.71 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 95.7 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 95.54 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.48 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.46 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 95.26 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.22 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 95.1 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.98 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.81 | |
| PLN02236 | 344 | choline kinase | 94.77 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.65 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 94.55 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.32 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 94.16 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 94.06 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.74 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.71 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.7 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.64 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 93.22 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 92.94 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 92.76 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 92.5 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 92.48 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.04 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 91.69 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 91.62 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 91.58 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 91.47 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 91.44 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-46 Score=302.61 Aligned_cols=177 Identities=28% Similarity=0.445 Sum_probs=153.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~-~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+.|+||||+||||++++...+. +++....+++.++++||.|||+ .+||||||||+|||++.. |.|||+|||.++..
T Consensus 153 isI~mEYMDgGSLd~~~k~~g~--i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNsk-GeVKicDFGVS~~l 229 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVGR--IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSK-GEVKICDFGVSGIL 229 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccC-CCEEeccccccHHh
Confidence 4689999999999999987644 9999999999999999999996 899999999999999998 89999999999975
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----chHHHHHHHHhhcCC
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM-----SNLQAAYAAAFKNVR 154 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~-----~~~~~~~~~~~~~~~ 154 (255)
... ...+++||..|||||.+.+ ..|+.++||||||++++|+.+|+.||... +..+....+......
T Consensus 230 vnS-~a~tfvGT~~YMsPERi~g--------~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP 300 (364)
T KOG0581|consen 230 VNS-IANTFVGTSAYMSPERISG--------ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPP 300 (364)
T ss_pred hhh-hcccccccccccChhhhcC--------CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCC
Confidence 555 6788999999999999864 68899999999999999999999999763 333444444443333
Q ss_pred CCCCC-CcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 155 PSAEN-VPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 155 ~~~~~-~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
..+.. ++++++.||..||++||.+||++.|+++|-
T Consensus 301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 34554 999999999999999999999999999983
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=293.07 Aligned_cols=177 Identities=33% Similarity=0.432 Sum_probs=156.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc-c
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-E 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~-~ 79 (255)
||||+||+.||.|+-+|++.+. +++..+..++.+|+.||.|||++||+||||||+|||++.+ |+++|+|||+++. .
T Consensus 100 LylVld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~-GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQ-GHIKLTDFGLCKEDL 176 (357)
T ss_pred EEEEEeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCC-CcEEEeccccchhcc
Confidence 6999999999999999997665 9999999999999999999999999999999999999999 8999999999994 3
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
.......+++||+.|||||++.+ ..|+.++|+||||+++|||++|.+||.+.+.......+........+..
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~--------~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ 248 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLG--------KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGY 248 (357)
T ss_pred cCCCccccccCCccccChHHHhc--------CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCcc
Confidence 34455677899999999999964 6789999999999999999999999999777666666666654555666
Q ss_pred CcHHHHHHHHHhcccCCCCCC----CHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARP----NFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rp----t~~~vl~~ 188 (255)
++.+.++++.++|+.||++|- ++.+|.+|
T Consensus 249 ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 249 LSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred CCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 999999999999999999994 56666655
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=297.03 Aligned_cols=191 Identities=47% Similarity=0.803 Sum_probs=167.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG-IIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~-i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+.|||||++||+|.+++....++.++...++.++.||+.||.|||+++ ||||||||+|||++.+..++||+|||+++..
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 479999999999999998854455999999999999999999999999 9999999999999988339999999999965
Q ss_pred ccc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC-C
Q 025244 80 SLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-A 157 (255)
Q Consensus 80 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~ 157 (255)
... ...+...||+.|||||++.+. ...|+.++||||||+++|||+||+.||.+....+..........++. +
T Consensus 195 ~~~~~~~~~~~GT~~wMAPEv~~~~------~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p 268 (362)
T KOG0192|consen 195 VISKTSMTSVAGTYRWMAPEVLRGE------KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP 268 (362)
T ss_pred ccccccccCCCCCccccChhhhcCC------CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC
Confidence 543 334447899999999999631 36799999999999999999999999999999888888877777776 4
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcC
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 197 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~ 197 (255)
..+++.+..+|.+||+.||.+||++.+++..|+.+.....
T Consensus 269 ~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 269 KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 5599999999999999999999999999999988766544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=297.84 Aligned_cols=183 Identities=28% Similarity=0.392 Sum_probs=154.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCC--CceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~--~~~kl~Dfg~a~~ 78 (255)
.||||||++||+|.+.+-.++. +.+.....+++|++.|+.|||++||+||||||+|||+..+. -.+||+|||+|+.
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 3899999999999999987654 88888899999999999999999999999999999997651 2689999999998
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc----CC
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN----VR 154 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~----~~ 154 (255)
......+.+.|||+.|.|||++... ....+..+.|+||+||+||-+++|.+||.+..........+... ..
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~k-----g~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p 403 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASK-----GVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP 403 (475)
T ss_pred cccceehhhhcCCccccChhheecC-----CeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence 8888889999999999999999751 12233458999999999999999999998765544333333222 22
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 155 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 155 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
+....++++..++|.+||..||++||++.|+++|-|
T Consensus 404 ~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 404 LQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 345678999999999999999999999999999854
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=298.04 Aligned_cols=177 Identities=31% Similarity=0.477 Sum_probs=156.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|||.|+|+.++|..++++.+. ++|.++..+++||+.||.|||+++|+|||||..|+|++++. +|||+|||+|....
T Consensus 93 VYivLELC~~~sL~el~Krrk~--ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRKP--LTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM-NVKIGDFGLATQLE 169 (592)
T ss_pred eEEEEEecCCccHHHHHHhcCC--CCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC-cEEecccceeeeec
Confidence 5899999999999999985444 99999999999999999999999999999999999999995 89999999998655
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
..+...+.|||+.|+|||++.. ...+..+||||+||+||-|+.|++||+... .+..+..+.......+..
T Consensus 170 ~~~Erk~TlCGTPNYIAPEVl~k--------~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-vkety~~Ik~~~Y~~P~~ 240 (592)
T KOG0575|consen 170 YDGERKKTLCGTPNYIAPEVLNK--------SGHSFEVDIWSLGCVMYTLLVGRPPFETKT-VKETYNKIKLNEYSMPSH 240 (592)
T ss_pred CcccccceecCCCcccChhHhcc--------CCCCCchhhhhhhhHHHhhhhCCCCcccch-HHHHHHHHHhcCcccccc
Confidence 4477889999999999999963 556889999999999999999999998744 445555555555556679
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
++.+.++||.++|+.||.+||++.+|+.+-
T Consensus 241 ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 241 LSAEAKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred cCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 999999999999999999999999999873
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=293.20 Aligned_cols=177 Identities=29% Similarity=0.414 Sum_probs=154.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
||+|+||++||+|.++|.+.+. +++..+..++.+|+.||+|||++|||||||||+|||++.+ ++++|+|||.|+...
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~d-mhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKD-GHIKITDFGSAKILS 225 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCC-CcEEEeeccccccCC
Confidence 6899999999999999998766 9999999999999999999999999999999999999999 699999999998432
Q ss_pred ccc--------------ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHH
Q 025244 81 LTE--------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 146 (255)
Q Consensus 81 ~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~ 146 (255)
... ...+++||..|.+||++.. ...+.++|+|+|||++|.|+.|++||.+.+....-.
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--------~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq 297 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--------SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ 297 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcC--------CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH
Confidence 211 1245899999999999964 667889999999999999999999999866554444
Q ss_pred HHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 147 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 147 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
++ .......++++++...+||+++|..||.+|++..+|.+|.
T Consensus 298 kI-~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 298 KI-QALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HH-HHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 43 3444456788999999999999999999999999999884
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=296.00 Aligned_cols=176 Identities=31% Similarity=0.530 Sum_probs=157.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
|+.||||++||+|.|.+.... +++.++..+++++++||+|||.+||+|||||.+|||++.+ |.+||+|||++....
T Consensus 345 LWVVMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~-g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMD-GSVKLTDFGFCAQIS 420 (550)
T ss_pred eEEEEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccC-CcEEEeeeeeeeccc
Confidence 689999999999999997654 9999999999999999999999999999999999999998 799999999998655
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC--CC
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--SA 157 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~ 157 (255)
... ...+.+||+.|||||+.. ...|+.+.||||||++++||+.|.+||-.....+..+.+....... .+
T Consensus 421 ~~~~KR~TmVGTPYWMAPEVvt--------rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~ 492 (550)
T KOG0578|consen 421 EEQSKRSTMVGTPYWMAPEVVT--------RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNP 492 (550)
T ss_pred cccCccccccCCCCccchhhhh--------hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCc
Confidence 443 457789999999999996 4789999999999999999999999999878877777766544433 36
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+.+++.+++|+.+||..|+.+|+++.|+|+|
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 7899999999999999999999999999997
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=275.29 Aligned_cols=182 Identities=29% Similarity=0.460 Sum_probs=157.1
Q ss_pred CEEEEecCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh--CC--CeecCCCCCcEEEeCCCCceEEecCc
Q 025244 1 MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHS--HG--IIHRDLKPENLLLTEDLKTIKLADFG 74 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~--~~--i~HrDikp~Nill~~~~~~~kl~Dfg 74 (255)
++||||||.+|+|.+.|+.. +++.+++..+++++.|++.||.++|+ .. |+||||||.||+++.+ |.|||+|||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLGDfG 173 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLGDFG 173 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-Cceeeccch
Confidence 47899999999999999864 45679999999999999999999999 44 9999999999999998 799999999
Q ss_pred ccccccccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC
Q 025244 75 LAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 153 (255)
Q Consensus 75 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 153 (255)
+++...... ...+.+|||.||+||++. ...|+++|||||+||++|||+.-++||.+.+-.+...++.....
T Consensus 174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~--------~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 174 LGRFLSSKTTFAHSLVGTPYYMSPERIH--------ESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY 245 (375)
T ss_pred hHhHhcchhHHHHhhcCCCcccCHHHHh--------cCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC
Confidence 999765443 346789999999999985 47799999999999999999999999999866666666666666
Q ss_pred CCCC-CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 154 RPSA-ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 154 ~~~~-~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
.|.+ ..+|.++..||..|+..||..||+.-.++..+..
T Consensus 246 ~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 6666 7889999999999999999999986555555443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=291.20 Aligned_cols=186 Identities=34% Similarity=0.622 Sum_probs=166.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++||||||+.|+|.++|+...+..+...+.+.++.||++|++||+++++|||||...||||+++ ..+||+|||+|+...
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~-~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED-LVVKISDFGLARLIG 354 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC-ceEEEcccccccccC
Confidence 5899999999999999998666669999999999999999999999999999999999999998 699999999999544
Q ss_pred ccccccc--CCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTEMMTA--ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
.+..... ..-...|.|||.+.. ..++.+||||||||+||||+| |+.||.++++.+.......+...|.+
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~--------~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P 426 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNY--------GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP 426 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhh--------CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC
Confidence 4332222 122468999999964 779999999999999999998 99999999999999999999999999
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
..+|+++.++|..||+.+|++|||++.+...|.++...
T Consensus 427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 99999999999999999999999999999888876543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=285.17 Aligned_cols=184 Identities=26% Similarity=0.422 Sum_probs=153.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++.|||++||+|.+++.+.+. .+++..+..+++||++||+|||++|++||||||+|||++...+.+||+|||+++...
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 4689999999999999999876 599999999999999999999999999999999999999832699999999998644
Q ss_pred c----ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CchHHHHHHHHhhcCC-
Q 025244 81 L----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG-MSNLQAAYAAAFKNVR- 154 (255)
Q Consensus 81 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~-~~~~~~~~~~~~~~~~- 154 (255)
. ........||+.|||||++.. +.....++|||||||++.||+||+.||.. ....+....+......
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~-------g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P 242 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRN-------GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP 242 (313)
T ss_pred cccccccccccccCCccccCchhhcC-------CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC
Confidence 2 222446789999999999863 12233599999999999999999999987 3444444555444433
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 155 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 155 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
..+..++.+.++|+.+|+..||.+|||+.++++|....
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 34677999999999999999999999999999986543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=288.01 Aligned_cols=183 Identities=28% Similarity=0.458 Sum_probs=156.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc-
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE- 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~- 79 (255)
+++||||+.||+|.++|.+.+. +.+.++..++.|+++|++|||++||+||||||+|||++.+.+++||+|||++...
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~--l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGR--LKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 5899999999999999998443 9999999999999999999999999999999999999987458999999999976
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
.......+.+||+.|+|||++.+ +...-+.++||||+||+||.|++|+.||.+.+ ....+..+.......+..
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~------~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-~~~l~~ki~~~~~~~p~~ 245 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSG------KGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-VPNLYRKIRKGEFKIPSY 245 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCC------CCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-HHHHHHHHhcCCccCCCC
Confidence 46667889999999999999974 11144679999999999999999999999844 344444444454555666
Q ss_pred C-cHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 160 V-PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 160 ~-~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
+ +.++..++.+||..||.+|+++.+++++ .|+.
T Consensus 246 ~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h--~w~~ 279 (370)
T KOG0583|consen 246 LLSPEARSLIEKMLVPDPSTRITLLEILEH--PWFQ 279 (370)
T ss_pred cCCHHHHHHHHHHcCCCcccCCCHHHHhhC--hhhc
Confidence 7 9999999999999999999999999965 4444
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=280.27 Aligned_cols=178 Identities=30% Similarity=0.464 Sum_probs=153.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-C----CceEEecCcc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-L----KTIKLADFGL 75 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~-~----~~~kl~Dfg~ 75 (255)
++||||||+||+|.++|++++. +++..+..++.|++.||++||+++||||||||.|||++.+ . -.+||+|||+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 5899999999999999998765 9999999999999999999999999999999999999864 1 2589999999
Q ss_pred ccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC-
Q 025244 76 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR- 154 (255)
Q Consensus 76 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~- 154 (255)
|+.........+.+|++.|||||++. ..+|+.|+|+||+|+++|+|++|+.||+.....+...........
T Consensus 162 AR~L~~~~~a~tlcGSplYMAPEV~~--------~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~ 233 (429)
T KOG0595|consen 162 ARFLQPGSMAETLCGSPLYMAPEVIM--------SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV 233 (429)
T ss_pred hhhCCchhHHHHhhCCccccCHHHHH--------hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc
Confidence 99988888888999999999999995 378999999999999999999999999987776665544433322
Q ss_pred -CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 155 -PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 155 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..+..++..+.+++...+..++.+|-+..+-..+
T Consensus 234 ~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 234 PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred CchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 2244566778899999999999999888876654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=268.97 Aligned_cols=165 Identities=32% Similarity=0.442 Sum_probs=147.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||.|+.++++.++ +++..+..++.||+.||+|||+++|++|||||+|||+|.+ |.+||+|||+|+...
T Consensus 119 lymvmeyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~-G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQN-GHIKITDFGFAKRVS 195 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccC-CcEEEEeccceEEec
Confidence 5899999999999999998665 9999999999999999999999999999999999999999 899999999999754
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
.. ..+.|||+.|+|||++.. ..++.++|.|||||++|||++|.+||.+....+...++ .......+..+
T Consensus 196 ~r--T~TlCGTPeYLAPEii~s--------k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI-~~~~v~fP~~f 264 (355)
T KOG0616|consen 196 GR--TWTLCGTPEYLAPEIIQS--------KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI-LEGKVKFPSYF 264 (355)
T ss_pred Cc--EEEecCCccccChHHhhc--------CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH-HhCcccCCccc
Confidence 33 678899999999999963 77899999999999999999999999987775544444 44444457788
Q ss_pred cHHHHHHHHHhcccCCCCC
Q 025244 161 PEELSIILTSCWKEDPNAR 179 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~R 179 (255)
+.++++|+.++|+.|-.+|
T Consensus 265 s~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 265 SSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CHHHHHHHHHHHhhhhHhh
Confidence 9999999999999999999
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=292.87 Aligned_cols=179 Identities=31% Similarity=0.493 Sum_probs=162.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|||.||++||.|+++|-++++ +.+.++++++.||+.|+.|+|..+|+|||+||+|+|++.+ +++||+|||+|....
T Consensus 87 lylvlEyv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~-~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVK-NNIKIADFGMASLEV 163 (786)
T ss_pred EEEEEEecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcc-cCEeeeccceeeccc
Confidence 6999999999999999998776 9999999999999999999999999999999999999998 579999999999888
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
.+....+.||++.|.+||++.+ ..+.+.++||||.||+||.|++|+.||++ ++...............+..+
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G-------~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f~MPs~I 235 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSG-------RPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVFEMPSNI 235 (786)
T ss_pred CCccccccCCCcccCCchhhcC-------CCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCcccCCCcC
Confidence 8888899999999999999975 34557799999999999999999999996 566666666666666677999
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
+.+.++||.+||..||.+|.|+++|++|-+
T Consensus 236 s~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 236 SSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred CHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 999999999999999999999999999854
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=278.06 Aligned_cols=180 Identities=28% Similarity=0.419 Sum_probs=160.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
|++|||||+ .+|.++++++ ++.|++..+..|+.||++||+|+|.+|+.|||+||+|||+..+ ..+||+|||+||...
T Consensus 85 L~fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~-~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 85 LYFVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGN-DVIKIADFGLAREVR 161 (538)
T ss_pred EeeeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEeccc-ceeEecccccccccc
Confidence 689999995 8999999987 6679999999999999999999999999999999999999976 489999999999877
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC----
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS---- 156 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 156 (255)
.....+..+.|.||+|||++. +.+.|+.+.|+||+||+++|+.+-++.|+|.+..++.+++......|.
T Consensus 162 SkpPYTeYVSTRWYRAPEvLL-------rs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLL-------RSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred cCCCcchhhhcccccchHHhh-------hccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence 777788889999999999997 368899999999999999999999999999999999888765333332
Q ss_pred -------------------------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 157 -------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 157 -------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
...++.+..++|.+|+..||.+|||+.|++++-.
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPF 293 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence 1235788999999999999999999999999843
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=278.58 Aligned_cols=179 Identities=27% Similarity=0.428 Sum_probs=166.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||+||+||+|.+.|.+.++.-++++.+++|+.|++.|+.|||+++|+|||||+.|||++.+ +.|+|+|||+|+...
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~-~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKD-KKVKLGDFGLAKILN 157 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcccc-CceeecchhhhhhcC
Confidence 5899999999999999999887779999999999999999999999999999999999999998 688999999999876
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
... ...+.+||+.||+||.+. +..|+.++|+|||||++|||++-+++|.+.+......++......|.+..
T Consensus 158 ~~~~~a~tvvGTp~YmcPEil~--------d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ 229 (426)
T KOG0589|consen 158 PEDSLASTVVGTPYYMCPEILS--------DIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSM 229 (426)
T ss_pred CchhhhheecCCCcccCHHHhC--------CCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCcc
Confidence 665 678899999999999996 47899999999999999999999999999887777777777778889999
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
++.+++.+|..||..+|..||++.+++.+
T Consensus 230 ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 230 YSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 99999999999999999999999999976
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=283.13 Aligned_cols=193 Identities=25% Similarity=0.415 Sum_probs=156.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|.||||+.||++..+++. ..+++.++..++..|+.||.|||++|||+||||.+|||+|.+ |++||+|||+++..-
T Consensus 444 l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~e-Gh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTE-GHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEccc-CcEEecccccccccC
Confidence 5899999999994444432 339999999999999999999999999999999999999999 899999999999543
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
......+++||+.|||||++.+ ..|+.+.|+|||||+||||+.|+.||.+.+..+.- ..+.......+..
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e--------~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F-dsI~~d~~~yP~~ 590 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTE--------QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF-DSIVNDEVRYPRF 590 (694)
T ss_pred CCCCccccccCChhhcChhhhcc--------CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHhcCCCCCCCc
Confidence 5567789999999999999964 78999999999999999999999999986655544 4444444456788
Q ss_pred CcHHHHHHHHHhcccCCCCCCC-----HHHHHHHH------HHhHhhcCCCCCCCCCc
Q 025244 160 VPEELSIILTSCWKEDPNARPN-----FTQIIQML------LNYLSAIAPPEPMIPHR 206 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt-----~~~vl~~l------~~~~~~~~~~~~~~~~~ 206 (255)
++.+...|++++|.+||.+|-. +.+|..|- ++.+......+|..|..
T Consensus 591 ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i 648 (694)
T KOG0694|consen 591 LSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTI 648 (694)
T ss_pred ccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCccc
Confidence 9999999999999999999964 45555542 22333344455555443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=259.27 Aligned_cols=178 Identities=28% Similarity=0.411 Sum_probs=153.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++||+|||+ .++.+.|.+..++ ++.+.+.++++|++.|+.|+|+++++||||||+||||+.+ |.+||+|||+|+...
T Consensus 76 lhLVFE~~d-hTvL~eLe~~p~G-~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~-gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 76 LHLVFEYCD-HTVLHELERYPNG-VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQN-GVVKLCDFGFARTLS 152 (396)
T ss_pred eEEEeeecc-hHHHHHHHhccCC-CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecC-CcEEeccchhhHhhc
Confidence 589999996 6777778776554 9999999999999999999999999999999999999998 799999999999765
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC-----
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR----- 154 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~----- 154 (255)
.....+..+.|.||+|||.+.+ ...|+...||||+||++.||++|.+.|++.+..++.+.+......
T Consensus 153 ~pgd~YTDYVATRWYRaPELLvG-------DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prh 225 (396)
T KOG0593|consen 153 APGDNYTDYVATRWYRAPELLVG-------DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRH 225 (396)
T ss_pred CCcchhhhhhhhhhccChhhhcc-------cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHH
Confidence 5666777899999999999974 578999999999999999999999999999999888776532211
Q ss_pred ---------------CC----------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 155 ---------------PS----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 155 ---------------~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
|. .+.++..+.+|+.+||+.||++|++-+|++.|
T Consensus 226 q~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 226 QSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11 12356778899999999999999999999865
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=264.61 Aligned_cols=227 Identities=25% Similarity=0.338 Sum_probs=171.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--CCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~--~~~~kl~Dfg~a~~ 78 (255)
|++|||+++||.|+..|++++...+++.++..|+.||..|+.|||+.+|.||||||+|+|.+.+ ...+||+|||+|+.
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence 5799999999999999999998899999999999999999999999999999999999999743 23689999999998
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHH----HHHHhh---
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA----YAAAFK--- 151 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----~~~~~~--- 151 (255)
........+.+-|+.|.|||++. ...|+...|+||+||++|-|++|.+||......... .++...
T Consensus 214 t~~~~~L~TPc~TPyYvaPevlg--------~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~ 285 (400)
T KOG0604|consen 214 TQEPGDLMTPCFTPYYVAPEVLG--------PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYE 285 (400)
T ss_pred cCCCccccCCcccccccCHHHhC--------chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCcc
Confidence 66666677889999999999984 466899999999999999999999999865542211 112222
Q ss_pred cCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCCcccCCCCCcCCCC-CCCCCCCccccc
Q 025244 152 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPE-SPGTSSLMTVRD 230 (255)
Q Consensus 152 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 230 (255)
...+....+|++.+++|+.+|..+|.+|.|+.+++++-+-.....-+..|.............+... ...+.++.+++.
T Consensus 286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t~~~l~~a~e~w~dvqeem~~~lA~mrv 365 (400)
T KOG0604|consen 286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLSTSRMLKEAVEAWDDVQEEMTETLATMRV 365 (400)
T ss_pred CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchhhhhcchhhhhhHHHHHHHHHHHHhccc
Confidence 2223345678999999999999999999999999998654444444444444333333333222221 122334455554
Q ss_pred cCCCC
Q 025244 231 DIGET 235 (255)
Q Consensus 231 ~~~~~ 235 (255)
+....
T Consensus 366 ~~~~v 370 (400)
T KOG0604|consen 366 DPLQV 370 (400)
T ss_pred Cccee
Confidence 44433
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=271.46 Aligned_cols=176 Identities=27% Similarity=0.399 Sum_probs=149.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
|||||||++||++..+|.+.+. +++..+..++.+++.|+..||+.|+|||||||+|+|||.+ |++||+|||++....
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~-GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDT--LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAK-GHIKLSDFGLSTGLD 292 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCC-CCEeeccccccchhh
Confidence 6999999999999999987665 9999999999999999999999999999999999999999 899999999985211
Q ss_pred c----------------------c-cc-------------------------cccCCCccceecccccccccccccccCC
Q 025244 81 L----------------------T-EM-------------------------MTAETGTYRWMAPELYSTVTLRQGEKKH 112 (255)
Q Consensus 81 ~----------------------~-~~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 112 (255)
. . .. ....+|||.|||||++.+ ..
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--------kg 364 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--------KG 364 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--------CC
Confidence 0 0 00 013469999999999974 56
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---hhcCCCCCCCCcHHHHHHHHHhcccCCCCCC---CHHHHH
Q 025244 113 YNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA---FKNVRPSAENVPEELSIILTSCWKEDPNARP---NFTQII 186 (255)
Q Consensus 113 ~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~vl 186 (255)
|+..+|+|||||++||||.|.+||.+.+..+...++. .....|....++.+.++||.+||. ||.+|- .+.||.
T Consensus 365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 8999999999999999999999999988777665544 334556677888999999999999 999996 477777
Q ss_pred HH
Q 025244 187 QM 188 (255)
Q Consensus 187 ~~ 188 (255)
+|
T Consensus 444 ~H 445 (550)
T KOG0605|consen 444 KH 445 (550)
T ss_pred cC
Confidence 76
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=263.75 Aligned_cols=179 Identities=28% Similarity=0.411 Sum_probs=155.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++||||||+||+|..+++++..+++++..+..++.+++.||+|||-.|||.|||||+||||.++ |++.|+||.++....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvred-GHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVRED-GHIMLSDFDLSLRCP 230 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecC-CcEEeeeccccccCC
Confidence 4799999999999999999999999999999999999999999999999999999999999999 899999999873100
Q ss_pred ------------------------------------c---------------------ccccccCCCccceecccccccc
Q 025244 81 ------------------------------------L---------------------TEMMTAETGTYRWMAPELYSTV 103 (255)
Q Consensus 81 ------------------------------------~---------------------~~~~~~~~gt~~y~aPE~~~~~ 103 (255)
. ......++||-.|+|||++.+
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G- 309 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG- 309 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-
Confidence 0 011234579999999999964
Q ss_pred cccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC-CCCCCCcHHHHHHHHHhcccCCCCCCC-
Q 025244 104 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPN- 181 (255)
Q Consensus 104 ~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt- 181 (255)
...+.+.|+|+|||++|||+.|..||++.++.+...++...... |....++..+++||+++|.+||.+|..
T Consensus 310 -------~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 310 -------EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGS 382 (459)
T ss_pred -------CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhcc
Confidence 44577999999999999999999999999998888887765554 345578899999999999999999987
Q ss_pred ---HHHHHHH
Q 025244 182 ---FTQIIQM 188 (255)
Q Consensus 182 ---~~~vl~~ 188 (255)
++||.+|
T Consensus 383 ~rGA~eIK~H 392 (459)
T KOG0610|consen 383 KRGAAEIKRH 392 (459)
T ss_pred ccchHHhhcC
Confidence 8888876
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=254.62 Aligned_cols=186 Identities=24% Similarity=0.394 Sum_probs=163.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|+|+|.|+.|.|+|+|...-. +++.+..++++|+++|+.|||.++|+||||||+|||++++. +++|+|||++....
T Consensus 98 ~FlVFdl~prGELFDyLts~Vt--lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~-~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSKVT--LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM-NIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhcccchHHHHhhhhee--ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc-ceEEeccceeeccC
Confidence 5899999999999999987554 99999999999999999999999999999999999999985 89999999999888
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC---CCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR---PSA 157 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~ 157 (255)
........|||++|.|||.+.+.... ....|+...|+|++||+||-++.|.+||......-....++.+... |..
T Consensus 175 ~GekLrelCGTPgYLAPEtikC~m~e--~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 175 PGEKLRELCGTPGYLAPETIKCSMYE--NHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred CchhHHHhcCCCcccChhheeeeccc--CCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence 88888889999999999999775432 3456888999999999999999999999876666555666655544 445
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
.+++...++||.+||+.||.+|.|++|++.|-.-
T Consensus 253 adis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 253 ADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred hhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 6788999999999999999999999999988543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=265.84 Aligned_cols=182 Identities=26% Similarity=0.486 Sum_probs=154.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
|++||.||.+||+.++|...-+.++++..+..++++++.||.|||.+|.||||||+.||||+.+ |.|||+|||.+-...
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~d-G~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSD-GTVKLADFGVSASLF 177 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCC-CcEEEcCceeeeeec
Confidence 6899999999999999998777779999999999999999999999999999999999999999 899999999765321
Q ss_pred c----ccc-cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC
Q 025244 81 L----TEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~----~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
. ... ..+++||++|||||++.. ....|+.|+||||||++..||.+|..||....+.+............
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q------~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~ 251 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQ------QLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPT 251 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhh------cccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCC
Confidence 1 111 267799999999999643 35678999999999999999999999999988888776655544321
Q ss_pred ---------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 156 ---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 156 ---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
....++..++++|..||.+||.+|||+.+++++-
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 1234567899999999999999999999999874
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=268.38 Aligned_cols=162 Identities=32% Similarity=0.588 Sum_probs=130.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccccc---ccccCCCccceeccccc
Q 025244 24 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELY 100 (255)
Q Consensus 24 ~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~ 100 (255)
.+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...... ......++..|+|||++
T Consensus 170 ~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 248 (338)
T cd05102 170 PLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248 (338)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC-CcEEEeecccccccccCcchhcccCCCCCccccCcHHh
Confidence 37788889999999999999999999999999999999988 699999999998532211 11233456789999988
Q ss_pred ccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhc-CCCCCCCCcHHHHHHHHHhcccCCCC
Q 025244 101 STVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKN-VRPSAENVPEELSIILTSCWKEDPNA 178 (255)
Q Consensus 101 ~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~ 178 (255)
.+ ..++.++||||||+++|||++ |..||.+....+......... ....+..+++++.+++.+||+.||.+
T Consensus 249 ~~--------~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 320 (338)
T cd05102 249 FD--------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE 320 (338)
T ss_pred hc--------CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence 53 567889999999999999997 999998755443333333222 22235577899999999999999999
Q ss_pred CCCHHHHHHHHHHhHh
Q 025244 179 RPNFTQIIQMLLNYLS 194 (255)
Q Consensus 179 Rpt~~~vl~~l~~~~~ 194 (255)
||++.++++.|++.+.
T Consensus 321 RPs~~el~~~l~~~~~ 336 (338)
T cd05102 321 RPTFSALVEILGDLLQ 336 (338)
T ss_pred CcCHHHHHHHHHHHHh
Confidence 9999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=261.03 Aligned_cols=182 Identities=24% Similarity=0.348 Sum_probs=152.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~-~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+++||||++||+|.+++...+ .+++...+.++.+++.||.|||+. +++||||||+||+++.+ +.+||+|||+++..
T Consensus 97 ~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~-~~~kl~dfg~~~~~ 173 (283)
T PHA02988 97 LSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN-YKLKIICHGLEKIL 173 (283)
T ss_pred eEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC-CcEEEcccchHhhh
Confidence 479999999999999998754 389999999999999999999984 99999999999999998 79999999999854
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC-CC
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-AE 158 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 158 (255)
... .....|+..|+|||++.+ ....++.++|||||||++|||++|+.||.+....+...........+. +.
T Consensus 174 ~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (283)
T PHA02988 174 SSP--PFKNVNFMVYFSYKMLND------IFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPL 245 (283)
T ss_pred ccc--cccccCcccccCHHHhhh------ccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Confidence 332 234578899999999853 124678899999999999999999999998766555444433333333 34
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 025244 159 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 193 (255)
Q Consensus 159 ~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~ 193 (255)
.+++.+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 246 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 246 DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 78899999999999999999999999999987654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=261.92 Aligned_cols=179 Identities=25% Similarity=0.415 Sum_probs=147.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.......+++..+..++.|++.||+|||++|++||||||+|||++.+ +.++|+|||++....
T Consensus 75 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~ 153 (285)
T cd05631 75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR-GHIRISDLGLAVQIP 153 (285)
T ss_pred EEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeCCCcEEcC
Confidence 4799999999999999876555559999999999999999999999999999999999999988 699999999998654
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHH---HHHHHhhcCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA---AYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~ 157 (255)
.........||..|+|||++.+ ..++.++|||||||++|||++|+.||.+...... .............
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd05631 154 EGETVRGRVGTVGYMAPEVINN--------EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYS 225 (285)
T ss_pred CCCeecCCCCCCCccCHhhhcC--------CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCC
Confidence 4333455679999999999853 5678899999999999999999999986543221 1122222223345
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPN-----FTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt-----~~~vl~~ 188 (255)
..++.++.+||.+||+.||.+||+ +++++++
T Consensus 226 ~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 226 EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 568899999999999999999997 8888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=264.18 Aligned_cols=176 Identities=28% Similarity=0.436 Sum_probs=147.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++..... +++..+..++.|++.||+|||++|++||||||+|||++.+ +.+||+|||+++...
T Consensus 70 ~~lv~E~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 70 LCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGI 146 (323)
T ss_pred EEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC-CCEEecccHHhcccc
Confidence 4799999999999999986543 8999999999999999999999999999999999999988 799999999987532
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
. ........||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.+........... ....+..
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-~~~~p~~ 217 (323)
T cd05595 147 SDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFPRT 217 (323)
T ss_pred CCCCccccccCCcCcCCcccccC--------CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCCCC
Confidence 2 222345679999999999853 56788999999999999999999999876654443333322 2234567
Q ss_pred CcHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARP-----NFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~ 188 (255)
+++++.++|.+||+.||.+|+ ++.+++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 899999999999999999998 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=244.13 Aligned_cols=187 Identities=26% Similarity=0.368 Sum_probs=158.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+.||+||++ .+|+..|++.. ..++...+..++.+++.||+|||++.|+||||||+|+|++++ |.+||+|||+|+...
T Consensus 76 l~lVfEfm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 76 LSLVFEFMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSD-GQLKIADFGLARFFG 152 (318)
T ss_pred eEEEEEecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCC-CcEEeecccchhccC
Confidence 469999996 89999998754 459999999999999999999999999999999999999999 799999999999765
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
.. ......+.|.||.|||.+.+ ...|+...|+||.||++.||+.|.+-|.+.+..++...+......|.+..
T Consensus 153 ~p~~~~~~~V~TRWYRAPELLfG-------sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~ 225 (318)
T KOG0659|consen 153 SPNRIQTHQVVTRWYRAPELLFG-------SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQ 225 (318)
T ss_pred CCCcccccceeeeeccChHHhcc-------chhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCccc
Confidence 44 33445588999999999986 46789999999999999999999999999999888877765554443322
Q ss_pred ---------------------------CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcCCC
Q 025244 160 ---------------------------VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 199 (255)
Q Consensus 160 ---------------------------~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~~~ 199 (255)
.+.+..+++.+||..||.+|.++.|++++ .++...+.|
T Consensus 226 WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~P~p 290 (318)
T KOG0659|consen 226 WPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSLPLP 290 (318)
T ss_pred CccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcCCCC
Confidence 34677899999999999999999999997 555543333
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=269.06 Aligned_cols=176 Identities=28% Similarity=0.419 Sum_probs=147.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++...+. +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 70 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DfG~a~~~~ 146 (323)
T cd05571 70 LCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEGI 146 (323)
T ss_pred EEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEeeCCCCcccc
Confidence 4799999999999999986543 8999999999999999999999999999999999999988 799999999987532
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+......... ......+..
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~-~~~~~~p~~ 217 (323)
T cd05571 147 SDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-MEEIRFPRT 217 (323)
T ss_pred cCCCcccceecCccccChhhhcC--------CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH-cCCCCCCCC
Confidence 2223345679999999999853 567889999999999999999999998765544333332 223334567
Q ss_pred CcHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARP-----NFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~ 188 (255)
+++++.++|.+||+.||++|| ++.+++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 899999999999999999999 79999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=252.60 Aligned_cols=184 Identities=29% Similarity=0.365 Sum_probs=157.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|||||||+ .+|..+|...++ +|...++..+..|++.|++|||.+.|+|||||++|+|++.. |.+||+|||+|+..+
T Consensus 152 iy~VMe~~E-hDLksl~d~m~q-~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~-G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 152 IYIVMEYVE-HDLKSLMETMKQ-PFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHK-GILKIADFGLAREYG 228 (419)
T ss_pred eeeeHHHHH-hhHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccC-CcEEecccchhhhhc
Confidence 589999997 799999998764 49999999999999999999999999999999999999988 799999999999766
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCC-
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE- 158 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 158 (255)
.. ...+..+.|.||.|||.+.+ ...|+.+.|+||+||++.|++++++-|.+.+..++...+......|...
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG-------~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~i 301 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLG-------AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAI 301 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcC-------CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcccc
Confidence 54 44566789999999999985 4678999999999999999999999999999888887776543333211
Q ss_pred ------------------------------CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 025244 159 ------------------------------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 196 (255)
Q Consensus 159 ------------------------------~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~ 196 (255)
.+++.-.+|+..+|..||.+|.|+.+.+++ .++...
T Consensus 302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~ 367 (419)
T KOG0663|consen 302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRET 367 (419)
T ss_pred CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccC
Confidence 134677889999999999999999999998 555443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=271.43 Aligned_cols=177 Identities=26% Similarity=0.433 Sum_probs=152.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
|+++||||.||++.+.|..... +.+.++.-++++++.||.|||.++.+|||||+.|||+..+ |.+||+|||.+....
T Consensus 86 LwiiMey~~gGsv~~lL~~~~~--~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSGNI--LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES-GDVKLADFGVAGQLT 162 (467)
T ss_pred HHHHHHHhcCcchhhhhccCCC--CccceeeeehHHHHHHhhhhhhcceecccccccceeEecc-CcEEEEecceeeeee
Confidence 4678999999999999986443 5888888899999999999999999999999999999999 899999999998544
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
.. ....+++||+.|||||++.+ ..|+.++||||||++.+||.+|.+|+.+.+++...+.+-.........+
T Consensus 163 ~~~~rr~tfvGTPfwMAPEVI~~--------~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~ 234 (467)
T KOG0201|consen 163 NTVKRRKTFVGTPFWMAPEVIKQ--------SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGD 234 (467)
T ss_pred chhhccccccccccccchhhhcc--------ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccc
Confidence 33 33478999999999999963 6789999999999999999999999998888655554444444334558
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+++.+++||..||++||+.||++.++++|
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 89999999999999999999999999986
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=257.73 Aligned_cols=178 Identities=30% Similarity=0.363 Sum_probs=152.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|+|+|+| +.+|.+.|+.+.. ++.+.+..+++|++.||.|+|+.||+||||||.|++++.++ .+||+|||+|+..+
T Consensus 101 vYiV~elM-etDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c-~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADC-DLKICDFGLARYLD 176 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCC-CEEeccccceeecc
Confidence 58999999 6999999987654 99999999999999999999999999999999999999995 88999999999765
Q ss_pred c---ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC-
Q 025244 81 L---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS- 156 (255)
Q Consensus 81 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~- 156 (255)
. ....+..+.|.||.|||++.. ...|+.+.||||+||++.||++|++-|.|.+...+...+......|.
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~-------~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLN-------SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhc-------cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 3 445567789999999999864 57899999999999999999999999998887655544332222111
Q ss_pred -----------------------------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 157 -----------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 157 -----------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
.++.++...+|+.+||..||.+|+|++|+++|-
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 235678899999999999999999999999983
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=272.58 Aligned_cols=178 Identities=33% Similarity=0.642 Sum_probs=158.1
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
+||||||..|-|..+|+..+. +.......|..+|+.|+.|||.+.|||||||.-||||+.+ ..|||+|||.++....
T Consensus 188 CIiMEfCa~GqL~~VLka~~~--itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKAGRP--ITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYD-DVVKISDFGTSKELSD 264 (904)
T ss_pred EEeeeccccccHHHHHhccCc--cCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeecc-ceEEeccccchHhhhh
Confidence 799999999999999987554 9999999999999999999999999999999999999988 5999999999997766
Q ss_pred ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-CCCCCCCC
Q 025244 82 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN-VRPSAENV 160 (255)
Q Consensus 82 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 160 (255)
-.....+.||..|||||++. ....+.|.||||||||||||+||..||++.+.....+-+.... ..|.+..+
T Consensus 265 ~STkMSFaGTVaWMAPEvIr--------nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstc 336 (904)
T KOG4721|consen 265 KSTKMSFAGTVAWMAPEVIR--------NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTC 336 (904)
T ss_pred hhhhhhhhhhHhhhCHHHhh--------cCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccC
Confidence 66677899999999999995 4677889999999999999999999999876655555443322 34668889
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
|..++-||+.||+..|..||++++++.||.
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 999999999999999999999999999985
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=275.45 Aligned_cols=179 Identities=28% Similarity=0.456 Sum_probs=151.9
Q ss_pred CEEEEecCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
++|||||++||+|.++|.+. ....+++.++..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~-~~~kL~DFgla~~ 218 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT-GIIKLGDFGFSKQ 218 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCC-CcEEEEeCcCcee
Confidence 48999999999999988653 23348999999999999999999999999999999999999988 7999999999985
Q ss_pred ccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC
Q 025244 79 ESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 79 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
..... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+...........+
T Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 290 (478)
T PTZ00267 219 YSDSVSLDVASSFCGTPYYLAPELWER--------KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP 290 (478)
T ss_pred cCCccccccccccCCCccccCHhHhCC--------CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 43321 2345679999999998853 567889999999999999999999998877666555555555555
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.+..++.++.++|.+||..||++||++.+++.+
T Consensus 291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 566788999999999999999999999999764
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=261.79 Aligned_cols=176 Identities=28% Similarity=0.431 Sum_probs=147.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++..... +++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 70 ~~lv~Ey~~~g~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kL~DfG~~~~~~ 146 (328)
T cd05593 70 LCFVMEYVNGGELFFHLSRERV--FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD-GHIKITDFGLCKEGI 146 (328)
T ss_pred EEEEEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC-CcEEEecCcCCccCC
Confidence 4799999999999999976543 9999999999999999999999999999999999999988 799999999987532
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+..... .......+..
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~-~~~~~~~p~~ 217 (328)
T cd05593 147 TDAATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-LMEDIKFPRT 217 (328)
T ss_pred CcccccccccCCcCccChhhhcC--------CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh-ccCCccCCCC
Confidence 2223345679999999999853 56788999999999999999999999876554433322 2222334567
Q ss_pred CcHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARP-----NFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~ 188 (255)
++.++.++|.+||+.||.+|+ ++.+++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 889999999999999999997 89999887
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=259.70 Aligned_cols=176 Identities=31% Similarity=0.467 Sum_probs=146.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++..... +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 71 ~~lv~e~~~gg~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 71 LFFVMEYLNGGDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD-GHIKIADFGMCKENM 147 (316)
T ss_pred EEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC-CCEEEccCcCCeECC
Confidence 4799999999999999987544 9999999999999999999999999999999999999988 799999999997532
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
. .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+..... .......+..
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i-~~~~~~~~~~ 218 (316)
T cd05592 148 NGEGKASTFCGTPDYIAPEILKG--------QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI-LNDRPHFPRW 218 (316)
T ss_pred CCCCccccccCCccccCHHHHcC--------CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH-HcCCCCCCCC
Confidence 2 233345679999999999853 45788999999999999999999999886654444333 2233334566
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFT-QIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~-~vl~~ 188 (255)
++.++.++|.+||+.||.+||++. +++++
T Consensus 219 ~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 219 ISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 889999999999999999999875 55554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=261.58 Aligned_cols=176 Identities=28% Similarity=0.384 Sum_probs=145.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+... +++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 71 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~-~~~kl~Dfg~~~~~~ 147 (323)
T cd05575 71 LYFVLDYVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGI 147 (323)
T ss_pred EEEEEcCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeccCCCcccc
Confidence 4799999999999999986543 8999999999999999999999999999999999999988 799999999987532
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+...... .........
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~-~~~~~~~~~ 218 (323)
T cd05575 148 EHSKTTSTFCGTPEYLAPEVLRK--------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL-NKPLRLKPN 218 (323)
T ss_pred cCCCccccccCChhhcChhhhcC--------CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH-cCCCCCCCC
Confidence 2223345679999999999853 557889999999999999999999998866544433333 233334556
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHH----HHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFT----QIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~----~vl~~ 188 (255)
++..+.++|.+||+.||.+||++. +++++
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 219 ISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred CCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 799999999999999999999874 55544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=263.98 Aligned_cols=176 Identities=28% Similarity=0.419 Sum_probs=146.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+... +++..+..++.|++.||+|||++|++||||||+|||++.+ +.+||+|||+++...
T Consensus 71 ~~iv~Ey~~~g~L~~~i~~~~~--l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~-~~~kL~DfG~~~~~~ 147 (320)
T cd05590 71 LFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGI 147 (320)
T ss_pred EEEEEcCCCCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeeCCCCeecC
Confidence 4799999999999999987544 9999999999999999999999999999999999999988 799999999987532
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
.........||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+...... ......+..
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~ 218 (320)
T cd05590 148 FNGKTTSTFCGTPDYIAPEILQE--------MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL-NDEVVYPTW 218 (320)
T ss_pred cCCCcccccccCccccCHHHHcC--------CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh-cCCCCCCCC
Confidence 2223345679999999999853 567889999999999999999999998866554443333 333334556
Q ss_pred CcHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNF------TQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~------~~vl~~ 188 (255)
++.++.++|.+||+.||.+||++ .++++|
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 219 LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 88999999999999999999998 666665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=258.41 Aligned_cols=178 Identities=28% Similarity=0.386 Sum_probs=147.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++.......+++..+..++.|++.||.|||++|++||||||+|||++.+ +.+||+|||+++...
T Consensus 84 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 161 (290)
T cd07862 84 LTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYS 161 (290)
T ss_pred EEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCC-CCEEEccccceEecc
Confidence 479999995 799999987655568999999999999999999999999999999999999988 799999999998654
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC-----
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP----- 155 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~----- 155 (255)
.........||..|+|||++.. ..++.++|||||||++|||++|++||.+....+...........+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 162 FQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred CCcccccccccccccChHHHhC--------CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 4444455678999999998853 457889999999999999999999998876655444333211111
Q ss_pred ---------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 ---------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....+++.+.+++.+||+.||++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 013467888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=257.66 Aligned_cols=175 Identities=27% Similarity=0.361 Sum_probs=147.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++...+. +++..+..++.|++.||+|||++|++||||||+|||++.+ +.+||+|||+++...
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE-GHIKLTDFGFAKKLR 152 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEEecCcchhcc
Confidence 4799999999999999987554 8999999999999999999999999999999999999988 799999999998543
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....... .....+..+
T Consensus 153 ~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~ 221 (291)
T cd05612 153 DR--TWTLCGTPEYLAPEVIQS--------KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA-GKLEFPRHL 221 (291)
T ss_pred CC--cccccCChhhcCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCcCCCccC
Confidence 22 234579999999999853 4568899999999999999999999988665544433332 233345567
Q ss_pred cHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARPN-----FTQIIQML 189 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt-----~~~vl~~l 189 (255)
+..+.++|.+||+.||.+||+ +.+++++-
T Consensus 222 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 222 DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 899999999999999999995 88888773
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=262.31 Aligned_cols=178 Identities=24% Similarity=0.329 Sum_probs=153.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|||+|||+ .+|.-++...+ -.|++.++..++.|+++||+|||++||+|||||.+||||+++ |.+||+|||+|+...
T Consensus 193 iYlVFeYMd-hDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~-G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 193 IYLVFEYMD-HDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNN-GVLKIADFGLARFYT 269 (560)
T ss_pred EEEEEeccc-chhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCC-CCEEeccccceeecc
Confidence 699999996 79999988643 349999999999999999999999999999999999999998 799999999999544
Q ss_pred cc--cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCC-
Q 025244 81 LT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA- 157 (255)
Q Consensus 81 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 157 (255)
.. ...+..+.|.||.|||.+.+ ...|+.+.|+||.||+|.||+.|++.|.+....++...+......|..
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG-------~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~ 342 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLG-------ATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTED 342 (560)
T ss_pred CCCCcccccceEEeeccChHHhcC-------CcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChh
Confidence 33 34677889999999999986 578999999999999999999999999999988888777654433321
Q ss_pred ---------------------------CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ---------------------------ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ---------------------------~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..++....+|+..+|..||.+|.|+.++++.
T Consensus 343 ~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 343 YWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 1245677889999999999999999999986
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=274.89 Aligned_cols=179 Identities=27% Similarity=0.467 Sum_probs=152.6
Q ss_pred CEEEEecCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++||||++||+|.++|.... ...+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 114 i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~-~~vkL~DFGls~~ 192 (496)
T PTZ00283 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFGFSKM 192 (496)
T ss_pred EEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCC-CCEEEEecccCee
Confidence 368999999999999997642 3458999999999999999999999999999999999999988 6999999999975
Q ss_pred ccc---ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC
Q 025244 79 ESL---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 79 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+...........+
T Consensus 193 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~ 264 (496)
T PTZ00283 193 YAATVSDDVGRTFCGTPYYVAPEIWRR--------KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264 (496)
T ss_pred ccccccccccccccCCcceeCHHHhCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 332 122345679999999999853 567889999999999999999999998876655555555555555
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.+..+++++.+++.+||+.||.+||++.+++++
T Consensus 265 ~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 677889999999999999999999999999876
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=254.49 Aligned_cols=182 Identities=32% Similarity=0.592 Sum_probs=151.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
+++||||++|++|.+++..... ..+++..++.++.|++.||.|||++|++||||||+||+++++ +
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~-~ 161 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG-L 161 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC-C
Confidence 3789999999999999986422 347889999999999999999999999999999999999988 6
Q ss_pred ceEEecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchH
Q 025244 67 TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 142 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~ 142 (255)
.++|+|||+++...... ......++..|+|||.+.. ..++.++|||||||++|||++ |..||.+....
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~ 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY--------GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhcc--------CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 89999999997532221 2233456789999998753 457889999999999999998 99999887766
Q ss_pred HHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 143 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
+...........+.+..++.++.+|+.+||+.||.+||++.+++++|++
T Consensus 234 ~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 5554444444445567889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=263.84 Aligned_cols=178 Identities=28% Similarity=0.397 Sum_probs=146.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+.+. +++..+..++.||+.||+|||++||+||||||+|||++.+ +.++|+|||+++...
T Consensus 71 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~ 147 (330)
T cd05586 71 LYLVTDYMSGGELFWHLQKEGR--FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT-GHIALCDFGLSKANL 147 (330)
T ss_pred EEEEEcCCCCChHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEecCCcCcCCC
Confidence 4899999999999999986544 9999999999999999999999999999999999999988 799999999987532
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
........+||..|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+................
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 220 (330)
T cd05586 148 TDNKTTNTFCGTTEYLAPEVLLD-------EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNV 220 (330)
T ss_pred CCCCCccCccCCccccCHHHHcC-------CCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 2233445679999999998853 23467899999999999999999999988665554444433333333445
Q ss_pred CcHHHHHHHHHhcccCCCCCC----CHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARP----NFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rp----t~~~vl~~ 188 (255)
++.++.++|.+||+.||.+|| ++.+++++
T Consensus 221 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 221 LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 789999999999999999998 57777765
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=262.26 Aligned_cols=176 Identities=30% Similarity=0.457 Sum_probs=145.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++..... +++..+..++.|++.||+|||++||+||||||+|||++.+ +.++|+|||+++...
T Consensus 71 ~~lv~E~~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 147 (316)
T cd05620 71 LFFVMEFLNGGDLMFHIQDKGR--FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD-GHIKIADFGMCKENV 147 (316)
T ss_pred EEEEECCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEeCccCCCeecc
Confidence 4799999999999999987543 8999999999999999999999999999999999999988 699999999987432
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+..... .......+..
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~-~~~~~~~~~~ 218 (316)
T cd05620 148 FGDNRASTFCGTPDYIAPEILQG--------LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI-RVDTPHYPRW 218 (316)
T ss_pred cCCCceeccCCCcCccCHHHHcC--------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-HhCCCCCCCC
Confidence 2223345679999999999853 56788999999999999999999999876654433332 2222333456
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFT-QIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~-~vl~~ 188 (255)
++.++.++|.+||+.||.+||++. ++++|
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 219 ITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 889999999999999999999974 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=262.38 Aligned_cols=176 Identities=26% Similarity=0.387 Sum_probs=146.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++.+ +.++|+|||+++...
T Consensus 68 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~ 144 (312)
T cd05585 68 LYLVLAFINGGELFHHLQREGR--FDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ-GHIALCDFGLCKLNM 144 (312)
T ss_pred EEEEEcCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC-CcEEEEECcccccCc
Confidence 4799999999999999987543 8999999999999999999999999999999999999988 799999999998532
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.... ........+..
T Consensus 145 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~ 215 (312)
T cd05585 145 KDDDKTNTFCGTPEYLAPELLLG--------HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK-ILQEPLRFPDG 215 (312)
T ss_pred cCCCccccccCCcccCCHHHHcC--------CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHH-HHcCCCCCCCc
Confidence 2223345679999999999853 5678899999999999999999999987655443333 33333344567
Q ss_pred CcHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPN---FTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt---~~~vl~~ 188 (255)
+++++.++|.+||+.||.+||+ +.+++.+
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 8899999999999999999975 6777765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=241.37 Aligned_cols=180 Identities=28% Similarity=0.390 Sum_probs=156.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--CCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~--~~~~kl~Dfg~a~~ 78 (255)
.+||+|+++|++|..-|-.+. .+++..+..+++||+++|.|+|.+||+|||+||+|+++.+. ...+||+|||+|..
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred eEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 389999999999988876653 38999999999999999999999999999999999999643 23689999999998
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC---C
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR---P 155 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---~ 155 (255)
..........+|||.|||||++. ...|+..+|||+.||+||-++.|++||.+.+......+++..... +
T Consensus 163 l~~g~~~~G~~GtP~fmaPEvvr--------kdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~ 234 (355)
T KOG0033|consen 163 VNDGEAWHGFAGTPGYLSPEVLK--------KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSP 234 (355)
T ss_pred eCCccccccccCCCcccCHHHhh--------cCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCc
Confidence 77666677889999999999995 578999999999999999999999999998777766666655543 3
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
....++++.++|+++||..||.+|.|+.|.++|-+
T Consensus 235 ~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 235 EWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred ccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 45678899999999999999999999999998754
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=262.15 Aligned_cols=177 Identities=29% Similarity=0.433 Sum_probs=146.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~-~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
++|||||++||+|.+++..... +++..+..++.||+.||+|||+ +||+||||||+|||++.+ +.+||+|||+++..
T Consensus 70 ~~lv~E~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~-~~~kL~Dfg~~~~~ 146 (325)
T cd05594 70 LCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEG 146 (325)
T ss_pred EEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC-CCEEEecCCCCeec
Confidence 4799999999999999976543 9999999999999999999997 799999999999999988 79999999998743
Q ss_pred c-cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCC
Q 025244 80 S-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE 158 (255)
Q Consensus 80 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 158 (255)
. .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+........ .......+.
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i-~~~~~~~p~ 217 (325)
T cd05594 147 IKDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-LMEEIRFPR 217 (325)
T ss_pred CCCCcccccccCCcccCCHHHHcc--------CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH-hcCCCCCCC
Confidence 2 2223345679999999999853 56788999999999999999999999876554433332 222333456
Q ss_pred CCcHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 025244 159 NVPEELSIILTSCWKEDPNARP-----NFTQIIQML 189 (255)
Q Consensus 159 ~~~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~l 189 (255)
.+++++.++|.+||+.||++|+ ++.+++++-
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 7889999999999999999996 899998873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=261.09 Aligned_cols=174 Identities=28% Similarity=0.374 Sum_probs=144.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++..... +.+..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 71 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~-~~~kl~DfG~a~~~~ 147 (325)
T cd05602 71 LYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENI 147 (325)
T ss_pred EEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEEccCCCCcccc
Confidence 4799999999999999986543 8888999999999999999999999999999999999988 799999999997432
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...... .........
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~-~~~~~~~~~ 218 (325)
T cd05602 148 EHNGTTSTFCGTPEYLAPEVLHK--------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL-NKPLQLKPN 218 (325)
T ss_pred cCCCCcccccCCccccCHHHHcC--------CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH-hCCcCCCCC
Confidence 2223445679999999999853 567889999999999999999999998766554433332 233334567
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQII 186 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl 186 (255)
++..+.++|.+||+.||.+||++.+.+
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 219 ITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 899999999999999999999877433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=256.01 Aligned_cols=179 Identities=27% Similarity=0.424 Sum_probs=158.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||..||.|.|||.+.+. +++.++..+++||.+|+.|+|.++++|||||.+|||++.+ +++||+|||++....
T Consensus 128 IvivMEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N-~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQN-NNIKIADFGLSNLYA 204 (668)
T ss_pred EEEEEEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCC-CCeeeeccchhhhhc
Confidence 5799999999999999998776 9999999999999999999999999999999999999999 699999999999888
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
......++||++-|.+||+.++ ..+-++..|.|||||+||-|+.|..||++.+......++..+..+. +.-
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG-------~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE--P~~ 275 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNG-------TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE--PET 275 (668)
T ss_pred cccHHHHhcCCcccCCccccCC-------CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC--CCC
Confidence 8888899999999999999975 2344678999999999999999999999987766666655554443 334
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
|.+...||++||..||++|.|+.+|..|.|-
T Consensus 276 PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 276 PSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred CchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 6788999999999999999999999999763
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=260.07 Aligned_cols=171 Identities=29% Similarity=0.388 Sum_probs=141.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc-
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE- 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~- 79 (255)
+++||||++||+|.+++.+.. .+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||+++..
T Consensus 71 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~ 147 (321)
T cd05603 71 LYFVLDYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGV 147 (321)
T ss_pred EEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEccCCCCccCC
Confidence 479999999999999997644 38899999999999999999999999999999999999988 79999999998753
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+... .........+..
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~i~~~~~~~~~~ 218 (321)
T cd05603 148 EPEETTSTFCGTPEYLAPEVLRK--------EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD-NILHKPLQLPGG 218 (321)
T ss_pred CCCCccccccCCcccCCHHHhcC--------CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH-HHhcCCCCCCCC
Confidence 22233345679999999999853 557889999999999999999999998865544333 333333344567
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFT 183 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~ 183 (255)
.+..+.++|.+||+.||.+||++.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCHHHHHHHHHHccCCHhhcCCCC
Confidence 789999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=249.59 Aligned_cols=181 Identities=25% Similarity=0.474 Sum_probs=149.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||+++|+|.+++..... +++..+..++.|++.||+|||++|++||||||.||+++.+ +.++|+|||+++...
T Consensus 70 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~ 146 (257)
T cd05116 70 WMLVMELAELGPLNKFLQKNKH--VTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALG 146 (257)
T ss_pred cEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC-CeEEECCCccccccC
Confidence 3789999999999999976543 8999999999999999999999999999999999999988 689999999997543
Q ss_pred cccc----cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCC
Q 025244 81 LTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
.... .....++..|+|||.+.. ..++.++|+||||+++|||++ |+.||.+....+...........+
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 218 (257)
T cd05116 147 ADENYYKAKTHGKWPVKWYAPECMNY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERME 218 (257)
T ss_pred CCCCeeeecCCCCCCccccCHhHhcc--------CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCC
Confidence 2211 122234578999998753 457789999999999999998 999998766655444444333334
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
.+..+++++.++|.+||+.||++||++.+|.+.|+++
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 5667899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=261.79 Aligned_cols=176 Identities=27% Similarity=0.429 Sum_probs=146.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++..... +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKENI 152 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCC-CCEEEeecCcceecC
Confidence 4799999999999999986554 8999999999999999999999999999999999999988 799999999987422
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
........+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.+..+...... ......+..
T Consensus 153 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~-~~~~~~~~~ 223 (324)
T cd05587 153 FGGKTTRTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM-EHNVSYPKS 223 (324)
T ss_pred CCCCceeeecCCccccChhhhcC--------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCCC
Confidence 2223345679999999999853 557889999999999999999999998866554444333 333334567
Q ss_pred CcHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNF-----TQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~-----~~vl~~ 188 (255)
++.++.+++.+||+.||.+|++. .+++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 224 LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 88999999999999999999976 566654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=262.18 Aligned_cols=178 Identities=28% Similarity=0.376 Sum_probs=143.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~-~~~kl~DfG~~~~~~ 156 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE-GHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCC-CCEEEeeCcCCcccc
Confidence 4799999999999999986544 9999999999999999999999999999999999999988 799999999997532
Q ss_pred cc--cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHHhhcCCC
Q 025244 81 LT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN---LQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~---~~~~~~~~~~~~~~ 155 (255)
.. .......||+.|+|||++.+ ...++.++|||||||++|||++|+.||..... .............+
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 229 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRG-------KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP 229 (332)
T ss_pred ccCCCccccccCCccccCHHHhcC-------CCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC
Confidence 22 22234679999999999853 23467799999999999999999999964321 12222222223333
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 188 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~ 188 (255)
.+..++..+.+++.+||+.||++|| ++.+++++
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 230 FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 4567889999999999999999999 77788876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=262.05 Aligned_cols=177 Identities=28% Similarity=0.388 Sum_probs=147.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++.+... +++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 71 ~~lv~E~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~-~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 71 LFFVMEYVNGGDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE-GHCKLADFGMCKEGI 147 (321)
T ss_pred EEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEeecccceecc
Confidence 4799999999999999986544 8999999999999999999999999999999999999988 799999999987532
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....... .....+..
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~-~~~~~p~~ 218 (321)
T cd05591 148 LNGVTTTTFCGTPDYIAPEILQE--------LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH-DDVLYPVW 218 (321)
T ss_pred cCCccccccccCccccCHHHHcC--------CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCC
Confidence 2223345679999999998853 5678899999999999999999999988665554443332 22333556
Q ss_pred CcHHHHHHHHHhcccCCCCCC-------CHHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARP-------NFTQIIQML 189 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rp-------t~~~vl~~l 189 (255)
++.++.+++.+||+.||++|| ++.+++++-
T Consensus 219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 789999999999999999999 888888763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=262.53 Aligned_cols=177 Identities=27% Similarity=0.428 Sum_probs=147.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+.. .+++..+..++.|++.||+|||++|++||||||+|||++.+ +.+||+|||+++...
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD-GHIKLADFGLCKKMN 152 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEeecCCCCccCc
Confidence 479999999999999998763 39999999999999999999999999999999999999988 799999999997543
Q ss_pred ccc------------------------------ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHH
Q 025244 81 LTE------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 130 (255)
Q Consensus 81 ~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~ 130 (255)
... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ell 224 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--------TPYGLECDWWSLGVILYEML 224 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcC--------CCCCCceeeEecchhhhhhc
Confidence 322 2234579999999999853 46788999999999999999
Q ss_pred hCCCCCCCCchHHHHHHHHh---hcCCCCCCCCcHHHHHHHHHhcccCCCCCCC-HHHHHHHH
Q 025244 131 HNKLPFEGMSNLQAAYAAAF---KNVRPSAENVPEELSIILTSCWKEDPNARPN-FTQIIQML 189 (255)
Q Consensus 131 ~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-~~~vl~~l 189 (255)
+|+.||.+............ ....+....+++++.++|.+||. ||.+||+ +.+++++.
T Consensus 225 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 225 YGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred cCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 99999988765554444333 11233344579999999999997 9999999 99999873
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=262.09 Aligned_cols=177 Identities=27% Similarity=0.459 Sum_probs=144.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc-
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE- 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~- 79 (255)
++|||||++||+|.+++.+.+. +++..+..++.|++.||.|||++|++||||||+|||++.+ +.+||+|||+++..
T Consensus 71 ~~lv~e~~~~g~L~~~~~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~ 147 (329)
T cd05588 71 LFFVIEFVSGGDLMFHMQRQRK--LPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGI 147 (329)
T ss_pred EEEEEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEECcCccccccc
Confidence 4899999999999999976543 9999999999999999999999999999999999999988 79999999998742
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCc--------hHHHHHHHHhh
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS--------NLQAAYAAAFK 151 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~--------~~~~~~~~~~~ 151 (255)
.........+||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.... ...........
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 219 (329)
T cd05588 148 RPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE 219 (329)
T ss_pred cCCCccccccCCccccCHHHHcC--------CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc
Confidence 22233445689999999999853 567889999999999999999999996321 11222333333
Q ss_pred cCCCCCCCCcHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 025244 152 NVRPSAENVPEELSIILTSCWKEDPNARPN------FTQIIQM 188 (255)
Q Consensus 152 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt------~~~vl~~ 188 (255)
.....+..++.++.++|.+||+.||.+|++ +.++++|
T Consensus 220 ~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 220 KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 333445678899999999999999999987 6788766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=261.04 Aligned_cols=176 Identities=28% Similarity=0.429 Sum_probs=147.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++...+. +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~kL~DfG~~~~~~ 152 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENM 152 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCC-CcEEEccCCCceecC
Confidence 4799999999999999987544 8999999999999999999999999999999999999998 799999999997533
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
. ........||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.+.......... .....+..
T Consensus 153 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-~~~~~p~~ 223 (323)
T cd05616 153 WDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-HNVAYPKS 223 (323)
T ss_pred CCCCccccCCCChhhcCHHHhcC--------CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCCCCc
Confidence 2 223345679999999999853 5678899999999999999999999988766554444333 33334567
Q ss_pred CcHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNF-----TQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~-----~~vl~~ 188 (255)
++.++.+++.+||+.||.+|++. .+++++
T Consensus 224 ~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 224 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred CCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 89999999999999999999974 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=257.07 Aligned_cols=175 Identities=24% Similarity=0.388 Sum_probs=145.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|..++... .+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 77 ~~lv~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 77 VCFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGM 152 (324)
T ss_pred EEEEEcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CcEEeCcccCCccCC
Confidence 48999999999999988642 39999999999999999999999999999999999999988 799999999987432
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
........+|++.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.+..+........ ....+..
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-~~~~p~~ 223 (324)
T cd05589 153 GFGDRTSTFCGTPEFLAPEVLTE--------TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND-EVRYPRF 223 (324)
T ss_pred CCCCcccccccCccccCHhHhcC--------CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCC
Confidence 2223345679999999999853 56788999999999999999999999886655544433332 2334567
Q ss_pred CcHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARP-----NFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~ 188 (255)
++..+.++|.+||+.||.+|| ++.+++++
T Consensus 224 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 224 LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 899999999999999999999 57777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=268.46 Aligned_cols=187 Identities=33% Similarity=0.596 Sum_probs=158.7
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc-
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES- 80 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~- 80 (255)
.||+-+|+|.+|..+|+..+.+ |+..+.+.|+.||++|+.|||.++|||||||..|||+.++ +.|||+|||++....
T Consensus 463 AIiTqwCeGsSLY~hlHv~etk-fdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~-~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETK-FDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED-LKVKIGDFGLATVKTR 540 (678)
T ss_pred eeeehhccCchhhhhccchhhh-hhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC-CcEEEecccceeeeee
Confidence 5899999999999999976544 9999999999999999999999999999999999999998 799999999997432
Q ss_pred --cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC--
Q 025244 81 --LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-- 156 (255)
Q Consensus 81 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 156 (255)
.........|...|||||++.. .....|++.+||||||+|+|||++|..||......+..+.+..+...+.
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRm-----qd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s 615 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRM-----QDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS 615 (678)
T ss_pred eccccccCCCccchhhhcHHHHhh-----cccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch
Confidence 2233445568899999999863 2456799999999999999999999999996555666666555544443
Q ss_pred --CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 157 --AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 157 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
..++++++++|+..||.+++++||.+.+|+..|+..+..
T Consensus 616 ~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 616 KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 456788999999999999999999999999988877653
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=248.10 Aligned_cols=183 Identities=28% Similarity=0.506 Sum_probs=150.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++++ +.+||+|||+++...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~df~~~~~~~ 155 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMT 155 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CcEEeCCCccccccc
Confidence 4799999999999999987655558999999999999999999999999999999999999988 799999999998644
Q ss_pred ccccc--ccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
..... ....++..|+|||.+.+ ..++.++||||||+++|||++ |..||.+.+..+.............+
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 227 (263)
T cd05052 156 GDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERP 227 (263)
T ss_pred cceeeccCCCCCccccCCHHHhcc--------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC
Confidence 32211 11234568999998753 557789999999999999998 99999876654443333333333446
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
..++.++.++|.+||..||++||++.++++.|+.+
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 67889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=248.37 Aligned_cols=176 Identities=29% Similarity=0.473 Sum_probs=150.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc-c
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-E 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~-~ 79 (255)
|+.||||++||.|.-+|.+.+ .+++.++..+..+|+.||.|||+++|+.||||.+|+|++.+ |++||+|||+++. .
T Consensus 243 lCFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkD-GHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKD-GHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccC-CceEeeecccchhcc
Confidence 578999999999999998754 49999999999999999999999999999999999999999 8999999999995 3
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
.......++|||+.|+|||++. ...|+.+.|+|.+||++|||+||+.||...+.... ...+.......+..
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVle--------DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL-FeLIl~ed~kFPr~ 390 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLE--------DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL-FELILMEDLKFPRT 390 (516)
T ss_pred cccceeccccCChhhcCchhhc--------cccccceeehhhhhHHHHHHHhccCcccccchhHH-HHHHHhhhccCCcc
Confidence 3455678899999999999994 47789999999999999999999999987554333 33332233334678
Q ss_pred CcHHHHHHHHHhcccCCCCC----C-CHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNAR----P-NFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~R----p-t~~~vl~~ 188 (255)
++++.+.|+..+|.+||.+| | .+.||.++
T Consensus 391 ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 391 LSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred CCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 89999999999999999999 3 46677665
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=256.80 Aligned_cols=176 Identities=29% Similarity=0.417 Sum_probs=147.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+... +++..+..++.|++.||+|||++|++||||||+||+++.+ +.++|+|||+++...
T Consensus 71 ~~lv~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 71 LFFVMEYVNGGDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE-GHIKIADFGMCKEGI 147 (318)
T ss_pred EEEEEcCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC-CcEEecccCCCeecC
Confidence 4799999999999999987544 9999999999999999999999999999999999999988 799999999987422
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
........+||..|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+......... ......+..
T Consensus 148 ~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~-~~~~~~~~~ 218 (318)
T cd05570 148 LGGVTTSTFCGTPDYIAPEILSY--------QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL-EDEVRYPRW 218 (318)
T ss_pred cCCCcccceecCccccCHHHhcC--------CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH-cCCCCCCCc
Confidence 2222344578999999999853 567889999999999999999999998766544433332 222333557
Q ss_pred CcHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNF-----TQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~-----~~vl~~ 188 (255)
++.++.++|.+||+.||.+||++ .+++++
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 88999999999999999999999 888775
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=250.90 Aligned_cols=185 Identities=28% Similarity=0.506 Sum_probs=152.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
+++||||++|++|.+++..+.. ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~-~ 160 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN-L 160 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC-C
Confidence 4799999999999999986432 237889999999999999999999999999999999999988 6
Q ss_pred ceEEecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchH
Q 025244 67 TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 142 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~ 142 (255)
.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|||++ |+.||......
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 232 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999997543221 1233456789999998753 567889999999999999998 99999876665
Q ss_pred HHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 143 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
+................++..+.+++.+||+.+|.+||++.++++.|.+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 233 EVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 5444433333333455678999999999999999999999999999988755
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=260.38 Aligned_cols=177 Identities=27% Similarity=0.439 Sum_probs=145.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++...+. +++..+..++.|++.||+|||++|++||||||+|||++.+ +.+||+|||+++...
T Consensus 71 ~~lv~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~ 147 (327)
T cd05617 71 LFLVIEYVNGGDLMFHMQRQRK--LPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGL 147 (327)
T ss_pred EEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC-CCEEEeccccceecc
Confidence 4799999999999999976544 9999999999999999999999999999999999999988 799999999987522
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC------chHHHHHHHHhhcC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM------SNLQAAYAAAFKNV 153 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~------~~~~~~~~~~~~~~ 153 (255)
........+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||... ...+..........
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 219 (327)
T cd05617 148 GPGDTTSTFCGTPNYIAPEILRG--------EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP 219 (327)
T ss_pred CCCCceecccCCcccCCHHHHCC--------CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC
Confidence 2233445689999999999853 56788999999999999999999999532 22233334444444
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 025244 154 RPSAENVPEELSIILTSCWKEDPNARPNF------TQIIQM 188 (255)
Q Consensus 154 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~------~~vl~~ 188 (255)
...+..++..+.++|.+||+.||.+|+++ .++++|
T Consensus 220 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 220 IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 44566788999999999999999999974 577665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=261.35 Aligned_cols=174 Identities=25% Similarity=0.335 Sum_probs=146.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+.+. +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAGR--FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK-GHVKVTDFGFAKKVP 169 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCC-CCEEEeeccCceEcC
Confidence 4799999999999999987554 8999999999999999999999999999999999999988 799999999998643
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
.. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+...... ......+..+
T Consensus 170 ~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~-~~~~~~p~~~ 238 (329)
T PTZ00263 170 DR--TFTLCGTPEYLAPEVIQS--------KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL-AGRLKFPNWF 238 (329)
T ss_pred CC--cceecCChhhcCHHHHcC--------CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh-cCCcCCCCCC
Confidence 32 234579999999999853 456789999999999999999999998766554443333 2233345568
Q ss_pred cHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARPN-----FTQIIQM 188 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt-----~~~vl~~ 188 (255)
+..+.++|.+||+.||.+||+ +.+++.|
T Consensus 239 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 239 DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 899999999999999999986 6888877
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=253.26 Aligned_cols=180 Identities=27% Similarity=0.407 Sum_probs=145.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.......+++..++.++.|++.||+|||+.|++||||||+||+++.+ +.++|+|||++....
T Consensus 68 ~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~~l~Dfg~~~~~~ 146 (277)
T cd05607 68 LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ-GNCRLSDLGLAVELK 146 (277)
T ss_pred EEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC-CCEEEeeceeeeecC
Confidence 4799999999999999977665568999999999999999999999999999999999999988 689999999988654
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHH---HH-HHHHhhcCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ---AA-YAAAFKNVRPS 156 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~---~~-~~~~~~~~~~~ 156 (255)
.........|+..|+|||++.+ ..++.++|+|||||++|||++|+.||.+..... .. ...........
T Consensus 147 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (277)
T cd05607 147 DGKTITQRAGTNGYMAPEILKE--------EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE 218 (277)
T ss_pred CCceeeccCCCCCccCHHHHcc--------CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc
Confidence 4333345678999999999853 457889999999999999999999997643211 11 11111122222
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
...++.++.++|.+||+.||.+||++.|+++.+
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 346789999999999999999999997766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=248.74 Aligned_cols=182 Identities=27% Similarity=0.505 Sum_probs=150.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++++|||.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~-~~~~l~dfg~~~~~~ 158 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEG-QLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD-LVCKISGFRRLQEDK 158 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCC-CcEEECCCccccccc
Confidence 4799999999999999987533 48999999999999999999999999999999999999988 699999999876432
Q ss_pred ccccc--ccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
..... ....++..|+|||++.+ ..++.++||||||+++||+++ |..||.+....+...........+.+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQY--------HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAP 230 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhh--------CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCC
Confidence 22111 12345678999998853 567889999999999999775 99999887665554444444444556
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
..++..+.+++.+||+.+|.+||++.++++.|.+.
T Consensus 231 ~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 231 RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 77899999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=258.65 Aligned_cols=172 Identities=28% Similarity=0.365 Sum_probs=143.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++..... +++..+..++.||+.||+|||++|++||||||+|||++.+ +.+||+|||+++...
T Consensus 71 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~-~~~kL~DfG~~~~~~ 147 (325)
T cd05604 71 LYFVLDFVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ-GHVVLTDFGLCKEGI 147 (325)
T ss_pred EEEEEcCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEeecCCcccCC
Confidence 4799999999999999976543 9999999999999999999999999999999999999988 799999999987432
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....... ........
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~-~~~~~~~~ 218 (325)
T cd05604 148 AQSDTTTTFCGTPEYLAPEVIRK--------QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH-KPLVLRPG 218 (325)
T ss_pred CCCCCcccccCChhhCCHHHHcC--------CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc-CCccCCCC
Confidence 2233345679999999999853 5577899999999999999999999988665544433332 22333456
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQ 184 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~ 184 (255)
.+..+.++|.+||+.||.+||++.+
T Consensus 219 ~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 219 ASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCHHHHHHHHHHhccCHHhcCCCCC
Confidence 8899999999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=258.95 Aligned_cols=176 Identities=28% Similarity=0.400 Sum_probs=147.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+.+. +.+..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 151 (323)
T cd05584 75 LYLILEYLSGGELFMHLEREGI--FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESI 151 (323)
T ss_pred EEEEEeCCCCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEeeCcCCeecc
Confidence 4899999999999999987544 8888999999999999999999999999999999999988 799999999987432
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
. ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+.+......... ......+..
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~-~~~~~~~~~ 222 (323)
T cd05584 152 HEGTVTHTFCGTIEYMAPEILMR--------SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL-KGKLNLPPY 222 (323)
T ss_pred cCCCcccccCCCccccChhhccC--------CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCC
Confidence 2 222344679999999999853 456789999999999999999999998866554433333 233344667
Q ss_pred CcHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARP-----NFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~ 188 (255)
+++++.++|.+||+.||++|| ++.+++++
T Consensus 223 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 223 LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 889999999999999999999 88988886
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=261.68 Aligned_cols=176 Identities=32% Similarity=0.441 Sum_probs=153.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++|.||+.| +|+.+|.+.+. ++++.+..++.+++.||.|||+++|+|||+||.|||+... +.+|++|||+|+..+
T Consensus 76 ~~vVte~a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 76 LWVVTEYAVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG-GTLKLCDFGLARAMS 151 (808)
T ss_pred EEEEehhhhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC-Cceeechhhhhhhcc
Confidence 5899999975 99999998665 9999999999999999999999999999999999999988 799999999999766
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
... ..+...||+.|||||+.. +..|+..+|+|||||++||+..|++||...+-.+....+... ....+..
T Consensus 152 ~~t~vltsikGtPlYmAPElv~--------e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d-~v~~p~~ 222 (808)
T KOG0597|consen 152 TNTSVLTSIKGTPLYMAPELVE--------EQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD-PVKPPST 222 (808)
T ss_pred cCceeeeeccCcccccCHHHHc--------CCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC-CCCCccc
Confidence 543 345678999999999984 478999999999999999999999999876555544444444 4444568
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
.+..+..+++.+|.+||.+|.++.+++.|-
T Consensus 223 ~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 223 ASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred ccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 899999999999999999999999999874
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=251.10 Aligned_cols=187 Identities=32% Similarity=0.493 Sum_probs=150.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
+++||||+++++|.+++..... ..+++..++.++.|++.||+|||++|++||||||+|||++.+ +
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~ 156 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN-L 156 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC-C
Confidence 4799999999999999976421 248889999999999999999999999999999999999988 6
Q ss_pred ceEEecCccccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHH
Q 025244 67 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAA 145 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~ 145 (255)
.+||+|||++..............+..|+|||++.. ..++.++||||||+++|||++ |..||.+....+..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~ 228 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY--------SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY 228 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 899999999874322211122233567999998753 557889999999999999997 99999886665544
Q ss_pred HHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 025244 146 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 196 (255)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~ 196 (255)
.........+.+..++.++.+|+.+||+.+|.+||++.++++.|.......
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 229 EKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 433333233345568899999999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=247.58 Aligned_cols=182 Identities=34% Similarity=0.548 Sum_probs=151.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+.....+++..++.++.|++.||+|||+.+++||||||+||+++.+ +.++|+|||+++...
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~ 154 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSES-LMCKIADFGLARVIE 154 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCC-CcEEECCCccceecC
Confidence 4799999999999999987655568999999999999999999999999999999999999988 699999999998543
Q ss_pred cccc--cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
.... .....++..|+|||++.. ..++.++|+||||+++|+|++ |..||.+................+..
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 226 (261)
T cd05072 155 DNEYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRM 226 (261)
T ss_pred CCceeccCCCccceecCCHHHhcc--------CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 3221 122345678999998753 457789999999999999998 99999876655554444434344455
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
..++.++.+++.+||+.+|++||+++++++.|++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 6788999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=260.32 Aligned_cols=183 Identities=28% Similarity=0.407 Sum_probs=147.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~-~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+|||+|||..|.+...= ..+. +++.++++++++++.||+|||.+|||||||||+|+|++++ |+|||+|||.+...
T Consensus 185 ~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~-g~VKIsDFGVs~~~ 260 (576)
T KOG0585|consen 185 LYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD-GTVKISDFGVSNEF 260 (576)
T ss_pred eEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC-CcEEeeccceeeec
Confidence 69999999988765432 2233 8999999999999999999999999999999999999999 89999999998754
Q ss_pred ------ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC
Q 025244 80 ------SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 153 (255)
Q Consensus 80 ------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 153 (255)
+........+||+.|+|||.+.+.. .....+.+.||||+||+||.|+.|+.||-+....+.-.++.....
T Consensus 261 ~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~----~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL 336 (576)
T KOG0585|consen 261 PQGSDEGSDDQLSRTVGTPAFFAPELCSGGN----SFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPL 336 (576)
T ss_pred ccCCccccHHHHhhcCCCccccchHhhcCCC----CccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcc
Confidence 2223344568999999999987522 123456799999999999999999999988555444444443332
Q ss_pred -CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 154 -RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 154 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
.|..+.+.+++++||.+||.+||++|.+..+|..|.+-
T Consensus 337 ~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 337 EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred cCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 23345678999999999999999999999999998763
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=259.97 Aligned_cols=176 Identities=29% Similarity=0.433 Sum_probs=147.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++...+. +++..+..++.|++.||.|||++|++||||||+|||++.+ +.+||+|||+++...
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLGV--LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS-GHIKLTDFGLSKGIV 152 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEEEeCcCCcccc
Confidence 4799999999999999986544 8999999999999999999999999999999999999988 799999999998543
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc---CCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN---VRPSA 157 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~ 157 (255)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+......... ..+..
T Consensus 153 ~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 222 (333)
T cd05600 153 T--YANSVVGSPDYMAPEVLRG--------KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVY 222 (333)
T ss_pred c--ccCCcccCccccChhHhcC--------CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCC
Confidence 3 3345679999999999853 467889999999999999999999998766554433332211 11211
Q ss_pred ----CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 158 ----ENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 158 ----~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
..++.++.++|.+||..+|.+||++.+++++-
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 25689999999999999999999999999873
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=267.28 Aligned_cols=180 Identities=24% Similarity=0.364 Sum_probs=145.1
Q ss_pred EEEEecCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 2 VIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
++||||++ ++|.+++... ....+++..+..++.|++.||+|||++||+||||||+|||++.+.+.+||+|||+++..
T Consensus 143 ~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 143 NVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred EEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 58999996 6888887642 23459999999999999999999999999999999999999876457999999999865
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC----
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---- 155 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---- 155 (255)
..........||+.|+|||++.+ ...++.++|||||||++|||++|.+||.+....+...........+
T Consensus 222 ~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 222 LAGQRSVSYICSRFYRAPELMLG-------ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ 294 (440)
T ss_pred cCCCCcccCCCCcCccCHHHhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 44444455678999999998753 2457889999999999999999999998876655444332211100
Q ss_pred ------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 156 ------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 156 ------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
.+...+.++.+||.+||..||.+|||+.|+++|-
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 1224678999999999999999999999999874
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=246.63 Aligned_cols=182 Identities=24% Similarity=0.515 Sum_probs=149.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 69 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~ 146 (257)
T cd05115 69 LMLVMEMASGGPLNKFLSGKKD-EITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ-HYAKISDFGLSKALG 146 (257)
T ss_pred eEEEEEeCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC-CcEEeccCCcccccc
Confidence 4799999999999999976432 48999999999999999999999999999999999999988 689999999997433
Q ss_pred cccc----cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCC
Q 025244 81 LTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
.... .....++..|+|||.+.. ..++.++|+||||+++||+++ |..||.+....+............
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 218 (257)
T cd05115 147 ADDSYYKARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLD 218 (257)
T ss_pred CCccceeccCCCCCCcccCCHHHHcc--------CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC
Confidence 2211 111233578999998753 457889999999999999996 999998877665554444444444
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
.+...++++.++|.+||..+|++||++.++.+.|+.+
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 5667889999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=257.41 Aligned_cols=176 Identities=31% Similarity=0.473 Sum_probs=145.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+... +++.++..++.|++.||.|||++|++||||||+|||++.+ +.+||+|||+++...
T Consensus 71 ~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~ 147 (316)
T cd05619 71 LFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD-GHIKIADFGMCKENM 147 (316)
T ss_pred EEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEccCCcceECC
Confidence 4799999999999999986543 8999999999999999999999999999999999999988 699999999987532
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
. ........||..|+|||++.+ ..++.++|+|||||++|||++|+.||.+.+..+........ ....+..
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-~~~~~~~ 218 (316)
T cd05619 148 LGDAKTCTFCGTPDYIAPEILLG--------QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD-NPCYPRW 218 (316)
T ss_pred CCCCceeeecCCccccCHHHHcC--------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCcc
Confidence 2 222345679999999999853 56788999999999999999999999886655444333322 2223456
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFT-QIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~-~vl~~ 188 (255)
++.++.++|.+||+.||++||++. +++++
T Consensus 219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 219 LTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred CCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 889999999999999999999996 66554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=261.07 Aligned_cols=174 Identities=25% Similarity=0.337 Sum_probs=147.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+... +++..+..++.|++.||.|||++|++||||||+|||++.+ +.+||+|||+++...
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKR--FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD-GFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEecCCCCeecC
Confidence 4799999999999999987554 9999999999999999999999999999999999999988 799999999998643
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
.. .....||+.|+|||++.+ ..++.++|+|||||++|||++|..||.+.+......... ......+..+
T Consensus 183 ~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~-~~~~~~p~~~ 251 (340)
T PTZ00426 183 TR--TYTLCGTPEYIAPEILLN--------VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL-EGIIYFPKFL 251 (340)
T ss_pred CC--cceecCChhhcCHHHHhC--------CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCCCC
Confidence 22 245679999999999853 456789999999999999999999998866544333333 3333345678
Q ss_pred cHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARP-----NFTQIIQM 188 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~ 188 (255)
++.+.++|++||+.||.+|+ ++.+++++
T Consensus 252 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 252 DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 89999999999999999995 89998887
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=247.56 Aligned_cols=179 Identities=30% Similarity=0.446 Sum_probs=154.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
++||+||++ .+|.+++....+ ..++...+..++.||+.||+|||+++|+||||||+||||+++ |.+||+|||+|+.
T Consensus 92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~-G~lKlaDFGlAra 169 (323)
T KOG0594|consen 92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSS-GVLKLADFGLARA 169 (323)
T ss_pred EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCC-CcEeeeccchHHH
Confidence 479999995 899999998764 358888999999999999999999999999999999999998 7999999999997
Q ss_pred cc-cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 79 ES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 79 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
.. .....+..++|.+|.|||++.+ ...|+...|+||+||+++||+++++.|.+.+..++...+......|..
T Consensus 170 ~~ip~~~yt~evvTlWYRaPEvLlG-------s~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 170 FSIPMRTYTPEVVTLWYRAPEVLLG-------STSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNE 242 (323)
T ss_pred hcCCcccccccEEEeeccCHHHhcC-------CCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCc
Confidence 66 3444677889999999999985 356899999999999999999999999999988888777654444432
Q ss_pred CC-----------------------------CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 EN-----------------------------VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~-----------------------------~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.. ..++..+++.+||+.+|.+|.++..++.|
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 21 12478889999999999999999999987
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=246.21 Aligned_cols=180 Identities=31% Similarity=0.566 Sum_probs=148.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+.....+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~ 153 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED-NVAKVSDFGLTKEAS 153 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC-CcEEecCCccceecc
Confidence 4799999999999999987665558999999999999999999999999999999999999988 799999999988533
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
... ....++..|+|||++.. ..++.++||||||+++|||++ |+.||......+................
T Consensus 154 ~~~--~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd05082 154 STQ--DTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 223 (256)
T ss_pred ccC--CCCccceeecCHHHHcc--------CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence 221 23345678999998743 557889999999999999997 9999987655444333333323334567
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
++..+.+++.+||+.+|++||++.++++.|..
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 224 CPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 88999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=249.20 Aligned_cols=186 Identities=29% Similarity=0.512 Sum_probs=153.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceE
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP-----------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 69 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~-----------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~k 69 (255)
+++||||+++++|.++|...+. ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~-~~~k 160 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN-LLVK 160 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC-CcEE
Confidence 4799999999999999985431 248999999999999999999999999999999999999988 7999
Q ss_pred EecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHH
Q 025244 70 LADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAA 145 (255)
Q Consensus 70 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~ 145 (255)
|+|||+++...... ......++..|+|||++.+ ..++.++|+||||+++|+|++ |..||.........
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~ 232 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999998543221 1223345778999998853 567889999999999999998 99999877665554
Q ss_pred HHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 146 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
..............++.++.+++.+||+.||.+||++.+++..|++....
T Consensus 233 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 233 ECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 44444444444567889999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=275.77 Aligned_cols=181 Identities=27% Similarity=0.426 Sum_probs=154.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
||+||||++||+|..++.+.. .+++..+..++.+|+.||.-||+.|+|||||||+|||++.. |++||+|||.+-...
T Consensus 150 LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~-GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKS-GHIKLADFGSCLKMD 226 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEeccc-CcEeeccchhHHhcC
Confidence 699999999999999999887 39999999999999999999999999999999999999998 899999999887655
Q ss_pred cccc--cccCCCccceeccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc---CC
Q 025244 81 LTEM--MTAETGTYRWMAPELYSTVTLRQGEK-KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN---VR 154 (255)
Q Consensus 81 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~ 154 (255)
.++. ....+|||.|++||++.. .+.+ +.|+..+|+||+||++|||+.|..||...+-.+..-+++... ..
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs----~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~F 302 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQS----QGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSF 302 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHh----hcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCC
Confidence 4433 456789999999999975 3344 789999999999999999999999999876666655555432 23
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCC---HHHHHHHH
Q 025244 155 PSAENVPEELSIILTSCWKEDPNARPN---FTQIIQML 189 (255)
Q Consensus 155 ~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~vl~~l 189 (255)
|....+|.+.++||.+.+. +|..|-. +.++..|.
T Consensus 303 P~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 303 PDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred CcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 4446699999999999885 7788876 88888874
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=261.14 Aligned_cols=161 Identities=32% Similarity=0.566 Sum_probs=129.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccccccc---cccCCCccceeccccc
Q 025244 24 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELY 100 (255)
Q Consensus 24 ~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~ 100 (255)
.+++.+++.++.|++.||+|||++|++||||||+|||++.+ +.++|+|||+++....... .....++..|+|||++
T Consensus 208 ~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~ 286 (374)
T cd05106 208 PLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 286 (374)
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC-CeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHh
Confidence 37888899999999999999999999999999999999987 6899999999975332211 1123356789999988
Q ss_pred ccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCC-CCCCCcHHHHHHHHHhcccCCCC
Q 025244 101 STVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP-SAENVPEELSIILTSCWKEDPNA 178 (255)
Q Consensus 101 ~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~ 178 (255)
.. ..++.++||||||+++|||++ |+.||..................+ .+...++++.++|.+||+.||.+
T Consensus 287 ~~--------~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 358 (374)
T cd05106 287 FD--------CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTE 358 (374)
T ss_pred cC--------CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhh
Confidence 53 567889999999999999997 999998765544433333333222 34456899999999999999999
Q ss_pred CCCHHHHHHHHHHhH
Q 025244 179 RPNFTQIIQMLLNYL 193 (255)
Q Consensus 179 Rpt~~~vl~~l~~~~ 193 (255)
||++.++++.|++.+
T Consensus 359 RPs~~~l~~~l~~~~ 373 (374)
T cd05106 359 RPTFSQISQLIQRQL 373 (374)
T ss_pred CcCHHHHHHHHHHHh
Confidence 999999999998754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=259.41 Aligned_cols=177 Identities=26% Similarity=0.451 Sum_probs=143.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++..... +++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 71 ~~lv~E~~~~~~L~~~~~~~~~--l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~-~~~kL~DfG~~~~~~ 147 (329)
T cd05618 71 LFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGL 147 (329)
T ss_pred EEEEEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CCEEEeeCCcccccc
Confidence 4799999999999999976543 9999999999999999999999999999999999999988 799999999987532
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCc--------hHHHHHHHHhh
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS--------NLQAAYAAAFK 151 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~--------~~~~~~~~~~~ 151 (255)
.........||..|+|||++.+ ..++.++|+||||+++|||++|+.||.... ...........
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~ 219 (329)
T cd05618 148 RPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 219 (329)
T ss_pred CCCCccccccCCccccCHHHHcC--------CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc
Confidence 2223345679999999999853 567889999999999999999999995211 11222233333
Q ss_pred cCCCCCCCCcHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 025244 152 NVRPSAENVPEELSIILTSCWKEDPNARPN------FTQIIQM 188 (255)
Q Consensus 152 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt------~~~vl~~ 188 (255)
.....+..++..+.++|.+||+.||.+||+ +.++++|
T Consensus 220 ~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 220 KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 333446678899999999999999999998 4677766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=245.71 Aligned_cols=182 Identities=33% Similarity=0.576 Sum_probs=152.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+.....+++..+..++.|++.||.|||++|++|+||||+||+++++ +.+||+|||++....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~-~~~kl~d~g~~~~~~ 155 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED-LVCKVADFGLARLIK 155 (261)
T ss_pred eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCC-ceEEEccccchhhcC
Confidence 4799999999999999987665668999999999999999999999999999999999999988 699999999997543
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCCC
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAE 158 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 158 (255)
... ......++..|++||.+.. ..++.++|+||||+++|+|++ |+.||.+....+...........+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 227 (261)
T cd05148 156 EDVYLSSDKKIPYKWTAPEAASH--------GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPA 227 (261)
T ss_pred CccccccCCCCceEecCHHHHcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCC
Confidence 221 1223345678999998753 557789999999999999998 899998776555554444443445567
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 159 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 159 ~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
.+++.+.++|.+||+.||.+|||+.++++.|++
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 228 KCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 888999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=245.19 Aligned_cols=184 Identities=31% Similarity=0.525 Sum_probs=151.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++||+|.+++.+.....+++..+..++.|++.||+|||+++++||||||+||+++++ +.++|+|||.++...
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~-~~~~L~dfg~~~~~~ 153 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIE 153 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCC-CcEEeccCCceeecc
Confidence 4799999999999999987554558999999999999999999999999999999999999988 689999999997543
Q ss_pred ccccc--ccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
..... ....++..|+|||+.. ...++.++|+||||+++|+|++ |..||.+....+...........+..
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~--------~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 225 (262)
T cd05071 154 DNEYTARQGAKFPIKWTAPEAAL--------YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP 225 (262)
T ss_pred ccccccccCCcccceecCHhHhc--------cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCc
Confidence 32211 2234567899999874 3557889999999999999999 88899876655544443333333445
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 193 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~ 193 (255)
..++..+.+++.+||+.||++||++.++++.|+.++
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 678899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=261.58 Aligned_cols=177 Identities=25% Similarity=0.407 Sum_probs=142.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+.+. +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~ikL~DFG~a~~~~ 152 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLGI--FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFR 152 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCC-CCEEEEeCCCCcccc
Confidence 4899999999999999987543 8999999999999999999999999999999999999988 799999999974211
Q ss_pred cc--------------------------------------------cccccCCCccceecccccccccccccccCCCCch
Q 025244 81 LT--------------------------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 116 (255)
Q Consensus 81 ~~--------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 116 (255)
.. ......+||+.|+|||++.+ ..++.+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~ 224 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--------TGYTQL 224 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--------CCCCcc
Confidence 00 00123479999999999853 557889
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc---CCCCCCCCcHHHHHHHHHhcccCCCCCC---CHHHHHHHH
Q 025244 117 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN---VRPSAENVPEELSIILTSCWKEDPNARP---NFTQIIQML 189 (255)
Q Consensus 117 ~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~vl~~l 189 (255)
+|||||||++|||++|+.||.+....+......... ..+....+++++.++|.+|+ .+|.+|+ ++.+++++-
T Consensus 225 ~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~ 302 (376)
T cd05598 225 CDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHP 302 (376)
T ss_pred eeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCC
Confidence 999999999999999999998876655443332211 12234467899999999977 5999999 899999873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=247.49 Aligned_cols=181 Identities=31% Similarity=0.538 Sum_probs=150.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCce
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 68 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~ 68 (255)
+++||||++|++|.++|...+. ..+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~-~~~ 161 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD-LVV 161 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC-CeE
Confidence 4799999999999999986431 347888999999999999999999999999999999999988 799
Q ss_pred EEecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHH
Q 025244 69 KLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 144 (255)
Q Consensus 69 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~ 144 (255)
+|+|||+++...... ......++..|+|||++.+ ..++.++||||||+++|||++ |..||.+....+.
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~ 233 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV 233 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhcc--------CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999997532221 1223345788999998853 567889999999999999998 9999987666555
Q ss_pred HHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 145 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
...............++..+.+++.+||+.||++||++.|+++.|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 234 IECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 5444444444445678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=244.42 Aligned_cols=182 Identities=31% Similarity=0.529 Sum_probs=150.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++|++|.+++.......+++..+..++.|++.||+|||++|++||||||+||+++++ +.++|+|||++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~-~~~~l~dfg~~~~~~ 153 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDG-LVCKIADFGLARLIE 153 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCC-ceEEeCCceeeeecc
Confidence 4799999999999999987655558999999999999999999999999999999999999988 689999999997543
Q ss_pred cccc--cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
.... .....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||.+.+..+...........+..
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCP 225 (260)
T ss_pred CcccccccCCCCCccccChHHHhc--------CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 3221 112235568999998753 557889999999999999999 89999886665555444433344456
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
...+..+.+++.+||..+|++|||+.++.+.|+.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 6788999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=246.10 Aligned_cols=184 Identities=24% Similarity=0.478 Sum_probs=149.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+++|+|.+++..... .+++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~-~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD-SIVQIADFGVADLLY 160 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEEcCCccceecc
Confidence 3689999999999999986543 38999999999999999999999999999999999999988 689999999997533
Q ss_pred ccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCC
Q 025244 81 LTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPS 156 (255)
Q Consensus 81 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 156 (255)
... ......++..|+|||.+.+ ..++.++||||||+++||+++ |+.||.+................+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILF--------GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ 232 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhcc--------CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC
Confidence 221 1223456778999998853 557889999999999999998 9999987655443322222223333
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
...++.++.+++.+||..||.+||++.++++.|.....
T Consensus 233 ~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 233 PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 45677899999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=244.23 Aligned_cols=182 Identities=32% Similarity=0.535 Sum_probs=149.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||+++...
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~-~~~~l~dfg~~~~~~ 153 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN-LVCKIADFGLARLIE 153 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CeEEECCCccceEcc
Confidence 4799999999999999987655558999999999999999999999999999999999999988 689999999997543
Q ss_pred cccc--cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
.... .....++..|+|||.+.. ..++.++|+||||+++|||++ |..||.+....+...........+..
T Consensus 154 ~~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T cd05069 154 DNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCP 225 (260)
T ss_pred CCcccccCCCccchhhCCHHHhcc--------CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 2221 122345678999998753 557889999999999999999 89999886655544433333333445
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
...+..+.+++.+||+.||.+||+++++++.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 6788999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=257.41 Aligned_cols=178 Identities=26% Similarity=0.347 Sum_probs=141.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+ +++|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 79 ~~lv~e~~-~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELM-ESDLHQVIKANDD--LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAF 154 (338)
T ss_pred EEEEEecC-CCCHHHHHHhccc--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEccCccccccc
Confidence 37999999 5799999986544 9999999999999999999999999999999999999988 799999999997432
Q ss_pred cc----cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh------
Q 025244 81 LT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF------ 150 (255)
Q Consensus 81 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~------ 150 (255)
.. .......||..|+|||++.+ ....++.++|||||||++|||++|+.||.+.+..........
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 228 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGS------FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhc------cccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 21 11234579999999998743 124678899999999999999999999987654332111100
Q ss_pred -------------------hcCCC-----CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 151 -------------------KNVRP-----SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 151 -------------------~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....+ ....+++.+.++|.+||+.||++||++.+++++
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 123467889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=259.79 Aligned_cols=177 Identities=24% Similarity=0.416 Sum_probs=141.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++.+.+. +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~-~~vkL~DFGla~~~~ 152 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLK 152 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CCEEEeeccCccccc
Confidence 4899999999999999987544 9999999999999999999999999999999999999988 799999999987432
Q ss_pred ccc------------------------------------ccccCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 025244 81 LTE------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAI 124 (255)
Q Consensus 81 ~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~ 124 (255)
... .....+||+.|+|||++.+ ..++.++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~~~~~DvwSlGv 224 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--------TGYNKLCDWWSLGV 224 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--------CCCCCchhhhhhHH
Confidence 110 0124579999999999853 55788999999999
Q ss_pred HHHHHHhCCCCCCCCchHHHHHHHHhhc---CCCCCCCCcHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 025244 125 VLWELLHNKLPFEGMSNLQAAYAAAFKN---VRPSAENVPEELSIILTSCWK--EDPNARPNFTQIIQM 188 (255)
Q Consensus 125 ~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~--~~p~~Rpt~~~vl~~ 188 (255)
++|||++|+.||.+....+....+.... ..+....+++++.++|.+++. .++..||++.+++++
T Consensus 225 il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 225 IMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9999999999998866655444443211 122234578999999998664 233356899999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=250.41 Aligned_cols=178 Identities=25% Similarity=0.385 Sum_probs=142.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++...+. .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 78 ~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~DfG~~~~~~ 154 (288)
T cd07871 78 LTLVFEYLD-SDLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK-GELKLADFGLARAKS 154 (288)
T ss_pred EEEEEeCCC-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEECcCcceeecc
Confidence 379999997 599999976543 37899999999999999999999999999999999999988 799999999997533
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC-----
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR----- 154 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~----- 154 (255)
.. .......+++.|+|||++.+ ...++.++|+|||||++|+|++|+.||.+.+..+...........
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07871 155 VPTKTYSNEVVTLWYRPPDVLLG-------STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET 227 (288)
T ss_pred CCCccccCceecccccChHHhcC-------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence 22 22344578999999998753 245788999999999999999999999876654443322211100
Q ss_pred ---------------C---------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 155 ---------------P---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 155 ---------------~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+ ....++.+..++|.+||+.||.+|||+.|+++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 013467889999999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=246.08 Aligned_cols=184 Identities=30% Similarity=0.511 Sum_probs=147.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
+++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 71 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~-~ 149 (270)
T cd05047 71 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-Y 149 (270)
T ss_pred ceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCC-C
Confidence 4799999999999999976431 237889999999999999999999999999999999999988 6
Q ss_pred ceEEecCccccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHH
Q 025244 67 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAA 145 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~ 145 (255)
.+||+|||++..............+..|+|||++.. ..++.++|+||||+++|||++ |..||.+.+..+..
T Consensus 150 ~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~ 221 (270)
T cd05047 150 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 221 (270)
T ss_pred eEEECCCCCccccchhhhccCCCCccccCChHHHcc--------CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH
Confidence 999999999864322211222234567999998743 557889999999999999997 99999876554433
Q ss_pred HHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 025244 146 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 193 (255)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~ 193 (255)
..............++.++.+++.+||+.||.+||++.+++..|...+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 222 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 333222223345567889999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=255.69 Aligned_cols=170 Identities=26% Similarity=0.430 Sum_probs=142.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+.+. +++.++..++.|++.||+|||++|++||||||+|||++.+ +.+||+|||+++...
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~-~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEHM 152 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEeccccccccC
Confidence 4799999999999999987554 9999999999999999999999999999999999999988 799999999987532
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
.. .......||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+............ .....+..
T Consensus 153 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~-~~~~~p~~ 223 (323)
T cd05615 153 VDGVTTRTFCGTPDYIAPEIIAY--------QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME-HNVSYPKS 223 (323)
T ss_pred CCCccccCccCCccccCHHHHcC--------CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCCCcc
Confidence 22 22344579999999999853 4578899999999999999999999988665544443333 23334567
Q ss_pred CcHHHHHHHHHhcccCCCCCCCH
Q 025244 160 VPEELSIILTSCWKEDPNARPNF 182 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~ 182 (255)
++.++.+++.+||+.+|.+|++.
T Consensus 224 ~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 224 LSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCHHHHHHHHHHcccCHhhCCCC
Confidence 88999999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=245.46 Aligned_cols=182 Identities=28% Similarity=0.501 Sum_probs=148.5
Q ss_pred EEEEecCCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 2 VIVTELLSGGTLRKYLLNM----RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~----~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
++||||+++|+|.+++... ....+++..++.++.|++.||+|||+++|+||||||+|||++.+ +.++|+|||+++
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~ 160 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN-MNVCVADFGLSK 160 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCC-CCEEECCCCccc
Confidence 6899999999999988532 22348899999999999999999999999999999999999988 689999999998
Q ss_pred ccccccc---cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcC
Q 025244 78 EESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNV 153 (255)
Q Consensus 78 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 153 (255)
....... .....++..|++||.+.. ..++.++|+||||+++|||++ |+.||.+....+..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 232 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLAD--------RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR 232 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccC--------CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence 6433221 122345678999998853 567889999999999999999 8999987665554444433333
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 154 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 154 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
.+....++..+.++|.+||+.||++||++.++++.|.+.
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 344567889999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=260.83 Aligned_cols=181 Identities=24% Similarity=0.392 Sum_probs=147.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.... +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~~---l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~~kL~DfG~~~~~~ 193 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNYD---IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCC-CCEEEEeccceeecc
Confidence 479999999999999997542 8889999999999999999999999999999999999988 799999999998643
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc---CCC
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN---VRP 155 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~~ 155 (255)
... .....+||+.|+|||++... .....++.++|+|||||++|||++|+.||.+.+............ ..+
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~ 269 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFP 269 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccC----CCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCC
Confidence 322 22456799999999998531 112457889999999999999999999998866554444433222 122
Q ss_pred CCCCCcHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNA--RPNFTQIIQML 189 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~--Rpt~~~vl~~l 189 (255)
....++.++.++|.+||+.+|.+ |+++.+++++-
T Consensus 270 ~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 270 DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 33467899999999999999988 99999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=256.86 Aligned_cols=183 Identities=24% Similarity=0.367 Sum_probs=148.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++.+... .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYED-QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRT-GHIKLADFGSAARLT 153 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCC-CCEEeccCCCCeECC
Confidence 4799999999999999987633 39999999999999999999999999999999999999988 799999999998543
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc---CCC
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN---VRP 155 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~~ 155 (255)
... ......||+.|+|||++...... ....++.++|||||||++|||++|+.||................ ..+
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 231 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGD--GKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFP 231 (330)
T ss_pred CCCceeeecccCCccccCHHHhcccccc--ccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCC
Confidence 322 22345789999999998642211 13457789999999999999999999998766555444333221 123
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....++.++.++|..||. +|.+||++.+++++
T Consensus 232 ~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 232 EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 344678999999999998 99999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=248.64 Aligned_cols=179 Identities=26% Similarity=0.410 Sum_probs=143.5
Q ss_pred CEEEEecCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++||||++||+|.+++... ....+++..++.++.|++.||.|||++||+||||||+||+++.+ +.++|+|||++..
T Consensus 68 ~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~ 146 (280)
T cd05608 68 LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND-GNVRISDLGLAVE 146 (280)
T ss_pred EEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCcccee
Confidence 47999999999999988643 23458999999999999999999999999999999999999987 7899999999975
Q ss_pred cccc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHH---HHHHHhhcCC
Q 025244 79 ESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA---AYAAAFKNVR 154 (255)
Q Consensus 79 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~ 154 (255)
.... .......||+.|+|||++.+ ..++.++|+||||+++|||++|+.||........ ..........
T Consensus 147 ~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 218 (280)
T cd05608 147 LKDGQSKTKGYAGTPGFMAPELLQG--------EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV 218 (280)
T ss_pred cCCCCccccccCCCcCccCHHHhcC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC
Confidence 4322 22334578999999999853 5677899999999999999999999976443211 1111222222
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 025244 155 PSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 188 (255)
Q Consensus 155 ~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~ 188 (255)
..+..++..+.+++.+||+.||++|| ++++++++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 23456889999999999999999999 77888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=250.80 Aligned_cols=177 Identities=25% Similarity=0.320 Sum_probs=139.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+++++|..+.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.+||+|||+++...
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 75 LYLVFEYVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN-DVLKLCDFGFARNLS 151 (287)
T ss_pred EEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccCccccc
Confidence 47999999987666554432 248999999999999999999999999999999999999988 799999999998643
Q ss_pred cc--cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc------
Q 025244 81 LT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN------ 152 (255)
Q Consensus 81 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~------ 152 (255)
.. .......|+..|+|||++.+ ..++.++|+|||||++|||++|++||.+.+..+.........
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 223 (287)
T cd07848 152 EGSNANYTEYVATRWYRSPELLLG--------APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAE 223 (287)
T ss_pred ccccccccccccccccCCcHHHcC--------CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHH
Confidence 22 12234578999999999853 457889999999999999999999998766544332221100
Q ss_pred --------------CCCC-----------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 153 --------------VRPS-----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 153 --------------~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..+. ...++.++.++|.+||+.||++|||++++++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 224 QMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 11367889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=250.76 Aligned_cols=187 Identities=30% Similarity=0.502 Sum_probs=148.7
Q ss_pred CEEEEecCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
.++||||++|++|.+++.+.. ...+++.+++.++.|++.||+|||++|++||||||+|||++.+ +
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~-~ 161 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-Y 161 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC-C
Confidence 479999999999999997643 1247899999999999999999999999999999999999988 6
Q ss_pred ceEEecCccccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHH
Q 025244 67 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAA 145 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~ 145 (255)
.++|+|||+++............++..|+|||.+.+ ..++.++||||||+++|||++ |..||.+.+..+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 233 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 233 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHhc--------cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH
Confidence 999999999874322211222334678999998753 457789999999999999998 99999876554433
Q ss_pred HHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 025244 146 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 196 (255)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~ 196 (255)
...........+..++.++.+++.+||+.+|++||++.+++..|.......
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 234 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 322222122234557899999999999999999999999999998776543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=243.68 Aligned_cols=179 Identities=28% Similarity=0.425 Sum_probs=149.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||+++...
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~-~~~~l~df~~~~~~~ 152 (256)
T cd08529 74 LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLS 152 (256)
T ss_pred EEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC-CCEEEcccccceecc
Confidence 4799999999999999987645569999999999999999999999999999999999999988 699999999988543
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
... ......|+..|+|||++.. ..++.++|+||||+++|+|++|+.||..................+....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd08529 153 DNTNFANTIVGTPYYLSPELCED--------KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQM 224 (256)
T ss_pred CccchhhccccCccccCHHHhcC--------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 322 2334578899999998853 4567899999999999999999999987765444444433333344457
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
++.++.++|.+||+.+|++||++.+++++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 88999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=246.72 Aligned_cols=183 Identities=31% Similarity=0.577 Sum_probs=150.1
Q ss_pred CEEEEecCCCCCHHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMR---------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 65 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~---------------~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~ 65 (255)
.++||||+++++|.+++.... +..+++..++.++.|++.||+|||++|++||||||+|||++++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~- 160 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ- 160 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC-
Confidence 479999999999999996432 1237888899999999999999999999999999999999988
Q ss_pred CceEEecCccccccccc---cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCch
Q 025244 66 KTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSN 141 (255)
Q Consensus 66 ~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~ 141 (255)
+.+||+|||+++..... .......++..|+|||++.+ ..++.++|+||||+++|||++ |..||.+...
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY--------GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhcc--------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 68999999999754322 11233456778999998853 457889999999999999998 9999987665
Q ss_pred HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 142 LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
.............+.+..++..+.+++.+||+.||.+||++.+++++|..+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 233 QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 554444444444555677899999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=245.22 Aligned_cols=184 Identities=24% Similarity=0.501 Sum_probs=149.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||+++|+|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~-~~~kL~dfG~~~~~~ 160 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKD-RIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSP-NHVKITDFGLARLLD 160 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC-CcEEECCCCceeecc
Confidence 3689999999999999986433 48999999999999999999999999999999999999887 689999999998543
Q ss_pred cccc---cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCC
Q 025244 81 LTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPS 156 (255)
Q Consensus 81 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 156 (255)
.... .....++..|+|||.+.+ ..++.++||||||+++|||++ |..||..................+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILH--------RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ 232 (279)
T ss_pred cccceeecCCCccchhhCCHHHhcc--------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC
Confidence 2221 112234678999998853 457889999999999999998 9999987655444333333333344
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
...++.++.+++.+||+.||++||++.++++.|.....
T Consensus 233 ~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 233 PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 56788999999999999999999999999998876644
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=269.79 Aligned_cols=186 Identities=25% Similarity=0.388 Sum_probs=153.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
++|.||||.||+|-|++..+....|++.++++|+.|+++|+++||... |||||||-+||||+.+ |..||||||-|..
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~-g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD-GNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC-CCEEeCccccccc
Confidence 479999999999999999876666999999999999999999999998 9999999999999998 7999999999873
Q ss_pred ccccc-c---------cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHH
Q 025244 79 ESLTE-M---------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA 148 (255)
Q Consensus 79 ~~~~~-~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~ 148 (255)
..... . .....-|+.|+|||++.-+ ++...+.|+|||+|||+||.|+....||++..... +
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDly-----sg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----I 266 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLY-----SGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----I 266 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhh-----cCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----E
Confidence 22111 0 0122468999999998654 24667889999999999999999999998743322 2
Q ss_pred Hhhc-CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 025244 149 AFKN-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 196 (255)
Q Consensus 149 ~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~ 196 (255)
.... ..|..+.++..+.+||+.||+.||.+||++.|++..+..+....
T Consensus 267 lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 267 LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 2222 23445788999999999999999999999999999988766543
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=255.36 Aligned_cols=179 Identities=26% Similarity=0.424 Sum_probs=155.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
|+|||..|+||+|.-+|.+.++..+++.+++.++.+|+.||++||+.+||.||+||+|||+|+. |+++|+|.|+|....
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~-GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDH-GHVRISDLGLAVEIP 338 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccC-CCeEeeccceEEecC
Confidence 6899999999999999999988889999999999999999999999999999999999999998 899999999999887
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHHhhcCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ---AAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~ 157 (255)
........+||.+|||||++.. ..|+.+.|+|||||++|||+.|+.||....... ...+.........+
T Consensus 339 ~g~~~~~rvGT~GYMAPEvl~n--------e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~ 410 (591)
T KOG0986|consen 339 EGKPIRGRVGTVGYMAPEVLQN--------EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS 410 (591)
T ss_pred CCCccccccCcccccCHHHHcC--------CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc
Confidence 7777777899999999999964 559999999999999999999999997643322 22233333344456
Q ss_pred CCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~ 188 (255)
..++++.+.|.+.+|++||.+|- .++++.+|
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 88999999999999999999995 45566665
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=256.70 Aligned_cols=160 Identities=35% Similarity=0.601 Sum_probs=128.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccccccc---cccCCCccceeccccc
Q 025244 24 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELY 100 (255)
Q Consensus 24 ~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~ 100 (255)
.+++..++.++.||+.||+|||++|++||||||+|||++.+ +.+||+|||+++....... .....++..|+|||++
T Consensus 210 ~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 288 (375)
T cd05104 210 ALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG-RITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESI 288 (375)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC-CcEEEecCccceeccCcccccccCCCCCCcceeChhHh
Confidence 37788899999999999999999999999999999999987 6899999999985432221 1123346679999998
Q ss_pred ccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCC-CCCCCCcHHHHHHHHHhcccCCCC
Q 025244 101 STVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNA 178 (255)
Q Consensus 101 ~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~ 178 (255)
.+ ..++.++||||||+++|||++ |..||.+................ ..+...+.++.+||.+||+.||++
T Consensus 289 ~~--------~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 360 (375)
T cd05104 289 FN--------CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLK 360 (375)
T ss_pred cC--------CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhH
Confidence 53 567889999999999999998 89999876554444444433322 234456789999999999999999
Q ss_pred CCCHHHHHHHHHHh
Q 025244 179 RPNFTQIIQMLLNY 192 (255)
Q Consensus 179 Rpt~~~vl~~l~~~ 192 (255)
||++.++++.|+..
T Consensus 361 RPs~~eil~~l~~~ 374 (375)
T cd05104 361 RPTFKQIVQLIEQQ 374 (375)
T ss_pred CcCHHHHHHHHHhh
Confidence 99999999998753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=257.55 Aligned_cols=178 Identities=26% Similarity=0.413 Sum_probs=142.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+... +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~-~~~kL~DFGl~~~~~ 152 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRMEV--FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFR 152 (381)
T ss_pred EEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC-CCEEEeeCcCCcccc
Confidence 4799999999999999987554 8999999999999999999999999999999999999988 799999999975321
Q ss_pred cc------------------------------------------------cccccCCCccceecccccccccccccccCC
Q 025244 81 LT------------------------------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKH 112 (255)
Q Consensus 81 ~~------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 112 (255)
.. ....+.+||+.|+|||++.+ ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~ 224 (381)
T cd05626 153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--------KG 224 (381)
T ss_pred cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--------CC
Confidence 00 00123579999999999853 45
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc---CCCCCCCCcHHHHHHHHHhc--ccCCCCCCCHHHHHH
Q 025244 113 YNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN---VRPSAENVPEELSIILTSCW--KEDPNARPNFTQIIQ 187 (255)
Q Consensus 113 ~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l--~~~p~~Rpt~~~vl~ 187 (255)
++.++|||||||++|||++|+.||......+......... ..+....+++++.++|.+|+ ..++..|+++.+++.
T Consensus 225 ~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 225 YTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred CCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 7889999999999999999999998866655444433211 22334467899999999944 556666999999998
Q ss_pred HH
Q 025244 188 ML 189 (255)
Q Consensus 188 ~l 189 (255)
|-
T Consensus 305 hp 306 (381)
T cd05626 305 HP 306 (381)
T ss_pred Cc
Confidence 73
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=243.08 Aligned_cols=179 Identities=28% Similarity=0.469 Sum_probs=149.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.......+++.+++.++.+++.||++||++|++|+||||+||+++.+ +.++|+|||++....
T Consensus 75 ~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~-~~~~l~df~~~~~~~ 153 (257)
T cd08223 75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT-NIIKVGDLGIARVLE 153 (257)
T ss_pred EEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC-CcEEEecccceEEec
Confidence 3799999999999999987555558999999999999999999999999999999999999988 699999999987543
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
.. .......+++.|+|||++.+ ..++.++|+||||+++++|++|+.||...+..............+....
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
T cd08223 154 NQCDMASTLIGTPYYMSPELFSN--------KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKD 225 (257)
T ss_pred ccCCccccccCCcCccChhHhcC--------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccc
Confidence 22 22344578999999998853 5577899999999999999999999987665554444433333344567
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+++.+.+++.+||+.||++||++.+++++
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 226 YSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 88999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=249.78 Aligned_cols=179 Identities=27% Similarity=0.420 Sum_probs=147.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++++ +.++|+|||++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY-GHIRISDLGLAVEIP 153 (285)
T ss_pred EEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC-CCEEEeeCCCceecC
Confidence 4799999999999999976555559999999999999999999999999999999999999988 799999999998654
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHH---HHHhhcCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY---AAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---~~~~~~~~~~~ 157 (255)
.........|+..|+|||++.+ ..++.++|+||+|+++|||++|+.||.+........ ...........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd05605 154 EGETIRGRVGTVGYMAPEVVKN--------ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYS 225 (285)
T ss_pred CCCccccccCCCCccCcHHhcC--------CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccC
Confidence 3333345678999999999853 567889999999999999999999998754432221 11122222234
Q ss_pred CCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~ 188 (255)
..++..+.++|.+||+.||.+|| ++.+++++
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 56889999999999999999999 88898876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=252.24 Aligned_cols=162 Identities=31% Similarity=0.596 Sum_probs=130.8
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccccc---ccccCCCccceeccccc
Q 025244 24 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELY 100 (255)
Q Consensus 24 ~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~ 100 (255)
.+++..+..++.|++.||+|||++||+||||||+|||++.+ +.++|+|||+++...... ......++..|+|||++
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 247 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI 247 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC-CcEEEeccccchhcccCcchhhccCCCCCccccCcHHh
Confidence 47889999999999999999999999999999999999987 689999999998543221 12234556789999988
Q ss_pred ccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCC-CCCCCCcHHHHHHHHHhcccCCCC
Q 025244 101 STVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNA 178 (255)
Q Consensus 101 ~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~ 178 (255)
.+ ..++.++|||||||++|||++ |..||.+....+........... ..+...++++.+++.+||+.+|++
T Consensus 248 ~~--------~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 319 (337)
T cd05054 248 FD--------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPED 319 (337)
T ss_pred cC--------CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhh
Confidence 53 567889999999999999997 99999875443333333322222 234567889999999999999999
Q ss_pred CCCHHHHHHHHHHhHh
Q 025244 179 RPNFTQIIQMLLNYLS 194 (255)
Q Consensus 179 Rpt~~~vl~~l~~~~~ 194 (255)
||++.+++++|...+.
T Consensus 320 RPs~~ell~~l~~~~~ 335 (337)
T cd05054 320 RPTFSELVEILGDLLQ 335 (337)
T ss_pred CcCHHHHHHHHHHHHh
Confidence 9999999999988765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=250.27 Aligned_cols=184 Identities=24% Similarity=0.501 Sum_probs=150.3
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
++|+||+++|+|.+++..... .+++..++.++.|++.||+|||++|++||||||+|||++.+ +.+||+|||+++....
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~-~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeeecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCC-CcEEEccccccccccC
Confidence 689999999999999987543 38889999999999999999999999999999999999988 6899999999985443
Q ss_pred ccc---cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 82 TEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 82 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
... .....++..|+|||++.. ..++.++||||||+++|||++ |..||.+....+...........+.+
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 233 (316)
T ss_pred CCcceeccCCccceeecChHHhcc--------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCC
Confidence 221 122334678999998853 567889999999999999997 99999876554433333333334446
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
..++.++.+++.+||..||.+||++.+++..+......
T Consensus 234 ~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 234 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 67789999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=242.67 Aligned_cols=182 Identities=34% Similarity=0.545 Sum_probs=150.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||+++...
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~ 154 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGEN-NICKVADFGLARVIK 154 (261)
T ss_pred eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCC-CCEEECCcceEEEcc
Confidence 4799999999999999987654558999999999999999999999999999999999999988 689999999998644
Q ss_pred ccccc--ccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
..... .....+..|+|||++.+ ..++.++|+||||+++|||++ |+.||.+................+..
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 226 (261)
T cd05068 155 EDIYEAREGAKFPIKWTAPEAALY--------NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCP 226 (261)
T ss_pred CCcccccCCCcCceeccCcccccc--------CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 22111 11122457999998753 557889999999999999999 99999886655554444433334456
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
..++..+.+++.+||+.+|.+||++.++++.|++
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 6788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=255.53 Aligned_cols=172 Identities=30% Similarity=0.444 Sum_probs=143.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+... +++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 73 ~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~ 149 (318)
T cd05582 73 LYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESI 149 (318)
T ss_pred EEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC-CcEEEeeccCCcccC
Confidence 4799999999999999976543 8999999999999999999999999999999999999988 699999999998543
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
.. .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+.+..+....... .....+..
T Consensus 150 ~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~-~~~~~p~~ 220 (318)
T cd05582 150 DHEKKAYSFCGTVEYMAPEVVNR--------RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK-AKLGMPQF 220 (318)
T ss_pred CCCCceecccCChhhcCHHHHcC--------CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc-CCCCCCCC
Confidence 33 23345679999999999853 4567899999999999999999999988665554443332 22334566
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQ 184 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~ 184 (255)
+++++.++|.+||+.||.+||++.+
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 8899999999999999999999443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=243.10 Aligned_cols=182 Identities=30% Similarity=0.543 Sum_probs=150.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... .+++..++.++.|++.||+|||++|++|+||||+||+++++ +.++|+|||+++...
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~-~~~~l~dfg~~~~~~ 157 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRRLE 157 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CCEEECccchhhccc
Confidence 4799999999999999987543 48999999999999999999999999999999999999988 689999999998653
Q ss_pred c-ccc--cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCC
Q 025244 81 L-TEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPS 156 (255)
Q Consensus 81 ~-~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 156 (255)
. ... .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||......+...........+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 229 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAY--------RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP 229 (266)
T ss_pred ccccceeccCCCCCccccChhhhcc--------CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 1 111 112344678999998853 457889999999999999998 9999987665555444443334455
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
...++..+.+++.+||+.+|++||++.+++++|.+.
T Consensus 230 ~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 667899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=242.63 Aligned_cols=181 Identities=30% Similarity=0.514 Sum_probs=149.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||+++|+|.++|.... .+++..++.++.|++.||+|||+.+++|+||||+||+++.+ +.+||+|||+++...
T Consensus 70 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~-~~~kl~df~~~~~~~ 146 (257)
T cd05060 70 LMLVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR-HQAKISDFGMSRALG 146 (257)
T ss_pred eEEEEEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC-CcEEeccccccceee
Confidence 379999999999999998765 38999999999999999999999999999999999999988 799999999998543
Q ss_pred ccccc----ccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCC
Q 025244 81 LTEMM----TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
..... ....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||...+..+...........+
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~ 218 (257)
T cd05060 147 AGSDYYRATTAGRWPLKWYAPECINY--------GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLP 218 (257)
T ss_pred cCCcccccccCccccccccCHHHhcC--------CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCC
Confidence 22211 11223467999998853 557889999999999999998 999998776655444443333345
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
.+..++..+.++|.+||..+|++||++.++++.|++.
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 5667889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=250.68 Aligned_cols=178 Identities=24% Similarity=0.379 Sum_probs=140.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++..... .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 78 LTLVFEYVH-TDLCQYMDKHPG-GLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDT-GELKLADFGLARAKS 154 (303)
T ss_pred EEEEEECCC-cCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECCCCcceecc
Confidence 479999995 789988876543 38899999999999999999999999999999999999988 799999999987533
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-CCC---
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN-VRP--- 155 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~--- 155 (255)
. ........+|+.|+|||++.+ ...++.++|+|||||++|+|++|..||.+.............. ..+
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
T cd07869 155 VPSHTYSNEVVTLWYRPPDVLLG-------STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNED 227 (303)
T ss_pred CCCccCCCCcccCCCCChHHHcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChh
Confidence 2 222344578999999998753 2457789999999999999999999998765443322221110 000
Q ss_pred ----------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 ----------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ----------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.....++.+.+++.+||+.||.+|||+.++++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 228 TWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 001235678999999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=248.02 Aligned_cols=186 Identities=34% Similarity=0.589 Sum_probs=150.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
+++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 99 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~-~ 177 (307)
T cd05098 99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-N 177 (307)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCC-C
Confidence 4799999999999999986532 237889999999999999999999999999999999999988 7
Q ss_pred ceEEecCccccccccccc---cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchH
Q 025244 67 TIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 142 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~ 142 (255)
.++|+|||+++....... .....++..|+|||++.+ ..++.++|+||||+++|||++ |..||.+....
T Consensus 178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred cEEECCCcccccccccchhhccccCCCccceeChHHhcc--------CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 999999999875432211 112234568999998853 557889999999999999998 88999775544
Q ss_pred HHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 143 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
+.............+..++.++.+++.+||..+|.+||++.++++.|...+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 250 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 33333333333344567889999999999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=246.50 Aligned_cols=186 Identities=32% Similarity=0.576 Sum_probs=151.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
+++||||+++|+|.+++.+... ..++...++.++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~-~ 174 (304)
T cd05101 96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN-N 174 (304)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCC-C
Confidence 4799999999999999986422 247788899999999999999999999999999999999988 7
Q ss_pred ceEEecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchH
Q 025244 67 TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 142 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~ 142 (255)
.+||+|||+++...... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+....
T Consensus 175 ~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred cEEECCCccceecccccccccccCCCCCceeeCchhhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99999999998543221 1223345678999998853 557889999999999999998 88899876655
Q ss_pred HHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 143 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
+................++..+.+++.+||+.+|++||++.++++.|.+++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 247 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 54444333333334567889999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=244.77 Aligned_cols=181 Identities=31% Similarity=0.574 Sum_probs=146.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEec
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 72 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~D 72 (255)
.++||||++|++|.+++.+... ..+++..++.++.|++.||.|||+.|++||||||+||+++++ +.++|+|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~-~~~~l~d 162 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIGD 162 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC-CCEEECC
Confidence 4799999999999999976432 235678889999999999999999999999999999999988 6999999
Q ss_pred Cccccccccccc---cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHH
Q 025244 73 FGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAA 148 (255)
Q Consensus 73 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~ 148 (255)
||+++....... .....++..|+|||.+.+ ..++.++|+||||+++|||++ |..||.+....+.....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhc--------CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999874322211 122345788999998853 557889999999999999998 78999876655444444
Q ss_pred HhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 149 AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 149 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
...........++..+.+++.+||+.||++||++.++++.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 443334446678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=247.79 Aligned_cols=178 Identities=29% Similarity=0.351 Sum_probs=145.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~kl~dfg~~~~~~ 159 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GQVKLADFGLARIYS 159 (288)
T ss_pred EEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccCcccccc
Confidence 379999996 699999987655559999999999999999999999999999999999999988 799999999998654
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC------
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR------ 154 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------ 154 (255)
.........||..|+|||++.+ ..++.++|||||||++|+|++|++||.+....+...........
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 160 CQMALTPVVVTLWYRAPEVLLQ--------STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred CcccCCCccccccccCchHhhC--------CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 4433445678999999998853 45788999999999999999999999876554433322211000
Q ss_pred --------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 155 --------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 155 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.....++..+.++|.+||+.||++||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0123467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=252.42 Aligned_cols=178 Identities=22% Similarity=0.406 Sum_probs=143.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~-~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+++||||++||+|.+++..... +++..+..++.|++.||.|||++ +|+||||||+|||++.+ +.++|+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~ 154 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR-GEIKLCDFGVSGQL 154 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCC-CcEEEccCcccccc
Confidence 4799999999999999987544 89999999999999999999986 59999999999999988 79999999998754
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-----------
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA----------- 148 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~----------- 148 (255)
... ......||..|+|||++.+ ..++.++|+|||||++|||++|+.||...+..+.....
T Consensus 155 ~~~-~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (331)
T cd06649 155 IDS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGE 225 (331)
T ss_pred ccc-ccccCCCCcCcCCHhHhcC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCC
Confidence 322 2345679999999999853 56788999999999999999999999764432221110
Q ss_pred ----------------------------------HhhcCCCC--CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 149 ----------------------------------AFKNVRPS--AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 149 ----------------------------------~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
......+. ...++.++.+||.+||+.||++|||+.+++++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 226 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred ccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 00001111 1246789999999999999999999999999854
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=242.10 Aligned_cols=179 Identities=32% Similarity=0.600 Sum_probs=146.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~ 151 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED-NVVKVSDFGLARYVL 151 (256)
T ss_pred eEEEEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCC-CcEEECCcccceecc
Confidence 4799999999999999986543 48999999999999999999999999999999999999988 799999999987543
Q ss_pred ccccc--ccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
..... ....++..|+|||.+.+ ..++.++|+||||+++|++++ |+.||...+..+...........+.+
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd05059 152 DDQYTSSQGTKFPVKWAPPEVFDY--------SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRP 223 (256)
T ss_pred cccccccCCCCCCccccCHHHhcc--------CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 22111 11223457999998853 557789999999999999999 89999876655544444333333445
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
..++.++.+++.+||+.+|++||++.++++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 66899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=240.82 Aligned_cols=180 Identities=34% Similarity=0.573 Sum_probs=145.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++....
T Consensus 68 ~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~ 145 (252)
T cd05084 68 IYIVMELVQGGDFLTFLRTEGP-RLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK-NVLKISDFGMSREEE 145 (252)
T ss_pred eEEEEeeccCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC-CcEEECccccCcccc
Confidence 4799999999999999976432 38999999999999999999999999999999999999988 689999999987533
Q ss_pred ccccc---ccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCC
Q 025244 81 LTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPS 156 (255)
Q Consensus 81 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 156 (255)
..... .....+..|+|||.+.. ..++.++|+||||+++|||++ |..||..................+.
T Consensus 146 ~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 217 (252)
T cd05084 146 DGVYASTGGMKQIPVKWTAPEALNY--------GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPC 217 (252)
T ss_pred cccccccCCCCCCceeecCchhhcC--------CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC
Confidence 22111 11123457999998853 457889999999999999997 8999977665544444433333445
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
...++..+.+++.+||+.+|++||++.++++.|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 5677899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=242.26 Aligned_cols=180 Identities=35% Similarity=0.629 Sum_probs=151.8
Q ss_pred CEEEEecCCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecC
Q 025244 1 MVIVTELLSGGTLRKYLLNMR-------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 73 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~-------~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Df 73 (255)
+++||||++|++|.+++.... ...+++..++.++.|++.||+|||++|++|+||||+||+++.+ +.++|+||
T Consensus 71 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~-~~~~l~df 149 (262)
T cd00192 71 LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED-LVVKISDF 149 (262)
T ss_pred eEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCC-CcEEEccc
Confidence 479999999999999998752 2349999999999999999999999999999999999999998 79999999
Q ss_pred ccccccccc---cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHH
Q 025244 74 GLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAA 149 (255)
Q Consensus 74 g~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~ 149 (255)
|.+...... .......++..|+|||.+.. ..++.++|+||||+++|+|++ |..||......+......
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~ 221 (262)
T cd00192 150 GLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD--------GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR 221 (262)
T ss_pred ccccccccccccccccCCCcCccccCHHHhcc--------CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 999864432 22334567889999998753 467889999999999999999 699998876655554444
Q ss_pred hhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 150 FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 150 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
.......+..++.++.+++.+||..+|.+||++.+++++|
T Consensus 222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 222 KGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred cCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 4444455677899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=241.16 Aligned_cols=179 Identities=28% Similarity=0.542 Sum_probs=146.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||+++...
T Consensus 74 ~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~ 151 (256)
T cd05114 74 LYIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSST-GVVKVSDFGMTRYVL 151 (256)
T ss_pred EEEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCC-CeEEECCCCCccccC
Confidence 4799999999999999986433 38999999999999999999999999999999999999988 689999999987533
Q ss_pred cccc--cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
.... .....++..|+|||++.+ ..++.++|+||||+++|||++ |+.||...+..+.............+
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 223 (256)
T cd05114 152 DDEYTSSSGAKFPVKWSPPEVFNF--------SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP 223 (256)
T ss_pred CCceeccCCCCCchhhCChhhccc--------CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC
Confidence 2211 122235568999998853 457789999999999999999 89999877665555544443333345
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
...+..+.+++.+||+.+|++||++.++++.|
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 56788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=231.53 Aligned_cols=179 Identities=25% Similarity=0.371 Sum_probs=158.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+||++||.++|+|...|+..+...+++..+..++.|++.||.|+|.++|+||||||+|+|++.+ +.+|++|||.+....
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~-~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAP 175 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCC-CCeeccCCCceeecC
Confidence 5899999999999999997776679999999999999999999999999999999999999998 799999999998755
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
.....+.+||..|.+||+.. +...+...|+|++|++.||++.|.+||...+ ....++.+.......+..+
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~--------~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~~~~p~~i 245 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVE--------GRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVDLKFPSTI 245 (281)
T ss_pred -CCCceeeecccccCCHhhcC--------CCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHccccCCccc
Confidence 44457889999999999885 4667889999999999999999999999877 4555555555555556899
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
+.+.+++|.+|+.++|.+|....|++++-+
T Consensus 246 s~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 246 SGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred ChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 999999999999999999999999999854
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=247.97 Aligned_cols=187 Identities=34% Similarity=0.571 Sum_probs=151.6
Q ss_pred CEEEEecCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
+++||||+++|+|.++|.+.. ...++...++.++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~-~ 171 (334)
T cd05100 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED-N 171 (334)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC-C
Confidence 479999999999999998642 1237788899999999999999999999999999999999988 6
Q ss_pred ceEEecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchH
Q 025244 67 TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 142 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~ 142 (255)
.+||+|||+++...... ......++..|+|||++.+ ..++.++||||||+++|||++ |..||.+....
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred cEEECCcccceecccccccccccCCCcCceEcCHHHhcc--------CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999998543221 1122334568999998853 567889999999999999998 88999876655
Q ss_pred HHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 025244 143 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 196 (255)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~ 196 (255)
+...........+.+..++.++.+++.+||+.+|.+||++.++++.|.......
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 244 ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 544444333333445677899999999999999999999999999998887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=256.43 Aligned_cols=177 Identities=24% Similarity=0.389 Sum_probs=144.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++...+. +++..+..++.|++.||+|||++||+||||||+|||++.+ +.++|+|||+++...
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLK 152 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEeecccceecc
Confidence 4799999999999999987543 9999999999999999999999999999999999999988 799999999986422
Q ss_pred ccc---------------------------------------ccccCCCccceecccccccccccccccCCCCchhhHHH
Q 025244 81 LTE---------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121 (255)
Q Consensus 81 ~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Dvws 121 (255)
... .....+||+.|+|||++.. ..++.++||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwS 224 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--------TGYNKECDWWS 224 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--------CCCCCeeeeec
Confidence 110 1113469999999999853 55788999999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHHHHHHHhhc---CCCCCCCCcHHHHHHHHHhcccCCCCCCC---HHHHHHHH
Q 025244 122 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKN---VRPSAENVPEELSIILTSCWKEDPNARPN---FTQIIQML 189 (255)
Q Consensus 122 lG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~vl~~l 189 (255)
|||++|||++|..||.+.+..+......... ..+....+++++.++|.+|+. +|.+|++ +.+++++-
T Consensus 225 lG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 225 LGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred chhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 9999999999999998876655444333211 122334578999999999996 9999997 99998863
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=240.74 Aligned_cols=184 Identities=31% Similarity=0.544 Sum_probs=146.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||+.+|+|.+++.+... ..++..+..++.|++.||.|||+++++||||||+|||++.+ +.+||+|||+++...
T Consensus 72 ~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~ 149 (262)
T cd05058 72 PLVVLPYMKHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES-FTVKVADFGLARDIY 149 (262)
T ss_pred cEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCcccccccc
Confidence 3789999999999999986543 36777888999999999999999999999999999999988 689999999997532
Q ss_pred ccc-----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCC
Q 025244 81 LTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVR 154 (255)
Q Consensus 81 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 154 (255)
... ......++..|+|||.+.. ..++.++||||||+++|||++ |.+||...+..+...........
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRL 221 (262)
T ss_pred CCcceeecccccCcCCccccChhHhcc--------CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC
Confidence 211 1123345778999998753 557889999999999999999 56677765554444333333333
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 155 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 155 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
+....++..+.+++.+||+.+|++||++.++++.|++.+.
T Consensus 222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 3355678999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=254.81 Aligned_cols=178 Identities=31% Similarity=0.450 Sum_probs=157.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCC---CceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL---KTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~---~~~kl~Dfg~a~ 77 (255)
+++|||+++||.|.+.|... . +++..+..++.|++.++.|||+.||+||||||+|+|+.... +.+|++|||++.
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-~--~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-H--YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-c--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 48999999999999999987 2 99999999999999999999999999999999999997542 379999999999
Q ss_pred ccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC---C
Q 025244 78 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV---R 154 (255)
Q Consensus 78 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~ 154 (255)
...........+||+.|+|||++.. ..|+...|+||+|+++|.|++|.+||.+.........+..... .
T Consensus 188 ~~~~~~~~~~~~Gtp~y~APEvl~~--------~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~ 259 (382)
T KOG0032|consen 188 FIKPGERLHTIVGTPEYVAPEVLGG--------RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTS 259 (382)
T ss_pred EccCCceEeeecCCccccCchhhcC--------CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCC
Confidence 8776667788999999999999853 6789999999999999999999999999887777666655544 3
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 155 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 155 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
+....++..++++|+.||..||.+|+++.++++|-
T Consensus 260 ~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp 294 (382)
T KOG0032|consen 260 EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHP 294 (382)
T ss_pred CCccccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence 34567889999999999999999999999999983
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=245.29 Aligned_cols=180 Identities=34% Similarity=0.625 Sum_probs=146.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+++|+|.++|.......+++..++.++.|++.||.|||+++++|++|+++||+++.+ +.+||+|||++....
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSN-GQVKLSDFGLSRPIS 154 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETT-TEEEEESTTTGEETT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccc
Confidence 3789999999999999998744559999999999999999999999999999999999999998 699999999998652
Q ss_pred cc---cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCC
Q 025244 81 LT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPS 156 (255)
Q Consensus 81 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 156 (255)
.. .......+...|+|||.+.. ..++.++||||||+++|||++ |+.||.+.+..+...........+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 226 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKD--------GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI 226 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHH--------SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS
T ss_pred ccccccccccccccccccccccccc--------cccccccccccccccccccccccccccccccccccccccccccccee
Confidence 21 12233456789999999854 447889999999999999999 7899988877666655555555555
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
+..++..+.++|..||+.||.+||++.++++.|
T Consensus 227 ~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 677899999999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=241.76 Aligned_cols=180 Identities=30% Similarity=0.460 Sum_probs=152.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.......+++..+..++.+++.||+|||++|++|+||||+||+++.+.+.++|+|||++....
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 74 LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153 (256)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence 37999999999999999876555589999999999999999999999999999999999998764578999999998655
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
.........++..|+|||.+.. ..++.++|+||||+++|+|++|+.||...+..............+....+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (256)
T cd08220 154 SKSKAYTVVGTPCYISPELCEG--------KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRY 225 (256)
T ss_pred CCccccccccCCcccCchhccC--------CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCc
Confidence 4443445678999999998853 45678999999999999999999999876655554444444444456678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+.++.+++.+||+.+|++|||+.+++++
T Consensus 226 ~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 226 SPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 8999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=242.98 Aligned_cols=179 Identities=26% Similarity=0.446 Sum_probs=151.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++++|||++....
T Consensus 73 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~ 151 (255)
T cd08219 73 LYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLT 151 (255)
T ss_pred EEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC-CcEEEcccCcceeec
Confidence 4799999999999999987555568999999999999999999999999999999999999988 799999999987543
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
.. .......|+..|+|||++.+ ..++.++|+||||+++|+|++|..||...+..............+.+..
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 223 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWEN--------MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSH 223 (255)
T ss_pred ccccccccccCCccccCHHHHcc--------CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcc
Confidence 32 22334578899999999853 4578899999999999999999999987665555555444445555667
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
++..+.++|.+||+.||++||++.+++..
T Consensus 224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 224 YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 88999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=241.50 Aligned_cols=182 Identities=32% Similarity=0.545 Sum_probs=151.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++|++|.+++.......+++.++..++.|++.||+|||+.|++||||||+||+++.+ +.++|+|||++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~ 153 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSET-LCCKIADFGLARLIE 153 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCC-CCEEEccCcceeecC
Confidence 4799999999999999987655568999999999999999999999999999999999999988 689999999997544
Q ss_pred cccc--cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
.... .....++..|+|||++.. ..++.++|+||||+++||+++ |+.||.+.+..+...........+..
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRP 225 (260)
T ss_pred CCCcccccCCcccccccCHHHhcc--------CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Confidence 2211 122345678999998853 456789999999999999998 99999877665544444333334456
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
...+.++.++|.+||+.+|++||++++++..|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 6788999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=250.58 Aligned_cols=179 Identities=25% Similarity=0.335 Sum_probs=155.1
Q ss_pred EEEEecCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 2 VIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
.|||||+| .+|.++++.. .+..++...+.-+..||++||+|||+.||+||||||.|+|+|.+.|.+||+|||.|+..
T Consensus 98 nlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 47999997 8999999853 23348888888899999999999999999999999999999988789999999999987
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC----
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---- 155 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---- 155 (255)
...+...+...|..|+|||.+.+ ...|+.+.||||.||++.||+.|++-|+|.+..++...+..-...|
T Consensus 177 ~~~epniSYicSRyYRaPELifg-------a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 177 VKGEPNISYICSRYYRAPELIFG-------ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED 249 (364)
T ss_pred ccCCCceeEEEeccccCHHHHcC-------ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 77777778888999999999985 5789999999999999999999999999988877776654322222
Q ss_pred ------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 ------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.....+++..+|+.++|..+|.+|.++.|++.+
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 123457899999999999999999999999986
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=242.20 Aligned_cols=182 Identities=31% Similarity=0.569 Sum_probs=149.8
Q ss_pred EEEEecCCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 2 VIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~----~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+++++||||||+||+++++ +.+||+|||+++
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~ 161 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED-MTVCVADFGLSK 161 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCC-CeEEECCcccee
Confidence 78999999999999986532 2358999999999999999999999999999999999999988 699999999998
Q ss_pred ccccccc---cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcC
Q 025244 78 EESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNV 153 (255)
Q Consensus 78 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 153 (255)
....... .....++..|+|||.+. ...++.++||||||+++|||++ |..||.+....+..........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~--------~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05035 162 KIYSGDYYRQGRIAKMPVKWIAIESLA--------DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR 233 (273)
T ss_pred eccccccccccccccCCccccCHhhcc--------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 5432211 11223567899999874 3567889999999999999999 8999988766555444444444
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 154 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 154 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
...+..++..+.+++.+||+.||++||++.++++.|+++
T Consensus 234 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 445677889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=240.88 Aligned_cols=179 Identities=28% Similarity=0.512 Sum_probs=147.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+++|+|.+++..... .+++..++.++.|++.||+|||+.|++|+||||+||+++.+ +.+||+|||.++...
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~d~g~~~~~~ 151 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVL 151 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CCEEECCCccceecC
Confidence 4899999999999999987543 48999999999999999999999999999999999999988 699999999987533
Q ss_pred ccccc--ccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
..... ....++..|++||.+.+ ..++.++|+||||+++|+|++ |..||......+..............
T Consensus 152 ~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd05113 152 DDEYTSSVGSKFPVRWSPPEVLLY--------SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP 223 (256)
T ss_pred CCceeecCCCccChhhCCHHHHhc--------CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC
Confidence 22211 12235678999998853 457889999999999999998 99999876655544444444344445
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
...+..+.+++.+||+.||.+||++.+++..+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 56789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=244.60 Aligned_cols=182 Identities=27% Similarity=0.513 Sum_probs=149.9
Q ss_pred CEEEEecCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
+++++||+++++|.+++.... +..+++..++.++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~-~ 161 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK-L 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC-C
Confidence 368999999999999996321 1237888899999999999999999999999999999999987 6
Q ss_pred ceEEecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchH
Q 025244 67 TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 142 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~ 142 (255)
.+||+|||+++...... ......+++.|+|||.+.. ..++.++||||||+++|||++ |..||.+....
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 233 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY--------GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 233 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhc--------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 89999999988543222 1223456789999998753 457889999999999999998 88899887666
Q ss_pred HHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 143 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
+...........+.+..++..+.+++.+||+.+|.+||++++++..|+.
T Consensus 234 ~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 DVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 5555555555555577899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=256.58 Aligned_cols=177 Identities=24% Similarity=0.382 Sum_probs=141.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++...+. +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~-~~~kl~DfGla~~~~ 152 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYDT--FSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRG-GHIKLSDFGLSTGFH 152 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEEeecccccccc
Confidence 4899999999999999986543 8999999999999999999999999999999999999988 799999999986321
Q ss_pred ccc------------------------------------------------ccccCCCccceecccccccccccccccCC
Q 025244 81 LTE------------------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKH 112 (255)
Q Consensus 81 ~~~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 112 (255)
... .....+||+.|+|||++.+ ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~ 224 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--------QG 224 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--------CC
Confidence 100 0012469999999999853 56
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh---cCCCCCCCCcHHHHHHHHHhcccCCCCC---CCHHHHH
Q 025244 113 YNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK---NVRPSAENVPEELSIILTSCWKEDPNAR---PNFTQII 186 (255)
Q Consensus 113 ~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~R---pt~~~vl 186 (255)
++.++|||||||++|||++|..||.+.+..+........ ...+....++.++.++|.+||. +|.+| +++.+++
T Consensus 225 ~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 225 YGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred CCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 788999999999999999999999876655443333221 1123334578999999999997 66665 5999999
Q ss_pred HHH
Q 025244 187 QML 189 (255)
Q Consensus 187 ~~l 189 (255)
++-
T Consensus 304 ~hp 306 (377)
T cd05629 304 SHP 306 (377)
T ss_pred cCC
Confidence 874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=245.81 Aligned_cols=184 Identities=34% Similarity=0.587 Sum_probs=149.2
Q ss_pred CEEEEecCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
+++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~-~ 169 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED-H 169 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC-C
Confidence 479999999999999997532 2348899999999999999999999999999999999999988 7
Q ss_pred ceEEecCccccccccccc---cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchH
Q 025244 67 TIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 142 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~ 142 (255)
.+||+|||+++....... .....++..|+|||++.. ..++.++|||||||++||+++ |..||.+....
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhcc--------CCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 999999999985432211 122334678999998743 567889999999999999997 99999876655
Q ss_pred HHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 025244 143 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 193 (255)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~ 193 (255)
+.............+...+..+.+++.+||..||++|||+.++++.|.+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 444433333333345667899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=243.79 Aligned_cols=181 Identities=28% Similarity=0.495 Sum_probs=148.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP-------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 67 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~-------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~ 67 (255)
.++||||+++++|.+++..... ..+++..++.++.|++.||+|||+.|++||||||+||+++++ +.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~-~~ 160 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG-LV 160 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC-CC
Confidence 4799999999999999986532 247889999999999999999999999999999999999987 69
Q ss_pred eEEecCccccccccccc---cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHH
Q 025244 68 IKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 143 (255)
Q Consensus 68 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~ 143 (255)
++|+|||+++....... .....+++.|+|||.+.+ ..++.++|+||||+++|||++ |.+||......+
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 232 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--------RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE 232 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhcc--------CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH
Confidence 99999999874322211 122335678999998853 557889999999999999998 999998766655
Q ss_pred HHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 144 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
.............+..+++.+.++|.+||+.||.+||++.++++.|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 233 AIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 54444433333445678899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=257.58 Aligned_cols=181 Identities=25% Similarity=0.394 Sum_probs=145.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~~---~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~-~~~kL~DFG~a~~~~ 193 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNYD---VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH-GHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEEecccceecc
Confidence 489999999999999997542 8899999999999999999999999999999999999988 799999999998643
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC---CC
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV---RP 155 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~~ 155 (255)
... ...+.+||+.|+|||++.+. .....++.++|+|||||++|||++|+.||.+.+............. .+
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p 269 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFP 269 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhcc----CCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCC
Confidence 222 22456799999999998541 1123477899999999999999999999988765554444433221 12
Q ss_pred CCCCCcHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNA--RPNFTQIIQML 189 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~--Rpt~~~vl~~l 189 (255)
....++..+++++..||..++.+ |+++.++++|-
T Consensus 270 ~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 270 EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 23457899999999999866544 88999999973
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=253.26 Aligned_cols=181 Identities=25% Similarity=0.415 Sum_probs=162.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
||||+|+-+||+|+|||.++... +.+..+.+++.||+.|+.|+|+..++||||||+|+++-+..|.|||.|||++..+.
T Consensus 92 lyLiLELGD~GDl~DyImKHe~G-l~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEG-LNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhcc-ccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 69999999999999999988654 99999999999999999999999999999999999999888999999999999888
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
......+.+|+..|.|||++.+ ..+..++.|||||||+||-|+||++||...+..+..-.++.-. ...+..+
T Consensus 171 PG~kL~TsCGSLAYSAPEILLG-------DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK-YtvPshv 242 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLG-------DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK-YTVPSHV 242 (864)
T ss_pred CcchhhcccchhhccCchhhhc-------CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc-ccCchhh
Confidence 8888899999999999999985 3445679999999999999999999999877766665555433 3357788
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
+.+.++||..||..||++|.+.++|...-|
T Consensus 243 S~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 243 SKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred hHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 999999999999999999999999988643
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=246.82 Aligned_cols=168 Identities=29% Similarity=0.457 Sum_probs=149.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
||.||||+.||+|--+|++.++ +.+..+..++.+|+-||-+||++||+.||||.+|||++.+ |++||+|||+++..-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~e-GHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENI 501 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccC-CceEeeecccccccc
Confidence 6899999999999999998776 9999999999999999999999999999999999999999 899999999998533
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
......+++||+.|+|||++.. ..|+.+.|+||+||+||||+.|++||++.+..+.-..++ ......+..
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~Y--------qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~-ehnvsyPKs 572 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM-EHNVSYPKS 572 (683)
T ss_pred cCCcceeeecCCCcccccceEEe--------cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-HccCcCccc
Confidence 3345678999999999999964 778999999999999999999999999977665554444 444456788
Q ss_pred CcHHHHHHHHHhcccCCCCCC
Q 025244 160 VPEELSIILTSCWKEDPNARP 180 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rp 180 (255)
+|.+...+....|.+.|.+|.
T Consensus 573 lSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 573 LSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ccHHHHHHHHHHhhcCCcccc
Confidence 999999999999999999993
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=240.50 Aligned_cols=182 Identities=29% Similarity=0.523 Sum_probs=149.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++||||||+||+++.+ +.++++|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~ 158 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSN-LECKVSDFGLSRVLE 158 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCC-CcEEECCCccceecc
Confidence 479999999999999998643 348999999999999999999999999999999999999988 689999999987543
Q ss_pred cccc--c--ccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCC
Q 025244 81 LTEM--M--TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~~~~--~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
.... . .....+..|+|||++.. ..++.++|+||||+++|||++ |+.||...+..............+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~ 230 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAY--------RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP 230 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhc--------CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC
Confidence 2211 1 11223457999998853 457889999999999999997 999998766655544444444445
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
....++..+.+++.+||+.+|++||++.++++.|.+.
T Consensus 231 ~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 231 APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 5667889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=247.69 Aligned_cols=180 Identities=24% Similarity=0.402 Sum_probs=146.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++...+...+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||++....
T Consensus 75 ~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~-~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 75 LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH-GHIRISDLGLAVHVP 153 (285)
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeccceeecC
Confidence 4799999999999999976655569999999999999999999999999999999999999988 689999999987544
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHHhhcCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL---QAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~ 157 (255)
.........|+..|+|||++.+ ..++.++|+||||+++|+|++|+.||...... ...............
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd05630 154 EGQTIKGRVGTVGYMAPEVVKN--------ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYS 225 (285)
T ss_pred CCccccCCCCCccccChHHHcC--------CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcC
Confidence 3333344578999999999853 56788999999999999999999999864322 111111111112234
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPN-----FTQIIQML 189 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt-----~~~vl~~l 189 (255)
..+++++.+++.+||+.||.+||+ +.+++++-
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~ 262 (285)
T cd05630 226 EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence 567899999999999999999999 88998863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=245.91 Aligned_cols=186 Identities=33% Similarity=0.584 Sum_probs=150.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
+++||||+++|+|.+++..... ..+++.++..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~-~ 171 (314)
T cd05099 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED-N 171 (314)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCC-C
Confidence 4799999999999999976431 348888999999999999999999999999999999999988 6
Q ss_pred ceEEecCccccccccccc---cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchH
Q 025244 67 TIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 142 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~ 142 (255)
.+||+|||+++....... .....++..|+|||++.+ ..++.++|+||||+++|+|++ |..||.+....
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHcc--------CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 899999999985432111 112234567999998853 557889999999999999999 89999876554
Q ss_pred HHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 143 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
+.............+..++.++.+++.+||+.||++||++.++++.|......
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 244 ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 44433333322334567789999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=243.12 Aligned_cols=181 Identities=33% Similarity=0.566 Sum_probs=148.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEec
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 72 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~D 72 (255)
+++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+++++||||||+||+++.+ +.+||+|
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~-~~~kl~d 162 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED-LTVKIGD 162 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC-CCEEECC
Confidence 4799999999999999976432 236788999999999999999999999999999999999998 7999999
Q ss_pred Ccccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHH
Q 025244 73 FGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAA 148 (255)
Q Consensus 73 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~ 148 (255)
||+++...... ......++..|+|||.+.. ..++.++|+||||+++||+++ |..||.+.+..+.....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 234 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--------GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhc--------CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence 99987533221 1223456789999998753 557889999999999999998 99999876665554444
Q ss_pred HhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 149 AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 149 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
........+..++.++.++|.+||+.+|++|||+.++++.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 433333446678899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=264.34 Aligned_cols=186 Identities=32% Similarity=0.592 Sum_probs=166.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCce
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 68 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~ 68 (255)
+++|+|||..|||.++|+.+.+ ..++..+.+.++.||+.|+.||-++.+|||||-..|+||.++. .|
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l-~V 642 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL-VV 642 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce-EE
Confidence 5899999999999999986532 1288899999999999999999999999999999999999984 99
Q ss_pred EEecCccccccccccccccC---CCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHH
Q 025244 69 KLADFGLAREESLTEMMTAE---TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 144 (255)
Q Consensus 69 kl~Dfg~a~~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~ 144 (255)
||+|||+++.....+..... .-..+|||||.+.. +.|+.+||||||||+|||+++ |+.||.+.++.+.
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly--------~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV 714 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY--------GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV 714 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhc--------CcccchhhhhhhhhhhhhhhccccCcccccchHHH
Confidence 99999999976555443322 23469999999874 789999999999999999998 9999999999999
Q ss_pred HHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 145 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
...+......+.++++|.++..||..||+.+|.+||++.||-..|+.+...
T Consensus 715 Ie~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 715 IECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 999999999999999999999999999999999999999999999988654
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=258.73 Aligned_cols=176 Identities=26% Similarity=0.433 Sum_probs=142.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++.+.+. +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~-g~~kL~DFGla~~~~ 152 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMGI--FPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFR 152 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEeECCCCcccc
Confidence 4899999999999999987543 8999999999999999999999999999999999999988 799999999975211
Q ss_pred c------------------------------------------------ccccccCCCccceecccccccccccccccCC
Q 025244 81 L------------------------------------------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKH 112 (255)
Q Consensus 81 ~------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 112 (255)
. .....+.+||+.|+|||++.+ ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~ 224 (382)
T cd05625 153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--------TG 224 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--------CC
Confidence 0 000123579999999999853 45
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc---CCCCCCCCcHHHHHHHHHhcccCCCCCCC---HHHHH
Q 025244 113 YNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN---VRPSAENVPEELSIILTSCWKEDPNARPN---FTQII 186 (255)
Q Consensus 113 ~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~vl 186 (255)
++.++|||||||++|||++|+.||.+.+..+......... ..+....++++..++|.+|+ .+|.+|++ +.+++
T Consensus 225 ~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 225 YTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred CCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 7889999999999999999999998876655544443211 22334567899999999976 59999987 88888
Q ss_pred HH
Q 025244 187 QM 188 (255)
Q Consensus 187 ~~ 188 (255)
+|
T Consensus 304 ~h 305 (382)
T cd05625 304 AH 305 (382)
T ss_pred cC
Confidence 76
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=256.08 Aligned_cols=187 Identities=33% Similarity=0.604 Sum_probs=161.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++||||+|+||+|.++|++.+. .++..+.+.++.+.+.||+|||+++++||||-..|+|++.+ +.+||+|||+++...
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~-~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKK-GVVKISDFGLSRAGS 313 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCC-CeEEeCccccccCCc
Confidence 6899999999999999998765 49999999999999999999999999999999999999998 578999999998654
Q ss_pred cccccc-cCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHh-hcCCCCC
Q 025244 81 LTEMMT-AETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAF-KNVRPSA 157 (255)
Q Consensus 81 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~-~~~~~~~ 157 (255)
...... ...-...|+|||.+.. +.|+.++|||||||++||+.+ |..||.+....+....+.. ....+.+
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~--------~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~ 385 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNT--------GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP 385 (474)
T ss_pred ceeeccccccCcceecChhhhcc--------CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC
Confidence 332222 2234579999999964 589999999999999999998 8889999998888777744 5555667
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcC
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 197 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~ 197 (255)
...|.++..++..|+..+|++||+|.++.+.++.......
T Consensus 386 ~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 386 SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 7888999999999999999999999999999988776544
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=256.34 Aligned_cols=182 Identities=25% Similarity=0.420 Sum_probs=145.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.... +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~-~~ikL~DfG~a~~~~ 193 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCC-CCEEEEeCCceeEcC
Confidence 479999999999999997542 8899999999999999999999999999999999999988 799999999998543
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc---CCC
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN---VRP 155 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~~ 155 (255)
... .....+||+.|+|||++... .....++.++|||||||++|||++|+.||.+.+.......+.... ..+
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 269 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP 269 (371)
T ss_pred cCCcccccCcccCccccCHHHHhcc----CCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCC
Confidence 322 22456799999999998641 112347889999999999999999999998866554444433222 123
Q ss_pred CCCCCcHHHHHHHHHhcccCCCC--CCCHHHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNA--RPNFTQIIQMLL 190 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~--Rpt~~~vl~~l~ 190 (255)
....++..++++|..||..++.+ |+++.+++++.+
T Consensus 270 ~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 270 DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 34568999999999999854443 789999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=242.67 Aligned_cols=184 Identities=26% Similarity=0.429 Sum_probs=148.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+++++|.+++.......+++..+..++.|++.||+|||+++++|+||||+||+++.+ +.++|+|||+++...
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~-~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCC-CCEEEccCCCceecc
Confidence 3799999999999999987655568999999999999999999999999999999999999988 689999999987543
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-CCCCCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN-VRPSAE 158 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~ 158 (255)
.. .......|+..|+|||++.... .....++.++|+|||||++|||++|+.||................ ......
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK 239 (272)
T ss_pred cccccCCcccccccccCHhHhcccc---CcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCC
Confidence 22 2234567899999999885321 113457789999999999999999999997765544443332221 122245
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 159 NVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 159 ~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.++.++.+++.+||..||.+||++.+++++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 240 KWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 678999999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=238.57 Aligned_cols=180 Identities=32% Similarity=0.613 Sum_probs=148.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.......+++..++.++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||+++...
T Consensus 73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~-~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSED-GVAKVSDFGLARVGS 151 (254)
T ss_pred cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CcEEECCCccceecc
Confidence 4799999999999999987655558999999999999999999999999999999999999988 699999999987533
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
.. ......+..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||...+..+................
T Consensus 152 ~~--~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 221 (254)
T cd05083 152 MG--VDNSKLPVKWTAPEALKH--------KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEG 221 (254)
T ss_pred cc--CCCCCCCceecCHHHhcc--------CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCc
Confidence 22 122344578999998753 567889999999999999997 9999987666544443333322333556
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
++..+.+++.+||+.+|++||++.++++.|++
T Consensus 222 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 78999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=240.63 Aligned_cols=177 Identities=27% Similarity=0.447 Sum_probs=147.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++...+. +++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.++|+|||+++...
T Consensus 79 ~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~ 155 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKAYGA--LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEEEEECCCCcHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceecc
Confidence 4799999999999999987554 8899999999999999999999999999999999999987 699999999987533
Q ss_pred ccccc----ccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC-C
Q 025244 81 LTEMM----TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-P 155 (255)
Q Consensus 81 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~ 155 (255)
..... ....++..|+|||++.+ ..++.++|+||||+++|||++|+.||...+.............. .
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 227 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISG--------EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQ 227 (263)
T ss_pred ccccccccccCCCcCccccCcceecc--------CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCC
Confidence 22111 23467889999999853 44788999999999999999999999876665554443333222 2
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.+..++..+.++|.+||..+|.+||++.+++++
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 228 LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 355788999999999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=242.94 Aligned_cols=185 Identities=29% Similarity=0.554 Sum_probs=149.6
Q ss_pred CEEEEecCCCCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCc
Q 025244 1 MVIVTELLSGGTLRKYLLNMR----------------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 58 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~----------------------~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~N 58 (255)
.++||||++|++|.+++.... ...+++..++.++.|++.||+|||+++++||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 478999999999999987532 1247888999999999999999999999999999999
Q ss_pred EEEeCCCCceEEecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCC
Q 025244 59 LLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKL 134 (255)
Q Consensus 59 ill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~ 134 (255)
|+++++ +.++|+|||+++...... ......++..|+|||.+.+ ..++.++||||||+++|||++ |..
T Consensus 158 ill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~ 228 (290)
T cd05045 158 VLVAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD--------HIYTTQSDVWSFGVLLWEIVTLGGN 228 (290)
T ss_pred EEEcCC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHcc--------CCcchHhHHHHHHHHHHHHHhcCCC
Confidence 999987 699999999997532221 1123345678999998753 457889999999999999998 999
Q ss_pred CCCCCchHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 135 PFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 135 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
||.+....+...........+.+..++.++.+++.+||+.+|++||++.++++.|++.+.
T Consensus 229 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 229 PYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 998765544333333222333456788999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=241.89 Aligned_cols=182 Identities=30% Similarity=0.548 Sum_probs=146.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCC--CceEEecC
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP-----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADF 73 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~-----~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~--~~~kl~Df 73 (255)
.++||||++|++|.+++.+... ..+++..++.++.||+.||+|||+++++||||||+||+++.+. ..+||+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 3799999999999999987542 2488999999999999999999999999999999999998652 25899999
Q ss_pred ccccccccccc---cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHH
Q 025244 74 GLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAA 149 (255)
Q Consensus 74 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~ 149 (255)
|+++....... ......+..|+|||++.+ ..++.++|||||||++|||++ |..||.+...........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~ 235 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLD--------GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhc--------CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99985432211 112233568999999853 557889999999999999997 999998766554443333
Q ss_pred hhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 150 FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 150 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
.......+..++..+.+++.+||+.+|++||++.+++++|.
T Consensus 236 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 33233345678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=245.53 Aligned_cols=181 Identities=28% Similarity=0.489 Sum_probs=142.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP-----------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~-----------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~ 63 (255)
+++||||++||+|.+++..... ..+++..++.++.|++.||.|||+.|++||||||+|||++.
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~ 173 (304)
T cd05096 94 LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGE 173 (304)
T ss_pred eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcC
Confidence 4799999999999999975321 23677888999999999999999999999999999999998
Q ss_pred CCCceEEecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 025244 64 DLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH--NKLPFEG 138 (255)
Q Consensus 64 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~--g~~p~~~ 138 (255)
+ +.+||+|||+++...... ......++..|+|||++.. ..++.++||||||+++|||++ +..||.+
T Consensus 174 ~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 244 (304)
T cd05096 174 N-LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM--------GKFTTASDVWAFGVTLWEILMLCKEQPYGE 244 (304)
T ss_pred C-ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc--------CCCCchhhhHHHHHHHHHHHHccCCCCCCc
Confidence 8 799999999998543221 1223455788999998753 557889999999999999986 5678877
Q ss_pred CchHHHHHHHHhh-------cCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 139 MSNLQAAYAAAFK-------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 139 ~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
.+..+........ .....+..+++.+.++|.+||+.||.+||++.++.+.|+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 245 LTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 6554433222110 011124567899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=269.47 Aligned_cols=185 Identities=32% Similarity=0.590 Sum_probs=161.7
Q ss_pred EEEEecCCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccc
Q 025244 2 VIVTELLSGGTLRKYLLNMR-----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 76 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~-----~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a 76 (255)
+|++|||+||+|..+|++.+ ...++....+.++.||++|+.||+++++|||||...|+|++.. ..|||+|||+|
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~-r~VKIaDFGlA 849 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER-RVVKIADFGLA 849 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc-CcEEEcccchh
Confidence 79999999999999999852 3459999999999999999999999999999999999999998 69999999999
Q ss_pred ccccccccccc-C--CCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhc
Q 025244 77 REESLTEMMTA-E--TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKN 152 (255)
Q Consensus 77 ~~~~~~~~~~~-~--~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 152 (255)
+.......... . .-...|||||.+. .+.++.++|||||||++||+++ |..||.+.++.+.........
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~--------d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg 921 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLK--------DGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG 921 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHh--------hcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC
Confidence 95443332211 1 2236899999995 3789999999999999999998 899999999999988777777
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 153 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 153 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
..+.+..+|..+.++|..||+.+|++||++..+++.+......
T Consensus 922 RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 922 RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 8888999999999999999999999999999999987766543
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=244.36 Aligned_cols=183 Identities=33% Similarity=0.583 Sum_probs=148.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+.....+++.++..++.|++.||+|||+++++|+||||+||+++.+ +.++++|||+++...
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~dfg~~~~~~ 192 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG-KIVKICDFGLARDIM 192 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCC-CeEEECCCccccccc
Confidence 4799999999999999987554458999999999999999999999999999999999999987 689999999998533
Q ss_pred ccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCC-C
Q 025244 81 LTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVR-P 155 (255)
Q Consensus 81 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~ 155 (255)
... ......++..|+|||.+.. ..++.++||||||+++|||++ |..||.+................ .
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 264 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA 264 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhcc--------CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC
Confidence 221 1122345778999998853 557889999999999999998 99999876654443333332222 2
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
.....++++.+++.+||+.+|++||++.++++.|.+.
T Consensus 265 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 265 QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 3456789999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=252.08 Aligned_cols=175 Identities=28% Similarity=0.382 Sum_probs=139.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 101 ~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~-~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 101 VYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAC 174 (359)
T ss_pred eEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEecCCCccccc
Confidence 379999996 577777743 28889999999999999999999999999999999999988 799999999998644
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc--------
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN-------- 152 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-------- 152 (255)
.........||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+............
T Consensus 175 ~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 175 TNFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred cCccCCCCcccCCCCCchhccC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 4444455678999999999853 567889999999999999999999998765433221111000
Q ss_pred ------------CCC---------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 153 ------------VRP---------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 153 ------------~~~---------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
..+ .....++++.++|.+||..||++|||+.|++++-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 000 0112357789999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=254.20 Aligned_cols=174 Identities=28% Similarity=0.363 Sum_probs=141.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 104 ~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~ 177 (364)
T cd07875 104 VYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAG 177 (364)
T ss_pred EEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCC-CcEEEEeCCCccccC
Confidence 379999995 688888853 28889999999999999999999999999999999999988 799999999998655
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC------
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR------ 154 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------ 154 (255)
.........||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..............
T Consensus 178 ~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 178 TSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CCCcccCCcccCCcCCHHHHhC--------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 4444455688999999999853 56788999999999999999999999877655443332211110
Q ss_pred --------------CC---------------------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 155 --------------PS---------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 155 --------------~~---------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+. ....+..+.++|.+||+.||.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 01124578999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=237.44 Aligned_cols=180 Identities=32% Similarity=0.607 Sum_probs=148.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||.++...
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~-~~~~l~d~g~~~~~~ 153 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED-LVAKVSDFGLAKEAS 153 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCC-CCEEEcccccccccc
Confidence 3799999999999999987665459999999999999999999999999999999999999988 689999999998653
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
... .....+..|+|||.+.. ..++.++|+||||+++|++++ |+.||......+.............+..
T Consensus 154 ~~~--~~~~~~~~~~ape~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd05039 154 QGQ--DSGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEG 223 (256)
T ss_pred ccc--ccCCCcccccCchhhcC--------CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccC
Confidence 222 23345678999998753 456789999999999999997 9999987654443333322222233556
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
+++.+.++|.+||..+|++||++.++++.|++
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 224 CPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 78999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=238.72 Aligned_cols=180 Identities=29% Similarity=0.468 Sum_probs=152.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.+||+|||++....
T Consensus 74 ~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~ 152 (256)
T cd08221 74 LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA-GLIKLGDFGISKILG 152 (256)
T ss_pred EEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC-CCEEECcCcceEEcc
Confidence 4789999999999999987644458999999999999999999999999999999999999988 689999999988543
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
... ......++..|+|||.+.+ ..++.++|+||||+++|||++|..||......+...........+....
T Consensus 153 ~~~~~~~~~~~~~~y~ape~~~~--------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd08221 153 SEYSMAETVVGTPYYMSPELCQG--------VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSV 224 (256)
T ss_pred cccccccccCCCccccCHhhcCC--------CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 322 2345678999999998753 4467789999999999999999999988666655555555555555667
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
++.++.++|.+||..+|.+||++.++++++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 225 YSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 889999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=253.08 Aligned_cols=176 Identities=25% Similarity=0.435 Sum_probs=142.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++.+.+. +++..+..++.|++.||+|||++||+||||||+|||++.+ +.++|+|||+++...
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~-~~vkL~DfG~~~~~~ 152 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLK 152 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEeeccCCcccc
Confidence 4899999999999999986544 8999999999999999999999999999999999999988 799999999986322
Q ss_pred cc------------------------------------cccccCCCccceecccccccccccccccCCCCchhhHHHHHH
Q 025244 81 LT------------------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAI 124 (255)
Q Consensus 81 ~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~ 124 (255)
.. ......+||+.|+|||++.+ ..++.++|+|||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--------~~~~~~~DiwSlGv 224 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--------TGYNKLCDWWSLGV 224 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--------CCCCCcceeccccc
Confidence 11 00124579999999999853 56788999999999
Q ss_pred HHHHHHhCCCCCCCCchHHHHHHHHhhc---CCCCCCCCcHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 025244 125 VLWELLHNKLPFEGMSNLQAAYAAAFKN---VRPSAENVPEELSIILTSCWKEDPNARPN---FTQIIQM 188 (255)
Q Consensus 125 ~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~vl~~ 188 (255)
++|||++|+.||.+.............. ..+....+++++.++|.+++. ||.+|++ +.++++|
T Consensus 225 ilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 225 IMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred eeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 9999999999998876655444433211 122233578999999999874 9999984 6787776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=258.84 Aligned_cols=181 Identities=27% Similarity=0.456 Sum_probs=152.3
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc-c
Q 025244 2 VIVTELLSGGTLRKYLLNMR-PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-E 79 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~-~ 79 (255)
-|.||-++||||.++|+..- +-.-++..+-.+.+||++||.|||++.|+|||||.+|+||+--.|.+||+|||.++. .
T Consensus 648 kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 648 KIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA 727 (1226)
T ss_pred EEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhc
Confidence 47899999999999998753 322378888899999999999999999999999999999987668999999999985 3
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHH-H-HhhcCCCCC
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA-A-AFKNVRPSA 157 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-~-~~~~~~~~~ 157 (255)
+......++.||..|||||++.. ....|+.++|||||||++.||.||++||......+.... + +.+...+.+
T Consensus 728 ginP~TETFTGTLQYMAPEvIDq------G~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iP 801 (1226)
T KOG4279|consen 728 GINPCTETFTGTLQYMAPEVIDQ------GPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIP 801 (1226)
T ss_pred cCCccccccccchhhhChHhhcc------CCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCc
Confidence 44556778999999999999965 345689999999999999999999999976655544432 2 233344557
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..++.+.+.+|.+|+..+|.+||++.+++..
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 7888999999999999999999999999864
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=269.91 Aligned_cols=182 Identities=23% Similarity=0.414 Sum_probs=148.7
Q ss_pred CEEEEecCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-------CCeecCCCCCcEEEeCC-------
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSH-------GIIHRDLKPENLLLTED------- 64 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~-------~i~HrDikp~Nill~~~------- 64 (255)
++|||||+++|+|.++|.... ...+++..++.|+.||+.||.|||+. +|+||||||+||||+.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 479999999999999997632 23499999999999999999999984 49999999999999642
Q ss_pred ---------CCceEEecCccccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 025244 65 ---------LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP 135 (255)
Q Consensus 65 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p 135 (255)
.+.+||+|||++............+||+.|+|||++.. ....++.++|||||||+||||++|+.|
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~g------e~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLH------ETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhc------cCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 13489999999986554444455689999999999853 234578899999999999999999999
Q ss_pred CCCCchHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 136 FEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
|........................+.++.+||..||..+|.+||++.|++.+
T Consensus 243 F~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 243 FHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 98766655555444443333345678999999999999999999999999965
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=244.07 Aligned_cols=179 Identities=25% Similarity=0.422 Sum_probs=146.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++...+...+++..+..++.|++.||.|||++||+||||||+||+++++ +.++|+|||++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 75 LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY-GHIRISDLGLAVKIP 153 (285)
T ss_pred EEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC-CCEEEecCCcceecC
Confidence 3799999999999999987655569999999999999999999999999999999999999988 689999999997544
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---hhcCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA---FKNVRPSA 157 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~ 157 (255)
.........|+..|+|||++.+ ..++.++|+||||+++|+|++|..||.+........... ........
T Consensus 154 ~~~~~~~~~g~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd05632 154 EGESIRGRVGTVGYMAPEVLNN--------QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS 225 (285)
T ss_pred CCCcccCCCCCcCccChHHhcC--------CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccC
Confidence 3333345678999999999853 567889999999999999999999998765443322221 11122234
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPN-----FTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt-----~~~vl~~ 188 (255)
..++.++.+|+..||+.||.+||+ +.+++.+
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 226 AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 568899999999999999999999 7777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=261.37 Aligned_cols=175 Identities=22% Similarity=0.309 Sum_probs=138.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCCCC-------------
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLK------------- 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~-~~i~HrDikp~Nill~~~~~------------- 66 (255)
+++|||++ |++|.+++.+.+. +++..+..++.||+.||.|||+ .||+||||||+|||++.+..
T Consensus 207 ~~iv~~~~-g~~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 207 MCIVMPKY-GPCLLDWIMKHGP--FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred EEEEEecc-CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence 37899999 8999999987644 9999999999999999999998 59999999999999986521
Q ss_pred --ceEEecCccccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHH
Q 025244 67 --TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 144 (255)
Q Consensus 67 --~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~ 144 (255)
.+||+|||.+..... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.
T Consensus 284 ~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~--------~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 284 PCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLG--------LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred CceEEECCCCccccCcc--ccccccCCccccCcHHhhc--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 489999998864322 2345689999999999863 5678899999999999999999999987665443
Q ss_pred HHHHHhhcC-------------------------CCC----------------CCCCcHHHHHHHHHhcccCCCCCCCHH
Q 025244 145 AYAAAFKNV-------------------------RPS----------------AENVPEELSIILTSCWKEDPNARPNFT 183 (255)
Q Consensus 145 ~~~~~~~~~-------------------------~~~----------------~~~~~~~l~~li~~~l~~~p~~Rpt~~ 183 (255)
......... .+. .....+.+.+||.+||..||.+|||++
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 322211100 000 001135678999999999999999999
Q ss_pred HHHHH
Q 025244 184 QIIQM 188 (255)
Q Consensus 184 ~vl~~ 188 (255)
|+++|
T Consensus 434 e~L~H 438 (467)
T PTZ00284 434 QMTTH 438 (467)
T ss_pred HHhcC
Confidence 99997
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=235.72 Aligned_cols=180 Identities=31% Similarity=0.567 Sum_probs=146.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++|++|.+++..... .+++..++.++.|++.+|.|||++|++||||||+||+++.+ +.++|+|||++....
T Consensus 67 ~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~ 144 (250)
T cd05085 67 IYIVMELVPGGDFLSFLRKKKD-ELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSRQED 144 (250)
T ss_pred cEEEEECCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC-CeEEECCCccceecc
Confidence 4799999999999999976443 38899999999999999999999999999999999999988 689999999987533
Q ss_pred ccccc--ccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
..... ....++..|+|||++.. ..++.++|+||||+++|++++ |..||.+...................
T Consensus 145 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 216 (250)
T cd05085 145 DGIYSSSGLKQIPIKWTAPEALNY--------GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCP 216 (250)
T ss_pred ccccccCCCCCCcccccCHHHhcc--------CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 22111 12234567999998853 457789999999999999998 99999876655444433333333345
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
..++..+.+++.+||+.+|++||++.++++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 668899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=252.17 Aligned_cols=174 Identities=28% Similarity=0.374 Sum_probs=140.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 97 ~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~-~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 97 VYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAG 170 (355)
T ss_pred eEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCC-CCEEEeeCcccccCC
Confidence 379999996 578887753 28889999999999999999999999999999999999988 799999999998655
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC------
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR------ 154 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------ 154 (255)
.........||..|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+...........
T Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 171 TSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred CccccCCccccCCccCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 4444455689999999999853 45788999999999999999999999876644332221111000
Q ss_pred -------------------------------C----CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 155 -------------------------------P----SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 155 -------------------------------~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+ .....+.++.++|.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 011235678999999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=238.04 Aligned_cols=182 Identities=34% Similarity=0.551 Sum_probs=150.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||+++++|.+++.......+++.++..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||.+....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~ 153 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLARVIE 153 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCCcceeecc
Confidence 3799999999999999987655558889999999999999999999999999999999999988 699999999987543
Q ss_pred cccc--cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
.... .....++..|+|||++.. ..++.++|+||||+++|++++ |..||.+.+..............+..
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP 225 (260)
T ss_pred CCCcccccCCcccccccCHhHhcc--------CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCc
Confidence 2211 122345677999998853 557889999999999999998 99999886655544444433333445
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
...+.++.+++.+||+.+|++||++.++++.|..
T Consensus 226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 6788999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=252.34 Aligned_cols=178 Identities=25% Similarity=0.398 Sum_probs=138.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+.. ..++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 147 ~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 147 IQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA-KNVKIADFGVSRILA 219 (353)
T ss_pred EEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEcccccceecc
Confidence 47999999999986532 25677888999999999999999999999999999999988 799999999998543
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHHhhcCCCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ---AAYAAAFKNVRPS 156 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~ 156 (255)
.. .......||..|+|||++.... ......+.++|||||||++|||++|+.||......+ .............
T Consensus 220 ~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 296 (353)
T PLN00034 220 QTMDPCNSSVGTIAYMSPERINTDL---NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEA 296 (353)
T ss_pred cccccccccccCccccCcccccccc---ccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCC
Confidence 22 2234567999999999874311 012334568999999999999999999997432211 1111222222333
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...++.++.+||.+||+.||++||++.|++++
T Consensus 297 ~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 297 PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 56788999999999999999999999999997
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=241.15 Aligned_cols=184 Identities=32% Similarity=0.576 Sum_probs=147.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEec
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 72 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~D 72 (255)
.++||||++||+|.+++.+... ...+...+..++.|++.||.|||+++++||||||+||+++.+ +.++|+|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~-~~~~L~D 162 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD-FTVKIGD 162 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC-CcEEECc
Confidence 4799999999999999986421 224667888999999999999999999999999999999988 6999999
Q ss_pred Ccccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHH
Q 025244 73 FGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAA 148 (255)
Q Consensus 73 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~ 148 (255)
||+++...... ......++..|+|||.+.+ ..++.++|+||||+++|||++ |..||.+....+.....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--------GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhcc--------CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99987432221 1122345678999998753 557889999999999999998 78899876665544433
Q ss_pred HhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 025244 149 AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 193 (255)
Q Consensus 149 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~ 193 (255)
............+..+.+++.+||+.||++||++.++++.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 333333445567899999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=237.29 Aligned_cols=181 Identities=30% Similarity=0.552 Sum_probs=148.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+++++|.+++.+.....+++..++.++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||+++...
T Consensus 70 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~ 148 (257)
T cd05040 70 LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD-DKVKIGDFGLMRALP 148 (257)
T ss_pred EEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC-CEEEecccccccccc
Confidence 4799999999999999987653458999999999999999999999999999999999999988 799999999998543
Q ss_pred ccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhc-CC
Q 025244 81 LTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKN-VR 154 (255)
Q Consensus 81 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~-~~ 154 (255)
... ......++..|+|||.+.. ..++.++|+||||+++|||++ |..||......+......... ..
T Consensus 149 ~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 220 (257)
T cd05040 149 QNEDHYVMEEHLKVPFAWCAPESLRT--------RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL 220 (257)
T ss_pred ccccceecccCCCCCceecCHHHhcc--------cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC
Confidence 321 1123456789999998753 567889999999999999998 999998766655444433222 22
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 155 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 155 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
+.....+..+.+++.+||+.+|.+||++.++++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 234567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=247.16 Aligned_cols=183 Identities=22% Similarity=0.362 Sum_probs=145.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++.+... .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~-~~~kL~DfG~a~~~~ 153 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLM 153 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEeecchheecc
Confidence 4799999999999999987433 38999999999999999999999999999999999999988 699999999987533
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC---C
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR---P 155 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---~ 155 (255)
... .....+||+.|+|||++.... .....++.++|||||||++|||++|+.||.+.+..+........... +
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p 230 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAME---DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 230 (332)
T ss_pred cCCcceecccccCccccCHHHHhccc---cCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCC
Confidence 221 223457999999999985311 01245788999999999999999999999887665555444332211 1
Q ss_pred -CCCCCcHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 025244 156 -SAENVPEELSIILTSCWKEDPNA--RPNFTQIIQM 188 (255)
Q Consensus 156 -~~~~~~~~l~~li~~~l~~~p~~--Rpt~~~vl~~ 188 (255)
....++.++.++|++||..++.+ |+++.+++++
T Consensus 231 ~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 231 AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 13467899999999999665544 6899999987
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=237.85 Aligned_cols=182 Identities=34% Similarity=0.540 Sum_probs=150.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+.....+++..+..++.+++.||.|||++|++|+||||+||+++.+ +.++|+|||+++...
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~ 154 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN-LVCKIADFGLARLIE 154 (261)
T ss_pred eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCC-CCEEECccccceecc
Confidence 4799999999999999987665569999999999999999999999999999999999999988 799999999987543
Q ss_pred cccc--cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
.... .....++..|+|||.+.+ ..++.++|+||||+++|++++ |+.||.+................+.+
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 226 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANY--------GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRP 226 (261)
T ss_pred chhhhhhhccCCCccccCHHHhcc--------CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 2211 112234568999998853 457789999999999999998 99999876655544444443344556
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
...+.++.+++.+||+.+|++||+++++++.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 6778999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=240.94 Aligned_cols=180 Identities=28% Similarity=0.497 Sum_probs=142.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+++++|.+++.... +++..++.++.|++.||.|||++|++||||||+||+++++ +.++|+|||+++...
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~~---l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~ 158 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVP 158 (283)
T ss_pred EEEEecCCCCCCHHHHHHHcC---CCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCC-CcEEEeecccccccC
Confidence 379999999999999997643 9999999999999999999999999999999999999988 699999999998543
Q ss_pred cccc----cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHH-------------
Q 025244 81 LTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ------------- 143 (255)
Q Consensus 81 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~------------- 143 (255)
.... .....++..|+|||.+.. ..++.++||||||+++|||++|..||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKE--------NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV 230 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcc--------cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccch
Confidence 2211 122345667999998753 457789999999999999999999986432110
Q ss_pred -HHHH-HHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 144 -AAYA-AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 144 -~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
.... .......+.+..++.++.+++.+||+.+|++||++.++++.|+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 0000 001111223456789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=237.38 Aligned_cols=184 Identities=30% Similarity=0.545 Sum_probs=151.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||+++|+|.+++..... .+++..++.++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~ 158 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSP-DCVKLGDFGLSRYLE 158 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecC-CCeEEccCceeeecc
Confidence 3799999999999999986443 48999999999999999999999999999999999999987 699999999987543
Q ss_pred cccc--cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
.... .....++..|+|||.+.. ..++.++|+||||+++||+++ |..||.+....+...........+.+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMP 230 (270)
T ss_pred cccceecCCCCccccccChhhhcc--------CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 3221 112234568999998753 457889999999999999986 99999887765555444444444556
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
..++..+.++|.+|+..+|.+||++.++++.|.+...
T Consensus 231 ~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 231 PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 7789999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=251.71 Aligned_cols=161 Identities=30% Similarity=0.558 Sum_probs=129.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccccc---ccccCCCccceeccccc
Q 025244 24 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELY 100 (255)
Q Consensus 24 ~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~ 100 (255)
.+++..++.++.|++.||+|||+++++||||||+|||++.+ +.+||+|||+++...... ......++..|+|||++
T Consensus 233 ~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~ 311 (400)
T cd05105 233 GLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI 311 (400)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC-CEEEEEeCCcceeccccccccccCCcCCCcceEChhhh
Confidence 37788889999999999999999999999999999999988 689999999998533221 12233567889999988
Q ss_pred ccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhc-CCCCCCCCcHHHHHHHHHhcccCCCC
Q 025244 101 STVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKN-VRPSAENVPEELSIILTSCWKEDPNA 178 (255)
Q Consensus 101 ~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~ 178 (255)
.+ ..++.++||||||+++|||++ |..||................ ..+....++.++.+++.+||+.||++
T Consensus 312 ~~--------~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 383 (400)
T cd05105 312 FD--------NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEK 383 (400)
T ss_pred cC--------CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhH
Confidence 53 557889999999999999997 999998765444333333322 23345678899999999999999999
Q ss_pred CCCHHHHHHHHHHhH
Q 025244 179 RPNFTQIIQMLLNYL 193 (255)
Q Consensus 179 Rpt~~~vl~~l~~~~ 193 (255)
||++.++.+.|...+
T Consensus 384 RPt~~~l~~~l~~l~ 398 (400)
T cd05105 384 RPSFLHLSDIVESLL 398 (400)
T ss_pred CcCHHHHHHHHHHHc
Confidence 999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=263.52 Aligned_cols=185 Identities=30% Similarity=0.564 Sum_probs=166.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++||+|||++|+|+.+|+++.++ |+..+...+++.|+.|+.||.++|++||||...|||++.+. .+||+|||++|...
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnL-vCKVsDFGLSRvle 782 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLE 782 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccce-EEEeccccceeecc
Confidence 57999999999999999988765 99999999999999999999999999999999999999985 89999999999543
Q ss_pred ccc--ccccCCC--ccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCC
Q 025244 81 LTE--MMTAETG--TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~~~--~~~~~~g--t~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
.+. ..++..| ..+|.|||.+.. ..++.++||||+|++|||.++ |..||.++++.+....+......|
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~--------RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLP 854 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLP 854 (996)
T ss_pred cCCCccccccCCccceeecChhHhhh--------cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCC
Confidence 222 2223323 468999999964 678999999999999999876 999999999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
.+.++|..|.+|+..||++|..+||.+.||+..|.++++.
T Consensus 855 pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 855 PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 9999999999999999999999999999999999998764
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=237.66 Aligned_cols=182 Identities=30% Similarity=0.546 Sum_probs=148.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... .+++.++..++.|++.||+|||++|++||||||+||+++.+ +.++++|||+++...
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~-~~~~l~dfg~~~~~~ 157 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN-LVCKVSDFGLSRVLE 157 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCC-CeEEeCCCCcccccc
Confidence 4799999999999999987543 38999999999999999999999999999999999999988 689999999998543
Q ss_pred cccc----cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCC
Q 025244 81 LTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
.... .....++..|++||.+.+ ..++.++|+||||+++||+++ |..||.+....+...........+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~ 229 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP 229 (267)
T ss_pred cccceeeecCCCccceeecCHhHhcc--------CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCC
Confidence 2211 112233568999998853 557889999999999999886 999998766555444443333344
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
....++..+.+++.+||+.+|.+||++.++++.|.+.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 230 APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 4567889999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=238.26 Aligned_cols=181 Identities=31% Similarity=0.610 Sum_probs=146.7
Q ss_pred CEEEEecCCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC-----ceEE
Q 025244 1 MVIVTELLSGGTLRKYLLNMR-----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK-----TIKL 70 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~-----~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~-----~~kl 70 (255)
.++||||++|++|.+++.+.. ...+++.+++.++.|++.||+|||+++++|+||||+||+++.+ + .+++
T Consensus 74 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~~~~~~l 152 (269)
T cd05044 74 QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEK-GYDADRVVKI 152 (269)
T ss_pred eEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecC-CCCCCcceEE
Confidence 479999999999999997642 2337889999999999999999999999999999999999876 4 7999
Q ss_pred ecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHH
Q 025244 71 ADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAY 146 (255)
Q Consensus 71 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~ 146 (255)
+|||+++...... ......++..|+|||.+.+ ..++.++||||||+++|||++ |..||......+...
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~ 224 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD--------GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ 224 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHcc--------CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHH
Confidence 9999987533221 1122345678999998853 557889999999999999998 999998766555444
Q ss_pred HHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 147 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 147 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
.............++..+.++|.+||..+|.+||++.++++.|+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 225 HVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 33333333345678899999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=237.73 Aligned_cols=182 Identities=30% Similarity=0.539 Sum_probs=147.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++....+ .+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~-~~~kl~dfg~~~~~~ 157 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLE 157 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCC-CcEEECCCccccccc
Confidence 4799999999999999986543 48999999999999999999999999999999999999987 689999999987432
Q ss_pred ccccc---ccC---CCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcC
Q 025244 81 LTEMM---TAE---TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNV 153 (255)
Q Consensus 81 ~~~~~---~~~---~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 153 (255)
..... ... ..+..|+|||.+.. ..++.++||||||+++||+++ |..||...+..+..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~ 229 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR 229 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhcc--------CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 22111 111 12457999998853 557889999999999999886 9999987766555444433334
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 154 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 154 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
.+....++..+.+++.+||..+|++||++.+++..|++.
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 455667889999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=243.76 Aligned_cols=179 Identities=24% Similarity=0.369 Sum_probs=142.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++...+. .+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++...
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 79 LTLVFEYLD-KDLKQYMDDCGN-IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKS 155 (309)
T ss_pred EEEEEeCCC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECccccceecC
Confidence 479999996 589998876543 38899999999999999999999999999999999999988 799999999997533
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC------
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV------ 153 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~------ 153 (255)
.. .......++..|+|||++.+ ...++.++||||||+++|+|++|+.||.+.+..+..........
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 228 (309)
T cd07872 156 VPTKTYSNEVVTLWYRPPDVLLG-------SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEET 228 (309)
T ss_pred CCccccccccccccccCCHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 22 22234568899999998753 24578899999999999999999999987655433322211100
Q ss_pred --------------CC---------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 154 --------------RP---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 154 --------------~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
.+ ....+++++.++|.+||+.||.+|||+.+++++-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 229 WPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred HhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 00 1134678999999999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=236.51 Aligned_cols=176 Identities=23% Similarity=0.418 Sum_probs=140.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC-------ceEEecC
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK-------TIKLADF 73 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~-------~~kl~Df 73 (255)
.++||||+++|+|.+++...+. .+++..++.++.|++.||+|||++|++||||||+||+++.+.. .++++||
T Consensus 74 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred cEEEEecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccc
Confidence 4799999999999999987543 4899999999999999999999999999999999999987632 2699999
Q ss_pred ccccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCchHHHHHHHHhhc
Q 025244 74 GLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNK-LPFEGMSNLQAAYAAAFKN 152 (255)
Q Consensus 74 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~-~p~~~~~~~~~~~~~~~~~ 152 (255)
|++..... .....++..|+|||++.. ...++.++|+||||+++|||++|. .||...+...... ....
T Consensus 153 g~~~~~~~---~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~--~~~~ 220 (258)
T cd05078 153 GISITVLP---KEILLERIPWVPPECIEN-------PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ--FYED 220 (258)
T ss_pred ccccccCC---chhccccCCccCchhccC-------CCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH--HHHc
Confidence 98875332 233567889999999853 244678999999999999999984 6665544433222 1222
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 153 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 153 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
....+...+.++.++|.+||+.||++||+++++++.|
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 221 RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 2233445668999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=238.22 Aligned_cols=177 Identities=28% Similarity=0.497 Sum_probs=146.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++...+. +++..+..++.|++.||+|||++|++||||+|+||+++.+ +.++|+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~-~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK-GGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCC-CCEEecccCCCcccc
Confidence 4799999999999999987644 8899999999999999999999999999999999999988 689999999987543
Q ss_pred ccc-------ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC
Q 025244 81 LTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 153 (255)
Q Consensus 81 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 153 (255)
... ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+...............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 229 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQ--------TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS 229 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhcc--------CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC
Confidence 111 1123457889999998853 4567899999999999999999999987665554444333333
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 154 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 154 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...+..++..+.++|.+||+.||.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 230 PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 33456788999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=237.60 Aligned_cols=184 Identities=26% Similarity=0.526 Sum_probs=151.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+++|+|.+++.+.... +++..++.++.|++.||+|||+.|++||||||+||+++.+ +.+||+|||+++...
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~-~~~kL~dfg~~~~~~ 160 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDN-IGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLD 160 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCC-CeEEECCCccccccc
Confidence 47999999999999999875433 8999999999999999999999999999999999999987 689999999998543
Q ss_pred ccccc---ccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCC
Q 025244 81 LTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPS 156 (255)
Q Consensus 81 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 156 (255)
..... ....++..|+|||.+.. ..++.++|+||||+++||+++ |+.||.+....+...........+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILH--------RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ 232 (279)
T ss_pred CcccceecCCCcccccccCHHHhhc--------CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC
Confidence 22211 11223568999998742 557789999999999999998 9999988765554444443333444
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
+...+.++.+++.+||..||++||++.++++.|.....
T Consensus 233 ~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 233 PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 56678999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=252.63 Aligned_cols=184 Identities=28% Similarity=0.445 Sum_probs=160.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
|+|+.|||.||.+...+-..+. .+++.++.-+++|++.||.|||+++|||||||..|||++-+ |.++|+|||.+....
T Consensus 104 LwiliEFC~GGAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tld-GdirLADFGVSAKn~ 181 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLD-GDIRLADFGVSAKNK 181 (1187)
T ss_pred eEEEEeecCCchHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEec-CcEeeecccccccch
Confidence 5899999999999999887654 49999999999999999999999999999999999999999 799999999876433
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC--CC
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--SA 157 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~ 157 (255)
. .....++.||+.|||||+..+... ....|+.++||||||++|.||..+.+|....+.+.....+....... .+
T Consensus 182 ~t~qkRDsFIGTPYWMAPEVvmCET~---KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqP 258 (1187)
T KOG0579|consen 182 STRQKRDSFIGTPYWMAPEVVMCETF---KDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQP 258 (1187)
T ss_pred hHHhhhccccCCcccccchheeeccc---cCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCc
Confidence 2 233467899999999999876543 45678999999999999999999999999999888888776654432 36
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
..|+..+.+|+.+||.+||..||++.++++|-
T Consensus 259 S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 259 SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred chhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 78999999999999999999999999999873
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=278.43 Aligned_cols=180 Identities=29% Similarity=0.414 Sum_probs=150.0
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
+|.||||+||+|.+++...+- .++.....+..|++.|++|||+.|||||||||+||+++.+ |.+|++|||.|+....
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri--~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRI--EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN-GLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcch--hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC-CcEEeecccceeEecC
Confidence 567999999999999986543 5566667788999999999999999999999999999998 7999999999985433
Q ss_pred c-----cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch-HHHHHHHHhhcCCC
Q 025244 82 T-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN-LQAAYAAAFKNVRP 155 (255)
Q Consensus 82 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~ 155 (255)
. .......||+.|||||++.+.. ...-..++||||||||+.||+||+.||...++ .+..+.+.......
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~-----~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTK-----GKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ 1461 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccc-----cCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC
Confidence 2 2234568999999999997632 23345699999999999999999999976553 45666666666666
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
.+..++++-+++|..||..||++|.++.|++++-
T Consensus 1462 ~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1462 IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 6778999999999999999999999999999874
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=241.52 Aligned_cols=184 Identities=24% Similarity=0.400 Sum_probs=147.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+++|+|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++....
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~-~~~~l~dfg~~~~~~ 172 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCcchhhhh
Confidence 3799999999999999987655558898899999999999999999999999999999999988 689999999987543
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-CCCCC
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-RPSAE 158 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~ 158 (255)
. ........|+..|+|||.+.... .....++.++|+||||+++|||++|..||................. .....
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~l~~~~---~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 249 (282)
T cd06636 173 RTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSK 249 (282)
T ss_pred ccccCCCcccccccccCHhhcCccc---CcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccc
Confidence 2 12234467899999999875311 1134567899999999999999999999976654443333222211 11234
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 159 NVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 159 ~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.++.++.++|.+||+.||.+||++.+++++
T Consensus 250 ~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 678999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=246.38 Aligned_cols=177 Identities=23% Similarity=0.400 Sum_probs=140.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~-~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
++|||||++||+|.+++...+. +++..+..++.+++.||.|||++ +++||||||+|||++.+ +.+||+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~ 154 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQL 154 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCC-CCEEEeeCCcchhh
Confidence 4799999999999999987543 88999999999999999999985 79999999999999988 68999999998753
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-----------
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA----------- 148 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~----------- 148 (255)
... ......|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||......+.....
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (333)
T cd06650 155 IDS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES 225 (333)
T ss_pred hhh-ccccCCCCccccCHHHhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccc
Confidence 222 2244578999999999853 45788999999999999999999999754432221100
Q ss_pred --------------------------------HhhcCCCC--CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 149 --------------------------------AFKNVRPS--AENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 149 --------------------------------~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
......+. ....+.++.+||.+||+.||++||++.+++++-
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~ 300 (333)
T cd06650 226 ETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA 300 (333)
T ss_pred ccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCH
Confidence 00001111 123568899999999999999999999999873
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=239.56 Aligned_cols=183 Identities=30% Similarity=0.430 Sum_probs=147.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++|++|.+++.+.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||++....
T Consensus 77 ~~~v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~ 154 (282)
T cd06643 77 LWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNT 154 (282)
T ss_pred EEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC-CCEEEcccccccccc
Confidence 379999999999999887533 348999999999999999999999999999999999999988 799999999987533
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC--CCCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--RPSA 157 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~ 157 (255)
.. .......++..|+|||++.... .....++.++|+|||||++|||++|++||...+..+.......... ...+
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd06643 155 RTIQRRDSFIGTPYWMAPEVVMCET---SKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQP 231 (282)
T ss_pred ccccccccccccccccCHhhccccC---CCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCc
Confidence 22 2234457899999999875311 1234567899999999999999999999987766555444433222 1234
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..++.++.++|.+||+.||.+||++.+++++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 5678999999999999999999999999886
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=241.03 Aligned_cols=178 Identities=24% Similarity=0.378 Sum_probs=143.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..++. +++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++....
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~-~~~~l~dfg~~~~~~ 148 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFS 148 (279)
T ss_pred EEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC-CCEEEccCCcceecc
Confidence 3799999999999999987554 9999999999999999999999999999999999999988 699999999987543
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHHhhcCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ--AAYAAAFKNVRPSAE 158 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~ 158 (255)
... .....|+..|+|||.+.. +..++.++|+||+||++|+|++|..||....... .............+.
T Consensus 149 ~~~-~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 220 (279)
T cd05633 149 KKK-PHASVGTHGYMAPEVLQK-------GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPD 220 (279)
T ss_pred ccC-ccCcCCCcCccCHHHhcC-------CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCcc
Confidence 222 234578999999998742 2456789999999999999999999997543211 111111122222355
Q ss_pred CCcHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 025244 159 NVPEELSIILTSCWKEDPNARP-----NFTQIIQML 189 (255)
Q Consensus 159 ~~~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~l 189 (255)
.++.++.++|.+||..||.+|| ++.++++|.
T Consensus 221 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 221 SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 6889999999999999999999 599998873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=238.94 Aligned_cols=182 Identities=24% Similarity=0.462 Sum_probs=142.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||+++...
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~-~~~~l~dfg~~~~~~ 160 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIE 160 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCC-CCEEECCCccccccc
Confidence 3799999999999999976533 48999999999999999999999999999999999999988 689999999998543
Q ss_pred ccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCc--------------hH
Q 025244 81 LTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS--------------NL 142 (255)
Q Consensus 81 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~--------------~~ 142 (255)
... ......++..|+|||++.+ ..++.++|+||||+++|||++++.|..... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQ--------SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV 232 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhcc--------CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccH
Confidence 221 1223456778999998753 457789999999999999999876543211 00
Q ss_pred HHHHH-HHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 143 QAAYA-AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 143 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
..... .......+....++..+.+|+.+||+.||++||++.++++.++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 233 TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111 111222334566889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=242.13 Aligned_cols=176 Identities=30% Similarity=0.518 Sum_probs=144.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+. .+++.++..++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++....
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~-~~~kl~dfg~~~~~~ 167 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQIT 167 (296)
T ss_pred EEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEECccccchhcc
Confidence 47999999999999999653 38899999999999999999999999999999999999988 699999999987533
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC--CCC
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSA 157 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~ 157 (255)
... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.................. +.+
T Consensus 168 ~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T cd06654 168 PEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239 (296)
T ss_pred ccccccCcccCCccccCHHHHcC--------CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCc
Confidence 221 2234578899999998853 45678999999999999999999999876654443333222111 224
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..++..+.++|.+||..+|++||++.+++++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 5678899999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=249.59 Aligned_cols=176 Identities=24% Similarity=0.352 Sum_probs=136.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++|||++ +++|.+++..... +++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 158 ~~lv~e~~-~~~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~-~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 158 TCLILPRY-KTDLYCYLAAKRN--IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP-GDVCLGDFGAACFPV 233 (391)
T ss_pred eEEEEecC-CCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCC-CCEEEEeCCcccccc
Confidence 37899999 5899999976543 8999999999999999999999999999999999999988 799999999997422
Q ss_pred c--ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch-------HHHHHHHH--
Q 025244 81 L--TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN-------LQAAYAAA-- 149 (255)
Q Consensus 81 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~-------~~~~~~~~-- 149 (255)
. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ........
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~ 305 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLAR--------DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR 305 (391)
T ss_pred cccccccccccCccCCCChhhhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH
Confidence 1 122345679999999999853 5678899999999999999999987643221 00000000
Q ss_pred ------------------------hh-cCCCC-------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 150 ------------------------FK-NVRPS-------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 150 ------------------------~~-~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.. ...+. ...++.++.++|.+||+.||.+|||+.|++++
T Consensus 306 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 306 SGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00 00000 11346789999999999999999999999987
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=240.50 Aligned_cols=176 Identities=30% Similarity=0.459 Sum_probs=143.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++|++|.+++... .+++.+++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++....
T Consensus 94 ~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kL~dfg~~~~~~ 169 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD-GRIKLSDFGFCAQVS 169 (292)
T ss_pred EEEEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEccCcchhhcc
Confidence 37999999999999988643 28999999999999999999999999999999999999988 699999999987432
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc--CCCCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN--VRPSA 157 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~ 157 (255)
.. .......|+..|+|||.+.. ..++.++|+||||+++|||++|+.||...+............ ..+..
T Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 241 (292)
T cd06658 170 KEVPKRKSLVGTPYWMAPEVISR--------LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDS 241 (292)
T ss_pred cccccCceeecCccccCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccc
Confidence 22 12234568899999998853 457789999999999999999999998766554433322211 11223
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...+..+.+++.+||..||.+|||+.+++++
T Consensus 242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 4578899999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=243.60 Aligned_cols=162 Identities=30% Similarity=0.559 Sum_probs=128.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccccc---ccccCCCccceecccccc
Q 025244 25 LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYS 101 (255)
Q Consensus 25 ~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~ 101 (255)
+++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++....... ......++..|+|||++.
T Consensus 176 ~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 254 (343)
T cd05103 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 254 (343)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC-CcEEEEecccccccccCcchhhcCCCCCCcceECcHHhc
Confidence 6778889999999999999999999999999999999988 699999999987532211 112234567899999875
Q ss_pred cccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhc-CCCCCCCCcHHHHHHHHHhcccCCCCC
Q 025244 102 TVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKN-VRPSAENVPEELSIILTSCWKEDPNAR 179 (255)
Q Consensus 102 ~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R 179 (255)
. ..++.++|+||||+++|+|++ |..||................ ..+.+...++++.+++.+||+.||.+|
T Consensus 255 ~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~R 326 (343)
T cd05103 255 D--------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 326 (343)
T ss_pred C--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 3 567889999999999999996 999998755433333322222 223344567899999999999999999
Q ss_pred CCHHHHHHHHHHhHhh
Q 025244 180 PNFTQIIQMLLNYLSA 195 (255)
Q Consensus 180 pt~~~vl~~l~~~~~~ 195 (255)
|++.+++++|+..++.
T Consensus 327 ps~~eil~~l~~~~~~ 342 (343)
T cd05103 327 PTFSELVEHLGNLLQA 342 (343)
T ss_pred cCHHHHHHHHHHHHhc
Confidence 9999999999887653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=249.00 Aligned_cols=178 Identities=30% Similarity=0.428 Sum_probs=142.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+. ++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.+ +.+||+|||+++...
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN-CVLKICDFGLARVEE 154 (372)
T ss_pred EEEEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC-CCEEeccccceeecc
Confidence 479999995 78999887544 39999999999999999999999999999999999999988 799999999998543
Q ss_pred cc--cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh-------
Q 025244 81 LT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK------- 151 (255)
Q Consensus 81 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~------- 151 (255)
.. .......++..|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..+........
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 227 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMG-------SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLE 227 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcC-------CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 22 22234568899999998853 244688999999999999999999999876654433222110
Q ss_pred ----------------cCC--------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 152 ----------------NVR--------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 152 ----------------~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
... ......++++.++|.+||+.||.+|||+.+++++-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 000 11234578899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=239.43 Aligned_cols=181 Identities=27% Similarity=0.425 Sum_probs=143.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+++++|.+++.+... +++..+..++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||+++...
T Consensus 81 ~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~ 157 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDN-GDVKLADFGVAAKIT 157 (267)
T ss_pred EEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEECcCccceeec
Confidence 3789999999999999976543 8999999999999999999999999999999999999988 689999999998543
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC----
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---- 155 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---- 155 (255)
.. .......|+..|+|||.+... ....++.++|+||||+++|||++|+.||..................+
T Consensus 158 ~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd06646 158 ATIAKRKSFIGTPYWMAPEVAAVE-----KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLK 232 (267)
T ss_pred ccccccCccccCccccCHhHcccc-----cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCc
Confidence 22 122345688999999987421 12446779999999999999999999997654433322221111111
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
....++..+.++|.+||+.+|++||+++++++++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1235688999999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=243.65 Aligned_cols=184 Identities=23% Similarity=0.370 Sum_probs=143.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+... .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLL 153 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCC-CCEEEEECCceeecC
Confidence 4899999999999999986433 38999999999999999999999999999999999999988 799999999987543
Q ss_pred cccc--cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC----C
Q 025244 81 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV----R 154 (255)
Q Consensus 81 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~----~ 154 (255)
.... .....||+.|+|||++.... .....++.++|||||||++|+|++|+.||.+.+..+.......... .
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 230 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQAME---DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP 230 (331)
T ss_pred CCCCccccceeccccccCHHHHhhcc---ccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCC
Confidence 3221 22346899999999985311 0124567899999999999999999999987665544433332211 1
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 025244 155 PSAENVPEELSIILTSCWKEDPNA--RPNFTQIIQML 189 (255)
Q Consensus 155 ~~~~~~~~~l~~li~~~l~~~p~~--Rpt~~~vl~~l 189 (255)
+....++..++++|++||..++.+ |+++.+++++-
T Consensus 231 ~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 231 PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 223457899999999988654443 78999999883
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=237.23 Aligned_cols=180 Identities=27% Similarity=0.428 Sum_probs=144.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++...+. +++.+++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~ 157 (267)
T cd06645 81 LWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDN-GHVKLADFGVSAQIT 157 (267)
T ss_pred EEEEEeccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECcceeeeEcc
Confidence 3799999999999999976554 9999999999999999999999999999999999999988 689999999987543
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC---
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--- 156 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 156 (255)
.. .......|+..|+|||++... ....++.++|+|||||++|+|++|..||..................+.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd06645 158 ATIAKRKSFIGTPYWMAPEVAAVE-----RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK 232 (267)
T ss_pred CcccccccccCcccccChhhhccc-----cCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccc
Confidence 22 122345789999999987421 134567899999999999999999999976554443333222222221
Q ss_pred -CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 -AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...++..+.++|.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 23567899999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=233.17 Aligned_cols=180 Identities=34% Similarity=0.596 Sum_probs=145.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++|++|.+++.+... .+++..+..++.+++.||+|||+++++||||||+||+++.+ +.++|+|||++....
T Consensus 67 ~~~v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~ 144 (251)
T cd05041 67 IYIVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSREEE 144 (251)
T ss_pred eEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC-CcEEEeecccccccc
Confidence 4799999999999999976433 38899999999999999999999999999999999999988 699999999997543
Q ss_pred ccccc---ccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCC
Q 025244 81 LTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPS 156 (255)
Q Consensus 81 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 156 (255)
..... ....++..|+|||.+.+ ..++.++|+||||+++|||++ |..||..................+.
T Consensus 145 ~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~ 216 (251)
T cd05041 145 GGIYTVSDGLKQIPIKWTAPEALNY--------GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA 216 (251)
T ss_pred CCcceeccccCcceeccCChHhhcc--------CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCC
Confidence 21111 12234567999998753 457889999999999999998 8899977665444333333323334
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
+...+..+.+++.+||..+|++||++.++++.|.
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 5677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=248.59 Aligned_cols=183 Identities=32% Similarity=0.521 Sum_probs=141.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG---IIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
.+||+||+++|+|.++|.......++|..+++|+.+++.||+|||... |+|||||++|||+|++ ..+||+|||+|+
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFGLa~ 225 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFGLAK 225 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCccCcc
Confidence 379999999999999999765325899999999999999999999864 9999999999999998 599999999997
Q ss_pred cccc-ccccccC-CCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCc--hH--HHHHH-HHh
Q 025244 78 EESL-TEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS--NL--QAAYA-AAF 150 (255)
Q Consensus 78 ~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~--~~--~~~~~-~~~ 150 (255)
.... .....+. .||.+|+|||.+.. +..+.++|||||||+|+|+++|+.+.+... .. ...+. ...
T Consensus 226 ~~~~~~~~~~~~~~gt~gY~~PEy~~~--------g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 226 LGPEGDTSVSTTVMGTFGYLAPEYAST--------GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred cCCccccceeeecCCCCccCChhhhcc--------CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 6543 3333333 89999999999853 678889999999999999999998876422 11 11111 111
Q ss_pred h------cCCCCC--CCCc-----HHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 151 K------NVRPSA--ENVP-----EELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 151 ~------~~~~~~--~~~~-----~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
. ...+.. ...+ ..+..+..+|++.+|.+||+|.||++.|+..
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 1 111111 2222 2356688899999999999999999988544
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=236.09 Aligned_cols=185 Identities=28% Similarity=0.530 Sum_probs=149.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 74 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg 74 (255)
.++++||+++++|.+++..... ..+++..++.++.|++.||+|||+++++||||||+||+++.+ +.+||+|||
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~-~~~kl~d~g 162 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE-LQVKITDNA 162 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCC-CcEEECCCC
Confidence 3789999999999999976432 348999999999999999999999999999999999999988 699999999
Q ss_pred cccccccccc---cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHh
Q 025244 75 LAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAF 150 (255)
Q Consensus 75 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~ 150 (255)
+++....... .....++..|+|||++.. ..++.++||||||+++||+++ |+.||......+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 234 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVN--------KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD 234 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhc--------CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc
Confidence 9985332211 122345778999998853 457889999999999999998 9999987655443333222
Q ss_pred hcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 151 KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 151 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
.........+++++.+++.+||..||++||++.++++.|.+...
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 22223345678999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=234.91 Aligned_cols=176 Identities=23% Similarity=0.389 Sum_probs=138.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC------ceEEecCc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK------TIKLADFG 74 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~------~~kl~Dfg 74 (255)
.++||||+++|+|..++..... .+++..++.++.|++.||+|||++|++||||||+|||++.+.. .++++|||
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 3799999999999999876433 3899999999999999999999999999999999999986521 28999999
Q ss_pred cccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHH-hCCCCCCCCchHHHHHHHHhhcC
Q 025244 75 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNV 153 (255)
Q Consensus 75 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~-~g~~p~~~~~~~~~~~~~~~~~~ 153 (255)
++...... ....++..|+|||.+.. ...++.++||||||+++|||+ .|..||......+... .....
T Consensus 158 ~~~~~~~~---~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~--~~~~~ 225 (262)
T cd05077 158 IPITVLSR---QECVERIPWIAPECVED-------SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER--FYEGQ 225 (262)
T ss_pred CCccccCc---ccccccccccChhhhcC-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH--HHhcC
Confidence 98753222 23467889999998742 355788999999999999998 5888887644333221 11122
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 154 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 154 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
.......+.++.+||.+||+.||.+||++.++++.+
T Consensus 226 ~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 226 CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 222334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=237.93 Aligned_cols=181 Identities=30% Similarity=0.557 Sum_probs=147.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEE
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--------------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--------------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nil 60 (255)
+++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++|++||||||+||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 4799999999999999975321 23778889999999999999999999999999999999
Q ss_pred EeCCCCceEEecCccccccccccc---cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 025244 61 LTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPF 136 (255)
Q Consensus 61 l~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~ 136 (255)
++.+ +.++|+|||+++....... ......+..|+|||.+.+ ..++.++|||||||++|||++ |..||
T Consensus 163 ~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~~~~~p~ 233 (288)
T cd05050 163 VGEN-MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY--------NRYTTESDVWAYGVVLWEIFSYGMQPY 233 (288)
T ss_pred ecCC-CceEECccccceecccCccccccCCCccChhhcCHHHHhc--------CCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 9988 7999999999875332211 122334667999998753 567889999999999999997 88899
Q ss_pred CCCchHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 137 EGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
.+....+...........+.+..++.++.++|.+||+.+|.+||++.|+++.|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 234 YGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 876665554444444444445678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=252.27 Aligned_cols=175 Identities=26% Similarity=0.383 Sum_probs=145.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe-CCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT-EDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~-~~~~~~kl~Dfg~a~~~ 79 (255)
+++|||++.|+-|.+.|...+. +. .++..|+.+|+.++.|||++|++||||||+|||++ +. ++++|+|||.++..
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~-g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSA-GHLRLTYFGFWSEL 466 (612)
T ss_pred eeeeehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCC-CcEEEEEechhhhC
Confidence 4899999999999999986553 33 77788999999999999999999999999999995 55 79999999999865
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
... ..+.+-|..|.|||++. ...|+.++|+||||++||+|++|+.||............+.. .+....
T Consensus 467 ~~~--~~tp~~t~~y~APEvl~--------~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~--~~~s~~ 534 (612)
T KOG0603|consen 467 ERS--CDTPALTLQYVAPEVLA--------IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM--PKFSEC 534 (612)
T ss_pred chh--hcccchhhcccChhhhc--------cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC--Cccccc
Confidence 444 45567789999999985 367899999999999999999999999876555333322211 112377
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
+|.+.++||.+||+.||.+|+++.++..+-+.
T Consensus 535 vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 535 VSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred cCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 89999999999999999999999999987443
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=243.79 Aligned_cols=182 Identities=19% Similarity=0.362 Sum_probs=140.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+++|+|.+++..+....+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++++||+......
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~-~~~~l~~~~~~~~~~ 152 (327)
T cd08227 74 LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMI 152 (327)
T ss_pred EEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC-CcEEEcccchhhccc
Confidence 4799999999999999987554458999999999999999999999999999999999999988 689999998654321
Q ss_pred cc--------cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc
Q 025244 81 LT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 152 (255)
Q Consensus 81 ~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 152 (255)
.. .......++..|+|||++.+ ....++.++|||||||++|||++|+.||......+.........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 226 (327)
T cd08227 153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQ------NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 226 (327)
T ss_pred cccccccccccccccccceecccChHHhhc------ccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCC
Confidence 11 01122356788999999853 12357889999999999999999999998655433222211110
Q ss_pred C---------------------------------------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025244 153 V---------------------------------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 187 (255)
Q Consensus 153 ~---------------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~ 187 (255)
. .+....+++.+.++|.+||+.||.+|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 227 VPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0 0011234678999999999999999999999998
Q ss_pred HH
Q 025244 188 ML 189 (255)
Q Consensus 188 ~l 189 (255)
+-
T Consensus 307 ~p 308 (327)
T cd08227 307 HS 308 (327)
T ss_pred Ch
Confidence 63
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=242.88 Aligned_cols=184 Identities=21% Similarity=0.332 Sum_probs=143.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++.+... .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~-~~~kl~DfG~a~~~~ 153 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMN 153 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCC-CCEEEEeccceeecc
Confidence 4799999999999999987433 38999999999999999999999999999999999999988 799999999997543
Q ss_pred cccc--cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC----
Q 025244 81 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR---- 154 (255)
Q Consensus 81 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---- 154 (255)
.... .....||+.|+|||++.+... ....++.++|+||||+++|||++|+.||...+..+...........
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p 230 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMED---GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhcccc---CCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCC
Confidence 3221 233579999999998853110 1135678999999999999999999999876655544443332211
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 025244 155 PSAENVPEELSIILTSCWKEDPNA--RPNFTQIIQML 189 (255)
Q Consensus 155 ~~~~~~~~~l~~li~~~l~~~p~~--Rpt~~~vl~~l 189 (255)
.....++.++.++|.+||..++++ |+++++++++.
T Consensus 231 ~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 231 SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 113457899999999999876654 46888888763
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=245.11 Aligned_cols=174 Identities=28% Similarity=0.366 Sum_probs=140.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++|||++ |++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||+++...
T Consensus 95 ~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 95 VYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED-CELRILDFGLARQAD 169 (343)
T ss_pred EEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCC-CCEEEcCCccceecC
Confidence 37899999 89999988643 39999999999999999999999999999999999999988 799999999998643
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC------
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR------ 154 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------ 154 (255)
.. .....||..|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+...........
T Consensus 170 ~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07878 170 DE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL 240 (343)
T ss_pred CC--cCCccccccccCchHhcC-------CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 32 345678999999999853 245788999999999999999999999876544433222111000
Q ss_pred ---------------C---------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 155 ---------------P---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 155 ---------------~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+ .....++.+.++|.+||..||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 012345678899999999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=238.76 Aligned_cols=183 Identities=23% Similarity=0.500 Sum_probs=147.7
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
++|+||+++|+|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++....
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~-~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSP-NHVKITDFGLARLLEG 161 (303)
T ss_pred eeeehhcCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCC-CceEEccccccccccC
Confidence 589999999999999986543 38899999999999999999999999999999999999887 6899999999985432
Q ss_pred ccc---cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 82 TEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 82 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
... .....++..|+|||++.+ ..++.++||||||+++||+++ |..||.+................+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHY--------RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQP 233 (303)
T ss_pred cccccccCCCccccccCCHHHhcc--------CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCC
Confidence 211 122345678999998753 557889999999999999997 99999875543333222223333345
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
..++..+.+++.+||..+|++||++.++++.|.....
T Consensus 234 ~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 234 PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 5678899999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=237.79 Aligned_cols=181 Identities=29% Similarity=0.539 Sum_probs=145.3
Q ss_pred CEEEEecCCCCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEe
Q 025244 1 MVIVTELLSGGTLRKYLLNMR---------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 71 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~---------~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~ 71 (255)
+++||||+++++|.+++.+.. ...+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~-~~~~l~ 172 (296)
T cd05051 94 LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKN-YTIKIA 172 (296)
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCC-CceEEc
Confidence 479999999999999998754 1248999999999999999999999999999999999999988 799999
Q ss_pred cCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCchHHHHH
Q 025244 72 DFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH--NKLPFEGMSNLQAAY 146 (255)
Q Consensus 72 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~--g~~p~~~~~~~~~~~ 146 (255)
|||+++...... ......++..|+|||.+.. ..++.++||||||+++|||++ |..||......+...
T Consensus 173 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~ 244 (296)
T cd05051 173 DFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL--------GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIE 244 (296)
T ss_pred cccceeecccCcceeecCcCCCCceecCHHHhhc--------CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHH
Confidence 999987533221 1233456788999998753 467889999999999999998 778887655544433
Q ss_pred HHHhh-------cCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 147 AAAFK-------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 147 ~~~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
..... ...+....++.++.+++.+||+.||.+||++.++++.|+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 245 NAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 32211 112234456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=234.66 Aligned_cols=179 Identities=27% Similarity=0.433 Sum_probs=149.4
Q ss_pred CEEEEecCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCeecCCCCCcEEEeCCCCceEEecC
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLH-----SHGIIHRDLKPENLLLTEDLKTIKLADF 73 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~L~~lH-----~~~i~HrDikp~Nill~~~~~~~kl~Df 73 (255)
+++||||++|++|.+++.... ...+++..++.++.|++.||.||| +.+++|+||||+||+++.+ +.++|+||
T Consensus 76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~-~~~kl~d~ 154 (265)
T cd08217 76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN-NNVKLGDF 154 (265)
T ss_pred EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC-CCEEEecc
Confidence 379999999999999997642 234899999999999999999999 8999999999999999988 79999999
Q ss_pred ccccccccccc-cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc
Q 025244 74 GLAREESLTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 152 (255)
Q Consensus 74 g~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 152 (255)
|++........ .....++..|+|||++.. ..++.++|+||||+++|+|++|+.||...+............
T Consensus 155 g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 226 (265)
T cd08217 155 GLAKILGHDSSFAKTYVGTPYYMSPEQLNH--------MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK 226 (265)
T ss_pred cccccccCCcccccccccCCCccChhhhcC--------CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC
Confidence 99986543332 345578999999999853 457789999999999999999999998876444433333333
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 153 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 153 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.......++..+.+++.+||+.+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 334466788999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=254.13 Aligned_cols=177 Identities=29% Similarity=0.422 Sum_probs=156.0
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
+|||||| -||-.|+|.-+++ ++.+.++..|+.+.+.||+|||+.+.||||||..|||+++. |.|||+|||.|.....
T Consensus 102 WLVMEYC-lGSAsDlleVhkK-plqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~-g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 102 WLVMEYC-LGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEP-GLVKLADFGSASIMAP 178 (948)
T ss_pred HHHHHHH-hccHHHHHHHHhc-cchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCC-CeeeeccccchhhcCc
Confidence 6899999 5888888876544 49999999999999999999999999999999999999988 8999999999876443
Q ss_pred ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC-CCCCC
Q 025244 82 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-SAENV 160 (255)
Q Consensus 82 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 160 (255)
..+++|||.|||||++... ..+.|+.++||||||++..|+...++|+-.++.+...+.+....... ....|
T Consensus 179 ---AnsFvGTPywMAPEVILAM-----DEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eW 250 (948)
T KOG0577|consen 179 ---ANSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW 250 (948)
T ss_pred ---hhcccCCccccchhHheec-----cccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchh
Confidence 4678999999999999753 46889999999999999999999999999998888888776554432 35679
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
+..+..|+..||++-|.+|||.++++.|-
T Consensus 251 S~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 251 SDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred HHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 99999999999999999999999999873
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=237.99 Aligned_cols=177 Identities=25% Similarity=0.386 Sum_probs=143.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++...+ .+++..+..++.|++.||.|||+++++||||||+||+++.+ +.++|+|||++....
T Consensus 72 ~~~v~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~-~~~kl~dfg~~~~~~ 148 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFS 148 (278)
T ss_pred EEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC-CCEEEccCcCccccC
Confidence 479999999999999997654 39999999999999999999999999999999999999988 699999999987543
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHHhhcCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ--AAYAAAFKNVRPSAE 158 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~ 158 (255)
.. ......|+..|+|||++.. ...++.++|+||+|+++|+|++|+.||.+..... .............+.
T Consensus 149 ~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (278)
T cd05606 149 KK-KPHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 220 (278)
T ss_pred cc-CCcCcCCCcCCcCcHHhcC-------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCC
Confidence 22 2234578999999999853 2357789999999999999999999997653221 111122222223345
Q ss_pred CCcHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 025244 159 NVPEELSIILTSCWKEDPNARP-----NFTQIIQM 188 (255)
Q Consensus 159 ~~~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~ 188 (255)
.++.++.+++.+||..+|.+|| ++.+++++
T Consensus 221 ~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 221 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 6789999999999999999999 99999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=250.36 Aligned_cols=179 Identities=30% Similarity=0.344 Sum_probs=150.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-CCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-LKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~-~~~~kl~Dfg~a~~~ 79 (255)
++||+|.+ +-+|.++|+.+...+++...+..++.||+.||.+||+.||||+||||+||||... ...+||+|||.+...
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 58999999 5899999999988889999999999999999999999999999999999999642 247999999999976
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC---
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--- 156 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 156 (255)
..... +.+.+..|+|||++.+ ..|+.+.|+|||||+++||++|.+.|.+.+..++...+......|.
T Consensus 342 ~q~vy--tYiQSRfYRAPEVILG--------lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 342 SQRVY--TYIQSRFYRAPEVILG--------LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred CCcce--eeeeccccccchhhcc--------CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 54432 7788999999999985 6789999999999999999999999999888777655542111110
Q ss_pred -----------------------------------------------CC------------CCcHHHHHHHHHhcccCCC
Q 025244 157 -----------------------------------------------AE------------NVPEELSIILTSCWKEDPN 177 (255)
Q Consensus 157 -----------------------------------------------~~------------~~~~~l~~li~~~l~~~p~ 177 (255)
.+ .-...+.++|.+||..||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 00 0114678999999999999
Q ss_pred CCCCHHHHHHHHH
Q 025244 178 ARPNFTQIIQMLL 190 (255)
Q Consensus 178 ~Rpt~~~vl~~l~ 190 (255)
+|+|..|+++|-+
T Consensus 492 ~R~tp~qal~Hpf 504 (586)
T KOG0667|consen 492 ERITPAQALNHPF 504 (586)
T ss_pred hcCCHHHHhcCcc
Confidence 9999999999843
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=235.14 Aligned_cols=176 Identities=23% Similarity=0.366 Sum_probs=139.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCC------CceEEecCc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL------KTIKLADFG 74 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~------~~~kl~Dfg 74 (255)
.++||||++||+|.+++.+..+ .+++..+..++.|++.||+|||++|++||||||+||+++... ..++++|||
T Consensus 91 ~~lv~ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g 169 (274)
T cd05076 91 NIMVEEFVEHGPLDVCLRKEKG-RVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPG 169 (274)
T ss_pred eEEEEecCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCc
Confidence 3799999999999999976433 489999999999999999999999999999999999997541 247999999
Q ss_pred cccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHH-hCCCCCCCCchHHHHHHHHhhcC
Q 025244 75 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNV 153 (255)
Q Consensus 75 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~-~g~~p~~~~~~~~~~~~~~~~~~ 153 (255)
++...... ....++..|+|||.+.+ ...++.++|+||||+++||++ +|+.||.+....+...... ..
T Consensus 170 ~~~~~~~~---~~~~~~~~~~aPe~~~~-------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~--~~ 237 (274)
T cd05076 170 VSFTALSR---EERVERIPWIAPECVPG-------GNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE--KK 237 (274)
T ss_pred cccccccc---cccccCCcccCchhhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHH--hc
Confidence 88643211 23457788999998753 245788999999999999995 6999998765443322211 12
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 154 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 154 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
...+...++++.++|.+||+.+|++||++.++++.|
T Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 238 HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 222344567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=237.14 Aligned_cols=176 Identities=28% Similarity=0.459 Sum_probs=146.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++|+||++|++|.+++... .+++..+..++.|++.||.|||+++++|+||+|+||+++++ +.++|+|||+++...
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~ 149 (274)
T cd06609 74 LWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEE-GDVKLADFGVSGQLT 149 (274)
T ss_pred EEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEcccccceeec
Confidence 47999999999999999864 48999999999999999999999999999999999999998 799999999998654
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
.. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+...................
T Consensus 150 ~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 221 (274)
T cd06609 150 STMSKRNTFVGTPFWMAPEVIKQ--------SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGN 221 (274)
T ss_pred ccccccccccCCccccChhhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCccc
Confidence 33 22344578889999999853 4478899999999999999999999987665444333332222222233
Q ss_pred -CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 160 -VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 160 -~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
++.++.+++.+||..+|++||++++++++
T Consensus 222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 222 KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 78999999999999999999999999886
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=234.30 Aligned_cols=183 Identities=27% Similarity=0.458 Sum_probs=145.5
Q ss_pred CEEEEecCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++||||++|++|.+++... ....+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++..
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~ 155 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRF 155 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEECcchhhhc
Confidence 47999999999999999752 22348999999999999999999999999999999999999988 7999999999875
Q ss_pred ccccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhh-cCCC
Q 025244 79 ESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ-AAYAAAFK-NVRP 155 (255)
Q Consensus 79 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~-~~~~~~~~-~~~~ 155 (255)
..... ......++..|+|||++.. ..++.++|+||||+++|+|++|..||.+..... ........ ...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~ape~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd08229 156 FSSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP 227 (267)
T ss_pred cccCCcccccccCCcCccCHHHhcC--------CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCC
Confidence 43222 2234578899999998853 456789999999999999999999997544321 11111111 1111
Q ss_pred -CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 156 -SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 156 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
.....+.++.+++.+||+.||++|||+.+|++.+.+.
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1345788999999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=234.99 Aligned_cols=177 Identities=28% Similarity=0.490 Sum_probs=145.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+... +++..+..++.|++.||+|||+.+++|+||+|+||+++.+ +.++|+|||++....
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~ 153 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLA 153 (265)
T ss_pred EEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC-CeEEeccchhhHhhh
Confidence 4799999999999999987544 8899999999999999999999999999999999999988 799999999987432
Q ss_pred c-------ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh--
Q 025244 81 L-------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK-- 151 (255)
Q Consensus 81 ~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~-- 151 (255)
. ........|+..|+|||++.+ ..++.++|+||||+++|+|++|+.||...+...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~ 225 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINE--------SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG 225 (265)
T ss_pred hccccccccccccccCCCccccChhhhcC--------CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC
Confidence 1 112234568899999999853 45678999999999999999999999876655444333222
Q ss_pred cCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 152 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 152 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
........++.++.++|++||+.+|.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 226 LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1223456688999999999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=247.08 Aligned_cols=184 Identities=26% Similarity=0.381 Sum_probs=141.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
|||||||-+ .+|..+|++.... +..-.+..+..|++.++.++|+.||||.||||.|+|+-. |.+||+|||+|....
T Consensus 435 lYmvmE~Gd-~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk--G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 435 LYMVMECGD-IDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK--GRLKLIDFGIANAIQ 510 (677)
T ss_pred EEEEeeccc-ccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe--eeEEeeeechhcccC
Confidence 689999984 8999999986543 332367778899999999999999999999999999976 689999999998543
Q ss_pred cc---cccccCCCccceecccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC
Q 025244 81 LT---EMMTAETGTYRWMAPELYSTVTLRQGE---KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 154 (255)
Q Consensus 81 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~---~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 154 (255)
.. -...+.+||+.||+||.+......+.. .-..++++|||||||+||+|+.|++||....+.......+.....
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~ 590 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNH 590 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCc
Confidence 32 234567999999999999765533211 123678999999999999999999999775544433333332211
Q ss_pred --CCCCCC-cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 155 --PSAENV-PEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 155 --~~~~~~-~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+.+..- ..++.++++.||+.||++||+..++|++
T Consensus 591 ~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 591 EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 111111 2349999999999999999999999987
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=232.78 Aligned_cols=180 Identities=37% Similarity=0.693 Sum_probs=149.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++|++|.+++.......+++..+..++.|++.||++||+.|++|+||||+||+++++ +.++|+|||+++...
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~-~~~~l~dfg~~~~~~ 154 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN-LVVKISDFGLSRDLY 154 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccC-CeEEEcccCCceecc
Confidence 3799999999999999987554448999999999999999999999999999999999999988 699999999998544
Q ss_pred cccccc--cCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
...... ...++..|+|||.+. ...++.++|+||||+++++|++ |..||...+..+...........+..
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~--------~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 226 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLK--------DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKP 226 (258)
T ss_pred cccccccccCCCcccccChHHhc--------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 332111 123678999999874 3567889999999999999998 88999876665555544444444556
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
...+.++.+++.+||..||++|||+.++++.|
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 227 ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 66899999999999999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=234.75 Aligned_cols=181 Identities=27% Similarity=0.484 Sum_probs=149.2
Q ss_pred CEEEEecCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~-~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
+++||||++|++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.+ +.++|+|||++.
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~ 162 (269)
T cd08528 84 LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGED-DKVTITDFGLAK 162 (269)
T ss_pred EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCC-CcEEEeccccee
Confidence 47999999999999998642 23348999999999999999999996 689999999999999988 689999999998
Q ss_pred ccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 78 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 78 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
............|+..|++||.+.+ ..++.++|+||||+++|+|++|+.||..................+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd08528 163 QKQPESKLTSVVGTILYSCPEIVKN--------EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP 234 (269)
T ss_pred ecccccccccccCcccCcChhhhcC--------CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC
Confidence 6544433445678999999998853 45788999999999999999999999876555444444333333333
Q ss_pred -CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 158 -ENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 158 -~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
..++..+.++|.+||+.||++||++.++..++.
T Consensus 235 ~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 235 EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 367899999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=241.36 Aligned_cols=179 Identities=31% Similarity=0.459 Sum_probs=145.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+.....+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~ 154 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES-GHIMLSDFDLSKQSD 154 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCC-CCEEEeecchhhccc
Confidence 4799999999999999987655569999999999999999999999999999999999999988 799999999987432
Q ss_pred ccc------------------------------ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHH
Q 025244 81 LTE------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 130 (255)
Q Consensus 81 ~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~ 130 (255)
... ......|+..|+|||++.+ ..++.++||||||+++|+|+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Di~slG~ll~~l~ 226 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--------DGHGSAVDWWTLGILLYEML 226 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--------CCCCchHHHHHHHHHHHHHh
Confidence 111 1113468889999999853 45688999999999999999
Q ss_pred hCCCCCCCCchHHHHHHHHhhcC-CCCCCCCcHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 025244 131 HNKLPFEGMSNLQAAYAAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPN----FTQIIQM 188 (255)
Q Consensus 131 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~~vl~~ 188 (255)
+|+.||.+.+............. .+....++..+.++|.+||..||++||+ +.+++.+
T Consensus 227 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 227 YGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 99999987766554444332222 2223337899999999999999999999 7777775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=234.14 Aligned_cols=183 Identities=27% Similarity=0.425 Sum_probs=145.1
Q ss_pred CEEEEecCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++||||+++++|.+++.... ...+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++..
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~-~~~~l~d~g~~~~ 155 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRF 155 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCC-CCEEECcccccee
Confidence 478999999999999987532 2348889999999999999999999999999999999999988 6899999999885
Q ss_pred ccccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHHhhcCC-C
Q 025244 79 ESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL-QAAYAAAFKNVR-P 155 (255)
Q Consensus 79 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~-~ 155 (255)
..... ......|+..|+|||.+.+ ..++.++|+||||+++|||++|+.||...... ............ +
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd08228 156 FSSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP 227 (267)
T ss_pred ccchhHHHhcCCCCccccChhhhcc--------CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC
Confidence 43222 2234578899999998853 45678999999999999999999999654322 122222222122 2
Q ss_pred C-CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 156 S-AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 156 ~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
. ....+..+.++|.+||+.+|++||++.++++.++..
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1 235778999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=234.40 Aligned_cols=186 Identities=26% Similarity=0.438 Sum_probs=142.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP---RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
+++||||+++|+|.+++..... ...++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 70 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~ 148 (269)
T cd05042 70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD-LSVKIGDYGLAL 148 (269)
T ss_pred eEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC-CcEEEecccccc
Confidence 4799999999999999987542 224677888999999999999999999999999999999998 699999999987
Q ss_pred cccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcC
Q 025244 78 EESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNV 153 (255)
Q Consensus 78 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 153 (255)
...... ......++..|+|||++...... .....++.++||||||+++|||++ |..||......+..........
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 227 (269)
T cd05042 149 EQYPEDYYITKDCHAVPLRWLAPELVEIRGQD-LLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD 227 (269)
T ss_pred ccccchheeccCCCCCcccccCHHHHhhcccc-ccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC
Confidence 432221 11223456789999987531100 012456789999999999999999 7889987665554444333222
Q ss_pred C----C-CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 154 R----P-SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 154 ~----~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
. + ....++..+.+++..|+ .||++||++.+|++.|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 228 IKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 1 1 13467888999999999 5999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=236.91 Aligned_cols=184 Identities=26% Similarity=0.423 Sum_probs=146.2
Q ss_pred CEEEEecCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++||||+++++|.+++.... +..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++..
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~-~~~~l~d~~~~~~ 162 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN-AEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccC-CeEEECCCcccee
Confidence 379999999999999997643 3458999999999999999999999999999999999999988 7999999999875
Q ss_pred ccc-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC--
Q 025244 79 ESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-- 155 (255)
Q Consensus 79 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-- 155 (255)
... ........|+..|+|||++..... ....++.++|+||||+++|+|++|+.||...................
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd06608 163 LDSTLGRRNTFIGTPYWMAPEVIACDEQ---PDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLK 239 (275)
T ss_pred cccchhhhcCccccccccCHhHhccccc---ccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCC
Confidence 332 222334568999999998753211 13456779999999999999999999998655544443333221111
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....+++.+.++|.+||..||++|||+.+++++
T Consensus 240 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 240 SPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 123467899999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=238.26 Aligned_cols=176 Identities=30% Similarity=0.520 Sum_probs=146.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+. .+++.++..++.+++.||+|||++|++||||||+||+++.+ +.++|+|||++....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~-~~~kl~dfg~~~~~~ 166 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQIT 166 (296)
T ss_pred EEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccchhcc
Confidence 47999999999999999753 38999999999999999999999999999999999999987 799999999987533
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC--CCCC
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--RPSA 157 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~ 157 (255)
... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+............. ...+
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T cd06655 167 PEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP 238 (296)
T ss_pred cccccCCCcCCCccccCcchhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCc
Confidence 222 2234568899999998853 4567899999999999999999999988776555443332221 1234
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..+++.+.++|.+||..||.+||++.+++.+
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 5678999999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=231.99 Aligned_cols=176 Identities=22% Similarity=0.363 Sum_probs=140.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC-------ceEEecC
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK-------TIKLADF 73 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~-------~~kl~Df 73 (255)
.++||||++||+|.+++..... .++...+..++.|++.||+|||++|++||||||+||+++.+ + .++|+||
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~-~~~~~~~~~~kl~Df 152 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARY-GLNEGYVPFIKLSDP 152 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecC-ccccCCceeEEeCCC
Confidence 3799999999999999987553 48999999999999999999999999999999999999876 4 6999999
Q ss_pred ccccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhc
Q 025244 74 GLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKN 152 (255)
Q Consensus 74 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 152 (255)
|++..... .....++..|+|||++.. ....++.++|+||||+++|+|++ |..||...+............
T Consensus 153 g~a~~~~~---~~~~~~~~~y~aPE~~~~------~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~ 223 (259)
T cd05037 153 GIPITVLS---REERVERIPWIAPECIRN------GQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH 223 (259)
T ss_pred Cccccccc---ccccccCCCccChhhhcC------CCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC
Confidence 99986433 223456778999999853 11367889999999999999999 578887654333222222111
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 153 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 153 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
.........+.++|.+||..+|.+||++.++++.|
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 224 --RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred --CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 11222347899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=234.04 Aligned_cols=181 Identities=30% Similarity=0.457 Sum_probs=146.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.... ..+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++....
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~ 152 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTED-GDVKLADFGVSAQLT 152 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCC-CCEEECccccchhhh
Confidence 479999999999999998752 239999999999999999999999999999999999999988 789999999987543
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC----
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---- 155 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---- 155 (255)
... ......++..|+|||.+... ....++.++|+||||+++|+|++|+.||.+.+..............+
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~-----~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 227 (262)
T cd06613 153 ATIAKRKSFIGTPYWMAPEVAAVE-----RKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLK 227 (262)
T ss_pred hhhhccccccCCccccCchhhccc-----ccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcccc
Confidence 322 23445788899999988531 11357789999999999999999999998877655544433332221
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....++.++.+++.+||..+|.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 123457889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=232.58 Aligned_cols=178 Identities=26% Similarity=0.479 Sum_probs=147.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+... +++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.+||+|||++....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~ 153 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKKYGS--FPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN-GVVKLADFGMAKQVV 153 (258)
T ss_pred EEEEEEecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccceecc
Confidence 4799999999999999987543 8899999999999999999999999999999999999988 699999999988644
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC-CCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAEN 159 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~ 159 (255)
.........|+..|++||.+.. ...++.++|+||||+++|+|++|+.||......+........... ..+..
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~-------~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 226 (258)
T cd06632 154 EFSFAKSFKGSPYWMAPEVIAQ-------QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDH 226 (258)
T ss_pred ccccccccCCCcceeCHHHhcC-------CCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCC
Confidence 3333455678999999998753 123788999999999999999999999876654444444332222 23456
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+++++.+++.+||+.+|.+||++.+++.+
T Consensus 227 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 227 LSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 78999999999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=231.24 Aligned_cols=179 Identities=29% Similarity=0.556 Sum_probs=143.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++|++|.+++..... .+++..++.++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||+++...
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~ 151 (256)
T cd05112 74 ICLVFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGEN-QVVKVSDFGMTRFVL 151 (256)
T ss_pred eEEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCC-CeEEECCCcceeecc
Confidence 3799999999999999986443 38899999999999999999999999999999999999987 689999999987543
Q ss_pred cccc--cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
.... .....++..|+|||.+.+ ..++.++|+||||+++|||++ |+.||....................+
T Consensus 152 ~~~~~~~~~~~~~~~~~aPe~~~~--------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd05112 152 DDQYTSSTGTKFPVKWSSPEVFSF--------SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP 223 (256)
T ss_pred cCcccccCCCccchhhcCHhHhcc--------CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC
Confidence 2211 112234578999998853 457789999999999999998 99999875554433333222222334
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
...+..+.+++.+||+.+|++||++.++++.|
T Consensus 224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 45689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=233.58 Aligned_cols=179 Identities=28% Similarity=0.453 Sum_probs=150.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++|++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++....
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~-~~~~l~d~~~~~~~~ 152 (256)
T cd08218 74 LYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLN 152 (256)
T ss_pred EEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEEeeccceeecC
Confidence 3799999999999999987554458999999999999999999999999999999999999987 689999999997543
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
... ......|+..|+|||++.+ ...+.++|+||||+++++|++|+.||......+...........+....
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd08218 153 STVELARTCIGTPYYLSPEICEN--------RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSH 224 (256)
T ss_pred cchhhhhhccCCccccCHHHhCC--------CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCccc
Confidence 322 2233468889999998853 4567799999999999999999999987666665555555554455667
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
++.++.++|.+||+.+|.+||++.+++++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 225 YSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 88999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=235.86 Aligned_cols=177 Identities=27% Similarity=0.438 Sum_probs=144.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++++|||++....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~-~~~~l~dfg~~~~~~ 152 (277)
T cd06642 77 LWIIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLT 152 (277)
T ss_pred eEEEEEccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC-CCEEEcccccccccc
Confidence 47999999999999998643 38999999999999999999999999999999999999988 799999999997543
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
... ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||.......................
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (277)
T cd06642 153 DTQIKRNTFVGTPFWMAPEVIKQ--------SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQ 224 (277)
T ss_pred CcchhhhcccCcccccCHHHhCc--------CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcc
Confidence 322 2233468899999998853 4578899999999999999999999976554443332222222222345
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
++.++.++|.+||+.+|++||++.+++.+-
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 225 YSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 788999999999999999999999999874
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=232.51 Aligned_cols=183 Identities=28% Similarity=0.453 Sum_probs=145.8
Q ss_pred CEEEEecCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++||||++|++|.+++.... ...+++.+++.++.+++.||.|||+.|++||||+|+||+++.+ +.++|+|||+++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~-~~~~l~d~~~~~~ 155 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT-GVVKLGDLGLGRF 155 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCC-CcEEEeccceeee
Confidence 378999999999999997532 2348999999999999999999999999999999999999988 6899999999875
Q ss_pred cccc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHhhcCCC
Q 025244 79 ESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL--QAAYAAAFKNVRP 155 (255)
Q Consensus 79 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~ 155 (255)
.... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... +...........+
T Consensus 156 ~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd08224 156 FSSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPP 227 (267)
T ss_pred ccCCCcccceecCCccccCHHHhcc--------CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCC
Confidence 3322 12234568899999998753 55788999999999999999999999654321 1111111222222
Q ss_pred CCC-CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 156 SAE-NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 156 ~~~-~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
.+. .++..+.++|.+||..+|++||++.++++.|+..
T Consensus 228 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 333 6778999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=236.43 Aligned_cols=179 Identities=29% Similarity=0.422 Sum_probs=142.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+++||||++ ++|.+++..... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++...
T Consensus 74 ~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~ 151 (285)
T cd07861 74 LYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK-GVIKLADFGLARAF 151 (285)
T ss_pred EEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC-CcEEECcccceeec
Confidence 479999997 689999876432 458999999999999999999999999999999999999988 79999999999754
Q ss_pred ccc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-----
Q 025244 80 SLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV----- 153 (255)
Q Consensus 80 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~----- 153 (255)
... .......++..|+|||++.+ ...++.++|+||||+++|+|++|+.||.+...............
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (285)
T cd07861 152 GIPVRVYTHEVVTLWYRAPEVLLG-------SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTED 224 (285)
T ss_pred CCCcccccCCcccccccChHHhcC-------CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 322 22234467899999998753 23467899999999999999999999987655443332211100
Q ss_pred -----------------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 154 -----------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 154 -----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
......+++++.++|.+||..||.+|||+.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 225 VWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00123478899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=233.40 Aligned_cols=178 Identities=29% Similarity=0.447 Sum_probs=145.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... .+++..+..++.|++.||.|||+.+++|+||+|+||+++++ +.++|+|||++....
T Consensus 73 ~~l~~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~-~~~~l~dfg~~~~~~ 150 (256)
T cd06612 73 LWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE-GQAKLADFGVSGQLT 150 (256)
T ss_pred EEEEEecCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC-CcEEEcccccchhcc
Confidence 4799999999999999976443 48999999999999999999999999999999999999988 689999999988544
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC--CCC
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSA 157 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~ 157 (255)
... ......++..|+|||++.+ ..++.++|+||||+++|+|++|+.||.................. ...
T Consensus 151 ~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 222 (256)
T cd06612 151 DTMAKRNTVIGTPFWMAPEVIQE--------IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDP 222 (256)
T ss_pred cCccccccccCCccccCHHHHhc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCch
Confidence 332 2234568889999998853 46788999999999999999999999876554443332221111 123
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..++..+.++|.+||+.||++||++.+++++
T Consensus 223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 4567899999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=236.34 Aligned_cols=178 Identities=28% Similarity=0.455 Sum_probs=146.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++... .+++..+..++.|++.||+|||+++++|+||+|+||+++.+ +.++|+|||++....
T Consensus 77 ~~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~-~~~~l~dfg~~~~~~ 152 (277)
T cd06640 77 LWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLT 152 (277)
T ss_pred EEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCC-CCEEEcccccceecc
Confidence 47999999999999999753 38899999999999999999999999999999999999988 689999999997543
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
... ......++..|+|||.+.+ ..++.++|+||||+++|||++|..||.......................
T Consensus 153 ~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (277)
T cd06640 153 DTQIKRNTFVGTPFWMAPEVIQQ--------SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGE 224 (277)
T ss_pred CCccccccccCcccccCHhHhcc--------CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchh
Confidence 322 2233467889999998853 4578899999999999999999999987665544433322222223446
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
++..+.+++.+||+.+|++||++.+++.+-.
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 225 FSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred hhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 7889999999999999999999999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=237.03 Aligned_cols=185 Identities=24% Similarity=0.403 Sum_probs=145.4
Q ss_pred CEEEEecCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++||||++|++|.+++... ....+++..+..++.|++.||.|||+++++||||||+||+++.+ +.++|+|||+++.
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~~~kl~dfg~~~~ 173 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE-GGVKLVDFGVSAQ 173 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCC-CCEEEccCCceee
Confidence 48999999999999988642 22348899999999999999999999999999999999999988 6899999999875
Q ss_pred cccc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC--CC
Q 025244 79 ESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--RP 155 (255)
Q Consensus 79 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~ 155 (255)
.... .......|+..|+|||++.... .....++.++|+|||||++|||++|+.||................. ..
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (286)
T cd06638 174 LTSTRLRRNTSVGTPFWMAPEVIACEQ---QLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH 250 (286)
T ss_pred cccCCCccccccCCCcccChhhhchhh---hccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCccc
Confidence 4322 2233457899999999875311 0124468899999999999999999999987655443332211111 11
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
.+..++..+.++|.+||+.||++||++.+++++.
T Consensus 251 ~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 2344678999999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=234.26 Aligned_cols=181 Identities=28% Similarity=0.473 Sum_probs=140.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||+++...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~ 159 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRE-RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE-NRVKIGDFGLTKVLP 159 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCC-CeEEECCCccccccc
Confidence 4799999999999999976433 38999999999999999999999999999999999999988 689999999998543
Q ss_pred cccc----cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHH-------------
Q 025244 81 LTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ------------- 143 (255)
Q Consensus 81 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~------------- 143 (255)
.... .....++..|+|||++.+ ..++.++|+||||+++|||++|..++.......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTE--------SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMI 231 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhcc--------CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccc
Confidence 2211 111233456999998853 557889999999999999999877654322110
Q ss_pred --HHHHHH-hhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 144 --AAYAAA-FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 144 --~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
...... .....+....++.++.+++.+||..+|++|||+.++++.|..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 000111 111223356678999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=236.22 Aligned_cols=183 Identities=29% Similarity=0.428 Sum_probs=145.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|..++.+... .+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||++....
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~ 161 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELDR-GLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNV 161 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCC-CCEEEccCccceecc
Confidence 4799999999999998876433 38999999999999999999999999999999999999887 799999999987532
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC--CCCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--RPSA 157 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~ 157 (255)
.. .......++..|+|||++..... ....++.++|+||||+++|||++|..||...+............. ....
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T cd06644 162 KTLQRRDSFIGTPYWMAPEVVMCETM---KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQP 238 (292)
T ss_pred ccccccceecCCccccCceeeccccc---cCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCC
Confidence 22 22234568899999998853110 124467899999999999999999999987665443333322211 1124
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..++.++.++|.+||+.||++||++.+++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 239 SKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 5678899999999999999999999999886
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=244.54 Aligned_cols=160 Identities=31% Similarity=0.581 Sum_probs=129.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccccc---ccccCCCccceecccccc
Q 025244 25 LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYS 101 (255)
Q Consensus 25 ~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~ 101 (255)
+++..++.++.|++.||+|||+++++||||||+|||++.+ +.++|+|||+++...... ......++..|+|||.+.
T Consensus 236 l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 314 (401)
T cd05107 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEG-KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF 314 (401)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCC-CEEEEEecCcceecccccccccCCCcCCCCceeChHHhc
Confidence 6677888999999999999999999999999999999987 689999999997532211 112335678899999885
Q ss_pred cccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcC-CCCCCCCcHHHHHHHHHhcccCCCCC
Q 025244 102 TVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNV-RPSAENVPEELSIILTSCWKEDPNAR 179 (255)
Q Consensus 102 ~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~R 179 (255)
. ..++.++|+||||+++|||++ |..||......+.......... .+.+..++.++.+++.+||..+|.+|
T Consensus 315 ~--------~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~R 386 (401)
T cd05107 315 N--------NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIR 386 (401)
T ss_pred C--------CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHC
Confidence 3 457889999999999999998 8999987655554444333332 23355678999999999999999999
Q ss_pred CCHHHHHHHHHHhH
Q 025244 180 PNFTQIIQMLLNYL 193 (255)
Q Consensus 180 pt~~~vl~~l~~~~ 193 (255)
|++.++++.|+..+
T Consensus 387 Ps~~ell~~L~~~~ 400 (401)
T cd05107 387 PDFSQLVHLVGDLL 400 (401)
T ss_pred cCHHHHHHHHHHHh
Confidence 99999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=236.06 Aligned_cols=183 Identities=30% Similarity=0.453 Sum_probs=147.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+.+. .+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~-~~~~l~d~g~~~~~~ 154 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNK 154 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCC-CCEEEccCccchhhc
Confidence 4799999999999999987543 49999999999999999999999999999999999999988 799999999887533
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC--CCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSA 157 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~ 157 (255)
.. .......++..|++||.+.... .....++.++|+||||+++|+|++|+.||.+.+..+........... ..+
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 231 (280)
T cd06611 155 STLQKRDTFIGTPYWMAPEVVACET---FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQP 231 (280)
T ss_pred ccccccceeecchhhcCHHHHhhcc---cCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCc
Confidence 22 2223456899999999875311 11244677999999999999999999999887655544433322211 124
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..++.++.++|.+||+.+|.+||++.+++++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 232 SKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 5678999999999999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=234.29 Aligned_cols=175 Identities=25% Similarity=0.376 Sum_probs=142.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.... .+++.++..++.|++.||.|||+.|++||||||+||+++.+.+.++|+|||+++...
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 479999999999999998764 499999999999999999999999999999999999999883389999999987543
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHhhcCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA---AAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~---~~~~~~~~~~ 157 (255)
.. ....++..|+|||++.+ ..++.++|+||||+++|+|++|+.||........... .......+..
T Consensus 162 ~~---~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T PHA03390 162 TP---SCYDGTLDYFSPEKIKG--------HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFI 230 (267)
T ss_pred CC---ccCCCCCcccChhhhcC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcc
Confidence 22 23468899999999853 4567899999999999999999999975443221111 1112222334
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPN-FTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt-~~~vl~~ 188 (255)
..+++.+.++|.+||+.+|.+||+ +++++++
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 231 KNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred cccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 568899999999999999999996 6998875
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=237.31 Aligned_cols=176 Identities=18% Similarity=0.291 Sum_probs=138.0
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
+++||++ ..++.+.+..... .++..+..++.|++.||+|||+++++||||||+|||++.+ +.++|+|||+++....
T Consensus 103 ~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~-~~~~l~DFGla~~~~~ 178 (294)
T PHA02882 103 FILLEKL-VENTKEIFKRIKC--KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN-NRGYIIDYGIASHFII 178 (294)
T ss_pred EEEEehh-ccCHHHHHHhhcc--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CcEEEEEcCCceeecc
Confidence 5788888 4678887765432 6788889999999999999999999999999999999987 6899999999975321
Q ss_pred c--------cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-----
Q 025244 82 T--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA----- 148 (255)
Q Consensus 82 ~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~----- 148 (255)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..........
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~ape~~~~--------~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~ 250 (294)
T PHA02882 179 HGKHIEYSKEQKDLHRGTLYYAGLDAHNG--------ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDF 250 (294)
T ss_pred CCcccccccccccccCCCccccCHHHhCC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHH
Confidence 1 11223469999999998853 56789999999999999999999999876332211110
Q ss_pred --HhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 149 --AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 149 --~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
...........++..+.+++..|+..+|++||++.++++.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 251 IKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 01111122456789999999999999999999999998865
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=236.22 Aligned_cols=179 Identities=25% Similarity=0.426 Sum_probs=145.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.......+++..+..++.|++.||.|||++|++||||+|+||+++++ +.++|+|||++....
T Consensus 68 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~ 146 (277)
T cd05577 68 LCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH-GNVRISDLGLAVELK 146 (277)
T ss_pred EEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEccCcchhhhc
Confidence 4799999999999999987665569999999999999999999999999999999999999988 699999999987544
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHHhhcCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL---QAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~ 157 (255)
.........++..|+|||++.+ ..++.++|+||||+++|+|++|+.||...... ..............+
T Consensus 147 ~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (277)
T cd05577 147 GGKKIKGRAGTPGYMAPEVLQG--------EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYP 218 (277)
T ss_pred cCCccccccCCCCcCCHHHhcC--------CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCC
Confidence 3333344567889999999853 44778999999999999999999999765431 111222222223335
Q ss_pred CCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~ 188 (255)
..+++.+.++|.+||+.||.+|| ++.+++++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 56789999999999999999999 66667765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=235.82 Aligned_cols=178 Identities=28% Similarity=0.381 Sum_probs=142.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+++++|..++..... +++..+..++.|++.||+|||++|++||||||+||+++++ +.++|+|||++....
T Consensus 75 ~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~ 151 (286)
T cd07847 75 LHLVFEYCDHTVLNELEKNPRG--VPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ-GQIKLCDFGFARILT 151 (286)
T ss_pred EEEEEeccCccHHHHHHhCCCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCC-CcEEECccccceecC
Confidence 3799999999888888765433 8999999999999999999999999999999999999988 799999999998644
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-------
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN------- 152 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~------- 152 (255)
... ......++..|+|||++.+ ...++.++|+||||+++|+|++|+.||.+....+.........
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07847 152 GPGDDYTDYVATRWYRAPELLVG-------DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH 224 (286)
T ss_pred CCcccccCcccccccCCHHHHhC-------CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 332 2234567889999998753 2456789999999999999999999998776654443322100
Q ss_pred -------------CCCC----------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 153 -------------VRPS----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 153 -------------~~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..+. ...++..+.+++.+||+.+|++||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 225 QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred hhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000 13467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=235.47 Aligned_cols=181 Identities=29% Similarity=0.530 Sum_probs=143.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEe
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP---------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 71 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~---------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~ 71 (255)
+++||||++|++|.+++..... ..+++..+..++.|++.||+|||+.|++||||||+||+++.+ +.++|+
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~-~~~~l~ 172 (296)
T cd05095 94 LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKN-YTIKIA 172 (296)
T ss_pred cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCC-CCEEec
Confidence 4799999999999999986432 236778899999999999999999999999999999999987 689999
Q ss_pred cCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCchHHHHH
Q 025244 72 DFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH--NKLPFEGMSNLQAAY 146 (255)
Q Consensus 72 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~--g~~p~~~~~~~~~~~ 146 (255)
|||+++...... ......++..|++||+... +.++.++|+|||||++|||++ |..||......+...
T Consensus 173 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 244 (296)
T cd05095 173 DFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--------GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIE 244 (296)
T ss_pred cCcccccccCCcceeccCcCcCccccCCHHHHhc--------CCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 999987533221 1122334678999998743 457889999999999999998 778997665544332
Q ss_pred HHHh-------hcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 147 AAAF-------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 147 ~~~~-------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
.... ....+.+..++..+.+++.+||+.||.+||++.++++.|+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 245 NTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 2111 1122345567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=240.45 Aligned_cols=180 Identities=22% Similarity=0.269 Sum_probs=134.4
Q ss_pred CEEEEecCCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC---CCCceEE
Q 025244 1 MVIVTELLSGGTLRKYLLNMR-------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE---DLKTIKL 70 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~-------~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~---~~~~~kl 70 (255)
+++||||+ +++|.+++.... ...+++..+..++.|++.||.|||++||+||||||+|||++. ..+.+||
T Consensus 75 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07868 75 VWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEE
Confidence 37899999 579999886432 224889999999999999999999999999999999999942 2268999
Q ss_pred ecCccccccccc----cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH----
Q 025244 71 ADFGLAREESLT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL---- 142 (255)
Q Consensus 71 ~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~---- 142 (255)
+|||+++..... .......||+.|+|||++.+ ...++.++|+||+||++|+|++|++||......
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~ 226 (317)
T cd07868 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 226 (317)
T ss_pred eecCceeccCCCCccccccCCccccccccCCHHHcC-------CCCcCchhhHHHHHHHHHHHHhCCCCccCCccccccc
Confidence 999999854322 12234678999999998853 245788999999999999999999999643321
Q ss_pred -----HHHHHHHhhcCCC-------------------------------------CCCCCcHHHHHHHHHhcccCCCCCC
Q 025244 143 -----QAAYAAAFKNVRP-------------------------------------SAENVPEELSIILTSCWKEDPNARP 180 (255)
Q Consensus 143 -----~~~~~~~~~~~~~-------------------------------------~~~~~~~~l~~li~~~l~~~p~~Rp 180 (255)
............+ .....+.++.++|.+||+.||.+||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 306 (317)
T cd07868 227 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI 306 (317)
T ss_pred ccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCC
Confidence 1100000000000 0112345688999999999999999
Q ss_pred CHHHHHHH
Q 025244 181 NFTQIIQM 188 (255)
Q Consensus 181 t~~~vl~~ 188 (255)
|++|++++
T Consensus 307 t~~e~l~h 314 (317)
T cd07868 307 TSEQAMQD 314 (317)
T ss_pred CHHHHhcC
Confidence 99999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=229.84 Aligned_cols=177 Identities=26% Similarity=0.468 Sum_probs=143.3
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 3 lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~-~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
+.||.| +.-++.++.+.. +.+++.-+-++...++.||.||.++ ||+|||+||+|||+|+. |++|++|||++-....
T Consensus 168 IcMelM-s~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~-GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 168 ICMELM-STCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER-GNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHH-HHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccC-CCEEeecccccceeec
Confidence 456777 455666666543 3488888888999999999999875 89999999999999998 7999999999987666
Q ss_pred ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch-HHHHHHHHhhcCCCC---C
Q 025244 82 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN-LQAAYAAAFKNVRPS---A 157 (255)
Q Consensus 82 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~---~ 157 (255)
....+...|-+.|||||.+.. .....|..++||||||++++||.||+.||.+.+. .+....+.. ...|. .
T Consensus 245 SkAhtrsAGC~~YMaPERidp-----~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~ 318 (391)
T KOG0983|consen 245 SKAHTRSAGCAAYMAPERIDP-----PDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGH 318 (391)
T ss_pred ccccccccCCccccCccccCC-----CCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcc
Confidence 655666789999999999863 2346788899999999999999999999998544 333333333 33333 3
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..+++.+.+++..||++|+.+||.+.++++|
T Consensus 319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 319 MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 4589999999999999999999999999987
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=235.99 Aligned_cols=184 Identities=26% Similarity=0.405 Sum_probs=145.1
Q ss_pred CEEEEecCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++||||++|++|.+++... ....+++..++.++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||++..
T Consensus 99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~-~~~kl~dfg~~~~ 177 (291)
T cd06639 99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE-GGVKLVDFGVSAQ 177 (291)
T ss_pred eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-CCEEEeecccchh
Confidence 37999999999999998742 22348999999999999999999999999999999999999988 6899999999885
Q ss_pred ccccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC--C
Q 025244 79 ESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--P 155 (255)
Q Consensus 79 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~ 155 (255)
..... ......|+..|+|||++.... .....++.++|+|||||++|||++|+.||.................. .
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQ---QYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL 254 (291)
T ss_pred cccccccccCccCCccccChhhhcCCC---CcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCC
Confidence 43222 223457889999999875311 01123678999999999999999999999876654444333222111 1
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....++..+.++|.+||+.+|++||++.+++++
T Consensus 255 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 234567889999999999999999999999886
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=231.02 Aligned_cols=180 Identities=29% Similarity=0.478 Sum_probs=149.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+.....+++..+..++.|++.||.|||+.+++|+||||+||+++++...++|+|||.+....
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 74 LFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153 (257)
T ss_pred EEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence 47999999999999999876554589999999999999999999999999999999999998874457999999987543
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
... ......|+..|+|||++.. ..++.++|+||||+++++|++|..||......+...........+....
T Consensus 154 ~~~~~~~~~~~~~~~~ape~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
T cd08225 154 DSMELAYTCVGTPYYLSPEICQN--------RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPN 225 (257)
T ss_pred CCcccccccCCCccccCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCC
Confidence 322 2233468899999998753 4577899999999999999999999987665555444444444444566
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.+.++.++|.+||..+|++||++.+++++
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 226 FSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 78999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=231.50 Aligned_cols=187 Identities=26% Similarity=0.416 Sum_probs=140.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP---RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
+++||||++||+|.+++..... ...++..+..++.|++.||+|||+++++||||||+||+++.+ +.++|+|||+++
T Consensus 70 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~-~~~kL~dfg~~~ 148 (269)
T cd05087 70 YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD-LTVKIGDYGLSH 148 (269)
T ss_pred cEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEECCccccc
Confidence 4799999999999999976432 235677788899999999999999999999999999999988 699999999987
Q ss_pred ccccccc---cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcC
Q 025244 78 EESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNV 153 (255)
Q Consensus 78 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 153 (255)
....... .....++..|+|||++...... .....++.++|+||||+++|||++ |+.||......+..........
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 227 (269)
T cd05087 149 NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGN-LLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227 (269)
T ss_pred cccCcceeecCCCcCCcccccCHhHhcccccc-ccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhccc
Confidence 4332211 1234577889999988531100 001235779999999999999996 9999987665544332222111
Q ss_pred C----CC-CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 154 R----PS-AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 154 ~----~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
. +. ....+..+.+++..|+ .+|++||++.+|+..|.
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 228 LKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1 11 2246788999999999 68999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=233.82 Aligned_cols=177 Identities=26% Similarity=0.340 Sum_probs=141.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+.+.... ..+++.+++.++.|++.||+|||+.|++||||||+||+++. +.+||+|||+++...
T Consensus 75 ~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~ 150 (282)
T cd07831 75 LALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD--DILKLADFGSCRGIY 150 (282)
T ss_pred EEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC--CCeEEEecccccccc
Confidence 479999996 68888887643 34899999999999999999999999999999999999988 689999999998654
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC------
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR------ 154 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------ 154 (255)
.........++..|+|||++.. ...++.++|+|||||++|||++|..||.+.+..+...........
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (282)
T cd07831 151 SKPPYTEYISTRWYRAPECLLT-------DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVL 223 (282)
T ss_pred cCCCcCCCCCCcccCChhHhhc-------CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 4433344568899999997642 245678999999999999999999999876554332221110000
Q ss_pred ----------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 155 ----------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 155 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.....++.++.++|.+||+.+|++||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0013467899999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=238.02 Aligned_cols=178 Identities=26% Similarity=0.422 Sum_probs=151.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
|++|||||-.|++.|.++.++ +.+++.++..+++..+.||+|||...-+|||||..|||++-+ |.+||+|||.|-...
T Consensus 103 LWIVMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~-G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD-GIAKLADFGVAGQLT 180 (502)
T ss_pred eEeehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc-chhhhhhccccchhh
Confidence 689999999999999998754 459999999999999999999999999999999999999988 799999999997543
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC---C
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---S 156 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~ 156 (255)
. -...++..||+.|||||++.. -.|+.++||||||++..||..|++||.+..+......+- .+..| .
T Consensus 181 DTMAKRNTVIGTPFWMAPEVI~E--------IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP-T~PPPTF~K 251 (502)
T KOG0574|consen 181 DTMAKRNTVIGTPFWMAPEVIEE--------IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP-TKPPPTFKK 251 (502)
T ss_pred hhHHhhCccccCcccccHHHHHH--------hccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc-CCCCCCCCC
Confidence 3 233467899999999999953 568889999999999999999999999877765543322 22222 2
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
++.++.++.++++.||-++|++|-|+.++++|-
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 567899999999999999999999999999873
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=232.03 Aligned_cols=181 Identities=25% Similarity=0.537 Sum_probs=146.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecC
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPR-------CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 73 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~-------~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Df 73 (255)
+++||||+++|+|.+++...... .+++..+..++.|++.||+|||++|++||||||+||+++.+ +.++++||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~-~~~~l~~~ 161 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ-REVKVSLL 161 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCC-CcEEEccc
Confidence 47999999999999999865521 48999999999999999999999999999999999999988 68999999
Q ss_pred cccccccccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHh
Q 025244 74 GLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAF 150 (255)
Q Consensus 74 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~ 150 (255)
|++....... ......++..|+|||.+.+ ...+.++||||||+++|+|++ |..||.+............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~ 233 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQE--------DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA 233 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc
Confidence 9987432211 1233456778999998753 456789999999999999998 8889977655444433332
Q ss_pred hcC-CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 151 KNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 151 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
... .+....++..+.+++.+||+.+|.+||++.+++..|.
T Consensus 234 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 222 2335568899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=234.18 Aligned_cols=178 Identities=28% Similarity=0.404 Sum_probs=143.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+ |++|.+++.... ..+++.+++.++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++....
T Consensus 74 ~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~ 150 (286)
T cd07832 74 FVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD-GVLKIADFGLARLFS 150 (286)
T ss_pred eEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC-CcEEEeeeeeccccc
Confidence 47999999 999999997654 349999999999999999999999999999999999999987 799999999998644
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC---
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--- 155 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--- 155 (255)
... ......|+..|+|||++.+ ...++.++||||+|+++|||++|.++|.+................+
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T cd07832 151 EEEPRLYSHQVATRWYRAPELLYG-------ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEE 223 (286)
T ss_pred CCCCCccccccCcccccCceeeec-------cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChH
Confidence 332 2344578999999998753 2446789999999999999999998887765544333222111100
Q ss_pred --------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 --------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 --------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.....+.++.++|.+||+.||.+||++++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 224 TWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 013456899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=234.38 Aligned_cols=181 Identities=26% Similarity=0.469 Sum_probs=142.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEE
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP----------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 70 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~----------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl 70 (255)
+++||||++|++|.+++..... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~-~~~kl 170 (295)
T cd05097 92 LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNH-YTIKI 170 (295)
T ss_pred cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCC-CcEEe
Confidence 4799999999999999975421 136788899999999999999999999999999999999987 68999
Q ss_pred ecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCchHHHH
Q 025244 71 ADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH--NKLPFEGMSNLQAA 145 (255)
Q Consensus 71 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~--g~~p~~~~~~~~~~ 145 (255)
+|||++....... ......++..|+|||++.. ..++.++|+||||+++|+|++ |..||......+..
T Consensus 171 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~ 242 (295)
T cd05097 171 ADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--------GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI 242 (295)
T ss_pred cccccccccccCcceeccCcCcCceeecChhhhcc--------CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH
Confidence 9999997533221 1122345678999998753 557889999999999999988 66788775544433
Q ss_pred HHHHh---h----cCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 146 YAAAF---K----NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 146 ~~~~~---~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
..... . .........++.+.+|+.+||+.||++||++.++++.|+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 243 ENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 22211 0 111224457899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=235.51 Aligned_cols=174 Identities=29% Similarity=0.384 Sum_probs=145.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... +++..+..++.|++.||.|||++|++|+||+|.||+++.+ +.+||+|||++....
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~ 152 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSGR--FPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD-GYIKITDFGFAKRVK 152 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEeeCCCccccC
Confidence 4799999999999999987643 8999999999999999999999999999999999999988 799999999998644
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
.. .....+++.|+|||.+.+ ...+.++|+||||+++|+|++|+.||...+....... ......+.+..+
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~ 221 (290)
T cd05580 153 GR--TYTLCGTPEYLAPEIILS--------KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK-ILEGKVRFPSFF 221 (290)
T ss_pred CC--CCCCCCCccccChhhhcC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HhcCCccCCccC
Confidence 33 344578999999998853 4567899999999999999999999987664333333 223333445667
Q ss_pred cHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARP-----NFTQIIQM 188 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~ 188 (255)
+..+.++|.+||..||.+|+ ++++++++
T Consensus 222 ~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 222 SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred CHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 89999999999999999999 77888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=236.67 Aligned_cols=178 Identities=35% Similarity=0.567 Sum_probs=143.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc-
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE- 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~- 79 (255)
+++||||+++++|.+++...+. +++..+..++.|++.||++||++|++|+||||+||+++.+ +.++|+|||.+...
T Consensus 73 ~~~v~~~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~-~~~~l~Dfg~~~~~~ 149 (260)
T PF00069_consen 73 LYIVMEYCPGGSLQDYLQKNKP--LSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN-GEVKLIDFGSSVKLS 149 (260)
T ss_dssp EEEEEEEETTEBHHHHHHHHSS--BBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT-SEEEESSGTTTEEST
T ss_pred cccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccc-ccccccccccccccc
Confidence 3799999999999999985444 9999999999999999999999999999999999999977 79999999999752
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---Hhhc---C
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA---AFKN---V 153 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~---~~~~---~ 153 (255)
..........++..|+|||++. ....++.++|+||||+++|+|++|..||............ .... .
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 222 (260)
T PF00069_consen 150 ENNENFNPFVGTPEYMAPEVLQ-------QGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS 222 (260)
T ss_dssp STTSEBSSSSSSGGGSCHHHHT-------TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH
T ss_pred cccccccccccccccccccccc-------ccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc
Confidence 3334455678899999999975 1366788999999999999999999999876322222111 1101 1
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 154 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 154 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.......+..+.++|.+||+.||++||++.+++++
T Consensus 223 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 223 SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112234899999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=236.57 Aligned_cols=178 Identities=23% Similarity=0.383 Sum_probs=141.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++..... .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~ 155 (301)
T cd07873 79 LTLVFEYLD-KDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKS 155 (301)
T ss_pred EEEEEeccc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCC-CcEEECcCcchhccC
Confidence 479999996 699999986543 48899999999999999999999999999999999999988 699999999997533
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC------
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV------ 153 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~------ 153 (255)
.. .......++..|+|||++.+ ...++.++||||||+++|+|++|++||.+.+..+..........
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 228 (301)
T cd07873 156 IPTKTYSNEVVTLWYRPPDILLG-------STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEET 228 (301)
T ss_pred CCCCcccccceeecccCcHHHhC-------CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence 22 22234467899999998753 24567899999999999999999999987665433322211100
Q ss_pred --------------CC---------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 154 --------------RP---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 154 --------------~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.+ ....+++.++++|.+||+.||.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred chhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 113567889999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=233.11 Aligned_cols=176 Identities=27% Similarity=0.479 Sum_probs=142.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... +++...+.++.|++.||+|||+.+++||||||+||+++.+ +.++|+|||+++...
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~ 157 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGA--LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEccCCCccccc
Confidence 3689999999999999986544 8899999999999999999999999999999999999987 689999999987432
Q ss_pred cc----cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC
Q 025244 81 LT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 156 (255)
Q Consensus 81 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 156 (255)
.. .......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||..................+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 229 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISG--------EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQ 229 (266)
T ss_pred cccccCCccccCCccccccCHHHhCC--------CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCC
Confidence 21 11223468899999998853 5578899999999999999999999987665554443333222222
Q ss_pred -CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 -AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+..+++.+.+++ .||..+|++||++++++++
T Consensus 230 ~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 230 LPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 345678889998 6888999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=231.17 Aligned_cols=177 Identities=28% Similarity=0.409 Sum_probs=145.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+... +++..+..++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||++....
T Consensus 68 ~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~-~~~~l~df~~~~~~~ 144 (262)
T cd05572 68 IYMLMEYCLGGELWTILRDRGL--FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN-GYVKLVDFGFAKKLK 144 (262)
T ss_pred cEEEEecCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC-CCEEEeeCCcccccC
Confidence 4799999999999999987543 8999999999999999999999999999999999999988 799999999998654
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCc--hHHHHHHHHh-hcCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS--NLQAAYAAAF-KNVRPSA 157 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~--~~~~~~~~~~-~~~~~~~ 157 (255)
.........++..|++||.+.. ..++.++|+||||+++|+|++|..||.... ..+....... ......+
T Consensus 145 ~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (262)
T cd05572 145 SGQKTWTFCGTPEYVAPEIILN--------KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP 216 (262)
T ss_pred cccccccccCCcCccChhHhcC--------CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC
Confidence 4333344578899999998743 456789999999999999999999997765 3333332221 2222334
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPN-----FTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt-----~~~vl~~ 188 (255)
...+.++.++|.+||..||++||+ +.|++++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 556899999999999999999999 7888775
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=233.24 Aligned_cols=177 Identities=24% Similarity=0.431 Sum_probs=142.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++|++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~ 152 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNT-GNVKLCDFGVAALLN 152 (277)
T ss_pred EEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCC-CCEEEccCCceeecC
Confidence 37999999999999998753 38999999999999999999999999999999999999987 799999999987543
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC-CC
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-AE 158 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 158 (255)
... ......|+..|+|||.+.. ...++.++|+||||+++|+|++|+.||.+.................. ..
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (277)
T cd06917 153 QNSSKRSTFVGTPYWMAPEVITE-------GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDN 225 (277)
T ss_pred CCccccccccCCcceeCHHHhcc-------CCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcc
Confidence 322 2334568899999998753 24467899999999999999999999987654433322111111111 22
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 159 NVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 159 ~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.++.++.+++.+||+.||++||++.+++.+
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 226 GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 378899999999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=229.04 Aligned_cols=187 Identities=24% Similarity=0.404 Sum_probs=141.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++||||++||+|.+++.+... ...+...+..++.|++.||+|||+++++||||||+|||++.+ +.++|+|||++..
T Consensus 70 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~-~~~~l~Dfg~~~~ 148 (268)
T cd05086 70 YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD-LTVKVGDYGIGPS 148 (268)
T ss_pred cEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC-ccEEecccccccc
Confidence 4799999999999999986432 236677788899999999999999999999999999999988 7899999999864
Q ss_pred cccc---cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcC-
Q 025244 79 ESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNV- 153 (255)
Q Consensus 79 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~- 153 (255)
.... .......++..|+|||++..... ......++.++||||||+++|||++ |..||......+..........
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (268)
T cd05086 149 RYKEDYIETEDDKCVPLRWLAPELVGEFHG-GLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV 227 (268)
T ss_pred cCcchhhhcccCCcCcccccCchhcccccC-ccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc
Confidence 2211 11234567889999998743110 0012345779999999999999997 5778876665544443322221
Q ss_pred ---CC-CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 154 ---RP-SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 154 ---~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
.+ ....+++.+.+++..|| .+|++||++.++++.|.
T Consensus 228 ~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 228 KLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11 13457788999999999 68999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=235.80 Aligned_cols=176 Identities=28% Similarity=0.429 Sum_probs=144.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++|++|.+++... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++....
T Consensus 93 ~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~-~~~kL~dfg~~~~~~ 168 (297)
T cd06659 93 LWVLMEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQIS 168 (297)
T ss_pred EEEEEecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC-CcEEEeechhHhhcc
Confidence 47999999999999988652 38999999999999999999999999999999999999988 799999999987433
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC--CCCC
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--RPSA 157 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~ 157 (255)
... ......|+..|+|||++.+ ..++.++|+||||+++|||++|+.||...+..+.......... ....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 240 (297)
T cd06659 169 KDVPKRKSLVGTPYWMAPEVISR--------TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNA 240 (297)
T ss_pred cccccccceecCccccCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCcccc
Confidence 221 2234578999999998853 4578899999999999999999999987665554433322111 1123
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..++..+.++|.+||+.+|++||++.+++++
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 4578899999999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=231.09 Aligned_cols=174 Identities=27% Similarity=0.364 Sum_probs=142.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++...+. +++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||+++...
T Consensus 72 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~ 148 (260)
T cd05611 72 LYLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT-GHLKLTDFGLSRNGL 148 (260)
T ss_pred EEEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEeecccceecc
Confidence 4799999999999999987544 8999999999999999999999999999999999999988 699999999987533
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC---CCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR---PSA 157 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~ 157 (255)
. .....++..|++||.+.+ ..++.++|+||||+++|+|++|..||...+..+........... ...
T Consensus 149 ~---~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (260)
T cd05611 149 E---NKKFVGTPDYLAPETILG--------VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVK 217 (260)
T ss_pred c---cccCCCCcCccChhhhcC--------CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCccc
Confidence 2 234568899999998853 34788999999999999999999999876655443333222211 123
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHH---HHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFT---QIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~---~vl~~ 188 (255)
..+++.+.++|.+||+.||++||++. |++.+
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 35789999999999999999999664 55444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=231.66 Aligned_cols=176 Identities=27% Similarity=0.452 Sum_probs=142.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+... +++..+..++.|++.||+|||+++++|+||||+||+++.+ +.++|+|||+++...
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGA--LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV-GNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCC-CCEEECcCccccccc
Confidence 3689999999999999986544 8889999999999999999999999999999999999988 799999999987432
Q ss_pred cc----cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC-
Q 025244 81 LT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP- 155 (255)
Q Consensus 81 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~- 155 (255)
.. .......|+..|+|||++.+ ..++.++|+||||+++|||++|+.||..................+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISG--------EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPV 229 (265)
T ss_pred cccccccccccCCCCccccChhhhcC--------CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCC
Confidence 21 11234568899999998853 456789999999999999999999998765544443333222222
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.+...+..+.++|.+|+. +|++||++++++++
T Consensus 230 ~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 230 LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 244567889999999995 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=235.67 Aligned_cols=178 Identities=29% Similarity=0.471 Sum_probs=140.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++...+. +++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||+++...
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~-~~~~l~dfg~~~~~~ 152 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIGA--LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKIGL 152 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCC-CCEEEeeCCCccccC
Confidence 4799999999999999987543 8999999999999999999999999999999999999987 799999999886311
Q ss_pred cc----------------cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHH
Q 025244 81 LT----------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 144 (255)
Q Consensus 81 ~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~ 144 (255)
.. .......++..|+|||.+.. ..++.++|+||||+++|||++|..||.+....+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~ 224 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--------QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 224 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 10 01112457889999998753 4578899999999999999999999987665544
Q ss_pred HHHHHhhcC-CCC-CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 145 AYAAAFKNV-RPS-AENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 145 ~~~~~~~~~-~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
......... .+. ...++.++.++|.+||+.||++||+..++.+.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 225 FGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred HHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 443333221 122 235789999999999999999999854444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=234.15 Aligned_cols=178 Identities=25% Similarity=0.385 Sum_probs=137.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++..... .+++..++.++.||++||.|||++|++||||||+||+++.+ +.++|+|||+++...
T Consensus 74 ~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~ 150 (284)
T cd07839 74 LTLVFEYCD-QDLKKYFDSCNG-DIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN-GELKLADFGLARAFG 150 (284)
T ss_pred eEEEEecCC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC-CcEEECccchhhccC
Confidence 479999996 689888876433 38999999999999999999999999999999999999988 799999999998543
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC------
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV------ 153 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~------ 153 (255)
.. .......++..|+|||++.+ ...++.++||||||+++|+|++|..|+......+..........
T Consensus 151 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
T cd07839 151 IPVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 223 (284)
T ss_pred CCCCCcCCCccccCCcChHHHhC-------CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChH
Confidence 22 22234567899999998753 23467899999999999999999888643332222211110000
Q ss_pred -----------------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 154 -----------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 154 -----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
......+++++.++|.+||+.||.+|||+.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 224 SWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00123467899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=245.18 Aligned_cols=176 Identities=25% Similarity=0.328 Sum_probs=138.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+ +++|.+++.... .+++.+++.++.|++.||.|||++||+||||||+|||++.+ +.++|+|||+++...
T Consensus 161 ~~lv~e~~-~~~l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~-~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 161 VCMVMPKY-KCDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEP-ENAVLGDFGAACKLD 236 (392)
T ss_pred EEEEehhc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEccCccccccC
Confidence 47999999 579999995443 39999999999999999999999999999999999999988 799999999997543
Q ss_pred ccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHHh----
Q 025244 81 LTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL---QAAYAAAF---- 150 (255)
Q Consensus 81 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~---~~~~~~~~---- 150 (255)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.+.... ........
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~ 308 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLAL--------DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQV 308 (392)
T ss_pred cccccccccccccccCccCHhHhcC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhcc
Confidence 221 1234579999999999853 56788999999999999999999999764321 11111000
Q ss_pred ---------------------hcCCC--------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 151 ---------------------KNVRP--------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 151 ---------------------~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....+ ....++.++.++|.+||..||++||++.+++.+
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 309 HPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 012346788999999999999999999999997
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=246.74 Aligned_cols=175 Identities=28% Similarity=0.533 Sum_probs=153.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+.+|+|++..|+|+.|+++++. ++...+..|++||+.||.|||++. |+|||||-+||||+.+.|.|||+|.|+|..
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 4689999999999999998876 999999999999999999999985 999999999999999889999999999986
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCC-
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA- 157 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 157 (255)
..... ....+|||.|||||+.- ..|+...||||||++|+||+|+..||..-.+..+.++.......|..
T Consensus 196 ~r~s~-aksvIGTPEFMAPEmYE---------E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl 265 (632)
T KOG0584|consen 196 LRKSH-AKSVIGTPEFMAPEMYE---------ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL 265 (632)
T ss_pred hhccc-cceeccCccccChHHHh---------hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh
Confidence 54443 34579999999999983 67899999999999999999999999877777777777766666541
Q ss_pred -CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 -ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 -~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.--.+++++||.+||.. ..+|+++.|+|.+
T Consensus 266 ~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 266 SKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred hccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 22258999999999999 9999999999986
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=233.35 Aligned_cols=178 Identities=30% Similarity=0.365 Sum_probs=142.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+ +++|.+++.... ..+++..++.++.|+++||.|||++|++|+||||+||+++.+ +.++|+|||+++...
T Consensus 77 ~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~ 153 (298)
T cd07841 77 INLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD-GVLKLADFGLARSFG 153 (298)
T ss_pred EEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC-CCEEEccceeeeecc
Confidence 47999999 899999998654 249999999999999999999999999999999999999988 799999999998544
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC----
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---- 155 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---- 155 (255)
.. .......++..|+|||.+.+ ...++.++|+||||+++|||++|.++|.+................+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (298)
T cd07841 154 SPNRKMTHQVVTRWYRAPELLFG-------ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN 226 (298)
T ss_pred CCCccccccccceeeeCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhh
Confidence 32 22334467889999998742 2456789999999999999999988887765543332221110000
Q ss_pred -----------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 -----------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 -----------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.....+.++.++|.+||+.||++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 013456889999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=236.41 Aligned_cols=178 Identities=24% Similarity=0.435 Sum_probs=141.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~-~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+++||||++|++|.+++...+. +++..+..++.|++.||.|||+ .+++||||||+||+++.+ +.++|+|||++...
T Consensus 74 ~~lv~ey~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~ 150 (308)
T cd06615 74 ISICMEHMDGGSLDQVLKKAGR--IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQL 150 (308)
T ss_pred EEEEeeccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecC-CcEEEccCCCcccc
Confidence 4799999999999999987543 8999999999999999999998 589999999999999988 68999999998753
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH----------
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA---------- 149 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~---------- 149 (255)
... ......|+..|+|||++.+ ..++.++|+||||+++|+|++|+.||...+.........
T Consensus 151 ~~~-~~~~~~~~~~~~aPE~~~~--------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 221 (308)
T cd06615 151 IDS-MANSFVGTRSYMSPERLQG--------THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKE 221 (308)
T ss_pred ccc-ccccCCCCcCccChhHhcC--------CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccC
Confidence 322 2345678999999998743 457789999999999999999999997544222111110
Q ss_pred -------------------------hhcCCCC--CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 150 -------------------------FKNVRPS--AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 150 -------------------------~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
.....+. ...++.+++++|.+||..||++||++.+++++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 222 SHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred CcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0000011 1235778999999999999999999999998843
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=233.03 Aligned_cols=176 Identities=28% Similarity=0.459 Sum_probs=143.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++|+||++|++|.+++.. . .+++..+..++.|++.||+|||++|++||||+|+||+++.+ +.++|+|||++....
T Consensus 91 ~~~v~e~~~~~~L~~~~~~-~--~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~ 166 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTH-T--RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD-GRVKLSDFGFCAQVS 166 (285)
T ss_pred EEEEEeccCCCCHHHHHHh-C--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC-CcEEEcccccchhhc
Confidence 3799999999999999987 2 38999999999999999999999999999999999999988 799999999887433
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC--CC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--SA 157 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~ 157 (255)
.. .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+............... ..
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd06648 167 KEVPRRKSLVGTPYWMAPEVISR--------LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNL 238 (285)
T ss_pred cCCcccccccCCccccCHHHhcC--------CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCccc
Confidence 22 12233568999999998753 457789999999999999999999998766544443333221111 12
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..++..+.++|.+||+.+|++||++.+++++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 3378899999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=237.37 Aligned_cols=176 Identities=30% Similarity=0.518 Sum_probs=143.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+. .+++.++..++.|++.||.|||+.|++||||||+|||++.+ +.++|+|||++....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~-~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQIT 166 (297)
T ss_pred EEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEECcCccceEcc
Confidence 47999999999999999753 28899999999999999999999999999999999999988 799999999987543
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC--CCC
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSA 157 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~ 157 (255)
... ......+++.|+|||.+.+ ..++.++|+||||+++|++++|..||.+.+.............. ..+
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (297)
T cd06656 167 PEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP 238 (297)
T ss_pred CCccCcCcccCCccccCHHHHcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCc
Confidence 222 2234568899999998853 55678999999999999999999999775544333222211111 124
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..++..+.+++.+||..+|++||++.+++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 5577899999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=221.62 Aligned_cols=187 Identities=24% Similarity=0.395 Sum_probs=147.2
Q ss_pred CEEEEecCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEeCCCCceEEecCccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGLA 76 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~--i~HrDikp~Nill~~~~~~~kl~Dfg~a 76 (255)
.|||+.|...|||.+.|.... +..+++.+.+.|+.++++||++||+.. +.||||||.|||++++ +.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~-~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS-GLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC-CceEEEeccCc
Confidence 489999999999999998753 335999999999999999999999998 9999999999999987 69999999988
Q ss_pred cccccccc----------cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHH--
Q 025244 77 REESLTEM----------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA-- 144 (255)
Q Consensus 77 ~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-- 144 (255)
+.....-. ......|..|+|||.+..- .+...+.++|||||||++|.|+.|..||+..-..-.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk-----~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl 251 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVK-----SHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL 251 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecc-----cCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence 74322211 1223468899999998652 245577899999999999999999999963221000
Q ss_pred HHHHHh-hcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 025244 145 AYAAAF-KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 193 (255)
Q Consensus 145 ~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~ 193 (255)
...+.. ....|....+|+.+.++|.+||+.||.+||++.+++..+.++.
T Consensus 252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 011111 1123445568999999999999999999999999999887653
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=230.99 Aligned_cols=180 Identities=28% Similarity=0.490 Sum_probs=145.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+++||||++|++|.+++..... ..+++..+..++.|++.||+|||++|++||||||+||+++++ +.++|+|||++...
T Consensus 74 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~ 152 (267)
T cd06610 74 LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED-GSVKIADFGVSASL 152 (267)
T ss_pred EEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccchHHHh
Confidence 3799999999999999986433 458999999999999999999999999999999999999988 68999999998743
Q ss_pred cccc-----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC
Q 025244 80 SLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 154 (255)
Q Consensus 80 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 154 (255)
.... ......|+..|++||++.. ...++.++|+||||+++|+|++|+.||...+..............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-------~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (267)
T cd06610 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQ-------VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPP 225 (267)
T ss_pred ccCccccccccccccCChhhcChHHHcc-------ccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCC
Confidence 3221 1234468999999998853 235788999999999999999999999876654443333322211
Q ss_pred CC-----CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 155 PS-----AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 155 ~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.. ...+++.+.+++.+||..||++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11 13567899999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=233.28 Aligned_cols=180 Identities=28% Similarity=0.390 Sum_probs=142.0
Q ss_pred CEEEEecCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
+++||||+++ +|.+++.... ...+++..++.++.||+.||.|||++|++||||||+||+++.+.+.++|+|||+++
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 3799999975 8999887543 23589999999999999999999999999999999999999833799999999987
Q ss_pred ccccc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC-
Q 025244 78 EESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP- 155 (255)
Q Consensus 78 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~- 155 (255)
..... .......+++.|+|||++.+ ...++.++|+||||+++|+|++|..||.+.+..............+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 232 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLG-------STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT 232 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhC-------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 54322 22233457889999998753 2446789999999999999999999998766555443322211000
Q ss_pred --------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 --------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 --------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....+++++.++|.+||..||.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 013578899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=244.44 Aligned_cols=184 Identities=32% Similarity=0.578 Sum_probs=163.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++||||+++-|.|..+|+.++. .++......+++||+.+|+|||+.+++||||...|||+.+. .-|||+|||+++...
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp-~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSP-QCVKLADFGLSRYLE 542 (974)
T ss_pred eeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCc-ceeeecccchhhhcc
Confidence 5899999999999999998654 49999999999999999999999999999999999999987 589999999999765
Q ss_pred cccccccCCC--ccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTEMMTAETG--TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
.........| ...|||||.++ ..+++.++|||.|||.+||++. |..||.+..+.+..-....+...|.+
T Consensus 543 d~~yYkaS~~kLPIKWmaPESIN--------fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P 614 (974)
T KOG4257|consen 543 DDAYYKASRGKLPIKWMAPESIN--------FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCP 614 (974)
T ss_pred ccchhhccccccceeecCccccc--------hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCC
Confidence 5544433344 46899999885 4779999999999999999986 99999999888888778888889999
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
+++|+.|..|+.+||+.+|.+||++.++...|.+.+.
T Consensus 615 ~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 615 PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 9999999999999999999999999999998876654
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=229.94 Aligned_cols=182 Identities=25% Similarity=0.405 Sum_probs=141.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPR-CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~-~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+++||||++|++|.+++...... ..++..+..++.|++.||+|||++|++||||||+||+++.+.+.++|+|||++...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 37999999999999999864321 12788888999999999999999999999999999999875468999999998753
Q ss_pred ccc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHh-hcCCCC
Q 025244 80 SLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA-YAAAF-KNVRPS 156 (255)
Q Consensus 80 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-~~~~~-~~~~~~ 156 (255)
... .......|+..|+|||.+.. ....++.++|+||||+++|+|++|+.||......... ..... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd06624 160 AGINPCTETFTGTLQYMAPEVIDK------GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI 233 (268)
T ss_pred ccCCCccccCCCCccccChhhhcc------ccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCC
Confidence 322 22233468899999998753 1234678999999999999999999999764432222 11111 112223
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+..+++++.+++.+||+.+|++||++.+++.+
T Consensus 234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 45678899999999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=229.10 Aligned_cols=182 Identities=27% Similarity=0.528 Sum_probs=145.3
Q ss_pred EEEEecCCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 2 VIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~----~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
++|+||+++|+|.+++.... ...++...++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~-~~~kl~dfg~~~ 161 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN-MTVCVADFGLSK 161 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCC-CCEEECcccccc
Confidence 68899999999999886422 1247888999999999999999999999999999999999987 689999999988
Q ss_pred cccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcC
Q 025244 78 EESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNV 153 (255)
Q Consensus 78 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 153 (255)
...... ......++..|++||.+.. ..++.++||||||+++|+|++ |+.||.+...............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05074 162 KIYSGDYYRQGCASKLPVKWLALESLAD--------NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR 233 (273)
T ss_pred cccCCcceecCCCccCchhhcCHhHHhc--------CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 543221 1223345678999998753 456789999999999999999 8999987655443333333323
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 154 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 154 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
.......+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 234 ~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 333456789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=241.02 Aligned_cols=177 Identities=26% Similarity=0.380 Sum_probs=135.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||+ .++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.++|+|||+++...
T Consensus 132 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 132 TCMVLPHY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDV-DQVCIGDLGAAQFPV 208 (357)
T ss_pred eEEEEEcc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEecCccccccc
Confidence 37999999 579999987643 349999999999999999999999999999999999999988 689999999997543
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCchH---------HHHHHHHh
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP-FEGMSNL---------QAAYAAAF 150 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p-~~~~~~~---------~~~~~~~~ 150 (255)
.........||..|+|||++.+ ..++.++|||||||++|||+++..+ |...... ........
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~ 280 (357)
T PHA03209 209 VAPAFLGLAGTVETNAPEVLAR--------DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS 280 (357)
T ss_pred cCcccccccccccccCCeecCC--------CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHH
Confidence 3333445679999999999853 5678899999999999999985544 3321111 00000000
Q ss_pred h-cCC----C----------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 151 K-NVR----P----------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 151 ~-~~~----~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
. ... + ....++.++.++|.+||+.||.+|||+.|+++|
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 281 TLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0 000 0 012456677889999999999999999999987
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=229.13 Aligned_cols=177 Identities=28% Similarity=0.454 Sum_probs=145.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~-~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+++||||++|++|.+++..... +++..++.++.|++.||+|||+ +|++|+||+|+||+++.+ +.++|+|||++...
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~ 150 (264)
T cd06623 74 ISIVLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK-GEVKIADFGISKVL 150 (264)
T ss_pred EEEEEEecCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCC-CCEEEccCccceec
Confidence 4799999999999999987543 9999999999999999999999 999999999999999988 79999999998854
Q ss_pred cccccc-ccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCc--hHHHHHHHHhh-cCCC
Q 025244 80 SLTEMM-TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS--NLQAAYAAAFK-NVRP 155 (255)
Q Consensus 80 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~--~~~~~~~~~~~-~~~~ 155 (255)
...... ....++..|+|||.+.. ..++.++|+||||+++|+|++|+.||.... ........... ....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 222 (264)
T cd06623 151 ENTLDQCNTFVGTVTYMSPERIQG--------ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS 222 (264)
T ss_pred ccCCCcccceeecccccCHhhhCC--------CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC
Confidence 433222 24568899999998753 467889999999999999999999997764 32232222222 2223
Q ss_pred CCCC-CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 SAEN-VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ~~~~-~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.... ++..+.++|.+||..+|++||++.+++++
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 3444 78999999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=227.79 Aligned_cols=178 Identities=26% Similarity=0.439 Sum_probs=150.1
Q ss_pred CEEEEecCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
.++||||++|++|.+++.+.. ...+++..++.++.|++.||+|||+.|++|+||+|.||+++.+ +.++|+|||++..
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~-~~~kl~d~g~~~~ 152 (256)
T cd08530 74 LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN-DLVKIGDLGISKV 152 (256)
T ss_pred EEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC-CcEEEeeccchhh
Confidence 379999999999999997632 2348999999999999999999999999999999999999987 6899999999986
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCC
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE 158 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 158 (255)
.... ......++..|++||.+.+ ..++.++|+||||+++|+|++|+.||...+..............+...
T Consensus 153 ~~~~-~~~~~~~~~~~~~Pe~~~~--------~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd08530 153 LKKN-MAKTQIGTPHYMAPEVWKG--------RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPP 223 (256)
T ss_pred hccC-CcccccCCccccCHHHHCC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCch
Confidence 4433 3344568899999998853 456779999999999999999999998877655555544444444556
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 159 NVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 159 ~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.++.++.+++.+||+.+|++||++.+++++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 224 IYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=235.23 Aligned_cols=183 Identities=24% Similarity=0.431 Sum_probs=143.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+++|+|.+++.......+++..+..++.|++.||+|||+++|+||||||+||+++.+ +.++++|||.+....
T Consensus 74 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~-~~~kl~d~~~~~~~~ 152 (314)
T cd08216 74 LYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD-GKVVLSGLRYSVSMI 152 (314)
T ss_pred EEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC-CceEEecCccceeec
Confidence 3799999999999999987655558999999999999999999999999999999999999987 799999999886432
Q ss_pred cc--------cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc
Q 025244 81 LT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 152 (255)
Q Consensus 81 ~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 152 (255)
.. .......++..|+|||++.. ....++.++|+||||+++|||++|+.||................
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~ 226 (314)
T cd08216 153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ------NLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGT 226 (314)
T ss_pred cccccccccccccccccccccccCHHHhcC------CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 11 11233457789999999853 12347789999999999999999999998765444332221110
Q ss_pred CC---------------------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 153 VR---------------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 153 ~~---------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
.. .....++.++.+++.+||+.||++||++.+++++-.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 227 VPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred CccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 00 001123467889999999999999999999998743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=239.08 Aligned_cols=179 Identities=27% Similarity=0.399 Sum_probs=157.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|++||-|-||.|+..|++++. |+...+..++..+++|++|||++|||.|||||+|++++.+ |-+||.|||+|+...
T Consensus 495 vYmLmEaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~-Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNR-GYLKLVDFGFAKKIG 571 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccC-CceEEeehhhHHHhc
Confidence 5789999999999999998766 9999999999999999999999999999999999999998 799999999999988
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC-CCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAEN 159 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~ 159 (255)
......+++||+.|.|||++.. .....++|.||||+++|||++|.+||.+.+++.....+...... ..+..
T Consensus 572 ~g~KTwTFcGTpEYVAPEIILn--------KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~ 643 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAPEIILN--------KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRR 643 (732)
T ss_pred cCCceeeecCCcccccchhhhc--------cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccc
Confidence 8888899999999999999874 34567999999999999999999999998887766555443322 23577
Q ss_pred CcHHHHHHHHHhcccCCCCCCC-----HHHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPN-----FTQIIQMLL 190 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt-----~~~vl~~l~ 190 (255)
++....++|+++...+|.+|-. +.+|..|-+
T Consensus 644 I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 644 ITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred cchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 8899999999999999999954 778887754
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=257.66 Aligned_cols=186 Identities=24% Similarity=0.352 Sum_probs=144.1
Q ss_pred CEEEEecCCCCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEe
Q 025244 1 MVIVTELLSGGTLRKYLLNMR---------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 71 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~---------~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~ 71 (255)
+++||||++||+|.+++.... ....+...++.++.|++.||+|||++||+||||||+||+++.+ +.++|+
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~d-g~vKLi 155 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF-GEVVIL 155 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCC-CCEEEE
Confidence 379999999999999997521 1225566788999999999999999999999999999999988 799999
Q ss_pred cCccccccccc-------------------cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhC
Q 025244 72 DFGLAREESLT-------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN 132 (255)
Q Consensus 72 Dfg~a~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g 132 (255)
|||+++..... ......+||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 156 DFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--------~~~S~kSDIWSLGVILyELLTG 227 (932)
T PRK13184 156 DWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--------VPASESTDIYALGVILYQMLTL 227 (932)
T ss_pred ecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--------CCCCcHhHHHHHHHHHHHHHHC
Confidence 99999754110 01123469999999998853 5678899999999999999999
Q ss_pred CCCCCCCchHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhHhh
Q 025244 133 KLPFEGMSNLQAAYAAAFKNVR--PSAENVPEELSIILTSCWKEDPNARP-NFTQIIQMLLNYLSA 195 (255)
Q Consensus 133 ~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp-t~~~vl~~l~~~~~~ 195 (255)
+.||.................. .....+++.+.+++.+||+.||++|| +++++++.|+.+...
T Consensus 228 ~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 228 SFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred CCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 9999875543333222111111 11246789999999999999999997 567777878777654
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=227.17 Aligned_cols=179 Identities=33% Similarity=0.523 Sum_probs=150.2
Q ss_pred CEEEEecCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++||||++|++|.+++.+.. ...+++..+..++.+++.||.|||++|++|+||+|+||+++.+ +.++|+|||++..
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~-~~~~l~d~~~~~~ 152 (258)
T cd08215 74 LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN-GLVKLGDFGISKV 152 (258)
T ss_pred EEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC-CcEEECCccceee
Confidence 379999999999999998753 3459999999999999999999999999999999999999987 6999999999985
Q ss_pred ccccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 79 ESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 79 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
..... ......|++.|+|||.+.. ..++.++|+||+|+++++|++|+.||...+..+...........+.+
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (258)
T cd08215 153 LSSTVDLAKTVVGTPYYLSPELCQN--------KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIP 224 (258)
T ss_pred cccCcceecceeeeecccChhHhcc--------CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCC
Confidence 44332 2334578899999998753 45778999999999999999999999876655544444444444455
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..++..+.+++.+||..+|++||++.+++++
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 225 SQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 6788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=226.41 Aligned_cols=178 Identities=34% Similarity=0.546 Sum_probs=146.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++|++|.+++.... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~ 149 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD-GEVKLIDFGLSAQLS 149 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC-CeEEEeecccccccc
Confidence 378999999999999998753 349999999999999999999999999999999999999987 799999999998654
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC--CC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--AE 158 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~ 158 (255)
.........++..|++||.+.. ..++.++|+||||+++|+|++|+.||...+................ ..
T Consensus 150 ~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (253)
T cd05122 150 DTKARNTMVGTPYWMAPEVING--------KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPE 221 (253)
T ss_pred ccccccceecCCcccCHHHHcC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCccc
Confidence 4332345678899999998853 3467899999999999999999999987655444443333222222 23
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 159 NVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 159 ~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.++..+.++|.+||+.||++|||+.+++++
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 348899999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=229.63 Aligned_cols=176 Identities=30% Similarity=0.419 Sum_probs=145.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.... .+++..+..++.|+++||.|||++|++|+||+|+||+++++ +.++|+|||++....
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~ 151 (258)
T cd05578 75 MYLVVDLLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ-GHVHITDFNIATKVT 151 (258)
T ss_pred EEEEEeCCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC-CCEEEeecccccccC
Confidence 479999999999999998753 38999999999999999999999999999999999999988 699999999998654
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch--HHHHHHHHhhcCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN--LQAAYAAAFKNVRPSAE 158 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~ 158 (255)
.........|+..|+|||.+.. ..++.++|+||||+++|+|++|..||...+. ...............+.
T Consensus 152 ~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (258)
T cd05578 152 PDTLTTSTSGTPGYMAPEVLCR--------QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPA 223 (258)
T ss_pred CCccccccCCChhhcCHHHHcc--------cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcc
Confidence 4433445678899999998853 4478899999999999999999999987654 22222222223344466
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCH--HHHHH
Q 025244 159 NVPEELSIILTSCWKEDPNARPNF--TQIIQ 187 (255)
Q Consensus 159 ~~~~~l~~li~~~l~~~p~~Rpt~--~~vl~ 187 (255)
.++.++.++|.+||+.||.+||++ .++++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 788999999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=237.20 Aligned_cols=180 Identities=22% Similarity=0.284 Sum_probs=133.5
Q ss_pred CEEEEecCCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC---CCCceEE
Q 025244 1 MVIVTELLSGGTLRKYLLNMR-------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE---DLKTIKL 70 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~-------~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~---~~~~~kl 70 (255)
+++||||++ ++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+|||+.. +.+.+||
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07867 75 VWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEE
Confidence 379999995 68988886321 224888999999999999999999999999999999999942 2268999
Q ss_pred ecCcccccccccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH----
Q 025244 71 ADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL---- 142 (255)
Q Consensus 71 ~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~---- 142 (255)
+|||+++...... ......||..|+|||++.+ ...++.++|||||||++|||++|++||......
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~ 226 (317)
T cd07867 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 226 (317)
T ss_pred eeccceeccCCCcccccccCcceecccccCcHHhcC-------CCccCcHHHHHhHHHHHHHHHhCCCCccccccccccc
Confidence 9999998543221 1234578999999998853 245788999999999999999999999643221
Q ss_pred -----HHHHHHHhhcC-------------------------------------CCCCCCCcHHHHHHHHHhcccCCCCCC
Q 025244 143 -----QAAYAAAFKNV-------------------------------------RPSAENVPEELSIILTSCWKEDPNARP 180 (255)
Q Consensus 143 -----~~~~~~~~~~~-------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp 180 (255)
........... .......+..+.+++.+||..||.+||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 306 (317)
T cd07867 227 NPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRI 306 (317)
T ss_pred ccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCccccc
Confidence 00000000000 000112345688899999999999999
Q ss_pred CHHHHHHH
Q 025244 181 NFTQIIQM 188 (255)
Q Consensus 181 t~~~vl~~ 188 (255)
|+.|++++
T Consensus 307 t~~e~l~h 314 (317)
T cd07867 307 TSEQALQD 314 (317)
T ss_pred CHHHHhcC
Confidence 99999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=228.88 Aligned_cols=179 Identities=27% Similarity=0.500 Sum_probs=144.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+.. .+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.++++|||+++...
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~ 159 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDAD-GICKISDFGISKKSD 159 (272)
T ss_pred eEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCC-CeEEEeecccccccc
Confidence 479999999999999998764 38999999999999999999999999999999999999988 799999999997533
Q ss_pred cc---cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC--
Q 025244 81 LT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-- 155 (255)
Q Consensus 81 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-- 155 (255)
.. .......|+..|+|||++.. ....++.++|+||||+++|++++|..||..................+
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHS------YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI 233 (272)
T ss_pred ccccccccccccCCccccCHHHhcc------ccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcC
Confidence 21 11234568899999998753 11346889999999999999999999997655544443322222111
Q ss_pred ---CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 ---SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....++..+.++|.+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 234 PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 123568899999999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=229.39 Aligned_cols=177 Identities=26% Similarity=0.473 Sum_probs=142.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~-~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+++||||++|++|.+++.... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.+ +.++|+|||.+...
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~-~~~~l~d~g~~~~~ 151 (265)
T cd06605 74 ISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSR-GQIKLCDFGVSGQL 151 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCC-CCEEEeecccchhh
Confidence 379999999999999998753 348999999999999999999999 999999999999999997 78999999998754
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCc----hHHHHHHHHhhcCCC
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS----NLQAAYAAAFKNVRP 155 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~----~~~~~~~~~~~~~~~ 155 (255)
..... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.... ..............+
T Consensus 152 ~~~~~-~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 222 (265)
T cd06605 152 VNSLA-KTFVGTSSYMAPERIQG--------NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP 222 (265)
T ss_pred HHHHh-hcccCChhccCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC
Confidence 32221 22678899999998853 467889999999999999999999997542 111111111121222
Q ss_pred -CCCC-CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 -SAEN-VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 -~~~~-~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.... ++.++.++|.+||..||++||++.+++.+
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 2222 78899999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=225.66 Aligned_cols=177 Identities=29% Similarity=0.530 Sum_probs=149.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++|++|.+++..... +++..+..++.|++.||.+||++|++||||||+||+++.+ +.++|+|||++....
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~ 150 (254)
T cd06627 74 LYIILEYAENGSLRQIIKKFGP--FPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD-GVVKLADFGVATKLN 150 (254)
T ss_pred EEEEEecCCCCcHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC-CCEEEeccccceecC
Confidence 3799999999999999987643 9999999999999999999999999999999999999987 799999999998644
Q ss_pred cccc-cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
.... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....................+..
T Consensus 151 ~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 222 (254)
T cd06627 151 DVSKDDASVVGTPYWMAPEVIEM--------SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEG 222 (254)
T ss_pred CCcccccccccchhhcCHhhhcC--------CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCC
Confidence 3322 234568899999998753 3367899999999999999999999987766555555444444445667
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
++..+.+++.+||..+|++||++.+++.+
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 88999999999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=238.26 Aligned_cols=173 Identities=28% Similarity=0.373 Sum_probs=139.3
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
++||||++ ++|.+.+... +++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++....
T Consensus 97 ~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 97 YLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGT 170 (353)
T ss_pred EEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEccCccceeCCC
Confidence 79999995 6899988643 8889999999999999999999999999999999999988 6999999999986554
Q ss_pred ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC-------
Q 025244 82 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR------- 154 (255)
Q Consensus 82 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------- 154 (255)
........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..............
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 171 SFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred CCCCCCCcccccccCHHHHhC--------CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 433445578899999998853 56788999999999999999999999876543322221110000
Q ss_pred -------------C-----------------C-----CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 155 -------------P-----------------S-----AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 155 -------------~-----------------~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+ . ....+..+.++|.+||+.||++||++.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0 11245678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=230.67 Aligned_cols=179 Identities=30% Similarity=0.518 Sum_probs=147.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||++....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~ 167 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD-GSVKLADFGFAAQLT 167 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCC-CCEEECccchhhhhc
Confidence 379999999999999999865 249999999999999999999999999999999999999987 799999999887433
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC--CC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--SA 157 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~ 157 (255)
.. .......++..|++||.+.+ ..++.++|+||||+++|+|++|+.||................... ..
T Consensus 168 ~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd06614 168 KEKSKRNSVVGTPYWMAPEVIKR--------KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNP 239 (286)
T ss_pred cchhhhccccCCcccCCHhHhcC--------CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcch
Confidence 22 12234567889999998753 456889999999999999999999998766655444433322222 23
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
..++..+.++|.+||+.+|.+||++.+++++.
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 34789999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=226.72 Aligned_cols=180 Identities=31% Similarity=0.481 Sum_probs=142.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++|+||++|++|.+++..... +++..+..++.+++.||.|||+.|++|+||+|+||+++++ +.+||+|||++....
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~ 150 (264)
T cd06626 74 VYIFMEYCSGGTLEELLEHGRI--LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN-GVIKLGDFGCAVKLK 150 (264)
T ss_pred EEEEEecCCCCcHHHHHhhcCC--CChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEcccccccccC
Confidence 4799999999999999986543 8889999999999999999999999999999999999987 799999999988543
Q ss_pred cccc-----cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhhcC-
Q 025244 81 LTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA-AYAAAFKNV- 153 (255)
Q Consensus 81 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~- 153 (255)
.... .....++..|+|||++.... ....+.++||||||+++|++++|+.||...+.... .........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-----~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 225 (264)
T cd06626 151 NNTTTMGEEVQSLAGTPAYMAPEVITGGK-----GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP 225 (264)
T ss_pred CCCCcccccccCCcCCcCccChhhccCCC-----CCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCC
Confidence 3221 12346788999999986411 13367899999999999999999999976543322 222222111
Q ss_pred -CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 154 -RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 154 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.+....+++.+.++|.+||+.+|++||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 226 PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 12233458899999999999999999999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=231.88 Aligned_cols=179 Identities=30% Similarity=0.351 Sum_probs=142.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++.... ..+++.++..++.|++.||+|||+.|++||||||+||+++.+ +.++|+|||++....
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~kL~dfg~~~~~~ 159 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDK-GCLKIADFGLARTYG 159 (309)
T ss_pred EEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccceeeecC
Confidence 479999996 68999988643 348999999999999999999999999999999999999988 799999999998644
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC----
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---- 155 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---- 155 (255)
.. .......++..|+|||++.+ ...++.++|+||||+++|||++|++||.+.+..+...........+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLG-------CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI 232 (309)
T ss_pred CccCCCCcccccccccChhhhcC-------CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 32 12233346788999998753 2456789999999999999999999998776655444332211000
Q ss_pred -------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 156 -------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 156 -------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
.....++.+.++|.+||+.||++|||+.+++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0122578899999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=228.84 Aligned_cols=179 Identities=27% Similarity=0.414 Sum_probs=142.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++.......+++..++.++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||++....
T Consensus 74 ~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~-~~~~l~dfg~~~~~~ 151 (284)
T cd07860 74 LYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFG 151 (284)
T ss_pred EEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEeeccchhhcc
Confidence 479999995 689999987655569999999999999999999999999999999999999988 699999999987543
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC----
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---- 155 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---- 155 (255)
.. .......++..|+|||++.+ ...++.++|+||||+++|+|++|+.||.+.+..............+
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd07860 152 VPVRTYTHEVVTLWYRAPEILLG-------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 224 (284)
T ss_pred cCccccccccccccccCCeEEec-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 22 12233457889999998753 2345778999999999999999999998765544333322111100
Q ss_pred ------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 ------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....++.++.++|.+||+.||.+||++++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 225 WPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 023467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=226.72 Aligned_cols=164 Identities=24% Similarity=0.307 Sum_probs=133.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++||+|.+++.+... +++..+..++.|++.||.|||++|++||||||+||+++.+ +.++++|||.+....
T Consensus 60 ~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~df~~~~~~~ 136 (237)
T cd05576 60 VFLVLQHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR-GHIQLTYFSRWSEVE 136 (237)
T ss_pred EEEEEecCCCCCHHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-CCEEEecccchhccc
Confidence 3799999999999999987544 8999999999999999999999999999999999999988 689999999876543
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
.. .....++..|+|||.+.. ..++.++|+||+|+++|||++|+.|+....... ........+..+
T Consensus 137 ~~--~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----~~~~~~~~~~~~ 201 (237)
T cd05576 137 DS--CDGEAVENMYCAPEVGGI--------SEETEACDWWSLGAILFELLTGKTLVECHPSGI-----NTHTTLNIPEWV 201 (237)
T ss_pred cc--cccCCcCccccCCcccCC--------CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----ccccccCCcccC
Confidence 22 233456778999998743 456789999999999999999998875422110 001111234567
Q ss_pred cHHHHHHHHHhcccCCCCCCCH
Q 025244 161 PEELSIILTSCWKEDPNARPNF 182 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt~ 182 (255)
+..++++|.+||+.||++||++
T Consensus 202 ~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 202 SEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred CHHHHHHHHHHccCCHHHhcCC
Confidence 8999999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=229.86 Aligned_cols=178 Identities=29% Similarity=0.445 Sum_probs=141.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+++++|.+++..... +++.+++.++.|++.||+|||+.|++|+||+|+||+++++ +.++|+|||++....
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~ 151 (286)
T cd07846 75 LYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLA 151 (286)
T ss_pred EEEEEecCCccHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CcEEEEeeeeeeecc
Confidence 4799999999999887765433 8999999999999999999999999999999999999988 799999999987533
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh--------
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK-------- 151 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~-------- 151 (255)
.. .......++..|+|||++.+ ...++.++||||||+++|||++|++||......+........
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07846 152 APGEVYTDYVATRWYRAPELLVG-------DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRH 224 (286)
T ss_pred CCccccCcccceeeccCcHHhcc-------ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhh
Confidence 22 22334568899999998753 234677999999999999999999999765544332221110
Q ss_pred ------------cCCC----------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 152 ------------NVRP----------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 152 ------------~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...+ ....++..+.+++.+||+.+|++||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000 123567889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=229.00 Aligned_cols=185 Identities=20% Similarity=0.374 Sum_probs=145.1
Q ss_pred CEEEEecCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMR-PRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~-~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++||||++|++|.+++.... ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.+ +.++|+|||++..
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~ 152 (286)
T cd06622 74 VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGN 152 (286)
T ss_pred EEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCC-CCEEEeecCCccc
Confidence 479999999999999987642 2248999999999999999999997 599999999999999987 7999999999875
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHhhcCCC
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA---AAFKNVRP 155 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~---~~~~~~~~ 155 (255)
.... ......++..|+|||.+.+.... ....++.++|+|||||++|+|++|+.||........... ........
T Consensus 153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd06622 153 LVAS-LAKTNIGCQSYMAPERIKSGGPN--QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT 229 (286)
T ss_pred ccCC-ccccCCCccCccCcchhcCCCCC--ccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCC
Confidence 4322 23345688899999988542211 123467899999999999999999999976443322211 11222223
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
.+..++.++.++|.+||+.+|++||++.+++++-
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 230 LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred CCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 3556889999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=230.20 Aligned_cols=172 Identities=27% Similarity=0.476 Sum_probs=137.5
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
++||||++|++|..+. .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++.....
T Consensus 75 ~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 75 SICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVN 147 (279)
T ss_pred EEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCC-CCEEEeeCCcceeccc
Confidence 6899999999997653 27888899999999999999999999999999999999998 7999999999975433
Q ss_pred ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHH------HHHHHHhhcCCC
Q 025244 82 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ------AAYAAAFKNVRP 155 (255)
Q Consensus 82 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~------~~~~~~~~~~~~ 155 (255)
. ......|+..|+|||++.+ ..++.++|+||||+++|+|++|+.||......+ ...........+
T Consensus 148 ~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (279)
T cd06619 148 S-IAKTYVGTNAYMAPERISG--------EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP 218 (279)
T ss_pred c-cccCCCCChhhcCceeecC--------CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC
Confidence 2 2344678999999999853 457889999999999999999999996532211 111111111111
Q ss_pred --CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 156 --SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 156 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
.....++++.++|.+||+.+|++||++.+++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 219 VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 2345778999999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=229.53 Aligned_cols=182 Identities=26% Similarity=0.491 Sum_probs=144.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~ 160 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE-DLVKISDFGLAKVLP 160 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccccccccc
Confidence 4799999999999999987543 38999999999999999999999999999999999999988 799999999998644
Q ss_pred cccc----cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHH-------------
Q 025244 81 LTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ------------- 143 (255)
Q Consensus 81 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~------------- 143 (255)
.... .....++..|++||.+.. ..++.++|+||||+++|||++|..|+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRT--------SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIV 232 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHcc--------CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccH
Confidence 2211 112344567999998753 457789999999999999999999986532211
Q ss_pred -HHHHHHh-hcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 144 -AAYAAAF-KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 144 -~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
....... ....+....++.++.+++.+||+.+|++||++.++++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111 122233456778999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=227.77 Aligned_cols=179 Identities=28% Similarity=0.409 Sum_probs=142.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++ ++|.+++.......+++..++.++.|++.||+|||+++++||||+|+||+++.+ +.++|+|||+++...
T Consensus 73 ~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~-~~~~l~df~~~~~~~ 150 (283)
T cd07835 73 LYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE-GALKLADFGLARAFG 150 (283)
T ss_pred EEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CcEEEeecccccccC
Confidence 379999995 799999987664459999999999999999999999999999999999999987 799999999997543
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC------
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV------ 153 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~------ 153 (255)
.. .......++..|+|||++.+ ...++.++|+||||+++|+|++|+.||.+.+.............
T Consensus 151 ~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd07835 151 VPVRTYTHEVVTLWYRAPEILLG-------SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDV 223 (283)
T ss_pred CCccccCccccccCCCCCceeec-------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence 22 12233456889999998753 23467899999999999999999999987665443333211100
Q ss_pred ----------------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 154 ----------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 154 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
......++..+.++|.+||+.||.+||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 224 WPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 01134567899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=227.52 Aligned_cols=178 Identities=24% Similarity=0.419 Sum_probs=141.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+.+. +++..++.++.|++.||.|||++|++|+||||+||+++.+...++|+|||++....
T Consensus 78 ~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 78 FNLFVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEEEEeccCCCcHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 4799999999999999987553 89999999999999999999999999999999999998764469999999987543
Q ss_pred ccc-----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHH---HHHhhc
Q 025244 81 LTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY---AAAFKN 152 (255)
Q Consensus 81 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---~~~~~~ 152 (255)
... ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||.......... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRG--------EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227 (268)
T ss_pred cccccCCccccccccccceeCHhHhcc--------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC
Confidence 221 1123467889999998853 456789999999999999999999997543322111 111111
Q ss_pred C-CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 153 V-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 153 ~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
. ...+..+++++.+++.+||..+|.+||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 1 22344678999999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=226.51 Aligned_cols=179 Identities=28% Similarity=0.433 Sum_probs=144.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||+ +|+|.+++.......+++..++.++.|++.+|.|||++|++|+||+|+||+++.+ +.++|+|||++....
T Consensus 73 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~ 150 (283)
T cd07830 73 LYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP-EVVKIADFGLAREIR 150 (283)
T ss_pred EEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CCEEEeecccceecc
Confidence 47999999 7899999987654458999999999999999999999999999999999999987 799999999998655
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC-----
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP----- 155 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~----- 155 (255)
.........++..|+|||++.. ...++.++|+||||++++||++|+.||......+...........+
T Consensus 151 ~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd07830 151 SRPPYTDYVSTRWYRAPEILLR-------STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW 223 (283)
T ss_pred CCCCcCCCCCcccccCceeeec-------CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhh
Confidence 4444445678899999998743 2446789999999999999999999997765544333221100000
Q ss_pred ------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 ------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.....+.++.++|++||+.+|++||++.|++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 224 PEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 011236789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=243.28 Aligned_cols=177 Identities=23% Similarity=0.303 Sum_probs=135.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.+||||++ +++|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||++.+ +.++|+|||+++...
T Consensus 235 ~~lv~e~~-~~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~-~~vkL~DFGla~~~~ 311 (461)
T PHA03211 235 TCLVLPKY-RSDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGP-EDICLGDFGAACFAR 311 (461)
T ss_pred EEEEEEcc-CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCC-CCEEEcccCCceecc
Confidence 37899999 5799999876433 49999999999999999999999999999999999999988 689999999997532
Q ss_pred ccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch-------HHHHHHHHh
Q 025244 81 LTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN-------LQAAYAAAF 150 (255)
Q Consensus 81 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~-------~~~~~~~~~ 150 (255)
... ......||..|+|||++.+ ..++.++|||||||++|||++|..++..... .........
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~--------~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~ 383 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAG--------DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR 383 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcC--------CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHH
Confidence 221 1224579999999999853 5578899999999999999998765432110 111111111
Q ss_pred hcC--------------------------CCC--------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 151 KNV--------------------------RPS--------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 151 ~~~--------------------------~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
... .+. ...++.++.+||.+||+.||.+|||+.|++++
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 384 QAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 000 01345688999999999999999999999987
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=229.58 Aligned_cols=177 Identities=27% Similarity=0.430 Sum_probs=141.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~-~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
++|||||++|++|.+++...+. +++..+..++.+++.||.|||+ .+++||||||+||+++.+ +.++|+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~d~gl~~~~ 154 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKGGP--IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSR-GQIKLCDFGVSGEL 154 (284)
T ss_pred EEEEEecCCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCC-CcEEEccCCcccch
Confidence 4799999999999999987543 8999999999999999999997 589999999999999988 69999999998743
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH-----------HHHHHH
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL-----------QAAYAA 148 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-----------~~~~~~ 148 (255)
... ......|+..|+|||++.+ ..++.++|+|||||++|++++|+.||...... ......
T Consensus 155 ~~~-~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd06620 155 INS-IADTFVGTSTYMSPERIQG--------GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI 225 (284)
T ss_pred hhh-ccCccccCcccCCHHHHcc--------CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH
Confidence 222 2234578999999998853 46778999999999999999999999764432 111111
Q ss_pred HhhcCCCC-CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 149 AFKNVRPS-AENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 149 ~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
........ ...++.++.+++.+||+.||.+||++.+++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 226 VQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11111111 223778999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=227.56 Aligned_cols=176 Identities=29% Similarity=0.461 Sum_probs=145.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++... .+++..+..++.|++.||.+||++|++|+||||.||+++.+ +.++|+|||++....
T Consensus 77 ~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~ 152 (277)
T cd06641 77 LWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLT 152 (277)
T ss_pred EEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC-CCEEEeecccceecc
Confidence 47999999999999999753 38999999999999999999999999999999999999988 789999999987543
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......................
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (277)
T cd06641 153 DTQIKRNTFVGTPFWMAPEVIKQ--------SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGN 224 (277)
T ss_pred cchhhhccccCCccccChhhhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcc
Confidence 221 2234568889999998753 4567899999999999999999999987655444333322222223456
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
++.++.+++.+||..+|.+||++.+++++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 225 YSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 78999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=230.36 Aligned_cols=178 Identities=26% Similarity=0.327 Sum_probs=141.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++..... .+++..++.++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++....
T Consensus 81 ~~lv~e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~ 157 (293)
T cd07843 81 IYMVMEYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR-GILKICDFGLAREYG 157 (293)
T ss_pred EEEEehhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-CcEEEeecCceeecc
Confidence 489999996 699999987543 48999999999999999999999999999999999999988 799999999998644
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC------
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV------ 153 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~------ 153 (255)
.. .......++..|+|||.+.+ ...++.++|+||||+++|+|++|..||......+..........
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 230 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLG-------AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI 230 (293)
T ss_pred CCccccccccccccccCchhhcC-------CccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHH
Confidence 33 22334567889999998753 23457899999999999999999999987665443322211100
Q ss_pred -----------------------CCC-CCC-CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 154 -----------------------RPS-AEN-VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 154 -----------------------~~~-~~~-~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
... ... +++.+.++|.+||+.||++||++.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 111 47889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=229.71 Aligned_cols=182 Identities=27% Similarity=0.468 Sum_probs=142.4
Q ss_pred CEEEEecCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~-~i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
+++||||++ |+|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||+++.+ +.+||+|||++.
T Consensus 75 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~-~~~kl~dfg~~~ 152 (283)
T cd06617 75 VWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRN-GQVKLCDFGISG 152 (283)
T ss_pred EEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC-CCEEEeeccccc
Confidence 479999996 7898888753 224589999999999999999999998 99999999999999988 799999999998
Q ss_pred ccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch-HHHHHHHHhhcCCC-
Q 025244 78 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN-LQAAYAAAFKNVRP- 155 (255)
Q Consensus 78 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~- 155 (255)
............++..|+|||.+.+.. ....++.++|+||||+++|+|++|+.||..... .+............
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd06617 153 YLVDSVAKTIDAGCKPYMAPERINPEL----NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQL 228 (283)
T ss_pred ccccccccccccCCccccChhhcCCcc----cccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCC
Confidence 644333333456889999999885311 114467899999999999999999999975332 22222222211111
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....++.++.++|.+||..+|++||++.+++++
T Consensus 229 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 229 PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 134578999999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=228.37 Aligned_cols=180 Identities=27% Similarity=0.390 Sum_probs=142.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++ ++|.+++.......+++..+..++.||+.||+|||++|++|+||+|+||+++.+.+.+||+|||++....
T Consensus 76 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 76 LYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred EEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 379999995 6899988766555578888899999999999999999999999999999998654679999999997543
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC----
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---- 155 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---- 155 (255)
.. .......++..|+|||++.+ ...++.++|+||||+++|+|++|+.||......+...........+
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (294)
T PLN00009 155 IPVRTFTHEVVTLWYRAPEILLG-------SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEET 227 (294)
T ss_pred CCccccccCceeecccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 22 22234567899999998742 2456789999999999999999999998766544443322111000
Q ss_pred ------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 ------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....+++++.+++.+||+.+|++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 228 WPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 123567889999999999999999999999986
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=223.73 Aligned_cols=177 Identities=32% Similarity=0.504 Sum_probs=146.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.... .+++..++.++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~ 152 (260)
T cd06606 76 LNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD-GVVKLADFGCAKRLG 152 (260)
T ss_pred EEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEcccccEEecc
Confidence 379999999999999998765 49999999999999999999999999999999999999987 799999999998655
Q ss_pred cccc---cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHh-hcCCC
Q 025244 81 LTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ-AAYAAAF-KNVRP 155 (255)
Q Consensus 81 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~-~~~~~~~-~~~~~ 155 (255)
.... .....++..|++||.+.. ...+.++|+||||+++++|++|..||....... ....... .....
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRG--------EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPE 224 (260)
T ss_pred cccccccccCCCCCccccCHhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcC
Confidence 4432 345678999999998853 347889999999999999999999998765222 2222221 22233
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.+..++..+.++|.+||+.||++||++.+++++
T Consensus 225 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 225 IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 355678999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=225.57 Aligned_cols=176 Identities=27% Similarity=0.459 Sum_probs=144.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... +++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||+++...
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~ 157 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGA--LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECccccccccc
Confidence 3689999999999999986544 8899999999999999999999999999999999999987 689999999998532
Q ss_pred cc----cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC-
Q 025244 81 LT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP- 155 (255)
Q Consensus 81 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~- 155 (255)
.. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..................+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 229 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISG--------EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPM 229 (264)
T ss_pred cccccCccccccCCcccccCHhhhcC--------CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCC
Confidence 21 11234568899999998853 456789999999999999999999998766555544443333222
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.+..+++.+.++|.+||. ++.+||++.+++.|
T Consensus 230 ~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 230 LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 356788999999999999 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=225.48 Aligned_cols=176 Identities=32% Similarity=0.469 Sum_probs=141.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+.+ .+++..++.++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||++....
T Consensus 68 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~ 144 (265)
T cd05579 68 LYLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN-GHLKLTDFGLSKVGL 144 (265)
T ss_pred EEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC-CCEEEEecccchhcc
Confidence 479999999999999998755 38999999999999999999999999999999999999988 799999999987533
Q ss_pred ccc---------ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh
Q 025244 81 LTE---------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 151 (255)
Q Consensus 81 ~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 151 (255)
... ......++..|++||.+.. ...+.++|+||||+++|++++|..||......+........
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~ 216 (265)
T cd05579 145 VRRQINLNDDEKEDKRIVGTPDYIAPEVILG--------QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG 216 (265)
T ss_pred cCcccccccccccccCcccCccccCHHHhcC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence 221 2233467889999998753 44678999999999999999999999876655444333322
Q ss_pred cC-CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025244 152 NV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 187 (255)
Q Consensus 152 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~ 187 (255)
.. .+....++..+.+++.+||+.+|.+||++.++.+
T Consensus 217 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~ 253 (265)
T cd05579 217 KIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEE 253 (265)
T ss_pred CcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHH
Confidence 21 1122234899999999999999999999944433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=232.75 Aligned_cols=183 Identities=21% Similarity=0.395 Sum_probs=141.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+.+++|.+++.+.....+++..+..++.|++.||+|||++|++||||||+||+++.+ +.++++||+.+....
T Consensus 74 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~-~~~~~~~~~~~~~~~ 152 (328)
T cd08226 74 LWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD-GLVSLSGLSHLYSLV 152 (328)
T ss_pred eEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC-CcEEEechHHHhhhh
Confidence 4799999999999999987655558999999999999999999999999999999999999988 699999998654221
Q ss_pred cccc--------cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc
Q 025244 81 LTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 152 (255)
Q Consensus 81 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 152 (255)
.... .....++..|+|||++.+ ....++.++|+||||+++|+|++|+.||.+....+.........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 226 (328)
T cd08226 153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQ------DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGP 226 (328)
T ss_pred ccCccccccccccccccCccCccChhhhcC------CCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCC
Confidence 1100 111234567999999853 22346789999999999999999999998765444332221110
Q ss_pred C----------------------------------------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 025244 153 V----------------------------------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQII 186 (255)
Q Consensus 153 ~----------------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl 186 (255)
. .+....++..+.++|++||..||++|||+.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l 306 (328)
T cd08226 227 PYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306 (328)
T ss_pred CCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0 011223567899999999999999999999999
Q ss_pred HHHH
Q 025244 187 QMLL 190 (255)
Q Consensus 187 ~~l~ 190 (255)
++-+
T Consensus 307 ~~~~ 310 (328)
T cd08226 307 SHAF 310 (328)
T ss_pred hCHH
Confidence 8754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=227.58 Aligned_cols=176 Identities=28% Similarity=0.457 Sum_probs=142.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++|++|.+++... .+++..+..++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||++....
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~ 167 (292)
T cd06657 92 LWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVS 167 (292)
T ss_pred EEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEcccccceecc
Confidence 37999999999999988643 28999999999999999999999999999999999999988 689999999887533
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc--CCCCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN--VRPSA 157 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~ 157 (255)
.. .......|+..|++||.+.+ ..++.++|+||+|+++|+|++|..||.+....+......... .....
T Consensus 168 ~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T cd06657 168 KEVPRRKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNL 239 (292)
T ss_pred cccccccccccCccccCHHHhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCc
Confidence 22 12234568899999998743 456789999999999999999999998765544333222111 11123
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..++..+.+++.+||+.+|.+||++.+++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 4578999999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=226.87 Aligned_cols=178 Identities=29% Similarity=0.367 Sum_probs=143.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++.......+++..++.++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++....
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~-~~~~l~dfg~~~~~~ 158 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD-GQVKIADFGLARIYS 158 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC-CCEEEeccCcceecc
Confidence 479999996 589999987554459999999999999999999999999999999999999998 799999999998654
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC-----
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP----- 155 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~----- 155 (255)
.........++..|+|||++.+ ..++.++|+||||+++|+|++|++||.+....+...........+
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQ--------SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW 230 (287)
T ss_pred CCcccccccccccccChHHhcc--------CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhc
Confidence 4433344567889999999853 456789999999999999999999998766554443332211100
Q ss_pred ---------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 ---------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....++..+.++|.+||+.||.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 012345778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=229.74 Aligned_cols=180 Identities=24% Similarity=0.443 Sum_probs=138.8
Q ss_pred EEEEecCCCCCHHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 2 VIVTELLSGGTLRKYLL---NMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~---~~~~~~~~~~~~~~~~~~i~~~L~~lH~~-~i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
++||||++ ++|.++.. ......+++..+..++.+++.||+|||+. +++||||||+||+++.+ +.++|+|||+++
T Consensus 79 ~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~ 156 (288)
T cd06616 79 WICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRN-GNIKLCDFGISG 156 (288)
T ss_pred EEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccC-CcEEEeecchhH
Confidence 68999995 56665443 23334599999999999999999999985 99999999999999987 689999999997
Q ss_pred ccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC--
Q 025244 78 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-- 155 (255)
Q Consensus 78 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-- 155 (255)
............|+..|+|||++.+. ....++.++|+||||+++|+|++|+.||..................+
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd06616 157 QLVDSIAKTRDAGCRPYMAPERIDPS-----ARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPIL 231 (288)
T ss_pred HhccCCccccccCccCccCHHHhccc-----cccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcC
Confidence 54433333445789999999998531 11357889999999999999999999997654222221111111111
Q ss_pred ---CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 ---SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....++.++.++|.+||+.||.+||++.+++++
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 123478999999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=243.80 Aligned_cols=179 Identities=31% Similarity=0.416 Sum_probs=156.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
||+||||+.||.++++|.+++. ..+..+..++.|++++++|||+++|+|||||.+|||++.++ ++||+|||++....
T Consensus 130 lylV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m-nikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM-NIKIADFGFSTFFD 206 (596)
T ss_pred eEEEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc-ceeeeccccceeec
Confidence 6899999999999999998776 77789999999999999999999999999999999999995 79999999999888
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
......+.+|++.|.|||++.+ ....++.+|+||+|+++|-|++|.+||++..-.+..........+ .+..+
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g-------~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r-Ip~~m 278 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNG-------KKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR-IPFYM 278 (596)
T ss_pred ccccccccCCCCCccChHhhcC-------cccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec-cccee
Confidence 8888889999999999999975 346678999999999999999999999986554444443333332 35567
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
+.+..++|+++|..+|.+|++.+++.++-+
T Consensus 279 s~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 279 SCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred echhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 889999999999999999999999998755
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=232.63 Aligned_cols=177 Identities=27% Similarity=0.357 Sum_probs=141.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+ +++|.+++...+. +++..+..++.|++.||.|||+++++||||||+||+++.+ +.+||+|||+++...
T Consensus 84 ~~lv~e~~-~~~L~~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELM-DTDLHQIIRSSQT--LSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCC-CCCHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECcCccccccC
Confidence 37999999 5799999986543 9999999999999999999999999999999999999988 699999999998543
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---------
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF--------- 150 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~--------- 150 (255)
.. .......++..|+|||.+.. ...++.++|+||||+++|+|++|+.||.+.+..........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLN-------CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232 (337)
T ss_pred CCcccccccccccCccChHHHhc-------CCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 32 22344568899999998753 23477899999999999999999999976543221111100
Q ss_pred -------------h--cC------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 151 -------------K--NV------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 151 -------------~--~~------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
. .. ......+++++.++|.+||+.+|.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0 00 00124578899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=227.74 Aligned_cols=178 Identities=28% Similarity=0.396 Sum_probs=139.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++++.|..++.+.. .+++.++..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++....
T Consensus 75 ~~iv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~ 151 (288)
T cd07833 75 LYLVFEYVERTLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSES-GVLKLCDFGFARALR 151 (288)
T ss_pred EEEEEecCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEEeeecccccC
Confidence 479999998776666555433 38999999999999999999999999999999999999987 799999999988544
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc------
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN------ 152 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~------ 152 (255)
... ......++..|+|||++.. ...++.++|+||||+++|+|++|++||.+....+.........
T Consensus 152 ~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (288)
T cd07833 152 ARPASPLTDYVATRWYRAPELLVG-------DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPS 224 (288)
T ss_pred CCccccccCcccccCCcCCchhcC-------CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 332 3344578899999999853 2267789999999999999999999998765443332211100
Q ss_pred --------------CC-----------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 153 --------------VR-----------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 153 --------------~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.. .....++.++.++|++||..+|++||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred HhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 0112347889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=229.88 Aligned_cols=177 Identities=29% Similarity=0.479 Sum_probs=143.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++|++|.+++.+.. +++.++..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~~---l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~-~~~kL~dfg~~~~~~ 166 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQIT 166 (293)
T ss_pred EEEEEecCCCCcHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCC-CCEEEccCcceeccc
Confidence 379999999999999997542 8899999999999999999999999999999999999987 689999999887433
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC--CCCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--RPSA 157 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~ 157 (255)
.. .......+++.|++||.+.. ..++.++|+||||+++|++++|+.||...+............. ....
T Consensus 167 ~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd06647 167 PEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP 238 (293)
T ss_pred ccccccccccCChhhcCchhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCc
Confidence 22 22234568899999998853 4567899999999999999999999987655443322221111 1123
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
..++..+.++|.+||..+|++||++.+++.+-
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 34678899999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=222.60 Aligned_cols=178 Identities=26% Similarity=0.420 Sum_probs=144.7
Q ss_pred CEEEEecCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
.++||||++|++|.+++.+. ....+++..++.++.|++.||.|||++|++|+||||+||+++. +.++|+|||++..
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~--~~~~l~d~g~~~~ 154 (260)
T cd08222 77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN--NLLKIGDFGVSRL 154 (260)
T ss_pred eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec--CCEeecccCceee
Confidence 37999999999999999752 2335899999999999999999999999999999999999975 4699999999875
Q ss_pred ccc-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 79 ESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 79 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
... ........|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T cd08222 155 LMGSCDLATTFTGTPYYMSPEALKH--------QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLP 226 (260)
T ss_pred cCCCcccccCCCCCcCccCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCc
Confidence 432 222344568899999998742 45677899999999999999999999875554444433333333335
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..++.++.++|.+||..+|++||++.+++++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 227 ETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred chhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 5678999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=233.26 Aligned_cols=176 Identities=28% Similarity=0.374 Sum_probs=138.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTN-CDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEECcccceeecc
Confidence 379999995 6898888643 39999999999999999999999999999999999999988 799999999987543
Q ss_pred ccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC---
Q 025244 81 LTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--- 153 (255)
Q Consensus 81 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--- 153 (255)
... ......|+..|+|||.+.+ ...++.++||||||+++|+|++|+.||.+.+.............
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~ 230 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS 230 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 221 1233568899999998642 24568899999999999999999999976554322211110000
Q ss_pred ------------------CC---------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 154 ------------------RP---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 154 ------------------~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.+ .....+.++.++|.+||+.+|.+||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 013457789999999999999999999999997
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=225.94 Aligned_cols=179 Identities=24% Similarity=0.377 Sum_probs=141.4
Q ss_pred CEEEEecCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMR-PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
++|||||++ ++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++++ +.++|+|||+++..
T Consensus 73 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~ 150 (284)
T cd07836 73 LMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR-GELKLADFGLARAF 150 (284)
T ss_pred EEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CcEEEeecchhhhh
Confidence 479999997 58999987654 2358999999999999999999999999999999999999988 79999999999754
Q ss_pred ccc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC---
Q 025244 80 SLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--- 155 (255)
Q Consensus 80 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--- 155 (255)
... .......++..|++||++.+ ...++.++|+||||+++|+|++|+.||.+.+..+...........+
T Consensus 151 ~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
T cd07836 151 GIPVNTFSNEVVTLWYRAPDVLLG-------SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTES 223 (284)
T ss_pred cCCccccccccccccccChHHhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Confidence 322 12234567889999998753 2346789999999999999999999998766544333222111000
Q ss_pred -------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 -------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 -------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..+..+..+.+++.+||+.||.+||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 224 TWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 012457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=231.97 Aligned_cols=179 Identities=28% Similarity=0.424 Sum_probs=141.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+. ++|.+++..... +++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~~~ 158 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQP--LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNED-CELRIGDFGMARGLS 158 (334)
T ss_pred EEEEEehhh-hhHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEecccccceeec
Confidence 479999995 799999976443 9999999999999999999999999999999999999988 799999999987533
Q ss_pred ccc-----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh----
Q 025244 81 LTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK---- 151 (255)
Q Consensus 81 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---- 151 (255)
... ......|+..|+|||.+.. ...++.++|+||||+++|||++|+.||.+.+...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~ 231 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLS-------LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP 231 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcC-------CcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCC
Confidence 221 1234578899999998753 234788999999999999999999999876543322111110
Q ss_pred ------------------cC---CCC-----CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 152 ------------------NV---RPS-----AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 152 ------------------~~---~~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
.. .+. ....+.++.++|.+||+.+|.+||++.+++.+-+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 00 000 1346789999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=227.12 Aligned_cols=179 Identities=26% Similarity=0.373 Sum_probs=141.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... +++..+..++.|++.||.|||++|++||||+|+||+++.+ +.++|+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~ 156 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRER--FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCC-CCEEEeeCccceecc
Confidence 3799999999999999987543 8899999999999999999999999999999999999988 799999999998543
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHHhhcCCC
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN---LQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~---~~~~~~~~~~~~~~ 155 (255)
... ......|+..|+|||.+.. ....++.++||||||+++|+|++|..||..... .............+
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRG------GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 230 (290)
T ss_pred cccccccccccCCcccCChhhccC------CCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC
Confidence 321 2234568899999998753 123456789999999999999999999964221 12222222223334
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 188 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~ 188 (255)
.+..++..+.+++.+||+.||.+|| ++.+++.+
T Consensus 231 ~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 231 YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 4566889999999999999999997 67777665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=226.86 Aligned_cols=178 Identities=24% Similarity=0.423 Sum_probs=137.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++ ++|.+++.+... .+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||+++...
T Consensus 78 ~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~ 154 (291)
T cd07844 78 LTLVFEYLD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER-GELKLADFGLARAKS 154 (291)
T ss_pred EEEEEecCC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCC-CCEEECccccccccC
Confidence 479999997 599999987543 48999999999999999999999999999999999999988 799999999987533
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-C-----
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN-V----- 153 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~----- 153 (255)
.. .......++..|+|||++.+ ...++.++||||+|+++|+|++|+.||.+.............. .
T Consensus 155 ~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07844 155 VPSKTYSNEVVTLWYRPPDVLLG-------STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEE 227 (291)
T ss_pred CCCccccccccccccCCcHHhhc-------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChh
Confidence 22 11223456889999998753 2346789999999999999999999997655221111111000 0
Q ss_pred ---------------------C---CCCCCCc--HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 154 ---------------------R---PSAENVP--EELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 154 ---------------------~---~~~~~~~--~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
. .....++ .++.+++.+||+.+|.+||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 0011233 788999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=224.87 Aligned_cols=178 Identities=30% Similarity=0.414 Sum_probs=143.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||.+....
T Consensus 73 ~~~v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~df~~~~~~~ 149 (283)
T cd05118 73 LYLVFEFMD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE-GVLKLADFGLARSFG 149 (283)
T ss_pred EEEEEeccC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC-CcEEEeeeeeeEecC
Confidence 479999996 59999888743 349999999999999999999999999999999999999987 689999999997544
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC----
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---- 155 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---- 155 (255)
... ......++..|+|||.+.+ ...++.++|+||||+++|+|++|+.||.+.+..+...........+
T Consensus 150 ~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (283)
T cd05118 150 SPVRPYTHYVVTRWYRAPELLLG-------DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEV 222 (283)
T ss_pred CCcccccCccCcccccCcHHHhc-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHh
Confidence 332 2234567889999998753 2357889999999999999999999998777655443332211110
Q ss_pred -------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 -------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 -------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....++.++.++|.+||+.||.+||++.+++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 223 WPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred cccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 012467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=226.74 Aligned_cols=181 Identities=29% Similarity=0.439 Sum_probs=146.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++ |+|.+.+..... .+++.++..++.|++.||.|||++|++||||+|+||+++.+ +.++|+|||++....
T Consensus 100 ~~lv~e~~~-g~l~~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~-~~~kl~dfg~~~~~~ 176 (317)
T cd06635 100 AWLVMEYCL-GSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASIAS 176 (317)
T ss_pred EEEEEeCCC-CCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCC-CCEEEecCCCccccC
Confidence 379999996 588888765433 38999999999999999999999999999999999999987 799999999987533
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC-CCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAEN 159 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~ 159 (255)
. .....|+..|+|||.+... ....++.++|+||||+++|+|++|+.||.................. .....
T Consensus 177 ~---~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (317)
T cd06635 177 P---ANSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE 248 (317)
T ss_pred C---cccccCCccccChhhhhcC-----CCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCcc
Confidence 2 2345788999999987421 1245778999999999999999999999876655554444333222 23446
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
+++.+.++|.+||+.+|.+||++.++++++...
T Consensus 249 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred ccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 788999999999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=225.69 Aligned_cols=179 Identities=29% Similarity=0.428 Sum_probs=140.3
Q ss_pred CEEEEecCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++||||++|++|.+++... ....+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||++..
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~ 154 (287)
T cd06621 76 IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK-GQVKLCDFGVSGE 154 (287)
T ss_pred EEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecC-CeEEEeecccccc
Confidence 47999999999999987642 23348899999999999999999999999999999999999988 6899999999875
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch----HHHHHHHHhhcCC
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN----LQAAYAAAFKNVR 154 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~ 154 (255)
..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... .............
T Consensus 155 ~~~~~-~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd06621 155 LVNSL-AGTFTGTSFYMAPERIQG--------KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN 225 (287)
T ss_pred ccccc-cccccCCccccCHHHhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc
Confidence 33221 123467889999998753 5578899999999999999999999976521 1111111111111
Q ss_pred CC-------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 155 PS-------AENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 155 ~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
+. ...+++.+.++|.+||..||.+|||+.|++++-
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 226 PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 11 124568899999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=226.08 Aligned_cols=180 Identities=25% Similarity=0.363 Sum_probs=142.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.... .+++..+..++.|++.||.|||+.+++||||||.||+++.+ +.++|+|||+++...
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~ 156 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEEECccccccc
Confidence 379999999999999997644 38999999999999999999999999999999999999988 689999999987533
Q ss_pred cccc--cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHHhhcCCC
Q 025244 81 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN---LQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~---~~~~~~~~~~~~~~ 155 (255)
.... .....|+..|++||.+.+ .....+.++|+||||+++|||++|..||..... .............+
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRG------GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP 230 (288)
T ss_pred cccccccccccCCccccCHHHhcC------CCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC
Confidence 2221 223468899999998753 112357799999999999999999999964321 11222222333344
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
.+..++..+.++|.+||+.||++|||+.++.+.|
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l 264 (288)
T cd05583 231 FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIK 264 (288)
T ss_pred CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHh
Confidence 5566889999999999999999999987766554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-32 Score=225.26 Aligned_cols=178 Identities=24% Similarity=0.389 Sum_probs=136.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||+. ++|.+++.... ..+.+..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||+++...
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYL-GELKLADFGLARAKS 154 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCC-CcEEEeccccccccC
Confidence 379999995 78888876543 237888889999999999999999999999999999999988 799999999987533
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-C-----
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN-V----- 153 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~----- 153 (255)
.. .......++..|+|||++.+ ...++.++|+||||+++|+|++|+.||.+.............. .
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07870 155 IPSQTYSSEVVTLWYRPPDVLLG-------ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED 227 (291)
T ss_pred CCCCCCCCccccccccCCceeec-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChh
Confidence 22 22234467899999998753 2346778999999999999999999998655432221111100 0
Q ss_pred ----------------C---CC-------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 154 ----------------R---PS-------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 154 ----------------~---~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
. +. ....+.++.+++.+|+..||.+|||+.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0 00 01225689999999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=234.87 Aligned_cols=185 Identities=30% Similarity=0.523 Sum_probs=159.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|||+|||..|+|.|||++..+..++....+.++.||.+|++||..+++|||||...|+|+.++ ..|||+|||+++...
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEn-hiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HIVKVADFGLSRLMT 416 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccccc-ceEEeeccchhhhhc
Confidence 6899999999999999999877668888889999999999999999999999999999999998 699999999999754
Q ss_pred cccccccCCC---ccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCC
Q 025244 81 LTEMMTAETG---TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPS 156 (255)
Q Consensus 81 ~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 156 (255)
.+. .+...| ...|.|||.+.. ..++.++|||+|||+|||+.| |-.||.+.+..+..-..........
T Consensus 417 gDT-YTAHAGAKFPIKWTAPEsLAy--------NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~ 487 (1157)
T KOG4278|consen 417 GDT-YTAHAGAKFPIKWTAPESLAY--------NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDG 487 (1157)
T ss_pred CCc-eecccCccCcccccCcccccc--------cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccC
Confidence 432 222223 467999998864 567889999999999999987 8899999887776666666666677
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
++.||+.+.+||+.||+.+|.+||+++++-+.++..+..
T Consensus 488 PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 488 PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 899999999999999999999999999999988766543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=231.06 Aligned_cols=174 Identities=30% Similarity=0.385 Sum_probs=141.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++|+||+ |++|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++....
T Consensus 95 ~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~-~~~kL~dfg~~~~~~ 169 (343)
T cd07851 95 VYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARHTD 169 (343)
T ss_pred EEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEcccccccccc
Confidence 47999999 78999999753 39999999999999999999999999999999999999988 799999999998643
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC-----
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP----- 155 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~----- 155 (255)
.. .....++..|+|||.+.. ...++.++||||||+++|++++|+.||.+................+
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 170 DE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred cc--ccCCcccccccCHHHHhC-------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 32 344578899999998742 2356789999999999999999999998766544333222111100
Q ss_pred -------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 -------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 -------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.....++++.++|.+||+.||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 012357899999999999999999999999886
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=218.96 Aligned_cols=176 Identities=34% Similarity=0.443 Sum_probs=145.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+++++|.+++..... +++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++....
T Consensus 68 ~~~v~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~ 144 (250)
T cd05123 68 LYLVLEYAPGGELFSHLSKEGR--FSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD-GHIKLTDFGLAKELS 144 (250)
T ss_pred eEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC-CcEEEeecCcceecc
Confidence 4799999999999999987543 8999999999999999999999999999999999999988 699999999998643
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
.. .......++..|++||.+.+ ...+.++|+||||+++|++++|+.||...+..+.... ......+.+..
T Consensus 145 ~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~ 215 (250)
T cd05123 145 SEGSRTNTFCGTPEYLAPEVLLG--------KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEK-ILKDPLRFPEF 215 (250)
T ss_pred cCCCcccCCcCCccccChHHhCC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HhcCCCCCCCC
Confidence 32 23345678899999998753 4467799999999999999999999987665333222 22333445666
Q ss_pred CcHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNF---TQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~---~~vl~~ 188 (255)
.+..+.+++.+||..||++||++ .+++++
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 78999999999999999999999 555543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=226.33 Aligned_cols=179 Identities=31% Similarity=0.438 Sum_probs=143.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++ |+|.+++..... .+++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.++|+|||++....
T Consensus 90 ~~lv~e~~~-g~l~~~~~~~~~-~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~-~~~kL~dfg~~~~~~ 166 (307)
T cd06607 90 AWLVMEYCL-GSASDILEVHKK-PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEP-GTVKLADFGSASLVS 166 (307)
T ss_pred EEEEHHhhC-CCHHHHHHHccc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCC-CCEEEeecCcceecC
Confidence 379999996 688888765433 38999999999999999999999999999999999999988 799999999987533
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC-CCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAEN 159 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~ 159 (255)
.. ....++..|+|||++... ....++.++||||||+++|||++|+.||.+.+.............. .....
T Consensus 167 ~~---~~~~~~~~y~aPE~~~~~-----~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (307)
T cd06607 167 PA---NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSND 238 (307)
T ss_pred CC---CCccCCccccCceeeecc-----CCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchh
Confidence 22 345688899999987421 1345778999999999999999999999876655544433322111 12345
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
++..+.++|.+||..+|++||++.+++.+.+
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 239 WSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred hCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 7889999999999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=229.37 Aligned_cols=177 Identities=29% Similarity=0.369 Sum_probs=143.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++.+.. .+++..++.++.|++.||+|||++|++||||||.||+++.+ +.++|+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~-~~~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN-CDLKICDFGLARGVD 154 (330)
T ss_pred eEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccCceEeec
Confidence 489999996 68999997654 49999999999999999999999999999999999999998 799999999998644
Q ss_pred ccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC-
Q 025244 81 LTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP- 155 (255)
Q Consensus 81 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~- 155 (255)
... ......++..|+|||++.+ ...++.++|+||||+++|+|++|++||.+....+...........+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 227 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLS-------SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227 (330)
T ss_pred ccccccccccccccccCcCCceeeec-------ccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCC
Confidence 332 2344568899999999864 2267889999999999999999999998766544333222111100
Q ss_pred -----------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 -----------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 -----------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....++.++.++|.+||+.+|.+||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 023467889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=223.54 Aligned_cols=178 Identities=27% Similarity=0.340 Sum_probs=140.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++.... ..+++..++.++.|++.||+|||++|++|+||||+||+++++ +.++|+|||++....
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~ 151 (287)
T cd07840 75 IYMVFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND-GVLKLADFGLARPYT 151 (287)
T ss_pred EEEEecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC-CCEEEccccceeecc
Confidence 479999996 59999987653 349999999999999999999999999999999999999998 799999999998544
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC---
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--- 155 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--- 155 (255)
... ......++..|+|||.+.+ ...++.++||||||+++|||++|+.||..................+
T Consensus 152 ~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd07840 152 KRNSADYTNRVITLWYRPPELLLG-------ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDE 224 (287)
T ss_pred CCCcccccccccccccCCceeeEc-------cccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchh
Confidence 332 1233467889999998753 2346789999999999999999999998766443332222111000
Q ss_pred --------------------------CCCC-CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 --------------------------SAEN-VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 --------------------------~~~~-~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.... ++..+.+++.+||..+|.+||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 225 NWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0011 37889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=227.04 Aligned_cols=176 Identities=28% Similarity=0.357 Sum_probs=140.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++... .+++..+..++.|++.||+|||+.|++||||||+||+++.+ +.+||+|||+++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~-~~~kl~d~g~~~~~~ 158 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSD-CRVKLADFGLARSLS 158 (337)
T ss_pred EEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccchhccc
Confidence 379999996 6999999764 38899999999999999999999999999999999999998 799999999997433
Q ss_pred ccc------ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-
Q 025244 81 LTE------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV- 153 (255)
Q Consensus 81 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~- 153 (255)
... ......|+..|+|||.+.+ ...++.++|+||||+++|+|++|+.||.+...............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLG-------STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231 (337)
T ss_pred cccccccCcchhcccccccccCceeeec-------cccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 221 2234568999999998753 24567899999999999999999999987654433222111100
Q ss_pred -----------------------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 154 -----------------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 154 -----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
......++.++.++|.+||+.||++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00123368899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=226.47 Aligned_cols=177 Identities=22% Similarity=0.270 Sum_probs=136.9
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
++||||+. ++|.+++.... ..+++.+++.++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||++.....
T Consensus 95 ~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~ 171 (310)
T cd07865 95 YLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD-GILKLADFGLARAFSL 171 (310)
T ss_pred EEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC-CcEEECcCCCcccccC
Confidence 79999995 68999887643 248999999999999999999999999999999999999988 7999999999975432
Q ss_pred cc-----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC---
Q 025244 82 TE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--- 153 (255)
Q Consensus 82 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--- 153 (255)
.. ......++..|+|||.+.+ ...++.++|+||||+++|||++|+.||.+.+.............
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 172 SKNSKPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccCCCCccCcccCccccCcHHhcC-------CcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 21 1223467889999998753 23457799999999999999999999987654433221111000
Q ss_pred -----------------CCC-----------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 154 -----------------RPS-----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 154 -----------------~~~-----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.+. ....+..+.++|.+||..||.+||++++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000 01124677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=240.26 Aligned_cols=180 Identities=30% Similarity=0.556 Sum_probs=158.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+.||||++++|||.+.|++..+..|-......++.||+.||.||.++++|||||...|+|+... ..|||+|||+.+...
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasp-rtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASP-RTVKICDFGLMRALG 263 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccc-ceeeeecccceeccC
Confidence 3589999999999999998545558888899999999999999999999999999999999886 699999999999765
Q ss_pred cccccccC----CCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCC
Q 025244 81 LTEMMTAE----TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~~~~~~~~----~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
..+....+ .....|+|||.+. ...++.++|||+|||++|||++ |..||.+....+.+..+......+
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLr--------h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLp 335 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLR--------HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLP 335 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhc--------cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCC
Confidence 54433322 3456899999985 4789999999999999999998 789999999999999888778888
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
.+..+++++.+++..||..+|++||++..|.+.+
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 8999999999999999999999999999997543
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=230.06 Aligned_cols=176 Identities=24% Similarity=0.308 Sum_probs=138.2
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
++||||++ ++|.+++.+. .+++..+..++.|++.||.|||+.|++||||||+||+++.+.+.++++|||+++....
T Consensus 92 ~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~ 167 (342)
T cd07854 92 YIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDP 167 (342)
T ss_pred EEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCC
Confidence 79999996 6999988643 3899999999999999999999999999999999999986546789999999875322
Q ss_pred cc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-----
Q 025244 82 TE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN----- 152 (255)
Q Consensus 82 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~----- 152 (255)
.. ......++..|+|||.+.. ...++.++|+|||||++|+|++|+.||.+..............
T Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 168 HYSHKGYLSEGLVTKWYRSPRLLLS-------PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred ccccccccccccccccccCHHHHhC-------ccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 11 1123457889999998742 2456789999999999999999999998765544332221110
Q ss_pred ------------------CCC------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 153 ------------------VRP------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 153 ------------------~~~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..+ ....++.++.++|.+||+.||.+||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000 123567889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=221.77 Aligned_cols=169 Identities=27% Similarity=0.467 Sum_probs=146.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc-c
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-E 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~-~ 79 (255)
||+|.||++||+|--+++++++ ++++.+..+..+|+.||.|||++||+.||||.+|+|++.. |++|++|+|+++. .
T Consensus 326 lffvieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldae-ghikltdygmcke~l 402 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccC-CceeecccchhhcCC
Confidence 6899999999999999987665 9999999999999999999999999999999999999998 7999999999985 4
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC-------CCchHHHHHHHHhhc
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE-------GMSNLQAAYAAAFKN 152 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~-------~~~~~~~~~~~~~~~ 152 (255)
.......+++||+.|+|||++. +..|+.+.|+|+|||+++||+.|+.||+ ..+..+-..+++...
T Consensus 403 ~~gd~tstfcgtpnyiapeilr--------geeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek 474 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILR--------GEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK 474 (593)
T ss_pred CCCcccccccCCCcccchhhhc--------ccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh
Confidence 4556778899999999999994 5789999999999999999999999995 223344455555555
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCC
Q 025244 153 VRPSAENVPEELSIILTSCWKEDPNARP 180 (255)
Q Consensus 153 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp 180 (255)
....+..++-....+++.-|++||.+|.
T Consensus 475 qiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 475 QIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cccccceeehhhHHHHHHhhcCCcHHhc
Confidence 5555667778888999999999999993
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=222.95 Aligned_cols=176 Identities=30% Similarity=0.450 Sum_probs=145.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+.+. +++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++++|||++....
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~-~~~~l~df~~~~~~~ 153 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD-MHIKITDFGTAKVLD 153 (280)
T ss_pred EEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEecCCccccccC
Confidence 4799999999999999987653 9999999999999999999999999999999999999988 799999999987433
Q ss_pred ccc---------------------ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 025244 81 LTE---------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM 139 (255)
Q Consensus 81 ~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 139 (255)
... ......++..|+|||++.. ..++.++|+||||++++++++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--------KPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCC--------CCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 221 1223457889999998753 44778999999999999999999999876
Q ss_pred chHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 025244 140 SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF----TQIIQM 188 (255)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~----~~vl~~ 188 (255)
.......... ......+..+++.+.++|.+||+.+|.+||++ .+++++
T Consensus 226 ~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 226 NEYLTFQKIL-KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred cHHHHHHHHH-hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 6443333322 33334456778999999999999999999999 887765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-33 Score=246.26 Aligned_cols=184 Identities=24% Similarity=0.409 Sum_probs=158.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
|+||||||.|||.-|+++...+..+.|+.+.-|++.++.||.+||.+.++|||||-.|||++.+ +.||+.|||.+...+
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e-~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLD 174 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEecc-CcEEEeeeeeeeeee
Confidence 6899999999999999998777779999999999999999999999999999999999999998 799999999988544
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC--CC
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--SA 157 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~ 157 (255)
. .....+.+||+.|||||++.+. +.....|+.++|+||||++..||..|.+|+-++.+...+..+....... .+
T Consensus 175 sT~grRnT~iGtP~WMAPEViac~---e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp 251 (953)
T KOG0587|consen 175 STVGRRNTFIGTPYWMAPEVIACD---ESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRP 251 (953)
T ss_pred cccccccCcCCCcccccceeeecc---cCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccch
Confidence 3 3456788999999999999763 3344567889999999999999999999999988877665443222211 15
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..+++++.++|..||.+|..+||++.++++|
T Consensus 252 ~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 252 KKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 6789999999999999999999999999875
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=227.97 Aligned_cols=177 Identities=28% Similarity=0.386 Sum_probs=138.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++++|||+ +++|.+++..... +++..++.++.|++.||.|||++|++||||||+|||++.+ +.++|+|||+++...
T Consensus 81 ~~~~~e~~-~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~-~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELM-EADLHQIIRSGQP--LTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD-CELKICDFGLARGFS 156 (332)
T ss_pred EEEEEecc-cCCHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCC-CCEEeCcCCCceecc
Confidence 37899999 4799999976443 9999999999999999999999999999999999999988 799999999997533
Q ss_pred ccc-----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh----
Q 025244 81 LTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK---- 151 (255)
Q Consensus 81 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---- 151 (255)
... ......|+..|+|||++.+ ...++.++|+||||+++|+|++|++||.+.+...........
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLS-------FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP 229 (332)
T ss_pred cccccccccccCcccCccccCcHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCC
Confidence 211 1233578999999998742 245678999999999999999999999865533222111100
Q ss_pred ---------------------cCC-----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 152 ---------------------NVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 152 ---------------------~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
... ......+..+.+++.+||+.||.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000 0123457889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=224.21 Aligned_cols=183 Identities=25% Similarity=0.444 Sum_probs=141.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~-~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+++||||+ +++|.+++..... .+++..+..++.|++.||+|||+ .|++||||+|+||+++++ +.++|+|||++...
T Consensus 89 ~~~v~e~~-~~~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~-~~~kL~dfg~~~~~ 165 (296)
T cd06618 89 VFICMELM-STCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDAS-GNVKLCDFGISGRL 165 (296)
T ss_pred EEEEeecc-CcCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCC-CCEEECccccchhc
Confidence 47999999 4688888776433 48999999999999999999997 599999999999999987 79999999998754
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhhcC--CCC
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA-YAAAFKNV--RPS 156 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-~~~~~~~~--~~~ 156 (255)
..........++..|+|||.+.+.. ....++.++|+||||+++|+|++|+.||......... ........ .+.
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06618 166 VDSKAKTRSAGCAAYMAPERIDPPD----PNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP 241 (296)
T ss_pred cCCCcccCCCCCccccCHhhcCCCC----CccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCC
Confidence 4333333446788999999985411 0234678999999999999999999999764332222 22222211 112
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
...++.++.+++.+||+.||.+||++.+++++.+
T Consensus 242 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 2347889999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=227.84 Aligned_cols=179 Identities=21% Similarity=0.256 Sum_probs=136.5
Q ss_pred CEEEEecCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC----CCCceEEecC
Q 025244 1 MVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE----DLKTIKLADF 73 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~----~~~~~kl~Df 73 (255)
+++||||++ ++|.+++.... ...+++..++.++.|++.||.|||+++++||||||+||+++. + +.+||+||
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~-~~~kl~Df 156 (316)
T cd07842 79 VYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPER-GVVKIGDL 156 (316)
T ss_pred EEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCcc-ceEEECCC
Confidence 489999996 68888876532 225899999999999999999999999999999999999998 6 68999999
Q ss_pred cccccccccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHH------
Q 025244 74 GLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ------ 143 (255)
Q Consensus 74 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~------ 143 (255)
|+++...... ......++..|+|||++.+ ...++.++|+||||+++++|++|+.||.+.....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~ 229 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF 229 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchh
Confidence 9988543221 1233467899999998753 2456789999999999999999999997544321
Q ss_pred ---HHHHHHh------------------------hcCCCCCC------------CCcHHHHHHHHHhcccCCCCCCCHHH
Q 025244 144 ---AAYAAAF------------------------KNVRPSAE------------NVPEELSIILTSCWKEDPNARPNFTQ 184 (255)
Q Consensus 144 ---~~~~~~~------------------------~~~~~~~~------------~~~~~l~~li~~~l~~~p~~Rpt~~~ 184 (255)
....... ........ ..+.++.+++.+||+.||++|||+.+
T Consensus 230 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~e 309 (316)
T cd07842 230 QRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEE 309 (316)
T ss_pred HHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence 0000000 00000011 45678999999999999999999999
Q ss_pred HHHH
Q 025244 185 IIQM 188 (255)
Q Consensus 185 vl~~ 188 (255)
++++
T Consensus 310 il~~ 313 (316)
T cd07842 310 ALEH 313 (316)
T ss_pred HhcC
Confidence 9875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=249.08 Aligned_cols=178 Identities=30% Similarity=0.457 Sum_probs=133.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc-
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE- 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~- 79 (255)
|||=||||+..+|.+++.++... -.....++++++|++||+|+|++|+|||||||.||+++++ +.|||+|||+|...
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~-~~VKIGDFGLAt~~~ 748 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSR-NSVKIGDFGLATDLK 748 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCC-CCeeecccccchhhh
Confidence 58889999988888888764421 1477899999999999999999999999999999999988 69999999999741
Q ss_pred ------------------ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch
Q 025244 80 ------------------SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 141 (255)
Q Consensus 80 ------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~ 141 (255)
......+..+||.-|+|||++.+.. ...|+.|+|+|||||+++||+. ||...-.
T Consensus 749 ~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~-----~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME 820 (1351)
T KOG1035|consen 749 ENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS-----SNKYNSKIDMYSLGIVLFEMLY---PFGTSME 820 (1351)
T ss_pred hhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc-----cccccchhhhHHHHHHHHHHhc---cCCchHH
Confidence 0111345678999999999996521 1368999999999999999984 4643222
Q ss_pred HHHHHHHHhhcCCCCCC----CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 142 LQAAYAAAFKNVRPSAE----NVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 142 ~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.............|.+. .--+.-..+|++|++.||.+|||+.|+++.
T Consensus 821 Ra~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 821 RASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 22222222222222221 112456789999999999999999999874
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=225.48 Aligned_cols=178 Identities=24% Similarity=0.304 Sum_probs=138.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+.+.... ..+++..+..++.|+++||+|||++|++|+||||+||+++++ +.++|+|||+++...
T Consensus 90 ~~lv~~~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~ 166 (311)
T cd07866 90 VYMVTPYMD-HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQ-GILKIADFGLARPYD 166 (311)
T ss_pred EEEEEecCC-cCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECcCccchhcc
Confidence 379999995 67888877543 349999999999999999999999999999999999999988 799999999997432
Q ss_pred ccc------------ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHH
Q 025244 81 LTE------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA 148 (255)
Q Consensus 81 ~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~ 148 (255)
... ......+++.|+|||.+.+ ...++.++||||||+++|||++|++||.+.+........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG-------ERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhC-------CCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 211 1123356888999998753 244678999999999999999999999876654433322
Q ss_pred HhhcCCC-----------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 149 AFKNVRP-----------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 149 ~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
......+ .....++.+.++|.+||+.||.+|||+.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 2111000 012344688999999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=225.09 Aligned_cols=179 Identities=28% Similarity=0.411 Sum_probs=143.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||+. |+|.+++..... .+++..+..++.|++.||.|||+++++||||||+||+++.+ +.++|+|||++....
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~~~-~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~ 166 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMA 166 (308)
T ss_pred eEEEEEccC-CCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCC-CcEEECCcccceeec
Confidence 379999996 688888865433 38999999999999999999999999999999999999987 799999999987543
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC-CCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAEN 159 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~ 159 (255)
. .....++..|+|||.+... ....++.++||||||+++|+|++|..||.................. .....
T Consensus 167 ~---~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (308)
T cd06634 167 P---ANXFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238 (308)
T ss_pred C---cccccCCccccCHHHHhhc-----ccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCccc
Confidence 2 2345688999999987421 1244677999999999999999999999876655444433332222 12446
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
++..+.++|.+||+.+|.+||++.+++++.+
T Consensus 239 ~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 7889999999999999999999999998744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=227.55 Aligned_cols=178 Identities=26% Similarity=0.347 Sum_probs=140.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ |+|.+++..... +++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||+++...
T Consensus 95 ~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~-~~~kl~dfg~~~~~~ 170 (335)
T PTZ00024 95 INLVMDIMA-SDLKKVVDRKIR--LTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK-GICKIADFGLARRYG 170 (335)
T ss_pred EEEEEeccc-cCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC-CCEEECCccceeecc
Confidence 479999996 699999976443 8999999999999999999999999999999999999988 799999999987543
Q ss_pred c---------------ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHH
Q 025244 81 L---------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 145 (255)
Q Consensus 81 ~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~ 145 (255)
. ........++..|+|||.+.+ ...++.++|+||||+++|+|++|+.||.+....+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 171 YPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG-------AEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cccccccccccccccccccccccccccCCCCChhccc-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 1 111223356889999998853 234678999999999999999999999877655443
Q ss_pred HHHHhhcCCC---------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 146 YAAAFKNVRP---------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 146 ~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
.........+ .....+.++.++|.+||+.+|++||++++++.+-
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 3222111100 0124578899999999999999999999999863
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=223.72 Aligned_cols=177 Identities=29% Similarity=0.453 Sum_probs=143.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||+. |+|.+++..... .+++.+++.++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++....
T Consensus 96 ~~lv~e~~~-~~l~~~l~~~~~-~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~-~~~kL~dfg~~~~~~ 172 (313)
T cd06633 96 AWLVMEYCL-GSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASKSS 172 (313)
T ss_pred EEEEEecCC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC-CCEEEeecCCCcccC
Confidence 379999995 688888875433 48999999999999999999999999999999999999988 689999999986432
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC-CCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-SAEN 159 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~ 159 (255)
......|+..|+|||++... ....++.++|+||||+++|+|++|..||...+............... ....
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNE 244 (313)
T ss_pred ---CCCCccccccccChhhcccc-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccc
Confidence 22355788999999987421 12457789999999999999999999998776655554443322221 2345
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
++..+.+++.+||+.+|.+||++.+++.+
T Consensus 245 ~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 245 WTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 77889999999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=223.92 Aligned_cols=178 Identities=24% Similarity=0.278 Sum_probs=139.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++| +|.+.+.... ..+++..+..++.|++.||+|||++|++|+||||+||+++++ +.+||+|||++....
T Consensus 91 ~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~ 167 (302)
T cd07864 91 FYLVFEYMDH-DLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK-GQIKLADFGLARLYN 167 (302)
T ss_pred EEEEEcccCc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CcEEeCccccccccc
Confidence 3799999975 7888877542 348999999999999999999999999999999999999988 699999999998543
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC----
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR---- 154 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---- 154 (255)
... ......++..|+|||.+.. ...++.++||||||+++|+|++|++||......+...........
T Consensus 168 ~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 168 SEESRPYTNKVITLWYRPPELLLG-------EERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred CCcccccccceeccCccChHHhcC-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 322 1223456788999998742 234577999999999999999999999876554433222221100
Q ss_pred -------------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 155 -------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 155 -------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.....++..+.+++.+||+.||.+||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0122468899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=207.19 Aligned_cols=162 Identities=25% Similarity=0.313 Sum_probs=127.6
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccccccccccCCC
Q 025244 11 GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 90 (255)
Q Consensus 11 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g 90 (255)
|||.+++..++ ..+++.+++.++.|++.||.|||+++ ||+|||++.+ +.+++ ||+++..... ...|
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~-~~~~~--fG~~~~~~~~----~~~g 66 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD-GLLKL--DGSVAFKTPE----QSRV 66 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc-cceee--ccceEeeccc----cCCC
Confidence 79999998643 34999999999999999999999998 9999999988 68888 9998864332 2368
Q ss_pred ccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC-------CCCCcH-
Q 025244 91 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-------AENVPE- 162 (255)
Q Consensus 91 t~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~- 162 (255)
|+.|+|||++.+ ..++.++|||||||++|||++|+.||..................+. ...++.
T Consensus 67 ~~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (176)
T smart00750 67 DPYFMAPEVIQG--------QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAA 138 (176)
T ss_pred cccccChHHhcC--------CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhh
Confidence 999999999853 5678899999999999999999999976544333222222211111 122333
Q ss_pred -HHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 163 -ELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 163 -~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
.+.++|.+||+.||.+||++.++++++.....
T Consensus 139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 139 RSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred hhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 69999999999999999999999999876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=219.16 Aligned_cols=178 Identities=29% Similarity=0.383 Sum_probs=141.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++.+.. ..+++..++.++.|++.||+|||++|++||||+|+||+++.+ +.++|+|||+++...
T Consensus 73 ~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~ 149 (282)
T cd07829 73 LYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD-GVLKLADFGLARAFG 149 (282)
T ss_pred eEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC-CCEEEecCCcccccC
Confidence 479999996 69999998763 239999999999999999999999999999999999999988 799999999998543
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC------
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV------ 153 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~------ 153 (255)
... ......++..|+|||.+.. ...++.++|+||||+++||+++|+.||.+...............
T Consensus 150 ~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (282)
T cd07829 150 IPLRTYTHEVVTLWYRAPEILLG-------SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES 222 (282)
T ss_pred CCccccCccccCcCcCChHHhcC-------CcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHH
Confidence 322 2334456788999998853 23678899999999999999999999987654433322211100
Q ss_pred -------------C---------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 154 -------------R---------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 154 -------------~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
. ......+..+.++|.+||..||.+||++.+++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 223 WPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred HHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0 0112347889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=237.62 Aligned_cols=179 Identities=19% Similarity=0.224 Sum_probs=133.1
Q ss_pred CEEEEecCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
.++|||++ +++|.+++.... ........+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 238 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~-~~vkL~DFGla~ 315 (501)
T PHA03210 238 TYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD-GKIVLGDFGTAM 315 (501)
T ss_pred eEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEEeCCCce
Confidence 37899999 578888876532 1123456778899999999999999999999999999999988 799999999998
Q ss_pred cccccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCc--hHHHHHHHHhhc
Q 025244 78 EESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP-FEGMS--NLQAAYAAAFKN 152 (255)
Q Consensus 78 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p-~~~~~--~~~~~~~~~~~~ 152 (255)
...... .....+||..|+|||++.+ ..++.++|||||||++|||++|..+ +.... ............
T Consensus 316 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~ 387 (501)
T PHA03210 316 PFEKEREAFDYGWVGTVATNSPEILAG--------DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387 (501)
T ss_pred ecCcccccccccccCCcCCCCchhhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhc
Confidence 543322 2234679999999999853 5678899999999999999998754 43221 111111111100
Q ss_pred C------------------------CC-------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 153 V------------------------RP-------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 153 ~------------------------~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
. .+ ....++.++.++|.+||+.||.+||++.|++.+-
T Consensus 388 ~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 388 SVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred ccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 0 00 0123566788899999999999999999999873
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=252.20 Aligned_cols=176 Identities=19% Similarity=0.242 Sum_probs=129.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC----------------
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED---------------- 64 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~---------------- 64 (255)
++++|||+ +++|.++|... ...+++.+++.++.||+.||.|||++||+||||||+||||+..
T Consensus 55 ~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~ 132 (793)
T PLN00181 55 IVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGS 132 (793)
T ss_pred hhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccc
Confidence 35679998 67999999754 3349999999999999999999999999999999999999542
Q ss_pred --CCceEEecCccccccccc-----------------cccccCCCccceecccccccccccccccCCCCchhhHHHHHHH
Q 025244 65 --LKTIKLADFGLAREESLT-----------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIV 125 (255)
Q Consensus 65 --~~~~kl~Dfg~a~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~ 125 (255)
.+.+|++|||+++..... ......+||+.|||||++.+ ..++.++|||||||+
T Consensus 133 ~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--------~~~~~~sDVwSlGvi 204 (793)
T PLN00181 133 DEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG--------SSSNCASDVYRLGVL 204 (793)
T ss_pred cccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc--------CCCCchhhhhhHHHH
Confidence 135677777777532110 00112468899999999853 567889999999999
Q ss_pred HHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 126 LWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 126 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
||||++|.+|+....... .........+...........++.+||+.+|.+||++.|++++
T Consensus 205 L~ELl~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 205 LFELFCPVSSREEKSRTM--SSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhhCCCchhhHHHHH--HHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 999999998875422111 1111111111111223556789999999999999999999875
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=216.69 Aligned_cols=185 Identities=25% Similarity=0.428 Sum_probs=144.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCC--CceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~--~~~kl~Dfg~a~~ 78 (255)
+|||||-|.||+|..+|+++.. +++.++..+..+|+.||.+||.+||.|||+||+|||-.... .-+||+||.+...
T Consensus 151 FYLVfEKm~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred EEEEEecccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence 5899999999999999997655 99999999999999999999999999999999999986542 2479999999863
Q ss_pred cccc--------cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH--------
Q 025244 79 ESLT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL-------- 142 (255)
Q Consensus 79 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-------- 142 (255)
.... ....+.+|+..|||||+..-. -+....|+.+.|.|||||++|-|++|.+||.+.=..
T Consensus 229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~f---v~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVF---VDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred cccCCCCCCCCCccccCcccchhhcchhHHhhh---ccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 2211 123466899999999987432 224467889999999999999999999999643211
Q ss_pred -----H-HHHHHHhhcCC--C--CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 143 -----Q-AAYAAAFKNVR--P--SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 143 -----~-~~~~~~~~~~~--~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
+ .+...+..... | ....++.+.+++|..+|..|+.+|-++.+++++-+
T Consensus 306 ~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 306 VCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred ccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 1 11111111111 1 24568899999999999999999999999998643
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=230.29 Aligned_cols=176 Identities=26% Similarity=0.434 Sum_probs=137.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
||+||||++||++-.+|-+.+- |++..+..++.++.+|+++.|..|+|||||||+|||||.+ |++||+|||++..+.
T Consensus 704 LYFVMdYIPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrd-GHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFR 780 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccC-Cceeeeeccccccce
Confidence 6899999999999999987665 9999999999999999999999999999999999999999 899999999985211
Q ss_pred cc---------c----------------------------------ccccCCCccceecccccccccccccccCCCCchh
Q 025244 81 LT---------E----------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKV 117 (255)
Q Consensus 81 ~~---------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~ 117 (255)
.. . .....+||+.|+|||++.. ..++..+
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r--------~g~~q~c 852 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR--------TGYTQLC 852 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--------cCccccc
Confidence 00 0 0113469999999999963 5678899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---hhcCCCCCCCCcHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 025244 118 DSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA---FKNVRPSAENVPEELSIILTSCWKEDPNARP---NFTQIIQM 188 (255)
Q Consensus 118 DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~vl~~ 188 (255)
|+||.||+||||+.|++||-+....+..++++ .....+...+++.+..++|.++.. +++.|. .+++|..|
T Consensus 853 dwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaH 928 (1034)
T KOG0608|consen 853 DWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAH 928 (1034)
T ss_pred hhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcC
Confidence 99999999999999999998766555443322 222234466788888888877542 556664 34445544
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=238.90 Aligned_cols=186 Identities=21% Similarity=0.237 Sum_probs=129.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPR------------------CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~------------------~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~ 62 (255)
++|||||+++++|.+++...... ......+..++.|++.||+|||++||+||||||+|||++
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~ 289 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFS 289 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEe
Confidence 47999999999999999754310 012334567899999999999999999999999999999
Q ss_pred CCCCceEEecCcccccccc--ccccccCCCccceecccccccccccccc--------------cCCCCchhhHHHHHHHH
Q 025244 63 EDLKTIKLADFGLAREESL--TEMMTAETGTYRWMAPELYSTVTLRQGE--------------KKHYNHKVDSYSFAIVL 126 (255)
Q Consensus 63 ~~~~~~kl~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~--------------~~~~~~~~DvwslG~~l 126 (255)
.+.+.+||+|||+++.... ........+++.|+|||.+......... ...++.++|||||||++
T Consensus 290 ~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL 369 (566)
T PLN03225 290 EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 369 (566)
T ss_pred CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHH
Confidence 7546899999999985322 2233456789999999976432110000 01244567999999999
Q ss_pred HHHHhCCCCCCCCchHHHHHHHHhhc----------CCC-C----------CCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 025244 127 WELLHNKLPFEGMSNLQAAYAAAFKN----------VRP-S----------AENVPEELSIILTSCWKEDPNARPNFTQI 185 (255)
Q Consensus 127 ~el~~g~~p~~~~~~~~~~~~~~~~~----------~~~-~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v 185 (255)
|||+++..++.. ............ ..+ . .........+||.+||+.||.+|||+.++
T Consensus 370 ~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~ 447 (566)
T PLN03225 370 LQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAA 447 (566)
T ss_pred HHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHH
Confidence 999997766542 111111111000 000 0 01112345689999999999999999999
Q ss_pred HHH
Q 025244 186 IQM 188 (255)
Q Consensus 186 l~~ 188 (255)
++|
T Consensus 448 L~H 450 (566)
T PLN03225 448 LAH 450 (566)
T ss_pred hCC
Confidence 997
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=225.13 Aligned_cols=172 Identities=28% Similarity=0.358 Sum_probs=137.0
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
++||||+. .+|.+++. ..+++..+..++.|++.||+|||++|++||||||+||+++.+ +.++|+|||+++....
T Consensus 96 ~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~-~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 96 YLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED-CELKILDFGLARHADA 169 (342)
T ss_pred EEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCCCCcCCCC
Confidence 79999995 57877663 138999999999999999999999999999999999999988 7999999999875432
Q ss_pred ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC--------
Q 025244 82 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-------- 153 (255)
Q Consensus 82 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-------- 153 (255)
. .....++..|+|||++.+ ...++.++|+||||+++|||++|+.||.+.+.............
T Consensus 170 ~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 170 E--MTGYVVTRWYRAPEVILN-------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred C--CCCceeeecccChhhhcC-------ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 2 234567889999998753 23467899999999999999999999987664443322221100
Q ss_pred ----------------CC------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 154 ----------------RP------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 154 ----------------~~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.+ .....+.++.++|.+||+.||.+||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 012467789999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=210.14 Aligned_cols=176 Identities=38% Similarity=0.531 Sum_probs=146.5
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
++||||+++++|.+++..... ++...++.++.+++.++.+||+.+++|+||+|.||+++.+ +.++++|||.+.....
T Consensus 63 ~l~~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~ 139 (244)
T smart00220 63 YLVMEYCDGGDLFDLLKKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED-GHVKLADFGLARQLDP 139 (244)
T ss_pred EEEEeCCCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC-CcEEEccccceeeecc
Confidence 789999999999999987554 8999999999999999999999999999999999999988 7999999999986555
Q ss_pred ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC--
Q 025244 82 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN-- 159 (255)
Q Consensus 82 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 159 (255)
........++..|++||.+.. ..++.++|+||||++++++++|..||.......................
T Consensus 140 ~~~~~~~~~~~~~~~pE~~~~--------~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (244)
T smart00220 140 GGLLTTFVGTPEYMAPEVLLG--------KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEW 211 (244)
T ss_pred ccccccccCCcCCCCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccc
Confidence 444556678899999998852 4567799999999999999999999987444444444333333222222
Q ss_pred -CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 160 -VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 160 -~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
++.++.+++.+||..+|++||++.+++++
T Consensus 212 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 212 KISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred cCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 88999999999999999999999999874
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=223.89 Aligned_cols=174 Identities=29% Similarity=0.348 Sum_probs=138.3
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
++|+|++ |++|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++++ +.++|+|||+++....
T Consensus 98 ~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 98 YLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARHTDD 172 (345)
T ss_pred EEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCC-CCEEEecccccccccc
Confidence 6788887 89999988653 38999999999999999999999999999999999999988 6999999999885432
Q ss_pred ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc---------
Q 025244 82 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN--------- 152 (255)
Q Consensus 82 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--------- 152 (255)
......++..|+|||.+.+ ...++.++|+||||+++|+|++|+.||...+............
T Consensus 173 --~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 173 --EMTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243 (345)
T ss_pred --cccccccCCCccCHHHHhC-------ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 2234578899999998742 2456789999999999999999999997655433222111100
Q ss_pred ---------------CCC------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 153 ---------------VRP------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 153 ---------------~~~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
..+ .....+.++.++|.+||+.||.+||++.+++++-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 000 0123578899999999999999999999999873
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=223.05 Aligned_cols=173 Identities=27% Similarity=0.356 Sum_probs=139.1
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
++||||+ |++|.+++... .+++..+..++.|++.||+|||+.|++||||||+||+++.+ +.++|+|||++.....
T Consensus 96 ~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~-~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 96 YLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQTDS 170 (343)
T ss_pred EEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeeccccccccc
Confidence 7999999 88999998743 38999999999999999999999999999999999999988 6899999999985432
Q ss_pred ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC-------
Q 025244 82 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR------- 154 (255)
Q Consensus 82 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------- 154 (255)
. .....++..|+|||.+.+ ...++.++|+||||+++|++++|+.||.+.+..............
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 171 E--MTGYVVTRWYRAPEVILN-------WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred C--ccccccCCcccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 2 234567899999998853 234678999999999999999999999876543332221110000
Q ss_pred -----------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 155 -----------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 155 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.....++..+.++|.+||+.||++||++.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0123567889999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=236.03 Aligned_cols=185 Identities=32% Similarity=0.603 Sum_probs=153.2
Q ss_pred CEEEEecCCCCCHHHHHHhcC------C--------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMR------P--------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~------~--------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
+++|+||++.|+|.++++..+ . ..++....+.++.||+.|++||+++.++||||-..|||++.+ .
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~-~ 455 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKN-K 455 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCC-C
Confidence 579999999999999999866 0 128888999999999999999999999999999999999998 6
Q ss_pred ceEEecCccccccccccccc--cCCC--ccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCch
Q 025244 67 TIKLADFGLAREESLTEMMT--AETG--TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSN 141 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~~~~~--~~~g--t~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~ 141 (255)
.+||+|||+++......... ...+ ...|||||.+. ...|+.++|||||||+||||++ |..||.+...
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~--------~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF--------DRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhc--------cCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 99999999999544333222 1222 34699999985 3678999999999999999998 8899998663
Q ss_pred HHHHHH-HHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 142 LQAAYA-AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 142 ~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
...... ...+.....+..+++++.++++.||+.+|++||++.++.+.+...+.
T Consensus 528 ~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 528 TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 333343 34444556688899999999999999999999999999999988654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=205.90 Aligned_cols=180 Identities=23% Similarity=0.293 Sum_probs=146.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||++|+ .+|..+|..... +++..++.+++.++..||.|+|.+.|+|||+|++|+||+.+ |.+||+|||+++..+
T Consensus 99 ~ylVf~~ce-hDLaGlLsn~~v-r~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~d-gilklADFGlar~fs 175 (376)
T KOG0669|consen 99 FYLVFDFCE-HDLAGLLSNRKV-RFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKD-GILKLADFGLARAFS 175 (376)
T ss_pred eeeeHHHhh-hhHHHHhcCccc-cccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCC-ceEEeecccccccee
Confidence 589999996 799999987533 49999999999999999999999999999999999999998 799999999998544
Q ss_pred ccc-----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC--
Q 025244 81 LTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-- 153 (255)
Q Consensus 81 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-- 153 (255)
... ..+..+.|.+|.+||.+.+ ...|+++.|+|..||++.||++|.+-+.+....++...+.....
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG-------~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLG-------DREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhc-------ccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 332 2344567999999999985 57789999999999999999999999988776655544322111
Q ss_pred C-------------------CCC-------------CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 154 R-------------------PSA-------------ENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 154 ~-------------------~~~-------------~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
. |.+ -.-.++..+++..+|..||.+|+++.+++++..
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 0 000 001246778999999999999999999999854
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=214.72 Aligned_cols=174 Identities=29% Similarity=0.372 Sum_probs=145.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|+||||| ..+|.+.+.-. ++.++...+++|++.|+.|||+.||+||||||+||++..+ ..+||.|||+|+...
T Consensus 96 ~y~v~e~m-~~nl~~vi~~e----lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~-~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILME----LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSD-CTLKILDFGLARTED 169 (369)
T ss_pred HHHHHHhh-hhHHHHHHHHh----cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecch-hheeeccchhhcccC
Confidence 47899999 48999999832 8889999999999999999999999999999999999998 599999999999877
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC----
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS---- 156 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 156 (255)
..-..+..+.|..|.|||++.+ ..+...+||||+||++.||++|+..|.+.+..++..+.......|.
T Consensus 170 ~~~~mtpyVvtRyyrapevil~--------~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 170 TDFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred cccccCchhheeeccCchheec--------cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 7756677889999999999975 3488899999999999999999999988777666544432221110
Q ss_pred -------------------------------------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 -------------------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 -------------------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...-+...++++.+||..||++|.+++++++|
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00112457889999999999999999999997
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=217.91 Aligned_cols=174 Identities=30% Similarity=0.424 Sum_probs=137.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+ +++|.+++... .+++..+..++.|+++||.|||++|++||||+|.||+++.+ +.++|+|||++....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~-~~~~l~dfg~~~~~~ 159 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN-CDLKICDFGLARIQD 159 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCC-CCEEeCccccccccC
Confidence 37999999 67999988643 27888888999999999999999999999999999999987 799999999987533
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh---------
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK--------- 151 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~--------- 151 (255)
. ......++..|+|||.+.+ ...++.++|+||||+++|+|++|+.||.+.............
T Consensus 160 ~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 160 P--QMTGYVSTRYYRAPEIMLT-------WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred C--CcCCCcccccccCceeeec-------cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 2 2234567889999998742 245788999999999999999999999775542221111000
Q ss_pred -------------c-----CCC---CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 152 -------------N-----VRP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 152 -------------~-----~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
. ..+ ....++..+.++|.+||+.+|++||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000 113467899999999999999999999999886
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=207.16 Aligned_cols=181 Identities=23% Similarity=0.282 Sum_probs=141.6
Q ss_pred CEEEEecCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC---CCceEEecCc
Q 025244 1 MVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED---LKTIKLADFG 74 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~---~~~~kl~Dfg 74 (255)
++||+||.+ .+|.+.|+-+. .+.++...+..++.||+.|+.|||++=|+||||||.|||+..+ .|.|||+|||
T Consensus 103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 479999997 79999998653 2458889999999999999999999999999999999999755 3689999999
Q ss_pred ccccccccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch---------
Q 025244 75 LAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN--------- 141 (255)
Q Consensus 75 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~--------- 141 (255)
+++.....- .....+.|.+|.|||.+.+ ...|+.+.|||++||++.||++-.+-|.+...
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLG-------a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq 254 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLG-------ARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ 254 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcc-------cccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence 999644331 2345678999999999985 57899999999999999999998887765332
Q ss_pred HHHHHHHHhhcCCCCCCC------------------------------------CcHHHHHHHHHhcccCCCCCCCHHHH
Q 025244 142 LQAAYAAAFKNVRPSAEN------------------------------------VPEELSIILTSCWKEDPNARPNFTQI 185 (255)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~------------------------------------~~~~l~~li~~~l~~~p~~Rpt~~~v 185 (255)
.++..++......|.... -++...+|+.++|+.||.+|.|+.+.
T Consensus 255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA 334 (438)
T KOG0666|consen 255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA 334 (438)
T ss_pred HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence 122223322222222111 12346679999999999999999999
Q ss_pred HHHH
Q 025244 186 IQML 189 (255)
Q Consensus 186 l~~l 189 (255)
+++.
T Consensus 335 leh~ 338 (438)
T KOG0666|consen 335 LEHP 338 (438)
T ss_pred hccc
Confidence 9984
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=217.09 Aligned_cols=177 Identities=24% Similarity=0.295 Sum_probs=142.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC----------------
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED---------------- 64 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~---------------- 64 (255)
++||+|.+ |-|+.++|..++-.+++...+..++.|+++++++||+.+++|-||||+|||+.+.
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceec
Confidence 36899999 8899999999887789999999999999999999999999999999999999422
Q ss_pred ---CCceEEecCccccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch
Q 025244 65 ---LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 141 (255)
Q Consensus 65 ---~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~ 141 (255)
.-.++|+|||-|+..... ..+.+.|..|.|||++.+ -.++..+||||+||+|+|+.+|...|+..++
T Consensus 245 ~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLg--------LGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILG--------LGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred cCCCcceEEEecCCcceeccC--cceeeeccccCCchheec--------cCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 125899999999864433 367789999999999986 4578899999999999999999999988776
Q ss_pred HHHHHHHH-hhcCCCC--------------------------------------------CCCCcHHHHHHHHHhcccCC
Q 025244 142 LQAAYAAA-FKNVRPS--------------------------------------------AENVPEELSIILTSCWKEDP 176 (255)
Q Consensus 142 ~~~~~~~~-~~~~~~~--------------------------------------------~~~~~~~l~~li~~~l~~~p 176 (255)
.+.+.... .....|. ....-.+|.+||++||..||
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 55332111 0000000 00011368899999999999
Q ss_pred CCCCCHHHHHHH
Q 025244 177 NARPNFTQIIQM 188 (255)
Q Consensus 177 ~~Rpt~~~vl~~ 188 (255)
.+|+|+.|++.|
T Consensus 395 ~~RiTl~EAL~H 406 (415)
T KOG0671|consen 395 ARRITLREALSH 406 (415)
T ss_pred cccccHHHHhcC
Confidence 999999999987
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=224.54 Aligned_cols=183 Identities=25% Similarity=0.460 Sum_probs=150.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+.+||||+++|+|.++|..+....+.-.....++.||++||+||.+.+++||||.+.|+|++.+ .++||+|||+++...
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e-~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGE-FTIKIADFGMSRNLY 688 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCc-ccEEecCcccccccc
Confidence 4689999999999999999854435566678899999999999999999999999999999999 699999999999654
Q ss_pred cccccc---cCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHH--hCCCCCCCCchHHHHHHHHhhcC--
Q 025244 81 LTEMMT---AETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL--HNKLPFEGMSNLQAAYAAAFKNV-- 153 (255)
Q Consensus 81 ~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~--~g~~p~~~~~~~~~~~~~~~~~~-- 153 (255)
...... ..+-..+|||+|.+.. +.++.++|+|+||+++||++ +...||....+.+.......-..
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsill--------gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~ 760 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILL--------GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQ 760 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHh--------ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCC
Confidence 443221 2344689999998864 77999999999999999985 57889988877776654432221
Q ss_pred -----CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 154 -----RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 154 -----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
.+.+.-+|..+.++|.+||..+-.+||+++++..+|++.
T Consensus 761 ~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 761 GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 223667899999999999999999999999999988754
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=226.94 Aligned_cols=180 Identities=32% Similarity=0.495 Sum_probs=140.0
Q ss_pred EEEEecCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCC-C--ceEEecCcccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL-K--TIKLADFGLAR 77 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~-~--~~kl~Dfg~a~ 77 (255)
++|||||.||||+..|++-.+ .++++.+.+.++.++..||.|||++||+||||||.||++-... | .-||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 689999999999999997543 5699999999999999999999999999999999999995321 2 35999999999
Q ss_pred ccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH----HHHHHHHhhcC
Q 025244 78 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL----QAAYAAAFKNV 153 (255)
Q Consensus 78 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~----~~~~~~~~~~~ 153 (255)
..+......+.+||..|.+||++-. .+.|+...|.|||||++|+++||..||...... +..+.......
T Consensus 173 el~d~s~~~S~vGT~~YLhPel~E~-------q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp 245 (732)
T KOG4250|consen 173 ELDDNSLFTSLVGTEEYLHPELYER-------QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKP 245 (732)
T ss_pred cCCCCCeeeeecCchhhcChHHHhh-------ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCC
Confidence 9888888999999999999999842 377899999999999999999999999533222 23333332221
Q ss_pred --------------------CCCCCCCcHH----HHHHHHHhcccCCCCCC--CHHHHHHH
Q 025244 154 --------------------RPSAENVPEE----LSIILTSCWKEDPNARP--NFTQIIQM 188 (255)
Q Consensus 154 --------------------~~~~~~~~~~----l~~li~~~l~~~p~~Rp--t~~~vl~~ 188 (255)
.|.+.++++. +-..+..+|.-+|++|- ...+....
T Consensus 246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~ 306 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAE 306 (732)
T ss_pred CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHH
Confidence 1222233333 44567778889999997 44444433
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=234.04 Aligned_cols=74 Identities=42% Similarity=0.749 Sum_probs=68.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
++|||||++|++|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 79 ~~lVmEy~~g~~L~~li~~~~~--l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~-g~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE-GHIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCC-CCEEEEeCCCCc
Confidence 4899999999999999986543 8899999999999999999999999999999999999988 799999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=214.66 Aligned_cols=187 Identities=27% Similarity=0.477 Sum_probs=143.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCeecCCCCCcEEEeCCCCceEEec
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--------GIIHRDLKPENLLLTEDLKTIKLAD 72 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~--------~i~HrDikp~Nill~~~~~~~kl~D 72 (255)
|+||+||.+.|||.|+|.+.. ++.+..++++..+++||+|||.. .|.|||||..|||+.++ +.+.|+|
T Consensus 284 LwLvTdYHe~GSL~DyL~r~t---v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn-~~C~IAD 359 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRNT---VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIAD 359 (513)
T ss_pred EEEeeecccCCcHHHHHhhcc---CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC-CcEEEee
Confidence 689999999999999999854 99999999999999999999953 49999999999999998 7999999
Q ss_pred Cccccccccc-----cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhC----------CCCCC
Q 025244 73 FGLAREESLT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN----------KLPFE 137 (255)
Q Consensus 73 fg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g----------~~p~~ 137 (255)
+|+|...... ...+..+||.+|||||++..-. +. ..-..-..+||||||.++||+..+ ++||.
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdeti-n~-~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETI-NM-KHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhc-Ch-hhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 9999853322 2346789999999999996421 10 111122479999999999999863 57887
Q ss_pred CCchHHHHHHHH-----hhcCCCCCC-CC-----cHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 025244 138 GMSNLQAAYAAA-----FKNVRPSAE-NV-----PEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 193 (255)
Q Consensus 138 ~~~~~~~~~~~~-----~~~~~~~~~-~~-----~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~ 193 (255)
+..+.+.....+ ....+|..+ .+ -..+.++|+.||..||..|-|+-.+.+.|.+..
T Consensus 438 d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred cCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 655443333332 233344322 22 246778999999999999999999988887665
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=226.38 Aligned_cols=181 Identities=25% Similarity=0.377 Sum_probs=150.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC--CCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE--DLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~--~~~~~kl~Dfg~a~~ 78 (255)
+|.|||-+ +|+..+.|....+.++++.....++.||+.||.|||.+||+|+||||+|||+.+ ++..+||+|||+|+.
T Consensus 638 vFVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 638 VFVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred EEEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence 58999999 567777776666667999999999999999999999999999999999999974 345899999999998
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhhcCCCCC
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ-AAYAAAFKNVRPSA 157 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~ 157 (255)
.+......+.+||+.|+|||++. .+.|+.+-|+||.||++|--+.|..||....... +..+...-......
T Consensus 717 IgEksFRrsVVGTPAYLaPEVLr--------nkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW 788 (888)
T KOG4236|consen 717 IGEKSFRRSVVGTPAYLAPEVLR--------NKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPW 788 (888)
T ss_pred cchhhhhhhhcCCccccCHHHHh--------hccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCch
Confidence 88777778899999999999995 4778999999999999999999999996544332 22222232333335
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
..++.+..+||..+|+..=.+|.+.++.+.+.+
T Consensus 789 ~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 789 SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred hhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 678899999999999999999999999887643
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-31 Score=207.44 Aligned_cols=179 Identities=23% Similarity=0.406 Sum_probs=142.3
Q ss_pred EEEEecCCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 2 VIVTELLSGGTLRKYLLN---MRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~---~~~~~~~~~~~~~~~~~i~~~L~~lH~~-~i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
++.||+|+ .||..+-.. ..+..+++.-.-.+..-.+.||.||-.. .||||||||+|||++.. |.+||+|||++-
T Consensus 139 WiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~-G~vKLCDFGIcG 216 (361)
T KOG1006|consen 139 WICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRH-GDVKLCDFGICG 216 (361)
T ss_pred eeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecC-CCEeeecccchH
Confidence 68899994 787765543 2344588887778888899999999865 89999999999999998 799999999997
Q ss_pred ccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC-
Q 025244 78 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS- 156 (255)
Q Consensus 78 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~- 156 (255)
.....-..+...|-..|||||.+.. ....|..+|||||||++|||+.||..||.+.+..-.........-.|.
T Consensus 217 qLv~SiAkT~daGCrpYmAPERi~p------~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l 290 (361)
T KOG1006|consen 217 QLVDSIAKTVDAGCRPYMAPERIDP------SDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPIL 290 (361)
T ss_pred hHHHHHHhhhccCCccccChhccCC------ccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCee
Confidence 6555544556688899999999864 234688899999999999999999999988765433333332222221
Q ss_pred -----CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 -----AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 -----~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.-+.+..+..+|.-||.+|...||.+.+++++
T Consensus 291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 23478899999999999999999999999875
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=225.37 Aligned_cols=183 Identities=24% Similarity=0.494 Sum_probs=159.0
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
.||++|+++|+|.|+++.++.. +.....+.|..||++||.|||+++++||||-..|||+.+- +.+||.|||+++....
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~-igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP-~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDN-IGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP-NHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhcc-ccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC-CeEEEEecchhhccCc
Confidence 4789999999999999987654 8889999999999999999999999999999999999987 6999999999996544
Q ss_pred cccc-c--cCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 82 TEMM-T--AETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 82 ~~~~-~--~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
.... . ...-.+.|||-|.+. ...++.++|||||||++||++| |..|+.+....+...........+.+
T Consensus 851 d~~ey~~~~gK~pikwmale~i~--------~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqP 922 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIR--------IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQP 922 (1177)
T ss_pred ccccccccccccCcHHHHHHHhh--------ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCC
Confidence 3322 1 222356788988874 4778999999999999999998 99999998888887777777777888
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
+.++.++..++.+||..|+..||+++++...+.+..+
T Consensus 923 piCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 923 PICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 9999999999999999999999999999998877654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=242.85 Aligned_cols=176 Identities=26% Similarity=0.357 Sum_probs=132.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH---SHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
.++||||++||+|.++++. +++.++..++.|++.||+||| +.+++||||||+||+++.+ +..++. ||...
T Consensus 758 ~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~ 830 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPG 830 (968)
T ss_pred CEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-ecccc
Confidence 4799999999999999963 889999999999999999999 6699999999999999987 466654 66554
Q ss_pred ccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch----HHHHHHHHhhc-
Q 025244 78 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN----LQAAYAAAFKN- 152 (255)
Q Consensus 78 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~- 152 (255)
.... .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||..... ...........
T Consensus 831 ~~~~---~~~~~~t~~y~aPE~~~~--------~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 899 (968)
T PLN00113 831 LLCT---DTKCFISSAYVAPETRET--------KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC 899 (968)
T ss_pred cccc---CCCccccccccCcccccC--------CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc
Confidence 3221 123468899999998853 5688899999999999999999999853211 11111100000
Q ss_pred -----CCCC-------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 153 -----VRPS-------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 153 -----~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
..+. ......++.+++.+||+.||++||++.|+++.|+...+
T Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 0011 01112357789999999999999999999999987654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=208.05 Aligned_cols=187 Identities=29% Similarity=0.422 Sum_probs=142.1
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCeecCCCCCcEEEeCCCCceEEec
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH---------GIIHRDLKPENLLLTEDLKTIKLAD 72 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---------~i~HrDikp~Nill~~~~~~~kl~D 72 (255)
+||+||.+.|+|.++|..+. +++.+..+++..++.||+|||+. .|+|||||..||||.+| .++.|+|
T Consensus 284 wLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D-lTccIaD 359 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND-LTCCIAD 359 (534)
T ss_pred eEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC-CcEEeec
Confidence 79999999999999998765 99999999999999999999964 59999999999999999 6999999
Q ss_pred Cccccccccc---cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCC------------CCC
Q 025244 73 FGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKL------------PFE 137 (255)
Q Consensus 73 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~------------p~~ 137 (255)
||+|...... ......+||.+|||||++-+...-+. ...-.+.||||+|.|||||+++.. ||.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d--~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQD--RDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhccccc--HHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 9999854432 22334789999999999976432221 222347999999999999997542 332
Q ss_pred ---CCc--hHHHHHHHHhhcCCCCCC------CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 138 ---GMS--NLQAAYAAAFKNVRPSAE------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 138 ---~~~--~~~~~~~~~~~~~~~~~~------~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
+.+ -.+....+..+..+|..+ .-...+++.+..||..|++.|.|+.=+.+.+.....
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 111 112222233344444321 224678999999999999999999988888776543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=186.59 Aligned_cols=178 Identities=28% Similarity=0.396 Sum_probs=150.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+-||+|||. -+|..+.....+. ++.+.+..++.|++.||.++|+.++.|||+||.|++|+.+ |.+|++|||+++.++
T Consensus 76 ltlvfe~cd-qdlkkyfdslng~-~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n-gelkladfglarafg 152 (292)
T KOG0662|consen 76 LTLVFEFCD-QDLKKYFDSLNGD-LDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN-GELKLADFGLARAFG 152 (292)
T ss_pred eEEeHHHhh-HHHHHHHHhcCCc-CCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC-CcEEecccchhhhcC
Confidence 468999994 7899998875443 9999999999999999999999999999999999999998 799999999999776
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCCC
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAE 158 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 158 (255)
... .....+.|.+|.+|.++.+ ...|+.+.|+||.||++.|+.. |++.|++.+..++..++......|...
T Consensus 153 ipvrcysaevvtlwyrppdvlfg-------akly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed 225 (292)
T KOG0662|consen 153 IPVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTED 225 (292)
T ss_pred CceEeeeceeeeeeccCcceeee-------eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccc
Confidence 553 4566788999999999986 4678999999999999999974 889999988888887776554444322
Q ss_pred C----------------------------CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 159 N----------------------------VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 159 ~----------------------------~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+ ++..-+++++++|.-+|.+|.++++.+++
T Consensus 226 ~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 226 QWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 2 22356789999999999999999998876
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=206.99 Aligned_cols=182 Identities=26% Similarity=0.388 Sum_probs=144.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CCeecCCCCCcEEEeC--CCCceEEecCccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--GIIHRDLKPENLLLTE--DLKTIKLADFGLA 76 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~--~i~HrDikp~Nill~~--~~~~~kl~Dfg~a 76 (255)
++-|+|||+|.+|.-+|++++- +++.++..|+.||+.||.||.+. -|||-||||.|||+-+ ..|.+||+|||++
T Consensus 543 FCTVLEYceGNDLDFYLKQhkl--mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKL--MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhh--hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 4569999999999999997665 99999999999999999999987 4999999999999953 3468999999999
Q ss_pred ccccccc--------ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHH
Q 025244 77 REESLTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA 148 (255)
Q Consensus 77 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~ 148 (255)
+..+... ......||.||++||.+.-++ .....+.+.||||+||++|.++.|+.||......+.....
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgk----ePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGK----EPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCC----CCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 8644321 234457999999999986532 2345788999999999999999999999764433332221
Q ss_pred -----HhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 149 -----AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 149 -----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
......|..+.++.+.++||++||+..-++|.+..++..+
T Consensus 697 NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 697 NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 1122345567789999999999999999999887776553
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=189.78 Aligned_cols=143 Identities=29% Similarity=0.444 Sum_probs=115.9
Q ss_pred CEEEEecCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~-~i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
+++.||.| ..||..+-.+- .+..+++.-.-+++..++.||.|||++ .++|||+||+|||++.+ |+||++|||++-
T Consensus 120 vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~-GqVKiCDFGIsG 197 (282)
T KOG0984|consen 120 VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYD-GQVKICDFGISG 197 (282)
T ss_pred EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccC-CcEEEcccccce
Confidence 47889999 48888776542 334599999999999999999999987 89999999999999998 899999999998
Q ss_pred ccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCc-hHHHHHHHH
Q 025244 78 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS-NLQAAYAAA 149 (255)
Q Consensus 78 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~-~~~~~~~~~ 149 (255)
.....-..+...|-..|||||.+... .....|+-++||||||++++||.+++.||+... +.++..+..
T Consensus 198 ~L~dSiAkt~daGCkpYmaPEri~~e----~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 198 YLVDSIAKTMDAGCKPYMAPERINPE----LNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred eehhhhHHHHhcCCCccCChhhcCcc----cCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 65544444446788899999998753 233478999999999999999999999997644 445544443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=214.87 Aligned_cols=186 Identities=22% Similarity=0.194 Sum_probs=132.6
Q ss_pred EEEEecCCCCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcE
Q 025244 2 VIVTELLSGGTLRKYLLNMRP----------------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 59 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~----------------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Ni 59 (255)
+|||||+++++|.++|..... ..+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 261 ~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NI 340 (507)
T PLN03224 261 WLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENL 340 (507)
T ss_pred EEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhE
Confidence 799999999999999975311 1245667888999999999999999999999999999
Q ss_pred EEeCCCCceEEecCccccccccccccc--cCCCccceecccccccccccccc--------------cCCCCchhhHHHHH
Q 025244 60 LLTEDLKTIKLADFGLAREESLTEMMT--AETGTYRWMAPELYSTVTLRQGE--------------KKHYNHKVDSYSFA 123 (255)
Q Consensus 60 ll~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~--------------~~~~~~~~DvwslG 123 (255)
|++.+ +.+||+|||+++......... ...+|+.|+|||.+......... ......+.|+||+|
T Consensus 341 Ll~~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlG 419 (507)
T PLN03224 341 LVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAG 419 (507)
T ss_pred EECCC-CcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHH
Confidence 99988 689999999997543322222 23457899999987532110000 00112357999999
Q ss_pred HHHHHHHhCCC-CCCCCchHHHHHH----------HHhh--cCCCCCCCCcHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 025244 124 IVLWELLHNKL-PFEGMSNLQAAYA----------AAFK--NVRPSAENVPEELSIILTSCWKEDP---NARPNFTQIIQ 187 (255)
Q Consensus 124 ~~l~el~~g~~-p~~~~~~~~~~~~----------~~~~--~~~~~~~~~~~~l~~li~~~l~~~p---~~Rpt~~~vl~ 187 (255)
|++++|++|.. ||.+......... .... ...+.....++..++++.+||..+| .+|+|+.|+++
T Consensus 420 vil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 420 VLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred HHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 99999999875 7654322211111 1100 0112234567899999999999876 68999999998
Q ss_pred H
Q 025244 188 M 188 (255)
Q Consensus 188 ~ 188 (255)
|
T Consensus 500 H 500 (507)
T PLN03224 500 H 500 (507)
T ss_pred C
Confidence 7
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-30 Score=203.26 Aligned_cols=178 Identities=30% Similarity=0.404 Sum_probs=141.3
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
|.|+|++ ..+|...|-.- ..++.+.+.-+++||+.||.|||+.||.||||||.|+|+++++ .+||+|||+++....
T Consensus 133 YV~TELm-QSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC-vLKICDFGLARvee~ 208 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC-ILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHH-HhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc-eEEecccccccccch
Confidence 4567777 47777777643 3499999999999999999999999999999999999999995 899999999996554
Q ss_pred c--cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC---
Q 025244 82 T--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--- 156 (255)
Q Consensus 82 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 156 (255)
. ..++..+.|-.|.|||.+.+ ...|+.+.||||.||++.|++.++..|...++.++...+......|.
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMG-------aRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~Ea 281 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMG-------ARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEA 281 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhc-------chhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHH
Confidence 3 34455678999999999975 46799999999999999999999999988777766554433222221
Q ss_pred ------------------CC------------CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 157 ------------------AE------------NVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 157 ------------------~~------------~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
.+ .-..+-..++..++..||++|.+.++.+.++.
T Consensus 282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 282 MKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11 11235667888899999999999999887753
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=183.83 Aligned_cols=175 Identities=22% Similarity=0.345 Sum_probs=142.0
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccccc
Q 025244 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 82 (255)
Q Consensus 3 lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~~ 82 (255)
||+||+++.+...+-.. ++...+..++.+++.||.|+|++||+|||+||.|++|+.....++|+|+|+|......
T Consensus 112 LiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 68899988887776643 7778889999999999999999999999999999999977678999999999977766
Q ss_pred cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCC-CCCchHHHHHHHHhhcC--------
Q 025244 83 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF-EGMSNLQAAYAAAFKNV-------- 153 (255)
Q Consensus 83 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~-~~~~~~~~~~~~~~~~~-------- 153 (255)
...+..+.+..|-.||.+.. -..|..+-|+|||||++..|+..+.|| .+.++.++..++.....
T Consensus 187 ~eYnVRVASRyfKGPELLVd-------y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred ceeeeeeehhhcCCchheee-------chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 66677788899999999864 466888999999999999999998887 45555555444321000
Q ss_pred -------CC--------------------C-CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 154 -------RP--------------------S-AENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 154 -------~~--------------------~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
.| . ..-.+++..+++.++|..|-++|+|+.|.+.|-
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 00 0 112458899999999999999999999999873
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=218.43 Aligned_cols=177 Identities=26% Similarity=0.364 Sum_probs=132.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC---CC-CceEEecCc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE---DL-KTIKLADFG 74 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~---~~-~~~kl~Dfg 74 (255)
+||..|.| .-+|.|++..... ........+.++.|+++||++||+.+|+||||||.||||+. +. .+++|+|||
T Consensus 578 ~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg 656 (903)
T KOG1027|consen 578 LYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFG 656 (903)
T ss_pred EEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccc
Confidence 48999999 5899999987411 11111345778999999999999999999999999999986 21 378999999
Q ss_pred ccccccccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCchHHHHHHHH
Q 025244 75 LAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAA 149 (255)
Q Consensus 75 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g-~~p~~~~~~~~~~~~~~ 149 (255)
+++...... ...+..||-+|+|||++.. .....+.|||||||++|+.++| ..||.+....+ .++.
T Consensus 657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~--------~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl 726 (903)
T KOG1027|consen 657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRE--------DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANIL 726 (903)
T ss_pred cccccCCCcchhhcccCCCCcccccCHHHHhc--------cccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhh
Confidence 999654332 2345679999999999964 3445599999999999999986 89997643322 2222
Q ss_pred hhcCCCC--CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 150 FKNVRPS--AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 150 ~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....... ...-..+..+||.+|++.+|..||++.+|+.|
T Consensus 727 ~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 727 TGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred cCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 2222111 11111288999999999999999999999987
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=191.57 Aligned_cols=184 Identities=27% Similarity=0.519 Sum_probs=155.2
Q ss_pred EEEEecCCCCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcc
Q 025244 2 VIVTELLSGGTLRKYLLNM------RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 75 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~------~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~ 75 (255)
+.++.++.-|+|..+|+.. ..+.++..+...++.|++.|++|||+.|++|.||...|++|++.. ++||+|=.+
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L-qVkltDsaL 442 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL-QVKLTDSAL 442 (563)
T ss_pred eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe-eEEeccchh
Confidence 5678888889999999832 224477788888999999999999999999999999999999884 899999999
Q ss_pred cccccccccc---ccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhh
Q 025244 76 AREESLTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFK 151 (255)
Q Consensus 76 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 151 (255)
++..-..+.. ...--...||+||.+. ...|+.++|+|||||+||||++ |+.|+...++.+.......+
T Consensus 443 SRDLFP~DYhcLGDnEnRPvkWMslEal~--------n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG 514 (563)
T KOG1024|consen 443 SRDLFPGDYHCLGDNENRPVKWMSLEALQ--------NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG 514 (563)
T ss_pred ccccCcccccccCCCCCCcccccCHHHHh--------hhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence 9853332211 1112346899999986 4789999999999999999998 99999999998888777777
Q ss_pred cCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 152 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 152 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
.....+.++|.++..++.-||+..|++||+++|++.-|.++-.
T Consensus 515 yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 515 YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 7777788999999999999999999999999999998877643
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=186.04 Aligned_cols=178 Identities=27% Similarity=0.385 Sum_probs=134.7
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE-eCCCCceEEecCccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL-TEDLKTIKLADFGLAREES 80 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill-~~~~~~~kl~Dfg~a~~~~ 80 (255)
+.||||++-|+|..-+...+ +.+....+++.|+++|+.|||+++++|||||.+|||| +.++.++||+|||+.+..+
T Consensus 98 vF~qE~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred EEeeccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 68999999999999987643 8899999999999999999999999999999999999 4555689999999998644
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---hhcCCC--
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA---FKNVRP-- 155 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~---~~~~~~-- 155 (255)
.. ......+..|.+||...... ...-...+.+|+|.||+++|.+++|++||......+..+... .....+
T Consensus 175 ~t--V~~~~~~~~y~~pe~~~~~~---ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 175 TT--VKYLEYVNNYHAPELCDTVV---NEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred ce--ehhhhhhcccCCcHHHhhcc---ccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence 33 22233467899999875431 123445778999999999999999999998544433332211 111111
Q ss_pred --CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025244 156 --SAENVPEELSIILTSCWKEDPNARPNFTQIIQ 187 (255)
Q Consensus 156 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~ 187 (255)
....+++.+..+.++-|..++++|--..++.+
T Consensus 250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred chhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 13457788999999999999999944444433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=207.31 Aligned_cols=180 Identities=27% Similarity=0.430 Sum_probs=155.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++++||||.||+|.+.-+-.+. +++.++..+.++.++||+|||++|-+|||||-.||+++.. |.+|++|||.+-...
T Consensus 87 lwicMEycgggslQdiy~~Tgp--lselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~-gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDE-GDVKLADFGVSAQIT 163 (829)
T ss_pred cEEEEEecCCCcccceeeeccc--chhHHHHHHHhhhhccchhhhcCCcccccccccceeeccc-CceeecccCchhhhh
Confidence 5899999999999997765444 9999999999999999999999999999999999999988 799999999887544
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC---
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--- 156 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 156 (255)
.. .....+.||+.|||||+..- ++.+.|...+|+|++|++..|+-.-++|.-+..+.+..+........|.
T Consensus 164 ati~KrksfiGtpywmapEvaav-----erkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lk 238 (829)
T KOG0576|consen 164 ATIAKRKSFIGTPYWMAPEVAAV-----ERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLK 238 (829)
T ss_pred hhhhhhhcccCCccccchhHHHH-----HhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCccc
Confidence 32 23456899999999998753 4567889999999999999999988999888888888777766666553
Q ss_pred -CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 -AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...+++.+.+|++.+|.++|++||+++.++.|
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 45688999999999999999999999998765
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=196.73 Aligned_cols=178 Identities=27% Similarity=0.375 Sum_probs=143.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
|+||+|-+ ..+|.++|.+.+. -++....+..++.|++-||..|-.-||+|.||||+|||+++....+||||||.|...
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~ 587 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFA 587 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccc
Confidence 68999999 5899999998754 458888899999999999999999999999999999999988778999999999865
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC------
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV------ 153 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~------ 153 (255)
+.... +....+..|.|||++.+ ..|+...|+||.||+|||+.||+..|++..+.+.+...+....
T Consensus 588 ~enei-tPYLVSRFYRaPEIiLG--------~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 588 SENEI-TPYLVSRFYRAPEIILG--------LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred ccccc-cHHHHHHhccCcceeec--------CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 55443 33456788999999975 6678899999999999999999999998776554433221000
Q ss_pred -------------------------------------CCC---------CCCC-------cHHHHHHHHHhcccCCCCCC
Q 025244 154 -------------------------------------RPS---------AENV-------PEELSIILTSCWKEDPNARP 180 (255)
Q Consensus 154 -------------------------------------~~~---------~~~~-------~~~l~~li~~~l~~~p~~Rp 180 (255)
.|. .+.+ -..|.+|+.+||..||++|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 000 0001 24688899999999999999
Q ss_pred CHHHHHHH
Q 025244 181 NFTQIIQM 188 (255)
Q Consensus 181 t~~~vl~~ 188 (255)
+..|+|.|
T Consensus 739 t~nqAL~H 746 (752)
T KOG0670|consen 739 TVNQALKH 746 (752)
T ss_pred CHHHHhcC
Confidence 99999886
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=174.76 Aligned_cols=146 Identities=37% Similarity=0.611 Sum_probs=126.1
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC-CCCceEEecCccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE-DLKTIKLADFGLAREES 80 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~-~~~~~kl~Dfg~a~~~~ 80 (255)
++||||++|++|.+++.... ..++...++.++.+++.+|.+||+.|++|+||+|.||+++. + +.++|+|||.+....
T Consensus 67 ~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~-~~~~l~d~~~~~~~~ 144 (215)
T cd00180 67 YLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDN-GKVKLADFGLSKLLT 144 (215)
T ss_pred EEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCC-CcEEEecCCceEEcc
Confidence 78999999999999998752 23899999999999999999999999999999999999998 6 689999999998544
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
... ......+...|++||.+.. ....+.+.|+|++|++++++
T Consensus 145 ~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~~D~~~lg~~~~~l------------------------------ 187 (215)
T cd00180 145 SDKSLLKTIVGTPAYMAPEVLLG-------KGYYSEKSDIWSLGVILYEL------------------------------ 187 (215)
T ss_pred CCcchhhcccCCCCccChhHhcc-------cCCCCchhhhHHHHHHHHHH------------------------------
Confidence 332 1233567889999998853 12667899999999999999
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..+.+++.+|++.||.+||++.+++++
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 789999999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=177.04 Aligned_cols=186 Identities=27% Similarity=0.363 Sum_probs=147.1
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCC----CceEEecCcccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL----KTIKLADFGLAR 77 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~----~~~kl~Dfg~a~ 77 (255)
|+||+.+ |.+|.++......+.++..+++.++.|++.+|.+||+.|++||||||+|+++.... ..+.|.|||+++
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 7999999 99999998777666799999999999999999999999999999999999998542 368999999998
Q ss_pred --cccccc--------c-cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHH
Q 025244 78 --EESLTE--------M-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 146 (255)
Q Consensus 78 --~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~ 146 (255)
...... . .....||..|+++.++.+ ...+++.|+||+++++.|+..|..||.+........
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--------~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~ 247 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--------IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS 247 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCC--------CccCCchhhhhHHHHHHHHhcCCCCCccccccchHH
Confidence 321111 1 123459999999998853 677889999999999999999999997755432221
Q ss_pred H---HHhhcCCC-CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 025244 147 A---AAFKNVRP-SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 196 (255)
Q Consensus 147 ~---~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~ 196 (255)
. ........ .....+.++..+...+-..+...+|.+..+...++......
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 248 KFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1 11111111 22345678888888888899999999999999988776654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=181.03 Aligned_cols=61 Identities=36% Similarity=0.554 Sum_probs=57.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEe
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLT 62 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~-~i~HrDikp~Nill~ 62 (255)
++||+|++ |.+|..+|....-++++...+..|++||+.||.|||.+ ||||-||||+|||+.
T Consensus 161 VCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 161 VCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred EEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 47999999 99999999998878899999999999999999999986 899999999999993
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=178.74 Aligned_cols=176 Identities=24% Similarity=0.368 Sum_probs=132.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc-
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE- 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~- 79 (255)
..+||||++..+-.++... ++..++..+++.++.||+++|.+||+||||||.|+|.+..-+.-.|.|||+|...
T Consensus 110 v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred eEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence 3689999999999999875 7788899999999999999999999999999999999977678899999999610
Q ss_pred ----------------cc--c---------------c-----------ccccCCCccceecccccccccccccccCCCCc
Q 025244 80 ----------------SL--T---------------E-----------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 115 (255)
Q Consensus 80 ----------------~~--~---------------~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 115 (255)
.. . . ......||++|.|||++.. -...+.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k-------~~~Qtt 257 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR-------CPRQTT 257 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh-------ccCcCC
Confidence 00 0 0 0002248999999999974 355678
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCchHHHH-------------HHHHh-----------------------hcC-----C
Q 025244 116 KVDSYSFAIVLWELLHNKLPFEGMSNLQAA-------------YAAAF-----------------------KNV-----R 154 (255)
Q Consensus 116 ~~DvwslG~~l~el~~g~~p~~~~~~~~~~-------------~~~~~-----------------------~~~-----~ 154 (255)
+.||||.||++..+++++.||-.....-.. .+... ... .
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 999999999999999999998422211000 00000 000 0
Q ss_pred C----------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 155 P----------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 155 ~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+ .....+..+.+++++||..||.+|.++++.|+|
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 011234578899999999999999999999987
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-24 Score=194.67 Aligned_cols=174 Identities=26% Similarity=0.370 Sum_probs=139.8
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccccc-
Q 025244 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 82 (255)
Q Consensus 4 V~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~~- 82 (255)
+||||++ +|..++..... ++..++-.++.|++.|+.|+|+.|+.|||+|++|+++..+ |.+||+|||.+......
T Consensus 399 ~mE~~~~-Dlf~~~~~~~~--~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~-g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSNGK--LTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTEN-GILKIIDFGAASVFRYPW 474 (601)
T ss_pred hhhcccH-HHHHHHhcccc--cchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecC-CceEEeecCcceeeccCc
Confidence 4999998 99999987533 8889999999999999999999999999999999999998 79999999998743222
Q ss_pred ----cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH-hhcC----
Q 025244 83 ----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA-FKNV---- 153 (255)
Q Consensus 83 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~-~~~~---- 153 (255)
......+|+..|+|||++.+ ........||||.|+++..|.+|+.||......+..+... ....
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~-------~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~ 547 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTG-------KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIF 547 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccc-------cccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccc
Confidence 33456789999999999964 2333457999999999999999999997655554432111 1111
Q ss_pred ---CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 154 ---RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 154 ---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
......++..-+.+|.+||+.||.+|.|+.+|++.
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 11134567888999999999999999999999985
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-23 Score=164.56 Aligned_cols=138 Identities=39% Similarity=0.541 Sum_probs=113.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++|+||+++++|.+++...... +++.....++.+++.++.+||+.+++|+||+|.||+++.+ +.++|+|||.+....
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~ 149 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD-GLVKLADFGLARFIH 149 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeeCceeeEec
Confidence 37899999999999999875432 7889999999999999999999999999999999999988 799999999988644
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CchHHHHHH
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG-MSNLQAAYA 147 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~-~~~~~~~~~ 147 (255)
... ......++..|++||.+. ....++.++|+|+||+++++|++|+.||.. .........
T Consensus 150 ~~~~~~~~~~~~~~~~~~pe~~~-------~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~ 212 (225)
T smart00221 150 RDLAALLKTVKGTPFYLAPEVLL-------GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSD 212 (225)
T ss_pred CcccccccceeccCCcCCHhHhc-------CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHH
Confidence 332 334557788999999873 124566799999999999999999999977 444434433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.3e-24 Score=182.20 Aligned_cols=126 Identities=25% Similarity=0.400 Sum_probs=110.6
Q ss_pred EEEEecC-CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 2 VIVTELL-SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 2 ~lV~Ey~-~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
||+||-. +|-+|+++|..+.. +++.++..|+.|++.|+++||++||+|||||-+|+.++.+ |-+||+|||.+....
T Consensus 645 yl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~-g~~klidfgsaa~~k 721 (772)
T KOG1152|consen 645 YLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSN-GFVKLIDFGSAAYTK 721 (772)
T ss_pred EEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhccccccccCceecccccccEEEecC-CeEEEeeccchhhhc
Confidence 6888876 57799999987665 9999999999999999999999999999999999999999 799999999887533
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~ 138 (255)
.+....++||..|.|||++.+ ....+..-|||+||++||-++....||..
T Consensus 722 -sgpfd~f~gtv~~aapevl~g-------~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 722 -SGPFDVFVGTVDYAAPEVLGG-------EKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred -CCCcceeeeeccccchhhhCC-------CccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 445678899999999999965 34456678999999999999999999863
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.4e-22 Score=153.81 Aligned_cols=195 Identities=22% Similarity=0.326 Sum_probs=153.0
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC--CCCceEEecCcccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE--DLKTIKLADFGLAREE 79 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~--~~~~~kl~Dfg~a~~~ 79 (255)
+||||++ |.||+++..-... .++..+++-++-|++.-++|+|.++++||||||+|+|..- ..+.+.++|||+|+..
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeeecc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 6899999 9999999886543 3999999999999999999999999999999999999863 3357899999999854
Q ss_pred cccc--------ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHH
Q 025244 80 SLTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA--YAAA 149 (255)
Q Consensus 80 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~--~~~~ 149 (255)
.... .....+||..|.+-..+.+ ...+.+.|+-|+|.+|.+...|..||.+....... +..+
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g--------~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI 236 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLG--------IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI 236 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhh--------hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence 3221 1234579999999887754 55688999999999999999999999986643322 2222
Q ss_pred hhcC--CC---CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCCc
Q 025244 150 FKNV--RP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHR 206 (255)
Q Consensus 150 ~~~~--~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~~~~~~~~~~ 206 (255)
.+.- .+ .....|.++...+..|-...-++-|++.-+.+.+..++..........-.+
T Consensus 237 ~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW 298 (341)
T KOG1163|consen 237 SEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDW 298 (341)
T ss_pred HHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeH
Confidence 2111 11 146789999999999999999999999998888887777766555544333
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=162.80 Aligned_cols=184 Identities=23% Similarity=0.307 Sum_probs=136.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC---CCceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED---LKTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~---~~~~kl~Dfg~a~ 77 (255)
+||||.-.+ .+|.+++-.+. .+.....-++.|+++|+.|||.+||.|||+|.+|||+.-+ ...+.|+|||.+-
T Consensus 318 lylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 318 LYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred EEEehhcch-hhHHHHHhcCC---CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 689999995 79999997644 6677777899999999999999999999999999999422 2367899999875
Q ss_pred cccc---c----cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHH-HH
Q 025244 78 EESL---T----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA-AA 149 (255)
Q Consensus 78 ~~~~---~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-~~ 149 (255)
..+. . .......|.-.-||||+....+... ....-.++|.|+.|.+.||++....||.+......... ..
T Consensus 394 Ad~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~--avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq 471 (598)
T KOG4158|consen 394 ADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN--AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ 471 (598)
T ss_pred eccccccccccccccccCCCcceecchhhhhcCCCCc--eeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh
Confidence 3221 1 1122345788899999987533111 11223489999999999999999999986333222111 12
Q ss_pred hhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 150 FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 150 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
.....+.+..+++.+++++..+|+.||.+|++..-..+.|.
T Consensus 472 e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 472 ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred hhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 22334457789999999999999999999998766655554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-22 Score=165.15 Aligned_cols=169 Identities=22% Similarity=0.353 Sum_probs=111.2
Q ss_pred EEEEecCCCCCHHHHHHh---cCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccc
Q 025244 2 VIVTELLSGGTLRKYLLN---MRPR--CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 76 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~---~~~~--~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a 76 (255)
+++|.-+ -+||.+++.- .... .+.....+.+..|++..+++||..|++|+||||+|++++.+ |.++|+||+..
T Consensus 115 ~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~-G~v~Lg~F~~~ 192 (288)
T PF14531_consen 115 FLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQD-GGVFLGDFSSL 192 (288)
T ss_dssp EEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TT-S-EEE--GGGE
T ss_pred hhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCC-CCEEEcChHHH
Confidence 6788888 4889888653 2221 13344446667899999999999999999999999999999 89999999988
Q ss_pred cccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC
Q 025244 77 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 156 (255)
Q Consensus 77 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 156 (255)
...+..... ...+..|.+||..............++.+.|.|+||+++|.|+||..||........... ....+
T Consensus 193 ~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~----~f~~C 266 (288)
T PF14531_consen 193 VRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW----DFSRC 266 (288)
T ss_dssp EETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----GGTTS
T ss_pred eecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc----cchhc
Confidence 765543322 344578999997643210000234578899999999999999999999975433221111 23334
Q ss_pred CCCCcHHHHHHHHHhcccCCCCC
Q 025244 157 AENVPEELSIILTSCWKEDPNAR 179 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~R 179 (255)
. ++|+.++.||..+|+.||.+|
T Consensus 267 ~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 267 R-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S----HHHHHHHHHHT-SSGGGS
T ss_pred C-CcCHHHHHHHHHHccCCcccC
Confidence 4 899999999999999999988
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-20 Score=151.88 Aligned_cols=189 Identities=24% Similarity=0.398 Sum_probs=151.1
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC----CCCceEEecCcccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE----DLKTIKLADFGLAR 77 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~----~~~~~kl~Dfg~a~ 77 (255)
.||||++ |-||+|+..-.+.+ |+..+++.++.|++.-++|+|++.+|.|||||+|+||.. +.+.+.++|||+|+
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~-FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRR-FSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCc-ccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 4899999 99999998866544 999999999999999999999999999999999999963 23468999999998
Q ss_pred ccccccc--------cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH--HHHHH
Q 025244 78 EESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL--QAAYA 147 (255)
Q Consensus 78 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~--~~~~~ 147 (255)
....... ..+..||.+||+-..+.+ .+.+.+.|+-|||=++.+.+.|..||.+.... ...+.
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG--------rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe 249 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLG--------REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE 249 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeecccc--------chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH
Confidence 5433322 245679999999998864 66788999999999999999999999875533 22232
Q ss_pred HHhhcCC--C---CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 025244 148 AAFKNVR--P---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 200 (255)
Q Consensus 148 ~~~~~~~--~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~~~~ 200 (255)
.+...-+ + ...++|.++..-+...-..+-.+-|+++-+...+.+.+.......
T Consensus 250 KIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~ 307 (449)
T KOG1165|consen 250 KIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETD 307 (449)
T ss_pred HhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcc
Confidence 2222211 1 145788999999999999999999999999888888877665443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-20 Score=157.66 Aligned_cols=183 Identities=32% Similarity=0.453 Sum_probs=142.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
.++|+||+.|++|.+++..... ..+.......++.|++.++.|+|+.+++|||+||+||+++.....++++|||.++..
T Consensus 73 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 73 LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence 3789999999999977776432 148999999999999999999999999999999999999987326999999999743
Q ss_pred cccc-------ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHH
Q 025244 80 SLTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN---LQAAYAAA 149 (255)
Q Consensus 80 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~---~~~~~~~~ 149 (255)
.... ......||..|++||.+.... ........|+||+|++++++++|..||..... ........
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~-----~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 227 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS-----LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII 227 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCC-----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHH
Confidence 3322 346678999999999885310 14678899999999999999999999877653 33333333
Q ss_pred hhcCCC-C----CCCC----cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 150 FKNVRP-S----AENV----PEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 150 ~~~~~~-~----~~~~----~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.....+ . .... ...+.+++..++..+|..|.+..+....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 228 LELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 333322 1 1111 1578999999999999999998887765
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.1e-22 Score=170.70 Aligned_cols=168 Identities=30% Similarity=0.496 Sum_probs=126.6
Q ss_pred CEEEEecCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMR-PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+++.|++|.-.+|.++|.+.. ...-+....+.++.|+..|+.| ++.+|||+||.||+...+ ..+||.|||+....
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d-~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD-DQLKIGDFGLVTSQ 406 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccc-hhhhhhhhhheeec
Confidence 578999999999999998543 2346677888999999999999 999999999999999888 58999999999865
Q ss_pred cccc-------ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhh
Q 025244 80 SLTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFK 151 (255)
Q Consensus 80 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 151 (255)
.... ..+..+||.+||+||.+. +..|+.++||||||++|+|++. -...+... ........
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~--------g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----~t~~d~r~ 474 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIR--------GQQYSEKVDIYALGLILAELLIQFSTQFERI----ATLTDIRD 474 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHh--------hhhhhhhcchhhHHHHHHHHHHHhccHHHHH----Hhhhhhhc
Confidence 4443 346678999999999885 4789999999999999999987 22232211 11111111
Q ss_pred cCCC-C-CCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 025244 152 NVRP-S-AENVPEELSIILTSCWKEDPNARPNFTQI 185 (255)
Q Consensus 152 ~~~~-~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~v 185 (255)
...| . ..+. +.-..|+.+++...|.+||++.+.
T Consensus 475 g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 475 GIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred CCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence 1112 1 1222 344579999999999999954443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.3e-22 Score=172.22 Aligned_cols=161 Identities=30% Similarity=0.470 Sum_probs=134.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++++++|..||+|...+.+... +.+.....+..+++-+++++|+.+++|||+|++||+++.+ |++++.|||+++..-
T Consensus 72 l~l~ld~~rgg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~-Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 72 LYLILDFLRGGDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLE-GHIKLTDFGLSKEAV 148 (612)
T ss_pred hhHhhhhcccchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeeccc-CccccCCchhhhHhH
Confidence 4678999999999999887655 8888888899999999999999999999999999999999 899999999998644
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
..... +||..|||||++.+ ...++|.||||++++||++|..||.. +. ...+.....+.+..+
T Consensus 149 ~~~~~---cgt~eymApEI~~g----------h~~a~D~ws~gvl~felltg~~pf~~----~~-~~~Il~~~~~~p~~l 210 (612)
T KOG0603|consen 149 KEKIA---CGTYEYRAPEIING----------HLSAADWWSFGVLAFELLTGTLPFGG----DT-MKRILKAELEMPREL 210 (612)
T ss_pred hhhhc---ccchhhhhhHhhhc----------cCCcccchhhhhhHHHHhhCCCCCch----HH-HHHHhhhccCCchhh
Confidence 43322 99999999999852 35689999999999999999999987 22 223333344557778
Q ss_pred cHHHHHHHHHhcccCCCCCCCH
Q 025244 161 PEELSIILTSCWKEDPNARPNF 182 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt~ 182 (255)
+....+++..++..+|.+|--.
T Consensus 211 ~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 211 SAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hHHHHHHHHHHHhhCHHHHhcc
Confidence 8999999999999999999543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=150.22 Aligned_cols=180 Identities=29% Similarity=0.512 Sum_probs=145.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEeCCCCceEEe--cCccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLA--DFGLA 76 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--i~HrDikp~Nill~~~~~~~kl~--Dfg~a 76 (255)
++++..||+-|||..+|.......++..++.+++.+++.|++|||+.. |.---|....++++++. +++|. |--++
T Consensus 262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfs 340 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFS 340 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceee
Confidence 478999999999999999887777889999999999999999999974 33446788899999884 55543 32111
Q ss_pred cccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC
Q 025244 77 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 156 (255)
Q Consensus 77 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 156 (255)
. ........+.||+||.++.-+ ....-.++|+|||++++||+.|...||.+.++.+.-.++.....++.
T Consensus 341 f------qe~gr~y~pawmspealqrkp-----ed~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ 409 (448)
T KOG0195|consen 341 F------QEVGRAYSPAWMSPEALQRKP-----EDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVH 409 (448)
T ss_pred e------eccccccCcccCCHHHHhcCc-----hhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccccc
Confidence 1 122334578999999986421 12234589999999999999999999999999998888877776654
Q ss_pred -CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 157 -AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 157 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
++.++..+.+++.-|++.||.+||.+.+++-.|++.
T Consensus 410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 788999999999999999999999999999888764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.5e-21 Score=173.67 Aligned_cols=179 Identities=21% Similarity=0.236 Sum_probs=127.7
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc-
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES- 80 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~- 80 (255)
|||-+|+ ..+|.|.|..++- +...+...++.|++.||..+|..||.|||||.+||||++= +.+.|+||.--+...
T Consensus 97 ylvRqyv-khnLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW-NW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 97 YLVRQYV-KHNLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW-NWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHHHHH-hhhhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee-chhhhhcccccCCccC
Confidence 3455677 4789999987654 8888889999999999999999999999999999999987 699999998665221
Q ss_pred ---ccc----ccccCCCccceeccccccccc--ccccccCC-CCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHH
Q 025244 81 ---LTE----MMTAETGTYRWMAPELYSTVT--LRQGEKKH-YNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAA 149 (255)
Q Consensus 81 ---~~~----~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~-~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~ 149 (255)
... ...+..--.+|+|||.+.... ........ .+++-||||+||+++|+++ |+++|.- .+.....
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr 248 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYR 248 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHh
Confidence 111 122333456899999986421 11222222 5779999999999999987 7888842 1111111
Q ss_pred hhc-CCCC---CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 150 FKN-VRPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 150 ~~~-~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
... ..+. ..--+..++.+|..|++.||.+|-++++.++.
T Consensus 249 ~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 249 SGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 110 0000 01112479999999999999999999999885
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.9e-19 Score=154.04 Aligned_cols=191 Identities=31% Similarity=0.464 Sum_probs=141.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-eecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI-IHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i-~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
++.|.+||..|+|.|.+..... .+++.-...+.++++.||+|+|...| .|+.++..|++++.. ..+|++|||+....
T Consensus 22 ~~~i~~~c~rGsl~D~i~~~~~-~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~-w~lklt~~Gl~~~~ 99 (484)
T KOG1023|consen 22 MIVIWEYCSRGSLLDILSNEDI-KLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSR-WVLKLTDFGLNSLL 99 (484)
T ss_pred eEEEEeeecCccHHhHHhcccc-CccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeee-EEEEechhhhcccc
Confidence 4689999999999999987433 38888888899999999999999876 999999999999998 58999999998754
Q ss_pred ccc---cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch----HHHHHHHHhhc
Q 025244 80 SLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN----LQAAYAAAFKN 152 (255)
Q Consensus 80 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~ 152 (255)
... .......-..-|.|||.+....... .....+.++|+||||++++|+++...||..... .+.........
T Consensus 100 ~~~~~~~~~~~~~~~~lw~aPellr~~~~~~-~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~ 178 (484)
T KOG1023|consen 100 EETAEPEAHHPIRKALLWTAPELLRGALSQS-LESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGG 178 (484)
T ss_pred cccccccccchhHHHHhccCHHHhccccccc-ccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcC
Confidence 321 1111122346799999986532111 112356789999999999999999999975222 22333322212
Q ss_pred ---CCCCC---CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 153 ---VRPSA---ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 153 ---~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
.+|.. ...++++..++.+||..+|.+||+++++-..+.....
T Consensus 179 ~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 179 SNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred CCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 22221 1455679999999999999999999999887765443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-18 Score=159.78 Aligned_cols=135 Identities=33% Similarity=0.497 Sum_probs=108.7
Q ss_pred HHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccccc----------------cccccCCCccceeccccc
Q 025244 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT----------------EMMTAETGTYRWMAPELY 100 (255)
Q Consensus 37 i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~~----------------~~~~~~~gt~~y~aPE~~ 100 (255)
++.+++|||+.||+|||+||+|++|+.- |++|++|||+++..... -.....+||+.|+|||++
T Consensus 152 mvla~Eylh~ygivhrdlkpdnllIT~m-GhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 152 MVLAVEYLHSYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred hhHHhHhhccCCeecCCCCCCcceeeec-ccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence 3788999999999999999999999986 89999999998732110 112345899999999998
Q ss_pred ccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--hcCCCCCCCCcHHHHHHHHHhcccCCCC
Q 025244 101 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF--KNVRPSAENVPEELSIILTSCWKEDPNA 178 (255)
Q Consensus 101 ~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~ 178 (255)
.. ..|+...|+|++|+++||.+-|+.||.+....+..-..+. ..+......++++.+++|.++|+.+|..
T Consensus 231 lr--------qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~ 302 (1205)
T KOG0606|consen 231 LR--------QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLC 302 (1205)
T ss_pred hh--------hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHh
Confidence 63 5688899999999999999999999998766554443332 2233345667899999999999999999
Q ss_pred CC
Q 025244 179 RP 180 (255)
Q Consensus 179 Rp 180 (255)
|-
T Consensus 303 Rl 304 (1205)
T KOG0606|consen 303 RL 304 (1205)
T ss_pred hc
Confidence 94
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=4e-18 Score=145.37 Aligned_cols=92 Identities=26% Similarity=0.258 Sum_probs=72.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC-CCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDL-KPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDi-kp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
.+|||||++|++|.. +. . .. ...++.+++++|.|||++||+|||| ||+|||++.+ +.++|+|||+++..
T Consensus 93 ~~LVmE~~~G~~L~~-~~--~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~-~~ikLiDFGlA~~~ 162 (365)
T PRK09188 93 DGLVRGWTEGVPLHL-AR--P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPD-GEAAVIDFQLASVF 162 (365)
T ss_pred cEEEEEccCCCCHHH-hC--c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCC-CCEEEEECccceec
Confidence 479999999999973 21 1 11 1457899999999999999999999 9999999877 68999999999854
Q ss_pred cccc---------ccccCCCccceeccccccc
Q 025244 80 SLTE---------MMTAETGTYRWMAPELYST 102 (255)
Q Consensus 80 ~~~~---------~~~~~~gt~~y~aPE~~~~ 102 (255)
.... .....++++.|+|||.+..
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 3221 1134568888999999864
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.3e-17 Score=130.49 Aligned_cols=120 Identities=17% Similarity=0.179 Sum_probs=89.6
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC-CCCcEEEeCCCCceEEecCccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDL-KPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDi-kp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++||||++|.+|.+.+.. ....++.|++.+|.++|++||+|||| ||+|||++.+ +.++|+|||++....
T Consensus 74 ~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~-g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED-GSPAVIDFQLAVRGN 143 (218)
T ss_pred EEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC-CCEEEEECCCceecC
Confidence 799999999999765421 11346789999999999999999999 7999999987 689999999998433
Q ss_pred ccccc--------------ccCCCccceecccccccccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCC
Q 025244 81 LTEMM--------------TAETGTYRWMAPELYSTVTLRQGEKKHYN-HKVDSYSFAIVLWELLHNKLPFEG 138 (255)
Q Consensus 81 ~~~~~--------------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~~DvwslG~~l~el~~g~~p~~~ 138 (255)
..... .....++.|++|+...- -...+ .+.+.++.|.-+|.++|+..++.+
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~-------l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRV-------LKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhh-------hccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 22210 01125677777774321 11223 467899999999999999988754
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.6e-17 Score=129.05 Aligned_cols=73 Identities=23% Similarity=0.285 Sum_probs=63.6
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL-HSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~l-H~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+|||||++|++|...+.... .++...+..++.|++.+|.++ |+.||+||||||+|||++. +.++|+|||++..
T Consensus 93 ~iVmE~i~g~~l~~~~~~~~--~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~--~~v~LiDFG~a~~ 166 (190)
T cd05147 93 VLVMEFIGDDGWAAPRLKDA--PLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD--GKLYIIDVSQSVE 166 (190)
T ss_pred EEEEEEeCCCCCcchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC--CcEEEEEcccccc
Confidence 69999999888776644333 389999999999999999999 7999999999999999984 5899999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.4e-16 Score=144.70 Aligned_cols=173 Identities=23% Similarity=0.299 Sum_probs=128.5
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC------CCCceEEecCcc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE------DLKTIKLADFGL 75 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~------~~~~~kl~Dfg~ 75 (255)
+||+||.+.|||.++++. .+.+++..+..+..|++..+++||..+|||+||||+|.||.. +...++|+|||.
T Consensus 770 ~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 699999999999999984 344999999999999999999999999999999999999942 224689999999
Q ss_pred ccccc---cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc
Q 025244 76 AREES---LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 152 (255)
Q Consensus 76 a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 152 (255)
+.... ........++|-.+-.+|+..+ ..++...|.|.|+.+++-|+.|+.- + ......
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~g--------rpWtYq~DyfGlAa~~h~mLFG~y~-------q---~~~g~~ 909 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREG--------RPWTYQIDYFGLAATVHVMLFGKYM-------E---VKNGSS 909 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcC--------CCCchhhhhHHHHHHHHHHHHHHHH-------H---hcCCcc
Confidence 87432 2334566778999999999854 6678899999999999999999631 1 000000
Q ss_pred CCCC---CCCCcH-HHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 153 VRPS---AENVPE-ELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 153 ~~~~---~~~~~~-~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
+... ...+-. ...+|+..+|+.|-..=|...++...++.++.
T Consensus 910 ~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 910 WMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred eeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 1110 111222 34468888888555445778888777766553
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=125.20 Aligned_cols=75 Identities=24% Similarity=0.217 Sum_probs=63.4
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~-~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|||||++|+++...+.... .++...+..++.|++.+|.++|+ .||+||||||+||+++ + +.++|+|||+++...
T Consensus 93 ~lVmE~~~g~~~~~~~l~~~--~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~-~~~~liDFG~a~~~~ 168 (190)
T cd05145 93 VLVMEFIGDDGSPAPRLKDV--PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D-GKPYIIDVSQAVELD 168 (190)
T ss_pred EEEEEEecCCCchhhhhhhc--cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C-CCEEEEEcccceecC
Confidence 79999999886554432222 37888999999999999999999 9999999999999998 5 689999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.9e-17 Score=129.69 Aligned_cols=98 Identities=17% Similarity=0.305 Sum_probs=73.6
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
+|||||++|.+|.++.. +++. ...+++.+|..+|+.|++|||+||+||+++.+ | ++|+|||..+....
T Consensus 119 ~lvmEyi~G~tL~~~~~------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~-g-i~liDfg~~~~~~e 186 (232)
T PRK10359 119 IMLIEYIEGVELNDMPE------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKN-G-LRIIDLSGKRCTAQ 186 (232)
T ss_pred EEEEEEECCccHHHhhh------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCC-C-EEEEECCCcccccc
Confidence 68999999999988742 3332 45699999999999999999999999999987 6 99999998875322
Q ss_pred ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHH
Q 025244 82 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 130 (255)
Q Consensus 82 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~ 130 (255)
...... ... ...+..++|+||||+++....
T Consensus 187 ~~a~d~-----------~vl--------er~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 187 RKAKDR-----------IDL--------ERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred hhhHHH-----------HHH--------HhHhcccccccceeEeehHHH
Confidence 211110 111 123456899999999987653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.2e-17 Score=145.45 Aligned_cols=179 Identities=26% Similarity=0.376 Sum_probs=140.8
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCeecCCCCCcEEEeCCCC-ceEEecCcccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-SHGIIHRDLKPENLLLTEDLK-TIKLADFGLAREE 79 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH-~~~i~HrDikp~Nill~~~~~-~~kl~Dfg~a~~~ 79 (255)
++++||..|+++.+.+........+...+..++.|+..++.|+| ..++.||||||+|.+++.. + ..+++|||+|...
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s-~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDES-GSALKIADFGLATAY 175 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccC-CCcccCCCchhhccc
Confidence 57889999999999994222213777788889999999999999 9999999999999999988 5 8999999999854
Q ss_pred cc----ccccccCCC-ccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc--
Q 025244 80 SL----TEMMTAETG-TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN-- 152 (255)
Q Consensus 80 ~~----~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-- 152 (255)
.. .......+| ++.|+|||...+ ........|+||.|+++.-+++|..||.........+......
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~-------~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~ 248 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSG-------KAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKG 248 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccc-------hhhcCCCcccccccccccccccCCCCccccccccccceeeccccc
Confidence 33 233445678 999999999863 2455678999999999999999999997655544332222111
Q ss_pred --CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 153 --VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 153 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.......++....+++.+++..+|..|.+.+++...
T Consensus 249 ~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 249 RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 122355677889999999999999999998887654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.54 E-value=1e-14 Score=118.25 Aligned_cols=73 Identities=26% Similarity=0.312 Sum_probs=62.9
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG-IIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~-i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+|||||++|++|...+.... .....++..++.|++.+|++||+.| ++||||||+||+++ + +.++|+|||.+..
T Consensus 124 ~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~-~~i~LiDFg~a~~ 197 (237)
T smart00090 124 VLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D-GKVVIIDVSQSVE 197 (237)
T ss_pred eEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C-CCEEEEEChhhhc
Confidence 69999999988877653322 2666677889999999999999999 99999999999998 5 6899999999875
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.2e-13 Score=112.12 Aligned_cols=69 Identities=28% Similarity=0.338 Sum_probs=59.0
Q ss_pred EEEEecCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 2 VIVTELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 2 ~lV~Ey~~g-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
++||||++| .+|.+++.+. .+++.. +.+++.+|.+||++||+||||||.|||++.+ +.++|+|||.++.
T Consensus 122 ~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~-~~v~LIDfg~~~~ 191 (239)
T PRK01723 122 DILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPD-GKFWLIDFDRGEL 191 (239)
T ss_pred eEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCC-CCEEEEECCCccc
Confidence 499999997 6999998653 255443 5789999999999999999999999999987 6899999998875
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.8e-13 Score=109.01 Aligned_cols=69 Identities=36% Similarity=0.574 Sum_probs=61.8
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
++||||++|++|.+++.... . ....++.+++.+|.++|+.|++|+|++|.|||++ + +.++|+|||.+..
T Consensus 75 ~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~ 143 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G-GKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C-CCEEEEECCcccC
Confidence 68999999999999997532 2 7788999999999999999999999999999999 4 6899999998875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.1e-13 Score=109.28 Aligned_cols=69 Identities=25% Similarity=0.292 Sum_probs=59.5
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
++||||++|++|.+.... .....++.+++.++.++|+.|++||||||+||+++.+ +.++|+|||++...
T Consensus 107 ~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~-~~~~liDfg~~~~~ 175 (198)
T cd05144 107 AVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD-EKIYIIDWPQMVST 175 (198)
T ss_pred eEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC-CcEEEEECCccccC
Confidence 789999999999775431 2345688999999999999999999999999999987 69999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.45 E-value=2e-13 Score=107.82 Aligned_cols=66 Identities=32% Similarity=0.533 Sum_probs=58.9
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
++||||++|++|.+++.... . .++.+++.+|.+||+.|++|+|++|.||+++ + +.++++|||++..
T Consensus 73 ~lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~-~~~~liDfg~a~~ 138 (199)
T TIGR03724 73 TIVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D-DKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C-CcEEEEECCCCcC
Confidence 79999999999999886532 1 6789999999999999999999999999999 4 6899999998875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.4e-13 Score=107.94 Aligned_cols=70 Identities=14% Similarity=0.164 Sum_probs=55.7
Q ss_pred EEEec--CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCeecCCCCCcEEEeCC---CCceEEecCccc
Q 025244 3 IVTEL--LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM-ECLHSHGIIHRDLKPENLLLTED---LKTIKLADFGLA 76 (255)
Q Consensus 3 lV~Ey--~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L-~~lH~~~i~HrDikp~Nill~~~---~~~~kl~Dfg~a 76 (255)
+|||| +++|||.+++.+. . +++. ..++.+++.++ +|||+++|+||||||+|||++.. ...++|+||+.+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-~--~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-R--YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-c--ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 5579999999763 2 6655 35678888887 99999999999999999999742 237999995544
Q ss_pred c
Q 025244 77 R 77 (255)
Q Consensus 77 ~ 77 (255)
.
T Consensus 157 ~ 157 (210)
T PRK10345 157 S 157 (210)
T ss_pred c
Confidence 3
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.9e-13 Score=121.57 Aligned_cols=65 Identities=31% Similarity=0.518 Sum_probs=58.7
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
++||||++|++|.+++. ....++.+++.+|.+||+.|++||||||+|||++ + +.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~-~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D-DRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C-CcEEEEeCccccc
Confidence 79999999999999885 2456889999999999999999999999999994 4 5899999999975
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.8e-13 Score=124.98 Aligned_cols=172 Identities=27% Similarity=0.338 Sum_probs=134.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||+|+.|++|...|+.-+. .+.+-+......+.+++++||...+.|+|++|.|+++..+ ++.+++|||......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~~--~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~-gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSGC--LSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYD-GHRPLTDFGTLSKVG 955 (1205)
T ss_pred cchhhHHhccCCchhhhhcCCC--cccccccchhHHHHhhhhccccchhhcccccccchhhccc-CCcccCccccccccc
Confidence 4789999999999999987653 6666677778899999999999999999999999999988 789999998432100
Q ss_pred -------c-------------------------ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHH
Q 025244 81 -------L-------------------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWE 128 (255)
Q Consensus 81 -------~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~e 128 (255)
. .......+||+.|.+||...+ ......+|+|++|++++|
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--------~~hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--------RRHGSAADWWSSGVCLFE 1027 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--------ccCCCcchhhhhhhhhhh
Confidence 0 011223468999999998864 445668999999999999
Q ss_pred HHhCCCCCCCCchHHHHHHHHhhc--CCCCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 025244 129 LLHNKLPFEGMSNLQAAYAAAFKN--VRPSAENVPEELSIILTSCWKEDPNARPNFT 183 (255)
Q Consensus 129 l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 183 (255)
.++|.+||......+....+.... +...+...+...++++...+..++.+|-.+.
T Consensus 1028 ~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1028 VLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999999998866655543333222 2223556778999999999999999997665
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.6e-12 Score=106.40 Aligned_cols=174 Identities=20% Similarity=0.280 Sum_probs=118.8
Q ss_pred EEEEecCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 2 VIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~--i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
.++.||++-|+|.++|++.+ ++.+......+|+.||+.||.|||+-. ++|+.+..+.|++..+ |.+|+.--.-..
T Consensus 148 iFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~n-gLIkig~~ap~s 226 (458)
T KOG1266|consen 148 IFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHN-GLIKIGSVAPDS 226 (458)
T ss_pred EEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCC-ceEEecccCccc
Confidence 57899999999999999754 345777888899999999999999874 9999999999999976 677664321111
Q ss_pred c-----cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCchHHHHHHHHhh
Q 025244 78 E-----ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP-FEGMSNLQAAYAAAFK 151 (255)
Q Consensus 78 ~-----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p-~~~~~~~~~~~~~~~~ 151 (255)
. ...........+-++|.+||.= .....+.++|||+||+..+||..+..- -.+.+..........
T Consensus 227 ~h~s~~~~~~~Ek~~~~~~~g~~a~~sg--------~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~- 297 (458)
T KOG1266|consen 227 THPSVNSTREAEKSVNTSLPGFSAPESG--------TTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIAN- 297 (458)
T ss_pred cchhhhhhhHhhhhccccCCccccCCcC--------cccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhh-
Confidence 0 0111112234567899999953 234456789999999999999887643 222222111111110
Q ss_pred cCCCCCCCCc-HHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 152 NVRPSAENVP-EELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 152 ~~~~~~~~~~-~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
....+. .--+.++.+|++..|..||++++++.|.
T Consensus 298 ----~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 298 ----VIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred ----heeeccCccccCcCcccccCCCCCCcchhhhhcCc
Confidence 000111 1234678999999999999999998763
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.5e-12 Score=100.49 Aligned_cols=72 Identities=28% Similarity=0.330 Sum_probs=57.3
Q ss_pred EEEEecCCCCCHHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 2 VIVTELLSGGTLRK-YLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~-~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~-~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
++||||++|+++.. .+.... .. .++..++.+++.++.++|. .|++|+||||+||+++ + +.++++|||.+...
T Consensus 91 ~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~-~~~~liDfg~a~~~ 164 (187)
T cd05119 91 VLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D-GKVYIIDVPQAVEI 164 (187)
T ss_pred EEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C-CcEEEEECcccccc
Confidence 68999999854332 122111 11 5678899999999999999 9999999999999999 5 68999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.4e-12 Score=112.82 Aligned_cols=175 Identities=25% Similarity=0.265 Sum_probs=129.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR----AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 76 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~----~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a 76 (255)
+|+=+|++ |.+|.++...... .++....+..+.+..+ ||.++|+.+++|-|+||.||+...+....+++|||+.
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred ceeeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 46677888 6888888875432 3778888889999999 9999999999999999999999988457899999999
Q ss_pred cccccccccc------cCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--chHHHHHHH
Q 025244 77 REESLTEMMT------AETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM--SNLQAAYAA 148 (255)
Q Consensus 77 ~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~--~~~~~~~~~ 148 (255)
.......... ...|...|++||... ..++..+|+|++|.++.+..++..++... +........
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~---------~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLN---------GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhc---------cccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 8665544221 125778899999985 56788999999999999999887655332 111111110
Q ss_pred HhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 149 AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 149 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
. .........+.++...+..++..+|..|++.+.+..+
T Consensus 342 ~--ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 342 Y--IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred c--CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 0 0111233455677779999999999999998887654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=4e-11 Score=93.79 Aligned_cols=73 Identities=18% Similarity=0.225 Sum_probs=57.1
Q ss_pred EEEEecCCCCCHHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 2 VIVTELLSGGTLRK-YLLNMRPRCLDVCVAIGFALDIARAMECL-HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~-~l~~~~~~~~~~~~~~~~~~~i~~~L~~l-H~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+|||||+.|+.+.. .+.+. .++..+...+..+++.+|..| |+.|++|+||++.||+++. +.+.|+|||.+...
T Consensus 100 ~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~--~~v~iIDF~qav~~ 174 (197)
T cd05146 100 VLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWHD--GKVWFIDVSQSVEP 174 (197)
T ss_pred EEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEC--CcEEEEECCCceeC
Confidence 69999996654422 23221 255566777889999999998 8999999999999999975 47999999988753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.5e-11 Score=91.01 Aligned_cols=66 Identities=32% Similarity=0.520 Sum_probs=57.3
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
.|||||++|..|.+.|... ...++..+-.-+.-||..||+|+||.++||+++++ .+.++|||++..
T Consensus 75 ~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGLg~~ 140 (204)
T COG3642 75 LIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGEF 140 (204)
T ss_pred EEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCcccc
Confidence 5899999999999999764 14566777788888999999999999999999876 599999999985
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.7e-10 Score=95.85 Aligned_cols=166 Identities=17% Similarity=0.339 Sum_probs=119.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccccccccccCCCccceeccccccccc
Q 025244 25 LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVT 104 (255)
Q Consensus 25 ~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 104 (255)
..+.-.+++++.++.+.+.||+.|.+-+|++++|+|++++ +.|.|.|-.--............+|...|.+||.-.-.+
T Consensus 114 ~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~-~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~s 192 (637)
T COG4248 114 CAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD-SKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPS 192 (637)
T ss_pred cccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC-ceEEEEcccceeeccCCceEecccCccccCCHHHhcccc
Confidence 7788899999999999999999999999999999999988 689998855333333344445668999999999764222
Q ss_pred ccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCchH-------HHHHH--------HHhhcCCCC-----CCCCcHH
Q 025244 105 LRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNL-------QAAYA--------AAFKNVRPS-----AENVPEE 163 (255)
Q Consensus 105 ~~~~~~~~~~~~~DvwslG~~l~el~~g-~~p~~~~~~~-------~~~~~--------~~~~~~~~~-----~~~~~~~ 163 (255)
. .+..-+...|.|.||+++++++.| +.||.+.... +.... .......+. ..-++++
T Consensus 193 f---~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~ 269 (637)
T COG4248 193 F---VGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPD 269 (637)
T ss_pred c---cccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHH
Confidence 1 223445689999999999999886 8999653321 11100 001111122 2335789
Q ss_pred HHHHHHHhccc--CCCCCCCHHHHHHHHHHhHh
Q 025244 164 LSIILTSCWKE--DPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 164 l~~li~~~l~~--~p~~Rpt~~~vl~~l~~~~~ 194 (255)
+..+..+|+.. ++.-|||++..+..|.....
T Consensus 270 vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 270 VQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 99999999965 46689999998887765543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.1e-10 Score=94.40 Aligned_cols=77 Identities=23% Similarity=0.232 Sum_probs=64.1
Q ss_pred EEEEecCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC------CCCceEEecCc
Q 025244 2 VIVTELLSGG-TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE------DLKTIKLADFG 74 (255)
Q Consensus 2 ~lV~Ey~~gg-sL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~------~~~~~kl~Dfg 74 (255)
+||||+++|. +|.+++.+......+......++.+++..+.-||+.||+|+|+++.|||++. +...+.++||+
T Consensus 111 ~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 111 FIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred EEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 6999999876 8999987533333666777889999999999999999999999999999975 12578999999
Q ss_pred cccc
Q 025244 75 LARE 78 (255)
Q Consensus 75 ~a~~ 78 (255)
.++.
T Consensus 191 r~~~ 194 (268)
T PRK15123 191 RAQI 194 (268)
T ss_pred cccc
Confidence 8853
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.14 E-value=9.6e-11 Score=103.16 Aligned_cols=74 Identities=28% Similarity=0.410 Sum_probs=58.2
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR-AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~-~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|||||++|++|.++...... ..+ ...++.+++. .+..+|..|++|+|+||.||+++.+ +.++++|||++...+
T Consensus 234 vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~-g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 234 VLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKD-GKIIALDFGIVGRLS 308 (437)
T ss_pred eEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCC-CcEEEEeCCCeeECC
Confidence 699999999999998754221 132 2345555555 4788999999999999999999888 799999999997644
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.8e-10 Score=87.54 Aligned_cols=77 Identities=31% Similarity=0.434 Sum_probs=63.6
Q ss_pred EEEEecCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCce--EEecCccccc
Q 025244 2 VIVTELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI--KLADFGLARE 78 (255)
Q Consensus 2 ~lV~Ey~~g-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~--kl~Dfg~a~~ 78 (255)
.|+|||++| .++.+++...-...........++.+|-+.+.-||.++++|+||..+||++.++.+.+ .++|||++..
T Consensus 86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 589999986 4899999876544344444478899999999999999999999999999998775555 8999999875
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.13 E-value=1e-10 Score=87.43 Aligned_cols=67 Identities=25% Similarity=0.365 Sum_probs=57.3
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH---GIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
++||||++|+++..+ +......++.+++.+|+++|.. +++|+|++|+||+++++ +.++++|||.++.
T Consensus 69 ~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~-~~~~l~Df~~~~~ 138 (155)
T cd05120 69 YLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG-KILGIIDWEYAGY 138 (155)
T ss_pred EEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC-cEEEEEecccccC
Confidence 789999998877654 3455566789999999999985 69999999999999986 6899999998874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.13 E-value=2e-11 Score=107.11 Aligned_cols=174 Identities=21% Similarity=0.217 Sum_probs=125.6
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
++=-|||+|+++...+.-.. .+++...+++..|++.++.++|++.++|+|+||.||++..+++..++.|||.+.....
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~--~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQ--MLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cCchhhhcCcchhhhhHHHH--hcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence 34468999998887774322 3888899999999999999999999999999999999998656788999999874211
Q ss_pred ccccccCCCcccee-cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 82 TEMMTAETGTYRWM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 82 ~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
. .....+..++. ..|.+. ....+..+.|++|||..+.+.+++..--.... . +........+.....
T Consensus 420 ~--~~~~~~~~r~~p~~~~~~-------e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~-~~~i~~~~~p~~~~~ 486 (524)
T KOG0601|consen 420 S--SGVFHHIDRLYPIAEILL-------EDYPHLSKADIFSLGLSVDEAITGSPLSESGV---Q-SLTIRSGDTPNLPGL 486 (524)
T ss_pred e--cccccccccccccchhhc-------cccccccccccccccccccccccCcccCcccc---c-ceeeecccccCCCch
Confidence 1 11222333444 245443 24567789999999999999999875432211 1 122223334444555
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
...+..+.+.++..++..||.+.++..+..
T Consensus 487 ~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 487 KLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred HHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 578888999999999999999988876644
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.05 E-value=8.9e-10 Score=87.57 Aligned_cols=75 Identities=33% Similarity=0.446 Sum_probs=64.4
Q ss_pred EEEEecCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCC--CceEEecCccccc
Q 025244 2 VIVTELLSGG-TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLARE 78 (255)
Q Consensus 2 ~lV~Ey~~gg-sL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~--~~~kl~Dfg~a~~ 78 (255)
+||+|+++|. +|.+++..... .+......++.+++..++-||+.||+|+|+++.|||++.+. ..+.++||+.++.
T Consensus 93 ~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 93 YLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred EEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 6899999984 89999987443 66667788999999999999999999999999999999772 2689999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.4e-10 Score=86.86 Aligned_cols=65 Identities=32% Similarity=0.423 Sum_probs=52.6
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-----eecCCCCCcEEEeCCCCceEEecCccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI-----IHRDLKPENLLLTEDLKTIKLADFGLA 76 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i-----~HrDikp~Nill~~~~~~~kl~Dfg~a 76 (255)
++||||++|.++.+.- .. ....+.+++.+|+.||+.++ +|+|++|.||+++ + +.++++|||.+
T Consensus 67 ~lv~e~i~G~~l~~~~-------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-~~~~liDf~~a 134 (170)
T cd05151 67 VLITEFIEGSELLTED-------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-GRLWLIDWEYA 134 (170)
T ss_pred eEEEEecCCCcccccc-------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-CeEEEEecccc
Confidence 6899999999876540 11 12346789999999999985 9999999999998 4 57999999988
Q ss_pred cc
Q 025244 77 RE 78 (255)
Q Consensus 77 ~~ 78 (255)
..
T Consensus 135 ~~ 136 (170)
T cd05151 135 GM 136 (170)
T ss_pred cC
Confidence 64
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=8.5e-11 Score=104.86 Aligned_cols=146 Identities=18% Similarity=0.311 Sum_probs=105.5
Q ss_pred HHHHHHHHHHHHhC-CCeecCCCCCcEEEeCCCCceEEecCcccccccc-cc---------ccccCCCccceeccccccc
Q 025244 34 ALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TE---------MMTAETGTYRWMAPELYST 102 (255)
Q Consensus 34 ~~~i~~~L~~lH~~-~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~-~~---------~~~~~~gt~~y~aPE~~~~ 102 (255)
+.+++.||.|+|.. ++||+.|.|++|.++.. +.+||+.|+.+..... .+ ......-...|.|||++..
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 45667899999975 89999999999999998 7999999998864322 11 1111234568999999864
Q ss_pred ccccccccCCCCchhhHHHHHHHHHHHH-hCCCCCCCCchHHHHHHHHh---hcCCCCCCCCcHHHHHHHHHhcccCCCC
Q 025244 103 VTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAF---KNVRPSAENVPEELSIILTSCWKEDPNA 178 (255)
Q Consensus 103 ~~~~~~~~~~~~~~~DvwslG~~l~el~-~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~ 178 (255)
...+.++|+||+|+++|.+. .|+.-+.............. .........+|+++.+=+.+++..+...
T Consensus 184 --------~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~ 255 (700)
T KOG2137|consen 184 --------TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAV 255 (700)
T ss_pred --------ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCccc
Confidence 45677999999999999998 56655544332222221111 1112234678999999999999999999
Q ss_pred CCCHHHHHHH
Q 025244 179 RPNFTQIIQM 188 (255)
Q Consensus 179 Rpt~~~vl~~ 188 (255)
||++.++...
T Consensus 256 rp~~~~l~~~ 265 (700)
T KOG2137|consen 256 RPTLDLLLSI 265 (700)
T ss_pred Ccchhhhhcc
Confidence 9987777654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.2e-09 Score=83.63 Aligned_cols=72 Identities=29% Similarity=0.385 Sum_probs=49.4
Q ss_pred EEEEecCC--CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 2 VIVTELLS--GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMEC-LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 2 ~lV~Ey~~--ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~-lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+|||||++ |..+..+.... ++......++.+++..+.. +|+.|++|+|+.+.||+++++ .+.++|||.+..
T Consensus 82 ~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~qav~ 155 (188)
T PF01163_consen 82 VIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFGQAVD 155 (188)
T ss_dssp EEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--GTTEEE
T ss_pred EEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEecCccee
Confidence 69999998 65565544321 2234456677788885555 579999999999999999876 799999998875
Q ss_pred c
Q 025244 79 E 79 (255)
Q Consensus 79 ~ 79 (255)
.
T Consensus 156 ~ 156 (188)
T PF01163_consen 156 S 156 (188)
T ss_dssp T
T ss_pred c
Confidence 3
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.6e-09 Score=95.63 Aligned_cols=72 Identities=21% Similarity=0.269 Sum_probs=50.4
Q ss_pred EEEEecCCCCCHHHHH--HhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC----ceEEecC
Q 025244 2 VIVTELLSGGTLRKYL--LNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK----TIKLADF 73 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l--~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~----~~kl~Df 73 (255)
+|||||++|+.|.++- ...+. +.+.+..+..++ ..+...|++|+|+||.||+++.+ + .++++||
T Consensus 237 VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~-------~Qif~~GffHaDpHPGNIlv~~~-g~~~~~i~llDF 308 (537)
T PRK04750 237 VMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF-------TQVFRDGFFHADMHPGNIFVSYD-PPENPRYIALDF 308 (537)
T ss_pred eEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH-------HHHHhCCeeeCCCChHHeEEecC-CCCCCeEEEEec
Confidence 5999999999998753 22220 012222223333 33456899999999999999987 5 8999999
Q ss_pred cccccccc
Q 025244 74 GLAREESL 81 (255)
Q Consensus 74 g~a~~~~~ 81 (255)
|++...+.
T Consensus 309 Givg~l~~ 316 (537)
T PRK04750 309 GIVGSLNK 316 (537)
T ss_pred ceEEECCH
Confidence 99975443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.3e-08 Score=80.42 Aligned_cols=65 Identities=31% Similarity=0.453 Sum_probs=53.0
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+|||||++|..|.+... +++. +...+.+++.-||+.|++|+|.+|.|++++.+ .++++||+..+.
T Consensus 119 ~ll~EYIeG~~l~d~~~------i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--~i~iID~~~k~~ 183 (229)
T PF06176_consen 119 VLLMEYIEGVELNDIED------IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--GIRIIDTQGKRM 183 (229)
T ss_pred EEEEEEecCeecccchh------cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--cEEEEECccccc
Confidence 58999999998877643 3332 44567788999999999999999999999865 599999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=3.2e-07 Score=82.17 Aligned_cols=114 Identities=18% Similarity=0.207 Sum_probs=85.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH-~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+|||+|-+ .-|..++.+.+ ......-+.||+.||.+|| +.+++|++|.-+.|+++.. |..||++|.++...
T Consensus 84 ~ylvTErV--~Pl~~~lk~l~-----~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~-GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 84 LYLVTERV--RPLETVLKELG-----KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNES-GEWKLGGLELVSKA 155 (690)
T ss_pred eEEEeecc--ccHHHHHHHhH-----HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCC-CcEEEeeeEEEecc
Confidence 58999998 57888887643 5555666889999999998 5679999999999999998 79999999988753
Q ss_pred ccccc-cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhC
Q 025244 80 SLTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN 132 (255)
Q Consensus 80 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g 132 (255)
..... .....--..|..|+.+. .-....|.|.||++++|++.|
T Consensus 156 ~~~~~~~~~~~~~~s~~~P~~~~----------~s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 156 SGFNAPAKSLYLIESFDDPEEID----------PSEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccCCcccccchhhhcccChhhcC----------ccccchhhhhHHHHHHHHhCc
Confidence 33221 11122223466676542 112467999999999999998
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.6e-07 Score=72.77 Aligned_cols=76 Identities=16% Similarity=0.155 Sum_probs=63.4
Q ss_pred EEEEecCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCc--eEEecCccccc
Q 025244 2 VIVTELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT--IKLADFGLARE 78 (255)
Q Consensus 2 ~lV~Ey~~g-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~--~kl~Dfg~a~~ 78 (255)
+||+|-++| -||.+++.+..-...+......++.+++..++-||+.|+.|+|+.+.||+++.+ +. ++++||.-++.
T Consensus 101 ~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 101 LLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccch
Confidence 689998843 589999876543346777788899999999999999999999999999999865 45 89999987763
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.6e-07 Score=72.96 Aligned_cols=74 Identities=30% Similarity=0.417 Sum_probs=56.3
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS----------------------------------- 46 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~----------------------------------- 46 (255)
++||||++|.+|.+.+.. . .++......++.+++.+|..||+
T Consensus 76 ~~v~e~i~G~~l~~~~~~-~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (223)
T cd05154 76 FYVMERVDGRVLRDRLLR-P--ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTD 152 (223)
T ss_pred eEEEEEeCCEecCCCCCC-C--CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccc
Confidence 799999999988876532 1 26666666777777777777773
Q ss_pred ---------------------CCCeecCCCCCcEEEeCC-CCceEEecCccccc
Q 025244 47 ---------------------HGIIHRDLKPENLLLTED-LKTIKLADFGLARE 78 (255)
Q Consensus 47 ---------------------~~i~HrDikp~Nill~~~-~~~~kl~Dfg~a~~ 78 (255)
..++|+|+++.||+++.+ .+.+.|+||+.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 153 EPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred ccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 236899999999999883 25688999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.4e-05 Score=70.13 Aligned_cols=157 Identities=13% Similarity=0.173 Sum_probs=109.3
Q ss_pred CEEEEecCCC-CCHHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSG-GTLRKYLLNMR-------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~g-gsL~~~l~~~~-------------~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
|+||++|.++ ++|.++-.... +..+++...|.++.|+..||.++|+.|+.-+-|.+.+|+++.+.
T Consensus 352 lvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~- 430 (655)
T KOG3741|consen 352 LVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM- 430 (655)
T ss_pred EEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc-
Confidence 5799999985 47777654321 22477899999999999999999999999999999999999884
Q ss_pred ceEEecCccccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHH
Q 025244 67 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 146 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~ 146 (255)
+++|..-|+......+. . |-+ .--.+-|.=.||.+++.|.||..--...+..+...
T Consensus 431 RIriS~C~i~Dvl~~d~-----------~--~~l-----------e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~ 486 (655)
T KOG3741|consen 431 RIRISGCGIMDVLQEDP-----------T--EPL-----------ESQQQNDLRDLGLLLLALATGTENSNRTDSTQSSH 486 (655)
T ss_pred eEEEecccceeeecCCC-----------C--cch-----------hHHhhhhHHHHHHHHHHHhhcccccccccchHHHH
Confidence 78877666554322221 0 111 11226799999999999999965422212222221
Q ss_pred HHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 147 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 147 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
.. .....++.+++++|......++++ -+..+++.++
T Consensus 487 ~~------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 487 LT------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HH------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 11 123456788999999999988886 5677776654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=8e-07 Score=72.01 Aligned_cols=69 Identities=30% Similarity=0.341 Sum_probs=53.5
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
.+||||++|-.|...- ++.+..-.++..|++-+..+-..|++|+|+++-||+++++ |.+.++||--+..
T Consensus 183 aVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~d-g~~~vIDwPQ~v~ 251 (304)
T COG0478 183 AVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED-GDIVVIDWPQAVP 251 (304)
T ss_pred eeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecC-CCEEEEeCccccc
Confidence 4899999986665532 2334445566777777777779999999999999999998 7899999965543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.06 E-value=1e-05 Score=65.03 Aligned_cols=73 Identities=26% Similarity=0.309 Sum_probs=54.5
Q ss_pred EEEEecCCCCCH--HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 2 VIVTELLSGGTL--RKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 2 ~lV~Ey~~ggsL--~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~-~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+|||||+. ..- .-.|.+- .++..++..+..++++.+.-|-. .+++|+||+.-|||+. + +.+.++|||-|..
T Consensus 142 VLvMEfIg-~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~-~~p~iID~~QaV~ 215 (268)
T COG1718 142 VLVMEFIG-DDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-D-GEPYIIDVSQAVT 215 (268)
T ss_pred eEEEEecc-CCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-C-CeEEEEECccccc
Confidence 69999994 331 1112211 14444677888999999998887 8999999999999999 4 5899999998875
Q ss_pred cc
Q 025244 79 ES 80 (255)
Q Consensus 79 ~~ 80 (255)
..
T Consensus 216 ~~ 217 (268)
T COG1718 216 ID 217 (268)
T ss_pred cC
Confidence 33
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.97 E-value=6.2e-05 Score=71.89 Aligned_cols=169 Identities=15% Similarity=0.134 Sum_probs=115.6
Q ss_pred EEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC---cEEEeCCCCceEEe--cCccccc
Q 025244 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE---NLLLTEDLKTIKLA--DFGLARE 78 (255)
Q Consensus 4 V~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~---Nill~~~~~~~kl~--Dfg~a~~ 78 (255)
..||+++.++.+.++.-+. ++......+..++++||.|+|+....|.-+... +--.+.. +.+.++ ||+..+.
T Consensus 264 ~~~~~s~~~~~~~~q~v~~--i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~ 340 (1351)
T KOG1035|consen 264 LQEICSKVELRSLLQSVGS--IPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGE-GVVAISLSDFDSSKP 340 (1351)
T ss_pred HHhhcCccchHHHHhhccc--cCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCcc-ceeecchhhhccccc
Confidence 3578888899998887654 888888889999999999999997666655444 3333344 355555 8888776
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCC
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE 158 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 158 (255)
............+..+.++|.... .........|+|.+|.....+..|..+-.-..... ... ..
T Consensus 341 l~d~~~~~~~~~~~~~~~~e~~~~------~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~--------~~l--~~ 404 (1351)
T KOG1035|consen 341 LPDNEKSFSDLLAEIRNADEDLKE------NTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPV--------SLL--DV 404 (1351)
T ss_pred CCCcccchhhcCcccccccccccc------ccchhhhhhHHHHHHHHHhhhhhcCcccccccchh--------hhh--cc
Confidence 555544444555667788887643 22334456799999999999988765432110000 000 11
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 159 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 159 ~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
.....+.+...+|+..+.++|+++.+++.+...
T Consensus 405 ~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~ 437 (1351)
T KOG1035|consen 405 LSTSELLDALPKCLDEDSEERLSALELLTHPFL 437 (1351)
T ss_pred ccchhhhhhhhhhcchhhhhccchhhhhhchhc
Confidence 111278889999999999999999999987543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.93 E-value=3e-05 Score=69.44 Aligned_cols=75 Identities=23% Similarity=0.313 Sum_probs=54.3
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|+|||++|-.+.+...-.. ..++.......+.++ -+..+-..|+.|.|.+|.||+++.+ |++.+.|||+....+
T Consensus 242 VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~ 316 (517)
T COG0661 242 VLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGFFHADPHPGNILVRSD-GRIVLLDFGIVGRLD 316 (517)
T ss_pred EEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCccccCCCccceEEecC-CcEEEEcCcceecCC
Confidence 68999999999999854322 226644433322222 2344556899999999999999999 799999999987544
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.79 E-value=6.7e-05 Score=67.18 Aligned_cols=75 Identities=24% Similarity=0.291 Sum_probs=52.4
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHH-HHHHHhCCCeecCCCCCcEEEeC---CCCceEEecCcccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA-MECLHSHGIIHRDLKPENLLLTE---DLKTIKLADFGLAR 77 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~-L~~lH~~~i~HrDikp~Nill~~---~~~~~kl~Dfg~a~ 77 (255)
+|+||||+|..+.|.-.-. ...++...+. ..+.++ +..+=..|++|+|-+|.||+++. ....+.+.|||+..
T Consensus 278 VLtME~~~G~~i~Dl~~i~-~~gi~~~~i~---~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~ 353 (538)
T KOG1235|consen 278 VLTMEYVDGIKINDLDAID-KRGISPHDIL---NKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYA 353 (538)
T ss_pred EEEEEecCCccCCCHHHHH-HcCCCHHHHH---HHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccc
Confidence 6999999999777653321 2227776444 344443 23344678999999999999984 23689999999987
Q ss_pred ccc
Q 025244 78 EES 80 (255)
Q Consensus 78 ~~~ 80 (255)
..+
T Consensus 354 ~is 356 (538)
T KOG1235|consen 354 VIS 356 (538)
T ss_pred ccc
Confidence 543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.72 E-value=1.2e-05 Score=72.10 Aligned_cols=120 Identities=24% Similarity=0.204 Sum_probs=84.0
Q ss_pred EEEEecCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 2 VIVTELLSGG-TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 2 ~lV~Ey~~gg-sL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++|+++.++ +....+.. ....+.+-+...+.+.-..+|+++|+..-+|+| ||+.++. ..+..||+......
T Consensus 310 ~i~~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE--EVKLLDFAVPPQLT 382 (829)
T ss_pred chhhhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc--ccccccccCCcccC
Confidence 4667777655 22221111 011133344445566677889999999888999 8888774 68999999988766
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 136 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~ 136 (255)
......+..+++.++|||+... ..+..+.|+|++|+--.++.-|-+|-
T Consensus 383 ~~~~~~t~~~~~~~~~pev~~~--------~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 383 RTMKPRTAIGTPEPLAPEVIQE--------NTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cccccccCCCCCCCCCchhhcc--------cccccCCCccCCCcchhhcCCCCCCC
Confidence 5555677889999999998753 55677899999998766776666664
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.70 E-value=9.3e-05 Score=57.84 Aligned_cols=75 Identities=23% Similarity=0.217 Sum_probs=59.0
Q ss_pred EEEEecCCCCCHHHH---HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCeecCCCCCcEEEeCCCCceEEecCcc
Q 025244 2 VIVTELLSGGTLRKY---LLNMRPRCLDVCVAIGFALDIARAMECLHS---HGIIHRDLKPENLLLTEDLKTIKLADFGL 75 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~---l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~i~HrDikp~Nill~~~~~~~kl~Dfg~ 75 (255)
++|.||...+++... +.+.. ..++..+.+++.++++.+.+++. ..+.-.|++++|+-++++ +++|++|.+.
T Consensus 32 ~~v~E~~~~~~~~~~~~~l~~~~--~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~-~~lk~iDld~ 108 (188)
T PF12260_consen 32 FYVVEYVGAGSLYGIYRPLSQFL--QSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDD-GRLKLIDLDD 108 (188)
T ss_pred EEEEEeecCcccccccccccccc--ccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCC-CcEEEEechh
Confidence 578999977765421 11111 17899999999999999999998 347779999999999988 7999999987
Q ss_pred cccc
Q 025244 76 AREE 79 (255)
Q Consensus 76 a~~~ 79 (255)
+...
T Consensus 109 v~~~ 112 (188)
T PF12260_consen 109 VFVE 112 (188)
T ss_pred cchh
Confidence 7643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.52 E-value=7.5e-06 Score=79.90 Aligned_cols=126 Identities=13% Similarity=0.132 Sum_probs=92.3
Q ss_pred EEEEecCCCCCHHHHHHhcCCCC--CCHHHHHHHHHHH-HHHHHHHHhC-----CCeecCCCCCcEEEeCCCCceEEecC
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRC--LDVCVAIGFALDI-ARAMECLHSH-----GIIHRDLKPENLLLTEDLKTIKLADF 73 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~--~~~~~~~~~~~~i-~~~L~~lH~~-----~i~HrDikp~Nill~~~~~~~kl~Df 73 (255)
+.+++|+.+|.+++.|-+.-.+. ....-+ ....++ +....-+|+. -.+|+++|+-|.+|..+ ..++++++
T Consensus 1307 ~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v-~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtn-y~v~~gk~ 1384 (2724)
T KOG1826|consen 1307 YIRSLYVEFGKLFSIIIKGLEESPDLDRSPV-HLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTN-YNVKLGKG 1384 (2724)
T ss_pred HHHHHHHHHhHHHHHHHhccccCCcchhchH-HHHHHHHHhccchhhhcccCCccchhhhhhhhccceecC-Cccccccc
Confidence 45788999999999998653321 222222 233333 6666666654 17899999999999988 48999999
Q ss_pred cccc-ccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 025244 74 GLAR-EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 137 (255)
Q Consensus 74 g~a~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~ 137 (255)
|+.+ ...........++++.|+.++..+. -.++.++|+|..|+.+|+...|..+|-
T Consensus 1385 gLdKIknp~~sf~Gl~l~sp~~v~qli~N~--------ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1385 GLDKIKNPVLSFFGLELCSPIYVLQLIKNE--------IKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred ccccccCchHhhhhhhhCCHHHHHHHHHHH--------HhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 9999 3333334456678899999998753 556777999999999999988887763
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00047 Score=56.05 Aligned_cols=30 Identities=20% Similarity=0.215 Sum_probs=25.7
Q ss_pred CCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 48 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 48 ~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
.++|+|+.|.|||++++ +.+.|+||+.+..
T Consensus 164 ~l~HgD~~~~Nil~~~~-~~~~iIDwe~a~~ 193 (244)
T cd05150 164 VVTHGDACLPNIIVDPG-KFSGFIDLGRLGV 193 (244)
T ss_pred EEECCCCCCccEEEeCC-cEEEEEEcccccc
Confidence 48999999999999986 5678999987753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.00089 Score=53.94 Aligned_cols=29 Identities=21% Similarity=0.219 Sum_probs=25.2
Q ss_pred CCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 48 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 48 ~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
.++|+|+.|.||+++++ + +.|+||+.+..
T Consensus 154 ~~~HgD~~~~Nii~~~~-~-~~iIDwe~a~~ 182 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGK-G-TYWIDLGDFGY 182 (226)
T ss_pred ceEecCCCCCcEEEcCC-C-cEEEechhcCc
Confidence 47899999999999886 5 89999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.00081 Score=54.43 Aligned_cols=30 Identities=33% Similarity=0.504 Sum_probs=25.1
Q ss_pred CCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 48 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 48 ~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++|+|+.+.||+++++ +..-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~-~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDG-RLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECC-CEEEEEeCcccCc
Confidence 58999999999999865 4456999998764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0015 Score=55.57 Aligned_cols=69 Identities=19% Similarity=0.269 Sum_probs=54.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~-~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+|++|++. |++|.-.-. ...+++..++.+.+..+.-+..+ ..-|||+.-.||+|+ + |++.|+||-+++.
T Consensus 301 ~yl~~kdh-gt~is~ik~------~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~-GnvtLIDfklsRl 370 (488)
T COG5072 301 LYLHFKDH-GTPISIIKA------DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E-GNVTLIDFKLSRL 370 (488)
T ss_pred EEEEEecC-Cceeeeeec------ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c-CceEEEEeeeeec
Confidence 47888887 666543221 55678888999988888777765 588999999999999 5 7999999999985
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0014 Score=54.99 Aligned_cols=67 Identities=28% Similarity=0.379 Sum_probs=50.2
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
++|||++.|..|.+.-.- .+.. .+...+..-+.-|-..|+||+|..--||+++.+ +.++++||--..
T Consensus 184 ~Vvmelv~g~Pl~~v~~v-----~d~~---~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd-~~i~vIDFPQmv 250 (465)
T KOG2268|consen 184 CVVMELVDGYPLRQVRHV-----EDPP---TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDD-DKIVVIDFPQMV 250 (465)
T ss_pred eeHHHhhcccceeeeeec-----CChH---HHHHHHHHHHHHHHHcCceecccchheeEEecC-CCEEEeechHhh
Confidence 478999988887765421 2222 234555666677889999999999999999987 689999997554
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.0046 Score=59.31 Aligned_cols=31 Identities=29% Similarity=0.545 Sum_probs=25.1
Q ss_pred CCeecCCCCCcEEEeCCCCc-eEEecCccccc
Q 025244 48 GIIHRDLKPENLLLTEDLKT-IKLADFGLARE 78 (255)
Q Consensus 48 ~i~HrDikp~Nill~~~~~~-~kl~Dfg~a~~ 78 (255)
.++|+|+++.||+++.+.+. +-|.||+++..
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 49999999999999853233 56999999874
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.013 Score=49.33 Aligned_cols=30 Identities=40% Similarity=0.652 Sum_probs=26.2
Q ss_pred CCCeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 47 ~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
.+++|+|+++.||+++.+ +.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGD-SVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECC-ceEEEeeccccc
Confidence 589999999999999987 556899998775
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.024 Score=47.96 Aligned_cols=31 Identities=35% Similarity=0.568 Sum_probs=25.9
Q ss_pred CCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 47 ~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
.+++|+|+.|.||+++.+ +..-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~-~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGD-RLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECC-ceEEEEecccccC
Confidence 379999999999999865 3457999998763
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.075 Score=41.88 Aligned_cols=63 Identities=29% Similarity=0.396 Sum_probs=42.7
Q ss_pred EEEecCCC------CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCC--C-ceEEec
Q 025244 3 IVTELLSG------GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--K-TIKLAD 72 (255)
Q Consensus 3 lV~Ey~~g------gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~--~-~~kl~D 72 (255)
+|+|.+-+ -||.+++.+.. ++. .. ...+-+-..||-+.+|+.+|++|.||++.... . .+.|+|
T Consensus 94 lv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 94 LVVELIRDADGNISPTLEDYLKEGG---LTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEEEEECCCCCcCccHHHHHHcCC---ccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 56666532 37899996543 655 32 33344455688899999999999999997432 2 467777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.016 Score=46.68 Aligned_cols=31 Identities=26% Similarity=0.439 Sum_probs=26.1
Q ss_pred CCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 48 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 48 ~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++|+|+.+.|||++++.+.+.++||..|..
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 5899999999999997225799999987763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.026 Score=47.19 Aligned_cols=31 Identities=35% Similarity=0.540 Sum_probs=26.2
Q ss_pred CCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 47 ~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
.+++|+|+.|.||+++++ +.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGD-ELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCC-ceEEEeehhhhcC
Confidence 379999999999999986 4568999987753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.035 Score=46.71 Aligned_cols=29 Identities=28% Similarity=0.573 Sum_probs=25.0
Q ss_pred CCCeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 47 ~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
.+++|+|+.+.||+++.+ .+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~--~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDN--EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeCC--cEEEEECcccc
Confidence 478999999999999873 68899998765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.036 Score=42.65 Aligned_cols=67 Identities=27% Similarity=0.308 Sum_probs=47.1
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCC-CCcEEEeCCCCceEEecCccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLK-PENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDik-p~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++|||++|..|.++-... +..+ +..+++.-.-|-..||-|..|. |...++.++ +.+.|+||.-|+.
T Consensus 88 ~i~me~i~G~~L~~~~~~~-----~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGG-----DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhhcCcchhhhhhcc-----cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 5679999998888876531 2222 3456666566778899999997 554444455 4799999998874
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.22 E-value=0.036 Score=45.88 Aligned_cols=45 Identities=33% Similarity=0.399 Sum_probs=33.6
Q ss_pred HHHHHHHHHHHHHhC--CCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 33 FALDIARAMECLHSH--GIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 33 ~~~~i~~~L~~lH~~--~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
.+..+-.++.-.+.. -++|.|+.|+|++.++. +.++|+||..|..
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~-~~l~LIDWEyAg~ 183 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDK-GGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCC-CcEEEEecccCCC
Confidence 344444444444444 58999999999999986 6899999988764
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.013 Score=46.74 Aligned_cols=32 Identities=34% Similarity=0.413 Sum_probs=20.9
Q ss_pred CCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 47 ~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
..++|+|+.|.||+++.+.+.+.|+||+.+..
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred cEEEEeccccccceeeeccceeEEEecccceE
Confidence 35999999999999993325667999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.024 Score=44.05 Aligned_cols=30 Identities=23% Similarity=0.442 Sum_probs=25.6
Q ss_pred CeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 49 IIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 49 i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.+|+|+.|.|++++++ + ++++||+.+...+
T Consensus 79 p~H~D~~~~N~~~~~~-~-~~lIDwe~a~~gD 108 (188)
T PRK10271 79 PLHMDVHAGNLVHSAS-G-LRLIDWEYAGDGD 108 (188)
T ss_pred eecCCCCCccEEEECC-C-EEEEeCCcccCCC
Confidence 6899999999999876 4 8999999887533
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.022 Score=47.86 Aligned_cols=31 Identities=35% Similarity=0.453 Sum_probs=26.0
Q ss_pred CCeecCCCCCcEEEeCC---CCceEEecCccccc
Q 025244 48 GIIHRDLKPENLLLTED---LKTIKLADFGLARE 78 (255)
Q Consensus 48 ~i~HrDikp~Nill~~~---~~~~kl~Dfg~a~~ 78 (255)
.++|+|+.+.||+++++ .+.+.++||..+..
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 58999999999999873 25799999988753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.77 E-value=0.04 Score=47.36 Aligned_cols=31 Identities=29% Similarity=0.583 Sum_probs=26.5
Q ss_pred CCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 48 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 48 ~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
.++|+|+++.|||++++.+.+.++||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 5899999999999986436799999988764
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.65 E-value=0.084 Score=45.48 Aligned_cols=72 Identities=26% Similarity=0.296 Sum_probs=53.8
Q ss_pred EEEEecCCCCCHH--HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 2 VIVTELLSGGTLR--KYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 2 ~lV~Ey~~ggsL~--~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~-~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+|||+|+ |++=+ -.|.. -.++...+..+-.+++.-+.-|.. -++||.||.--|+|+.. |.+.|+|.+-+..
T Consensus 240 VLVM~Fl-Grdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd--G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 240 VLVMEFL-GRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD--GKLYIIDVSQSVE 313 (520)
T ss_pred eEeeeec-cCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC--CEEEEEEcccccc
Confidence 6999999 44321 12222 227777788888888888887765 48999999999999976 5899999988764
Q ss_pred c
Q 025244 79 E 79 (255)
Q Consensus 79 ~ 79 (255)
.
T Consensus 314 ~ 314 (520)
T KOG2270|consen 314 H 314 (520)
T ss_pred C
Confidence 3
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=94.55 E-value=0.031 Score=45.77 Aligned_cols=29 Identities=31% Similarity=0.512 Sum_probs=25.4
Q ss_pred CCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 48 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 48 ~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
.++|+|+.|.||+++++ + +.|+||+.+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~-~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQ-G-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCC-C-CEEEeccccCc
Confidence 48999999999999986 4 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.32 E-value=0.037 Score=46.01 Aligned_cols=31 Identities=32% Similarity=0.575 Sum_probs=25.3
Q ss_pred CCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 48 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 48 ~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
.++|+|+++.||+++++.+..-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997523356999998875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.16 E-value=0.073 Score=45.10 Aligned_cols=49 Identities=27% Similarity=0.346 Sum_probs=31.9
Q ss_pred HHHHHHHHHHHHHHHH----hCCCeecCCCCCcEEEeCCCC-----------------ceEEecCccccc
Q 025244 30 AIGFALDIARAMECLH----SHGIIHRDLKPENLLLTEDLK-----------------TIKLADFGLARE 78 (255)
Q Consensus 30 ~~~~~~~i~~~L~~lH----~~~i~HrDikp~Nill~~~~~-----------------~~kl~Dfg~a~~ 78 (255)
...++.|++.-.-.+- ..+.+|-||||+|||+-+... .++|-||.+++.
T Consensus 281 ikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 350 (444)
T PHA03111 281 IKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQV 350 (444)
T ss_pred HHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHH
Confidence 4456677765443342 346999999999999954311 345677777764
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=94.06 E-value=0.13 Score=40.46 Aligned_cols=32 Identities=28% Similarity=0.390 Sum_probs=25.9
Q ss_pred CCCeecCCCCCcEEEeCCC-C---ceEEecCccccc
Q 025244 47 HGIIHRDLKPENLLLTEDL-K---TIKLADFGLARE 78 (255)
Q Consensus 47 ~~i~HrDikp~Nill~~~~-~---~~kl~Dfg~a~~ 78 (255)
..++|||+.+.||++..+. | .+.++||..++.
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 3589999999999998542 2 589999988764
|
subfamily of choline kinases |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.74 E-value=0.1 Score=44.02 Aligned_cols=30 Identities=20% Similarity=0.243 Sum_probs=26.7
Q ss_pred CCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 48 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 48 ~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++|+|+.+.|++++++ +.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~-~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDET-RGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCC-CCEEEEEhhhccc
Confidence 79999999999999887 5789999987764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.71 E-value=0.074 Score=45.26 Aligned_cols=50 Identities=26% Similarity=0.349 Sum_probs=31.4
Q ss_pred HHHHHHHHHHHHHHHH----hCCCeecCCCCCcEEEeCCCC-----------------ceEEecCcccccc
Q 025244 30 AIGFALDIARAMECLH----SHGIIHRDLKPENLLLTEDLK-----------------TIKLADFGLAREE 79 (255)
Q Consensus 30 ~~~~~~~i~~~L~~lH----~~~i~HrDikp~Nill~~~~~-----------------~~kl~Dfg~a~~~ 79 (255)
+..++.|++.-.--+- ..+.+|-||||+|||+-+... .++|-||.+++..
T Consensus 277 vkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 277 VKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 3445556544321121 346999999999999943311 4567888888753
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.70 E-value=0.1 Score=44.51 Aligned_cols=30 Identities=40% Similarity=0.618 Sum_probs=25.0
Q ss_pred CeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 49 IIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 49 i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+||+|+.|.||+++.+...+.++|||-+..
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 999999999999998722378999987753
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.64 E-value=0.038 Score=43.82 Aligned_cols=30 Identities=40% Similarity=0.633 Sum_probs=20.0
Q ss_pred CCeecCCCCCcEEE-eCCCCceEEecCccccc
Q 025244 48 GIIHRDLKPENLLL-TEDLKTIKLADFGLARE 78 (255)
Q Consensus 48 ~i~HrDikp~Nill-~~~~~~~kl~Dfg~a~~ 78 (255)
.+.|.|+.+.|||+ +.+ +.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~-~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKD-GEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSS-SCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCC-CeEEEecHHHHhh
Confidence 48999999999999 455 6899999998863
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.22 E-value=0.058 Score=48.32 Aligned_cols=72 Identities=14% Similarity=0.082 Sum_probs=45.9
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC-----------CCCCcHHHHHHHHHhcccCCCCCCCHH
Q 025244 115 HKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-----------AENVPEELSIILTSCWKEDPNARPNFT 183 (255)
Q Consensus 115 ~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rpt~~ 183 (255)
+++||||+|.++.++.-|...+......+.......-...+. .-.++..+.++...|+-..|..||...
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~ 189 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPM 189 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchh
Confidence 599999999999999999877765444443332221111111 112345666778888888888887555
Q ss_pred HHH
Q 025244 184 QII 186 (255)
Q Consensus 184 ~vl 186 (255)
+..
T Consensus 190 ~~~ 192 (725)
T KOG1093|consen 190 ELS 192 (725)
T ss_pred HHh
Confidence 443
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=92.94 E-value=0.23 Score=42.43 Aligned_cols=30 Identities=33% Similarity=0.475 Sum_probs=25.7
Q ss_pred CeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 49 IIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 49 i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+.|.|+.+.|||++++.+.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 789999999999985546899999988753
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=92.76 E-value=0.11 Score=41.65 Aligned_cols=37 Identities=24% Similarity=0.344 Sum_probs=30.8
Q ss_pred HHHHHHHHh--CCCeecCCCCCcEEEeCCCCceEEecCcc
Q 025244 38 ARAMECLHS--HGIIHRDLKPENLLLTEDLKTIKLADFGL 75 (255)
Q Consensus 38 ~~~L~~lH~--~~i~HrDikp~Nill~~~~~~~kl~Dfg~ 75 (255)
+..|.-.|+ .+.+|+|..|+|||-+.. |-+||.|=+.
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~-G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKF-GYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCC-CCEEecChhh
Confidence 466777784 369999999999999988 7999999653
|
The function of this family is unknown. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.50 E-value=0.1 Score=44.23 Aligned_cols=33 Identities=24% Similarity=0.454 Sum_probs=28.3
Q ss_pred CCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 48 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 48 ~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
.++|+|+.+.|++++.+ +.+-|+||+++...+.
T Consensus 199 ~lvHGD~~~gNlii~~~-~~~gVlDwe~~~lGDP 231 (321)
T COG3173 199 VLVHGDYRPGNLIIDPG-RPTGVLDWELATLGDP 231 (321)
T ss_pred eeeeCCcccCCEEEeCC-CeeEEEeccccccCCc
Confidence 48999999999999988 4688999999986443
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=92.48 E-value=0.17 Score=44.17 Aligned_cols=31 Identities=26% Similarity=0.422 Sum_probs=26.4
Q ss_pred hCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 46 SHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 46 ~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
.+.++|+|+.|.|||++++ .+|++|..++..
T Consensus 226 ~~aLlHGDlHtGSI~v~~~--~~kvIDpEFAfy 256 (409)
T PRK12396 226 AQALIHGDLHTGSVFVKND--STKVIDPEFAFY 256 (409)
T ss_pred chhhccCcCCCCCEEecCC--ceEEEccccccc
Confidence 4569999999999999986 589999887764
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.04 E-value=0.31 Score=42.56 Aligned_cols=29 Identities=31% Similarity=0.285 Sum_probs=24.2
Q ss_pred CCCeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 47 ~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
....|.|+-+.||+.+++ .+.++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~~--~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ--GIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCC--CEEEEEecccc
Confidence 357999999999998654 69999997765
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.69 E-value=0.14 Score=50.37 Aligned_cols=32 Identities=38% Similarity=0.511 Sum_probs=25.7
Q ss_pred CCCeecCCCCCcEEEeCCC-CceE-EecCccccc
Q 025244 47 HGIIHRDLKPENLLLTEDL-KTIK-LADFGLARE 78 (255)
Q Consensus 47 ~~i~HrDikp~Nill~~~~-~~~k-l~Dfg~a~~ 78 (255)
.++||.|+.+.||+++.+. +.+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999998762 1454 999998764
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.62 E-value=0.24 Score=48.64 Aligned_cols=31 Identities=23% Similarity=0.293 Sum_probs=25.0
Q ss_pred CCCeecCCCCCcEEEeCCC-Cc---eEEecCcccc
Q 025244 47 HGIIHRDLKPENLLLTEDL-KT---IKLADFGLAR 77 (255)
Q Consensus 47 ~~i~HrDikp~Nill~~~~-~~---~kl~Dfg~a~ 77 (255)
.++||.|+++.||+++.+. +. .-|+|||-+.
T Consensus 208 ~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 208 LQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred ccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 5799999999999998652 22 3699999775
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=91.58 E-value=0.15 Score=44.64 Aligned_cols=30 Identities=27% Similarity=0.429 Sum_probs=25.8
Q ss_pred CCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 47 ~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
..++|+|+.+.|||+..+ .++++||.++..
T Consensus 223 ~~l~HgDl~~gni~~~~~--~~~viD~E~a~~ 252 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE--ETKVIDPEFAFY 252 (401)
T ss_pred CceeeccCCcccEEeeCC--CcEEEecccccc
Confidence 368999999999999876 589999987764
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.47 E-value=0.67 Score=40.70 Aligned_cols=60 Identities=20% Similarity=0.216 Sum_probs=43.2
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCeecCCCCCcEEEeCC
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAME-CLHSHGIIHRDLKPENLLLTED 64 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~-~lH~~~i~HrDikp~Nill~~~ 64 (255)
+||=+|.+|-++..++.... .+++...+++.-...|+- .+--.+++|.|+.|.||++.-+
T Consensus 321 vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred eeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 57888999999999997654 344445555555555543 3445689999999999999643
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=91.44 E-value=0.35 Score=40.38 Aligned_cols=30 Identities=37% Similarity=0.492 Sum_probs=24.8
Q ss_pred CeecCCCCCcEEEeCCC-C---ceEEecCccccc
Q 025244 49 IIHRDLKPENLLLTEDL-K---TIKLADFGLARE 78 (255)
Q Consensus 49 i~HrDikp~Nill~~~~-~---~~kl~Dfg~a~~ 78 (255)
++|||++.+|||+..+. | .++++||.+++.
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeeccccccC
Confidence 89999999999997552 2 589999987764
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 255 | ||||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-22 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-21 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-21 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-21 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-21 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-20 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-20 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-20 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-20 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-20 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-20 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-20 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-20 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-20 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-20 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-20 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-20 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-20 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-20 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-20 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-20 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-20 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-20 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-20 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-20 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-20 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-20 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-19 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-19 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-19 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-19 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-19 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-19 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-19 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-18 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-18 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-18 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-18 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-18 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-18 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-18 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-18 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-18 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-18 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-18 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-18 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-18 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-18 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-18 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-17 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-17 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-16 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-16 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-16 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-16 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-16 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-16 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-16 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-16 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-16 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-16 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-16 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-15 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-15 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-15 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-14 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-14 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-14 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-14 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-14 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-14 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-14 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 9e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-13 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-13 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-13 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-13 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-13 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-13 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-13 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-13 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-13 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-12 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-12 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-12 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-12 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-12 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-12 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-12 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-12 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-11 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-11 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-11 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-11 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-11 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-10 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-10 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-08 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 9e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-07 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-07 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-07 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-07 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-07 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-07 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-07 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-07 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-07 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-07 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-07 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-07 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-07 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-07 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-07 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-07 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-07 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-07 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-07 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-07 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-07 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-07 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-07 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-07 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-07 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-07 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 4e-07 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-06 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-06 |
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 5e-87
Identities = 65/236 (27%), Positives = 111/236 (47%), Gaps = 20/236 (8%)
Query: 3 IVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHSH---GIIHRDLKPEN 58
+V E GG+L L P A+ + L ++ + LHS +IHRDLKP N
Sbjct: 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN 135
Query: 59 LLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
LLL +K+ DFG A + + MT G+ WMAPE++ E +Y+ K D
Sbjct: 136 LLLVAGGTVLKICDFGTACD--IQTHMTNNKGSAAWMAPEVF--------EGSNYSEKCD 185
Query: 119 SYSFAIVLWELLHNKLPFEGMSNL-QAAYAAAFKNVRPS-AENVPEELSIILTSCWKEDP 176
+S+ I+LWE++ + PF+ + A RP +N+P+ + ++T CW +DP
Sbjct: 186 VFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDP 245
Query: 177 NARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRDDI 232
+ RP+ +I++++ + + + + + +S LPP G +
Sbjct: 246 SQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHS----LPPGEDGRVEPYVDFAEF 297
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 9e-87
Identities = 71/211 (33%), Positives = 108/211 (51%), Gaps = 18/211 (8%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHSHG--IIHRDLKPE 57
+ IVTE LS G+L + L R LD + A D+A+ M LH+ I+HR+LK
Sbjct: 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSP 168
Query: 58 NLLLTEDLKTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 116
NLL+ + T+K+ DFGL+R ++ T + GT WMAPE+ + N K
Sbjct: 169 NLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL--------RDEPSNEK 219
Query: 117 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSIILTSCWKED 175
D YSF ++LWEL + P+ ++ Q A FK R N+ +++ I+ CW +
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNE 279
Query: 176 PNARPNFTQIIQMLLNYLSAIAPPEPMIPHR 206
P RP+F I+ +L + + PP P+R
Sbjct: 280 PWKRPSFATIMDLLRPLIKSAVPP----PNR 306
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 6e-85
Identities = 58/196 (29%), Positives = 100/196 (51%), Gaps = 18/196 (9%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLL 60
+V E + G L LL+ + + V + LDIA +E + + I+HRDL+ N+
Sbjct: 98 MVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIF 156
Query: 61 LTEDLK----TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 116
L + K+ADFGL+++ ++ G ++WMAPE E++ Y K
Sbjct: 157 LQSLDENAPVCAKVADFGLSQQS--VHSVSGLLGNFQWMAPETIG------AEEESYTEK 208
Query: 117 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA--FKNVRPS-AENVPEELSIILTSCWK 173
D+YSFA++L+ +L + PF+ S + + + +RP+ E+ P L ++ CW
Sbjct: 209 ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWS 268
Query: 174 EDPNARPNFTQIIQML 189
DP RP+F+ I++ L
Sbjct: 269 GDPKKRPHFSYIVKEL 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 250 bits (642), Expect = 6e-84
Identities = 50/192 (26%), Positives = 89/192 (46%), Gaps = 13/192 (6%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPEN 58
++T + G+L L +D A+ FALD+AR M LH+ I L +
Sbjct: 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRS 143
Query: 59 LLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
+++ ED+ T +++ + W+APE L++ + D
Sbjct: 144 VMIDEDM-TARISMADVKFSFQ----SPGRMYAPAWVAPEA-----LQKKPEDTNRRSAD 193
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSIILTSCWKEDPN 177
+SFA++LWEL+ ++PF +SN++ A + +RP+ + +S ++ C EDP
Sbjct: 194 MWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPA 253
Query: 178 ARPNFTQIIQML 189
RP F I+ +L
Sbjct: 254 KRPKFDMIVPIL 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 4e-83
Identities = 50/198 (25%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ I+T L G TL + + + LDV A +I + M LH+ GI+H+DLK +N+
Sbjct: 104 LAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVF 162
Query: 61 LTEDLKTIKLADFGLAREESLT------EMMTAETGTYRWMAPELYSTVTL-RQGEKKHY 113
D + + DFGL + + + + G +APE+ ++ + +K +
Sbjct: 163 Y--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPF 220
Query: 114 NHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--SAENVPEELSIILTSC 171
+ D ++ + +EL + PF+ + ++P S + +E+S IL C
Sbjct: 221 SKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG-TGMKPNLSQIGMGKEISDILLFC 279
Query: 172 WKEDPNARPNFTQIIQML 189
W + RP FT+++ ML
Sbjct: 280 WAFEQEERPTFTKLMDML 297
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 5e-82
Identities = 67/200 (33%), Positives = 101/200 (50%), Gaps = 23/200 (11%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG---IIHRDLKPE 57
+ +V E GG L + L + + + + +A+ IAR M LH IIHRDLK
Sbjct: 81 LCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS 137
Query: 58 NLLLTEDL-------KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 110
N+L+ + + K +K+ DFGLARE T M+A G Y WMAPE+
Sbjct: 138 NILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYAWMAPEVI--------RA 188
Query: 111 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-AENVPEELSIILT 169
++ D +S+ ++LWELL ++PF G+ L AY A + PE + ++
Sbjct: 189 SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLME 248
Query: 170 SCWKEDPNARPNFTQIIQML 189
CW DP++RP+FT I+ L
Sbjct: 249 DCWNPDPHSRPSFTNILDQL 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 3e-80
Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 15/197 (7%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ IVT+ G +L +L + ++ I A AR M+ LH+ IIHRDLK N+
Sbjct: 94 LAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIF 152
Query: 61 LTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKV 117
L ED T+K+ DFGLA E+S +G+ WMAPE+ +R + Y+ +
Sbjct: 153 LHEDN-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV-----IRMQDSNPYSFQS 206
Query: 118 DSYSFAIVLWELLHNKLPFEGMSNLQAAYAA-AFKNVRPSA----ENVPEELSIILTSCW 172
D Y+F IVL+EL+ +LP+ ++N ++ P N P+ + ++ C
Sbjct: 207 DVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECL 266
Query: 173 KEDPNARPNFTQIIQML 189
K+ + RP+F +I+ +
Sbjct: 267 KKKRDERPSFPRILAEI 283
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-68
Identities = 62/220 (28%), Positives = 88/220 (40%), Gaps = 27/220 (12%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+TE + GGTLR + +M + + FA DIA M LHS IIHRDL N L+
Sbjct: 84 FITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR 142
Query: 63 EDLKTIKLADFGLAREESLTEM---------------MTAETGTYRWMAPELYSTVTLRQ 107
E+ + +ADFGLAR + G WMAPE+ +
Sbjct: 143 ENK-NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM-----ING 196
Query: 108 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK-NVRPSA-ENVPEELS 165
+ Y+ KVD +SF IVL E++ + + + N P
Sbjct: 197 ---RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFF 253
Query: 166 IILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPH 205
I C DP RP+F ++ L +A P+ P
Sbjct: 254 PITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQ 293
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-62
Identities = 54/223 (24%), Positives = 90/223 (40%), Gaps = 40/223 (17%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS--------HGIIHR 52
+ ++T G+L YL + LD + L IA + LH I HR
Sbjct: 81 LWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHR 137
Query: 53 DLKPENLLLTEDLKTIKLADFGLAREESLTEMM-----TAETGTYRWMAPELYSTVTLRQ 107
DLK +N+L+ ++ +AD GLA S + GT R+MAPE+ Q
Sbjct: 138 DLKSKNILVKKNG-QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETI--Q 194
Query: 108 GEKKHYNHKVDSYSFAIVLWELL----------HNKLPFEGMSNLQAAY-----AAAFKN 152
+ +VD ++F +VLWE+ K PF + ++
Sbjct: 195 VDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQ 254
Query: 153 VRPS------AENVPEELSIILTSCWKEDPNARPNFTQIIQML 189
RP+ ++ L+ ++ CW ++P+AR +I + L
Sbjct: 255 QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 3e-62
Identities = 51/230 (22%), Positives = 91/230 (39%), Gaps = 42/230 (18%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--------GIIHR 52
+ ++T+ G+L YL + LD + A + LH+ I HR
Sbjct: 110 LYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHR 166
Query: 53 DLKPENLLLTEDLKTIKLADFGLAREESLTEM-----MTAETGTYRWMAPE-LYSTVTLR 106
DLK +N+L+ ++ T +AD GLA + GT R+M PE L ++
Sbjct: 167 DLKSKNILVKKNG-TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRN 225
Query: 107 QGEKKHYNHKVDSYSFAIVLWELL----------HNKLPFEGMSNLQAAY-----AAAFK 151
+ D YSF ++LWE+ +LP+ + +Y K
Sbjct: 226 HFQ---SYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIK 282
Query: 152 NVRPS------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195
+RPS ++ ++ ++T CW +P +R ++ + L +
Sbjct: 283 KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-57
Identities = 52/224 (23%), Positives = 88/224 (39%), Gaps = 42/224 (18%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--------GIIHR 52
+ +V++ G+L YL + V I AL A + LH I HR
Sbjct: 115 LWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 171
Query: 53 DLKPENLLLTEDLKTIKLADFGLAREES-----LTEMMTAETGTYRWMAPE-LYSTVTLR 106
DLK +N+L+ ++ T +AD GLA + GT R+MAPE L ++ ++
Sbjct: 172 DLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 230
Query: 107 QGEKKHYNHKVDSYSFAIVLWELL----------HNKLPFEGMSNLQAAY-----AAAFK 151
E + D Y+ +V WE+ +LP+ + + +
Sbjct: 231 HFE---SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 287
Query: 152 NVRPSAEN------VPEELSIILTSCWKEDPNARPNFTQIIQML 189
+RP+ N ++ I+ CW + AR +I + L
Sbjct: 288 KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 6e-52
Identities = 56/246 (22%), Positives = 88/246 (35%), Gaps = 50/246 (20%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS---------HGIIHRD 53
+V E G+L KYL D + A + R + LH+ I HRD
Sbjct: 89 LVMEYYPNGSLXKYL---SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRD 145
Query: 54 LKPENLLLTEDLKTIKLADFGLAREESLTEM---------MTAETGTYRWMAPE-LYSTV 103
L N+L+ D T ++DFGL+ + + +E GT R+MAPE L V
Sbjct: 146 LNSRNVLVKNDG-TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAV 204
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELLH---NKLPFEGMSNLQAAYAA------------ 148
LR E +VD Y+ ++ WE+ + P E + Q A+
Sbjct: 205 NLRDXE--SALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQ 262
Query: 149 ---AFKNVRP-------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 198
+ + RP L + CW +D AR + + +
Sbjct: 263 VLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322
Query: 199 PEPMIP 204
+ + P
Sbjct: 323 NKSVSP 328
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 6e-50
Identities = 54/222 (24%), Positives = 81/222 (36%), Gaps = 42/222 (18%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH----------GIIHR 52
++T G+L +L + + A +AR + LH I HR
Sbjct: 99 LITAFHEKGSLSDFL---KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHR 155
Query: 53 DLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLRQGE 109
D+K +N+LL +L T +ADFGLA + GT R+MAPE+ Q +
Sbjct: 156 DIKSKNVLLKNNL-TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRD 214
Query: 110 KKHYNHKVDSYSFAIVLWELL-----------HNKLPFEGM-----SNLQAAYAAAFKNV 153
++D Y+ +VLWEL LPFE S K
Sbjct: 215 ---AFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKK 271
Query: 154 RPSAEN------VPEELSIILTSCWKEDPNARPNFTQIIQML 189
RP + L + CW D AR + + + +
Sbjct: 272 RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERI 313
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 6e-45
Identities = 63/196 (32%), Positives = 89/196 (45%), Gaps = 24/196 (12%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IV EL+ GG +L R L V + D A ME L S IHRDL N L+T
Sbjct: 189 IVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT 247
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNHKVDS 119
E +K++DFG++REE+ + +W APE L G Y+ + D
Sbjct: 248 EKN-VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE-----ALNYG---RYSSESDV 298
Query: 120 YSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCWK 173
+SF I+LWE P+ +SN Q + V P E P+ + ++ CW
Sbjct: 299 WSFGILLWETFSLGASPYPNLSNQQ-----TREFVEKGGRLPCPELCPDAVFRLMEQCWA 353
Query: 174 EDPNARPNFTQIIQML 189
+P RP+F+ I Q L
Sbjct: 354 YEPGQRPSFSTIYQEL 369
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 9e-45
Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 27/211 (12%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I+TE + G+L +L L + + A IA M + IHRDL+ N+L++
Sbjct: 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 143
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNHKVDS 119
+ L + K+ADFGLAR E TA G +W APE + G + K D
Sbjct: 144 DTL-SCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPE-----AINYG---TFTIKSDV 193
Query: 120 YSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCWK 173
+SF I+L E++ H ++P+ GM+N + +N+ +N PEEL ++ CWK
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPE-----VIQNLERGYRMVRPDNCPEELYQLMRLCWK 248
Query: 174 EDPNARPNFTQIIQMLLNYLSAIAP---PEP 201
E P RP F + +L ++ +A P+P
Sbjct: 249 ERPEDRPTFDYLRSVLEDFFTATEGQYQPQP 279
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-44
Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 14/200 (7%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IVTE +S G+L +L + L + + A IA M + +HRDL+ N+L+
Sbjct: 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 314
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
E+L K+ADFGLAR E + +W APE + K D +
Sbjct: 315 ENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVW 365
Query: 121 SFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNA 178
SF I+L EL ++P+ GM N + + R P PE L ++ CW+++P
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNRE-VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEE 424
Query: 179 RPNFTQIIQMLLNYLSAIAP 198
RP F + L +Y ++ P
Sbjct: 425 RPTFEYLQAFLEDYFTSTEP 444
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-44
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 24/202 (11%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I+TE ++ G L YL + + V + A I+ AME L IHRDL N L+
Sbjct: 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 145
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNHKVDS 119
E+ +K+ADFGL+R + + TA G +W APE +L ++ K D
Sbjct: 146 ENH-LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE-----SLAYN---KFSIKSDV 195
Query: 120 YSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCWK 173
++F ++LWE+ + P+ G+ Q ++ + E PE++ ++ +CW+
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEKDYRMERPEGCPEKVYELMRACWQ 250
Query: 174 EDPNARPNFTQIIQMLLNYLSA 195
+P+ RP+F +I Q
Sbjct: 251 WNPSDRPSFAEIHQAFETMFQE 272
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-44
Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 20/196 (10%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IVTE ++ G+L YL + L + F+LD+ AME L + +HRDL N+L++
Sbjct: 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS 323
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNHKVDS 119
ED K++DFGL +E S + + +W APE +K ++ K D
Sbjct: 324 EDN-VAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALR--------EKKFSTKSDV 369
Query: 120 YSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPN 177
+SF I+LWE+ ++P+ + K + + + P + ++ +CW D
Sbjct: 370 WSFGILLWEIYSFGRVPYPRIPLKD-VVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAA 428
Query: 178 ARPNFTQIIQMLLNYL 193
RP F Q+ + L +
Sbjct: 429 TRPTFLQLREQLEHIR 444
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-44
Identities = 69/207 (33%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I+TE ++ G+L +L + + I F+ IA M + IHRDL+ N+L++
Sbjct: 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS 318
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNHKVDS 119
L K+ADFGLAR E TA G +W APE + + K D
Sbjct: 319 ASL-VCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAIN--------FGSFTIKSDV 368
Query: 120 YSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPN 177
+SF I+L E++ + ++P+ GMSN + A + R P EN PEEL I+ CWK P
Sbjct: 369 WSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRMPRPENCPEELYNIMMRCWKNRPE 427
Query: 178 ARPNFTQIIQMLLNYLSAIAPPEPMIP 204
RP F I +L ++ +A IP
Sbjct: 428 ERPTFEYIQSVLDDFYTATESQYEEIP 454
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 9e-44
Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 14/200 (7%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IVTE +S G+L +L + L + + A IA M + +HRDL+ N+L+
Sbjct: 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 397
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
E+L K+ADFGLAR E + +W APE + K D +
Sbjct: 398 ENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVW 448
Query: 121 SFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNA 178
SF I+L EL ++P+ GM N + + R P PE L ++ CW+++P
Sbjct: 449 SFGILLTELTTKGRVPYPGMVNRE-VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEE 507
Query: 179 RPNFTQIIQMLLNYLSAIAP 198
RP F + L +Y ++ P
Sbjct: 508 RPTFEYLQAFLEDYFTSTEP 527
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 9e-44
Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 28/201 (13%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IVTE ++ G+L YL + L + F+LD+ AME L + +HRDL N+L++
Sbjct: 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS 151
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNHKVDS 119
ED K++DFGL +E S + + +W APE LR+ ++ K D
Sbjct: 152 EDN-VAKVSDFGLTKEAS-----STQDTGKLPVKWTAPE-----ALREK---KFSTKSDV 197
Query: 120 YSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCWK 173
+SF I+LWE+ ++P+ + V + + P + ++ +CW
Sbjct: 198 WSFGILLWEIYSFGRVPYPRIPLKD-----VVPRVEKGYKMDAPDGCPPAVYEVMKNCWH 252
Query: 174 EDPNARPNFTQIIQMLLNYLS 194
D RP+F Q+ + L + +
Sbjct: 253 LDAAMRPSFLQLREQLEHIKT 273
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 1e-43
Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 16/198 (8%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I+TE ++ G L YL + + V + A I+ AME L IHR+L N L+
Sbjct: 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG 352
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNHKVDS 119
E+ +K+ADFGL+R + + TA G +W APE + ++ K D
Sbjct: 353 ENH-LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA--------YNKFSIKSDV 402
Query: 120 YSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPN 177
++F ++LWE+ + P+ G+ Q Y K+ R E PE++ ++ +CW+ +P+
Sbjct: 403 WAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRMERPEGCPEKVYELMRACWQWNPS 461
Query: 178 ARPNFTQIIQMLLNYLSA 195
RP+F +I Q
Sbjct: 462 DRPSFAEIHQAFETMFQE 479
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-43
Identities = 50/187 (26%), Positives = 82/187 (43%), Gaps = 14/187 (7%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I E GTL +++ R LD +A+ I + ++ +HS +I+RDLKP N+ L
Sbjct: 97 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV 156
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 122
+ K +K+ DFGL T GT R+M+PE + Y +VD Y+
Sbjct: 157 DT-KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQI--------SSQDYGKEVDLYAL 207
Query: 123 AIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF 182
++L ELLH S + + ++ +L + P RPN
Sbjct: 208 GLILAELLHVCDTAFETSKF---FTDLRDGIISD--IFDKKEKTLLQKLLSKKPEDRPNT 262
Query: 183 TQIIQML 189
++I++ L
Sbjct: 263 SEILRTL 269
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-42
Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 29/202 (14%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I+TE ++ G L YL MR R + D+ AME L S +HRDL N L+
Sbjct: 96 IITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN 154
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNHKV 117
+ +K++DFGL+R E T+ G+ RW PE +YS ++ K
Sbjct: 155 DQG-VVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSK----------FSSKS 202
Query: 118 DSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSC 171
D ++F +++WE+ K+P+E +N + +++ E++ I+ SC
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSET-----AEHIAQGLRLYRPHLASEKVYTIMYSC 257
Query: 172 WKEDPNARPNFTQIIQMLLNYL 193
W E + RP F ++ +L+ +
Sbjct: 258 WHEKADERPTFKILLSNILDVM 279
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-42
Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 37/223 (16%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVA--------------IGFALDIARAMECLHS 46
+ ++ E S G LR+YL RP ++ + +AR ME L S
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175
Query: 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTV 103
IHRDL N+L+TE+ +K+ADFGLAR+ + + T +WMAPE
Sbjct: 176 QKCIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE----- 229
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSA 157
L Y H+ D +SF +++WE+ P+ G+ + FK ++
Sbjct: 230 ALFDRV---YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-----FKLLKEGHRMDKP 281
Query: 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 200
N EL +++ CW P+ RP F Q+++ L L+ E
Sbjct: 282 ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE 324
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-42
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V + G LR ++ N V IGF L +A+ M+ L S +HRDL N +L
Sbjct: 104 VVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 162
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTY-----RWMAPELYSTVTLRQGEKKHYNHKV 117
E T+K+ADFGLAR+ E + T +WMA E +L+ + + K
Sbjct: 163 EKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-----SLQTQK---FTTKS 213
Query: 118 DSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSC 171
D +SF ++LWEL+ P+ ++ + E P+ L ++ C
Sbjct: 214 DVWSFGVLLWELMTRGAPPYPDVNTFDI-----TVYLLQGRRLLQPEYCPDPLYEVMLKC 268
Query: 172 WKEDPNARPNFTQIIQMLLNYLSAIAPPE 200
W RP+F++++ + S
Sbjct: 269 WHPKAEMRPSFSELVSRISAIFSTFIGEH 297
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-42
Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 29/204 (14%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IVTE +S G L YL + L+ + D+ M L SH IHRDL N L+
Sbjct: 80 IVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD 138
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNHKV 117
DL +K++DFG+ R + + GT +W APE Y Y+ K
Sbjct: 139 RDL-CVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKWSAPEVFHYFK----------YSSKS 186
Query: 118 DSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSC 171
D ++F I++WE+ K+P++ +N + V + + I+ SC
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSE-----VVLKVSQGHRLYRPHLASDTIYQIMYSC 241
Query: 172 WKEDPNARPNFTQIIQMLLNYLSA 195
W E P RP F Q++ +
Sbjct: 242 WHELPEKRPTFQQLLSSIEPLREK 265
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-42
Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
++ + G L +++ + + V I F L +AR ME L +HRDL N +L
Sbjct: 100 VLLPYMCHGDLLQFIRSPQRN-PTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD 158
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTY-----RWMAPELYSTVTLRQGEKKHYNHKV 117
E T+K+ADFGLAR+ E + + + +W A E +L+ + K
Sbjct: 159 ESF-TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE-----SLQTYR---FTTKS 209
Query: 118 DSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSC 171
D +SF ++LWELL P+ + + P E P+ L ++ C
Sbjct: 210 DVWSFGVLLWELLTRGAPPYRHIDPFDL-----THFLAQGRRLPQPEYCPDSLYQVMQQC 264
Query: 172 WKEDPNARPNFTQIIQMLLNYLSAIAPPE 200
W+ DP RP F ++ + +SA+
Sbjct: 265 WEADPAVRPTFRVLVGEVEQIVSALLGDH 293
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-42
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ I+ EL + G LR +L + LD+ I +A ++ A+ L S +HRD+ N+L
Sbjct: 90 VWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL 148
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPE--LYSTVTLRQGEKKHYNHK 116
++ + +KL DFGL+R + A G +WMAPE + + +
Sbjct: 149 VSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF----------RRFTSA 197
Query: 117 VDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTS 170
D + F + +WE+L H PF+G+ N + P N P L ++T
Sbjct: 198 SDVWMFGVCMWEILMHGVKPFQGVKNNDV-----IGRIENGERLPMPPNCPPTLYSLMTK 252
Query: 171 CWKEDPNARPNFTQIIQMLLNYLSA 195
CW DP+ RP FT++ L L
Sbjct: 253 CWAYDPSRRPRFTELKAQLSTILEE 277
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-42
Identities = 48/200 (24%), Positives = 88/200 (44%), Gaps = 20/200 (10%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ ++T+L+ G L Y+ + + + + + IA+ M L ++HRDL N+L
Sbjct: 91 VQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 149
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNH 115
+ +K+ DFGLA+ E G +WMA E L+ Y H
Sbjct: 150 VKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI----------YTH 198
Query: 116 KVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWK 173
+ D +S+ + +WEL+ P++G+ + + K R P ++ +I+ CW
Sbjct: 199 QSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMRKCWM 257
Query: 174 EDPNARPNFTQIIQMLLNYL 193
D ++RP F ++I
Sbjct: 258 IDADSRPKFRELIIEFSKMA 277
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-42
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 29/204 (14%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+VTE + G L YL R +G LD+ M L +IHRDL N L+
Sbjct: 80 LVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG 138
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNHKV 117
E+ IK++DFG+ R + T+ TGT +W +PE +S Y+ K
Sbjct: 139 ENQ-VIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSR----------YSSKS 186
Query: 118 DSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSC 171
D +SF +++WE+ K+P+E SN + +++ + I+ C
Sbjct: 187 DVWSFGVLMWEVFSEGKIPYENRSNSEV-----VEDISTGFRLYKPRLASTHVYQIMNHC 241
Query: 172 WKEDPNARPNFTQIIQMLLNYLSA 195
W+E P RP F+++++ L +
Sbjct: 242 WRERPEDRPAFSRLLRQLAEIAES 265
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-41
Identities = 69/248 (27%), Positives = 107/248 (43%), Gaps = 42/248 (16%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVA--------------IGFALDIARAMECLHS 46
+ ++ E S G LR+YL RP L+ + A +AR ME L S
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209
Query: 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTV 103
IHRDL N+L+TED +K+ADFGLAR+ + T +WMAPE
Sbjct: 210 KKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE----- 263
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSA 157
L Y H+ D +SF ++LWE+ P+ G+ + FK ++
Sbjct: 264 ALFDRI---YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-----FKLLKEGHRMDKP 315
Query: 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPP 217
N EL +++ CW P+ RP F Q+++ L ++ + E + +
Sbjct: 316 SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE-----MGYYHHHHHHDY 370
Query: 218 ESPGTSSL 225
+ P T +L
Sbjct: 371 DIPTTENL 378
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-41
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 17/217 (7%)
Query: 3 IVTELLSGGTLRKYLLNMRP----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 58
++ + G L +LL R L + + F +DIA ME L S IHRDL N
Sbjct: 108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARN 167
Query: 59 LLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNH 115
+L ED+ T+ +ADFGL+R+ + + +W+A E +L Y
Sbjct: 168 CMLAEDM-TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE-----SLADNL---YTV 218
Query: 116 KVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKE 174
D ++F + +WE++ + P+ G+ N + N EE+ ++ CW
Sbjct: 219 HSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSA 278
Query: 175 DPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSE 211
DP RP+FT + L N L ++ N E
Sbjct: 279 DPKQRPSFTCLRMELENILGHLSVLSTSQDPLYINIE 315
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-41
Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 37/223 (16%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVA--------------IGFALDIARAMECLHS 46
+ ++ E S G LR+YL RP ++ + +AR ME L S
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221
Query: 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTV 103
IHRDL N+L+TE+ +K+ADFGLAR+ + + T +WMAPE
Sbjct: 222 QKCIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE----- 275
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSA 157
L Y H+ D +SF +++WE+ P+ G+ + FK ++
Sbjct: 276 ALFDRV---YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-----FKLLKEGHRMDKP 327
Query: 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 200
N EL +++ CW P+ RP F Q+++ L L+ E
Sbjct: 328 ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE 370
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-41
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 27/207 (13%)
Query: 3 IVTELLSGGTLRKYLLNMRPRC----LDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 58
++ + G L YLL R + + + F +DIA ME L + +HRDL N
Sbjct: 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARN 177
Query: 59 LLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNH 115
+L +D+ T+ +ADFGL+++ + +W+A E +L Y
Sbjct: 178 CMLRDDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE-----SLADRV---YTS 228
Query: 116 KVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILT 169
K D ++F + +WE+ P+ G+ N + + + E+ +EL I+
Sbjct: 229 KSDVWAFGVTMWEIATRGMTPYPGVQNHE-----MYDYLLHGHRLKQPEDCLDELYEIMY 283
Query: 170 SCWKEDPNARPNFTQIIQMLLNYLSAI 196
SCW+ DP RP F+ + L L ++
Sbjct: 284 SCWRTDPLDRPTFSVLRLQLEKLLESL 310
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-41
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V + G LR ++ N V IGF L +A+ M+ L S +HRDL N +L
Sbjct: 168 VVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD 226
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTY-----RWMAPELYSTVTLRQGEKKHYNHKV 117
E T+K+ADFGLAR+ E + T +WMA E +L+ + + K
Sbjct: 227 EKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE-----SLQTQK---FTTKS 277
Query: 118 DSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSC 171
D +SF ++LWEL+ P+ ++ + E P+ L ++ C
Sbjct: 278 DVWSFGVLLWELMTRGAPPYPDVNTFDI-----TVYLLQGRRLLQPEYCPDPLYEVMLKC 332
Query: 172 WKEDPNARPNFTQIIQMLLNYLSAIAPPE 200
W RP+F++++ + S
Sbjct: 333 WHPKAEMRPSFSELVSRISAIFSTFIGEH 361
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-41
Identities = 64/237 (27%), Positives = 107/237 (45%), Gaps = 37/237 (15%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRC--------LDVCVAIGFALDIARAMECLHSHGIIHR 52
+++ EL++ G L+ YL ++RP + I A +IA M L+++ +HR
Sbjct: 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR 162
Query: 53 DLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTVTLRQGE 109
DL N ++ ED T+K+ DFG+ R+ T+ RWM+PE +L+ G
Sbjct: 163 DLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE-----SLKDGV 216
Query: 110 KKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEE 163
+ D +SF +VLWE+ + P++G+SN Q + V +N P+
Sbjct: 217 ---FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-----LRFVMEGGLLDKPDNCPDM 268
Query: 164 LSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESP 220
L ++ CW+ +P RP+F +II + + EP F PE
Sbjct: 269 LFELMRMCWQYNPKMRPSFLEIISSIKEEM------EPGFREVSFYYSEENKLPEPE 319
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-41
Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 32/231 (13%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I+TE + G L K+L V +G IA M+ L + +HRDL N+L+
Sbjct: 123 IITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN 181
Query: 63 EDLKTIKLADFGLARE-ESLTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNHK 116
+L K++DFGL+R E E +G RW APE Y + +
Sbjct: 182 SNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY----------RKFTSA 230
Query: 117 VDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTS 170
D +SF IV+WE++ + + P+ +SN + K + P+ + P + ++
Sbjct: 231 SDVWSFGIVMWEVMTYGERPYWELSNHEV-----MKAINDGFRLPTPMDCPSAIYQLMMQ 285
Query: 171 CWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPG 221
CW+++ RP F I+ +L + A P+ + F+ +I P + G
Sbjct: 286 CWQQERARRPKFADIVSILDKLIRA---PDSLKTLADFDPRVSIRLPSTSG 333
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 8e-41
Identities = 54/237 (22%), Positives = 100/237 (42%), Gaps = 23/237 (9%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ ++T+L+ G L Y+ + + + + + IA+ M L ++HRDL N+L
Sbjct: 91 VQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 149
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNH 115
+ +K+ DFGLA+ E G +WMA E L+ Y H
Sbjct: 150 VKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI----------YTH 198
Query: 116 KVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWK 173
+ D +S+ + +WEL+ P++G+ + + K R P ++ +I+ CW
Sbjct: 199 QSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMVKCWM 257
Query: 174 EDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRD 230
D ++RP F ++I P+ + + + P +S +LM D
Sbjct: 258 IDADSRPKFRELIIEFSKMARD---PQRYLVIQGDERMHLPSPTDSNFYRALMDEED 311
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-40
Identities = 52/240 (21%), Positives = 94/240 (39%), Gaps = 24/240 (10%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +VT+ L G+L ++ R L + + + + IA+ M L HG++HR+L N+L
Sbjct: 89 LQLVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVL 147
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNHKV 117
L +++ADFG+A + + +WMA E Y H+
Sbjct: 148 LKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF--------GKYTHQS 198
Query: 118 DSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKED 175
D +S+ + +WEL+ P+ G+ + K R + ++ +++ CW D
Sbjct: 199 DVWSYGVTVWELMTFGAEPYAGLRLAE-VPDLLEKGERLAQPQICTIDVYMVMVKCWMID 257
Query: 176 PNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRDDIGET 235
N RP F ++ P R + P +PG + E
Sbjct: 258 ENIRPTFKELANEFTRMARD--------PPRYLVIKRESGPGIAPGPEPHGLTNKKLEEV 309
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-40
Identities = 55/205 (26%), Positives = 86/205 (41%), Gaps = 27/205 (13%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
I+ EL G L YL + L V + ++L I +AM L S +HRD+ N+L
Sbjct: 87 TWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNIL 145
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPE--LYSTVTLRQGEKKHYNHK 116
+ +KL DFGL+R + A +WM+PE + +
Sbjct: 146 VASPE-CVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR----------FTTA 194
Query: 117 VDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTS 170
D + FA+ +WE+L K PF + N + P + P L ++T
Sbjct: 195 SDVWMFAVCMWEILSFGKQPFFWLENKDV-----IGVLEKGDRLPKPDLCPPVLYTLMTR 249
Query: 171 CWKEDPNARPNFTQIIQMLLNYLSA 195
CW DP+ RP FT+++ L +
Sbjct: 250 CWDYDPSDRPRFTELVCSLSDVYQM 274
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-40
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ I+ EL + G LR +L + LD+ I +A ++ A+ L S +HRD+ N+L
Sbjct: 465 VWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL 523
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPELYSTVTLRQGEKKHYNHKVD 118
++ + +KL DFGL+R + A G +WMAPE ++ + D
Sbjct: 524 VSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-----SINFR---RFTSASD 574
Query: 119 SYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCW 172
+ F + +WE+L H PF+G+ N + P N P L ++T CW
Sbjct: 575 VWMFGVCMWEILMHGVKPFQGVKNND-----VIGRIENGERLPMPPNCPPTLYSLMTKCW 629
Query: 173 KEDPNARPNFTQIIQMLLNYLSA 195
DP+ RP FT++ L L
Sbjct: 630 AYDPSRRPRFTELKAQLSTILEE 652
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-40
Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 41/218 (18%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVA--------------IGFALDIARAMECLHSHG 48
+V E + G L K+L P + + + A IA M L S
Sbjct: 94 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH 153
Query: 49 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPE--LYSTV 103
+HRDL N L+ +L +K+ DFG++R+ T+ T RWM PE +Y
Sbjct: 154 FVHRDLATRNCLVGANL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK- 211
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSA 157
+ + D +SF ++LWE+ + K P+ +SN + + +
Sbjct: 212 ---------FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV-----IECITQGRVLERP 257
Query: 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195
P+E+ ++ CW+ +P R N +I ++L A
Sbjct: 258 RVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKA 295
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-40
Identities = 61/214 (28%), Positives = 90/214 (42%), Gaps = 30/214 (14%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVA----------------IGFALDIARAMECLHS 46
++TE G L +L R + + + F+ +A+ M L S
Sbjct: 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS 163
Query: 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTV 103
IHRDL N+LLT K+ DFGLAR+ + +WMAPE
Sbjct: 164 KNCIHRDLAARNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE----- 217
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVP 161
++ Y + D +S+ I LWEL P+ GM Y + R S E+ P
Sbjct: 218 SIFNCV---YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAP 274
Query: 162 EELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195
E+ I+ +CW DP RP F QI+Q++ +S
Sbjct: 275 AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-40
Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 24/208 (11%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
M +VTEL G+L L + + +A+ +A M L S IHRDL NLL
Sbjct: 95 MKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 153
Query: 61 LTEDLKTIKLADFGLARE-ESLTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYN 114
L +K+ DFGL R + + + W APE T ++
Sbjct: 154 LATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT----------FS 202
Query: 115 HKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCW 172
H D++ F + LWE+ + + P+ G++ Q + + R P E+ P+++ ++ CW
Sbjct: 203 HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCW 262
Query: 173 KEDPNARPNFTQIIQMLLNYLSAIAPPE 200
P RP F L ++L P +
Sbjct: 263 AHKPEDRPTFVA----LRDFLLEAQPTD 286
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 5e-40
Identities = 48/206 (23%), Positives = 89/206 (43%), Gaps = 21/206 (10%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+++V E+ GG L K+L+ R + V ++ M+ L +HRDL N+L
Sbjct: 84 LMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL 142
Query: 61 LTEDLKTIKLADFGLAREESLTEMM-TAETGT---YRWMAPE--LYSTVTLRQGEKKHYN 114
L K++DFGL++ + TA + +W APE + ++
Sbjct: 143 LVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK----------FS 191
Query: 115 HKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCW 172
+ D +S+ + +WE L + + P++ M + A + R P EL +++ CW
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-MAFIEQGKRMECPPECPPELYALMSDCW 250
Query: 173 KEDPNARPNFTQIIQMLLNYLSAIAP 198
RP+F + Q + ++A
Sbjct: 251 IYKWEDRPDFLTVEQRMRACYYSLAS 276
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-40
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 37/223 (16%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRC-----LDVCVAIGFALDIARAMECLHSHGIIHRDLK 55
I+ EL++GG L+ +L RPR L + + A DIA + L + IHRD+
Sbjct: 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 167
Query: 56 PENLLLT---EDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTVTLRQGE 109
N LLT K+ DFG+AR+ +WM PE +G
Sbjct: 168 ARNCLLTCPGPGR-VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE-----AFMEGI 221
Query: 110 KKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEE 163
+ K D++SF ++LWE+ +P+ SN + + V +N P
Sbjct: 222 ---FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-----LEFVTSGGRMDPPKNCPGP 273
Query: 164 LSIILTSCWKEDPNARPNFTQIIQMLL------NYLSAIAPPE 200
+ I+T CW+ P RPNF I++ + + ++ P E
Sbjct: 274 VYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIE 316
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-40
Identities = 50/217 (23%), Positives = 88/217 (40%), Gaps = 36/217 (16%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVA-------------IGFALDIARAMECLHSH 47
+++V E + G L ++L + P + + A +A M L
Sbjct: 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 177
Query: 48 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTVT 104
+HRDL N L+ + L +K+ DFG++R+ T+ T RWM PE +
Sbjct: 178 HFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE-----S 231
Query: 105 LRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAE 158
+ + + + D +SF +VLWE+ + K P+ +SN +A +
Sbjct: 232 ILYRK---FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA-----IDCITQGRELERPR 283
Query: 159 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195
P E+ I+ CW+ +P R + + L A
Sbjct: 284 ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-39
Identities = 47/206 (22%), Positives = 77/206 (37%), Gaps = 14/206 (6%)
Query: 1 MVIVTELLSGGTLRKYLL-NMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 59
V++ E G+L L L + D+ M L +GI+HR++KP N+
Sbjct: 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI 143
Query: 60 LLTEDL---KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 116
+ KL DFG ARE E + GT ++ P++Y LR+ +K Y
Sbjct: 144 MRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 117 VDSYSFAIVLWELLHNKLPFEG----------MSNLQAAYAAAFKNVRPSAENVPEELSI 166
VD +S + + LPF M + + + AEN P + S
Sbjct: 204 VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG 263
Query: 167 ILTSCWKEDPNARPNFTQIIQMLLNY 192
+ + T ++ +L
Sbjct: 264 DMPVSCSLSRGLQVLLTPVLANILEA 289
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-39
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 28/219 (12%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVA--------------IGFALDIARAMECLHS 46
++++ E G L YL + R + VA I ++ +A+ ME L S
Sbjct: 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 166
Query: 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTV 103
IHRDL N+LL+E +K+ DFGLAR+ + +WMAPE
Sbjct: 167 RKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE----- 220
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVP 161
T+ Y + D +SF ++LWE+ P+ G+ + + R + +
Sbjct: 221 TIFDRV---YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT 277
Query: 162 EELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 200
E+ + CW +P+ RP F+++++ L N L A A +
Sbjct: 278 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 316
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-39
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 37/223 (16%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRC-----LDVCVAIGFALDIARAMECLHSHGIIHRDLK 55
I+ EL++GG L+ +L RPR L + + A DIA + L + IHRD+
Sbjct: 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 208
Query: 56 PENLLLT---EDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTVTLRQGE 109
N LLT K+ DFG+AR+ +WM PE +G
Sbjct: 209 ARNCLLTCPGPGR-VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE-----AFMEGI 262
Query: 110 KKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEE 163
+ K D++SF ++LWE+ +P+ SN + + V +N P
Sbjct: 263 ---FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-----LEFVTSGGRMDPPKNCPGP 314
Query: 164 LSIILTSCWKEDPNARPNFTQIIQMLL------NYLSAIAPPE 200
+ I+T CW+ P RPNF I++ + + ++ P E
Sbjct: 315 VYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIE 357
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-39
Identities = 50/203 (24%), Positives = 82/203 (40%), Gaps = 29/203 (14%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I E GTL + + I A+ +HS GIIHRDLKP N+ +
Sbjct: 92 IQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID 150
Query: 63 EDLKTIKLADFGLAR---------------EESLTEMMTAETGTYRWMAPELYSTVTLRQ 107
E + +K+ DFGLA+ ++ +T+ GT ++A E+
Sbjct: 151 ES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD------ 203
Query: 108 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN---LQAAYAAAFKNVRPSAENVPEEL 164
HYN K+D YS I+ +E+++ GM L+ + + + +N +
Sbjct: 204 -GTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVE 260
Query: 165 SIILTSCWKEDPNARPNFTQIIQ 187
I+ DPN RP ++
Sbjct: 261 KKIIRLLIDHDPNKRPGARTLLN 283
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-39
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 28/212 (13%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+IVTE + G+L +L + + +G + M L G +HRDL N+L
Sbjct: 125 AMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVL 183
Query: 61 LTEDLKTIKLADFGLARE-ESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNHK 116
+ +L K++DFGL+R E + TG RW APE + ++
Sbjct: 184 VDSNL-VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE-----AIAFR---TFSSA 234
Query: 117 VDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTS 170
D +SF +V+WE+L + + P+ M+N +V P+ P L ++
Sbjct: 235 SDVWSFGVVMWEVLAYGERPYWNMTNRD-----VISSVEEGYRLPAPMGCPHALHQLMLD 289
Query: 171 CWKEDPNARPNFTQIIQMLLNYLSAIAPPEPM 202
CW +D RP F+QI+ +L + + PE +
Sbjct: 290 CWHKDRAQRPRFSQIVSVLDALIRS---PESL 318
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-39
Identities = 53/205 (25%), Positives = 84/205 (40%), Gaps = 22/205 (10%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
++V E+ G L KYL R + I ++ M+ L +HRDL N+L
Sbjct: 92 WMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVL 149
Query: 61 LTEDLKTIKLADFGLARE-ESLTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYN 114
L K++DFGL++ + A+T +W APE Y ++
Sbjct: 150 LVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK----------FS 198
Query: 115 HKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCW 172
K D +SF +++WE + + P+ GM + A K R P E+ ++ CW
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TAMLEKGERMGCPAGCPREMYDLMNLCW 257
Query: 173 KEDPNARPNFTQIIQMLLNYLSAIA 197
D RP F + L NY +
Sbjct: 258 TYDVENRPGFAAVELRLRNYYYDVV 282
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 3e-39
Identities = 53/213 (24%), Positives = 88/213 (41%), Gaps = 37/213 (17%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVA--------------IGFALDIARAMECLHSHG 48
++ S G L ++L+ P + IA ME L SH
Sbjct: 89 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH 148
Query: 49 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTVTL 105
++H+DL N+L+ + L +K++D GL RE + + RWMAPE +
Sbjct: 149 VVHKDLATRNVLVYDKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPE-----AI 202
Query: 106 RQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAEN 159
G ++ D +S+ +VLWE+ + P+ G SN + +R P ++
Sbjct: 203 MYG---KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV-----VEMIRNRQVLPCPDD 254
Query: 160 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192
P + ++ CW E P+ RP F I L +
Sbjct: 255 CPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 287
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-39
Identities = 64/233 (27%), Positives = 97/233 (41%), Gaps = 35/233 (15%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IVTE + G+L +L + V +G IA M+ L G +HRDL N+L+
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181
Query: 63 EDLKTIKLADFGLARE-ESLTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNHK 116
+L K++DFGL R E E G RW +PE Y + +
Sbjct: 182 SNL-VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY----------RKFTSA 230
Query: 117 VDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTS 170
D +S+ IVLWE++ + + P+ MSN K V P + P L ++
Sbjct: 231 SDVWSYGIVLWEVMSYGERPYWEMSNQDV-----IKAVDEGYRLPPPMDCPAALYQLMLD 285
Query: 171 CWKEDPNARPNFTQIIQMLLNY------LSAIAPPEPMIPHRIFNSENTILPP 217
CW++D N RP F QI+ +L L I + + + N +
Sbjct: 286 CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITT 338
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-39
Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 44/218 (20%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVA--------------IGFALDIARAMECLHSHG 48
+ E G L +L R D A + FA D+AR M+ L
Sbjct: 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 162
Query: 49 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE--LYSTV 103
IHRDL N+L+ E+ K+ADFGL+R + E+ +T RWMA E YS
Sbjct: 163 FIHRDLAARNILVGENY-VAKIADFGLSRGQ---EVYVKKTMGRLPVRWMAIESLNYSV- 217
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSA 157
Y D +S+ ++LWE++ P+ GM+ + ++ +
Sbjct: 218 ---------YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LYEKLPQGYRLEKP 263
Query: 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195
N +E+ ++ CW+E P RP+F QI+ L L
Sbjct: 264 LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-39
Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 22/230 (9%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IV E + G TLR + P + AI D +A+ H +GIIHRD+KP N++++
Sbjct: 93 IVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150
Query: 63 EDLKTIKLADFGLAREESLTEMMTAET----GTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
+K+ DFG+AR + + +T GT ++++PE Q + + D
Sbjct: 151 AT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE--------QARGDSVDARSD 201
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-RPSAEN--VPEELSIILTSCWKED 175
YS VL+E+L + PF G S + AY ++ PSA + + +L ++ ++
Sbjct: 202 VYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN 261
Query: 176 PNARP-NFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSS 224
P R ++ L+ + P P + ++E T L + G S
Sbjct: 262 PENRYQTAAEMRADLVRVHNGEPPEAPKVLT---DAERTSLLSSAAGNLS 308
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-39
Identities = 50/229 (21%), Positives = 83/229 (36%), Gaps = 18/229 (7%)
Query: 1 MVIVTELLSGGTLRKYLL-NMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 59
V++ E G+L L L + D+ M L +GI+HR++KP N+
Sbjct: 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI 143
Query: 60 LLTEDL---KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 116
+ KL DFG ARE E + GT ++ P++Y LR+ +K Y
Sbjct: 144 MRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 117 VDSYSFAIVLWELLHNKLPFEG----------MSNLQAAYAAAFKNVRPSAENVPEELSI 166
VD +S + + LPF M + + + AEN P + S
Sbjct: 204 VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG 263
Query: 167 ILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTIL 215
+ + T ++ +L + + F + IL
Sbjct: 264 DMPVSCSLSRGLQVLLTPVLANILE----ADQEKCWGFDQFFAETSDIL 308
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-38
Identities = 52/225 (23%), Positives = 95/225 (42%), Gaps = 45/225 (20%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVA----------------------IGFALDIA 38
++++ E G+LR +L R + I FA I+
Sbjct: 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQIS 160
Query: 39 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWM 95
+ M+ L ++HRDL N+L+ E +K++DFGL+R+ + + +WM
Sbjct: 161 QGMQYLAEMKLVHRDLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWM 219
Query: 96 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR 154
A E +L Y + D +SF ++LWE++ P+ G+ + F ++
Sbjct: 220 AIE-----SLFDHI---YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL-----FNLLK 266
Query: 155 -----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194
+N EE+ ++ CWK++P+ RP F I + L +
Sbjct: 267 TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-38
Identities = 58/218 (26%), Positives = 88/218 (40%), Gaps = 35/218 (16%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVA---------------------IGFALDIARAM 41
++ E G L YL + R + + + + FA +A+ M
Sbjct: 126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 185
Query: 42 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE 98
E L +HRDL N+L+T K +K+ DFGLAR+ +WMAPE
Sbjct: 186 EFLEFKSCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 244
Query: 99 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PS 156
+L +G Y K D +S+ I+LWE+ P+ G+ Y +
Sbjct: 245 -----SLFEGI---YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ 296
Query: 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194
EE+ II+ SCW D RP+F + L L+
Sbjct: 297 PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-38
Identities = 53/215 (24%), Positives = 83/215 (38%), Gaps = 36/215 (16%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVA------------IGFALDIARAMECLHSHGII 50
++TE G L +L + F+ +A+ M L S I
Sbjct: 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCI 186
Query: 51 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLRQ 107
HRD+ N+LLT K+ DFGLAR+ + +WMAPE ++
Sbjct: 187 HRDVAARNVLLTNGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPE-----SIFD 240
Query: 108 GEKKHYNHKVDSYSFAIVLWELL-HNKLPFEG-MSNLQAAYAAAFKNVR-----PSAENV 160
Y + D +S+ I+LWE+ P+ G + N + +K V+
Sbjct: 241 CV---YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-----FYKLVKDGYQMAQPAFA 292
Query: 161 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195
P+ + I+ +CW +P RP F QI L
Sbjct: 293 PKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-38
Identities = 53/204 (25%), Positives = 79/204 (38%), Gaps = 35/204 (17%)
Query: 3 IVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 61
I +L L+ ++ + V + L IA A+E LHS G++HRDLKP N+
Sbjct: 92 IQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF 151
Query: 62 TEDLKTIKLADFGLAR-------------EESLTEMMTAETGTYRWMAPELYSTVTLRQG 108
T D +K+ DFGL T + GT +M+PE
Sbjct: 152 TMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI-------- 202
Query: 109 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEE 163
Y+HKVD +S ++L+ELL+ PF +VR P
Sbjct: 203 HGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL----TDVRNLKFPPLFTQKYPC 255
Query: 164 LSIILTSCWKEDPNARPNFTQIIQ 187
+++ P RP II+
Sbjct: 256 EYVMVQDMLSPSPMERPEAINIIE 279
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-38
Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 16/229 (6%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IV + GG L K + + + + + I A++ +H I+HRD+K +N+ LT
Sbjct: 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT 159
Query: 63 EDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
+D T++L DFG+AR S E+ A GT +++PE+ E K YN+K D ++
Sbjct: 160 KD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC--------ENKPYNNKSDIWA 210
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN 181
VL+EL K FE S + P + + +L +++ +K +P RP+
Sbjct: 211 LGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPS 270
Query: 182 FTQIIQM------LLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSS 224
I++ + +LS E + +P + P +
Sbjct: 271 VNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQ 319
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-38
Identities = 51/224 (22%), Positives = 86/224 (38%), Gaps = 44/224 (19%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ ++ E L G+LR YL + R +D + + I + ME L + IHRDL N+L
Sbjct: 88 LKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL 146
Query: 61 LTEDLKTIKLADFGLARE-ESLTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYN 114
+ + +K+ DFGL + E + W APE S ++
Sbjct: 147 VENEN-RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK----------FS 195
Query: 115 HKVDSYSFAIVLWELL----------------HNKLPFEGMSNLQAAYAAAFKNVR---- 154
D +SF +VL+EL M + ++
Sbjct: 196 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH-----LIELLKNNGR 250
Query: 155 -PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 197
P + P+E+ +I+T CW + N RP+F + + +A
Sbjct: 251 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-38
Identities = 48/215 (22%), Positives = 90/215 (41%), Gaps = 43/215 (20%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ ++ E L G+L++YL + + +++ + +A+ I + M+ L S +HRDL N+L
Sbjct: 100 IKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVL 158
Query: 61 LTEDLKTIKLADFGLARE-ESLTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYN 114
+ + +K+ DFGL + E+ E T + W APE + S +
Sbjct: 159 VESEH-QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK----------FY 207
Query: 115 HKVDSYSFAIVLWELL---------------HNKLPFEGMSNLQAAYAAAFKNVR----- 154
D +SF + L ELL M+ + ++
Sbjct: 208 IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR-----LVNTLKEGKRL 262
Query: 155 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189
P N P+E+ ++ CW+ P+ R +F +I+
Sbjct: 263 PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-37
Identities = 55/233 (23%), Positives = 94/233 (40%), Gaps = 45/233 (19%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVA----------------------IGFALDIA 38
M ++ E ++ G L ++L +M P + + A +A
Sbjct: 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 184
Query: 39 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWM 95
M L +HRDL N L+ E++ +K+ADFGL+R + A+ RWM
Sbjct: 185 AGMAYLSERKFVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWM 243
Query: 96 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR 154
PE ++ Y + D +++ +VLWE+ + P+ GM++ + VR
Sbjct: 244 PPE-----SIFYNR---YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV-----IYYVR 290
Query: 155 -----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPM 202
EN P EL ++ CW + P RP+F I ++L +
Sbjct: 291 DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGTVGV 343
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-37
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E + G TL +Y+ + P L V AI F I ++ H I+HRD+KP+N+L+
Sbjct: 88 LVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID 145
Query: 63 EDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
+ KT+K+ DFG+A+ S T + GT ++ +PE Q + + + D Y
Sbjct: 146 SN-KTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE--------QAKGEATDECTDIY 196
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--RPSAEN--VPEELSIILTSCWKEDP 176
S IVL+E+L + PF G + + A +V + +P+ LS ++ ++D
Sbjct: 197 SIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDK 256
Query: 177 NARP-NFTQIIQMLLNYLSAIAPPEPMI 203
R ++ L + L E +
Sbjct: 257 ANRYKTIQEMKDDLSSVLHENRANEDVY 284
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-37
Identities = 51/224 (22%), Positives = 86/224 (38%), Gaps = 44/224 (19%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ ++ E L G+LR YL + R +D + + I + ME L + IHRDL N+L
Sbjct: 119 LKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL 177
Query: 61 LTEDLKTIKLADFGLARE-ESLTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYN 114
+ + +K+ DFGL + E + W APE S ++
Sbjct: 178 VENEN-RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK----------FS 226
Query: 115 HKVDSYSFAIVLWELL----------------HNKLPFEGMSNLQAAYAAAFKNVR---- 154
D +SF +VL+EL M + ++
Sbjct: 227 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH-----LIELLKNNGR 281
Query: 155 -PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 197
P + P+E+ +I+T CW + N RP+F + + +A
Sbjct: 282 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-37
Identities = 53/227 (23%), Positives = 85/227 (37%), Gaps = 45/227 (19%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V E + G+LR YL + + + FA I M LH+ IHRDL N+L
Sbjct: 110 LQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVL 166
Query: 61 LTEDLKTIKLADFGLARE-ESLTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYN 114
L D +K+ DFGLA+ E W APE +
Sbjct: 167 LDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK----------FY 215
Query: 115 HKVDSYSFAIVLWELL---------------HNKLPFEGMSNLQAAYAAAFKNVR----- 154
+ D +SF + L+ELL + M+ L+ + +
Sbjct: 216 YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR-----LTELLERGERL 270
Query: 155 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 201
P + P E+ ++ +CW+ + + RP F +I +L P
Sbjct: 271 PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-37
Identities = 54/194 (27%), Positives = 97/194 (50%), Gaps = 20/194 (10%)
Query: 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENL 59
V+VTEL++ GTL+ YL R + + + V + I + ++ LH+ IIHRDLK +N+
Sbjct: 105 VLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNI 162
Query: 60 LLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
+T ++K+ D GLA + + GT +MAPE+Y ++ Y+ VD
Sbjct: 163 FITGPTGSVKIGDLGLATLKRASFAKA-VIGTPEFMAPEMY---------EEKYDESVDV 212
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA--ENVPEELSIILTSCWKEDPN 177
Y+F + + E+ ++ P+ N Y V+P++ + E+ I+ C +++ +
Sbjct: 213 YAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKD 272
Query: 178 ARPNFTQIIQMLLN 191
R + LLN
Sbjct: 273 ERYSIKD----LLN 282
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-37
Identities = 47/206 (22%), Positives = 89/206 (43%), Gaps = 21/206 (10%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+++V E+ GG L K+L+ R + V ++ M+ L +HR+L N+L
Sbjct: 410 LMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVL 468
Query: 61 LTEDLKTIKLADFGLAREESLTEMM-TAETGT---YRWMAPE--LYSTVTLRQGEKKHYN 114
L K++DFGL++ + TA + +W APE + ++
Sbjct: 469 LVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK----------FS 517
Query: 115 HKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCW 172
+ D +S+ + +WE L + + P++ M + A + R P EL +++ CW
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-MAFIEQGKRMECPPECPPELYALMSDCW 576
Query: 173 KEDPNARPNFTQIIQMLLNYLSAIAP 198
RP+F + Q + ++A
Sbjct: 577 IYKWEDRPDFLTVEQRMRACYYSLAS 602
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-37
Identities = 51/201 (25%), Positives = 79/201 (39%), Gaps = 27/201 (13%)
Query: 3 IVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 61
I +L L+ ++ + V + + IA A+E LHS G++HRDLKP N+
Sbjct: 138 IQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF 197
Query: 62 TEDLKTIKLADFGLAR-------------EESLTEMMTAETGTYRWMAPELYSTVTLRQG 108
T D +K+ DFGL T + GT +M+PE Q
Sbjct: 198 TMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE--------QI 248
Query: 109 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSII 167
+Y+HKVD +S ++L+ELL+ F P + ++
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMM 305
Query: 168 LTSCWKEDPNARPNFTQIIQM 188
+ P RP T II+
Sbjct: 306 VQDMLSPSPTERPEATDIIEN 326
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-36
Identities = 52/222 (23%), Positives = 83/222 (37%), Gaps = 33/222 (14%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V E L G LR +L R R LD + ++ I + ME L S +HRDL N+L
Sbjct: 101 LRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 159
Query: 61 LTEDLKTIKLADFGLARE-ESLTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYN 114
+ + +K+ADFGLA+ + W APE + ++
Sbjct: 160 VESEA-HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI----------FS 208
Query: 115 HKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR--------------PSAEN 159
+ D +SF +VL+EL + + P+
Sbjct: 209 RQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPA 268
Query: 160 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 201
P E+ ++ CW P RP+F+ + L S E
Sbjct: 269 CPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET 310
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-36
Identities = 47/223 (21%), Positives = 85/223 (38%), Gaps = 38/223 (17%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E + G+L YL + +++ + A +A AM L + +IH ++ +N+LL
Sbjct: 89 LVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLI 147
Query: 63 EDLK-------TIKLADFGLAREESLTEMMTAETGTY----RWMAPE--LYSTVTLRQGE 109
+ IKL+D G++ W+ PE
Sbjct: 148 REEDRKTGNPPFIKLSDPGISIT-------VLPKDILQERIPWVPPECIENP-------- 192
Query: 110 KKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQA--AYAAAFKNVRPSAENVPEELSI 166
K+ N D +SF LWE+ P + + + Y + P EL+
Sbjct: 193 -KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPK----AAELAN 247
Query: 167 ILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFN 209
++ +C +P+ RP+F II+ L + + P H +
Sbjct: 248 LINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGS-HHHHHH 289
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-36
Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 24/213 (11%)
Query: 3 IVTELLSGGTLRKYLLNMRPR--CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
++ GTL + ++ + L + L I R +E +H+ G HRDLKP N+L
Sbjct: 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNIL 166
Query: 61 LTEDLKTIKLADFGLAR----------EESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 110
L ++ L D G + + A+ T + APEL +++
Sbjct: 167 LGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL---FSVQSHCV 222
Query: 111 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSAENVPEELSIIL 168
+ + D +S VL+ ++ + P++ + + A A +N P + L +L
Sbjct: 223 --IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLL 280
Query: 169 TSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 201
S DP+ RP+ + L+ L A+ PP P
Sbjct: 281 NSMMTVDPHQRPHIPLL----LSQLEALQPPAP 309
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-35
Identities = 46/196 (23%), Positives = 87/196 (44%), Gaps = 19/196 (9%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E L +L + +D + ++ A+ +H HGI+H DLKP N L+
Sbjct: 105 MVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 161
Query: 63 EDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPEL---YSTVTLRQGEKKHYNHK 116
+ +KL DFG+A ++ + + ++ GT +M PE S+ K + K
Sbjct: 162 DG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK 219
Query: 117 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-----ENVPEELSIILTSC 171
D +S +L+ + + K PF+ + N + + P+ + ++L +L C
Sbjct: 220 SDVWSLGCILYYMTYGKTPFQQIINQ---ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCC 276
Query: 172 WKEDPNARPNFTQIIQ 187
K DP R + +++
Sbjct: 277 LKRDPKQRISIPELLA 292
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-35
Identities = 47/196 (23%), Positives = 87/196 (44%), Gaps = 19/196 (9%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E L +L + +D + ++ A+ +H HGI+H DLKP N L+
Sbjct: 86 MVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 142
Query: 63 EDLKTIKLADFGLARE-ESLTEMMTAET--GTYRWMAPEL---YSTVTLRQGEKKHYNHK 116
+ +KL DFG+A + + T + ++ GT +M PE S+ K + K
Sbjct: 143 DG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK 200
Query: 117 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-----ENVPEELSIILTSC 171
D +S +L+ + + K PF+ + N + + P+ + ++L +L C
Sbjct: 201 SDVWSLGCILYYMTYGKTPFQQIIN---QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCC 257
Query: 172 WKEDPNARPNFTQIIQ 187
K DP R + +++
Sbjct: 258 LKRDPKQRISIPELLA 273
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-35
Identities = 47/188 (25%), Positives = 73/188 (38%), Gaps = 14/188 (7%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ + TEL G +L+++ L G+ D A+ LHS G++H D+KP N+
Sbjct: 132 LYLQTEL-CGPSLQQHCEA-WGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF 189
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
L KL DFGL E + G R+MAPEL L+ Y D +
Sbjct: 190 LGPR-GRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL-----LQGS----YGTAADVF 239
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
S + + E+ N G Q + + EL +L + DP R
Sbjct: 240 SLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTA--GLSSELRSVLVMMLEPDPKLRA 297
Query: 181 NFTQIIQM 188
++ +
Sbjct: 298 TAEALLAL 305
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-35
Identities = 46/196 (23%), Positives = 86/196 (43%), Gaps = 19/196 (9%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E L +L + +D + ++ A+ +H HGI+H DLKP N L+
Sbjct: 133 MVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 189
Query: 63 EDLKTIKLADFGLARE-ESLTEMMTAET--GTYRWMAPEL---YSTVTLRQGEKKHYNHK 116
+ +KL DFG+A + + T + ++ G +M PE S+ K + K
Sbjct: 190 DG--MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPK 247
Query: 117 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-----ENVPEELSIILTSC 171
D +S +L+ + + K PF+ + N + + P+ + ++L +L C
Sbjct: 248 SDVWSLGCILYYMTYGKTPFQQIINQ---ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCC 304
Query: 172 WKEDPNARPNFTQIIQ 187
K DP R + +++
Sbjct: 305 LKRDPKQRISIPELLA 320
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-34
Identities = 53/185 (28%), Positives = 83/185 (44%), Gaps = 21/185 (11%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+ L++G L L P L A+ I A++ H+ G HRD+KPEN+L++
Sbjct: 111 VDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS 168
Query: 63 EDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
D L DFG+A +E LT++ GT +MAPE + + H ++ D
Sbjct: 169 AD-DFAYLVDFGIASATTDEKLTQLGNT-VGTLYYMAPE--------RFSESHATYRADI 218
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-RPSAEN--VPEEL-SIILTSCWKED 175
Y+ VL+E L P++G L A + + RPS +P ++I K +
Sbjct: 219 YALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAK-N 276
Query: 176 PNARP 180
P R
Sbjct: 277 PEDRY 281
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 31/214 (14%), Positives = 72/214 (33%), Gaps = 31/214 (14%)
Query: 10 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 69
G L + + L + L + R + LH +G++H L+P +++L + +
Sbjct: 190 GEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VF 246
Query: 70 LADFGLAREESLTEMMTAETGTYRWMAPEL---YSTVTLRQGEKKHYNHKVDSYSFAIVL 126
L F + + + + PEL +T++ + + D+++ +V+
Sbjct: 247 LTGFEHLVRDG---ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303
Query: 127 WELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQII 186
+ + LP F++ + N+P+ + +L + R Q +
Sbjct: 304 YWIWCADLPITK-DAALGGSEWIFRSCK----NIPQPVRALLEGFLRYPKEDRLLPLQAM 358
Query: 187 QMLLNYLSAIAPPEPMIPHRIFNSENTILPPESP 220
+ + T L P
Sbjct: 359 E-----------------TPEYEQLRTELSAALP 375
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-34
Identities = 53/200 (26%), Positives = 78/200 (39%), Gaps = 16/200 (8%)
Query: 1 MVIVTELLSGGTLRKYLLNM-RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 59
++ E GG LRKYL L DI+ A+ LH + IIHRDLKPEN+
Sbjct: 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENI 152
Query: 60 LL--TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKV 117
+L K+ D G A+E E+ T GT +++APEL E+K Y V
Sbjct: 153 VLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL--------EQKKYTVTV 204
Query: 118 DSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPN 177
D +SF + +E + PF + + + + S PN
Sbjct: 205 DYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPN 264
Query: 178 ARPNFTQI-----IQMLLNY 192
+Q +L +
Sbjct: 265 HLSGILAGKLERWLQCMLMW 284
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-33
Identities = 53/194 (27%), Positives = 78/194 (40%), Gaps = 17/194 (8%)
Query: 3 IVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHS-----HGIIHRDLK 55
IV E GG L + + LD + + A++ H H ++HRDLK
Sbjct: 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 56 PENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 114
P N+ L + +KL DFGLAR T GT +M+PE + YN
Sbjct: 144 PANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM--------NRMSYN 194
Query: 115 HKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKE 174
K D +S +L+EL PF S + A R +EL+ I+T
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNL 254
Query: 175 DPNARPNFTQIIQM 188
RP+ +I++
Sbjct: 255 KDYHRPSVEEILEN 268
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 3e-33
Identities = 29/222 (13%), Positives = 71/222 (31%), Gaps = 15/222 (6%)
Query: 9 SGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66
+ T + LL+ + L + L + R + LH +G++H L+P +++L +
Sbjct: 190 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG- 248
Query: 67 TIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAI 124
+ L F + + + A + Q D+++ +
Sbjct: 249 GVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPF---GQHHPTLMTFAFDTWTLGL 305
Query: 125 VLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQ 184
++ + LP F++ + N+P+ + +L + R Q
Sbjct: 306 AIYWIWCADLPNTD-DAALGGSEWIFRSCK----NIPQPVRALLEGFLRYPKEDRLLPLQ 360
Query: 185 IIQ--MLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSS 224
++ + ++ P+ + PP
Sbjct: 361 AMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPD 402
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 14/170 (8%)
Query: 31 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 90
I ++ +A+ ME L S IHRDL N+LL+E +K+ DFGLAR+ +
Sbjct: 196 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGD 254
Query: 91 T---YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAY 146
+WMAPE + Y + D +SF ++LWE+ P+ G+ +
Sbjct: 255 ARLPLKWMAPE--------TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 306
Query: 147 AAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195
+ R + + E+ + CW +P+ RP F+++++ L N L A
Sbjct: 307 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-32
Identities = 50/238 (21%), Positives = 83/238 (34%), Gaps = 26/238 (10%)
Query: 2 VIVTELLSGGTLRKYLLNMRPR-CLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPEN 58
++ L G L ++L M R L + RA++ +H IIHRDLK EN
Sbjct: 109 FLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVEN 168
Query: 59 LLLTEDLKTIKLADFGLAR-------------EESLTEMMTAETGTYRWMAPELYSTVTL 105
LLL+ TIKL DFG A +L E T + PE+ +
Sbjct: 169 LLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS- 226
Query: 106 RQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELS 165
K D ++ +L+ L + PFE + P +
Sbjct: 227 ----NFPIGEKQDIWALGCILYLLCFRQHPFED-GAKLRIVNGKYS--IPPHDTQYTVFH 279
Query: 166 IILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTS 223
++ + + +P R + +++ L ++A P P +N +
Sbjct: 280 SLIRAMLQVNPEERLSIAEVVHQLQE-IAAARNVNPKSPITELLEQNGGYGSATLSRG 336
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-31
Identities = 53/194 (27%), Positives = 87/194 (44%), Gaps = 19/194 (9%)
Query: 3 IVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
IV EL G L + + + + R + + + + A+E +HS ++HRD+KP N+
Sbjct: 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVF 168
Query: 61 LTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
+T +KL D GL R S T + GT +M+PE + YN K D
Sbjct: 169 ITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI--------HENGYNFKSDI 219
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP-----EELSIILTSCWKE 174
+S +L+E+ + PF G + Y+ K + +P EEL ++ C
Sbjct: 220 WSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINP 277
Query: 175 DPNARPNFTQIIQM 188
DP RP+ T + +
Sbjct: 278 DPEKRPDVTYVYDV 291
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 2e-31
Identities = 24/198 (12%), Positives = 59/198 (29%), Gaps = 21/198 (10%)
Query: 2 VIVTELLSG--GTLRKYL--LNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 57
+++ S L L + + + + R L S G++H P+
Sbjct: 164 LLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPD 223
Query: 58 NLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKV 117
NL + D + L D + A + + E + H +
Sbjct: 224 NLFIMPDG-RLMLGDVSALWKVG--TRGPASSVPVTYAPRE------FLNASTATFTHAL 274
Query: 118 DSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE--------NVPEELSIILT 169
+++ + ++ + LPF ++ P + +P+ + ++
Sbjct: 275 NAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG 334
Query: 170 SCWKEDPNARPNFTQIIQ 187
D R + ++
Sbjct: 335 RFLNFDRRRRLLPLEAME 352
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-31
Identities = 36/207 (17%), Positives = 71/207 (34%), Gaps = 29/207 (14%)
Query: 1 MVIVTELLSGGTLRKYLLNMRP---RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 57
V+V EL S GTL + + + + + I FA+ + +E +H IIH D+KP+
Sbjct: 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPD 201
Query: 58 NLLLTEDL----------KTIKLADFGLAREESL---TEMMTAETGTYRWMAPELYSTVT 104
N +L + L D G + + L + TA+ T + E+
Sbjct: 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML---- 257
Query: 105 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEEL 164
K +N+++D + A ++ +L + F+ +
Sbjct: 258 ----SNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR-----LPHLDMW 308
Query: 165 SIILTSCWKEDPNARPNFTQIIQMLLN 191
+ +++ L
Sbjct: 309 NEFFHVMLNIPDCHHLPSLDLLRQKLK 335
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-30
Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 12/186 (6%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E+ G + +YL N R + A F I M LHSHGI+HRDL NLLLT
Sbjct: 88 LVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT 146
Query: 63 EDLKTIKLADFGLA-REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
++ IK+ADFGLA + + E GT +++PE+ + + + + D +S
Sbjct: 147 RNM-NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT--------RSAHGLESDVWS 197
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN 181
+ + LL + PF+ ++ + E ++ + +P R +
Sbjct: 198 LGCMFYTLLIGRPPFDT-DTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLS 256
Query: 182 FTQIIQ 187
+ ++
Sbjct: 257 LSSVLD 262
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-30
Identities = 48/204 (23%), Positives = 76/204 (37%), Gaps = 26/204 (12%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IV E + G +L++ + L V AI + L+I A+ LHS G+++ DLKPEN++LT
Sbjct: 161 IVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT 216
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 122
E+ +KL D G + + GT + APE+ T D Y+
Sbjct: 217 EE--QLKLIDLGAVSRINSFGYL---YGTPGFQAPEIVRT---------GPTVATDIYTV 262
Query: 123 AIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP-N 181
L L + G Y + +L DP R
Sbjct: 263 GRTLAALTLDLPTRNG------RYVDGL-PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTT 315
Query: 182 FTQIIQMLLNYLSAIAPPEPMIPH 205
++ L L + + +P
Sbjct: 316 AEEMSAQLTGVLREVVAQDTGVPR 339
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-29
Identities = 34/208 (16%), Positives = 70/208 (33%), Gaps = 35/208 (16%)
Query: 1 MVIVTELLSGGTLRKYLL--NMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 58
M+I E +GG+L + L + R + +HS ++H D+KP N
Sbjct: 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSN 145
Query: 59 LLLTED------------------LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELY 100
+ ++ K+ D G ++ E G R++A E+
Sbjct: 146 IFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT--RISSPQV-EEGDSRFLANEVL 202
Query: 101 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-EN 159
E + K D ++ A+ + + + + P +
Sbjct: 203 Q-------ENYTHLPKADIFALALTVVCAAGAEPLPRNGD----QWHEIRQGRLPRIPQV 251
Query: 160 VPEELSIILTSCWKEDPNARPNFTQIIQ 187
+ +E + +L DP RP+ +++
Sbjct: 252 LSQEFTELLKVMIHPDPERRPSAMALVK 279
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-29
Identities = 36/151 (23%), Positives = 68/151 (45%), Gaps = 15/151 (9%)
Query: 3 IVTELLSGGTLRKYLLN------MRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLK 55
I+ E + ++ K+ + + V + + +H+ I HRD+K
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179
Query: 56 PENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 115
P N+L+ ++ +KL+DFG + ++ + GTY +M PE +S E +
Sbjct: 180 PSNILMDKN-GRVKLSDFGESEYMVDKKIKGSR-GTYEFMPPEFFS------NESSYNGA 231
Query: 116 KVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 146
KVD +S I L+ + +N +PF +L +
Sbjct: 232 KVDIWSLGICLYVMFYNVVPFSLKISLVELF 262
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-29
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 16/221 (7%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V EL +L + R + L A + I + LH + +IHRDLK NL L
Sbjct: 118 VVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 175
Query: 63 EDLKTIKLADFGLA-REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
EDL +K+ DFGLA + E E GT ++APE+ S KK ++ +VD +S
Sbjct: 176 EDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS--------KKGHSFEVDVWS 226
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN 181
+++ LL K PFE S L+ Y KN +++ + ++ + DP ARP
Sbjct: 227 IGCIMYTLLVGKPPFET-SCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPT 285
Query: 182 FTQIIQ---MLLNYLSAIAPPEPMIPHRIFNSENTILPPES 219
+++ Y+ A P + F+ + L P +
Sbjct: 286 INELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSN 326
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 4e-29
Identities = 48/191 (25%), Positives = 86/191 (45%), Gaps = 25/191 (13%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
++ E GT+ + L + D + ++A A+ HS +IHRD+KPENLLL
Sbjct: 86 LILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG 143
Query: 63 EDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
+K+ADFG + GT ++ PE+ E + ++ KVD +
Sbjct: 144 SAG-ELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMI--------EGRMHDEKVDLW 191
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI----ILTSCWKEDP 176
S ++ +E L K PFE + Q Y K + P+ ++ +++ K +P
Sbjct: 192 SLGVLCYEFLVGKPPFEA-NTYQETY----KRISRVEFTFPDFVTEGARDLISRLLKHNP 246
Query: 177 NARPNFTQIIQ 187
+ RP ++++
Sbjct: 247 SQRPMLREVLE 257
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-28
Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V EL +L + R + L A + I + LH + +IHRDLK NL L
Sbjct: 92 VVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 149
Query: 63 EDLKTIKLADFGLA-REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
EDL +K+ DFGLA + E E GT ++APE+ S KK ++ +VD +S
Sbjct: 150 EDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS--------KKGHSFEVDVWS 200
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN 181
+++ LL K PFE S L+ Y KN +++ + ++ + DP ARP
Sbjct: 201 IGCIMYTLLVGKPPFET-SCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPT 259
Query: 182 FTQIIQ---MLLNYLSAIAPP 199
+++ Y+ A P
Sbjct: 260 INELLNDEFFTSGYIPARLPI 280
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-28
Identities = 49/189 (25%), Positives = 91/189 (48%), Gaps = 15/189 (7%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V EL++ G + + L A + D+ + +E LH IIHRD+KP NLL+
Sbjct: 115 MVFELVNQGPVMEVPTLKP---LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG 171
Query: 63 EDLKTIKLADFGLAREESLTEMMTAET-GTYRWMAPELYSTVTLRQGEKKHYN-HKVDSY 120
ED IK+ADFG++ E ++ + + T GT +MAPE S +K ++ +D +
Sbjct: 172 ED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLS------ETRKIFSGKALDVW 224
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFK-NVR-PSAENVPEELSIILTSCWKEDPNA 178
+ + L+ + + PF + ++ + P ++ E+L ++T ++P +
Sbjct: 225 AMGVTLYCFVFGQCPFMD-ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPES 283
Query: 179 RPNFTQIIQ 187
R +I
Sbjct: 284 RIVVPEIKL 292
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-28
Identities = 43/204 (21%), Positives = 79/204 (38%), Gaps = 16/204 (7%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
++ E G L K L + D + F ++A A+ H +IHRD+KPENLL+
Sbjct: 91 LMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG 148
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 122
+K+ADFG + T GT ++ PE+ E K ++ KVD +
Sbjct: 149 YKG-ELKIADFGWSVHAPSLRRRTM-CGTLDYLPPEMI--------EGKTHDEKVDLWCA 198
Query: 123 AIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF 182
++ +E L PF+ + + + + +++ + P R
Sbjct: 199 GVLCYEFLVGMPPFDS-PSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPL 257
Query: 183 TQIIQ---MLLNYLSAIAPPEPMI 203
+++ + N + P
Sbjct: 258 KGVMEHPWVKANSRRVLPPVYQST 281
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-28
Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 18/186 (9%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I ELL GG+L + + M L A+ + +E LH+ I+H D+K +N+LL+
Sbjct: 127 IFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 184
Query: 63 EDLKTIKLADFG----LAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHK 116
D L DFG L + ++T + GT MAPE V + + + K
Sbjct: 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE----VVMGKP----CDAK 236
Query: 117 VDSYSFAIVLWELLHNKLPFEGMSNLQAAY--AAAFKNVRPSAENVPEELSIILTSCWKE 174
VD +S ++ +L+ P+ A+ +R + + + ++
Sbjct: 237 VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRK 296
Query: 175 DPNARP 180
+P R
Sbjct: 297 EPVHRA 302
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-28
Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 14/183 (7%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
M +V +LL GG LR Y L + F ++ A++ L + IIHRD+KP+N+L
Sbjct: 90 MFMVVDLLLGGDLR-YHLQ-QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNIL 147
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
L E + + DF +A +T GT +MAPE+ + Y+ VD +
Sbjct: 148 LDEH-GHVHITDFNIAAMLPRETQITTMAGTKPYMAPEM-----FSSRKGAGYSFAVDWW 201
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI----ILTSCWKEDP 176
S + +ELL + P+ S+ + + P S +L + +P
Sbjct: 202 SLGVTAYELLRGRRPYHIRSS--TSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNP 259
Query: 177 NAR 179
+ R
Sbjct: 260 DQR 262
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-28
Identities = 51/188 (27%), Positives = 82/188 (43%), Gaps = 22/188 (11%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIG-FALDIARAMECLHSHGIIHRDLKPENLLL 61
I E + GG+L L + D IG + I ++ LH + I+HRD+K +N+L+
Sbjct: 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLI 155
Query: 62 TEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
+K++DFG ++ + TGT ++MAPE+ + Y D +
Sbjct: 156 NTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII------DKGPRGYGKAADIW 209
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFK----NVRPSAENVPEELSII----LTSCW 172
S + E+ K PF L AA FK V P +PE +S + C+
Sbjct: 210 SLGCTIIEMATGKPPF---YELGEPQAAMFKVGMFKVHPE---IPESMSAEAKAFILKCF 263
Query: 173 KEDPNARP 180
+ DP+ R
Sbjct: 264 EPDPDKRA 271
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 45/200 (22%), Positives = 76/200 (38%), Gaps = 26/200 (13%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I EL TL++Y+ + I + LHS I+HRDLKP N+L++
Sbjct: 95 IAIELC-AATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILIS 152
Query: 63 EDLKT----IKLADFGLAR----EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 114
++DFGL + + GT W+APE+ L + K++
Sbjct: 153 MPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM-----LSEDCKENPT 207
Query: 115 HKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI------I 167
+ VD +S V + ++ PF Q A S + + E +
Sbjct: 208 YTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----ANILLGACSLDCLHPEKHEDVIAREL 263
Query: 168 LTSCWKEDPNARPNFTQIIQ 187
+ DP RP+ +++
Sbjct: 264 IEKMIAMDPQKRPSAKHVLK 283
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-27
Identities = 48/212 (22%), Positives = 80/212 (37%), Gaps = 29/212 (13%)
Query: 3 IVTELLSGGTL-----RKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 57
I EL L K + + + I IA + LHS IIHRDLKP+
Sbjct: 86 IALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144
Query: 58 NLLLTEDLKT------------IKLADFGLAR-----EESLTEMMTAETGTYRWMAPELY 100
N+L++ + I ++DFGL + + S + +GT W APEL
Sbjct: 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELL 204
Query: 101 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSAEN 159
Q K+ +D +S V + +L K PF + ++ ++
Sbjct: 205 EESNNLQT-KRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCL 263
Query: 160 VPEELSI----ILTSCWKEDPNARPNFTQIIQ 187
L +++ DP RP ++++
Sbjct: 264 HDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 47/180 (26%), Positives = 82/180 (45%), Gaps = 14/180 (7%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
V L++GG L+ ++ +M A+ +A +I +E LH I++RDLKPEN+LL +
Sbjct: 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDD 321
Query: 64 DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFA 123
I+++D GLA + + GT +MAPE V + Y D ++
Sbjct: 322 H-GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPE----VVKNER----YTFSPDWWALG 372
Query: 124 IVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI----ILTSCWKEDPNAR 179
+L+E++ + PF+ + + V+ E E S + + +DP R
Sbjct: 373 CLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 16/203 (7%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
++ E SGG + YL + + A I A++ H I+HRDLK ENLLL
Sbjct: 91 LIMEYASGGEVFDYL--VAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD 148
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-HKVDSYS 121
D+ IK+ADFG + E ++ + A G + APEL+ K Y+ +VD +S
Sbjct: 149 ADMN-IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQ--------GKKYDGPEVDVWS 199
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN 181
++L+ L+ LPF+G NL+ + + + +L +P R
Sbjct: 200 LGVILYTLVSGSLPFDG-QNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGT 258
Query: 182 FTQIIQ---MLLNYLSAIAPPEP 201
QI++ + + P
Sbjct: 259 LEQIMKDRWINAGHEEDELKPFV 281
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 47/150 (31%), Positives = 66/150 (44%), Gaps = 31/150 (20%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR----AMECLHSHGIIHRD 53
+V E GG L D + A I + + LH H I+HRD
Sbjct: 113 LVMECYKGGEL-----------FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRD 161
Query: 54 LKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 111
LKPENLLL E IK+ DFGL+ + M GT ++APE+ +K
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL---------RK 212
Query: 112 HYNHKVDSYSFAIVLWELLHNKLPFEGMSN 141
Y+ K D +S ++L+ LL PF G ++
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPPFGGQTD 242
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-25
Identities = 47/136 (34%), Positives = 70/136 (51%), Gaps = 9/136 (6%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IV EL+ GG L ++ + L + + A++ LH +GIIHRDLKPEN+LL+
Sbjct: 216 IVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 273
Query: 63 --EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
E+ IK+ DFG ++ T +M GT ++APE+ L YN VD +
Sbjct: 274 SQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV-----LVSVGTAGYNRAVDCW 328
Query: 121 SFAIVLWELLHNKLPF 136
S ++L+ L PF
Sbjct: 329 SLGVILFICLSGYPPF 344
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-25
Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 37/224 (16%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR----AMECLHSHGIIHRD 53
+V E+ +GG L D ++ A I R + +H + I+HRD
Sbjct: 103 LVGEVYTGGEL-----------FDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 151
Query: 54 LKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 111
LKPENLLL I++ DFGL+ ++ M + GT ++APE+
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL---------HG 202
Query: 112 HYNHKVDSYSFAIVLWELLHNKLPFEGMSN---LQAAYAAAFKNVRPSAENVPEELSIIL 168
Y+ K D +S ++L+ LL PF G + L+ + P + V E ++
Sbjct: 203 TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLI 262
Query: 169 TSCWKEDPNARPNFTQIIQ---MLLNYLSAIAPPEPMIPHRIFN 209
P+ R + + + I+ P + + I N
Sbjct: 263 RKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILN 306
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-25
Identities = 52/199 (26%), Positives = 81/199 (40%), Gaps = 34/199 (17%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR----AMECLHSHGIIHRD 53
IV EL +GG L D + A I + + +H H I+HRD
Sbjct: 98 IVGELYTGGEL-----------FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 54 LKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 111
LKPEN+LL E IK+ DFGL+ M GT ++APE+ +
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL---------RG 197
Query: 112 HYNHKVDSYSFAIVLWELLHNKLPFEGMSN---LQAAYAAAFKNVRPSAENVPEELSIIL 168
Y+ K D +S ++L+ LL PF G + L+ + P + ++ ++
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI 257
Query: 169 TSCWKEDPNARPNFTQIIQ 187
P+ R TQ ++
Sbjct: 258 RKMLTFHPSLRITATQCLE 276
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-24
Identities = 52/186 (27%), Positives = 90/186 (48%), Gaps = 22/186 (11%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
V E ++GG L ++ R R L A ++ +I+ A+ LH GII+RDLK +N+LL
Sbjct: 88 VIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 145
Query: 64 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
+ IKL D+G+ +E L T T GT ++APE + + Y VD ++
Sbjct: 146 E-GHIKLTDYGMCKEG-LRPGDTTSTFCGTPNYIAPE----ILRGED----YGFSVDWWA 195
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYAAA----FKNVRPSAENVPEELSI----ILTSCWK 173
++++E++ + PF+ + + F+ + +P LS+ +L S
Sbjct: 196 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLN 255
Query: 174 EDPNAR 179
+DP R
Sbjct: 256 KDPKER 261
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 36/137 (26%), Positives = 69/137 (50%), Gaps = 7/137 (5%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
V + GG L LL+ L +A + ++ A++ +H +HRD+KP+N+L+
Sbjct: 152 VMDYYVGGDLL-TLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM 210
Query: 64 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
+ I+LADFG + + + GT +++PE+ + +G K Y + D +S
Sbjct: 211 NGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI---LQAMEGGKGRYGPECDWWS 266
Query: 122 FAIVLWELLHNKLPFEG 138
+ ++E+L+ + PF
Sbjct: 267 LGVCMYEMLYGETPFYA 283
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-24
Identities = 49/182 (26%), Positives = 85/182 (46%), Gaps = 16/182 (8%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
+ + ++GG L +L + + +I A+E LH GII+RD+K EN+LL
Sbjct: 137 ILDYINGGELFTHL--SQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS 194
Query: 64 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
+ + L DFGL++E E A GT +MAP++ +G ++ VD +S
Sbjct: 195 N-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV------RGGDSGHDKAVDWWS 247
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI----ILTSCWKEDPN 177
++++ELL PF + + A + + S P+E+S ++ +DP
Sbjct: 248 LGVLMYELLTGASPFTV-DGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPK 306
Query: 178 AR 179
R
Sbjct: 307 KR 308
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 46/150 (30%), Positives = 68/150 (45%), Gaps = 31/150 (20%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR----AMECLHSHGIIHRD 53
+VTE GG L + + A +I + + LH H I+HRD
Sbjct: 123 LVTEFYEGGEL-----------FEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRD 171
Query: 54 LKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 111
+KPEN+LL L IK+ DFGL+ S + GT ++APE+ KK
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL---------KK 222
Query: 112 HYNHKVDSYSFAIVLWELLHNKLPFEGMSN 141
YN K D +S ++++ LL PF G ++
Sbjct: 223 KYNEKCDVWSCGVIMYILLCGYPPFGGQND 252
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-24
Identities = 52/186 (27%), Positives = 90/186 (48%), Gaps = 22/186 (11%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
V E ++GG L ++ R R L A ++ +I+ A+ LH GII+RDLK +N+LL
Sbjct: 131 VIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 188
Query: 64 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
+ IKL D+G+ +E L T T GT ++APE + + Y VD ++
Sbjct: 189 E-GHIKLTDYGMCKEG-LRPGDTTSTFCGTPNYIAPE----ILRGED----YGFSVDWWA 238
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYA----AAFKNVRPSAENVPEELSI----ILTSCWK 173
++++E++ + PF+ + + F+ + +P LS+ +L S
Sbjct: 239 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLN 298
Query: 174 EDPNAR 179
+DP R
Sbjct: 299 KDPKER 304
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 3e-24
Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 14/137 (10%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
V E L+GG L ++ D+ A +A +I ++ LHS GI++RDLK +N+LL +
Sbjct: 96 VMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK 153
Query: 64 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
D IK+ADFG+ +E + T GT ++APE+ + YNH VD +S
Sbjct: 154 D-GHIKIADFGMCKEN-MLGDAKTNTFCGTPDYIAPEIL--------LGQKYNHSVDWWS 203
Query: 122 FAIVLWELLHNKLPFEG 138
F ++L+E+L + PF G
Sbjct: 204 FGVLLYEMLIGQSPFHG 220
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 3e-24
Identities = 49/192 (25%), Positives = 83/192 (43%), Gaps = 29/192 (15%)
Query: 4 VTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 61
V +++GG +R ++ N+ AI + I +E LH II+RDLKPEN+LL
Sbjct: 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL 322
Query: 62 TEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
+D ++++D GLA E + GT +MAPEL + Y+ VD
Sbjct: 323 DDD-GNVRISDLGLAVEL-KAGQTKTKGYAGTPGFMAPELL--------LGEEYDFSVDY 372
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 179
++ + L+E++ + PF + + V A P++ S P ++
Sbjct: 373 FALGVTLYEMIAARGPFRA-RGEKVENKELKQRVLEQAVTYPDKFS----------PASK 421
Query: 180 PNFTQIIQMLLN 191
+ LL
Sbjct: 422 ----DFCEALLQ 429
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-24
Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 5/137 (3%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
V E GG L LL+ + +A + +I A++ +H G +HRD+KP+N+LL
Sbjct: 139 VMEYYVGGDLL-TLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR 197
Query: 64 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
I+LADFG + + + GT +++PE+ V G Y + D ++
Sbjct: 198 CGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGS-YGPECDWWA 255
Query: 122 FAIVLWELLHNKLPFEG 138
+ +E+ + + PF
Sbjct: 256 LGVFAYEMFYGQTPFYA 272
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 8e-24
Identities = 55/215 (25%), Positives = 88/215 (40%), Gaps = 26/215 (12%)
Query: 1 MVIVTELLSGGT--LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 58
M +V E G + + R VC A G+ + +E LHS GI+H+D+KP N
Sbjct: 83 MYMVMEYCVCGMQEMLDSVPEKR---FPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGN 139
Query: 59 LLLTEDLKTIKLADFGLARE-ESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNH 115
LLLT T+K++ G+A T T G+ + PE+ + G
Sbjct: 140 LLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN------GLDTFSGF 192
Query: 116 KVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI----ILTSC 171
KVD +S + L+ + PFEG N+ + +N+ + +P + +L
Sbjct: 193 KVDIWSAGVTLYNITTGLYPFEG-DNIYKLF----ENIGKGSYAIPGDCGPPLSDLLKGM 247
Query: 172 WKEDPNARPNFTQIIQM--LLNYLSAIAPPEPMIP 204
+ +P R + QI Q P P+ P
Sbjct: 248 LEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPP 282
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 8e-24
Identities = 41/138 (29%), Positives = 66/138 (47%), Gaps = 14/138 (10%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
G L KY+ + D + +I A+E LH GIIHRDLKPEN+LL E
Sbjct: 108 GLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE 165
Query: 64 DLKTIKLADFGLARE-ESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
D+ I++ DFG A+ ++ A + GT ++++PEL +K D +
Sbjct: 166 DMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL--------TEKSACKSSDLW 216
Query: 121 SFAIVLWELLHNKLPFEG 138
+ ++++L+ PF
Sbjct: 217 ALGCIIYQLVAGLPPFRA 234
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-23
Identities = 51/193 (26%), Positives = 90/193 (46%), Gaps = 18/193 (9%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLD-VCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 61
+V E G++ + N + L +A +I R + LH H +IHRD+K +N+LL
Sbjct: 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRGLSHLHQHKVIHRDIKGQNVLL 162
Query: 62 TEDLKTIKLADFGLAREESLTEMMTAET---GTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
TE+ + +KL DFG++ + L + GT WMAPE+ + + Y+ K D
Sbjct: 163 TENAE-VKLVDFGVSAQ--LDRTVGRRNTFIGTPYWMAPEV---IACDENPDATYDFKSD 216
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII----LTSCWKE 174
+S I E+ P M ++A + +N P + ++ S + SC +
Sbjct: 217 LWSLGITAIEMAEGAPPLCDMHPMRALFLIP-RNPAPRLK--SKKWSKKFQSFIESCLVK 273
Query: 175 DPNARPNFTQIIQ 187
+ + RP Q+++
Sbjct: 274 NHSQRPATEQLMK 286
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-23
Identities = 46/140 (32%), Positives = 62/140 (44%), Gaps = 13/140 (9%)
Query: 3 IVTELLSGGTL--RKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
IV E GG L R R + L + A+ HS ++H+DLKPEN+L
Sbjct: 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENIL 156
Query: 61 LT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
IK+ DFGLA E T GT +MAPE++ K+ K D
Sbjct: 157 FQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF---------KRDVTFKCD 207
Query: 119 SYSFAIVLWELLHNKLPFEG 138
+S +V++ LL LPF G
Sbjct: 208 IWSAGVVMYFLLTGCLPFTG 227
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-23
Identities = 46/104 (44%), Positives = 66/104 (63%), Gaps = 12/104 (11%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRW 94
+A A++ LHS GII+RDLKPEN+LL E+ IKL DFGL++ ES+ A + GT +
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSK-ESIDHEKKAYSFCGTVEY 192
Query: 95 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
MAPE V R+G + D +SF ++++E+L LPF+G
Sbjct: 193 MAPE----VVNRRG----HTQSADWWSFGVLMFEMLTGTLPFQG 228
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-23
Identities = 46/137 (33%), Positives = 72/137 (52%), Gaps = 14/137 (10%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
V E +GG L +L R R A + +I A+E LHS +++RD+K ENL+L +
Sbjct: 83 VMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK 140
Query: 64 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
D IK+ DFGL +E +++ T +T GT ++APE V Y VD +
Sbjct: 141 D-GHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPE----VLEDND----YGRAVDWWG 190
Query: 122 FAIVLWELLHNKLPFEG 138
+V++E++ +LPF
Sbjct: 191 LGVVMYEMMCGRLPFYN 207
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-23
Identities = 40/104 (38%), Positives = 59/104 (56%), Gaps = 12/104 (11%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRW 94
I+ A+ LH GII+RDLKPEN++L +KL DFGL + ES+ + T GT +
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCK-ESIHDGTVTHTFCGTIEY 187
Query: 95 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
MAPE + +R G +N VD +S +++++L PF G
Sbjct: 188 MAPE----ILMRSG----HNRAVDWWSLGALMYDMLTGAPPFTG 223
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-23
Identities = 46/137 (33%), Positives = 71/137 (51%), Gaps = 14/137 (10%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
V E ++GG L ++ + R D A +A +I A+ LH GII+RDLK +N+LL
Sbjct: 102 VMEFVNGGDLMFHI--QKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDH 159
Query: 64 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
+ KLADFG+ +E + +T T GT ++APE + Y VD ++
Sbjct: 160 E-GHCKLADFGMCKEG-ICNGVTTATFCGTPDYIAPE----ILQEML----YGPAVDWWA 209
Query: 122 FAIVLWELLHNKLPFEG 138
++L+E+L PFE
Sbjct: 210 MGVLLYEMLCGHAPFEA 226
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-23
Identities = 52/193 (26%), Positives = 92/193 (47%), Gaps = 18/193 (9%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLD-VCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 61
I+ E GG + ++ R L + + + A+ LHS IIHRDLK N+L+
Sbjct: 93 IMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLHSKRIIHRDLKAGNVLM 150
Query: 62 TEDLKTIKLADFGLAREESLTEMMT-AET--GTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
T + I+LADFG++ + + + ++ GT WMAPE+ V + Y++K D
Sbjct: 151 TLE-GDIRLADFGVSAK--NLKTLQKRDSFIGTPYWMAPEV---VMCETMKDTPYDYKAD 204
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII----LTSCWKE 174
+S I L E+ + P ++ ++ A K+ P+ P + S+ L +
Sbjct: 205 IWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSDPPTLLT-PSKWSVEFRDFLKIALDK 262
Query: 175 DPNARPNFTQIIQ 187
+P RP+ Q+++
Sbjct: 263 NPETRPSAAQLLE 275
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-23
Identities = 51/137 (37%), Positives = 71/137 (51%), Gaps = 14/137 (10%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
V + ++GG L +L R RC A +A +IA A+ LHS I++RDLKPEN+LL
Sbjct: 117 VLDYINGGELFYHL--QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS 174
Query: 64 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
I L DFGL +E + T T GT ++APE V +Q Y+ VD +
Sbjct: 175 Q-GHIVLTDFGLCKEN-IEHNSTTSTFCGTPEYLAPE----VLHKQP----YDRTVDWWC 224
Query: 122 FAIVLWELLHNKLPFEG 138
VL+E+L+ PF
Sbjct: 225 LGAVLYEMLYGLPPFYS 241
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-23
Identities = 45/145 (31%), Positives = 73/145 (50%), Gaps = 11/145 (7%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
V E + GG L + N + A + ++ A++ +HS G IHRD+KP+N+LL +
Sbjct: 147 VMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK 203
Query: 64 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
+KLADFG + + M+ +T GT +++PE V QG +Y + D +S
Sbjct: 204 SGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE----VLKSQGGDGYYGRECDWWS 258
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAY 146
+ L+E+L PF +L Y
Sbjct: 259 VGVFLYEMLVGDTPFYA-DSLVGTY 282
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-23
Identities = 47/136 (34%), Positives = 70/136 (51%), Gaps = 9/136 (6%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IV EL+ GG L ++ + L + + A++ LH +GIIHRDLKPEN+LL+
Sbjct: 91 IVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 148
Query: 63 --EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
E+ IK+ DFG ++ T +M GT ++APE+ L YN VD +
Sbjct: 149 SQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV-----LVSVGTAGYNRAVDCW 203
Query: 121 SFAIVLWELLHNKLPF 136
S ++L+ L PF
Sbjct: 204 SLGVILFICLSGYPPF 219
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-23
Identities = 46/137 (33%), Positives = 78/137 (56%), Gaps = 14/137 (10%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
V E ++GG L ++ + A+ +A +IA + L S GII+RDLK +N++L
Sbjct: 99 VMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS 156
Query: 64 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
+ IK+ADFG+ + E++ + +T +T GT ++APE + Q Y VD ++
Sbjct: 157 E-GHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAPE----IIAYQP----YGKSVDWWA 206
Query: 122 FAIVLWELLHNKLPFEG 138
F ++L+E+L + PFEG
Sbjct: 207 FGVLLYEMLAGQAPFEG 223
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 6e-23
Identities = 46/147 (31%), Positives = 64/147 (43%), Gaps = 31/147 (21%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR----AMECLHSHGIIHRD 53
IV EL +GG L D + A I + + +H H I+HRD
Sbjct: 98 IVGELYTGGEL-----------FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 54 LKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 111
LKPEN+LL E IK+ DFGL+ M GT ++APE+ +
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL---------RG 197
Query: 112 HYNHKVDSYSFAIVLWELLHNKLPFEG 138
Y+ K D +S ++L+ LL PF G
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPFYG 224
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 9e-23
Identities = 33/151 (21%), Positives = 68/151 (45%), Gaps = 17/151 (11%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIARAMECLHSHGIIHRDLKPENLLL 61
+VT ++ G+ + + ++ +AI + L + +A++ +H G +HR +K ++L+
Sbjct: 103 VVTSFMAYGSAKDLICTHFMDGMNE-LAIAYILQGVLKALDYIHHMGYVHRSVKASHILI 161
Query: 62 TEDLKTIKLADFGLA--------REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 113
+ D + L+ R+ + + W++PE+ L+Q + Y
Sbjct: 162 SVD-GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV-----LQQ-NLQGY 214
Query: 114 NHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 144
+ K D YS I EL + +PF+ M Q
Sbjct: 215 DAKSDIYSVGITACELANGHVPFKDMPATQM 245
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 9e-23
Identities = 39/147 (26%), Positives = 60/147 (40%), Gaps = 31/147 (21%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR----AMECLHSHGIIHRD 53
+V EL +GG L + V A I + A+ H + HRD
Sbjct: 83 LVMELCTGGEL-----------FERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRD 131
Query: 54 LKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 111
LKPEN L +KL DFGLA +MM + GT +++P++ +
Sbjct: 132 LKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL---------EG 182
Query: 112 HYNHKVDSYSFAIVLWELLHNKLPFEG 138
Y + D +S ++++ LL PF
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGYPPFSA 209
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 9e-23
Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 15/167 (8%)
Query: 30 AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK-TIKLADFGLAR-----EESLTE 83
I A+ LH+ GI HRD+KPEN L + + IKL DFGL++
Sbjct: 170 ISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYY 229
Query: 84 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN-- 141
MT + GT ++APE+ L + Y K D++S ++L LL +PF G+++
Sbjct: 230 GMTTKAGTPYFVAPEV-----LN-TTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD 283
Query: 142 -LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 187
+ P+ + +L++ + + R + + +Q
Sbjct: 284 TISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-22
Identities = 46/191 (24%), Positives = 85/191 (44%), Gaps = 13/191 (6%)
Query: 3 IVTELLSGGTLRKY-LLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLL 60
I EL+ + Y + + + + + A+ I +A+E LHS +IHRD+KP N+L
Sbjct: 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVL 142
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
+ +K+ DFG++ L + + + G +MAPE + +K Y+ K D
Sbjct: 143 INAL-GQVKMCDFGISGY--LVDDVAKDIDAGCKPYMAPE----RINPELNQKGYSVKSD 195
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--AENVPEELSIILTSCWKEDP 176
+S I + EL + P++ + P A+ E + C K++
Sbjct: 196 IWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNS 255
Query: 177 NARPNFTQIIQ 187
RP + +++Q
Sbjct: 256 KERPTYPELMQ 266
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-22
Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 20/206 (9%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+ E SGG L + + A F + + LH GI HRD+KPENLLL
Sbjct: 82 LFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139
Query: 63 EDLKTIKLADFGLA---REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-HKVD 118
E +K++DFGLA R + ++ GT ++APEL ++ ++ VD
Sbjct: 140 ER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK--------RREFHAEPVD 190
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN--VRPSAENVPEELSIILTSCWKEDP 176
+S IVL +L +LP++ S+ Y+ + + + +L E+P
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENP 250
Query: 177 NARPNFTQIIQ---MLLNYLSAIAPP 199
+AR I + P
Sbjct: 251 SARITIPDIKKDRWYNKPLKKGAKRP 276
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 95.5 bits (237), Expect = 1e-22
Identities = 46/137 (33%), Positives = 77/137 (56%), Gaps = 14/137 (10%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
V E ++GG L ++ + A+ +A +IA + L S GII+RDLK +N++L
Sbjct: 420 VMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS 477
Query: 64 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
+ IK+ADFG+ +E + + +T +T GT ++APE + Q Y VD ++
Sbjct: 478 E-GHIKIADFGMCKEN-IWDGVTTKTFCGTPDYIAPE----IIAYQP----YGKSVDWWA 527
Query: 122 FAIVLWELLHNKLPFEG 138
F ++L+E+L + PFEG
Sbjct: 528 FGVLLYEMLAGQAPFEG 544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-22
Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 41/217 (18%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLD------VCVAIGFALDIARAMECLHSHGIIHRDLKP 56
+V E L+GG+L + C+D VC + +A+E LHS+ +IHRD+K
Sbjct: 94 VVMEYLAGGSLTDV---VTETCMDEGQIAAVC------RECLQALEFLHSNQVIHRDIKS 144
Query: 57 ENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GTYRWMAPELYSTVTLRQGEKKHY 113
+N+LL D ++KL DFG + +T + + GT WMAPE+ + +K Y
Sbjct: 145 DNILLGMD-GSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYWMAPEVVT--------RKAY 193
Query: 114 NHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS--- 170
KVD +S I+ E++ + P+ + L+A Y A N P +N PE+LS I
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQN-PEKLSAIFRDFLN 251
Query: 171 -CWKEDPNARPNFTQIIQMLLN--YLSAIAPPEPMIP 204
C + D R + + LL +L P + P
Sbjct: 252 RCLEMDVEKRGSAKE----LLQHQFLKIAKPLSSLTP 284
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-22
Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 31/200 (15%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVA-----IGFAL-DIARAMECLHSHGIIHRDLKP 56
+V +LLSGG++ + ++ + I L ++ +E LH +G IHRD+K
Sbjct: 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKA 149
Query: 57 ENLLLTEDLKTIKLADFG----LAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEK 110
N+LL ED ++++ADFG LA +T +T GT WMAPE+ +
Sbjct: 150 GNILLGED-GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME-------QV 201
Query: 111 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII--- 167
+ Y+ K D +SF I EL P+ ++ +N PS E ++ ++
Sbjct: 202 RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL-QNDPPSLETGVQDKEMLKKY 260
Query: 168 -------LTSCWKEDPNARP 180
++ C ++DP RP
Sbjct: 261 GKSFRKMISLCLQKDPEKRP 280
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-22
Identities = 53/193 (27%), Positives = 84/193 (43%), Gaps = 27/193 (13%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E +SGG L Y+ ++ A I A++ H H ++HRDLKPEN+LL
Sbjct: 88 MVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD 145
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-HKVDSYS 121
+ K+ADFGL+ S E + G+ + APE+ S + Y +VD +S
Sbjct: 146 AHMN-AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS--------GRLYAGPEVDIWS 196
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAY----AAAFK---NVRPSAENVPEELSIILTSCWKE 174
++L+ LL LPF+ ++ + F + S + L +L
Sbjct: 197 CGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLNRSVATL---LMHMLQV---- 248
Query: 175 DPNARPNFTQIIQ 187
DP R I +
Sbjct: 249 DPLKRATIKDIRE 261
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-22
Identities = 41/143 (28%), Positives = 61/143 (42%), Gaps = 23/143 (16%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR----AMECLHSHGIIHRD 53
+V +L+ G L D I R + LH I+HRD
Sbjct: 101 LVFDLMKKGEL-----------FDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRD 149
Query: 54 LKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 113
LKPEN+LL +D+ IKL DFG + + E + GT ++APE+ Y
Sbjct: 150 LKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSM--NDNHPGY 206
Query: 114 NHKVDSYSFAIVLWELLHNKLPF 136
+VD +S ++++ LL PF
Sbjct: 207 GKEVDMWSTGVIMYTLLAGSPPF 229
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-22
Identities = 52/212 (24%), Positives = 81/212 (38%), Gaps = 32/212 (15%)
Query: 4 VTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
V + G+L L + L + A A + LH + IHRD+K N+LL
Sbjct: 108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD 167
Query: 63 EDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
E T K++DFGLAR + + T M + GT +MAPE G K D
Sbjct: 168 EAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE-ALR-----G---EITPKSDI 217
Query: 120 YSFAIVLWELLHNKLPFE---GMSNLQAAYAAAFKN--------VRPSAENVPEE----- 163
YSF +VL E++ + L ++ + +
Sbjct: 218 YSFGVVLLEIITGLPAVDEHREPQLL-LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAM 276
Query: 164 LSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195
S+ C E N RP+ ++ Q+L ++
Sbjct: 277 YSVAS-QCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-22
Identities = 43/150 (28%), Positives = 62/150 (41%), Gaps = 31/150 (20%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCV---------AIGFALDIARAMECLHSHGIIH 51
+V++ EL+SGG L D A F I + LH+ I H
Sbjct: 90 VVLILELVSGGEL-----------FDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
Query: 52 RDLKPENLLL---TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 108
DLKPEN++L + IKL DFGLA E GT ++APE+ +
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI-----VNY- 192
Query: 109 EKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
+ + D +S ++ + LL PF G
Sbjct: 193 --EPLGLEADMWSIGVITYILLSGASPFLG 220
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-22
Identities = 42/189 (22%), Positives = 73/189 (38%), Gaps = 10/189 (5%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLL 61
I EL+ + + + + I +A+ L HG+IHRD+KP N+LL
Sbjct: 101 IAMELMGTCAEKLKK--RMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL 158
Query: 62 TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
E + IKL DFG++ + G +MAPE + Y+ + D +S
Sbjct: 159 DERGQ-IKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKP---DYDIRADVWS 214
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP---EELSIILTSCWKEDPNA 178
I L EL + P++ + P + + C +D
Sbjct: 215 LGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRK 274
Query: 179 RPNFTQIIQ 187
RP + ++++
Sbjct: 275 RPKYNKLLE 283
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-22
Identities = 40/150 (26%), Positives = 61/150 (40%), Gaps = 31/150 (20%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCV---------AIGFALDIARAMECLHSHGIIH 51
++++ EL++GG L D A F I + LHS I H
Sbjct: 89 VILILELVAGGEL-----------FDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 52 RDLKPENLLL---TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 108
DLKPEN++L IK+ DFGLA + GT ++APE+ +
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-----VNY- 191
Query: 109 EKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
+ + D +S ++ + LL PF G
Sbjct: 192 --EPLGLEADMWSIGVITYILLSGASPFLG 219
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 2e-22
Identities = 39/135 (28%), Positives = 70/135 (51%), Gaps = 11/135 (8%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
+ +L++GG L +L +A +I +E +H+ +++RDLKP N+LL E
Sbjct: 270 ILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE 327
Query: 64 DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFA 123
++++D GLA + S + + GT+ +MAPE+ L++G Y+ D +S
Sbjct: 328 H-GHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEV-----LQKGVA--YDSSADWFSLG 378
Query: 124 IVLWELLHNKLPFEG 138
+L++LL PF
Sbjct: 379 CMLFKLLRGHSPFRQ 393
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-22
Identities = 43/150 (28%), Positives = 62/150 (41%), Gaps = 31/150 (20%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCV---------AIGFALDIARAMECLHSHGIIH 51
+V++ EL+SGG L D A F I + LH+ I H
Sbjct: 90 VVLILELVSGGEL-----------FDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
Query: 52 RDLKPENLLL---TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 108
DLKPEN++L + IKL DFGLA E GT ++APE+ +
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI-----VNY- 192
Query: 109 EKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138
+ + D +S ++ + LL PF G
Sbjct: 193 --EPLGLEADMWSIGVITYILLSGASPFLG 220
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-22
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 32/211 (15%)
Query: 1 MVIVTELLSGGTLRKYLL--NMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 58
M+++ + + G L+++L ++ + + + AR + LH+ IIHRD+K N
Sbjct: 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSIN 169
Query: 59 LLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 115
+LL E+ K+ DFG+++ E T + T GT ++ PE +
Sbjct: 170 ILLDENF-VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK--------GRLTE 220
Query: 116 KVDSYSFAIVLWELLHNKLPF-----EGMSNLQAAYAAAFKNVRPSAENV---------P 161
K D YSF +VL+E+L + M NL A +A N + V P
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIVQSLPREMVNL-AEWAVESHNNGQLEQIVDPNLADKIRP 279
Query: 162 EELSIILT---SCWKEDPNARPNFTQIIQML 189
E L C RP+ ++ L
Sbjct: 280 ESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-22
Identities = 44/145 (30%), Positives = 62/145 (42%), Gaps = 22/145 (15%)
Query: 1 MVIVTELLSGGTL------RKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDL 54
+V+V E + GG L Y L I F I + +H I+H DL
Sbjct: 161 IVLVMEYVDGGELFDRIIDESYNLTEL-------DTILFMKQICEGIRHMHQMYILHLDL 213
Query: 55 KPENLLL-TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 113
KPEN+L D K IK+ DFGLAR E + GT ++APE+ +
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN--------YDFV 265
Query: 114 NHKVDSYSFAIVLWELLHNKLPFEG 138
+ D +S ++ + LL PF G
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSPFLG 290
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-22
Identities = 54/198 (27%), Positives = 83/198 (41%), Gaps = 33/198 (16%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLD------VCVAIGFALDIARAMECLHSHGIIHRDLKP 56
IV E G++ ++ +R + L + + +E LH IHRD+K
Sbjct: 101 IVMEYCGAGSVSD-IIRLRNKTLTEDEIATIL------QSTLKGLEYLHFMRKIHRDIKA 153
Query: 57 ENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GTYRWMAPELYSTVTLRQGEKKHY 113
N+LL + KLADFG+A + LT+ M GT WMAPE+ + Y
Sbjct: 154 GNILLNTE-GHAKLADFGVAGQ--LTDTMAKRNTVIGTPFWMAPEVIQ--------EIGY 202
Query: 114 NHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII----LT 169
N D +S I E+ K P+ + ++A + N P+ PE S +
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP-TNPPPTFRK-PELWSDNFTDFVK 260
Query: 170 SCWKEDPNARPNFTQIIQ 187
C + P R TQ++Q
Sbjct: 261 QCLVKSPEQRATATQLLQ 278
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-22
Identities = 36/130 (27%), Positives = 51/130 (39%), Gaps = 31/130 (23%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCV---------AIGFALDIARAMECLHSHGIIH 51
+V++ EL+SGG L D A F I + LHS I H
Sbjct: 83 VVLILELVSGGEL-----------FDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAH 131
Query: 52 RDLKPENLLL---TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 108
DLKPEN++L IKL DFG+A + GT ++APE+ +
Sbjct: 132 FDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI-----VNY- 185
Query: 109 EKKHYNHKVD 118
+ + D
Sbjct: 186 --EPLGLEAD 193
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-22
Identities = 47/154 (30%), Positives = 71/154 (46%), Gaps = 12/154 (7%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I+ E + GG L + + A DI A++ LHSH I HRD+KPENLL T
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYT 162
Query: 63 --EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
E +KL DFG A+E + + T T ++APE+ + Y+ D +
Sbjct: 163 SKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVL--------GPEKYDKSCDMW 213
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 154
S ++++ LL PF + QA + +R
Sbjct: 214 SLGVIMYILLCGFPPFYSNTG-QAISPGMKRRIR 246
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-22
Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 22/145 (15%)
Query: 1 MVIVTELLSGGTL------RKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDL 54
MV++ E LSGG L Y ++ I + ++ +H H I+H D+
Sbjct: 123 MVLILEFLSGGELFDRIAAEDYKMSEA-------EVINYMRQACEGLKHMHEHSIVHLDI 175
Query: 55 KPENLLL-TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 113
KPEN++ T+ ++K+ DFGLA + + E++ T T + APE+ +++
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV--------DREPV 227
Query: 114 NHKVDSYSFAIVLWELLHNKLPFEG 138
D ++ ++ + LL PF G
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAG 252
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 4e-22
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 24/217 (11%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E +SGG L Y+ LD + I ++ H H ++HRDLKPEN+LL
Sbjct: 93 MVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD 150
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-HKVDSYS 121
+ K+ADFGL+ S E + G+ + APE+ S + Y +VD +S
Sbjct: 151 AHMN-AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS--------GRLYAGPEVDIWS 201
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI----ILTSCWKEDPN 177
++L+ LL LPF+ ++ + K + P+ L+ +L + DP
Sbjct: 202 SGVILYALLCGTLPFDD-DHVPTLF----KKICDGIFYTPQYLNPSVISLLKHMLQVDPM 256
Query: 178 ARPNFTQIIQ---MLLNYLSAIAPPEPMIPHRIFNSE 211
R I + + + P +P + + E
Sbjct: 257 KRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDE 293
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-22
Identities = 31/120 (25%), Positives = 52/120 (43%), Gaps = 10/120 (8%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
++++ E +GG + L + I I + LH + I+H DLKP+N+L
Sbjct: 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNIL 163
Query: 61 LT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
L+ L IK+ DFG++R+ + GT ++APE+ L D
Sbjct: 164 LSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI-----LNY---DPITTATD 215
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-22
Identities = 56/248 (22%), Positives = 91/248 (36%), Gaps = 25/248 (10%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+ E SGG L + + A F + + LH GI HRD+KPENLLL
Sbjct: 82 LFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139
Query: 63 EDLKTIKLADFGLA---REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-HKVD 118
E +K++DFGLA R + ++ GT ++APEL ++ ++ VD
Sbjct: 140 ER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK--------RREFHAEPVD 190
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN--VRPSAENVPEELSIILTSCWKEDP 176
+S IVL +L +LP++ S+ Y+ + + + +L E+P
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENP 250
Query: 177 NARPNFTQIIQ---MLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRDDIG 233
+AR I + P + S S +
Sbjct: 251 SARITIPDIKKDRWYNKPL-----KKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNS 305
Query: 234 ETPKAKMG 241
+ G
Sbjct: 306 ASRTPGSG 313
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-22
Identities = 41/188 (21%), Positives = 72/188 (38%), Gaps = 20/188 (10%)
Query: 2 VIVTELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
V++ E L ++ L +A F + A+ H+ G++HRD+K EN+L
Sbjct: 124 VLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENIL 181
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-HKVDS 119
+ + +KL DFG T + GT + PE Y+
Sbjct: 182 IDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIR--------YHRYHGRSAAV 232
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 179
+S I+L++++ +PFE + + V E ++ C P+ R
Sbjct: 233 WSLGILLYDMVCGDIPFEHDEEIIRG-----QVFFRQ--RVSSECQHLIRWCLALRPSDR 285
Query: 180 PNFTQIIQ 187
P F +I
Sbjct: 286 PTFEEIQN 293
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 9e-22
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 41/218 (18%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLD------VCVAIGFALDIARAMECLHSHGIIHRDLKP 56
++ E L GG L + L+ VC + +A+ LH+ G+IHRD+K
Sbjct: 119 VLMEFLQGGALTDI---VSQVRLNEEQIATVC------EAVLQALAYLHAQGVIHRDIKS 169
Query: 57 ENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GTYRWMAPELYSTVTLRQGEKKHY 113
+++LLT D +KL+DFG +++ + GT WMAPE+ S + Y
Sbjct: 170 DSILLTLD-GRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVIS--------RSLY 218
Query: 114 NHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII----LT 169
+VD +S I++ E++ + P+ S +QA + P +N ++S + L
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR-DSPPPKLKN-SHKVSPVLRDFLE 276
Query: 170 SCWKEDPNARPNFTQIIQMLLN--YLSAIAPPEPMIPH 205
DP R + LL+ +L PE ++P
Sbjct: 277 RMLVRDPQERATAQE----LLDHPFLLQTGLPECLVPL 310
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-21
Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 23/143 (16%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR----AMECLHSHGIIHRD 53
+V +L+ G L D I R A+ LH++ I+HRD
Sbjct: 177 LVFDLMRKGEL-----------FDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRD 225
Query: 54 LKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 113
LKPEN+LL ++++ I+L+DFG + E + GT ++APE+ Y
Sbjct: 226 LKPENILLDDNMQ-IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSM--DETHPGY 282
Query: 114 NHKVDSYSFAIVLWELLHNKLPF 136
+VD ++ ++L+ LL PF
Sbjct: 283 GKEVDLWACGVILFTLLAGSPPF 305
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-21
Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 25/213 (11%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E +GG L Y++ + + F I A+E H H I+HRDLKPENLLL
Sbjct: 86 MVIEY-AGGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD 142
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-HKVDSYS 121
++L +K+ADFGL+ + + G+ + APE+ + K Y +VD +S
Sbjct: 143 DNLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN--------GKLYAGPEVDVWS 193
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI----ILTSCWKEDPN 177
IVL+ +L +LPF+ + + K V +P+ LS ++ DP
Sbjct: 194 CGIVLYVMLVGRLPFDD-EFIPNLF----KKVNSCVYVMPDFLSPGAQSLIRRMIVADPM 248
Query: 178 ARPNFTQIIQ---MLLNYLSAIAPPEPMIPHRI 207
R +I + +N + P E +
Sbjct: 249 QRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYA 281
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-21
Identities = 47/213 (22%), Positives = 80/213 (37%), Gaps = 33/213 (15%)
Query: 2 VIVTEL-LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
++V E L L Y+ L + F + A++ HS G++HRD+K EN+L
Sbjct: 114 MLVLERPLPAQDLFDYI--TEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENIL 171
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-HKVDS 119
+ KL DFG + GT + PE S + Y+
Sbjct: 172 IDLRRGCAKLIDFGSGALLHDEPYTDFD-GTRVYSPPEWIS--------RHQYHALPATV 222
Query: 120 YSFAIVLWELLHNKLPFEGMSN-LQAAYAAAFKNVRPSAENVPEELSI----ILTSCWKE 174
+S I+L++++ +PFE L+A + P +S ++ C
Sbjct: 223 WSLGILLYDMVCGDIPFERDQEILEAEL------------HFPAHVSPDCCALIRRCLAP 270
Query: 175 DPNARPNFTQIIQ---MLLNYLSAIAPPEPMIP 204
P++RP+ +I+ M P P
Sbjct: 271 KPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGP 303
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-21
Identities = 51/217 (23%), Positives = 80/217 (36%), Gaps = 30/217 (13%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I+ E SGG L + + N R A F + + HS I HRDLK EN LL
Sbjct: 93 IIMEYASGGELYERICN-AGR-FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD 150
Query: 63 EDLKT-IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-HKVDSY 120
+K+ DFG ++ L + GT ++APE+ ++ Y+ D +
Sbjct: 151 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--------RQEYDGKIADVW 202
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR------PSAENVPEE----LSIILTS 170
S + L+ +L PFE Y + + P + E +S I +
Sbjct: 203 SCGVTLYVMLVGAYPFED-PEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVA 261
Query: 171 CWKEDPNARPNFTQIIQ---MLLNYLSAIAPPEPMIP 204
DP R + +I L N + +
Sbjct: 262 ----DPATRISIPEIKTHSWFLKNLPADLMNESNTGS 294
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-21
Identities = 38/139 (27%), Positives = 67/139 (48%), Gaps = 10/139 (7%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
MV++ E +SGG L + + + + + A+ + + + + +H + +H DLKPEN++
Sbjct: 229 MVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIM 287
Query: 61 L-TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
T+ +KL DFGL + + TGT + APE+ E K + D
Sbjct: 288 FTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA--------EGKPVGYYTDM 339
Query: 120 YSFAIVLWELLHNKLPFEG 138
+S ++ + LL PF G
Sbjct: 340 WSVGVLSYILLSGLSPFGG 358
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-21
Identities = 58/183 (31%), Positives = 86/183 (46%), Gaps = 21/183 (11%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIARAMECLHSHGIIHRDLKPENLLL 61
I+ E L GG+ + P LD I L +I + ++ LHS IHRD+K N+LL
Sbjct: 97 IIMEYLGGGSALDL---LEPGPLDE-TQIATILREILKGLDYLHSEKKIHRDIKAANVLL 152
Query: 62 TEDLKTIKLADFGLAREESLTEMMTAET---GTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
+E +KLADFG+A LT+ GT WMAPE V + Y+ K D
Sbjct: 153 SEH-GEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPE----VIKQSA----YDSKAD 201
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE-NVPEELSIILTSCWKEDPN 177
+S I EL + P + ++ + KN P+ E N + L + +C ++P+
Sbjct: 202 IWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACLNKEPS 260
Query: 178 ARP 180
RP
Sbjct: 261 FRP 263
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-21
Identities = 33/208 (15%), Positives = 66/208 (31%), Gaps = 47/208 (22%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E + GG+L++ + + P AI +A A + H G+ P + ++
Sbjct: 108 VVAEWIRGGSLQE-VADTSP---SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS 163
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 122
D + LA + + + D
Sbjct: 164 ID-GDVVLAYPATMPDAN----------------------------------PQDDIRGI 188
Query: 123 AIVLWELLHNKLPFEG---MSNLQAAYAAAFKN-VRPSAEN--VPEELSIILTSCWKEDP 176
L+ LL N+ P S L A + P+ + +P ++S + + D
Sbjct: 189 GASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDG 248
Query: 177 NARPNFTQIIQMLLNYLSAIAPPEPMIP 204
R + L+ +A+A ++
Sbjct: 249 GIRS--ASTLLNLMQQATAVADRTEVLG 274
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 2e-21
Identities = 47/147 (31%), Positives = 71/147 (48%), Gaps = 30/147 (20%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIG---------FALDIARAMECLHSHGIIHRD 53
+V +L++GG L + VA I ++ HS+GI+HR+
Sbjct: 82 LVFDLVTGGEL-----------FEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 130
Query: 54 LKPENLLLTEDLK--TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 111
LKPENLLL K +KLADFGLA E + +E GT +++PE+ L+ K
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV-----LK---KD 182
Query: 112 HYNHKVDSYSFAIVLWELLHNKLPFEG 138
Y+ VD ++ ++L+ LL PF
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPPFWD 209
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-21
Identities = 40/109 (36%), Positives = 55/109 (50%), Gaps = 11/109 (10%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--YRW 94
+ R++ +HS GI HRD+KP+NLLL D +KL DFG A++ E + + YR
Sbjct: 165 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR- 223
Query: 95 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 143
APEL T Y +D +S VL ELL + F G S +
Sbjct: 224 -APELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 264
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-21
Identities = 46/137 (33%), Positives = 70/137 (51%), Gaps = 17/137 (12%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
+ + + GG L L + + VA +A ++ A+E LHS II+RDLKPEN+LL +
Sbjct: 84 IMDYIEGGELFSLL--RKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK 141
Query: 64 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
+ IK+ DFG A+ T GT ++APE V + YN +D +S
Sbjct: 142 N-GHIKITDFGFAKYVP----DVTYTLCGTPDYIAPE----VVSTKP----YNKSIDWWS 188
Query: 122 FAIVLWELLHNKLPFEG 138
F I+++E+L PF
Sbjct: 189 FGILIYEMLAGYTPFYD 205
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-21
Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 63
V E ++GG + +L R A +A I E LHS +I+RDLKPENLL+ +
Sbjct: 119 VMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ 176
Query: 64 DLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
I++ DFG A+ T GT +APE + L +G YN VD ++
Sbjct: 177 Q-GYIQVTDFGFAKRVK----GRTWTLCGTPEALAPE----IILSKG----YNKAVDWWA 223
Query: 122 FAIVLWELLHNKLPFEG 138
++++E+ PF
Sbjct: 224 LGVLIYEMAAGYPPFFA 240
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-21
Identities = 50/157 (31%), Positives = 70/157 (44%), Gaps = 30/157 (19%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR----AMECLHSHGIIHRD 53
+V EL++GG L D V G+ A D + A+ LH +GI+HRD
Sbjct: 125 LVLELVTGGEL-----------FDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRD 173
Query: 54 LKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 111
LKPENLL +K+ADFGL++ +M GT + APE+ LR
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEI-----LR---GC 225
Query: 112 HYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA 148
Y +VD +S I+ + LL PF Q +
Sbjct: 226 AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR 262
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-21
Identities = 37/109 (33%), Positives = 54/109 (49%), Gaps = 11/109 (10%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE--TGTYRW 94
+ R++ +HS GI HRD+KP+NLLL +KL DFG A+ E + + YR
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR- 208
Query: 95 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 143
APEL T +Y +D +S V+ EL+ + F G S +
Sbjct: 209 -APELIFGAT-------NYTTNIDIWSTGCVMAELMQGQPLFPGESGID 249
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 5e-21
Identities = 35/145 (24%), Positives = 62/145 (42%), Gaps = 22/145 (15%)
Query: 1 MVIVTELLSGGTL------RKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDL 54
+V++ E +SG + + LN R + + + A++ LHSH I H D+
Sbjct: 76 LVMIFEFISGLDIFERINTSAFELNER-------EIVSYVHQVCEALQFLHSHNIGHFDI 128
Query: 55 KPENLLL-TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 113
+PEN++ T TIK+ +FG AR+ + + APE+ +
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV-----HQH---DVV 180
Query: 114 NHKVDSYSFAIVLWELLHNKLPFEG 138
+ D +S +++ LL PF
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLA 205
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-21
Identities = 47/193 (24%), Positives = 83/193 (43%), Gaps = 13/193 (6%)
Query: 3 IVTELLSGGTLR--KYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENL 59
I EL+S + KY+ ++ + + L +A+ L IIHRD+KP N+
Sbjct: 98 ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNI 157
Query: 60 LLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
LL IKL DFG++ + + T + G +MAPE ++ Y+ + D
Sbjct: 158 LLDRS-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE----RIDPSASRQGYDVRSDV 212
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE-----ELSIILTSCWKE 174
+S I L+EL + P+ +++ K P N E + C +
Sbjct: 213 WSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTK 272
Query: 175 DPNARPNFTQIIQ 187
D + RP + ++++
Sbjct: 273 DESKRPKYKELLK 285
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 8e-21
Identities = 50/187 (26%), Positives = 81/187 (43%), Gaps = 20/187 (10%)
Query: 3 IVTEL-LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 61
+V E SG L ++ PR LD +A + A+ L IIHRD+K EN+++
Sbjct: 106 LVMEKHGSGLDLFAFIDR-HPR-LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI 163
Query: 62 TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-HKVDSY 120
ED TIKL DFG A ++ GT + APE+ Y +++ +
Sbjct: 164 AEDF-TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM--------GNPYRGPELEMW 214
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
S + L+ L+ + PF L+ AA P V +EL +++ + P R
Sbjct: 215 SLGVTLYTLVFEENPFC---ELEETVEAAIHP--PY--LVSKELMSLVSGLLQPVPERRT 267
Query: 181 NFTQIIQ 187
+++
Sbjct: 268 TLEKLVT 274
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 8e-21
Identities = 46/138 (33%), Positives = 72/138 (52%), Gaps = 15/138 (10%)
Query: 4 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLT 62
V E +GG L +L R R A + +I A++ LHS +++RDLK ENL+L
Sbjct: 226 VMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD 283
Query: 63 EDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
+D IK+ DFGL +E + + T +T GT ++APE+ E Y VD +
Sbjct: 284 KD-GHIKITDFGLCKEG-IKDGATMKTFCGTPEYLAPEVL--------EDNDYGRAVDWW 333
Query: 121 SFAIVLWELLHNKLPFEG 138
+V++E++ +LPF
Sbjct: 334 GLGVVMYEMMCGRLPFYN 351
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 9e-21
Identities = 57/197 (28%), Positives = 86/197 (43%), Gaps = 34/197 (17%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLD------VCVAIGFALDIARAMECLHSHGIIHRDLKP 56
+V E G LL + + L V + + LHSH +IHRD+K
Sbjct: 131 LVMEYCLGSASD--LLEVHKKPLQEVEIAAVT------HGALQGLAYLHSHNMIHRDVKA 182
Query: 57 ENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYN 114
N+LL+E +KL DFG A + M A + GT WMAPE+ + ++ Y+
Sbjct: 183 GNILLSEP-GLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEV-----ILAMDEGQYD 231
Query: 115 HKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII----LTS 170
KVD +S I EL K P M+ + A Y A +N P+ + S + S
Sbjct: 232 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPALQ--SGHWSEYFRNFVDS 288
Query: 171 CWKEDPNARPNFTQIIQ 187
C ++ P RP +++
Sbjct: 289 CLQKIPQDRPTSEVLLK 305
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-20
Identities = 29/107 (27%), Positives = 53/107 (49%), Gaps = 10/107 (9%)
Query: 39 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM-AP 97
+A++ HS GI+HRD+KP N+++ + + ++L D+GLA + + R+ P
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RYFKGP 199
Query: 98 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP-FEGMSNLQ 143
EL + Y++ +D +S +L ++ K P F G N
Sbjct: 200 ELLVDY-------QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 239
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-20
Identities = 47/144 (32%), Positives = 72/144 (50%), Gaps = 24/144 (16%)
Query: 3 IVTELLSGGTL------RKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 56
+V +L++GG L R++ A I ++ HS+GI+HR+LKP
Sbjct: 105 LVFDLVTGGELFEDIVAREFYSEA--------DASHCIQQILESIAYCHSNGIVHRNLKP 156
Query: 57 ENLLLTEDLK--TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 114
ENLLL K +KLADFGLA E + +E GT +++PE+ L+ K Y+
Sbjct: 157 ENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV-----LK---KDPYS 208
Query: 115 HKVDSYSFAIVLWELLHNKLPFEG 138
VD ++ ++L+ LL PF
Sbjct: 209 KPVDIWACGVILYILLVGYPPFWD 232
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-20
Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 32/152 (21%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF---------ALDIARAMECLHSHGIIHRD 53
+VTEL+ GG L LD + F I + +E LH+ G++HRD
Sbjct: 93 VVTELMKGGEL-----------LDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRD 141
Query: 54 LKPENLLLT---EDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGE 109
LKP N+L + ++I++ DFG A++ + ++ T ++APE V RQG
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE----VLERQG- 196
Query: 110 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 141
Y+ D +S ++L+ +L PF +
Sbjct: 197 ---YDAACDIWSLGVLLYTMLTGYTPFANGPD 225
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-20
Identities = 44/142 (30%), Positives = 64/142 (45%), Gaps = 10/142 (7%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IV E L GG L + + + A I A++ LHS I HRD+KPENLL T
Sbjct: 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 195
Query: 63 --EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
+KL DFG A+E + +T T ++APE+ + Y+ D +
Sbjct: 196 SKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--------GPEKYDKSCDMW 247
Query: 121 SFAIVLWELLHNKLPFEGMSNL 142
S ++++ LL PF L
Sbjct: 248 SLGVIMYILLCGYPPFYSNHGL 269
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-20
Identities = 45/147 (30%), Positives = 69/147 (46%), Gaps = 31/147 (21%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF---------ALDIARAMECLHSHGIIHRD 53
+V +L+SGG L D + G + A++ LH +GI+HRD
Sbjct: 83 LVMQLVSGGEL-----------FDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRD 131
Query: 54 LKPENLLL--TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 111
LKPENLL E+ I + DFGL++ E +M+ GT ++APE+ +K
Sbjct: 132 LKPENLLYLTPEENSKIMITDFGLSKMEQ-NGIMSTACGTPGYVAPEVL--------AQK 182
Query: 112 HYNHKVDSYSFAIVLWELLHNKLPFEG 138
Y+ VD +S ++ + LL PF
Sbjct: 183 PYSKAVDCWSIGVITYILLCGYPPFYE 209
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-20
Identities = 42/158 (26%), Positives = 64/158 (40%), Gaps = 33/158 (20%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF---------ALDIARAMECLHSHGIIHRD 53
+V E + GG++ L D+A A++ LH+ GI HRD
Sbjct: 88 LVFEKMRGGSI-----------LSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 54 LKPENLLLT--EDLKTIKLADFGLAR--------EESLTEMMTAETGTYRWMAPELYSTV 103
LKPEN+L + +K+ DF L T + G+ +MAPE+ V
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV---V 193
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 141
E Y+ + D +S ++L+ LL PF G
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-20
Identities = 40/141 (28%), Positives = 64/141 (45%), Gaps = 13/141 (9%)
Query: 3 IVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+V E + G L ++ VA + I A+ H + IIHRD+KP +L
Sbjct: 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVL 162
Query: 61 LT--EDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKV 117
L E+ +KL FG+A + + GT +MAPE+ ++ ++ Y V
Sbjct: 163 LASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV-----VK---REPYGKPV 214
Query: 118 DSYSFAIVLWELLHNKLPFEG 138
D + ++L+ LL LPF G
Sbjct: 215 DVWGCGVILFILLSGCLPFYG 235
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-19
Identities = 44/166 (26%), Positives = 69/166 (41%), Gaps = 33/166 (19%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF---------ALDIARAMECLHSHGIIHRD 53
+V ELL+GG L + + A+ +H G++HRD
Sbjct: 83 LVMELLNGGEL-----------FERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRD 131
Query: 54 LKPENLLLT--EDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 110
LKPENLL T D IK+ DFG AR + + T + APEL L +
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL-----LN---Q 183
Query: 111 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA--FKNVR 154
Y+ D +S ++L+ +L ++PF+ +A K ++
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK 229
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 1e-19
Identities = 43/203 (21%), Positives = 79/203 (38%), Gaps = 20/203 (9%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLL 61
I E + GG+L + L + + ++ + + + L H I+HRD+KP N+L+
Sbjct: 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKV--SIAVIKGLTYLREKHKIMHRDVKPSNILV 165
Query: 62 TEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLR-QGEKKHYNHKVD 118
IKL DFG++ + L + M A + GT +M+PE R QG HY+ + D
Sbjct: 166 NSR-GEIKLCDFGVSGQ--LIDSM-ANSFVGTRSYMSPE-------RLQGT--HYSVQSD 212
Query: 119 SYSFAIVLWELLHNKLPF-EGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPN 177
+S + L E+ + P + + + + D
Sbjct: 213 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSR 272
Query: 178 ARPNFTQIIQMLLNYLSAIAPPE 200
+++ ++N P
Sbjct: 273 PPMAIFELLDYIVNEPPPKLPSG 295
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-19
Identities = 39/109 (35%), Positives = 56/109 (51%), Gaps = 11/109 (10%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--YRW 94
+ RA+ +HS GI HRD+KP+NLL+ T+KL DFG A++ +E A + YR
Sbjct: 150 LFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR- 208
Query: 95 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 143
APEL T Y +D +S V EL+ K F G +++
Sbjct: 209 -APELMLGAT-------EYTPSIDLWSIGCVFGELILGKPLFSGETSID 249
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-19
Identities = 48/133 (36%), Positives = 61/133 (45%), Gaps = 13/133 (9%)
Query: 13 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 72
LR YL P L R ++ LH++ I+HRDLKPEN+L+T T+KLAD
Sbjct: 105 LRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GTVKLAD 163
Query: 73 FGLAREESLTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 130
FGLAR S +T T YR APE+ L Y VD +S + E+
Sbjct: 164 FGLARIYSYQMALTPVVVTLWYR--APEVL----L--QST--YATPVDMWSVGCIFAEMF 213
Query: 131 HNKLPFEGMSNLQ 143
K F G S
Sbjct: 214 RRKPLFCGNSEAD 226
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-19
Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 12/109 (11%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--YRW 94
I + LH G++HRDL P N+LL ++ I + DF LARE++ T YR
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNND-ITICDFNLAREDTADANKTHYVTHRWYR- 200
Query: 95 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 143
APEL + K + VD +S V+ E+ + K F G +
Sbjct: 201 -APELV-------MQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 47/148 (31%), Positives = 70/148 (47%), Gaps = 31/148 (20%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR----AMECLHSHGIIHRD 53
++ +L++GG L + VA + A + A+ H G++HR+
Sbjct: 87 LIFDLVTGGEL-----------FEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRN 135
Query: 54 LKPENLLLTEDLK--TIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 110
LKPENLLL LK +KLADFGLA E E + GT +++PE+ LR K
Sbjct: 136 LKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV-----LR---K 187
Query: 111 KHYNHKVDSYSFAIVLWELLHNKLPFEG 138
Y VD ++ ++L+ LL PF
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYPPFWD 215
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-19
Identities = 45/138 (32%), Positives = 64/138 (46%), Gaps = 23/138 (16%)
Query: 13 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 72
L YL + + + R ++ LHSH ++HRDLKP+N+L+T IKLAD
Sbjct: 105 LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLAD 163
Query: 73 FGLAREESLTEMMTAETGT--YRWMAPEL-----YSTVTLRQGEKKHYNHKVDSYSFAIV 125
FGLAR S +T+ T YR APE+ Y+T VD +S +
Sbjct: 164 FGLARIYSFQMALTSVVVTLWYR--APEVLLQSSYAT-------------PVDLWSVGCI 208
Query: 126 LWELLHNKLPFEGMSNLQ 143
E+ K F G S++
Sbjct: 209 FAEMFRRKPLFRGSSDVD 226
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-18
Identities = 36/105 (34%), Positives = 53/105 (50%), Gaps = 11/105 (10%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM- 95
+ ++ LHS GIIHRDLKP N+++ D +K+ DFGLAR + MMT T R+
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVT-RYYR 193
Query: 96 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 140
APE+ Y VD +S ++ E++ + F G
Sbjct: 194 APEVILG--------MGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-18
Identities = 38/106 (35%), Positives = 55/106 (51%), Gaps = 13/106 (12%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--YRW 94
+ ++ LHS GIIHRDLKP N+++ D +K+ DFGLAR + MMT T YR
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTRYYR- 230
Query: 95 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 140
APE+ Y VD +S ++ E++ +K+ F G
Sbjct: 231 -APEVILG--------MGYKENVDIWSVGCIMGEMVRHKILFPGRD 267
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-18
Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 13/110 (11%)
Query: 37 IARAMECLH--SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--Y 92
+ R++ CLH S + HRD+KP N+L+ E T+KL DFG A++ S +E A + Y
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYY 197
Query: 93 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 142
R APEL HY VD +S + E++ + F G ++
Sbjct: 198 R--APELIFGNQ-------HYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 4e-18
Identities = 40/135 (29%), Positives = 60/135 (44%), Gaps = 14/135 (10%)
Query: 12 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 71
T+ L + R + + +A+ H H IHRD+KPEN+L+T+ IKL
Sbjct: 87 TVLHEL-DRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH-SVIKLC 144
Query: 72 DFGLAREESL-TEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWE 128
DFG AR + ++ E T YR +PEL + Y VD ++ V E
Sbjct: 145 DFGFARLLTGPSDYYDDEVATRWYR--SPELL----VGD---TQYGPPVDVWAIGCVFAE 195
Query: 129 LLHNKLPFEGMSNLQ 143
LL + G S++
Sbjct: 196 LLSGVPLWPGKSDVD 210
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 4e-18
Identities = 44/134 (32%), Positives = 64/134 (47%), Gaps = 14/134 (10%)
Query: 13 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 72
L+K L + L + + R + H H I+HRDLKP+NLL+ D +KLAD
Sbjct: 105 LKKVLDENKTG-LQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD-GALKLAD 162
Query: 73 FGLAREESL-TEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 129
FGLAR + T E T YR AP++ L K Y+ VD +S + E+
Sbjct: 163 FGLARAFGIPVRSYTHEVVTLWYR--APDV-----LMGS--KKYSTSVDIWSIGCIFAEM 213
Query: 130 LHNKLPFEGMSNLQ 143
+ K F G+++
Sbjct: 214 ITGKPLFPGVTDDD 227
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 5e-18
Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 32/179 (17%)
Query: 34 ALDIARAMECLHSHG---IIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAE 88
AL AR + LH H IIHRD+K N+LL E+ + DFGLA+ + T + TA
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTHVTTAV 195
Query: 89 TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA 148
GT +APE ST G + K D + + ++L EL+ + F+
Sbjct: 196 RGTIGHIAPEYLST-----G---KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247
Query: 149 AFKNVRPSAEN---------------VPEELSIILT---SCWKEDPNARPNFTQIIQML 189
V+ + EE+ ++ C + P RP +++++ML
Sbjct: 248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 80.2 bits (199), Expect = 5e-18
Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 14/134 (10%)
Query: 13 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 72
L+K L L+ A F L + + H ++HRDLKP+NLL+ + +K+AD
Sbjct: 86 LKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIAD 143
Query: 73 FGLAREESL-TEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 129
FGLAR + T E T YR AP++ L K Y+ +D +S + E+
Sbjct: 144 FGLARAFGIPVRKYTHEIVTLWYR--APDV-----LMGS--KKYSTTIDIWSVGCIFAEM 194
Query: 130 LHNKLPFEGMSNLQ 143
++ F G+S
Sbjct: 195 VNGTPLFPGVSEAD 208
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 6e-18
Identities = 41/135 (30%), Positives = 63/135 (46%), Gaps = 15/135 (11%)
Query: 13 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 72
L+KY + LD + F + + + HS ++HRDLKP+NLL+ + +KLA+
Sbjct: 87 LKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLAN 144
Query: 73 FGLAREESL-TEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 129
FGLAR + +AE T YR P++ L K Y+ +D +S + EL
Sbjct: 145 FGLARAFGIPVRCYSAEVVTLWYR--PPDV-----LFGA--KLYSTSIDMWSAGCIFAEL 195
Query: 130 LHNKLP-FEGMSNLQ 143
+ P F G
Sbjct: 196 ANAGRPLFPGNDVDD 210
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-17
Identities = 42/108 (38%), Positives = 57/108 (52%), Gaps = 12/108 (11%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW-M 95
I R ++ +HS IIHRDLKP NL + ED + +K+ DFGLAR + MT T RW
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR--HTADEMTGYVAT-RWYR 196
Query: 96 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 143
APE+ HYN VD +S ++ ELL + F G ++
Sbjct: 197 APEIMLNW-------MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 237
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-17
Identities = 37/100 (37%), Positives = 49/100 (49%), Gaps = 13/100 (13%)
Query: 12 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 71
T+ L + P LD V + I + HSH IIHRD+KPEN+L+++ +KL
Sbjct: 109 TILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS-GVVKLC 166
Query: 72 DFGLAREESL-TEMMTAETGT--YRWMAPEL------YST 102
DFG AR + E+ E T YR APEL Y
Sbjct: 167 DFGFARTLAAPGEVYDDEVATRWYR--APELLVGDVKYGK 204
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-17
Identities = 38/108 (35%), Positives = 56/108 (51%), Gaps = 12/108 (11%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM- 95
+ + + +H+ GIIHRDLKP NL + ED + +K+ DFGLAR+ MT T RW
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQAD--SEMTGYVVT-RWYR 192
Query: 96 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 143
APE+ Y VD +S ++ E++ K F+G +L
Sbjct: 193 APEVI-------LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 233
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-17
Identities = 40/113 (35%), Positives = 55/113 (48%), Gaps = 16/113 (14%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGT- 91
I R ++ +HS ++HRDLKP NLLL +K+ DFGLAR + T +T T
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 92 -YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 143
YR APE+ K Y +D +S +L E+L N+ F G L
Sbjct: 196 WYR--APEIM-------LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 239
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-17
Identities = 40/108 (37%), Positives = 57/108 (52%), Gaps = 12/108 (11%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW-M 95
+ + ++ +HS G++HRDLKP NL + ED + +K+ DFGLAR MT T RW
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCE-LKILDFGLARHAD--AEMTGYVVT-RWYR 190
Query: 96 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 143
APE+ HYN VD +S ++ E+L K F+G L
Sbjct: 191 APEVI-------LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 231
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-17
Identities = 32/113 (28%), Positives = 52/113 (46%), Gaps = 15/113 (13%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGT- 91
+ R ++ +HS ++HRDLKP NL + + +K+ DFGLAR S ++ T
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 92 -YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 143
YR +P L +Y +D ++ + E+L K F G L+
Sbjct: 189 WYR--SPRLL-------LSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE 232
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-17
Identities = 44/138 (31%), Positives = 64/138 (46%), Gaps = 18/138 (13%)
Query: 13 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT----I 68
L+KY+ + + V F + + HS +HRDLKP+NLLL+ + +
Sbjct: 119 LKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVL 176
Query: 69 KLADFGLAREESL-TEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIV 125
K+ DFGLAR + T E T YR PE+ L G +HY+ VD +S A +
Sbjct: 177 KIGDFGLARAFGIPIRQFTHEIITLWYR--PPEIL----L--GS-RHYSTSVDIWSIACI 227
Query: 126 LWELLHNKLPFEGMSNLQ 143
E+L F G S +
Sbjct: 228 WAEMLMKTPLFPGDSEID 245
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 14/134 (10%)
Query: 13 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 72
L++YL + +++ F + R + H ++HRDLKP+NLL+ E +KLAD
Sbjct: 86 LKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER-GELKLAD 143
Query: 73 FGLAREESL-TEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 129
FGLAR +S+ T+ E T YR P++ L Y+ ++D + + +E+
Sbjct: 144 FGLARAKSIPTKTYDNEVVTLWYR--PPDI-----LLGS--TDYSTQIDMWGVGCIFYEM 194
Query: 130 LHNKLPFEGMSNLQ 143
+ F G + +
Sbjct: 195 ATGRPLFPGSTVEE 208
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-16
Identities = 41/138 (29%), Positives = 72/138 (52%), Gaps = 17/138 (12%)
Query: 13 LRKYL----LNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 68
L+KY+ + PR L++ + F + + + H + I+HRDLKP+NLL+ + +
Sbjct: 89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR-GQL 147
Query: 69 KLADFGLAREESL-TEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIV 125
KL DFGLAR + ++E T YR AP++ + G + Y+ +D +S +
Sbjct: 148 KLGDFGLARAFGIPVNTFSSEVVTLWYR--APDVL----M--GS-RTYSTSIDIWSCGCI 198
Query: 126 LWELLHNKLPFEGMSNLQ 143
L E++ K F G ++ +
Sbjct: 199 LAEMITGKPLFPGTNDEE 216
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-16
Identities = 31/78 (39%), Positives = 39/78 (50%), Gaps = 2/78 (2%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IV E L GG L + + + A I A++ LHS I HRD+KPENLL T
Sbjct: 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 151
Query: 63 --EDLKTIKLADFGLARE 78
+KL DFG A+E
Sbjct: 152 SKRPNAILKLTDFGFAKE 169
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-16
Identities = 36/117 (30%), Positives = 49/117 (41%), Gaps = 23/117 (19%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-----------EESLTEMM 85
RA++ LH +IHRDLKP NLL+ + +K+ DFGLAR M
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSNLLINSNCD-LKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 86 TAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 140
T YR APE+ Y+ +D +S +L EL + F G
Sbjct: 180 VEFVATRWYR--APEVM-------LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-16
Identities = 43/108 (39%), Positives = 55/108 (50%), Gaps = 13/108 (12%)
Query: 39 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT--YRWM 95
+ +E LH H I+HRDLKP NLLL E+ +KLADFGLA+ T + T YR
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYR-- 179
Query: 96 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 143
APEL L + Y VD ++ +L ELL G S+L
Sbjct: 180 APEL-----LFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 220
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 9e-15
Identities = 33/112 (29%), Positives = 53/112 (47%), Gaps = 20/112 (17%)
Query: 39 RAMECLHSHGIIHRDLKPENLLLTEDLK---TIKLADFGLARE-----ESLTEMMTAETG 90
+ LH++ ++HRDLKP N+L+ + +K+AD G AR + L + +
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD-LDPVVV 197
Query: 91 T--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 140
T YR APEL L G +HY +D ++ + ELL ++ F
Sbjct: 198 TFWYR--APELL----L--GA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-14
Identities = 37/138 (26%), Positives = 57/138 (41%), Gaps = 18/138 (13%)
Query: 13 LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 72
L L N+ + + + + +H + I+HRD+K N+L+T D +KLAD
Sbjct: 110 LAGLLSNVLVK-FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLAD 167
Query: 73 FGLARE-----ESLTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIV 125
FGLAR S T T YR PEL L GE + Y +D + +
Sbjct: 168 FGLARAFSLAKNSQPNRYTNRVVTLWYR--PPELL----L--GE-RDYGPPIDLWGAGCI 218
Query: 126 LWELLHNKLPFEGMSNLQ 143
+ E+ +G +
Sbjct: 219 MAEMWTRSPIMQGNTEQH 236
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 42/144 (29%), Positives = 65/144 (45%), Gaps = 12/144 (8%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ + ELLS L + + + + + + FA I + ++ LH + IIH DLKPEN+L
Sbjct: 174 ICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENIL 232
Query: 61 LTEDLKT-IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
L + ++ IK+ DFG + E ++ YR APE V L Y +D
Sbjct: 233 LKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYR--APE----VILGAR----YGMPIDM 282
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQ 143
+S +L ELL G
Sbjct: 283 WSLGCILAELLTGYPLLPGEDEGD 306
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 1e-14
Identities = 28/105 (26%), Positives = 46/105 (43%), Gaps = 15/105 (14%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMA 96
+ ++ +HS GI+HRDLKP N L+ +D ++K+ DFGLAR E ++
Sbjct: 165 LLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 97 PELYSTVTLRQGEKKHYNHKV--------------DSYSFAIVLW 127
T + K+ V ++Y+ AI +W
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVW 268
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-14
Identities = 36/128 (28%), Positives = 56/128 (43%), Gaps = 34/128 (26%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR------------------- 77
+ + ++ LHS G++HRD+KP N+LL + +K+ADFGL+R
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 78 ---EESLTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN 132
+ ++T T YR APE+ Y +D +S +L E+L
Sbjct: 177 TENFDDDQPILTDYVATRWYR--APEILLGS-------TKYTKGIDMWSLGCILGEILCG 227
Query: 133 KLPFEGMS 140
K F G S
Sbjct: 228 KPIFPGSS 235
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 8e-14
Identities = 40/144 (27%), Positives = 65/144 (45%), Gaps = 17/144 (11%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENL 59
+V+V E+L G L + R + + + + ++ +H GIIH D+KPEN+
Sbjct: 105 VVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV 163
Query: 60 LLT-----EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 114
L+ E+L IK+AD G A + +T YR +PE V L +
Sbjct: 164 LMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR--SPE----VLLGAP----WG 213
Query: 115 HKVDSYSFAIVLWELLHNKLPFEG 138
D +S A +++EL+ FE
Sbjct: 214 CGADIWSTACLIFELITGDFLFEP 237
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-13
Identities = 52/211 (24%), Positives = 86/211 (40%), Gaps = 35/211 (16%)
Query: 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 61
V+V ELL G +L + L N R + + A + +E +HS IHRD+KP+N L+
Sbjct: 81 VMVMELL-GPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLM 138
Query: 62 --TEDLKTIKLADFGLARE--ESLTEMMTAE------TGTYRWMAPELYSTVTLRQGEKK 111
+ + + DFGLA++ ++ T TGT R+ S T
Sbjct: 139 GLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA-----SINT------- 186
Query: 112 HYNH----KVDSYSFAIVLWELLHNKLPFEGM--SNLQAAYA--AAFKNVRPSAE---NV 160
H + D S VL LP++G+ + + Y + K P
Sbjct: 187 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 246
Query: 161 PEELSIILTSCWKEDPNARPNFTQIIQMLLN 191
P E + L C + +P+++ + Q+ N
Sbjct: 247 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 4e-13
Identities = 36/119 (30%), Positives = 52/119 (43%), Gaps = 35/119 (29%)
Query: 37 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR------------------- 77
+ +H GIIHRDLKP N LL +D +K+ DFGLAR
Sbjct: 138 LLLGENFIHESGIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 78 ----EESLTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 130
++L + +T+ T YR APEL +++Y +D +S + ELL
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYR--APELILL-------QENYTKSIDIWSTGCIFAELL 246
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-12
Identities = 41/146 (28%), Positives = 67/146 (45%), Gaps = 14/146 (9%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--GIIHRDLKPEN 58
+ +V E+LS L L N R + + + FA + A+ L + IIH DLKPEN
Sbjct: 131 LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPEN 189
Query: 59 LLLTEDLKT-IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKV 117
+LL ++ IK+ DFG + + ++ YR +PE V L Y+ +
Sbjct: 190 ILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SPE----VLLGMP----YDLAI 239
Query: 118 DSYSFAIVLWELLHNKLPFEGMSNLQ 143
D +S +L E+ + F G + +
Sbjct: 240 DMWSLGCILVEMHTGEPLFSGANEVD 265
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-12
Identities = 45/213 (21%), Positives = 85/213 (39%), Gaps = 37/213 (17%)
Query: 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 61
V+V +LL G +L + LL++ R V A + ++ +H +++RD+KP+N L+
Sbjct: 82 VLVIDLL-GPSL-EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI 139
Query: 62 ----TEDLKTIKLADFGLARE--ESLTEMMTAE------TGTYRWMAPELYSTVTLRQGE 109
+++ I + DFG+ + + +T+ +GT R+M S T
Sbjct: 140 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM-----SINT----- 189
Query: 110 KKHYNH----KVDSYSFAIVLWELLHNKLPFEGM--SNLQAAYA--AAFKNVRPSAE--- 158
H + D + V L LP++G+ + + Y K P E
Sbjct: 190 --HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 247
Query: 159 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191
PEE + +A P++ + +
Sbjct: 248 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-11
Identities = 39/215 (18%), Positives = 71/215 (33%), Gaps = 37/215 (17%)
Query: 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 61
++ + G L+K + + + +L I +E +H H +H D+K NLLL
Sbjct: 128 FMIMDRF-GSDLQK-IYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL 185
Query: 62 -TEDLKTIKLADFGLARE----ESLTEMMTAE----TGTYRWMAPELYSTVTLRQGEKKH 112
++ + L D+GLA GT + S H
Sbjct: 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT-----SIDA-------H 233
Query: 113 YNH----KVDSYSFAIVLWELLHNKLPFEGM--SNLQAAYA--------AAFKNVRPSAE 158
+ D + + L LP+E + A+ + A
Sbjct: 234 NGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAA 293
Query: 159 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 193
N P E++ + + D +P + + +LL L
Sbjct: 294 NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-11
Identities = 27/81 (33%), Positives = 45/81 (55%), Gaps = 6/81 (7%)
Query: 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 61
+V ELL G +L + L ++ R + + A+ + ME +HS +I+RD+KPEN L+
Sbjct: 81 AMVLELL-GPSL-EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI 138
Query: 62 ----TEDLKTIKLADFGLARE 78
+ + I + DF LA+E
Sbjct: 139 GRPGNKTQQVIHIIDFALAKE 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 6e-11
Identities = 48/213 (22%), Positives = 84/213 (39%), Gaps = 39/213 (18%)
Query: 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 61
V+V +LL G +L + L N R L + + A + +E +HS +HRD+KP+N L+
Sbjct: 79 VLVMDLL-GPSL-EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136
Query: 62 --TEDLKTIKLADFGLAREESLTEMMTAE----------TGTYRWMAPELYSTVTLRQGE 109
+ + DFGLA++ + T + TGT R+ S T
Sbjct: 137 GLGRRANQVYIIDFGLAKK--YRDTSTHQHIPYRENKNLTGTARYA-----SVNT----- 184
Query: 110 KKHYNH----KVDSYSFAIVLWELLHNKLPFEGM--SNLQAAYA--AAFKNVRPSAE--- 158
H + D S VL L LP++G+ + Y + K
Sbjct: 185 --HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCR 242
Query: 159 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191
P E + C + +P+++ + ++ +
Sbjct: 243 GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-10
Identities = 20/78 (25%), Positives = 34/78 (43%), Gaps = 2/78 (2%)
Query: 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 61
+V L G +L+ L L + A + A+E LH + +H ++ EN+ +
Sbjct: 134 FLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192
Query: 62 -TEDLKTIKLADFGLARE 78
ED + LA +G A
Sbjct: 193 DPEDQSQVTLAGYGFAFR 210
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-10
Identities = 39/161 (24%), Positives = 57/161 (35%), Gaps = 29/161 (18%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
M I ELL G ++L + + A + A+ LH + + H DLKPEN+L
Sbjct: 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENIL 155
Query: 61 LTEDLKT------------------IKLADFGLAREESLTEMMTAETGTYRWMAPELYST 102
I++ADFG A + T YR PE
Sbjct: 156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYR--PPE---- 209
Query: 103 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 143
V L G + D +S +L+E F+ N +
Sbjct: 210 VILELG----WAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-10
Identities = 14/46 (30%), Positives = 26/46 (56%), Gaps = 1/46 (2%)
Query: 34 ALDIARAMECLHSHGIIHRDLKPENLLL-TEDLKTIKLADFGLARE 78
+ + +E +H + +H D+K NLLL ++ + LAD+GL+
Sbjct: 157 GIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-10
Identities = 40/161 (24%), Positives = 60/161 (37%), Gaps = 29/161 (18%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ IV ELL G + ++ + A I +++ LHS+ + H DLKPEN+L
Sbjct: 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENIL 150
Query: 61 LTEDLKT------------------IKLADFGLAREESLTEMMTAETGTYRWMAPELYST 102
+ T IK+ DFG A + T YR APE
Sbjct: 151 FVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR--APE---- 204
Query: 103 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 143
V L G ++ D +S +L E F + +
Sbjct: 205 VILALG----WSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 9e-10
Identities = 40/192 (20%), Positives = 66/192 (34%), Gaps = 60/192 (31%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENL 59
+ +V E+L G L K+++ + L + + + ++ LH+ IIH D+KPEN+
Sbjct: 120 ICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENI 178
Query: 60 LLT------------------------------------------------EDLKTIKLA 71
LL+ + +K+A
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 72 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH 131
D G A +T YR + E V + G YN D +S A + +EL
Sbjct: 239 DLGNACWVHKHFTEDIQTRQYR--SLE----VLIGSG----YNTPADIWSTACMAFELAT 288
Query: 132 NKLPFEGMSNLQ 143
FE S +
Sbjct: 289 GDYLFEPHSGEE 300
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-09
Identities = 43/169 (25%), Positives = 66/169 (39%), Gaps = 39/169 (23%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
M ++ E L G +L + + + + ++I +A+ L + H DLKPEN+L
Sbjct: 111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENIL 169
Query: 61 LTEDLKT------------------------IKLADFGLAREESLTEMMTA--ETGTYRW 94
L + IKL DFG A +S + + T YR
Sbjct: 170 LDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYR- 226
Query: 95 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 143
APE V L G ++ D +SF VL EL L F +++
Sbjct: 227 -APE----VILNLG----WDVSSDMWSFGCVLAELYTGSLLFRTHEHME 266
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 2e-04
Identities = 19/77 (24%), Positives = 27/77 (35%), Gaps = 5/77 (6%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-SHGIIHRDLKPENLLL 61
IV E GG L MR + + A + ++ S HRDL N+LL
Sbjct: 139 IVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 62 TEDLKTIKLADFGLARE 78
+ KL +
Sbjct: 196 KKT-SLKKLHYTLNGKS 211
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 19/83 (22%), Positives = 33/83 (39%), Gaps = 13/83 (15%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
I+ ++G + + + + +G LH + +IH DL N +
Sbjct: 414 KRIMMSYINGKLAKDVIEDNLDIAYKIGEIVG----------KLHKNDVIHNDLTTSNFI 463
Query: 61 LTEDLKTIKLADFGLAREESLTE 83
+DL I DFGL + +L E
Sbjct: 464 FDKDLYII---DFGLGKISNLDE 483
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 3e-04
Identities = 39/261 (14%), Positives = 80/261 (30%), Gaps = 56/261 (21%)
Query: 3 IVTELLSGGTLR----KYLLNMR-PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLK-P 56
I+ E + G K++ + ++ + L+ A + + P
Sbjct: 332 IIAESIRDGLATWDNWKHVNCDKLTTIIESSLN---VLEPAEYRKMFDRLSVFPPSAHIP 388
Query: 57 ENLL-------LTEDLKTI--KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQ 107
LL + D+ + KL + L ++ + T P +Y +
Sbjct: 389 TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQP-------KESTIS--IPSIYL-ELKVK 438
Query: 108 GEKKHYNHK--VDSYSFAIVLWELLHNKLPFEGMSNLQA-AYAAAF-----KNVRPSAEN 159
E ++ H+ VD Y+ + + + Y + KN+ E
Sbjct: 439 LENEYALHRSIVDHYN--------IPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEH-PER 489
Query: 160 VPEELSIILTSCWKE--------DPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSE 211
+ + L + E NA + +Q L Y I +P R+ N+
Sbjct: 490 MTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDP-KYERLVNAI 548
Query: 212 NTILPPESPGTSSLMTVRDDI 232
LP + + + D+
Sbjct: 549 LDFLP--KIEENLICSKYTDL 567
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 255 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.98 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.7 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.54 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.34 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.81 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.79 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.64 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.53 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.35 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.28 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.05 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.85 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.53 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.46 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.77 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.74 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.73 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.05 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.82 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.02 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 94.4 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 93.21 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 93.04 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 92.52 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 91.32 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 91.23 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 90.45 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.5 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.4 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 86.02 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 83.94 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 81.6 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=346.32 Aligned_cols=179 Identities=29% Similarity=0.463 Sum_probs=160.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|||||||+||+|.++|...+...+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLN 176 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTT-CCEEECSTTEESCCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-CCEEEcccccceeec
Confidence 5899999999999999987766668999999999999999999999999999999999999988 799999999998654
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
.. ....+.+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+..+...++......+....
T Consensus 177 ~~~~~~~~~~GT~~YmAPE~l~~--------~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~ 248 (350)
T 4b9d_A 177 STVELARACIGTPYYLSPEICEN--------KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLH 248 (350)
T ss_dssp HHHHHHHHHHSCCTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred CCcccccccCCCccccCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCcc
Confidence 43 23456789999999999853 5689999999999999999999999999888777777777666667788
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+|+++.+||.+||++||++|||+.|++++
T Consensus 249 ~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 249 YSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999999999986
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=330.98 Aligned_cols=186 Identities=31% Similarity=0.533 Sum_probs=153.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++||||||+||+|.++|..... .+++.+++.++.||+.||+|||+++|+||||||+|||++++ +.+||+|||+|+...
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~-~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEG-LTVKIGDFGLATVKS 183 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETT-EEEEECCCSSCBC--
T ss_pred EEEEEEcCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCC-CcEEEeeccCceecc
Confidence 5899999999999999986543 39999999999999999999999999999999999999998 699999999998543
Q ss_pred c---ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-CCC-
Q 025244 81 L---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN-VRP- 155 (255)
Q Consensus 81 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~- 155 (255)
. .....+.+||+.|||||++.+. ....|+.++|||||||++|||+||+.||.+.+............ ..|
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~-----~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~ 258 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQ-----DNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD 258 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCC-----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC
T ss_pred cCCcceeecccccCCCccCHHHhhcc-----CCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC
Confidence 2 2234567899999999998531 23468999999999999999999999999877665555444333 222
Q ss_pred ---CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 025244 156 ---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 193 (255)
Q Consensus 156 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~ 193 (255)
....+|+++.+||.+||+.||++|||+.|++++|+.+.
T Consensus 259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 24578999999999999999999999999999987654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-50 Score=336.49 Aligned_cols=187 Identities=23% Similarity=0.264 Sum_probs=156.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|||||||+||+|.++|.+.+. +++.++..++.||+.||+|||++||+||||||+|||++.++..+||+|||+|+...
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred EEEEEeccCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 4899999999999999987654 99999999999999999999999999999999999999883369999999998643
Q ss_pred ccc------ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC
Q 025244 81 LTE------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 154 (255)
Q Consensus 81 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 154 (255)
... .....+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+....+......
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~--------~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~ 274 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMG--------KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP 274 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG
T ss_pred CCCcccceecCCccccCccccCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC
Confidence 322 1234679999999999853 56889999999999999999999999876655544444443321
Q ss_pred --CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcC
Q 025244 155 --PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 197 (255)
Q Consensus 155 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~ 197 (255)
..+..+++++.++|.+||++||.+|||+.|++++|...+....
T Consensus 275 ~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 2356899999999999999999999999999999988876543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=330.10 Aligned_cols=186 Identities=29% Similarity=0.513 Sum_probs=162.6
Q ss_pred CEEEEecCCCCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceE
Q 025244 1 MVIVTELLSGGTLRKYLLNMR-----------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 69 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~-----------~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~k 69 (255)
++||||||+||+|.++|.+++ ...+++.+++.++.||+.||+|||+++|+||||||+|||++.+ +.+|
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~-~~~K 168 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN-LLVK 168 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC-CcEE
Confidence 489999999999999998643 3459999999999999999999999999999999999999998 6999
Q ss_pred EecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHH
Q 025244 70 LADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAA 145 (255)
Q Consensus 70 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~ 145 (255)
|+|||+|+...... ......||+.|||||++.+ ..++.++|||||||++|||+| |+.||.+.+..+..
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--------~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~ 240 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 240 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcC--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999998543322 2233468999999999863 678999999999999999998 89999998887777
Q ss_pred HHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 146 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
..+......+.+..+|+++.+||.+||+.||++|||+.++++.|++....
T Consensus 241 ~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 241 ECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 77666666667788999999999999999999999999999999887654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=336.09 Aligned_cols=181 Identities=28% Similarity=0.461 Sum_probs=154.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|||||||+||+|.+++.+. .+++.++..++.||+.||+|||++||+||||||+|||++.+ |.+||+|||+|+...
T Consensus 146 ~~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVS 221 (346)
T ss_dssp EEEEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECC
T ss_pred EEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCC-CCEEEecCcCceecC
Confidence 58999999999999999763 29999999999999999999999999999999999999988 799999999998654
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC--CCC
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSA 157 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~ 157 (255)
. .....+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+....+...... +..
T Consensus 222 ~~~~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~ 293 (346)
T 4fih_A 222 KEVPRRKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNL 293 (346)
T ss_dssp SSSCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCG
T ss_pred CCCCcccccccCcCcCCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCcc
Confidence 3 334567899999999999853 56899999999999999999999999987766655544433221 224
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
..+++++++||.+||+.||++|||+.|+++| .++..
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H--p~~~~ 329 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH--PFLAK 329 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC--GGGGG
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC--HhhcC
Confidence 5689999999999999999999999999987 44443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=327.71 Aligned_cols=176 Identities=29% Similarity=0.575 Sum_probs=151.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
++||||||+||+|.++|.+.+. +++..+..++.||+.||+|||++| |+||||||+|||++...+.+||+|||+|+.
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 4899999999999999987654 999999999999999999999998 999999999999986337999999999985
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC--
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-- 156 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 156 (255)
... ....+.+||+.|||||++. +.|+.++|||||||++|||++|+.||.+................+.
T Consensus 182 ~~~-~~~~~~~GTp~YmAPE~~~---------~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~ 251 (290)
T 3fpq_A 182 KRA-SFAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 251 (290)
T ss_dssp CCT-TSBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG
T ss_pred CCC-CccCCcccCccccCHHHcC---------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCC
Confidence 433 3345679999999999874 3488999999999999999999999988776666665555444332
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...+++++.+||.+||+.||++|||+.|+++|
T Consensus 252 ~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 252 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 45678899999999999999999999999986
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=330.23 Aligned_cols=186 Identities=26% Similarity=0.479 Sum_probs=155.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP-------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 67 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~-------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~ 67 (255)
++||||||+||+|.++|.++.. ..+++.+++.++.||+.||+|||+++|+||||||+|||++.+ +.
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~-~~ 196 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG-LV 196 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-TE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC-Cc
Confidence 4899999999999999986532 348999999999999999999999999999999999999998 69
Q ss_pred eEEecCccccccccc---cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHH
Q 025244 68 IKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 143 (255)
Q Consensus 68 ~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~ 143 (255)
+||+|||+++..... ......+||+.|||||++.+ ..++.++|||||||++|||+| |+.||.+.+..+
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--------~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~ 268 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--------RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcC--------CCCCccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999854332 22345679999999999853 678999999999999999998 899999988877
Q ss_pred HHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 144 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
....+......+.+..+|+++.+||.+||+.||++|||+.||+++|+.+.+.
T Consensus 269 ~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 269 AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 7766666655666788999999999999999999999999999999887654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=328.95 Aligned_cols=183 Identities=28% Similarity=0.525 Sum_probs=160.9
Q ss_pred CEEEEecCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
++||||||+||||.++|.... +..+++.+++.++.||+.||+|||+++|+||||||+|||++++ +
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~-~ 182 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK-L 182 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-G
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC-C
Confidence 589999999999999997542 1348999999999999999999999999999999999999998 6
Q ss_pred ceEEecCccccccccc---cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchH
Q 025244 67 TIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 142 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~ 142 (255)
.+||+|||+++..... ......+||+.|||||++.+ ..++.++|||||||++|||+| |+.||.+.+..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--------~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~ 254 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY--------GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhC--------CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999854332 22345689999999999863 678999999999999999998 89999998887
Q ss_pred HHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 143 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
+....+......+.+..+|+++.+||.+||+.||.+|||+.||+++|+.+
T Consensus 255 ~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 255 DVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 77777666666777889999999999999999999999999999999764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=326.64 Aligned_cols=176 Identities=30% Similarity=0.443 Sum_probs=151.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|||||||+||+|.++|.+.+. +++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT-SCEEEESSEEEEC--
T ss_pred EEEEEEcCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCC-CCEEecccccceecc
Confidence 4899999999999999987654 9999999999999999999999999999999999999998 799999999998543
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
......+.+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+..+....+... ..+.+..
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~--------~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-~~~~p~~ 248 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNR--------RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA-KLGMPQF 248 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHT--------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCTT
T ss_pred CCCccccccccCcccCCHHHhcc--------CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC-CCCCCCc
Confidence 3334567899999999999853 66889999999999999999999999987766665554443 3445678
Q ss_pred CcHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNF-----TQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~-----~~vl~~ 188 (255)
+|+++.+||.+||++||++|||+ +|+++|
T Consensus 249 ~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 249 LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 99999999999999999999984 677776
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=321.93 Aligned_cols=177 Identities=29% Similarity=0.404 Sum_probs=142.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+||||||+ +|+|.++|.+.+. +++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 88 ~~ivmEy~-~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH-LNVKIADFGLSNIMT 163 (275)
T ss_dssp EEEEEECC-CEEHHHHHHHSCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-CCEEECCSSCC----
T ss_pred EEEEEeCC-CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCC-CCEEEeecCCCeecC
Confidence 48999999 7899999987654 9999999999999999999999999999999999999988 799999999998766
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
......+.+||+.|||||++.+ ...++.++|||||||++|||++|+.||.+.+..+... .......+.+..+
T Consensus 164 ~~~~~~~~~GT~~Y~APE~~~~-------~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~-~i~~~~~~~p~~~ 235 (275)
T 3hyh_A 164 DGNFLKTSCGSPNYAAPEVISG-------KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFK-NISNGVYTLPKFL 235 (275)
T ss_dssp -----------CTTSCHHHHSS-------SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHTCCCCCTTS
T ss_pred CCCccCCeeECcccCChhhhcC-------CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH-HHHcCCCCCCCCC
Confidence 5555667899999999999863 2335679999999999999999999998865544433 3334444456789
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
++++++||.+||+.||++|||++|+++|-
T Consensus 236 s~~~~~li~~~L~~dP~~R~s~~eil~hp 264 (275)
T 3hyh_A 236 SPGAAGLIKRMLIVNPLNRISIHEIMQDD 264 (275)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHCH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHcCc
Confidence 99999999999999999999999999973
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=329.00 Aligned_cols=176 Identities=25% Similarity=0.350 Sum_probs=153.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|||||||+||+|.++|.+.+. +++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~--l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~-g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLS 183 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCC-CCEEEEEcCCceecC
Confidence 5899999999999999987655 9999999999999999999999999999999999999988 799999999998643
Q ss_pred c---ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 L---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
. .....+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+....+.... ...+
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~p 254 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE-YDFP 254 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHH--------SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCC
T ss_pred CCCCcccccCcccCcccCCHHHHcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCC
Confidence 2 233467799999999999863 568899999999999999999999999877666555554433 3446
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..+++++++||.+||++||.+|||++|++.+
T Consensus 255 ~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 255 EKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred cccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 7899999999999999999999999987544
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=337.25 Aligned_cols=181 Identities=29% Similarity=0.471 Sum_probs=155.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|||||||+||+|.+++...+ +++.++..++.||+.||+|||++||+||||||+|||++.+ |.+||+|||+|+...
T Consensus 223 ~~iVmEy~~gG~L~~~i~~~~---l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~-g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVS 298 (423)
T ss_dssp EEEEEECCTTEEHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTT-CCEEECCCTTCEECC
T ss_pred EEEEEeCCCCCcHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC-CCEEEecCccceECC
Confidence 589999999999999997643 9999999999999999999999999999999999999998 799999999998654
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC--CCCC
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--RPSA 157 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~ 157 (255)
. .....+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+....+..... .+..
T Consensus 299 ~~~~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~ 370 (423)
T 4fie_A 299 KEVPRRKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNL 370 (423)
T ss_dssp SSCCCBCCCEECTTTCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCT
T ss_pred CCCccccccccCcCcCCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCccc
Confidence 3 334567899999999999853 5689999999999999999999999998777666555443322 2234
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
..+++++++||.+||..||++|||+.|+++| .++..
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~H--p~~~~ 406 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH--PFLAK 406 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC--GGGGG
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC--HHhcC
Confidence 6789999999999999999999999999987 44443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=330.95 Aligned_cols=187 Identities=29% Similarity=0.536 Sum_probs=159.3
Q ss_pred CEEEEecCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
++||||||+||+|.++|+... +..+++.+++.++.||+.||+|||+++|+||||||+|||++++ +
T Consensus 144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~-~ 222 (353)
T 4ase_A 144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-N 222 (353)
T ss_dssp CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-G
T ss_pred EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC-C
Confidence 589999999999999998642 2348999999999999999999999999999999999999988 6
Q ss_pred ceEEecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchH
Q 025244 67 TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 142 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~ 142 (255)
.+||+|||+|+...... .....+||+.|||||++.+ ..|+.++|||||||++|||+| |+.||.+....
T Consensus 223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--------~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred CEEECcchhhhhcccCCCceeeccccccccccCHHHHhc--------CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999998543221 2345678999999999863 678999999999999999998 99999987655
Q ss_pred HHHHHHHhh-cCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 025244 143 QAAYAAAFK-NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 196 (255)
Q Consensus 143 ~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~ 196 (255)
+........ ...+.+..+++++.++|.+||+.||.+|||+.|++++|.+++++.
T Consensus 295 ~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 295 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 555444443 334456789999999999999999999999999999999887653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=306.24 Aligned_cols=189 Identities=25% Similarity=0.367 Sum_probs=142.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCeecCCCCCcEEEeCCCCceEEec
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--------GIIHRDLKPENLLLTEDLKTIKLAD 72 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~--------~i~HrDikp~Nill~~~~~~~kl~D 72 (255)
++||||||+||+|.++|++.. +++..++.++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~~---l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~-~~~Ki~D 151 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIAD 151 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECC
T ss_pred EEEEecCCCCCcHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC-CCEEEEe
Confidence 479999999999999998643 99999999999999999999987 99999999999999998 7999999
Q ss_pred Ccccccccccc-----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCc-------
Q 025244 73 FGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS------- 140 (255)
Q Consensus 73 fg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~------- 140 (255)
||+|+...... .....+||+.|||||++.+... .....++.++|||||||++|||++|.+||....
T Consensus 152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~--~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~ 229 (303)
T 3hmm_A 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN--MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229 (303)
T ss_dssp CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSC--TTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred CCCCccccCCCCceeeecccccccccccCHHHhccccc--ccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch
Confidence 99998543221 1234579999999999854110 011246779999999999999999977653211
Q ss_pred -------hHHHHHHHH-hhcCCCCCC------CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 141 -------NLQAAYAAA-FKNVRPSAE------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 141 -------~~~~~~~~~-~~~~~~~~~------~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
..+...... ....+|..+ ..+..+.+||.+||+.||++|||+.||++.|+.+.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 112222222 222333221 1335789999999999999999999999999887653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=308.66 Aligned_cols=176 Identities=26% Similarity=0.378 Sum_probs=140.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++.. +++.++..++.|++.||+|||++||+||||||+|||++.+.+.+||+|||+|+...
T Consensus 95 ~~lvmE~~~g~~L~~~~~~-----l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILNS-----LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEEEECCCCCCHHHHHTT-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEEEeCCCcccHHHHHcC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 4899999999999999942 89999999999999999999999999999999999999876799999999997432
Q ss_pred cc-----------------------------cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh
Q 025244 81 LT-----------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH 131 (255)
Q Consensus 81 ~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~ 131 (255)
.. ....+.+||+.|+|||++.+ ...++.++||||+||++|||++
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-------~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK-------CPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHHH
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcC-------CCCCCCccchhhhHHHHHHHHH
Confidence 21 11234679999999999863 3457889999999999999999
Q ss_pred CCCCCCCCchH-HHHHHHHhh-----------------------------------------------------cCCCCC
Q 025244 132 NKLPFEGMSNL-QAAYAAAFK-----------------------------------------------------NVRPSA 157 (255)
Q Consensus 132 g~~p~~~~~~~-~~~~~~~~~-----------------------------------------------------~~~~~~ 157 (255)
|+.||...+.. +....+... ......
T Consensus 243 G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 322 (361)
T 4f9c_A 243 GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGW 322 (361)
T ss_dssp TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------C
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccc
Confidence 99999654432 222211100 000113
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..+++++.+||.+||+.||.+|+|++|+++|
T Consensus 323 ~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 323 NEVPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp TTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 4578899999999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=312.34 Aligned_cols=177 Identities=26% Similarity=0.406 Sum_probs=149.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|||||||+ |+|.++|.+.+. +++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~--l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~-~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQP--LTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNEN-CELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-CCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCC-CCEEEeecceeeecc
Confidence 489999995 789999986544 9999999999999999999999999999999999999988 799999999998543
Q ss_pred c-----ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC
Q 025244 81 L-----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
. .....+.+||+.|||||++.+ ...++.++||||+||++|||++|++||.+.+..+....+......+
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~-------~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p 282 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLS-------LHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP 282 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred cCccccccccccceeChHhcCHHHhcC-------CCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 2 223456799999999999863 3457899999999999999999999999988777665554332221
Q ss_pred C------------------------------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 S------------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ~------------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
. ...+++++.+||.+||..||.+|||+.|+++|
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1 13468899999999999999999999999997
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=325.35 Aligned_cols=178 Identities=25% Similarity=0.374 Sum_probs=152.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|||||||+||+|.++|.+.+. +++..+..++.||+.||+|||++||+||||||+|||++.+ |.+||+|||+|+...
T Consensus 267 lylVmEy~~GGdL~~~l~~~~~--l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~-G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFS 343 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT-SCEEECCCTTCEECS
T ss_pred EEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCC-CCEEecccceeeecC
Confidence 5899999999999999988655 9999999999999999999999999999999999999998 799999999998654
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch--HHHHHHHHhhcCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN--LQAAYAAAFKNVRPSAE 158 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~ 158 (255)
.. ...+.+||+.|||||++.. +..|+.++|+|||||++|||++|++||.+... ...............+.
T Consensus 344 ~~-~~~t~~GTp~YmAPEvl~~-------~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~ 415 (689)
T 3v5w_A 344 KK-KPHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415 (689)
T ss_dssp SC-CCCSCCSCGGGCCHHHHST-------TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCT
T ss_pred CC-CCCCccCCcCccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCc
Confidence 43 3456799999999999852 34688999999999999999999999976432 22233334444445567
Q ss_pred CCcHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 025244 159 NVPEELSIILTSCWKEDPNARPN-----FTQIIQML 189 (255)
Q Consensus 159 ~~~~~l~~li~~~l~~~p~~Rpt-----~~~vl~~l 189 (255)
.+++++++||.+||+.||.+|++ +.|+++|-
T Consensus 416 ~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 89999999999999999999997 78998874
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=304.62 Aligned_cols=176 Identities=30% Similarity=0.448 Sum_probs=132.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+|||||||+||+|.+++..... ...++..++.++.||++||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 90 l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~-~~vKl~DFGla~~~ 168 (299)
T 4g31_A 90 LYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAM 168 (299)
T ss_dssp EEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCCCC---
T ss_pred EEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCC-CcEEEccCccceec
Confidence 4799999999999999987543 124556788999999999999999999999999999999988 79999999999854
Q ss_pred cccc-------------ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHH
Q 025244 80 SLTE-------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 146 (255)
Q Consensus 80 ~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~ 146 (255)
.... ...+.+||+.|||||++.+ ..|+.++|||||||++|||++ ||.+........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--------~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 169 DQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--------NSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp -----------------------CCCTTSCHHHHTT--------CCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred CCCccccccccccccccccCCcccCccccCHHHHcC--------CCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 3221 1234679999999999853 568999999999999999996 776532222222
Q ss_pred HHHhhcCCC-CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 147 AAAFKNVRP-SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 147 ~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
........| .....++.+.+||.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 222221111 123345678899999999999999999999986
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=318.45 Aligned_cols=179 Identities=24% Similarity=0.370 Sum_probs=156.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-CCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-LKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~-~~~~kl~Dfg~a~~~ 79 (255)
++||||||+||+|.++|.+... .+++.++..++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+++..
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTTS-CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EEEEEeecCCCcHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 5899999999999999975432 39999999999999999999999999999999999999853 368999999999977
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC---
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--- 156 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 156 (255)
.......+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+....+........
T Consensus 308 ~~~~~~~~~~GT~~y~APEv~~~--------~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 379 (573)
T 3uto_A 308 DPKQSVKVTTGTAEFAAPEVAEG--------KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA 379 (573)
T ss_dssp CTTSEEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGG
T ss_pred cCCCceeeeEECccccCHHHhCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCccc
Confidence 66666677899999999999863 5688999999999999999999999999887777666655443322
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...+++++++||.+||+.||.+||++.|+++|
T Consensus 380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 380 FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 35789999999999999999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=283.86 Aligned_cols=177 Identities=29% Similarity=0.407 Sum_probs=153.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++...+. +++.++..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD-MNIKIADFGFSNEFT 165 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSTTCCGGGS
T ss_pred EEEEEECCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCC-CCEEEeeccCceecC
Confidence 4799999999999999987655 9999999999999999999999999999999999999988 699999999998766
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
........+||+.|+|||++.+ ....+.++|||||||++|+|++|+.||.+.+..+........ ....+..+
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~p~~~ 237 (328)
T 3fe3_A 166 VGGKLDAFCGAPPYAAPELFQG-------KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIPFYM 237 (328)
T ss_dssp SSCGGGTTSSSGGGCCHHHHHT-------CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCTTS
T ss_pred CCCccccccCCcceeCcccccC-------CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCCC
Confidence 5555677889999999999863 233457999999999999999999999987665554444433 33445678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
++++.++|.+||+.||.+|||+.|++++
T Consensus 238 s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 238 STDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 9999999999999999999999999987
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=278.64 Aligned_cols=177 Identities=28% Similarity=0.425 Sum_probs=151.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+.+. +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCC-CCEEEeeccchhhcc
Confidence 4899999999999999987654 9999999999999999999999999999999999999988 799999999998532
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
......+.+||+.|+|||++.+ ..++.++|+||||+++|||++|+.||.+.+..+....+.. .....+..
T Consensus 157 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~-~~~~~p~~ 227 (337)
T 1o6l_A 157 SDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-EEIRFPRT 227 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSS--------SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCCCTT
T ss_pred cCCCcccccccChhhCChhhhcC--------CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCC
Confidence 2334456789999999999853 5678899999999999999999999988665554444333 33334567
Q ss_pred CcHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARP-----NFTQIIQML 189 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~l 189 (255)
+++++.++|.+||+.||.+|| ++.++++|-
T Consensus 228 ~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 899999999999999999999 899999873
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=283.59 Aligned_cols=186 Identities=32% Similarity=0.577 Sum_probs=158.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
+++||||++||+|.+++..... ..+++.+++.++.||+.||+|||++||+||||||+|||++.+ +
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~ 240 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-N 240 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-C
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCC-C
Confidence 5899999999999999987542 348899999999999999999999999999999999999988 7
Q ss_pred ceEEecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchH
Q 025244 67 TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 142 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~ 142 (255)
.+||+|||+++...... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+....
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHhcC--------CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999998543321 2234567889999999853 568899999999999999999 99999987766
Q ss_pred HHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 143 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
+.............+..++.++.++|.+||+.||.+||++.|+++.|+.++..
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 313 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 55554444444455678899999999999999999999999999999988754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=283.88 Aligned_cols=177 Identities=25% Similarity=0.436 Sum_probs=150.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc-c
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-E 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~-~ 79 (255)
++|||||++||+|.+++.+.+. +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++. .
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~-g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCC
T ss_pred EEEEEEcCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCC-CCEEEeecceeeecc
Confidence 4899999999999999987654 9999999999999999999999999999999999999998 7999999999985 3
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCc--------hHHHHHHHHhh
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS--------NLQAAYAAAFK 151 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~--------~~~~~~~~~~~ 151 (255)
.......+.+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.... ..+........
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~--------~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~ 276 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 276 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred cCCCccccccCCcccCCchhhcC--------CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence 33444567789999999999853 567889999999999999999999996432 12233444444
Q ss_pred cCCCCCCCCcHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 025244 152 NVRPSAENVPEELSIILTSCWKEDPNARPNF------TQIIQM 188 (255)
Q Consensus 152 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~------~~vl~~ 188 (255)
.....+..++.++.+||.+||+.||.+||++ .++++|
T Consensus 277 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 277 KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 4455567899999999999999999999985 677776
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=283.07 Aligned_cols=177 Identities=29% Similarity=0.399 Sum_probs=147.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++.+.+. +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCC-CCEEEccccceeecc
Confidence 4899999999999999987654 9999999999999999999999999999999999999988 799999999998533
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
......+.+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+.. .....+..
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-~~~~~p~~ 246 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQE--------MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-DEVVYPTW 246 (353)
T ss_dssp C---------CCGGGCCHHHHHH--------HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCCCTT
T ss_pred cCCccccccCCCcCeEChhhcCC--------CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCCCCC
Confidence 2334456789999999999853 4578899999999999999999999998766555544443 33344567
Q ss_pred CcHHHHHHHHHhcccCCCCCCCH------HHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNF------TQIIQML 189 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~------~~vl~~l 189 (255)
+++++.++|.+||+.||.+||++ .++++|-
T Consensus 247 ~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 247 LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 89999999999999999999998 8888763
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=277.85 Aligned_cols=188 Identities=35% Similarity=0.608 Sum_probs=148.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~--i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
+++||||++||+|.+++.+... ..+++..++.++.|++.||+|||++| |+||||||+||+++.+ +.+||+|||+++
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~ 187 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSR 187 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT-CCEEECCCC---
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC-CcEEECCCCCCc
Confidence 4899999999999999986432 23899999999999999999999999 9999999999999988 799999999998
Q ss_pred ccccc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-CCC
Q 025244 78 EESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN-VRP 155 (255)
Q Consensus 78 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~ 155 (255)
..... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+......... ...
T Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 259 (309)
T 3p86_A 188 LKASTFLSSKSAAGTPEWMAPEVLRD--------EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE 259 (309)
T ss_dssp --------------CCTTSCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred cccccccccccCCCCccccChhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 53332 22345679999999999853 557889999999999999999999999877766555544333 334
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcC
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 197 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~ 197 (255)
.+..+++++.++|.+||+.||.+||++.++++.|+.++....
T Consensus 260 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 467889999999999999999999999999999998876543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=278.15 Aligned_cols=185 Identities=28% Similarity=0.524 Sum_probs=157.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++..... .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN-LVCKVSDFGLSRVLE 202 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCSSCEECC
T ss_pred cEEEeeCCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCC-CCEEECCCCcccccc
Confidence 4899999999999999976533 39999999999999999999999999999999999999988 799999999998543
Q ss_pred ccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCC
Q 025244 81 LTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
... ......+|+.|+|||++.+ ..++.++||||||+++|||++ |..||.+....+...........+
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~ 274 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAF--------RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP 274 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred cCccceeeccCCCCcccccCHhHhcC--------CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC
Confidence 321 1223456788999999853 457889999999999999999 999999887777766666665666
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
.+..+++.+.++|.+||+.||.+||++.++++.|+.+...
T Consensus 275 ~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 275 APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 6788999999999999999999999999999999988764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=287.50 Aligned_cols=183 Identities=28% Similarity=0.444 Sum_probs=142.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--CCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~--~~~~kl~Dfg~a~~ 78 (255)
++|||||++||+|.++|.......+++.++..++.||+.||.|||++||+||||||+|||++.+ .+.+||+|||+++.
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 4799999999999999987665569999999999999999999999999999999999999872 26899999999986
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHH----HHHHHHhhcCC
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ----AAYAAAFKNVR 154 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~----~~~~~~~~~~~ 154 (255)
..........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..... ...........
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~ 285 (400)
T 1nxk_A 214 TTSHNSLTTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285 (400)
T ss_dssp CC-----------CTTCCGGGSCC--------CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC
T ss_pred cCCCCccccCCCCCCccCHhhcCC--------CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc
Confidence 555444567789999999999853 568889999999999999999999997654321 11122222221
Q ss_pred ---CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 155 ---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 155 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
+....++.++.+||.+||+.||.+|||+.+++++-+-
T Consensus 286 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 286 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 2235689999999999999999999999999998553
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=275.05 Aligned_cols=176 Identities=30% Similarity=0.491 Sum_probs=151.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+.. +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQIT 167 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECC
T ss_pred EEEEEECCCCCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCC-CCEEEeeCCCceecC
Confidence 479999999999999998753 9999999999999999999999999999999999999988 799999999988544
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC--CCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSA 157 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~ 157 (255)
.. .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+................ ..+
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (297)
T 3fxz_A 168 PEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239 (297)
T ss_dssp STTCCBCCCCSCGGGCCHHHHHC--------SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCG
T ss_pred CcccccCCccCCcCccChhhhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCc
Confidence 32 23445689999999999853 56788999999999999999999999887766665554433322 235
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..++..+.++|.+||+.||.+||++.|++++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 5788999999999999999999999999987
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=279.98 Aligned_cols=190 Identities=33% Similarity=0.566 Sum_probs=162.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
+++||||++||+|.+++..... ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~ 228 (382)
T 3tt0_A 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-N 228 (382)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-C
T ss_pred eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCC-C
Confidence 5899999999999999987642 349999999999999999999999999999999999999988 7
Q ss_pred ceEEecCccccccccc---cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchH
Q 025244 67 TIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 142 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~ 142 (255)
.+||+|||+++..... .......+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....
T Consensus 229 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 229 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred cEEEcccCcccccccccccccccCCCCCcceeCHHHhcC--------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999854332 22334567899999999853 568899999999999999999 99999987766
Q ss_pred HHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcCCC
Q 025244 143 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 199 (255)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~~~ 199 (255)
+.............+..+++++.++|.+||+.||.+||++.+++++|+.........
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 301 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 655555555455557789999999999999999999999999999999988765433
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=280.19 Aligned_cols=177 Identities=27% Similarity=0.401 Sum_probs=151.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++.+.+. +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENI 172 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCC-CcEEEEeCCcccccc
Confidence 4899999999999999987654 9999999999999999999999999999999999999988 799999999998532
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
........+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.+..+....+.. .....+..
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-~~~~~p~~ 243 (353)
T 2i0e_A 173 WDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-HNVAYPKS 243 (353)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTT--------CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCCCTT
T ss_pred cCCcccccccCCccccChhhhcC--------CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh-CCCCCCCC
Confidence 2334456789999999999853 5678899999999999999999999998766555444443 33344667
Q ss_pred CcHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPN-----FTQIIQML 189 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt-----~~~vl~~l 189 (255)
++.++.+||.+||..||.+||+ +.++++|-
T Consensus 244 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 244 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence 8999999999999999999995 57887763
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=280.85 Aligned_cols=178 Identities=26% Similarity=0.356 Sum_probs=151.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC---ceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK---TIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~---~~kl~Dfg~a~ 77 (255)
+++||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+.+ .+||+|||+++
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 489999999999999997654 3999999999999999999999999999999999999987632 79999999998
Q ss_pred ccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC-
Q 025244 78 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS- 156 (255)
Q Consensus 78 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~- 156 (255)
...........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 239 (361)
T 2yab_A 168 EIEDGVEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE 239 (361)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred EcCCCCccccCCCCccEECchHHcC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence 7655555566789999999999853 5678899999999999999999999998776655554443332221
Q ss_pred --CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 --AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...+++.+.+||.+||..||.+|||+.|+++|
T Consensus 240 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 240 EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 25688999999999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=282.78 Aligned_cols=191 Identities=20% Similarity=0.271 Sum_probs=153.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe--CCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~--~~~~~~kl~Dfg~a~~ 78 (255)
++|||||+ |++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ .+ +.+||+|||+++.
T Consensus 127 ~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~-~~~kl~DFG~a~~ 203 (364)
T 3op5_A 127 RFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP-DQVYLVDYGLAYR 203 (364)
T ss_dssp EEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT-TCEEECCCTTCEE
T ss_pred EEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC-CeEEEEECCccee
Confidence 37999999 999999998753 3499999999999999999999999999999999999998 66 7999999999975
Q ss_pred cccccc--------cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh
Q 025244 79 ESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF 150 (255)
Q Consensus 79 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 150 (255)
...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+............
T Consensus 204 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~ 275 (364)
T 3op5_A 204 YCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--------VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSK 275 (364)
T ss_dssp SSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHH
T ss_pred cccCCcccccccCcccccCCCCCccCHHHhCC--------CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHH
Confidence 433221 133459999999999853 5588999999999999999999999985332222111111
Q ss_pred hcC----------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcCCCCCC
Q 025244 151 KNV----------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPM 202 (255)
Q Consensus 151 ~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~~~~~~ 202 (255)
... ......++.++.++|..||+.||.+||++.++++.|++.+.........
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~ 337 (364)
T 3op5_A 276 IRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDG 337 (364)
T ss_dssp HHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCC
Confidence 000 0113577899999999999999999999999999999998876655443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=289.58 Aligned_cols=186 Identities=33% Similarity=0.554 Sum_probs=160.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLARVIE 335 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-CCEEECSTTGGGGBC
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCC-CcEEEeeCCCceEcC
Confidence 5899999999999999986543348999999999999999999999999999999999999988 799999999998644
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
... ......++..|+|||++.. ..++.++||||||+++|||++ |+.||.+.+..+...........+.+
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~ 407 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP 407 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCC
T ss_pred CCceeccCCCcccccccCHHHhcc--------CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 322 1233456789999999853 568899999999999999999 99999998877776666666566667
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
..+++++.+||.+||+.||.+|||+.++++.|+++...
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 88999999999999999999999999999999877543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=270.17 Aligned_cols=185 Identities=30% Similarity=0.549 Sum_probs=148.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYME 167 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC--------
T ss_pred cEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCC-CCEEECccccccccC
Confidence 479999999999999998654 349999999999999999999999999999999999999988 799999999998644
Q ss_pred cccc--cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
.... .....+++.|+|||++.. ..++.++||||||+++|||++ |..||.+....+...........+.+
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 239 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 239 (281)
T ss_dssp -----------CCGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred cccccccccCCCcccccChhhccc--------CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCC
Confidence 3221 233457789999999853 567889999999999999996 99999987766665555555555667
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
..+++.+.++|.+||+.||.+||++.++++.|+.....
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 78999999999999999999999999999999887653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=266.74 Aligned_cols=184 Identities=28% Similarity=0.548 Sum_probs=157.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVL 157 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG-GCEEECCTTGGGGBC
T ss_pred eEEEEEeCCCCcHHHHHHhcCc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCC-CCEEecccccccccc
Confidence 3799999999999999976543 49999999999999999999999999999999999999988 699999999998543
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
... ......+|+.|+|||++.+ ..++.++||||||+++|+|++ |+.||.+....+.............+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (269)
T 4hcu_A 158 DDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 229 (269)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred ccccccccCcccccccCCHHHhcC--------CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCC
Confidence 322 2234457889999999853 567889999999999999999 99999987776666555555455556
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
...++.+.+++.+||+.||.+||++.+++++|++...
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 7789999999999999999999999999999988765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=276.67 Aligned_cols=181 Identities=20% Similarity=0.270 Sum_probs=153.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-CCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-LKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~-~~~~kl~Dfg~a~~~ 79 (255)
+++||||++||+|.+++.... ..+++.+++.++.|++.||.|||++||+||||||+|||++.+ .+.+||+|||+++..
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 76 LVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 479999999999999997643 249999999999999999999999999999999999999862 268999999999876
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC---
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--- 156 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 156 (255)
..........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+.............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 226 (321)
T 1tki_A 155 KPGDNFRLLFTAPEYYAPEVHQH--------DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA 226 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTT--------CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred CCCCccccccCChhhcCcHHhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh
Confidence 55555556789999999999853 4568899999999999999999999998776665555554443322
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
...++.++.++|.+||..||.+|||+.|++++-+
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 2478899999999999999999999999999754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=280.01 Aligned_cols=176 Identities=31% Similarity=0.481 Sum_probs=150.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+.+. +++.++..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCC-CCEEEeEChhhhhcc
Confidence 4899999999999999987654 9999999999999999999999999999999999999988 799999999998532
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
........+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.+..+....+.. .....+..
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~-~~~~~p~~ 240 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAPEILLG--------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-DNPFYPRW 240 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCCCTT
T ss_pred cCCCcccCCCCCcccCChhhhcC--------CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh-CCCCCCcc
Confidence 2233456789999999999853 5678899999999999999999999998766555444433 33334567
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFT-QIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~-~vl~~ 188 (255)
++.++.++|.+||..||.+||++. ++++|
T Consensus 241 ~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 241 LEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp SCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred cCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 899999999999999999999997 77765
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=271.35 Aligned_cols=178 Identities=30% Similarity=0.368 Sum_probs=152.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 94 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~ 171 (308)
T 3g33_A 94 VTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GTVKLADFGLARIYS 171 (308)
T ss_dssp EEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTT-SCEEECSCSCTTTST
T ss_pred EEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEEeeCccccccC
Confidence 379999996 699999998766669999999999999999999999999999999999999988 799999999998765
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC----
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS---- 156 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 156 (255)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...........+.
T Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (308)
T 3g33_A 172 YQMALTPVVVTLWYRAPEVLLQ--------STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243 (308)
T ss_dssp TCCCSGGGGCCCSSCCHHHHHT--------SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred CCcccCCccccccccCchHHcC--------CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 5555566789999999999853 5678899999999999999999999998777666555443221111
Q ss_pred ----------------------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 ----------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 ----------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...+++.+.++|.+||+.||.+|||+.|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 13577899999999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=281.39 Aligned_cols=184 Identities=32% Similarity=0.531 Sum_probs=156.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++...+. .+++..++.++.|++.||+|||++|++||||||+|||++.+ +.+||+|||+++...
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~-~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK-NVLKISDFGMSREEA 264 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCGGGCEECT
T ss_pred cEEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCC-CcEEECcCCCceecC
Confidence 5899999999999999986543 38999999999999999999999999999999999999988 799999999998543
Q ss_pred ccccc---ccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCC
Q 025244 81 LTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPS 156 (255)
Q Consensus 81 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 156 (255)
..... ....++..|+|||++.. ..++.++||||||+++|||++ |..||.+....+...........+.
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 336 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNY--------GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC 336 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC
T ss_pred CCceeecCCCCCCCcCcCCHhHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 32211 12235778999999853 457889999999999999998 9999998877766655555555566
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
+..+++++.++|.+||+.||.+|||+.++++.|+.+..
T Consensus 337 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 77899999999999999999999999999999988754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=279.36 Aligned_cols=187 Identities=29% Similarity=0.531 Sum_probs=158.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCC--CceEEecC
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP-----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADF 73 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~-----~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~--~~~kl~Df 73 (255)
+++||||++||+|.+++..... ..+++..++.++.|++.||+|||++||+||||||+|||++.+. ..+||+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCC
Confidence 4799999999999999987542 3489999999999999999999999999999999999998541 35999999
Q ss_pred ccccccccc---cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHH
Q 025244 74 GLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAA 149 (255)
Q Consensus 74 g~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~ 149 (255)
|+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+....+......
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFME--------GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999843222 22234567999999999853 568899999999999999998 999999887776666666
Q ss_pred hhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 150 FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 150 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
..........++..+.+||.+||+.||.+||++.+++++|+.....
T Consensus 301 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 301 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 5555556778899999999999999999999999999999877653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=276.77 Aligned_cols=177 Identities=25% Similarity=0.436 Sum_probs=148.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+.+. +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCGGGCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC-CCEEEEecccccccc
Confidence 4899999999999999987654 9999999999999999999999999999999999999988 799999999998532
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCc--------hHHHHHHHHhh
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS--------NLQAAYAAAFK 151 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~--------~~~~~~~~~~~ 151 (255)
........+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.... ...........
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~ 233 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 233 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH
T ss_pred CCCCcccccCCCccccCccccCC--------CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc
Confidence 3334556789999999999853 567889999999999999999999996521 12223333334
Q ss_pred cCCCCCCCCcHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 025244 152 NVRPSAENVPEELSIILTSCWKEDPNARPNF------TQIIQM 188 (255)
Q Consensus 152 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~------~~vl~~ 188 (255)
.....+..++.++.++|.+||+.||.+||++ .++++|
T Consensus 234 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 234 KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 4444567789999999999999999999985 677776
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=273.29 Aligned_cols=175 Identities=26% Similarity=0.340 Sum_probs=151.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+.+. +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECS
T ss_pred EEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCC-CCEEEcccccceecc
Confidence 4899999999999999987654 9999999999999999999999999999999999999988 799999999998644
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
.. ..+.+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.+..+....+... ....+..+
T Consensus 193 ~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~ 261 (350)
T 1rdq_E 193 GR--TWTLCGTPEALAPEIILS--------KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-KVRFPSHF 261 (350)
T ss_dssp SC--BCCCEECGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCTTC
T ss_pred CC--cccccCCccccCHHHhcC--------CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC-CCCCCCCC
Confidence 32 345689999999999853 56788999999999999999999999987665554444433 33446678
Q ss_pred cHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARPN-----FTQIIQML 189 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt-----~~~vl~~l 189 (255)
+.++.++|.+||+.||.+||+ +.++++|-
T Consensus 262 ~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 999999999999999999998 89998874
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=274.95 Aligned_cols=186 Identities=30% Similarity=0.542 Sum_probs=157.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP----------------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 58 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~----------------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~N 58 (255)
+++||||++||+|.+++..... ..+++.+++.++.|++.||.|||++||+||||||+|
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N 204 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 204 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcce
Confidence 4899999999999999987531 459999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEecCccccccccc---cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCC
Q 025244 59 LLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKL 134 (255)
Q Consensus 59 ill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~ 134 (255)
||++.+ +.+||+|||+++..... .......+|+.|+|||++.+ ..++.++||||||+++|||++ |..
T Consensus 205 Il~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 205 CLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--------NRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp EEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EEECCC-CeEEEeecCCCcccccCccccccCCCcccceecChhhhcc--------CCcCcccccHHHHHHHHHHHhcCCC
Confidence 999988 69999999999854322 12234568899999998853 567899999999999999999 999
Q ss_pred CCCCCchHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 135 PFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 135 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
||.+....+.............+..++.++.++|.+||+.||.+||++.+++++|++....
T Consensus 276 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred cCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 9998777666665555555556778999999999999999999999999999999887643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=267.65 Aligned_cols=185 Identities=29% Similarity=0.534 Sum_probs=158.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVL 171 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGG-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-SCEEECSTTGGGGBC
T ss_pred eEEEEeccCCCcHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCC-CCEEEcccccccccc
Confidence 3799999999999999987433 39999999999999999999999999999999999999988 699999999998543
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
... ......+|+.|+|||++.+ ..++.++||||||+++|+|++ |+.||......+.............+
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMY--------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 243 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred ccccccccCCccCcccCCHHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC
Confidence 322 2233456789999999863 457889999999999999998 99999988777666666555555556
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
...++.+.++|.+||+.||.+||++.+++++|++....
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 77899999999999999999999999999999988754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=285.68 Aligned_cols=184 Identities=30% Similarity=0.548 Sum_probs=157.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++...+...+++..++.++.|++.||+|||++|++||||||+|||++.+ +.+||+|||+++...
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-SCEEECCCTTCEECC
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCC-CCEEEeeCCCccccc
Confidence 4799999999999999998766558999999999999999999999999999999999999988 799999999998543
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
.. .....++..|+|||++.+ ..++.++||||||+++|||++ |+.||.+....+...........+.+..
T Consensus 341 ~~--~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~ 410 (450)
T 1k9a_A 341 ST--QDTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 410 (450)
T ss_dssp --------CCCTTTSCHHHHHS--------SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTT
T ss_pred cc--ccCCCCCcceeCHHHhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence 22 233467889999999853 568899999999999999998 9999998776666655555555556778
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
+++++.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 411 ~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 411 CPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999999999999887643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=279.25 Aligned_cols=171 Identities=29% Similarity=0.384 Sum_probs=147.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++.+.+. +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCBCGGGB
T ss_pred EEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC-CCEEEeeCccccccc
Confidence 4899999999999999987654 9999999999999999999999999999999999999988 799999999998532
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
........+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.+..+....+... ....+..
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 261 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHK--------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PLQLKPN 261 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS-CCCCCSS
T ss_pred cCCCccccccCCccccCHHHhCC--------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-ccCCCCC
Confidence 3334556789999999999853 56788999999999999999999999987665554444433 3334567
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFT 183 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~ 183 (255)
++.++.++|.+||+.||.+||++.
T Consensus 262 ~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 262 ITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred CCHHHHHHHHHHcccCHHhCCCCC
Confidence 899999999999999999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=272.40 Aligned_cols=178 Identities=29% Similarity=0.483 Sum_probs=144.8
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
++||||++|++|.+++...+. +++.+++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETT-SCEEECCCSCC-----
T ss_pred EEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCC-CCEEEeeccCcccccc
Confidence 899999999999999987654 9999999999999999999999999999999999999988 7999999999985432
Q ss_pred c----cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC-
Q 025244 82 T----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS- 156 (255)
Q Consensus 82 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~- 156 (255)
. .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+...........+.
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARG--------DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 240 (311)
T ss_dssp -------------CCTTCCHHHHHT--------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH
T ss_pred cccccccccccCcCcccCCHHHhcC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc
Confidence 2 12234568999999999853 5678899999999999999999999998777766665555444332
Q ss_pred --CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 157 --AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 157 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
...++.++.++|.+||+.||.+||+..+++.+-.
T Consensus 241 ~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 276 (311)
T 3ork_A 241 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 276 (311)
T ss_dssp HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHH
Confidence 3568999999999999999999998887776543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=274.09 Aligned_cols=177 Identities=27% Similarity=0.388 Sum_probs=150.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC----ceEEecCccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK----TIKLADFGLA 76 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~----~~kl~Dfg~a 76 (255)
+++||||++||+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.+ + .+||+|||++
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~-~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDR-NVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCS-SSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecC-CCCCCCEEEEECCCC
Confidence 479999999999999997654 39999999999999999999999999999999999999876 4 7999999999
Q ss_pred cccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC
Q 025244 77 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 156 (255)
Q Consensus 77 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 156 (255)
+............||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+.............
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred eECCCCCccccccCCcCcCCceeecC--------CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC
Confidence 87654444556789999999999853 5678899999999999999999999988766555544443332221
Q ss_pred ---CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 ---AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 ---~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...++..+.++|.+||+.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 25678999999999999999999999999987
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=273.87 Aligned_cols=180 Identities=27% Similarity=0.433 Sum_probs=152.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+... +++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVH--FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEH-GHVHITDFNIAAMLP 166 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCC-CCEEEeccceeeecc
Confidence 4899999999999999987544 9999999999999999999999999999999999999988 799999999998765
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch--HHHHHHHHhhcCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN--LQAAYAAAFKNVRPSAE 158 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~ 158 (255)
........+||+.|+|||++... .+..++.++|||||||++|||++|+.||..... ...............+.
T Consensus 167 ~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~ 241 (384)
T 4fr4_A 167 RETQITTMAGTKPYMAPEMFSSR-----KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS 241 (384)
T ss_dssp TTCCBCCCCSCGGGCCGGGTCCC-----SSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCT
T ss_pred CCCceeccCCCccccCCeeeccC-----CCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCC
Confidence 55556778899999999998531 134578899999999999999999999975332 33333444445555677
Q ss_pred CCcHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 025244 159 NVPEELSIILTSCWKEDPNARPN-FTQIIQM 188 (255)
Q Consensus 159 ~~~~~l~~li~~~l~~~p~~Rpt-~~~vl~~ 188 (255)
.+++++.+||.+||+.||.+||+ +.+++++
T Consensus 242 ~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred cCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 89999999999999999999998 7777765
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=275.80 Aligned_cols=184 Identities=24% Similarity=0.485 Sum_probs=154.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++..... .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRG-ALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP-SQVQVADFGVADLLP 166 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGG-GSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSS-SCEEECSCSGGGGSC
T ss_pred cEEEEEeCCCCCHHHHHHHccc-cCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCC-CeEEECCCCcccccC
Confidence 3799999999999999987532 38999999999999999999999999999999999999988 799999999998643
Q ss_pred ccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCC
Q 025244 81 LTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPS 156 (255)
Q Consensus 81 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 156 (255)
... ......||..|+|||++.+ ..++.++||||||+++|+|++ |+.||.+....+.............
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHF--------GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ 238 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC
T ss_pred cccccccccCCCCcccccChHHhcc--------CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC
Confidence 322 2344567889999999853 568899999999999999999 9999998776666555555555555
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
+..++.++.++|.+||+.||.+||++.+++++|+....
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 239 PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 67788899999999999999999999999999987754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=269.53 Aligned_cols=184 Identities=30% Similarity=0.479 Sum_probs=150.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++...+. +++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN-KTLKIFDFGIAKALS 162 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCSSSTTC-
T ss_pred EEEEEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEEeCCCccccc
Confidence 4799999999999999987654 9999999999999999999999999999999999999988 799999999998644
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC---
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--- 155 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--- 155 (255)
... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.................
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKG--------EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTT 234 (294)
T ss_dssp ------------CCSSCCHHHHHT--------CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHH
T ss_pred cccccccCccccCccccCHhHhcC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcch
Confidence 322 2334579999999999853 557889999999999999999999999877666555544433322
Q ss_pred -CCCCCcHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhHhh
Q 025244 156 -SAENVPEELSIILTSCWKEDPNARP-NFTQIIQMLLNYLSA 195 (255)
Q Consensus 156 -~~~~~~~~l~~li~~~l~~~p~~Rp-t~~~vl~~l~~~~~~ 195 (255)
....+++.+.++|.+||+.||.+|| ++.++.+.|......
T Consensus 235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 2467899999999999999999999 888888888766543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=277.44 Aligned_cols=162 Identities=30% Similarity=0.555 Sum_probs=136.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccccc---cccccCCCccceecccccc
Q 025244 25 LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYS 101 (255)
Q Consensus 25 ~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~ 101 (255)
+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..... .......||+.|+|||++.
T Consensus 190 l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 268 (359)
T 3vhe_A 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 268 (359)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CcEEEEeccceeeecccccchhccccCCCceeEChhhhc
Confidence 8899999999999999999999999999999999999988 69999999999854322 2233456889999999985
Q ss_pred cccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhh-cCCCCCCCCcHHHHHHHHHhcccCCCCC
Q 025244 102 TVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFK-NVRPSAENVPEELSIILTSCWKEDPNAR 179 (255)
Q Consensus 102 ~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~R 179 (255)
+ ..++.++||||||+++|||++ |+.||.+....+........ .....+..+++++.++|.+||+.||.+|
T Consensus 269 ~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 340 (359)
T 3vhe_A 269 D--------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 340 (359)
T ss_dssp H--------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred C--------CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 3 567899999999999999998 99999887655544444333 3344567789999999999999999999
Q ss_pred CCHHHHHHHHHHhHhh
Q 025244 180 PNFTQIIQMLLNYLSA 195 (255)
Q Consensus 180 pt~~~vl~~l~~~~~~ 195 (255)
|++.+++++|+.++.+
T Consensus 341 ps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 341 PTFSELVEHLGNLLQA 356 (359)
T ss_dssp CCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHH
Confidence 9999999999988764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=280.91 Aligned_cols=181 Identities=25% Similarity=0.411 Sum_probs=152.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++.+.. +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~~---~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~-g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMN 219 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECC
T ss_pred EEEEEeCCCCCcHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCC-CCEEEeccceeEeec
Confidence 489999999999999997642 9999999999999999999999999999999999999988 799999999998644
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhh---cCCC
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK---NVRP 155 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~~~ 155 (255)
... ...+.+||+.|+|||++... .....++.++|||||||++|||++|+.||.+.+.......+... ...+
T Consensus 220 ~~~~~~~~~~~gt~~Y~APE~l~~~----~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p 295 (410)
T 3v8s_A 220 KEGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP 295 (410)
T ss_dssp TTSEEECCSCCSCGGGCCHHHHHTT----TTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred cCCcccccCCcCCccccCHHHhhcc----CCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCC
Confidence 332 23467899999999998641 11122678999999999999999999999987766655554432 2344
Q ss_pred CCCCCcHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNA--RPNFTQIIQML 189 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~--Rpt~~~vl~~l 189 (255)
....++.++++||.+||..+|.+ ||++.++++|-
T Consensus 296 ~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 296 DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 45678999999999999999988 99999999984
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=266.86 Aligned_cols=188 Identities=21% Similarity=0.298 Sum_probs=151.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCc-----eEEecCcc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT-----IKLADFGL 75 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~-----~kl~Dfg~ 75 (255)
.++||||+ |++|.+++...+. .+++..++.++.|++.||+|||++||+||||||+||+++.+ +. +||+|||+
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRP-NSKNANMIYVVDFGM 157 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCS-SSTTTTCEEECCCTT
T ss_pred eEEEEEec-CCCHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccC-CCCCCCeEEEEECcc
Confidence 37999999 9999999987543 39999999999999999999999999999999999999866 34 99999999
Q ss_pred cccccccc--------ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch---HHH
Q 025244 76 AREESLTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN---LQA 144 (255)
Q Consensus 76 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~---~~~ 144 (255)
++...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+... .+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 229 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--------REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 229 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcC--------CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHH
Confidence 98543321 1345679999999999853 5678999999999999999999999987432 222
Q ss_pred HHHHHhhcC-CC---CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcCCC
Q 025244 145 AYAAAFKNV-RP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 199 (255)
Q Consensus 145 ~~~~~~~~~-~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~~~ 199 (255)
......... .+ ....+++++.++|.+||+.||.+||++.++++.|++........
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 230 YERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 222111111 11 13478899999999999999999999999999999988765443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=282.04 Aligned_cols=177 Identities=29% Similarity=0.428 Sum_probs=150.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~-~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
++|||||++||+|.+++...+. +++..+..++.|++.||+|||+ +||+||||||+|||++.+ +.+||+|||+++..
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~-~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEG 299 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSS-SCEEECCCCCCCTT
T ss_pred EEEEEeeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCC-CCEEEccCCCceec
Confidence 4799999999999999987654 9999999999999999999998 999999999999999988 79999999999853
Q ss_pred c-cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCC
Q 025244 80 S-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE 158 (255)
Q Consensus 80 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 158 (255)
. ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....... .....+.
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~-~~~~~p~ 370 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-EEIRFPR 370 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHT--------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCCCT
T ss_pred cCCCcccccccCCccccCHhhcCC--------CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh-CCCCCCc
Confidence 2 3334456789999999999853 5688999999999999999999999988766554444433 3334466
Q ss_pred CCcHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 025244 159 NVPEELSIILTSCWKEDPNARP-----NFTQIIQML 189 (255)
Q Consensus 159 ~~~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~l 189 (255)
.+++++.+||.+||+.||.+|| ++.++++|-
T Consensus 371 ~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 371 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 7899999999999999999999 999999873
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=272.64 Aligned_cols=183 Identities=24% Similarity=0.504 Sum_probs=155.8
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTHHHHHTT
T ss_pred EEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCC-CCEEEccCcceeEccC
Confidence 689999999999999987543 39999999999999999999999999999999999999988 6999999999985433
Q ss_pred cc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 82 TE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 82 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
.. ......+|..|+|||++.+ ..++.++||||||+++|||++ |+.||.+....+...........+.+
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 241 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred CcccccccCCCccccccChHHhcc--------CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCC
Confidence 22 2233456889999999853 568899999999999999999 99999987766665555555555667
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
..++.++.+++.+||+.||.+||++.+++++|+....
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 242 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 7889999999999999999999999999999987754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=281.52 Aligned_cols=179 Identities=25% Similarity=0.328 Sum_probs=152.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--CCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~--~~~~kl~Dfg~a~~ 78 (255)
+++||||++||+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.+ .+.+||+|||+++.
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~--~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEEEEEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 4799999999999999987654 9999999999999999999999999999999999999842 36899999999986
Q ss_pred cccc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC--
Q 025244 79 ESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-- 155 (255)
Q Consensus 79 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-- 155 (255)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+............
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 234 (444)
T 3soa_A 163 VEGEQQAWFGFAGTPGYLSPEVLRK--------DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS 234 (444)
T ss_dssp CCTTCCBCCCSCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT
T ss_pred ecCCCceeecccCCcccCCHHHhcC--------CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCc
Confidence 4433 23355789999999999853 567889999999999999999999999877666655555443322
Q ss_pred -CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 156 -SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 156 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
....+++++.+||.+||+.||.+|||+.|++++-
T Consensus 235 ~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 235 PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHP 269 (444)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 2357899999999999999999999999999873
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=266.28 Aligned_cols=184 Identities=28% Similarity=0.517 Sum_probs=157.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++...+. .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||+++...
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD-LCVKVSDFGMTRYVL 155 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTT-CCEEECCTTCEEECC
T ss_pred eEEEEEccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCC-CCEEEccCccceecc
Confidence 3799999999999999987543 39999999999999999999999999999999999999988 799999999998543
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
... ......+|+.|+|||++.+ ..++.++||||||+++|+|++ |+.||......+.............+
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 227 (268)
T 3sxs_A 156 DDQYVSSVGTKFPVKWSAPEVFHY--------FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP 227 (268)
T ss_dssp TTCEEECCSCCCCGGGCCHHHHHH--------SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred hhhhhcccCCCcCcccCCHHHHhc--------cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC
Confidence 332 2233456788999999853 456789999999999999999 99999988777766666655555566
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
...++.+.++|.+||+.||.+|||+.+++++|+.+..
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 7789999999999999999999999999999987643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=277.08 Aligned_cols=185 Identities=30% Similarity=0.545 Sum_probs=147.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++.+.+. .+++.+++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN-LVCKVSDFGLGRVLE 198 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC-------
T ss_pred eEEEEeCCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCC-CCEEECcCccccccc
Confidence 4899999999999999987543 49999999999999999999999999999999999999988 699999999998543
Q ss_pred ccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCC
Q 025244 81 LTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
... ......++..|+|||++.+ ..++.++||||||+++|||++ |+.||.+....+...........+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~ 270 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAY--------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP 270 (373)
T ss_dssp ---------------CTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC
T ss_pred cCCccceeccCCCcCCCccChhhhcc--------CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 321 1122345778999999853 568889999999999999998 999999877766665555555556
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
....++..+.++|.+||+.||.+||++.++++.|+.....
T Consensus 271 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 6778999999999999999999999999999999988764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=270.11 Aligned_cols=186 Identities=28% Similarity=0.538 Sum_probs=157.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP----------------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 58 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~----------------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~N 58 (255)
+++||||++||+|.+++..... ..+++.+++.++.|++.||+|||++|++||||||+|
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N 180 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchhe
Confidence 4899999999999999987543 238999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCC
Q 025244 59 LLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKL 134 (255)
Q Consensus 59 ill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~ 134 (255)
|+++.+ +.+||+|||+++...... ......+|+.|+|||++.+ ..++.++||||||+++|||++ |..
T Consensus 181 Ili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 181 ILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD--------HIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp EEEETT-TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred EEEcCC-CCEEEccccccccccccccceeccCCCCcccccChhhhcC--------CCcCchhhHHHHHHHHHHHHhCCCC
Confidence 999988 799999999998543322 2234467889999999853 457889999999999999999 999
Q ss_pred CCCCCchHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 135 PFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 135 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
||.+..................+..+++++.++|.+||+.||.+||++.+++++|++.+..
T Consensus 252 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 252 PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp SSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 9988776655544444444455678899999999999999999999999999999987653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=271.60 Aligned_cols=175 Identities=29% Similarity=0.419 Sum_probs=150.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 81 ~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVP 157 (318)
T ss_dssp EEEEECCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT-SCEEECCCSSCEECS
T ss_pred EEEEEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCC-CCEEEeecCcceecC
Confidence 4799999999999999987554 9999999999999999999999999999999999999988 799999999998643
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
. ...+.+||+.|+|||++.+ ..++.++|+||||+++|||++|+.||.+.+..+....+... ....+..+
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~p~~~ 226 (318)
T 1fot_A 158 D--VTYTLCGTPDYIAPEVVST--------KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-ELRFPPFF 226 (318)
T ss_dssp S--CBCCCCSCTTTCCHHHHTT--------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-CCCCCTTS
T ss_pred C--ccccccCCccccCHhHhcC--------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCCC
Confidence 3 2345689999999999853 56788999999999999999999999887665554444433 33345678
Q ss_pred cHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARP-----NFTQIIQML 189 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~l 189 (255)
++++.++|.+||..||.+|| +++++++|-
T Consensus 227 ~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 227 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 99999999999999999999 899998873
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=269.95 Aligned_cols=188 Identities=24% Similarity=0.346 Sum_probs=150.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCc-----eEEecCcc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT-----IKLADFGL 75 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~-----~kl~Dfg~ 75 (255)
+++||||+ |++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +. +||+|||+
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~-~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRP-GNKTQQVIHIIDFAL 156 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG-GGTCTTSEEECCCTT
T ss_pred cEEEEEeC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccC-CCCCCceEEEEEccc
Confidence 37999999 999999998753 349999999999999999999999999999999999999877 45 99999999
Q ss_pred ccccccccc--------cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH---HH
Q 025244 76 AREESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL---QA 144 (255)
Q Consensus 76 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~---~~ 144 (255)
++....... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+.... +.
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~ 228 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG--------KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKER 228 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcC--------CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHH
Confidence 985433221 245689999999999853 56789999999999999999999999874332 11
Q ss_pred HHHHHhhcC-CC---CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 025244 145 AYAAAFKNV-RP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 200 (255)
Q Consensus 145 ~~~~~~~~~-~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~~~~ 200 (255)
......... .+ ....+| ++.++|..||+.||.+||++.++++.|++.........
T Consensus 229 ~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 287 (330)
T 2izr_A 229 YQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMF 287 (330)
T ss_dssp HHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCC
Confidence 111111111 11 123455 99999999999999999999999999998887665443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=277.17 Aligned_cols=179 Identities=27% Similarity=0.379 Sum_probs=151.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCC--CceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~--~~~kl~Dfg~a~~ 78 (255)
+++||||++||+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.+. +.+||+|||+++.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEEEEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 3799999999999999986543 99999999999999999999999999999999999998642 3699999999987
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC--
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-- 156 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 156 (255)
...........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.............
T Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 252 (362)
T 2bdw_A 181 VNDSEAWHGFAGTPGYLSPEVLKK--------DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP 252 (362)
T ss_dssp CTTCCSCCCSCSCTTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred ecCCcccccCCCCccccCHHHHcc--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence 655554556789999999999853 5678899999999999999999999998776655554444333222
Q ss_pred -CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 157 -AENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 157 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
...+++++.+||.+||+.||.+||++.+++++-
T Consensus 253 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 286 (362)
T 2bdw_A 253 EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 286 (362)
T ss_dssp GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 246789999999999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=285.14 Aligned_cols=186 Identities=31% Similarity=0.524 Sum_probs=155.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++.......+++..++.++.|++.||+|||++|++||||||+|||++.+ +.+||+|||+++...
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIE 331 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC---
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCC-CCEEECCCccceecC
Confidence 4899999999999999986544459999999999999999999999999999999999999988 699999999998543
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
... ......++..|+|||++.. ..++.++||||||+++|||++ |+.||.+....+...........+.+
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~ 403 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP 403 (452)
T ss_dssp -----------CCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred CCceecccCCcccccccCHhHHhc--------CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 322 1223456789999998853 568899999999999999999 99999988877766666555556667
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
..+++.+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 88999999999999999999999999999999887654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=268.22 Aligned_cols=185 Identities=25% Similarity=0.470 Sum_probs=148.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++...
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLP 165 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCCSCC---
T ss_pred eEEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCC-CeEEEccCccccccc
Confidence 4799999999999999987543 39999999999999999999999999999999999999988 799999999998543
Q ss_pred ccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH--------------
Q 025244 81 LTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL-------------- 142 (255)
Q Consensus 81 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-------------- 142 (255)
... ......++..|+|||++.+ ..++.++||||||+++|||++|..||......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTE--------SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcC--------CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh
Confidence 321 2234457888999999853 56789999999999999999999998643211
Q ss_pred --HHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 143 --QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 143 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
............+.+..+++++.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 11111222333445678899999999999999999999999999999887654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=295.40 Aligned_cols=176 Identities=27% Similarity=0.412 Sum_probs=152.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+||||||++||+|.++|...+. +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~-g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSS-SCEEECCCTTCEECC
T ss_pred EEEEEeCcCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCC-CcEEEeecceeeccc
Confidence 4899999999999999997654 9999999999999999999999999999999999999998 799999999998532
Q ss_pred -cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
......+.+||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+.+..+....+.. .....+..
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~--------~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~-~~~~~p~~ 564 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-HNVAYPKS 564 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTC--------CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS-SCCCCCTT
T ss_pred cCCcccccccCCCcccCHhhhcC--------CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh-CCCCCCcc
Confidence 3334566789999999999853 5678999999999999999999999998766555544443 33445678
Q ss_pred CcHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNF-----TQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~-----~~vl~~ 188 (255)
+++++.+||.+||+.||.+||++ ++|++|
T Consensus 565 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 565 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 99999999999999999999997 778776
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=264.19 Aligned_cols=184 Identities=29% Similarity=0.527 Sum_probs=154.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++|++|.+++...+. .+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP-ECVKLGDFGLSRYIE 164 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEET-TEEEECCCCGGGCC-
T ss_pred CEEEEecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCC-CcEEeCccCCCcccc
Confidence 3799999999999999987543 38999999999999999999999999999999999999988 699999999998544
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
... ......+++.|+|||++.+ ..++.++||||||+++|+|++ |+.||......+...........+.+
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINF--------RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP 236 (281)
T ss_dssp --------CCCCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC
T ss_pred cccccccccCCCCcceeCchhhcc--------CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC
Confidence 322 2234457889999998853 567889999999999999998 99999876666555555555555667
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
..+++.+.++|.+||+.||.+||++.+++++|+....
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 7889999999999999999999999999999987764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=275.98 Aligned_cols=187 Identities=29% Similarity=0.521 Sum_probs=149.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++||+|.+++..... .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMY 243 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC-------
T ss_pred eEEEEECCCCCCHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCC-CCEEEeecccccccc
Confidence 4799999999999999986443 48999999999999999999999999999999999999988 699999999998543
Q ss_pred ccc-----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCC
Q 025244 81 LTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVR 154 (255)
Q Consensus 81 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 154 (255)
... ......+|+.|+|||++.+ ..++.++||||||+++|||++ |.+||.+....+...........
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~ 315 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 315 (373)
T ss_dssp --------------CCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC
T ss_pred ccccccccccCCCCCcccccChHHhcC--------CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC
Confidence 221 1233457789999999853 567899999999999999999 78888876665555555544445
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcC
Q 025244 155 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 197 (255)
Q Consensus 155 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~ 197 (255)
..+..++..+.++|.+||+.||.+||++.++++.|+.......
T Consensus 316 ~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 316 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 5567789999999999999999999999999999998886543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=271.46 Aligned_cols=187 Identities=30% Similarity=0.502 Sum_probs=155.6
Q ss_pred CEEEEecCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
+++||||++||+|.+++.... ...+++..++.++.|++.||.|||++||+||||||+||+++.+ +
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~-~ 179 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-Y 179 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-G
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC-C
Confidence 479999999999999998653 2359999999999999999999999999999999999999988 6
Q ss_pred ceEEecCccccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHH
Q 025244 67 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAA 145 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~ 145 (255)
.+||+|||+++............+++.|+|||++.+ ..++.++||||||+++|+|++ |+.||.+....+..
T Consensus 180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~ 251 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251 (327)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred eEEEcccCcCccccccccccCCCCCccccChhhhcc--------ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH
Confidence 999999999985444333344567889999998853 456889999999999999998 99999887665544
Q ss_pred HHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 025244 146 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 196 (255)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~ 196 (255)
...........+..+++++.++|.+||+.||.+||++.+++++|.......
T Consensus 252 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 252 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 443333334456678999999999999999999999999999999888754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=266.74 Aligned_cols=187 Identities=30% Similarity=0.531 Sum_probs=158.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLARLIE 160 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCC-CCEEECCCccccccc
Confidence 4799999999999999976543349999999999999999999999999999999999999988 699999999998644
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
... ......++..|+|||++.+ ..++.++||||||+++|||++ |+.||.+....+..............
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred CcccccccCCCCccCccChhhhcc--------CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCc
Confidence 322 1233456789999999853 456789999999999999999 99999887766655555444444556
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 196 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~ 196 (255)
..+++++.++|.+||+.||.+||++.++++.|++++...
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 788999999999999999999999999999999887654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=278.66 Aligned_cols=185 Identities=24% Similarity=0.350 Sum_probs=149.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++.+.+. .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~-g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGE-RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC-GHIRLADFGSCLKLR 213 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCC-CCEEEeechhheecc
Confidence 4899999999999999987543 39999999999999999999999999999999999999988 799999999998644
Q ss_pred cccc--cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc---CCC
Q 025244 81 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN---VRP 155 (255)
Q Consensus 81 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~~ 155 (255)
.... ....+||+.|+|||++..... ......++.++|+|||||++|||++|+.||.+.+..+....+.... ..+
T Consensus 214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~-~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 292 (412)
T 2vd5_A 214 ADGTVRSLVAVGTPDYLSPEILQAVGG-GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP 292 (412)
T ss_dssp TTSCEECSSCCSCGGGCCHHHHHHHHT-CTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred CCCccccceeccccCcCCHHHHhhccc-CcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCC
Confidence 3322 335689999999999863100 0012457889999999999999999999999877666554444321 122
Q ss_pred -CCCCCcHHHHHHHHHhcccCCCCC---CCHHHHHHHH
Q 025244 156 -SAENVPEELSIILTSCWKEDPNAR---PNFTQIIQML 189 (255)
Q Consensus 156 -~~~~~~~~l~~li~~~l~~~p~~R---pt~~~vl~~l 189 (255)
....+++++++||.+||. +|.+| |+++++++|-
T Consensus 293 ~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 293 LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp ----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 235789999999999999 99998 5899998873
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=270.37 Aligned_cols=186 Identities=31% Similarity=0.531 Sum_probs=153.2
Q ss_pred EEEEecCCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 2 VIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~----~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
++||||++||+|.+++.... ...+++..++.++.|++.||+|||++|++||||||+|||++.+ +.+||+|||+++
T Consensus 107 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~-~~~kl~Dfg~a~ 185 (323)
T 3qup_A 107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED-MTVCVADFGLSR 185 (323)
T ss_dssp EEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC--
T ss_pred EEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC-CCEEEeeccccc
Confidence 79999999999999997543 1248999999999999999999999999999999999999988 799999999998
Q ss_pred cccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcC
Q 025244 78 EESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNV 153 (255)
Q Consensus 78 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 153 (255)
...... ......+++.|+|||++.+ ..++.++||||||+++|+|++ |+.||.+....+..........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~ 257 (323)
T 3qup_A 186 KIYSGDYYRQGCASKLPVKWLALESLAD--------NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257 (323)
T ss_dssp ---------------CCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred cccccccccccccccCcccccCchhhcC--------CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence 543322 1223456789999999853 567899999999999999999 9999998877776666666655
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 025244 154 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 196 (255)
Q Consensus 154 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~ 196 (255)
.+....+++++.++|.+||+.||.+||++.++++.|++.+...
T Consensus 258 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 258 LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 6667889999999999999999999999999999999888754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=264.66 Aligned_cols=186 Identities=30% Similarity=0.529 Sum_probs=156.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.++||||++||+|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMY 179 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECSCGGGCCCS
T ss_pred eEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCC-CCEEECccccccccc
Confidence 479999999999999998643 348999999999999999999999999999999999999988 699999999998543
Q ss_pred ccc-----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCC
Q 025244 81 LTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVR 154 (255)
Q Consensus 81 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 154 (255)
... ......+|+.|+|||.+.+ ..++.++||||||+++|+|++ |.+||.+....+...........
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 251 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC
T ss_pred ccchhccccccCCCCCccccChHHhcC--------CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC
Confidence 322 1234467889999999853 567889999999999999999 67778776666665555555555
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 025244 155 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 196 (255)
Q Consensus 155 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~ 196 (255)
..+..++..+.++|.+||+.||.+||++.++++.|+......
T Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 252 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 557788999999999999999999999999999999887653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=266.45 Aligned_cols=186 Identities=33% Similarity=0.578 Sum_probs=156.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPR----------------CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 64 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~----------------~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~ 64 (255)
+++||||++||+|.+++...... .+++..++.++.|++.||+|||++|++||||||+||+++.+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCC
Confidence 47999999999999999875432 48999999999999999999999999999999999999988
Q ss_pred CCceEEecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCc
Q 025244 65 LKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMS 140 (255)
Q Consensus 65 ~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~ 140 (255)
+.+||+|||+++...... ......+|+.|+|||++.+ ..++.++||||||+++|+|++ |+.||.+..
T Consensus 182 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 182 -RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp -TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred -CCEEEccccccccccccccceeccCCCCcceeeChHHhcC--------CCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 799999999998544332 1234457889999998853 567899999999999999998 999998876
Q ss_pred hHHHHHHHHhhcC-CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 141 NLQAAYAAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 141 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
............. ......++..+.++|.+||+.||.+||++.+++++|++.+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 5554444443333 334567899999999999999999999999999999988765
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=277.64 Aligned_cols=179 Identities=23% Similarity=0.394 Sum_probs=151.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-CCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-LKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~-~~~~kl~Dfg~a~~~ 79 (255)
+++||||++||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+++..
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence 479999999999999997643 249999999999999999999999999999999999999743 357999999999876
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC---C
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---S 156 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~ 156 (255)
..........||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+............ .
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 273 (387)
T 1kob_A 202 NPDEIVKVTTATAEFAAPEIVDR--------EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 273 (387)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST
T ss_pred CCCcceeeeccCCCccCchhccC--------CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence 55544555689999999999853 567889999999999999999999999877666555544433322 2
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...+++++.++|.+||+.||.+||++.+++++
T Consensus 274 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 35689999999999999999999999999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=260.43 Aligned_cols=184 Identities=29% Similarity=0.556 Sum_probs=156.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVL 155 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGG-GCEEECCTTGGGGBC
T ss_pred eEEEEeCCCCCcHHHHHhhCcc-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCC-CCEEEcccccccccc
Confidence 4799999999999999987543 48999999999999999999999999999999999999988 689999999998543
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
... ......++..|+|||++.+ ..++.++||||||+++|+|++ |+.||.+....+.............+
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 227 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 227 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred cccccccccccccccccChhhhcC--------CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCC
Confidence 321 2234467889999999853 567889999999999999999 89999887766655555444444456
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
..++..+.+++.+||+.||.+||++.+++++|+.+..
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 6789999999999999999999999999999988765
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=271.32 Aligned_cols=186 Identities=31% Similarity=0.506 Sum_probs=153.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcE
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP---------------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 59 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~---------------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Ni 59 (255)
+++||||++||+|.+++..... ..+++..++.++.|++.||+|||++||+||||||+||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 203 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 203 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence 5899999999999999987543 2378999999999999999999999999999999999
Q ss_pred EEeCCCCceEEecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCC
Q 025244 60 LLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLP 135 (255)
Q Consensus 60 ll~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p 135 (255)
|++.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|+|++ |..|
T Consensus 204 ll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 204 LVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--------GIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp EEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred EEcCC-CcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc--------CCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 99988 799999999998543322 1233457889999998853 567899999999999999998 9999
Q ss_pred CCCCchHHHHHHHHhhcC-CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 136 FEGMSNLQAAYAAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
|.+............... .+.+..+++++.++|.+||+.||.+||++.+++++|+.....
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 988765555444444333 334667899999999999999999999999999999887653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=272.86 Aligned_cols=179 Identities=24% Similarity=0.378 Sum_probs=148.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC---CCCceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE---DLKTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~---~~~~~kl~Dfg~a~ 77 (255)
+++||||++||+|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++. + +.+||+|||+++
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~-~~~kL~Dfg~a~ 182 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPL-GDIKIVDFGMSR 182 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTB-CCEEECCGGGCE
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCC-CcEEEeeCcccc
Confidence 479999999999999997655556999999999999999999999999999999999999987 4 689999999998
Q ss_pred ccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC--
Q 025244 78 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-- 155 (255)
Q Consensus 78 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-- 155 (255)
............||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+............
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 254 (327)
T 3lm5_A 183 KIGHACELREIMGTPEYLAPEILNY--------DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE 254 (327)
T ss_dssp EC---------CCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred ccCCccccccccCCcCccCCeeecC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc
Confidence 7655554556789999999999853 567889999999999999999999999877666655544433322
Q ss_pred -CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 -SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....+++.+.++|.+||+.||.+||++.+++++
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 245688999999999999999999999999987
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=268.56 Aligned_cols=185 Identities=29% Similarity=0.530 Sum_probs=152.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHTTT-CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC-----
T ss_pred cEEEEeCCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCC-CcEEECCCCcchhhc
Confidence 3799999999999999987533 49999999999999999999999999999999999999988 799999999998543
Q ss_pred ccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCC
Q 025244 81 LTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
... ......+|..|+|||++.+ ..++.++||||||+++|||++ |+.||.+....+...........+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 270 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISY--------RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 270 (333)
T ss_dssp ------------CCCGGGSCHHHHHS--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred cccccccccCCCCccccccCchhccc--------CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC
Confidence 321 1223356789999999853 567889999999999999998 999998877766655555554555
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
....++..+.++|.+||+.||.+||++.++++.|+.....
T Consensus 271 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 271 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 6778999999999999999999999999999999988754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=273.57 Aligned_cols=189 Identities=17% Similarity=0.226 Sum_probs=153.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC--ceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK--TIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~--~~kl~Dfg~a~~ 78 (255)
++|||||+ |++|.+++.......+++..++.++.|++.||.|||++||+||||||+|||++.+ + .+||+|||+++.
T Consensus 133 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~-~~~~~kl~Dfg~a~~ 210 (352)
T 2jii_A 133 RFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE-DQSQVTLAGYGFAFR 210 (352)
T ss_dssp EEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETT-EEEEEEECCGGGCBC
T ss_pred EEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCC-CCceEEEecCcceee
Confidence 37999999 9999999997644459999999999999999999999999999999999999987 5 899999999975
Q ss_pred ccccc--------ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCc-hHHHHHHHH
Q 025244 79 ESLTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS-NLQAAYAAA 149 (255)
Q Consensus 79 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~-~~~~~~~~~ 149 (255)
..... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+.. .........
T Consensus 211 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 282 (352)
T 2jii_A 211 YCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--------CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQK 282 (352)
T ss_dssp SSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHH
T ss_pred ccCCCccccccccccccccCCccccCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHH
Confidence 43322 1234579999999999853 568899999999999999999999998754 222222211
Q ss_pred ---hhcCCCC------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcCCC
Q 025244 150 ---FKNVRPS------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 199 (255)
Q Consensus 150 ---~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~~~ 199 (255)
....... ...+++++.++|.+||+.||.+||++.++++.|+.........
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 283 QKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp HHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 1111111 1256899999999999999999999999999999988765433
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=285.75 Aligned_cols=185 Identities=28% Similarity=0.505 Sum_probs=157.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN-HLVKVADFGLSRLMT 369 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-GCEEECCTTCEECCT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCC-CcEEEeecccceecc
Confidence 5899999999999999998666669999999999999999999999999999999999999988 699999999998643
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
... ......++..|+|||++.. ..++.++||||||+++|||++ |..||.+.+..+...........+.+
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 441 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP 441 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC
T ss_pred CCceeecCCCcCCcceeCHhHHhc--------CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 322 1223456789999999853 457889999999999999999 99999987766655544444445557
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
..+++.+.+||.+||+.||.+||++.++++.|+.++.
T Consensus 442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 7899999999999999999999999999999987643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=289.27 Aligned_cols=180 Identities=24% Similarity=0.401 Sum_probs=153.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++...+...+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~-g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDH-GHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCC-CCeEEEecccceecc
Confidence 4899999999999999988766669999999999999999999999999999999999999988 799999999998765
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHHhhcCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN---LQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~ 157 (255)
........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+... ...............+
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl~~--------~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p 409 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVVKN--------ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS 409 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHHTT--------CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC
T ss_pred cCccccccCCCccccCHHHHcC--------CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC
Confidence 5544566789999999999853 4578899999999999999999999987532 2333333334444446
Q ss_pred CCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARP-----NFTQIIQML 189 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~l 189 (255)
..+++++.+||.+||+.||.+|| ++.++++|-
T Consensus 410 ~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 410 ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 77899999999999999999999 789998873
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=265.48 Aligned_cols=186 Identities=28% Similarity=0.506 Sum_probs=159.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.+ +.++|+|||+++...
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMT 162 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGG-GCEEECCCCGGGTSC
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCC-CCEEEccCccceecc
Confidence 3799999999999999998766679999999999999999999999999999999999999988 699999999998544
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
... ......+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||.+.+..+.............+
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP 234 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC
T ss_pred CCccccccCCccccCcCChhhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCC
Confidence 322 2233456789999999853 567889999999999999999 99999887766655555555455567
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
..+++.+.++|.+||+.||.+||++.++++.|+..+..
T Consensus 235 ~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 78999999999999999999999999999999887654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=265.12 Aligned_cols=184 Identities=27% Similarity=0.478 Sum_probs=155.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++...+. +++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALR 168 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEECC
T ss_pred cEEEEEeCCCCCHHHHHHhCcC--CCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCC-CcEEEccCCcceeec
Confidence 3799999999999999987544 9999999999999999999999999999999999999988 699999999998543
Q ss_pred cccc----cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCC
Q 025244 81 LTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
.... .....+++.|+|||++.+ ..++.++||||||+++|+|++ |+.||.+....+............
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 240 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG 240 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred cCCCcccccccCCCCceeeChHHhcc--------CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 3221 223456789999999853 446789999999999999999 999999877766555555544455
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
.+..+++.+.++|.+||+.||.+||++.++++.|++++..
T Consensus 241 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 241 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 5678899999999999999999999999999999988754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=265.62 Aligned_cols=186 Identities=32% Similarity=0.588 Sum_probs=144.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASET-KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED-NTVKIGDFGLATEKS 171 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-TEEEECCCC------
T ss_pred cEEEEEecCCCcHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC-CCEEEccceeccccc
Confidence 4799999999999999976443 49999999999999999999999999999999999999998 799999999997533
Q ss_pred c---ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC-C-
Q 025244 81 L---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-P- 155 (255)
Q Consensus 81 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~- 155 (255)
. ........||+.|+|||++... ....++.++||||||+++|+|++|+.||.+....+........... +
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQ-----DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246 (289)
T ss_dssp ------------CCCTTCCHHHHC---------CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC
T ss_pred cccccccccccCCCccccCchhhccc-----CCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc
Confidence 2 2223445799999999988521 2356788999999999999999999999887666555544433322 2
Q ss_pred ---CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 025244 156 ---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 193 (255)
Q Consensus 156 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~ 193 (255)
....+++.+.++|.+||+.||.+||++.++++.|+++.
T Consensus 247 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 23478899999999999999999999999999998764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=264.48 Aligned_cols=188 Identities=24% Similarity=0.490 Sum_probs=158.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDFGLSKALG 161 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCCTTCEECT
T ss_pred cEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCC-CCEEECcccceeeec
Confidence 379999999999999997543 349999999999999999999999999999999999999988 799999999998543
Q ss_pred ccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCC
Q 025244 81 LTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
... ......+|+.|+|||++.+ ..++.++||||||+++|+|++ |+.||.+....+...........+
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~ 233 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 233 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC
T ss_pred cCcceeeccccccccccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCC
Confidence 221 1233456899999999853 457889999999999999998 999998877666555555544455
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcCC
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 198 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~~ 198 (255)
.+..+++++.++|.+||+.||.+||++.+++++|+..+.....
T Consensus 234 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 234 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 5678999999999999999999999999999999998866443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=264.15 Aligned_cols=187 Identities=24% Similarity=0.348 Sum_probs=151.2
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE---eCCCCceEEecCccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL---TEDLKTIKLADFGLARE 78 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill---~~~~~~~kl~Dfg~a~~ 78 (255)
++||||+ |++|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||+ +.+ +.+||+|||+++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~-~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGT-TCEEECCCTTCEE
T ss_pred EEEEEcc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCC-CeEEEecCcccee
Confidence 7999999 9999999986443 39999999999999999999999999999999999999 566 6899999999985
Q ss_pred ccccc--------ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH---HHHHH
Q 025244 79 ESLTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL---QAAYA 147 (255)
Q Consensus 79 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~---~~~~~ 147 (255)
..... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.... +....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 229 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 229 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcC--------CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhh
Confidence 43322 1235679999999999853 56788999999999999999999999764322 11111
Q ss_pred HHhhc-CCC---CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcCCC
Q 025244 148 AAFKN-VRP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 199 (255)
Q Consensus 148 ~~~~~-~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~~~ 199 (255)
..... ..+ ....+++++.++|.+||+.||.+||++.++++.|++........
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 230 ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred hhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 11111 111 13567899999999999999999999999999999988776543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=264.67 Aligned_cols=188 Identities=24% Similarity=0.347 Sum_probs=151.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe---CCCCceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT---EDLKTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~---~~~~~~kl~Dfg~a~ 77 (255)
+++||||+ |++|.+++..... .+++..++.++.|++.||+|||++|++||||||+|||++ .+ +.+||+|||+++
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~-~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAK 156 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGT-TCEEECCCTTCE
T ss_pred eEEEEEec-CCCHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCC-CeEEEeeCCCcc
Confidence 37999999 9999999985433 499999999999999999999999999999999999995 55 689999999998
Q ss_pred ccccccc--------cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH---HHHH
Q 025244 78 EESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL---QAAY 146 (255)
Q Consensus 78 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~---~~~~ 146 (255)
....... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+.... +...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 228 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 228 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred cccccccccccccccccccccccccCChhhhcC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh
Confidence 5443221 245679999999999853 56788999999999999999999999764321 1111
Q ss_pred HHHhhcC-CC---CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcCCC
Q 025244 147 AAAFKNV-RP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 199 (255)
Q Consensus 147 ~~~~~~~-~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~~~ 199 (255)
....... .+ ....+++++.++|.+||+.||.+||++.++++.|+........+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 229 RISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred hhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 1111111 11 13568899999999999999999999999999999988775544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=278.61 Aligned_cols=176 Identities=26% Similarity=0.365 Sum_probs=145.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAE-CHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEESS
T ss_pred EEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCC-CCEEecCCccccccc
Confidence 489999996 6999999864 39999999999999999999999999999999999999998 699999999997532
Q ss_pred c----------------------ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 025244 81 L----------------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 138 (255)
Q Consensus 81 ~----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~ 138 (255)
. .......+||++|+|||++.+ ...++.++|||||||++|||++|++||.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG-------STKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcC-------CCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 2 112344689999999999853 35688999999999999999999999998
Q ss_pred CchHHHHHHHHhhcCCCC----------------------------------------------CCCCcHHHHHHHHHhc
Q 025244 139 MSNLQAAYAAAFKNVRPS----------------------------------------------AENVPEELSIILTSCW 172 (255)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~l~~li~~~l 172 (255)
.+.......+......|. ...+++++.+||.+||
T Consensus 234 ~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 234 SSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 877666555432222111 1267889999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 025244 173 KEDPNARPNFTQIIQM 188 (255)
Q Consensus 173 ~~~p~~Rpt~~~vl~~ 188 (255)
+.||.+|||+.|+++|
T Consensus 314 ~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 314 QFNPNKRISANDALKH 329 (388)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred ccCcccCCCHHHHhCC
Confidence 9999999999999987
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=269.23 Aligned_cols=183 Identities=24% Similarity=0.504 Sum_probs=152.5
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
++||||+++|+|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTC------
T ss_pred eEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCC-CCEEEccCcceeEccC
Confidence 689999999999999987543 39999999999999999999999999999999999999988 6999999999985433
Q ss_pred cc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 82 TE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 82 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
.. ......+|+.|+|||++.+ ..++.++||||||+++|||++ |+.||.+....+...........+.+
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 241 (327)
T ss_dssp ----------CCCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred ccccccccCCCccccccCHHHHcC--------CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 22 2233456889999999863 568899999999999999999 99999987776666655555556667
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
..++.++.++|.+||+.||.+||++.++++.|.....
T Consensus 242 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 242 PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 7899999999999999999999999999999988764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=271.33 Aligned_cols=185 Identities=34% Similarity=0.491 Sum_probs=148.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++..... .+++.+++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 82 LNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN-KNVVVADFGLARLMV 159 (310)
T ss_dssp EEEEEECCTTCBHHHHHHHCCT-TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTT-SCEEECCCTTCEECC
T ss_pred eEEEEEecCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCC-CCEEEeecccceecc
Confidence 3799999999999999987533 39999999999999999999999999999999999999988 799999999998543
Q ss_pred cccc---------------cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHH-
Q 025244 81 LTEM---------------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA- 144 (255)
Q Consensus 81 ~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~- 144 (255)
.... .....||+.|+|||++.+ ..++.++||||||+++|||++|..||........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~ 231 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--------RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD 231 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcC--------CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence 2211 115679999999999853 5678899999999999999999999865322110
Q ss_pred ---HHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcC
Q 025244 145 ---AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 197 (255)
Q Consensus 145 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~ 197 (255)
....... ...+..+++.+.++|.+||+.||.+||++.++++.|+.+.....
T Consensus 232 ~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 232 FGLNVRGFLD--RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp SSBCHHHHHH--HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred Hhhhhhcccc--ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0000111 12346778899999999999999999999999999988765543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=273.39 Aligned_cols=179 Identities=28% Similarity=0.379 Sum_probs=147.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++..... +++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFR 156 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTTTB--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECE
T ss_pred EEEEEEcCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCC-CCEEEEEeeccceec
Confidence 3799999999999999976543 9999999999999999999999999999999999999988 699999999997533
Q ss_pred c---ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC--CC
Q 025244 81 L---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--RP 155 (255)
Q Consensus 81 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~ 155 (255)
. ........||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+............... .+
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 229 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKR-------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHC-------SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTST
T ss_pred cCCcccccCCCccCcCccCcHHhcc-------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCC
Confidence 2 222345689999999999853 23346789999999999999999999987655433333322222 22
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
....+++.+.+||.+||+.||.+|||+.|++++-
T Consensus 230 ~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 230 PWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 2356889999999999999999999999999873
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=272.51 Aligned_cols=177 Identities=30% Similarity=0.396 Sum_probs=139.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC---CCCceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE---DLKTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~---~~~~~kl~Dfg~a~ 77 (255)
+++||||++||+|.+++...+. +++.+++.++.|++.||.|||++||+||||||+|||++. + +.+||+|||+++
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~-~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPD-APLKIADFGLSK 199 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTT-CCEEECCCC---
T ss_pred EEEEEEeCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCC-CCEEEccCcccc
Confidence 3799999999999999986543 999999999999999999999999999999999999975 4 689999999998
Q ss_pred ccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC---
Q 025244 78 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--- 154 (255)
Q Consensus 78 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--- 154 (255)
............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+...........
T Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~ 271 (349)
T 2w4o_A 200 IVEHQVLMKTVCGTPGYCAPEILRG--------CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI 271 (349)
T ss_dssp -------------CGGGSCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCC
T ss_pred ccCcccccccccCCCCccCHHHhcC--------CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccC
Confidence 6554444556789999999999853 56788999999999999999999999876665544443333222
Q ss_pred -CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 155 -PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 155 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+....++.++.+||.+||+.||++||++.+++++
T Consensus 272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 272 SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2235688999999999999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=275.94 Aligned_cols=180 Identities=26% Similarity=0.369 Sum_probs=152.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC-CCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE-DLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~-~~~~~kl~Dfg~a~~~ 79 (255)
++|||||++|++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||+.. +.+.+||+|||+++..
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESY-NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EEEEEeCCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 4799999999999999976432 3899999999999999999999999999999999999952 2268999999999876
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC---
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--- 156 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 156 (255)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.............
T Consensus 240 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 311 (373)
T 2x4f_A 240 KPREKLKVNFGTPEFLAPEVVNY--------DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE 311 (373)
T ss_dssp CTTCBCCCCCSSCTTCCHHHHTT--------CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGG
T ss_pred CCccccccccCCCcEeChhhccC--------CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhh
Confidence 55555556689999999998853 5678899999999999999999999998777666555554433322
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
...+++++.+||.+||+.||.+||++.+++++-
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp 344 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKHP 344 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 356899999999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=268.24 Aligned_cols=188 Identities=31% Similarity=0.571 Sum_probs=158.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
+++||||++||+|.+++..... ..+++..++.++.|++.||+|||++||+||||||+||+++.+ +
T Consensus 116 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~ 194 (334)
T 2pvf_A 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-N 194 (334)
T ss_dssp CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-C
T ss_pred eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCC-C
Confidence 5899999999999999987542 248999999999999999999999999999999999999988 7
Q ss_pred ceEEecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchH
Q 025244 67 TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 142 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~ 142 (255)
.+||+|||+++...... ......+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....
T Consensus 195 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 195 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred CEEEccccccccccccccccccCCCCcccceeChHHhcC--------CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 99999999998544322 2234467889999998853 457889999999999999999 99999887766
Q ss_pred HHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcC
Q 025244 143 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 197 (255)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~ 197 (255)
+.............+..++.++.++|.+||+.||.+||++.+++++|+.+.....
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 5555444444455567889999999999999999999999999999998876543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=288.60 Aligned_cols=188 Identities=23% Similarity=0.485 Sum_probs=157.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNR-HYAKISDFGLSKALG 487 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCSTTTTCC
T ss_pred eEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCC-CcEEEeeccCccccc
Confidence 479999999999999997643 349999999999999999999999999999999999999988 699999999998643
Q ss_pred cccc----cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCC
Q 025244 81 LTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
.... .....+++.|+|||++.. ..++.++|||||||++|||++ |+.||.+....+...........+
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~--------~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~ 559 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 559 (613)
T ss_dssp --------------CCTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC
T ss_pred CCCceeeeccCCCCccceeCHhhhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 3221 122345689999999853 568899999999999999998 999999888777666666555556
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcCC
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 198 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~~ 198 (255)
.+..+++++.+||.+||+.||.+||++.++++.|+........
T Consensus 560 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 6778999999999999999999999999999999988765443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=283.76 Aligned_cols=178 Identities=28% Similarity=0.402 Sum_probs=152.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++.+.+. +++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~-~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSSS--CCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTT-CCEEECCCSSCEECC
T ss_pred EEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecC-CCeEEEeccchhhcc
Confidence 4899999999999999986544 9999999999999999999999999999999999999988 699999999998765
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
......+.+||+.|+|||++.+ ....+.++|||||||++|+|++|+.||.+........... ......+..+
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~-~~~~~~p~~~ 239 (476)
T 2y94_A 168 DGEFLRTSCGSPNYAAPEVISG-------RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC-DGIFYTPQYL 239 (476)
T ss_dssp TTCCBCCCCSCSTTCCHHHHTT-------CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH-TTCCCCCTTC
T ss_pred ccccccccCCCcCeEChhhccC-------CCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh-cCCcCCCccC
Confidence 5555567789999999999863 2234679999999999999999999998866554444333 3334446678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
++++.++|.+||+.||.+|||+.+++++-
T Consensus 240 s~~~~~Li~~~L~~dP~~Rpt~~eil~hp 268 (476)
T 2y94_A 240 NPSVISLLKHMLQVDPMKRATIKDIREHE 268 (476)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence 99999999999999999999999999873
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=280.13 Aligned_cols=184 Identities=21% Similarity=0.349 Sum_probs=151.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++.+... .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~-g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFED-RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLM 226 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHHccC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCC-CCEEEcchhhhhhcc
Confidence 4899999999999999987432 39999999999999999999999999999999999999988 799999999997543
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc---CCC
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN---VRP 155 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~~ 155 (255)
... .....+||+.|+|||++.... .....++.++|||||||++|||++|+.||.+.+..+....+.... ..|
T Consensus 227 ~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 303 (437)
T 4aw2_A 227 EDGTVQSSVAVGTPDYISPEILQAME---GGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303 (437)
T ss_dssp TTSCEECCSCCSCGGGCCHHHHHHHH---TSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred cCCCcccccccCCcCeeChHHHhhcc---cCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCC
Confidence 322 234468999999999985210 013457889999999999999999999999877666655544321 222
Q ss_pred -CCCCCcHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 025244 156 -SAENVPEELSIILTSCWKEDPNA--RPNFTQIIQML 189 (255)
Q Consensus 156 -~~~~~~~~l~~li~~~l~~~p~~--Rpt~~~vl~~l 189 (255)
....+++++.+||.+||..+|++ ||+++|+++|-
T Consensus 304 ~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 304 TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 23568999999999999888888 99999999873
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=269.06 Aligned_cols=177 Identities=27% Similarity=0.373 Sum_probs=147.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-SCEEECCCSCC----
T ss_pred EEEEEeCCCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCC-CcEEEEeCCcccccc
Confidence 4899999999999999987654 8999999999999999999999999999999999999988 799999999998533
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
. .......+||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....... .....+..
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-~~~~~p~~ 243 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILMR--------SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK-CKLNLPPY 243 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTT--------SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCCCTT
T ss_pred cCCccccccCCCcCccCHhhCcC--------CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-CCCCCCCC
Confidence 2 233455689999999999853 5678899999999999999999999998766555444433 33344567
Q ss_pred CcHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARP-----NFTQIIQML 189 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~l 189 (255)
+++++.++|.+||..||.+|| ++.++++|-
T Consensus 244 ~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 244 LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 899999999999999999999 788998873
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=273.35 Aligned_cols=191 Identities=24% Similarity=0.385 Sum_probs=150.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE----eCCCCceEEecCcc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL----TEDLKTIKLADFGL 75 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill----~~~~~~~kl~Dfg~ 75 (255)
++|||||++|++|.+++..... ..+++..++.++.|++.||+|||++||+||||||+|||+ +.+ +.+||+|||+
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kL~Dfg~ 162 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGA 162 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSC-EEEEECCCTT
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCC-ceEEEccCCC
Confidence 3799999999999999987543 339999999999999999999999999999999999998 555 5799999999
Q ss_pred ccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch----HHHHHHHHhh
Q 025244 76 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN----LQAAYAAAFK 151 (255)
Q Consensus 76 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~----~~~~~~~~~~ 151 (255)
++............||+.|+|||++............++.++|||||||++|||++|+.||..... .+........
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 987665555566789999999998854322222246788899999999999999999999964332 2233333322
Q ss_pred cCC--------------------CC----CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 152 NVR--------------------PS----AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 152 ~~~--------------------~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
... +. ...++..+.++|.+||+.||++||++.|++++..+.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 211 11 123456788999999999999999999999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=265.73 Aligned_cols=186 Identities=28% Similarity=0.525 Sum_probs=153.1
Q ss_pred EEEEecCCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 2 VIVTELLSGGTLRKYLLNM----RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~----~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
++||||++||+|.+++... ....+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+++
T Consensus 117 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~-~~~kl~Dfg~~~ 195 (313)
T 3brb_A 117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD-MTVCVADFGLSK 195 (313)
T ss_dssp EEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTT-SCEEECSCSCC-
T ss_pred EEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CcEEEeecCcce
Confidence 7999999999999999642 23459999999999999999999999999999999999999988 699999999998
Q ss_pred cccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcC
Q 025244 78 EESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNV 153 (255)
Q Consensus 78 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 153 (255)
...... ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+..........
T Consensus 196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 267 (313)
T 3brb_A 196 KIYSGDYYRQGRIAKMPVKWIAIESLAD--------RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267 (313)
T ss_dssp ---------------CCGGGSCHHHHHS--------SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred ecccccccCcccccCCCccccCchhhcC--------CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence 543321 2233457889999999853 567889999999999999999 8999988776666555555555
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 025244 154 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 196 (255)
Q Consensus 154 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~ 196 (255)
...+..+++.+.++|.+||+.||.+||++.+++++|++.....
T Consensus 268 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 268 LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 5567788999999999999999999999999999999887654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=261.51 Aligned_cols=186 Identities=31% Similarity=0.660 Sum_probs=147.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCCeecCCCCCcEEEeCCCCceEEecCccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHS---HGIIHRDLKPENLLLTEDLKTIKLADFGLA 76 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~---~~i~HrDikp~Nill~~~~~~~kl~Dfg~a 76 (255)
+++||||++||+|.+++..... ..++...++.++.|++.||+|||+ +||+||||||+||+++.+...+||+|||++
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence 4799999999999999986543 237889999999999999999999 899999999999999987334899999999
Q ss_pred cccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHhhcCC
Q 025244 77 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL--QAAYAAAFKNVR 154 (255)
Q Consensus 77 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~ 154 (255)
...... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ............
T Consensus 154 ~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 223 (307)
T 2eva_A 154 CDIQTH--MTNNKGSAAWMAPEVFEG--------SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP 223 (307)
T ss_dssp -------------CCTTSSCHHHHTC--------CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC
T ss_pred cccccc--cccCCCCCceEChhhhCC--------CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC
Confidence 754322 234579999999999853 56788999999999999999999999764332 222333333344
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 025244 155 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 196 (255)
Q Consensus 155 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~ 196 (255)
+....++..+.++|.+||+.||.+||++.++++.|+......
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 456778999999999999999999999999999998876544
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=268.10 Aligned_cols=177 Identities=28% Similarity=0.429 Sum_probs=148.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+. .+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 117 ~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~ 192 (321)
T 2c30_A 117 LWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQIS 192 (321)
T ss_dssp EEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CcEEEeeeeeeeecc
Confidence 37999999999999998753 39999999999999999999999999999999999999988 699999999998544
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC--CCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSA 157 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~ 157 (255)
.. .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+....+........... ...
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2c30_A 193 KDVPKRKSLVGTPYWMAPEVISR--------SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS 264 (321)
T ss_dssp SSSCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTG
T ss_pred cCccccccccCCccccCHhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCcc
Confidence 32 22345689999999999853 56788999999999999999999999887665554443332221 123
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
..+++.+.++|.+||+.||.+||++.+++++.
T Consensus 265 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 265 HKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 45789999999999999999999999999873
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=267.47 Aligned_cols=185 Identities=30% Similarity=0.564 Sum_probs=156.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEec
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 72 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~D 72 (255)
+++||||++||+|.+++..... ..+++..++.++.|++.||.|||++||+||||||+||+++.+ +.+||+|
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~-~~~kl~D 181 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIGD 181 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT-CCEEECC
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC-CeEEECc
Confidence 4799999999999999986421 347899999999999999999999999999999999999988 7999999
Q ss_pred Ccccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHH
Q 025244 73 FGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAA 148 (255)
Q Consensus 73 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~ 148 (255)
||+++...... ......+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+.....
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred CccccccccccccccccCCCCCCCccChhhhcc--------CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 99998543322 2234467889999999853 567889999999999999999 89999987776666655
Q ss_pred HhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 149 AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 149 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
......+....++..+.++|.+||+.||.+||++.+++++|++...
T Consensus 254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 5555556677899999999999999999999999999999976543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=260.92 Aligned_cols=179 Identities=37% Similarity=0.748 Sum_probs=145.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CeecCCCCCcEEEeCC-------CCceEE
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG---IIHRDLKPENLLLTED-------LKTIKL 70 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---i~HrDikp~Nill~~~-------~~~~kl 70 (255)
+++||||++|++|.+++... .+++..++.++.|++.||+|||++| ++||||||+||+++.+ .+.+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp CEEEEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred eEEEEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 48999999999999999643 3999999999999999999999999 8999999999999862 368999
Q ss_pred ecCccccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh
Q 025244 71 ADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF 150 (255)
Q Consensus 71 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 150 (255)
+|||+++...... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..........
T Consensus 158 ~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 228 (271)
T 3dtc_A 158 TDFGLAREWHRTT-KMSAAGAYAWMAPEVIRA--------SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM 228 (271)
T ss_dssp CCCCC--------------CCGGGSCHHHHHH--------CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT
T ss_pred ccCCccccccccc-ccCCCCccceeCHHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc
Confidence 9999998544332 234579999999998853 5678899999999999999999999998777666655554
Q ss_pred hcCC-CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 151 KNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 151 ~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
.... +.+..+++.+.++|.+||+.||.+||++.+++++|+.
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 229 NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 4433 3467789999999999999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=290.79 Aligned_cols=184 Identities=27% Similarity=0.481 Sum_probs=156.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 444 ~~lv~E~~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~-~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALR 520 (635)
T ss_dssp EEEEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCTTHHHHTT
T ss_pred EEEEEEccCCCCHHHHHhhCCC--CCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC-CCEEEEEcCCccccc
Confidence 3799999999999999987544 9999999999999999999999999999999999999988 699999999998543
Q ss_pred ccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCC
Q 025244 81 LTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+....+...........+
T Consensus 521 ~~~~~~~~~~~~~~t~~y~APE~~~~--------~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~ 592 (635)
T 4fl3_A 521 ADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG 592 (635)
T ss_dssp C-------------CGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred cCccccccccCCCCceeeeChhhhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 322 1233456789999999853 568899999999999999998 999999988777666666666666
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
.+..+++++.+||.+||+.||++||++.++++.|++++..
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 6788999999999999999999999999999999988754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=259.74 Aligned_cols=183 Identities=26% Similarity=0.467 Sum_probs=154.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++||||++||+|.+++.......+++..++.++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||++..
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~-~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED-MTARISMADVKFS 162 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT-SCEEEEGGGSCCT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC-cceeEEeccceee
Confidence 479999999999999999876556999999999999999999999999 9999999999999988 6899999988764
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC-CCC
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSA 157 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~ 157 (255)
.. .....||+.|+|||++.+. ....++.++||||||+++|||++|+.||.+....+........... ..+
T Consensus 163 ~~----~~~~~~t~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (271)
T 3kmu_A 163 FQ----SPGRMYAPAWVAPEALQKK-----PEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP 233 (271)
T ss_dssp TS----CTTCBSCGGGSCHHHHHSC-----GGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred ec----ccCccCCccccChhhhccC-----CCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC
Confidence 22 2345789999999998641 1223445899999999999999999999987777665555544433 346
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 193 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~ 193 (255)
..+++++.++|.+||+.||.+|||+.++++.|+...
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 234 PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 678999999999999999999999999999998753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=269.96 Aligned_cols=181 Identities=25% Similarity=0.379 Sum_probs=148.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEESCSSEEEECC
T ss_pred EEEEeecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CcEEEeeCCCCeecc
Confidence 4799999999999999987654 9999999999999999999999999999999999999988 699999999998543
Q ss_pred cc--cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCc---hHHHHHHHHhhcCCC
Q 025244 81 LT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS---NLQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~---~~~~~~~~~~~~~~~ 155 (255)
.. ......+||+.|+|||++.+ ....++.++|||||||++|||++|+.||.... ..............+
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 284 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRG------GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTT------CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC
T ss_pred cCCCCcccCcccCcCccChhhhcC------CCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC
Confidence 22 22344679999999999853 22456789999999999999999999997432 222233333344445
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARP-----NFTQIIQMLL 190 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~l~ 190 (255)
.+..++..+.+||.+||..||.+|| ++.+++++.+
T Consensus 285 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 285 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 5678899999999999999999999 9999998753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=271.90 Aligned_cols=180 Identities=23% Similarity=0.421 Sum_probs=146.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC---ceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK---TIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~---~~kl~Dfg~a~ 77 (255)
+++||||++||+|.+++.+.+. +++.++..++.||+.||+|||++||+||||||+|||+..+.+ .+||+|||+++
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~--~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCTT--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 4899999999999999987544 999999999999999999999999999999999999854322 49999999998
Q ss_pred cccc-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCc---hHHHHHHHHhhcC
Q 025244 78 EESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS---NLQAAYAAAFKNV 153 (255)
Q Consensus 78 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~---~~~~~~~~~~~~~ 153 (255)
.... .....+.+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.. ..+..........
T Consensus 169 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 240 (342)
T 2qr7_A 169 QLRAENGLLMTPCYTANFVAPEVLER--------QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF 240 (342)
T ss_dssp ECBCTTCCBCCSSCCSSCCCHHHHHH--------HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCC
T ss_pred cCcCCCCceeccCCCccccCHHHhcC--------CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCc
Confidence 5433 233456789999999999853 346779999999999999999999997632 2222223332222
Q ss_pred CC---CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 154 RP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 154 ~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
.. ....+++++.+||.+||..||.+||++.++++|-+
T Consensus 241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 21 23568999999999999999999999999998754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=261.62 Aligned_cols=177 Identities=25% Similarity=0.391 Sum_probs=151.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE---eCCCCceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL---TEDLKTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill---~~~~~~~kl~Dfg~a~ 77 (255)
+++||||++|++|.+++..... +++..++.++.|++.||+|||++|++||||||+||++ +.+ +.++|+|||++.
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~-~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPD-SPLKLIDFGLAA 157 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTT-CCEEECCCTTCE
T ss_pred EEEEEeccCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCC-CcEEEEecccce
Confidence 3799999999999999987654 9999999999999999999999999999999999999 555 689999999998
Q ss_pred ccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 78 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 78 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
............||+.|+|||++. +.++.++||||||+++|+|++|+.||.+....+..............
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (277)
T 3f3z_A 158 RFKPGKMMRTKVGTPYYVSPQVLE---------GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE 228 (277)
T ss_dssp ECCTTSCBCCCCSCTTTCCHHHHT---------TCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred eccCccchhccCCCCCccChHHhc---------ccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 765555556678999999999874 34788999999999999999999999987766655555444333321
Q ss_pred ---CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 158 ---ENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 158 ---~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
..+++.+.++|.+||+.||.+||++.+++++-
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~ 263 (277)
T 3f3z_A 229 KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHE 263 (277)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 36889999999999999999999999999863
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=266.54 Aligned_cols=178 Identities=26% Similarity=0.357 Sum_probs=150.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC---ceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK---TIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~---~~kl~Dfg~a~ 77 (255)
+++||||++|++|.+++..... +++..++.++.|++.||+|||++|++||||||+||+++.+.. .+||+|||+++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSC--EEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEEcCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 4799999999999999986543 999999999999999999999999999999999999987722 79999999998
Q ss_pred ccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC-
Q 025244 78 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS- 156 (255)
Q Consensus 78 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~- 156 (255)
............||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+.............
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 239 (321)
T 2a2a_A 168 EIEDGVEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE 239 (321)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred ecCccccccccCCCCCccCcccccC--------CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh
Confidence 6555444556689999999999853 5678899999999999999999999988766555544433322221
Q ss_pred --CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 --AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...++..+.++|.+||+.||.+||++.+++++
T Consensus 240 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 240 EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 25678999999999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=287.92 Aligned_cols=186 Identities=31% Similarity=0.524 Sum_probs=159.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.++|.......+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIE 414 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCTTSTTTCC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCC-CcEEEcccccceecC
Confidence 5899999999999999986544459999999999999999999999999999999999999988 699999999998644
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
... ......++..|+|||++.. ..++.++||||||+++|||++ |+.||.+....+...........+.+
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~ 486 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP 486 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred CCceecccCCcCcccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 322 1223456789999998853 568899999999999999999 99999988877766666555555667
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
..++..+.+||.+||+.||++||++.++++.|+.++..
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 78999999999999999999999999999999877643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=275.87 Aligned_cols=178 Identities=29% Similarity=0.408 Sum_probs=147.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+ +|+|.+++...+. +++.+++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 84 ~~lv~E~~-~g~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMT 159 (336)
T ss_dssp EEEEECCC-CEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTT-CCEEECCSSCTBTTT
T ss_pred EEEEEECC-CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCC-CCEEEEEeccceecc
Confidence 47999999 7899999987654 9999999999999999999999999999999999999988 699999999998766
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
........+||+.|+|||++.+ ....+.++||||||+++|+|++|+.||.+....... ..........+..+
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-~~i~~~~~~~p~~~ 231 (336)
T 3h4j_B 160 DGNFLKTSCGSPNYAAPEVING-------KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-KKVNSCVYVMPDFL 231 (336)
T ss_dssp TSBTTCCCTTSTTTSCGGGSCC-------SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-CCCCSSCCCCCTTS
T ss_pred CCcccccccCCcCcCCHHHHcC-------CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-HHHHcCCCCCcccC
Confidence 5555667789999999999863 222367999999999999999999999764322111 11111122235568
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
++++.++|.+||+.||.+|||+.|++++-+
T Consensus 232 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 232 SPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 899999999999999999999999999844
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=281.19 Aligned_cols=185 Identities=23% Similarity=0.354 Sum_probs=149.9
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe---CCCCceEEecCccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT---EDLKTIKLADFGLARE 78 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~---~~~~~~kl~Dfg~a~~ 78 (255)
+|||||+ |++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++ .+ +.+||+|||+++.
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~-~~vkL~DFGla~~ 155 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFGLAKK 155 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGT-TCEEECCCTTCEE
T ss_pred EEEEECC-CCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCC-CeEEEEeCCccee
Confidence 7999999 9999999986433 399999999999999999999999999999999999994 55 6899999999985
Q ss_pred cccccc--------cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH---HHHHH
Q 025244 79 ESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL---QAAYA 147 (255)
Q Consensus 79 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~---~~~~~ 147 (255)
...... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.... +....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 227 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLG--------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHhcC--------CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH
Confidence 443221 225679999999999853 56889999999999999999999999875431 11111
Q ss_pred HHhhcC----CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcC
Q 025244 148 AAFKNV----RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 197 (255)
Q Consensus 148 ~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~ 197 (255)
...... ......++.++.+||.+||+.||++||++.++++.|+.++....
T Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 228 ISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp HHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 111111 11135778999999999999999999999999999988876543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=266.50 Aligned_cols=187 Identities=29% Similarity=0.536 Sum_probs=155.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
+++||||++||+|.+++..... ..+++..++.++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~-~ 185 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-N 185 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-G
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC-C
Confidence 4899999999999999987543 128899999999999999999999999999999999999987 6
Q ss_pred ceEEecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchH
Q 025244 67 TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 142 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~ 142 (255)
.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....
T Consensus 186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred CEEECCCccccccccCccceeccCCCcceeecCchhhcc--------ccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 99999999998543221 2234467889999999853 567899999999999999998 99999876654
Q ss_pred HHHHHHHhh-cCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 025244 143 QAAYAAAFK-NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 196 (255)
Q Consensus 143 ~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~ 196 (255)
......... .....+..+++.+.++|.+||+.||.+||++.+++++|+..+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 444433333 333445678999999999999999999999999999999887653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=259.13 Aligned_cols=186 Identities=30% Similarity=0.524 Sum_probs=156.6
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
++||||+.||+|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++....
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES-FTVKVADFGLARDILD 176 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECCTTSSCTTTT
T ss_pred EEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CcEEeCcCCCcccccC
Confidence 79999999999999998743 348999999999999999999999999999999999999988 6999999999975332
Q ss_pred c-----cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCC
Q 025244 82 T-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 82 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
. .......+++.|+|||.+.+ ..++.++||||||+++|+|++ |.+||...+..+...........+
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQT--------YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP 248 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC
T ss_pred CcccccccCcCCCCCccccChhhhcc--------CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC
Confidence 2 12234567899999999853 567889999999999999999 555666655555555555555556
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcC
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 197 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~ 197 (255)
.+..+++.+.++|.+||+.||.+|||+.++++.|+.......
T Consensus 249 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 677889999999999999999999999999999999887654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=268.85 Aligned_cols=180 Identities=24% Similarity=0.351 Sum_probs=146.1
Q ss_pred CEEEEecCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCC--CceEEecCccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLA 76 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~--~~~kl~Dfg~a 76 (255)
++|||||++|++|.+++.+.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+. +.+||+|||++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 489999999999999887542 33489999999999999999999999999999999999998652 24999999999
Q ss_pred ccccccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC
Q 025244 77 REESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 77 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
+...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.. .+............
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~ 251 (351)
T 3c0i_A 181 IQLGESGLVAGGRVGTPHFMAPEVVKR--------EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKM 251 (351)
T ss_dssp EECCTTSCBCCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCC
T ss_pred eEecCCCeeecCCcCCcCccCHHHHcC--------CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCC
Confidence 8654432 2345689999999999853 557889999999999999999999998743 22222222222222
Q ss_pred C---CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 156 S---AENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 156 ~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
. ...+++++.+||.+||+.||.+||++.+++++-
T Consensus 252 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 252 NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence 1 256889999999999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=263.38 Aligned_cols=184 Identities=30% Similarity=0.548 Sum_probs=149.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEAS 168 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC-----
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCC-CcEEEeecccccccc
Confidence 4899999999999999987654448899999999999999999999999999999999999988 799999999998543
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
.. .....++..|+|||++.+ ..++.++||||||+++|+|++ |+.||......+................
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (278)
T 1byg_A 169 ST--QDTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 238 (278)
T ss_dssp ---------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTT
T ss_pred cc--ccCCCccccccCHHHhCC--------CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCccc
Confidence 32 233467889999999853 567889999999999999998 9999988665555444433333445677
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
+++.+.++|.+||+.||.+||++.++++.|+.....
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 239 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 899999999999999999999999999999887543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=271.61 Aligned_cols=180 Identities=25% Similarity=0.360 Sum_probs=134.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCC-CceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL-KTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~-~~~kl~Dfg~a~~~ 79 (255)
+++||||++||+|.+++...+. +++..++.++.|++.||+|||++||+||||||+|||++.+. +.+||+|||+++..
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EEEEEEeCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 4799999999999999987654 99999999999999999999999999999999999998662 24999999999854
Q ss_pred ccccccccCCCccceecccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCchH----HHHHHHHhhc-C
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY-NHKVDSYSFAIVLWELLHNKLPFEGMSNL----QAAYAAAFKN-V 153 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~----~~~~~~~~~~-~ 153 (255)
..........||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.... .......... .
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 240 (361)
T 3uc3_A 169 VLHSQPKSTVGTPAYIAPEVLLR--------QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS 240 (361)
T ss_dssp ------------CTTSCHHHHHC--------SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCC
T ss_pred cccCCCCCCcCCCCcCChhhhcC--------CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCC
Confidence 44444556689999999999853 334 34599999999999999999999864432 1112222111 2
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 154 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 154 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
.+....+++++.+||.+||+.||.+|||+.|+++|-+
T Consensus 241 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 241 IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 2334468999999999999999999999999999843
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=275.32 Aligned_cols=181 Identities=18% Similarity=0.364 Sum_probs=144.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||.+....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~-~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCGGGCEECE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccccceeec
Confidence 4799999999999999998755569999999999999999999999999999999999999988 799999999886432
Q ss_pred cc--------cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc
Q 025244 81 LT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 152 (255)
Q Consensus 81 ~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 152 (255)
.. .......||+.|+|||++.+ ....++.++|||||||++|||++|+.||.+.+..+.........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 253 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ------NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHST------TSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred cccccccccccccccccccccccCHHHHhc------cCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 11 11233478999999999853 22467889999999999999999999998755444332221110
Q ss_pred ---------------------------------------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025244 153 ---------------------------------------------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 187 (255)
Q Consensus 153 ---------------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~ 187 (255)
..+....+++++.+||.+||+.||.+|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 01123457889999999999999999999999998
Q ss_pred H
Q 025244 188 M 188 (255)
Q Consensus 188 ~ 188 (255)
+
T Consensus 334 h 334 (389)
T 3gni_B 334 H 334 (389)
T ss_dssp S
T ss_pred C
Confidence 7
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=265.29 Aligned_cols=178 Identities=28% Similarity=0.381 Sum_probs=145.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ |+|.+++..... .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 94 ~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 94 LTLVFEFME-KDLKKVLDENKT-GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD-GALKLADFGLARAFG 170 (311)
T ss_dssp EEEEEECCS-EEHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEETT
T ss_pred EEEEEcCCC-CCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCC-CCEEEccCcCceecC
Confidence 479999997 589998886543 49999999999999999999999999999999999999988 799999999998644
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC---
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--- 156 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 156 (255)
.. .......||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+....+...........+.
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 243 (311)
T 3niz_A 171 IPVRSYTHEVVTLWYRAPDVLMG-------SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE 243 (311)
T ss_dssp SCCC---CCCCCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTT
T ss_pred CCcccccCCcccCCcCCHHHhcC-------CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHH
Confidence 22 33445678999999999853 24578899999999999999999999987666555444332211111
Q ss_pred --------------------------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 --------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 --------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...+++++.+||.+||+.||.+|||+.|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 23467899999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=273.99 Aligned_cols=180 Identities=19% Similarity=0.267 Sum_probs=145.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC--ceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK--TIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~--~~kl~Dfg~a~~ 78 (255)
+++||||+ |++|.+++...+ .+++.+++.++.|++.||+|||++||+||||||+|||++.+ + .+||+|||+++.
T Consensus 127 ~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~~~kL~Dfg~a~~ 202 (345)
T 2v62_A 127 RFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-NPDQVYLADYGLSYR 202 (345)
T ss_dssp EEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS-STTSEEECCCTTCEE
T ss_pred EEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC-CCCcEEEEeCCCcee
Confidence 48999999 999999998765 39999999999999999999999999999999999999876 4 899999999975
Q ss_pred ccccc--------ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHH
Q 025244 79 ESLTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA-AYAAA 149 (255)
Q Consensus 79 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-~~~~~ 149 (255)
..... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+...... .....
T Consensus 203 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 274 (345)
T 2v62_A 203 YCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--------VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK 274 (345)
T ss_dssp SSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--------CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHH
T ss_pred cccccccccchhccccccCCCccccCHHHhcC--------CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHH
Confidence 43221 1245579999999999853 5678999999999999999999999964222111 11111
Q ss_pred --hhcCCC-------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 150 --FKNVRP-------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 150 --~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
.....+ ....+++++.++|.+||+.||.+||++.++++.|+..
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 275 TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 111111 1227889999999999999999999999999998654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=264.70 Aligned_cols=179 Identities=27% Similarity=0.407 Sum_probs=146.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 113 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 188 (298)
T 2zv2_A 113 LYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED-GHIKIADFGVSNEFK 188 (298)
T ss_dssp EEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCEECS
T ss_pred EEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC-CCEEEecCCCccccc
Confidence 4799999999999887543 349999999999999999999999999999999999999988 799999999998644
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-CCCCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-RPSAE 158 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~ 158 (255)
.. .......||+.|+|||++.+. ....++.++||||||+++|+|++|+.||.+............... .+...
T Consensus 189 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 263 (298)
T 2zv2_A 189 GSDALLSNTVGTPAFMAPESLSET-----RKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQP 263 (298)
T ss_dssp SSSCEECCCCSCGGGCCGGGCCTT-----CCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSSS
T ss_pred cccccccCCcCCccccChhhhccC-----CCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCCcc
Confidence 32 233456899999999998531 011246789999999999999999999988665544433333222 23346
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 159 NVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 159 ~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.+++++.++|.+||+.||.+||++.|+++|
T Consensus 264 ~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 264 DIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 789999999999999999999999999886
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=269.92 Aligned_cols=183 Identities=26% Similarity=0.390 Sum_probs=153.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++|++|.+++..... +++..+..++.|++.||.|||+.|++||||||+|||++.+ +.++|+|||++....
T Consensus 175 ~~lv~e~~~g~~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~-~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN-MQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEEecCcccccC
Confidence 4799999999999999987544 9999999999999999999999999999999999999988 799999999998765
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC---C
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS---A 157 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~ 157 (255)
.........||+.|+|||++.+... .....++.++||||||+++|+|++|+.||.+.................. .
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMD--ETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTC--TTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CCcccccCCCCCCccChhhcccccc--ccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 5555566789999999998854211 0123578899999999999999999999988766555544444333322 2
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..++..+.++|.+||+.||.+||++.+++++
T Consensus 330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 4678899999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=260.84 Aligned_cols=181 Identities=28% Similarity=0.452 Sum_probs=151.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 173 (284)
T 2a19_B 95 LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT-KQVKIGDFGLVTSLK 173 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEESS
T ss_pred EEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC-CCEEECcchhheecc
Confidence 3799999999999999987654559999999999999999999999999999999999999988 699999999998655
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
.........||+.|+|||++.+ ..++.++||||||+++|+|++|..|+... ......... ......+
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~~~--~~~~~~~ 240 (284)
T 2a19_B 174 NDGKRTRSKGTLRYMSPEQISS--------QDYGKEVDLYALGLILAELLHVCDTAFET---SKFFTDLRD--GIISDIF 240 (284)
T ss_dssp CCSCCCCCCSCCTTSCHHHHHC--------SCCCTHHHHHHHHHHHHHHHSCCSSHHHH---HHHHHHHHT--TCCCTTS
T ss_pred ccccccccCCcccccChhhhcc--------CCCcchhhhHHHHHHHHHHHhcCCcchhH---HHHHHHhhc--ccccccC
Confidence 5544556679999999999853 56788999999999999999999887431 111111111 2234568
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 161 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
+..+.++|.+||+.||.+||++.+++++|+.+...
T Consensus 241 ~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 241 DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 89999999999999999999999999999877543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=259.87 Aligned_cols=180 Identities=31% Similarity=0.582 Sum_probs=148.8
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEeCCCCc-----eEEecCc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKT-----IKLADFG 74 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--i~HrDikp~Nill~~~~~~-----~kl~Dfg 74 (255)
++||||++||+|.+++.+... .+++..++.++.|++.||+|||++| ++||||||+||+++.+ +. +||+|||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~-~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL-DENAPVCAKVADFG 174 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC-CTTCSCCEEECCCT
T ss_pred eEEEEecCCCCHHHHHhcccC-CccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc-CCCCceeEEeCCCC
Confidence 689999999999999976543 4999999999999999999999999 9999999999999876 44 9999999
Q ss_pred cccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHHhhc
Q 025244 75 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA--YAAAFKN 152 (255)
Q Consensus 75 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~ 152 (255)
+++.... ......||+.|+|||++.. ....++.++||||||+++|+|++|+.||......... .......
T Consensus 175 ~~~~~~~--~~~~~~g~~~y~aPE~~~~------~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 175 LSQQSVH--SVSGLLGNFQWMAPETIGA------EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp TCBCCSS--CEECCCCCCTTSCGGGSSC------SSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred ccccccc--cccccCCCccccCchhhcc------CCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 9985433 2345689999999999843 2345678999999999999999999999876544332 2222222
Q ss_pred -CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 153 -VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 153 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
....+..+++.+.++|.+||+.||.+||++.++++.|++
T Consensus 247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 223466789999999999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=259.13 Aligned_cols=178 Identities=28% Similarity=0.383 Sum_probs=152.1
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCC--CceEEecCcccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLAREE 79 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~--~~~kl~Dfg~a~~~ 79 (255)
++||||++|++|.+++..... +++..+..++.|++.||.|||++|++||||||+||+++.+. +.+||+|||++...
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 799999999999999987654 99999999999999999999999999999999999998652 34999999999876
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC---C
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---S 156 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~ 156 (255)
..........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+................. .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T 3kk8_A 159 NDSEAWHGFAGTPGYLSPEVLKK--------DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 230 (284)
T ss_dssp CSSCBCCCSCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred ccCccccCCCCCcCCcCchhhcC--------CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchh
Confidence 65555566789999999999853 557889999999999999999999998877666555544443322 2
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
...+++++.++|.+||+.||.+||++.|++++-
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 231 WDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred hcccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence 357889999999999999999999999999974
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=260.22 Aligned_cols=179 Identities=30% Similarity=0.482 Sum_probs=142.9
Q ss_pred CEEEEecCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--CCceEEecCccc
Q 025244 1 MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLA 76 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~--~~~~kl~Dfg~a 76 (255)
+++||||++||+|.+++... ....+++..++.++.|++.||+|||++||+||||||+||+++.+ .+.+||+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 37999999999999999753 22449999999999999999999999999999999999999532 257999999999
Q ss_pred cccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC-
Q 025244 77 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP- 155 (255)
Q Consensus 77 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~- 155 (255)
+............||+.|+|||++. ..++.++||||||+++|+|++|+.||.+....+............
T Consensus 175 ~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (285)
T 3is5_A 175 ELFKSDEHSTNAAGTALYMAPEVFK---------RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA 245 (285)
T ss_dssp CC----------CTTGGGCCHHHHT---------TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred eecCCcccCcCcccccCcCChHHhc---------cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc
Confidence 8655554456678999999999874 357889999999999999999999999877655554444333222
Q ss_pred -CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 -SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....+++++.++|.+||+.||.+||++.|++++
T Consensus 246 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 246 VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 234578999999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=265.47 Aligned_cols=186 Identities=28% Similarity=0.480 Sum_probs=142.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCeecCCCCCcEEEeCCCCceEEec
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH--------SHGIIHRDLKPENLLLTEDLKTIKLAD 72 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH--------~~~i~HrDikp~Nill~~~~~~~kl~D 72 (255)
+++||||++||+|.++++.. .+++..++.++.|++.||+||| ++||+||||||+|||++.+ +.+||+|
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~-~~~kl~D 156 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIAD 156 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECC
T ss_pred eEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC-CCEEEee
Confidence 37999999999999999643 3999999999999999999999 9999999999999999988 6999999
Q ss_pred Cccccccccccc-----cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhC----------CCCCC
Q 025244 73 FGLAREESLTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN----------KLPFE 137 (255)
Q Consensus 73 fg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g----------~~p~~ 137 (255)
||+++....... .....||+.|+|||++.+.... ....++.++||||||+++|||++| +.||.
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV--DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCT--TCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCC--CcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999974332211 2345799999999998641100 000344699999999999999999 88886
Q ss_pred CCch----HHHHHHHHh-hcCCCCC------CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 138 GMSN----LQAAYAAAF-KNVRPSA------ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 138 ~~~~----~~~~~~~~~-~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
.... ......... ....+.. ...++.+.++|.+||+.||.+|||+.++++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 5322 122222221 1112211 12457899999999999999999999999998763
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=261.28 Aligned_cols=178 Identities=29% Similarity=0.405 Sum_probs=143.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++..... .+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++...
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 75 LVLVFEHLD-QDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFG 151 (288)
T ss_dssp EEEEEECCS-EEHHHHHHTSTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCTTHHHHHC
T ss_pred EEEEEEecC-CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEEeECccccccC
Confidence 479999997 599999986533 49999999999999999999999999999999999999988 799999999998543
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC----
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---- 155 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---- 155 (255)
.. .......||+.|+|||++.+ ...++.++||||||+++|||++|+.||.+.+..+...........+
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 224 (288)
T 1ob3_A 152 IPVRKYTHEIVTLWYRAPDVLMG-------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224 (288)
T ss_dssp C---------CCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccccccccccccccCchheeC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhh
Confidence 22 22345578999999999853 2457889999999999999999999999877665554443211110
Q ss_pred ------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 ------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....+++++.++|.+||+.||.+|||+.|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 123578999999999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=282.33 Aligned_cols=179 Identities=26% Similarity=0.443 Sum_probs=149.4
Q ss_pred CEEEEecCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
++|||||++||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~-g~vkL~DFGla~~ 338 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD-GNVRISDLGLAVE 338 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCEE
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCC-CCEEEeecceeee
Confidence 489999999999999998754 3459999999999999999999999999999999999999988 7999999999986
Q ss_pred ccccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCc---hHHHHHHHHhhcCC
Q 025244 79 ESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS---NLQAAYAAAFKNVR 154 (255)
Q Consensus 79 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~---~~~~~~~~~~~~~~ 154 (255)
..... .....+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.. ..............
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~--------~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~ 410 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLG--------EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV 410 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC
T ss_pred ccCCCcccccccCCccccChhhhcC--------CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc
Confidence 54332 2344689999999999853 567889999999999999999999998753 22333333334444
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 025244 155 PSAENVPEELSIILTSCWKEDPNARPNF-----TQIIQM 188 (255)
Q Consensus 155 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~-----~~vl~~ 188 (255)
..+..+++++.+||.+||+.||.+||++ .++++|
T Consensus 411 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 411 TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 4567889999999999999999999964 777765
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=267.71 Aligned_cols=186 Identities=27% Similarity=0.478 Sum_probs=153.7
Q ss_pred CEEEEecCCCCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCce
Q 025244 1 MVIVTELLSGGTLRKYLLNMR------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 68 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~------------~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~ 68 (255)
+++||||++||+|.+++.... ...+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~ 203 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG-HVA 203 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG-GEE
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC-CeE
Confidence 489999999999999998642 2348999999999999999999999999999999999999988 699
Q ss_pred EEecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHH
Q 025244 69 KLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 144 (255)
Q Consensus 69 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~ 144 (255)
||+|||+++...... ......+|+.|+|||++.+ ..++.++||||||+++|||++ |..||.+......
T Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD--------CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred EECccccccccccccceeecCCCCCCccccCHHHhcc--------CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 999999998543221 1233457889999998853 567899999999999999998 9999987665554
Q ss_pred HHHHHhhcC-CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 145 AYAAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 145 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
......... ...+..++..+.++|.+||+.||.+||++.+++++|+.....
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 276 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 444443333 334566889999999999999999999999999999877643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=281.51 Aligned_cols=174 Identities=28% Similarity=0.366 Sum_probs=139.3
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
+|||||++ ++|.+.+.. .+++.++..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 143 ~lv~E~~~-~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 143 YLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGT 216 (464)
T ss_dssp EEEEECCS-EEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCCC-----
T ss_pred EEEEeCCC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCC-CCEEEEEEEeeeecCC
Confidence 89999996 568777753 28999999999999999999999999999999999999988 6999999999987665
Q ss_pred ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC-----
Q 025244 82 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS----- 156 (255)
Q Consensus 82 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 156 (255)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+......+.
T Consensus 217 ~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 217 SFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp CCCC----CCCTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred CcccCCCcccccccCHHHHcC--------CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 555566789999999999863 5688899999999999999999999999877666555443222211
Q ss_pred ---------------CCC---------------------CcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 157 ---------------AEN---------------------VPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 157 ---------------~~~---------------------~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
... .++++.+||.+||+.||.+|||+.|+++|-
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 000 156789999999999999999999999974
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=267.87 Aligned_cols=188 Identities=26% Similarity=0.391 Sum_probs=145.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCeecCCCCCcEEEeCCCCceEE
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH----------GIIHRDLKPENLLLTEDLKTIKL 70 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~----------~i~HrDikp~Nill~~~~~~~kl 70 (255)
+++||||++||+|.+++.... +++..++.++.|++.||+|||+. ||+||||||+|||++.+ +.+||
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~-~~~kL 172 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACI 172 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT-CCEEE
T ss_pred EEEEEecCCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC-CeEEE
Confidence 379999999999999998643 99999999999999999999999 99999999999999988 79999
Q ss_pred ecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch------
Q 025244 71 ADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN------ 141 (255)
Q Consensus 71 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~------ 141 (255)
+|||+++...... ......||+.|+|||++.+... ....++.++||||||+++|||++|+.||.+...
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAIN---FQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCC---CCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccc---cCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 9999997543222 2334679999999999864110 012345688999999999999999999975321
Q ss_pred ---------HHHHHHH-HhhcCCCCCC------CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 142 ---------LQAAYAA-AFKNVRPSAE------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 142 ---------~~~~~~~-~~~~~~~~~~------~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
....... ......+... ..+.++.+||.+||+.||.+|||+.++++.|+.+.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111111 1122222211 2245699999999999999999999999999887653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=263.83 Aligned_cols=172 Identities=27% Similarity=0.398 Sum_probs=140.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||+ +++|.+++...+. .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWGA-SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR-GRCKLGDFGLLVELG 208 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGG-GCEEECCCTTCEECC
T ss_pred EEEEEecc-CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEccceeeeecc
Confidence 47999999 7899999987643 49999999999999999999999999999999999999988 699999999998766
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC--CCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--SAE 158 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~ 158 (255)
.........||+.|+|||++. +.++.++||||||+++|||++|..|+.+..... .......+ ...
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~ 275 (311)
T 3p1a_A 209 TAGAGEVQEGDPRYMAPELLQ---------GSYGTAADVFSLGLTILEVACNMELPHGGEGWQ----QLRQGYLPPEFTA 275 (311)
T ss_dssp ------CCCCCGGGCCGGGGG---------TCCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH----HHTTTCCCHHHHT
T ss_pred cCCCCcccCCCccccCHhHhc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH----HHhccCCCccccc
Confidence 555556677999999999874 357889999999999999999977765532221 11111111 135
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 159 NVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 159 ~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.+++++.++|.+||+.||++|||+.+++++
T Consensus 276 ~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 276 GLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 678999999999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=264.84 Aligned_cols=177 Identities=28% Similarity=0.397 Sum_probs=150.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... +++.+++.++.|++.||.|||++||+||||||+||+++.+ +.+||+|||+++...
T Consensus 116 ~~lv~e~~~~~~L~~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVE 192 (335)
T ss_dssp EEEEECCCTTCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCC-CCEEEeeccCceecc
Confidence 4799999999999999987654 9999999999999999999999999999999999999988 699999999998643
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
. ........||..|+|||++.+ ..++.++||||||+++|+|++|+.||......+...... ......+..
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~ 263 (335)
T 2owb_A 193 YDGERKKVLCGTPNYIAPEVLSK--------KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK-KNEYSIPKH 263 (335)
T ss_dssp STTCCBCCCCSCCSSCCHHHHHT--------SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-HTCCCCCTT
T ss_pred cCcccccccCCCccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh-cCCCCCCcc
Confidence 2 223345679999999999853 457889999999999999999999998866555443333 333344567
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
++..+.++|.+||+.||.+||++.+++++-
T Consensus 264 ~~~~~~~li~~~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 264 INPVAASLIQKMLQTDPTARPTINELLNDE 293 (335)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 889999999999999999999999999873
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=267.98 Aligned_cols=185 Identities=29% Similarity=0.465 Sum_probs=149.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE-AHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCGGGCEECC
T ss_pred EEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCC-CCEEEcccccceecc
Confidence 3799999999999999987433 39999999999999999999999999999999999999988 799999999998543
Q ss_pred ccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH--------------
Q 025244 81 LTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL-------------- 142 (255)
Q Consensus 81 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-------------- 142 (255)
... ......||..|+|||++.+ ..++.++||||||+++|+|++|+.||......
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSD--------NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHH
T ss_pred cCCccceeeccCCccccccCHHHhcc--------CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccH
Confidence 222 2234568889999999853 45678999999999999999999998643321
Q ss_pred HHHH-HHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 143 QAAY-AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 143 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
.... ........+....+++.+.++|.+||+.||.+||++.+++++|+.....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 1111 1222333445678899999999999999999999999999999887654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=276.85 Aligned_cols=179 Identities=26% Similarity=0.394 Sum_probs=150.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--CCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~--~~~~kl~Dfg~a~~ 78 (255)
+++||||++||+|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++.+ .+.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEEEEEcCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 4799999999999999987654 9999999999999999999999999999999999999642 24799999999986
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC---
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--- 155 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--- 155 (255)
..........+||+.|+|||++. +.++.++|||||||++|+|++|+.||.+....+............
T Consensus 174 ~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (486)
T 3mwu_A 174 FQQNTKMKDRIGTAYYIAPEVLR---------GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP 244 (486)
T ss_dssp BCCC----CCTTGGGGCCGGGGG---------SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG
T ss_pred CCCCCccCCCcCCCCCCCHHHhC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 65555556678999999999984 347889999999999999999999999877766665555444332
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
....+++++.++|.+||+.||.+|||+.+++++-+
T Consensus 245 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 23567899999999999999999999999999743
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=257.40 Aligned_cols=177 Identities=26% Similarity=0.413 Sum_probs=147.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++..... +++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~-~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAP 160 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTT-SCEEECSCCEESCC-
T ss_pred EEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCC-CCEEEEeccccccCC
Confidence 3799999999999999987654 9999999999999999999999999999999999999988 799999999987543
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
.. ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+.... ........+..+
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~ 230 (279)
T 3fdn_A 161 SS-RRTDLCGTLDYLPPEMIEG--------RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-ISRVEFTFPDFV 230 (279)
T ss_dssp --------CCCCTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-HHHTCCCCCTTS
T ss_pred cc-cccccCCCCCccCHhHhcc--------CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH-HHhCCCCCCCcC
Confidence 32 2345678999999999853 5667899999999999999999999988665544433 333344456678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
++.+.++|.+||+.||.+||++.+++++-+
T Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 231 TEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred CHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 999999999999999999999999999844
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=264.45 Aligned_cols=187 Identities=29% Similarity=0.532 Sum_probs=155.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--CCceEEecC
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP-----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADF 73 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~-----~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~--~~~~kl~Df 73 (255)
+++||||++|++|.+++..... ..+++..++.++.|++.||.|||++|++||||||+|||++.+ ...+||+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence 4899999999999999987642 348999999999999999999999999999999999999843 246999999
Q ss_pred ccccccccc---cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHH
Q 025244 74 GLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAA 149 (255)
Q Consensus 74 g~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~ 149 (255)
|+++..... .......||+.|+|||++.+ ..++.++||||||+++|+|++ |+.||.+....+......
T Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 259 (327)
T 2yfx_A 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFME--------GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259 (327)
T ss_dssp HHHHHHHC------CCGGGSCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred ccccccccccccccCCCcCCCcceeCHhHhcC--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence 999743222 12234567899999998853 567889999999999999998 999998877666555555
Q ss_pred hhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 150 FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 150 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
..........++..+.++|.+||+.||.+||++.+++++|+.....
T Consensus 260 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 5545555678899999999999999999999999999999877653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=259.09 Aligned_cols=176 Identities=29% Similarity=0.577 Sum_probs=149.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++||||++|++|.+++..... +++..++.++.|++.||.|||++| ++||||||+||+++.+.+.+||+|||++..
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEEecCCCCHHHHHHHccC--CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 3799999999999999987654 999999999999999999999999 999999999999984337999999999975
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC--
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-- 156 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 156 (255)
.... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||.+................+.
T Consensus 182 ~~~~-~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (290)
T 1t4h_A 182 KRAS-FAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 251 (290)
T ss_dssp CCTT-SBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG
T ss_pred cccc-ccccccCCcCcCCHHHHh---------ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcccc
Confidence 4332 234567999999999874 3478899999999999999999999988766666655554443332
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....++++.++|.+||+.||.+||++.+++++
T Consensus 252 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 252 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 44567899999999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=258.55 Aligned_cols=177 Identities=28% Similarity=0.397 Sum_probs=150.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... +++.+++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 90 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVE 166 (294)
T ss_dssp EEEEEECCTTCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCC-CCEEEEeccCceecc
Confidence 3799999999999999987654 9999999999999999999999999999999999999988 799999999998643
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
. ........||+.|+|||++.+ ..++.++|+||||+++|+|++|+.||......+...... ......+..
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 237 (294)
T 2rku_A 167 YDGERKKVLCGTPNYIAPEVLSK--------KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK-KNEYSIPKH 237 (294)
T ss_dssp STTCCBCCCCSCCSSCCHHHHTT--------SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-TTCCCCCTT
T ss_pred cCccccccccCCCCcCCcchhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-hccCCCccc
Confidence 2 223345679999999999853 457889999999999999999999998866554443333 333344667
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
++..+.++|.+||+.||.+||++.+++++-
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 238 INPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred cCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 899999999999999999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=266.21 Aligned_cols=187 Identities=26% Similarity=0.455 Sum_probs=151.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+.. +++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCGGGCEECC
T ss_pred EEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCC-CCEEECCcccccccc
Confidence 379999999999999997653 9999999999999999999999999999999999999988 799999999998644
Q ss_pred ccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHH-------------
Q 025244 81 LTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ------------- 143 (255)
Q Consensus 81 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~------------- 143 (255)
... ......+|..|+|||++.+ ..++.++||||||+++|+|++|+.||.......
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 257 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKE--------YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcC--------CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhH
Confidence 322 2334568889999999854 456789999999999999999999996532210
Q ss_pred --HHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcCCC
Q 025244 144 --AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 199 (255)
Q Consensus 144 --~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~~~ 199 (255)
...........+....++.++.+||.+||+.||.+||++.++++.|+.+......+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 258 LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 11111222334456788999999999999999999999999999999887665433
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=262.75 Aligned_cols=183 Identities=24% Similarity=0.467 Sum_probs=149.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEECC
T ss_pred EEEEEEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCC-CCEEECccccccccc
Confidence 3799999999999999976543 39999999999999999999999999999999999999988 699999999998544
Q ss_pred ccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------------chH
Q 025244 81 LTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM--------------SNL 142 (255)
Q Consensus 81 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~--------------~~~ 142 (255)
... ......||..|+|||++.+ ..++.++||||||+++|+|++|..|+... ...
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQ--------SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH
T ss_pred CCCcceeccCCCCCCccccCCeeecC--------CCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH
Confidence 322 2334568889999999854 45678999999999999999999876421 111
Q ss_pred HHHH-HHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 025244 143 QAAY-AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 193 (255)
Q Consensus 143 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~ 193 (255)
.... ........+.+..+++.+.++|.+||+.||.+|||+.++++.|+.++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111 22223334456788999999999999999999999999999998764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=277.80 Aligned_cols=178 Identities=28% Similarity=0.397 Sum_probs=153.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--CCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~--~~~~kl~Dfg~a~~ 78 (255)
+++||||++||+|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+++.
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 4799999999999999987654 9999999999999999999999999999999999999753 24599999999987
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC--
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-- 156 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 156 (255)
..........+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.............
T Consensus 189 ~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (494)
T 3lij_A 189 FENQKKMKERLGTAYYIAPEVLR---------KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP 259 (494)
T ss_dssp CBTTBCBCCCCSCTTTCCHHHHT---------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG
T ss_pred CCCCccccccCCCcCeeCHHHHc---------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch
Confidence 66555556778999999999874 3578899999999999999999999998777666655554443322
Q ss_pred -CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 157 -AENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 157 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
...+++.+.++|.+||+.||.+|||+.++++|-
T Consensus 260 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp 293 (494)
T 3lij_A 260 EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293 (494)
T ss_dssp GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCc
Confidence 356899999999999999999999999999873
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=257.06 Aligned_cols=178 Identities=29% Similarity=0.404 Sum_probs=141.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... +++..++.++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTT-SCEEECCCCGGGCCC
T ss_pred EEEEEeccCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCC-CCEEEeecccccccC
Confidence 3799999999999999987654 9999999999999999999999999999999999999988 699999999998755
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
.........||+.|+|||++.+ ....+.++|+||||+++|+|++|+.||.......... .........+..+
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (276)
T 2h6d_A 163 DGEFLRTSCGSPNYAAPEVISG-------RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFK-KIRGGVFYIPEYL 234 (276)
T ss_dssp C-------------CCTGGGTT-------SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHCCCCCCTTS
T ss_pred CCcceecccCCccccCHHHHcC-------CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH-HhhcCcccCchhc
Confidence 5444456679999999999853 1233679999999999999999999998765544433 3333344456678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
+..+.++|.+||+.||.+||++.+++++-
T Consensus 235 ~~~l~~li~~~l~~~p~~Rps~~~~l~h~ 263 (276)
T 2h6d_A 235 NRSVATLLMHMLQVDPLKRATIKDIREHE 263 (276)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHhCh
Confidence 99999999999999999999999999973
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=267.30 Aligned_cols=178 Identities=28% Similarity=0.437 Sum_probs=126.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCC--CceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~--~~~kl~Dfg~a~~ 78 (255)
+++||||++||+|.+++...+. +++.++..++.|++.||+|||++||+||||||+|||++.+. ..+||+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEEEEEccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 3799999999999999987644 99999999999999999999999999999999999998652 2799999999985
Q ss_pred cccc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHHhh
Q 025244 79 ESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL------QAAYAAAFK 151 (255)
Q Consensus 79 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~------~~~~~~~~~ 151 (255)
.... ......+||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.... .........
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~ 230 (325)
T 3kn6_A 159 KPPDNQPLKTPCFTLHYAAPELLNQ--------NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK 230 (325)
T ss_dssp CCC------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT
T ss_pred cCCCCCcccccCCCcCccCHHHhcC--------CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc
Confidence 4332 23355678999999999853 56788999999999999999999999764331 112222222
Q ss_pred cCCCCC----CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 152 NVRPSA----ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 152 ~~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...... ..+++++.+||.+||+.||.+||++.+++++
T Consensus 231 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 231 GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp TCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 111111 3578999999999999999999999999876
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=273.31 Aligned_cols=181 Identities=26% Similarity=0.312 Sum_probs=147.8
Q ss_pred CEEEEecCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~--~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++||||++ ++|.+.+.. .....+++..+..++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+++.
T Consensus 128 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 128 LNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 368999996 577777764 23345999999999999999999999999999999999999997646789999999986
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC---
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--- 155 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--- 155 (255)
..........+||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..+....+......+
T Consensus 207 ~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 207 LVRGEPNVSYICSRYYRAPELIFG-------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279 (420)
T ss_dssp CCTTCCCCSCCSCTTSCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cccCCCceeeeeCCCcCCHHHHcC-------CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 554444556789999999999853 2467889999999999999999999999877666555443321110
Q ss_pred -------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 156 -------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 156 -------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
....+++++.+||.+||+.||.+||++.|+++|-
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 1235678999999999999999999999999873
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=266.71 Aligned_cols=174 Identities=26% Similarity=0.353 Sum_probs=147.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+ |++|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 105 ~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQAD 179 (367)
T ss_dssp CEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECC
T ss_pred EEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCC-CCEEEEeeecccccc
Confidence 48999999 89999999863 39999999999999999999999999999999999999988 699999999998644
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC-----
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP----- 155 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~----- 155 (255)
.. ....+||++|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..+....+......+
T Consensus 180 ~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 180 SE--MTGYVVTRWYRAPEVILN-------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp SS--CCSSCSCGGGCCTHHHHT-------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cc--cCcCcCCCCcCCHHHHhC-------CCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 32 345689999999998853 2568889999999999999999999999877665554433221111
Q ss_pred -------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 -------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 -------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.....++.+.+||.+||..||.+|||+.++++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 124568999999999999999999999999997
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=263.04 Aligned_cols=179 Identities=26% Similarity=0.434 Sum_probs=147.0
Q ss_pred CEEEEecCCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 76 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~----~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a 76 (255)
++|||||++ |+|.+++.... ...+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 78 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~ 155 (317)
T 2pmi_A 78 LTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR-GQLKLGDFGLA 155 (317)
T ss_dssp EEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCSSC
T ss_pred EEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCC-CCEEECcCccc
Confidence 479999997 69999997642 2348999999999999999999999999999999999999988 79999999999
Q ss_pred cccccc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC
Q 025244 77 REESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 77 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
+..... .......||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+....+...........+
T Consensus 156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 228 (317)
T 2pmi_A 156 RAFGIPVNTFSSEVVTLWYRAPDVLMG-------SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP 228 (317)
T ss_dssp EETTSCCCCCCCCCSCCTTCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred eecCCCcccCCCCcccccccCchHhhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 864422 23345678999999999853 2457889999999999999999999999877665554443211110
Q ss_pred ---------------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 ---------------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ---------------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....++.++.+||.+||+.||.+|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 229 NESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 112578899999999999999999999999987
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=262.52 Aligned_cols=178 Identities=27% Similarity=0.381 Sum_probs=142.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... +++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQRG--VPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH-SVIKLCDFGFARLLT 153 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSSC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECC
T ss_pred EEEEEEeCCCchHHHHHhhhcC--CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCC-CCEEEeeCCCchhcc
Confidence 3799999999999998876544 9999999999999999999999999999999999999988 799999999998644
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC------
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV------ 153 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~------ 153 (255)
. ........||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+....+..........
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
T 4agu_A 154 GPSDYYDDEVATRWYRSPELLVG-------DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH 226 (311)
T ss_dssp ------------GGGCCHHHHHT-------CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred CcccccCCCcCCccccChHHHhc-------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccc
Confidence 2 233345679999999999853 35678899999999999999999999998776655443322110
Q ss_pred --------------CCC----------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 154 --------------RPS----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 154 --------------~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.+. ...++.++.++|.+||+.||.+|||+.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 14678899999999999999999999999987
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=263.28 Aligned_cols=184 Identities=27% Similarity=0.502 Sum_probs=143.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCeecCCCCCcEEEeCCCCceEEec
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--------GIIHRDLKPENLLLTEDLKTIKLAD 72 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~--------~i~HrDikp~Nill~~~~~~~kl~D 72 (255)
+++||||++||+|.+++.... +++..++.++.|++.||+|||++ ||+||||||+|||++.+ +.+||+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~kl~D 185 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIAD 185 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECC
T ss_pred eEEEEeccCCCcHHHHhhccC---CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC-CCEEEEe
Confidence 379999999999999997643 99999999999999999999999 99999999999999988 6999999
Q ss_pred Cccccccccccc-----cccCCCccceecccccccccccccccCCCCc------hhhHHHHHHHHHHHHhC---------
Q 025244 73 FGLAREESLTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNH------KVDSYSFAIVLWELLHN--------- 132 (255)
Q Consensus 73 fg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~------~~DvwslG~~l~el~~g--------- 132 (255)
||+++....... .....||+.|+|||++.+ ..... ++|||||||++|||++|
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE--------SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTT--------CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhccc--------ccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 999975433221 235579999999999864 22222 49999999999999999
Q ss_pred -CCCCCCCch----HHHHHHHH-hhcCCCCC------CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 025244 133 -KLPFEGMSN----LQAAYAAA-FKNVRPSA------ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 196 (255)
Q Consensus 133 -~~p~~~~~~----~~~~~~~~-~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~ 196 (255)
+.||..... ........ .....+.. ..+++++.++|.+||+.||.+||++.+++++|+.+....
T Consensus 258 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 258 YQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 777754322 11222211 12222221 245678999999999999999999999999999887653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=259.13 Aligned_cols=178 Identities=25% Similarity=0.359 Sum_probs=141.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 76 ~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 76 LTLVFEFCD-QDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFG 152 (292)
T ss_dssp EEEEEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECC
T ss_pred EEEEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceecC
Confidence 479999996 56777766533 239999999999999999999999999999999999999988 799999999998644
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCC-CCCchHHHHHHHHhhcCCC---
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF-EGMSNLQAAYAAAFKNVRP--- 155 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~-~~~~~~~~~~~~~~~~~~~--- 155 (255)
.. .......||+.|+|||++.+ ...++.++||||||+++|+|++|..|| .+.+..+...........+
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~ 225 (292)
T 3o0g_A 153 IPVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225 (292)
T ss_dssp SCCSCCCSCCSCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred CccccccCCccccCCcChHHHcC-------CCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 32 33455688999999999853 244788999999999999999888775 4444443333332211111
Q ss_pred -------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 -------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 -------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....++.++.+||.+||+.||++|||+.|+++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 123478899999999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=259.43 Aligned_cols=178 Identities=28% Similarity=0.386 Sum_probs=151.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ |+|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 94 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~ 171 (326)
T 1blx_A 94 LTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYS 171 (326)
T ss_dssp EEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECSCCSCCCCC
T ss_pred EEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCC-CCEEEecCccccccc
Confidence 379999997 699999998766669999999999999999999999999999999999999988 799999999998665
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC-----
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP----- 155 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~----- 155 (255)
.........||..|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+...........+
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 172 FQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp GGGGGCCCCCCCTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred CCCCccccccccceeCHHHHhc--------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence 5544556789999999999853 557889999999999999999999999877665554443211110
Q ss_pred ---------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 ---------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....++..+.+||.+||+.||.+||++.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 124678999999999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=279.07 Aligned_cols=178 Identities=25% Similarity=0.408 Sum_probs=153.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe---CCCCceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT---EDLKTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~---~~~~~~kl~Dfg~a~ 77 (255)
+++||||++||+|.+++...+. +++..++.++.|++.||.|||++||+||||||+|||++ .+ +.+||+|||+++
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~-~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKD-ANIRIIDFGLST 177 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTCSC--CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTT-CCEEECCTTHHH
T ss_pred EEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCC-CcEEEEeeeeeE
Confidence 4799999999999999987554 99999999999999999999999999999999999995 34 689999999998
Q ss_pred ccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC-
Q 025244 78 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS- 156 (255)
Q Consensus 78 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~- 156 (255)
............||+.|+|||++. +.++.++|||||||++|+|++|++||.+.+..+.............
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 248 (484)
T 3nyv_A 178 HFEASKKMKDKIGTAYYIAPEVLH---------GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL 248 (484)
T ss_dssp HBCCCCSHHHHTTGGGTCCHHHHH---------TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS
T ss_pred EcccccccccCCCCccccCceeec---------CCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 665555555668999999999984 3578899999999999999999999998877766665555443322
Q ss_pred --CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 157 --AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 157 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
...+++++.+||.+||+.||.+|||+.++++|-+
T Consensus 249 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 249 PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 3468899999999999999999999999999744
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=277.74 Aligned_cols=179 Identities=29% Similarity=0.437 Sum_probs=153.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC--ceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK--TIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~--~~kl~Dfg~a~~ 78 (255)
++|||||++||+|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.+.. .+||+|||+++.
T Consensus 121 ~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 198 (504)
T 3q5i_A 121 FYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198 (504)
T ss_dssp EEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEE
T ss_pred EEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEE
Confidence 4799999999999999987654 999999999999999999999999999999999999987622 699999999987
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC--
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-- 156 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 156 (255)
...........||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.............
T Consensus 199 ~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 269 (504)
T 3q5i_A 199 FSKDYKLRDRLGTAYYIAPEVLK---------KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269 (504)
T ss_dssp CCTTSCBCCCCSCTTTCCHHHHT---------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred cCCCCccccccCCcCCCCHHHhc---------cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 66555556778999999999874 3578899999999999999999999998777666555554433322
Q ss_pred -CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 157 -AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 157 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
...+++++.+||.+||+.||.+|||+.|++++-+
T Consensus 270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 2578999999999999999999999999998743
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=261.40 Aligned_cols=181 Identities=24% Similarity=0.456 Sum_probs=145.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCc--------eEEec
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT--------IKLAD 72 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~--------~kl~D 72 (255)
.++||||++||+|.+++.+... .+++..++.++.|++.||.|||++||+||||||+|||++.+ +. +||+|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIRE-EDRKTGNPPFIKLSD 164 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEEC-CBGGGTBCCEEEECC
T ss_pred CEEEEECCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecC-Ccccccccceeeecc
Confidence 4799999999999999987543 38999999999999999999999999999999999999887 45 99999
Q ss_pred CccccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCchHHHHHHHHhh
Q 025244 73 FGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNK-LPFEGMSNLQAAYAAAFK 151 (255)
Q Consensus 73 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~-~p~~~~~~~~~~~~~~~~ 151 (255)
||++...... ....||..|+|||++.+ ...++.++||||||+++|||++|. +||......... ... .
T Consensus 165 fg~~~~~~~~---~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~-~ 232 (289)
T 4fvq_A 165 PGISITVLPK---DILQERIPWVPPECIEN-------PKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFY-E 232 (289)
T ss_dssp CCSCTTTSCH---HHHHHTTTTSCHHHHHC-------GGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHH-H
T ss_pred CcccccccCc---cccCCcCcccCHHHhCC-------CCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHh-h
Confidence 9999754332 23457889999999853 245788999999999999999954 555544433322 222 2
Q ss_pred cCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 152 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 152 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
.....+...++++.++|.+||+.||.+||++.+++++|+.++..
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 233 DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 23334556688999999999999999999999999999877653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=256.23 Aligned_cols=177 Identities=23% Similarity=0.334 Sum_probs=150.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++...+. +++..++.++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK-GELKIADFGWSVHAP 165 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT-CCEEECCCTTCEECS
T ss_pred EEEEEEeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCC-CCEEEecccccccCc
Confidence 3799999999999999987654 9999999999999999999999999999999999999988 699999999987543
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
.. ......|++.|+|||++.+ ..++.++|+||||+++|+|++|+.||......+....... .....+..+
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~ 235 (284)
T 2vgo_A 166 SL-RRRTMCGTLDYLPPEMIEG--------KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN-VDLKFPPFL 235 (284)
T ss_dssp SS-CBCCCCSCGGGCCHHHHTT--------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-TCCCCCTTS
T ss_pred cc-ccccccCCCCcCCHHHhcc--------CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc-cccCCCCcC
Confidence 32 2345679999999999853 4578899999999999999999999988666554443333 333345678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
+.++.++|.+||+.||.+||++.+++++-+
T Consensus 236 ~~~~~~li~~~l~~~p~~Rps~~~ll~h~~ 265 (284)
T 2vgo_A 236 SDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265 (284)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTCHH
T ss_pred CHHHHHHHHHHhhcCHhhCCCHHHHhhCHH
Confidence 999999999999999999999999998743
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=266.99 Aligned_cols=177 Identities=25% Similarity=0.310 Sum_probs=144.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC-----------------
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE----------------- 63 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~----------------- 63 (255)
++|||||+ |++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccc
Confidence 47999999 999999999876666999999999999999999999999999999999999974
Q ss_pred -------CCCceEEecCccccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 025244 64 -------DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 136 (255)
Q Consensus 64 -------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~ 136 (255)
..+.+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILN--------LGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcC--------CCCCCccchHHHHHHHHHHHHCCCCC
Confidence 136899999999986433 2345689999999999863 56889999999999999999999999
Q ss_pred CCCchHHHHHHHHhhcCCCC---------------------------------------------CCCCcHHHHHHHHHh
Q 025244 137 EGMSNLQAAYAAAFKNVRPS---------------------------------------------AENVPEELSIILTSC 171 (255)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~l~~li~~~ 171 (255)
.+....+............. ....++.+.+||.+|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 339 (360)
T 3llt_A 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI 339 (360)
T ss_dssp CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence 88766554433322111100 001236788999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 025244 172 WKEDPNARPNFTQIIQM 188 (255)
Q Consensus 172 l~~~p~~Rpt~~~vl~~ 188 (255)
|+.||.+|||+.|++++
T Consensus 340 L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 340 LQIDPTLRPSPAELLKH 356 (360)
T ss_dssp CCSSGGGSCCHHHHTTS
T ss_pred hcCChhhCCCHHHHhcC
Confidence 99999999999999876
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=273.47 Aligned_cols=176 Identities=26% Similarity=0.304 Sum_probs=146.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCc--eEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT--IKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~--~kl~Dfg~a~~ 78 (255)
+++||||++ ++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.+ +. +||+|||+++.
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~-~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ-GRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESST-TSCCEEECCCTTCEE
T ss_pred EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccC-CCcceEEeeccccee
Confidence 479999995 799999998766669999999999999999999999999999999999999987 45 99999999975
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC--
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-- 156 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 156 (255)
... ...+.+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+...........+.
T Consensus 252 ~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~ 321 (429)
T 3kvw_A 252 EHQ--RVYTYIQSRFYRAPEVILG--------ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK 321 (429)
T ss_dssp TTC--CCCSSCSCGGGCCHHHHHT--------BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cCC--cccccCCCCCccChHHHhC--------CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 432 2345689999999999863 5678999999999999999999999998776655544332111110
Q ss_pred --------------------------------------------------------CCCCcHHHHHHHHHhcccCCCCCC
Q 025244 157 --------------------------------------------------------AENVPEELSIILTSCWKEDPNARP 180 (255)
Q Consensus 157 --------------------------------------------------------~~~~~~~l~~li~~~l~~~p~~Rp 180 (255)
....++.+.+||.+||+.||.+||
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp 401 (429)
T 3kvw_A 322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401 (429)
T ss_dssp HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence 112367899999999999999999
Q ss_pred CHHHHHHH
Q 025244 181 NFTQIIQM 188 (255)
Q Consensus 181 t~~~vl~~ 188 (255)
|+.|+++|
T Consensus 402 ta~e~L~H 409 (429)
T 3kvw_A 402 TPGQALRH 409 (429)
T ss_dssp CHHHHHTS
T ss_pred CHHHHhCC
Confidence 99999997
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=274.22 Aligned_cols=181 Identities=29% Similarity=0.400 Sum_probs=139.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCC--CceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~--~~~kl~Dfg~a~~ 78 (255)
+++||||++||+|.+++...+. +++..+..++.|++.||+|||++||+||||||+|||++.+. ..+||+|||+++.
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSCC--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred eEEEEEcCCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 3799999999999999976543 99999999999999999999999999999999999997541 3599999999997
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC--
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-- 156 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 156 (255)
..........+||+.|+|||++... ....++.++||||||+++|+|++|+.||.+..................
T Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~ 366 (419)
T 3i6u_A 292 LGETSLMRTLCGTPTYLAPEVLVSV-----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366 (419)
T ss_dssp CC-----------CTTCCTTTTC---------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred cCCCccccccCCCCCccCceeeecC-----CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence 6655555677899999999998531 135578899999999999999999999986544333222222222211
Q ss_pred --CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 --AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...+++.+.++|.+||+.||.+||++.++++|
T Consensus 367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 24678999999999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=268.88 Aligned_cols=179 Identities=27% Similarity=0.357 Sum_probs=149.5
Q ss_pred EEEEecCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 2 VIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~--~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
++||||++ |+|.+.+.. .....+++..+..++.|++.||+|||++||+||||||+|||++.+.+.+||+|||+++..
T Consensus 114 ~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 192 (383)
T 3eb0_A 114 NVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL 192 (383)
T ss_dssp EEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCccc
Confidence 69999997 688888875 233459999999999999999999999999999999999999854379999999999876
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC----
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---- 155 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---- 155 (255)
..........||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..+...........+
T Consensus 193 ~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~ 265 (383)
T 3eb0_A 193 IPSEPSVAYICSRFYRAPELMLG-------ATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQ 265 (383)
T ss_dssp CTTSCCCCCCCCSSCCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCCCCCcCcccCCCccCHHHhcC-------CCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 55555566789999999998853 3457889999999999999999999999887776665554322111
Q ss_pred ------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 ------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.+..+++++.+||.+||+.||.+|||+.|+++|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 266 MIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 134578899999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=258.59 Aligned_cols=184 Identities=29% Similarity=0.556 Sum_probs=151.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+++++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMRALP 172 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEECC
T ss_pred ceeeEecccCCCHHHHHHhccC-CcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCC-CCEEEcccccccccc
Confidence 4799999999999999987532 39999999999999999999999999999999999999988 699999999998543
Q ss_pred ccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhc-CC
Q 025244 81 LTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKN-VR 154 (255)
Q Consensus 81 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~-~~ 154 (255)
... ......+|..|+|||++.+ ..++.++||||||+++|+|++ |+.||.+....+......... ..
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKT--------RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred ccccchhhhccCCCCceeeCchhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC
Confidence 322 1234467889999999853 446789999999999999999 999999877666555444333 23
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 155 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 155 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
+....++.++.++|.+||+.||.+||++.++++.|++...
T Consensus 245 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 245 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 3456789999999999999999999999999999987643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=263.28 Aligned_cols=178 Identities=29% Similarity=0.370 Sum_probs=148.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 87 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 87 ISLVFDFME-TDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFG 163 (346)
T ss_dssp CEEEEECCS-EEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCGGGSTTT
T ss_pred eEEEEEcCC-CCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCC-CCEEEEecccceecc
Confidence 489999997 48999997654 348899999999999999999999999999999999999988 799999999998643
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC---
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--- 156 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 156 (255)
. ........||+.|+|||++.+ ...++.++||||||+++|+|++|.+||.+.+..+...........+.
T Consensus 164 ~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 164 SPNRAYTHQVVTRWYRAPELLFG-------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 236 (346)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTT-------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CCcccCCcccccccccCchHhhC-------CCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence 3 233455689999999998853 24578899999999999999999999998777666555443222111
Q ss_pred ------------------------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 ------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 ------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...++.++.++|.+||+.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 13457899999999999999999999999997
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=261.30 Aligned_cols=178 Identities=24% Similarity=0.388 Sum_probs=142.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ |+|.+++...+. .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 75 LTLVFEYLD-KDLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER-GELKLADFGLARAKS 151 (324)
T ss_dssp EEEEEECCS-EEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTT-CCEEECSSSEEECC-
T ss_pred EEEEecccc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCC-CCEEEccCccccccc
Confidence 479999996 699999987543 49999999999999999999999999999999999999988 799999999998544
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC---
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--- 156 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 156 (255)
. ........||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+.+..+...........+.
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLG-------STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEET 224 (324)
T ss_dssp -----------CGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CCccccccccCcccccChhhhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHh
Confidence 2 223345578999999998853 34578899999999999999999999998776665554433222211
Q ss_pred --------------------------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 --------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 --------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...+++++.+||.+||+.||.+|||+.|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp STTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred chhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 13467899999999999999999999999997
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=256.85 Aligned_cols=179 Identities=28% Similarity=0.387 Sum_probs=146.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCC---CceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL---KTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~---~~~kl~Dfg~a~ 77 (255)
+++||||++|++|.+++..... +++..++.++.|++.||.|||++|++||||||+||+++.+. ..+||+|||++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEeecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 3799999999999999987554 99999999999999999999999999999999999998762 179999999998
Q ss_pred ccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC-
Q 025244 78 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS- 156 (255)
Q Consensus 78 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~- 156 (255)
............||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+.............
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T 3bhy_A 161 KIEAGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE 232 (283)
T ss_dssp ECC--------CCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH
T ss_pred eccCCCcccccCCCcCccCcceecC--------CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc
Confidence 6554444456679999999998853 5678899999999999999999999988766555444433322221
Q ss_pred --CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 157 --AENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 157 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
...++..+.++|.+||..||.+||++.+++++-
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 233 EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence 256789999999999999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=259.49 Aligned_cols=178 Identities=29% Similarity=0.455 Sum_probs=152.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++... .+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++....
T Consensus 95 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 95 LWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLT 170 (303)
T ss_dssp EEEEEECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECB
T ss_pred EEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCC-CCEEEeecccceecC
Confidence 37999999999999999753 39999999999999999999999999999999999999988 699999999998644
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.......................
T Consensus 171 ~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T 3a7i_A 171 DTQIKRNTFVGTPFWMAPEVIKQ--------SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGN 242 (303)
T ss_dssp TTBCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSS
T ss_pred ccccccCccCCCcCccCHHHHhc--------CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccc
Confidence 332 2345679999999999853 5577899999999999999999999988776665555444444445667
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
++..+.++|.+||+.||.+||++.+++++.+
T Consensus 243 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 243 YSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 8999999999999999999999999998754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=255.77 Aligned_cols=180 Identities=27% Similarity=0.400 Sum_probs=149.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++++ |.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~-~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALH 160 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECC
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCC-CcEEeeccccccccC
Confidence 37999999765 8888887666669999999999999999999999999999999999999988 799999999998543
Q ss_pred c---ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 L---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
. ........||+.|+|||++.+ ....++.++||||||+++|+|++|+.||.+....+..... .......+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i-~~~~~~~~ 233 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANG------LDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI-GKGSYAIP 233 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTC------CSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHCCCCCC
T ss_pred ccccccccccCCCCCCCcChhhccC------cccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH-hcCCCCCC
Confidence 2 223345679999999998853 1223467999999999999999999999886655444333 33334456
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
..++..+.++|.+||+.||.+||++.+++++-
T Consensus 234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred CccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 67899999999999999999999999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=265.73 Aligned_cols=183 Identities=28% Similarity=0.375 Sum_probs=145.9
Q ss_pred CEEEEecCCCCCHHHHHHhcC--------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--------------------------------------PRCLDVCVAIGFALDIARAME 42 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--------------------------------------~~~~~~~~~~~~~~~i~~~L~ 42 (255)
+++||||++||+|.+++.... ...+++..++.++.|++.||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 379999999999999995211 112467788899999999999
Q ss_pred HHHhCCCeecCCCCCcEEEeCCC-CceEEecCccccccccc-----cccccCCCccceecccccccccccccccCCCCch
Q 025244 43 CLHSHGIIHRDLKPENLLLTEDL-KTIKLADFGLAREESLT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 116 (255)
Q Consensus 43 ~lH~~~i~HrDikp~Nill~~~~-~~~kl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 116 (255)
|||++||+||||||+||+++.+. ..+||+|||+++..... .......||+.|+|||++.+ ....++.+
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~ 256 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT------TNESYGPK 256 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC------SSSCCCTH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc------CCCCCCcH
Confidence 99999999999999999998652 27999999999853221 12345679999999999853 23567889
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC---CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 117 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 117 ~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
+||||||+++|||++|+.||.+....+............. ...+++++.++|.+||+.||.+||++.+++++-
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp 332 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence 9999999999999999999998877766665555443322 234789999999999999999999999999873
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=266.25 Aligned_cols=186 Identities=23% Similarity=0.394 Sum_probs=147.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++||||++||+|.+++..... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN-FVPKITDFGISKK 188 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTT-CCEEECCCTTCEE
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCC-CCEEEeecccccc
Confidence 4899999999999999976532 348999999999999999999999999999999999999988 7999999999985
Q ss_pred ccc---ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHH-----H-HHHH
Q 025244 79 ESL---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA-----A-YAAA 149 (255)
Q Consensus 79 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-----~-~~~~ 149 (255)
... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+....+. . ....
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 260 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIK--------GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHH--------CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH
T ss_pred cccccccccccccCCCccccCHHHhcC--------CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc
Confidence 332 122334568999999999853 4578899999999999999999999975432211 0 0011
Q ss_pred hhc-C----CC-----CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 150 FKN-V----RP-----SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 150 ~~~-~----~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
... . .+ .....+..+.+++.+||+.||++||++.+++++|+..+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 000 0 00 1123457899999999999999999999999999987653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=264.07 Aligned_cols=178 Identities=27% Similarity=0.384 Sum_probs=141.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC----CCceEEecCccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED----LKTIKLADFGLA 76 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~----~~~~kl~Dfg~a 76 (255)
++|||||++ |+|.+++..... +++..++.++.|++.||+|||++||+||||||+|||++.+ .+.+||+|||++
T Consensus 108 ~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 108 LHLIFEYAE-NDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEEEECCS-EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEEEecCC-CCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 479999997 699999987655 9999999999999999999999999999999999999533 146999999999
Q ss_pred ccccc-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC
Q 025244 77 REESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 77 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
+.... ........||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+....+...........+
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEILLG-------SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP 257 (329)
T ss_dssp HHHC-----------CCTTCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred cccCCcccccCCCcCCccccCHHHhcC-------CCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 85432 223345678999999999853 2457889999999999999999999999887776665554432222
Q ss_pred CCC-----------------------------CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 SAE-----------------------------NVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ~~~-----------------------------~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
... .+++++.+||.+||+.||.+|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 111 167899999999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=282.82 Aligned_cols=185 Identities=30% Similarity=0.546 Sum_probs=156.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++...+ ..+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~-~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYME 542 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCCCCCSCC
T ss_pred eEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCC-CCEEEEecCCCeecC
Confidence 489999999999999998654 348999999999999999999999999999999999999988 799999999998643
Q ss_pred cccc--cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
.... .....+|+.|+|||++.+ ..++.++||||||+++|||++ |..||.+....+...........+.+
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 614 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 614 (656)
T ss_dssp C----------CCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCC
T ss_pred CCcceeccCCCCCcceeCHHHhcC--------CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 3221 233457789999999853 568889999999999999997 99999988777766666655556667
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
..+++.+.++|.+||+.||.+||++.++++.|...+..
T Consensus 615 ~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 615 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 88999999999999999999999999999999887653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=265.53 Aligned_cols=181 Identities=28% Similarity=0.444 Sum_probs=127.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--CCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~--~~~~kl~Dfg~a~~ 78 (255)
+++||||++||+|.+++.+.....+++.+++.++.|++.||.|||++||+||||||+||+++.+ .+.+||+|||+++.
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 3799999999999999998766669999999999999999999999999999999999999853 24699999999986
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHH----HH---hh
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA----AA---FK 151 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~----~~---~~ 151 (255)
.... ......||+.|+|||++.. ..++.++||||||+++|+|++|+.||.+......... .. ..
T Consensus 181 ~~~~-~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (336)
T 3fhr_A 181 TTQN-ALQTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG 251 (336)
T ss_dssp C-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred cccc-ccccCCCCcCccChhhhCC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence 4432 2345678999999999853 4567899999999999999999999976544332111 11 11
Q ss_pred cCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 152 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 152 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
...+....+++++.+||.+||+.||.+|||+.+++++-+
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 112223578999999999999999999999999999754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=265.02 Aligned_cols=171 Identities=25% Similarity=0.356 Sum_probs=145.5
Q ss_pred CEEEEecCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGG-TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~gg-sL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+++||||+.+| +|.+++..... +++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAED-FTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCC--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCC-CcEEEeecccceEC
Confidence 37999999766 99999987554 9999999999999999999999999999999999999988 79999999999876
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
..........||+.|+|||++.+ ...++.++||||||+++|+|++|+.||..... ........+..
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~~~~~~ 246 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMG-------NPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------TVEAAIHPPYL 246 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTT-------CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------GTTTCCCCSSC
T ss_pred CCCCceeccCCCccccChhhhcC-------CCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------HHhhccCCCcc
Confidence 55555556789999999999853 22347899999999999999999999976322 11222334556
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+++++.+||.+||+.||.+||++.+++++
T Consensus 247 ~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 247 VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999999999999997
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=261.38 Aligned_cols=181 Identities=29% Similarity=0.407 Sum_probs=150.8
Q ss_pred CEEEEecCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CeecCCCCCcEEEeCCCCceEEecC
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHG-----IIHRDLKPENLLLTEDLKTIKLADF 73 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~-----i~HrDikp~Nill~~~~~~~kl~Df 73 (255)
+++||||++|++|.+++.... ...+++..++.++.|++.||+|||++| ++||||||+||+++.+ +.+||+||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~-~~~kl~df 160 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDF 160 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS-SCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC-CCEEEecC
Confidence 479999999999999998642 334999999999999999999999999 9999999999999988 69999999
Q ss_pred ccccccccc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc
Q 025244 74 GLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 152 (255)
Q Consensus 74 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 152 (255)
|+++..... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+.........
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~ 232 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNR--------MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 232 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHC--------C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred chheeeccccccccccCCCccccChHHhcc--------CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc
Confidence 999854332 12234578999999999853 457889999999999999999999999877665555555554
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 153 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 153 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
....+..++.++.++|.+||+.||.+||++.+++++++
T Consensus 233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 233 FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 44556788999999999999999999999999998754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=272.75 Aligned_cols=177 Identities=25% Similarity=0.338 Sum_probs=135.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+ +++|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~--l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~-~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPVY--LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD-CSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSCC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-CCEEECCCTTCBCTT
T ss_pred EEEEEecc-ccchhhhcccCCC--CCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCC-CCEeecccccchhcc
Confidence 48999999 6899999986543 9999999999999999999999999999999999999998 699999999998543
Q ss_pred cc----------------------------cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-
Q 025244 81 LT----------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH- 131 (255)
Q Consensus 81 ~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~- 131 (255)
.. ......+||++|+|||++.. ...++.++|||||||++|||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-------QENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHTT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhC-------CCCCCcHhHHHHHHHHHHHHHHh
Confidence 21 12345678999999998642 3568899999999999999998
Q ss_pred ----------CCCCCCCCch--------------------HHHHHHHHhhcC---------------------CC-----
Q 025244 132 ----------NKLPFEGMSN--------------------LQAAYAAAFKNV---------------------RP----- 155 (255)
Q Consensus 132 ----------g~~p~~~~~~--------------------~~~~~~~~~~~~---------------------~~----- 155 (255)
|+++|.+.+. ......+..... .+
T Consensus 281 ~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (458)
T 3rp9_A 281 IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGT 360 (458)
T ss_dssp STTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCC
T ss_pred ccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCC
Confidence 7777766431 111111110000 00
Q ss_pred ----CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 ----SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....+++++.+||.+||..||.+|||+.|+++|
T Consensus 361 ~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 361 DLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp CGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 124568999999999999999999999999997
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=265.18 Aligned_cols=189 Identities=25% Similarity=0.415 Sum_probs=142.4
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCeecCCCCCcEEEeCCCCceEEec
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH---------GIIHRDLKPENLLLTEDLKTIKLAD 72 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---------~i~HrDikp~Nill~~~~~~~kl~D 72 (255)
+|||||++||+|.+++.... .++..++.++.|++.||+|||++ ||+||||||+|||++.+ +.+||+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~kL~D 163 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND-GTCVISD 163 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT-SCEEECC
T ss_pred EEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC-CcEEEee
Confidence 79999999999999997654 68899999999999999999999 99999999999999988 7999999
Q ss_pred Cccccccccc---------cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch--
Q 025244 73 FGLAREESLT---------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN-- 141 (255)
Q Consensus 73 fg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~-- 141 (255)
||+++..... .......||+.|+|||++.+.... .....++.++||||||+++|||++|..||.....
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNL-RDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCG-GGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCccc-ccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999754321 122345799999999998642100 0013456789999999999999999766532111
Q ss_pred ---------------HHHHHHHH-hhcCCCC-CC------CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 142 ---------------LQAAYAAA-FKNVRPS-AE------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 142 ---------------~~~~~~~~-~~~~~~~-~~------~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
........ .....+. +. .+++.+.+||.+||+.||++|||+.|+++.|+.++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 11111111 1111111 11 1345899999999999999999999999999988754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=260.77 Aligned_cols=183 Identities=25% Similarity=0.412 Sum_probs=139.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC--ceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK--TIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~--~~kl~Dfg~a~~ 78 (255)
+++||||++||+|.+++..... +++..+..++.|++.||+|||++||+||||||+|||++.+.. .+||+|||+++.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEEEEEcCCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 4799999999999999987654 999999999999999999999999999999999999987621 399999999874
Q ss_pred cccc--------cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH--------
Q 025244 79 ESLT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL-------- 142 (255)
Q Consensus 79 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-------- 142 (255)
.... ......+||+.|+|||++..... ....++.++||||||+++|||++|+.||.+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE---EASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSH---HHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccc---cccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 3221 11234569999999999853110 0134678999999999999999999999765321
Q ss_pred ------HHHHHHHhhcCCCCC----CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 143 ------QAAYAAAFKNVRPSA----ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 143 ------~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..............+ ..++.++.+||.+||+.||.+||++.+++++
T Consensus 241 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 241 ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111222222222111 4678999999999999999999999999987
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=263.82 Aligned_cols=179 Identities=28% Similarity=0.417 Sum_probs=149.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++ |+|.+++..... .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 129 ~~lv~e~~~-g~l~~~l~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMA 205 (348)
T ss_dssp EEEEEECCS-EEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TEEEECCCTTCBSSS
T ss_pred EEEEEecCC-CCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEeeccCceecC
Confidence 379999996 789998875433 49999999999999999999999999999999999999988 799999999998644
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC-CCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAEN 159 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~ 159 (255)
.. ....||+.|+|||++... ....++.++||||||+++|||++|+.||.+.+.............. .....
T Consensus 206 ~~---~~~~gt~~y~aPE~~~~~-----~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (348)
T 1u5q_A 206 PA---NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 277 (348)
T ss_dssp SB---CCCCSCGGGCCHHHHHTT-----SSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred CC---CcccCCcceeCHhhhccc-----cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Confidence 32 356899999999988421 1356788999999999999999999999887766665554443332 23457
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
+++.+.++|.+||+.||.+||++.+++++.+
T Consensus 278 ~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 278 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 8999999999999999999999999998754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=276.37 Aligned_cols=177 Identities=13% Similarity=0.165 Sum_probs=138.9
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVA------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 75 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~------~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~ 75 (255)
+|||||++ |+|.+++...+.. +++..+ +.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 164 ~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kL~DFG~ 240 (371)
T 3q60_A 164 LLLMPAAS-VDLELLFSTLDFV-YVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD-GRLMLGDVSA 240 (371)
T ss_dssp EEEECCCS-EEHHHHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTT-SCEEECCGGG
T ss_pred EEEecCCC-CCHHHHHHHhccc-cchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCC-CCEEEEecce
Confidence 89999997 8999999875322 444455 6777999999999999999999999999999988 7999999999
Q ss_pred ccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-------
Q 025244 76 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA------- 148 (255)
Q Consensus 76 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~------- 148 (255)
++...... ....+|+.|+|||++.+ ....++.++|||||||++|||++|+.||.+..........
T Consensus 241 a~~~~~~~--~~~~~t~~y~aPE~~~~------~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 312 (371)
T 3q60_A 241 LWKVGTRG--PASSVPVTYAPREFLNA------STATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVP 312 (371)
T ss_dssp EEETTCEE--EGGGSCGGGCCHHHHTC------SEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSC
T ss_pred eeecCCCc--cCccCCcCCcChhhccC------CCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhc
Confidence 98654322 24466799999999853 1256789999999999999999999999875322110000
Q ss_pred -HhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 149 -AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 149 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
......+....+++.+.+||.+||+.||++||++.+++++-
T Consensus 313 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 354 (371)
T 3q60_A 313 GTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354 (371)
T ss_dssp CCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred cccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence 00111122357899999999999999999999999998763
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=261.78 Aligned_cols=185 Identities=26% Similarity=0.425 Sum_probs=144.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++....
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-CCEEECCCTTTC---
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCC-CCEEEeeCcCceecC
Confidence 3799999999999999987654559999999999999999999999999999999999999988 799999999998543
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-CCCCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-RPSAE 158 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~ 158 (255)
.. .......||+.|+|||++.... .....++.++||||||+++|+|++|+.||.+............... .....
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 2x7f_A 181 RTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK 257 (326)
T ss_dssp ----------CCGGGCCHHHHC-----------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCS
T ss_pred cCccccccccCCccccChhhhcccc---ccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCcc
Confidence 22 2234567999999999985311 1135678899999999999999999999988776655444333222 22346
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 159 NVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 159 ~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
.++..+.++|.+||..||.+||++.+++++-
T Consensus 258 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 258 KWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp CSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred ccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 7899999999999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=268.31 Aligned_cols=180 Identities=23% Similarity=0.301 Sum_probs=146.1
Q ss_pred CEEEEecCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~--~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++||||+++ +|.+.+.. .....+++..+..++.|++.||+|||++||+||||||+|||++.+.+.+||+|||+++.
T Consensus 113 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 113 LNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 3699999975 55554442 12344999999999999999999999999999999999999994337999999999987
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC---
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--- 155 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--- 155 (255)
...........||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..+...........+
T Consensus 192 ~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 192 LIAGEPNVSYICSRYYRAPELIFG-------ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE 264 (394)
T ss_dssp CCTTCCCCSSCSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccCCCCCcccccCcCccCHHHHcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 655555566789999999998853 3458899999999999999999999999887766655443321111
Q ss_pred -------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 -------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 -------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....+++++.+||.+||+.||.+|||+.++++|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 123478899999999999999999999999987
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=259.57 Aligned_cols=183 Identities=25% Similarity=0.404 Sum_probs=142.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... +++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++....
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD-DFAYLVDFGIASATT 185 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSCCC-----
T ss_pred EEEEEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCC-CCEEEecCccCcccc
Confidence 4799999999999999987654 9999999999999999999999999999999999999988 799999999997543
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC---C
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR---P 155 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---~ 155 (255)
... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+...... ......... .
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~ 256 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSE--------SHATYRADIYALTCVLYECLTGSPPYQGDQLSVM-GAHINQAIPRPST 256 (309)
T ss_dssp -----------CCGGGCCGGGTCC------------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH-HHHHHSCCCCGGG
T ss_pred ccccccccccCCCcCccCHHHHcC--------CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH-HHHhccCCCCccc
Confidence 322 2234578999999999853 5678899999999999999999999987654422 222222211 1
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhHhh
Q 025244 156 SAENVPEELSIILTSCWKEDPNARP-NFTQIIQMLLNYLSA 195 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rp-t~~~vl~~l~~~~~~ 195 (255)
....++.++.++|.+||+.||.+|| +++++++.|+..+..
T Consensus 257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 2467889999999999999999999 999999999876554
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=262.88 Aligned_cols=178 Identities=22% Similarity=0.271 Sum_probs=144.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+.+..... .+++.+++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 99 ~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 99 IYLVFDFCE-HDLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFS 175 (351)
T ss_dssp EEEEEECCS-EEHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECC
T ss_pred EEEEEeccC-CCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CCEEEccchhccccc
Confidence 379999996 588888876533 39999999999999999999999999999999999999988 699999999998543
Q ss_pred c-----ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC
Q 025244 81 L-----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
. ........||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+................+
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccccCCcccccCccCchhhcC-------CCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 1 222345678999999998853 2457889999999999999999999999877665554443322221
Q ss_pred CCC---C----------------------------CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 SAE---N----------------------------VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ~~~---~----------------------------~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
... . .++.+.+||.+||+.||.+|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 111 0 26779999999999999999999999997
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=274.85 Aligned_cols=177 Identities=15% Similarity=0.284 Sum_probs=137.3
Q ss_pred EEEEecCCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRP-----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 76 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~-----~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a 76 (255)
+|||||+ +|+|.+++...+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 176 ~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kL~DFG~a 253 (377)
T 3byv_A 176 FFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR-GGVFLTGFEHL 253 (377)
T ss_dssp EEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCGGGC
T ss_pred EEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEEechhh
Confidence 6999999 6899999987532 113347888899999999999999999999999999999988 79999999999
Q ss_pred cccccccccccCCCccceeccccccccc---ccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC
Q 025244 77 REESLTEMMTAETGTYRWMAPELYSTVT---LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 153 (255)
Q Consensus 77 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 153 (255)
+.... ......| +.|+|||++.+.. ........++.++|||||||++|||++|+.||.+....... ...
T Consensus 254 ~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~-----~~~ 325 (377)
T 3byv_A 254 VRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGS-----EWI 325 (377)
T ss_dssp EETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCS-----GGG
T ss_pred eecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccch-----hhh
Confidence 86433 3345678 9999999986420 00000125789999999999999999999999764422211 111
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 154 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 154 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
......+++++.+||.+||+.||.+||++.+++++
T Consensus 326 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 326 FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 22346789999999999999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=266.30 Aligned_cols=182 Identities=20% Similarity=0.235 Sum_probs=146.4
Q ss_pred CEEEEecCCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC-----------CCC
Q 025244 1 MVIVTELLSGGTLRKYLLNM---RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE-----------DLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~---~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~-----------~~~ 66 (255)
.+|||||++||+|.+++... ....+++..++.++.|++.||+|||++||+||||||+|||++. + +
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~-~ 220 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLS-A 220 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------C-T
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccccc-C
Confidence 37999999999999999853 2345999999999999999999999999999999999999987 5 6
Q ss_pred ceEEecCccccccc---cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHH
Q 025244 67 TIKLADFGLAREES---LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 143 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~ 143 (255)
.+||+|||+++... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN--------KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT--------CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC--------CCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 99999999997432 2334456789999999999853 457899999999999999999999996432210
Q ss_pred HHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhHhhc
Q 025244 144 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR-PNFTQIIQMLLNYLSAI 196 (255)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R-pt~~~vl~~l~~~~~~~ 196 (255)
. ...........++.+.+++..||+.+|.+| |++.++.+.|++++...
T Consensus 293 ~-----~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 C-----KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp E-----EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred e-----eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 0 000111122346889999999999999999 57888888888877653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=266.15 Aligned_cols=185 Identities=24% Similarity=0.414 Sum_probs=142.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++||||+ .+++|.+++.+... +++.+++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||+++...
T Consensus 131 ~~lv~E~-~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~--~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 131 IYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEEEEEC-CSEEHHHHHHHCSS--CCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS--SCEEECCCSSSCCC-
T ss_pred EEEEEec-CCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC--CeEEEEecCcccccc
Confidence 4899995 58999999987653 899999999999999999999999999999999999964 589999999998643
Q ss_pred ccc---ccccCCCccceecccccccccccc---cccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHH-HHhhcC
Q 025244 81 LTE---MMTAETGTYRWMAPELYSTVTLRQ---GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA-AAFKNV 153 (255)
Q Consensus 81 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~---~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-~~~~~~ 153 (255)
... .....+||+.|+|||++.+..... .....++.++|||||||++|||++|+.||.+......... ......
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~ 285 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 285 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc
Confidence 322 234568999999999985421100 0123688899999999999999999999987544333222 222222
Q ss_pred -CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 154 -RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 154 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
...+...+.++.+||.+||+.||.+||++.+++++.+
T Consensus 286 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 286 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 2234556789999999999999999999999999854
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=256.44 Aligned_cols=183 Identities=24% Similarity=0.367 Sum_probs=152.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... +++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++....
T Consensus 99 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 99 FFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFSCQLD 175 (298)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECC
T ss_pred EEEEEeccCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCC-CcEEEecccchhhcC
Confidence 3799999999999999987644 9999999999999999999999999999999999999988 699999999998755
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC---C
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS---A 157 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~ 157 (255)
.........||+.|+|||++.+... .....++.++||||||+++|+|++|+.||.+.................. .
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
T 1phk_A 176 PGEKLREVCGTPSYLAPEIIECSMN--DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253 (298)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHC--TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred CCcccccccCCccccCHHHhccccc--cccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccc
Confidence 5545556789999999998853211 1134578899999999999999999999988766555544444333322 2
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..++..+.++|.+||+.||.+||++.+++++
T Consensus 254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 4678999999999999999999999999886
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=270.15 Aligned_cols=177 Identities=28% Similarity=0.331 Sum_probs=136.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++ |+|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~~--l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPIF--LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQD-CSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEEC-
T ss_pred EEEEEecCC-cCHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCC-CCEEEccCCCccccc
Confidence 489999995 799999986543 9999999999999999999999999999999999999988 699999999998543
Q ss_pred ccc-----------------------ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhC-----
Q 025244 81 LTE-----------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN----- 132 (255)
Q Consensus 81 ~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g----- 132 (255)
... .....+||++|+|||++.. ...++.++|||||||++|||++|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-------~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL-------QENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhc-------CCCCCcccccchHHHHHHHHHhcccccc
Confidence 221 2356789999999998642 35688999999999999999984
Q ss_pred ------CCCCCCCch-----------------HHHHHHHHhhcCC-----------------------CC-------CCC
Q 025244 133 ------KLPFEGMSN-----------------LQAAYAAAFKNVR-----------------------PS-------AEN 159 (255)
Q Consensus 133 ------~~p~~~~~~-----------------~~~~~~~~~~~~~-----------------------~~-------~~~ 159 (255)
.++|.+.+. ..+...+...... .. ...
T Consensus 254 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (432)
T 3n9x_A 254 NDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPS 333 (432)
T ss_dssp SSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTT
T ss_pred cccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCC
Confidence 444544321 1111111110000 00 145
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+++++.+||.+||+.||.+|||+.|+++|
T Consensus 334 ~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 334 ISDDGINLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 78999999999999999999999999997
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=261.99 Aligned_cols=186 Identities=25% Similarity=0.419 Sum_probs=141.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||. +++|.+++...+. +++.++..++.|++.||+|||++||+||||||+|||+++ +.+||+|||+++...
T Consensus 84 ~~lv~e~~-~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~--~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 84 IYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEEEECCC-SEEHHHHHHHSCC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--TEEEECCCSSSCCC-
T ss_pred EEEEEeCC-CCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC--CcEEEeecccccccC
Confidence 47999965 8999999987654 999999999999999999999999999999999999974 589999999998643
Q ss_pred ccc---ccccCCCccceecccccccccccc---cccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-hcC
Q 025244 81 LTE---MMTAETGTYRWMAPELYSTVTLRQ---GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF-KNV 153 (255)
Q Consensus 81 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~---~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~ 153 (255)
... .....+||+.|+|||++.+..... .....++.++|||||||++|||++|+.||.+............ ...
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence 322 234567999999999985321110 0125678899999999999999999999987544333322222 222
Q ss_pred -CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 154 -RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 154 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
...+...+.++.++|.+||+.||.+|||+.+++++.+-
T Consensus 239 ~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 239 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 22355667899999999999999999999999998653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=255.92 Aligned_cols=177 Identities=29% Similarity=0.428 Sum_probs=148.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE---eCCCCceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL---TEDLKTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill---~~~~~~~kl~Dfg~a~ 77 (255)
+++||||++|++|.+++...+. +++..++.++.|++.||.|||++|++||||||+||++ +.+ +.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~-~~~kl~Dfg~~~ 157 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEEN-SKIMITDFGLSK 157 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTT-CCEEBCSCSTTC
T ss_pred EEEEEEcCCCccHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCC-CCEEEccCCcce
Confidence 3799999999999999987654 9999999999999999999999999999999999999 555 689999999997
Q ss_pred ccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC---
Q 025244 78 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--- 154 (255)
Q Consensus 78 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--- 154 (255)
..... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+................
T Consensus 158 ~~~~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 228 (304)
T 2jam_A 158 MEQNG-IMSTACGTPGYVAPEVLAQ--------KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES 228 (304)
T ss_dssp CCCCB-TTHHHHSCCCBCCTTTBSS--------CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCT
T ss_pred ecCCC-ccccccCCCCccChHHhcc--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 54332 2334568999999999853 56788999999999999999999999887665544444333222
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 155 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 155 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
+....+++++.++|.+||+.||.+||++.+++++-
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 229 PFWDDISESAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 22457889999999999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=257.20 Aligned_cols=184 Identities=24% Similarity=0.419 Sum_probs=137.6
Q ss_pred CEEEEecCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~-~i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
+++||||++ |+|.+++... ....+++..++.++.|++.||+|||++ |++||||||+||+++.+ +.+||+|||+++
T Consensus 81 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~ 158 (290)
T 3fme_A 81 VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINAL-GQVKMCDFGISG 158 (290)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTT-CCEEBCCC----
T ss_pred EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC-CCEEEeecCCcc
Confidence 379999996 6998888652 334599999999999999999999998 99999999999999988 699999999998
Q ss_pred ccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC--C
Q 025244 78 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--P 155 (255)
Q Consensus 78 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~ 155 (255)
............||+.|+|||++... .....++.++||||||+++|+|++|+.||.................. .
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 234 (290)
T 3fme_A 159 YLVDDVAKDIDAGCKPYMAPERINPE----LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL 234 (290)
T ss_dssp -----------CCCCCCSCHHHHSCC----TTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC
T ss_pred cccccccccccCCCccccChhhcChh----hcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc
Confidence 65555444556799999999997321 02356788999999999999999999999864443333333322222 2
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
....+++++.++|.+||+.||.+|||+.+++++-+
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~ 269 (290)
T 3fme_A 235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 269 (290)
T ss_dssp CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcc
Confidence 24578999999999999999999999999998643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=259.56 Aligned_cols=177 Identities=23% Similarity=0.265 Sum_probs=144.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC----------------
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED---------------- 64 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~---------------- 64 (255)
+++||||+ +++|.+++...+...+++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 37999999 8999999998765569999999999999999999999999999999999999863
Q ss_pred --CCceEEecCccccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH
Q 025244 65 --LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 142 (255)
Q Consensus 65 --~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~ 142 (255)
.+.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+..
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILA--------LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp ESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTT--------SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccCCCceEeeCcccccCccc--cccccCCccccChHHhhC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 257999999999864322 345689999999999853 56788999999999999999999999887665
Q ss_pred HHHHHHHhhcCC-------------------------------------------CCCCCCcHHHHHHHHHhcccCCCCC
Q 025244 143 QAAYAAAFKNVR-------------------------------------------PSAENVPEELSIILTSCWKEDPNAR 179 (255)
Q Consensus 143 ~~~~~~~~~~~~-------------------------------------------~~~~~~~~~l~~li~~~l~~~p~~R 179 (255)
+........... ......++++.+||.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 443322111100 0112235789999999999999999
Q ss_pred CCHHHHHHH
Q 025244 180 PNFTQIIQM 188 (255)
Q Consensus 180 pt~~~vl~~ 188 (255)
||+.|++++
T Consensus 321 pt~~ell~h 329 (339)
T 1z57_A 321 ITLREALKH 329 (339)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=256.11 Aligned_cols=189 Identities=27% Similarity=0.437 Sum_probs=141.8
Q ss_pred CEEEEecCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++||||++|++|.+++... ....+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+++.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~-~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRF 185 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCC-----
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCC-CCEEEEeccceee
Confidence 37999999999999999753 23459999999999999999999999999999999999999988 7999999999985
Q ss_pred cccc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHhhcCCC
Q 025244 79 ESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL--QAAYAAAFKNVRP 155 (255)
Q Consensus 79 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~ 155 (255)
.... .......|++.|+|||++.. ..++.++||||||+++|+|++|+.||.+.... ............+
T Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 257 (310)
T 2wqm_A 186 FSSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP 257 (310)
T ss_dssp -------------CCSSCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC
T ss_pred ecCCCccccccCCCeeEeChHHhCC--------CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC
Confidence 4332 22334578999999998853 56788999999999999999999999764322 2222222222222
Q ss_pred C-CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcCC
Q 025244 156 S-AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 198 (255)
Q Consensus 156 ~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~~ 198 (255)
. ...++.++.++|.+||+.||.+||++.++++.|+.+......
T Consensus 258 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 258 LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 2 356889999999999999999999999999999988765443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=259.96 Aligned_cols=187 Identities=24% Similarity=0.374 Sum_probs=146.7
Q ss_pred CEEEEecCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++||||++||+|.+++... ....+++.+++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++.
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~dfg~~~~ 183 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCSSCEE
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC-CCEEEEecCcchh
Confidence 37999999999999999863 23459999999999999999999999999999999999999988 6999999999875
Q ss_pred ccccc----------ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH--HHHH
Q 025244 79 ESLTE----------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL--QAAY 146 (255)
Q Consensus 79 ~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~--~~~~ 146 (255)
..... ......||+.|+|||++... ....++.++||||||+++|+|++|+.||...... ....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 258 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ-----SHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCC-----SEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH
T ss_pred cccccccccccccccccccccCCcccCCHhHhccC-----CCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH
Confidence 33211 11234579999999998531 1123678999999999999999999999532111 1111
Q ss_pred HHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 025244 147 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 193 (255)
Q Consensus 147 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~ 193 (255)
........+....++.++.++|.+||+.||.+||++.+++++|+...
T Consensus 259 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 259 AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 12222233445678999999999999999999999999999997653
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=258.77 Aligned_cols=192 Identities=24% Similarity=0.437 Sum_probs=149.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++...+ ..+++..++.++.|++.||+|||++|++||||||+||+++ + +.+||+|||+++...
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~-~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-N-GKVVITDFGLFSISG 180 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC---
T ss_pred eEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-C-CCEEEeecCCccccc
Confidence 479999999999999998654 3499999999999999999999999999999999999998 4 589999999987432
Q ss_pred c------ccccccCCCccceecccccccccccc-cccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC
Q 025244 81 L------TEMMTAETGTYRWMAPELYSTVTLRQ-GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 153 (255)
Q Consensus 81 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 153 (255)
. ........||+.|+|||++....... .....++.++||||||+++|||++|+.||.+...............
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 260 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK 260 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC
Confidence 1 12233456899999999986422110 1124578899999999999999999999988776655544443332
Q ss_pred CCC-CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 154 RPS-AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 154 ~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
... ...++.++.++|.+||+.||.+||++.++++.|+.....
T Consensus 261 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 222 346889999999999999999999999999999876654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=259.08 Aligned_cols=176 Identities=21% Similarity=0.296 Sum_probs=143.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.. +++..+..++.|++.||+|||++||+||||||+|||++.+.+.+||+|||+++...
T Consensus 108 ~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 3799999999999999853 88999999999999999999999999999999999999774589999999998655
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHHh---------
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL-QAAYAAAF--------- 150 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-~~~~~~~~--------- 150 (255)
.........||..|+|||++.+ ...++.++||||||+++|+|++|+.||...... +.......
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 183 PGQEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255 (330)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred CCCccccccccccccChhhhcC-------CCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhh
Confidence 5555566789999999999853 356788999999999999999999999543322 22111110
Q ss_pred ---hcC------------------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 151 ---KNV------------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 151 ---~~~------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
... ......+++++.+||.+||+.||.+|||+.|+++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 00112278999999999999999999999999987
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=263.49 Aligned_cols=176 Identities=28% Similarity=0.416 Sum_probs=138.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+++||||++||+|.+++.+... ...++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 136 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~ 214 (332)
T 3qd2_B 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAM 214 (332)
T ss_dssp EEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCC-CCEEEeecCccccc
Confidence 3799999999999999987543 235666789999999999999999999999999999999988 79999999999864
Q ss_pred ccc-------------cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHH
Q 025244 80 SLT-------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 146 (255)
Q Consensus 80 ~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~ 146 (255)
... .......||+.|+|||++.+ ..++.++||||||+++|||++|..|+.. .....
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~ 283 (332)
T 3qd2_B 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG--------NNYSHKVDIFSLGLILFELLYSFSTQME---RVRII 283 (332)
T ss_dssp SCC--------------CCCSCC-CGGGSCHHHHHC--------CCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHH
T ss_pred ccchhhccccccccccccccccCCCcCccChHHhcC--------CCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHH
Confidence 432 12234579999999999853 5678899999999999999998776532 11111
Q ss_pred HHHhhcCCC-CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 147 AAAFKNVRP-SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 147 ~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
........+ .....++++.++|.+||+.||.+||++.+++++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 284 TDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 111111111 123456788999999999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=256.72 Aligned_cols=177 Identities=27% Similarity=0.404 Sum_probs=126.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRN-MNIKIADFGLATQLK 163 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTT-CCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEEEeecceeecc
Confidence 379999999999999998753 349999999999999999999999999999999999999988 699999999998644
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
.. .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||............. ......+..
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 234 (278)
T 3cok_A 164 MPHEKHYTLCGTPNYISPEIATR--------SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV-LADYEMPSF 234 (278)
T ss_dssp ------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC-SSCCCCCTT
T ss_pred CCCCcceeccCCCCcCCcchhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh-hcccCCccc
Confidence 22 22334678999999998853 456789999999999999999999998755433322211 112223556
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
++.++.++|.+||+.||.+||++.+++++
T Consensus 235 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 235 LSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 88999999999999999999999999886
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=271.87 Aligned_cols=194 Identities=25% Similarity=0.390 Sum_probs=151.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE----eCCCCceEEecCcc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL----TEDLKTIKLADFGL 75 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill----~~~~~~~kl~Dfg~ 75 (255)
+++||||++||+|.+++..... ..+++..++.++.|++.||+|||++||+||||||+|||+ +.+ +.+||+|||+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kL~DFG~ 162 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGA 162 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSC-EEEEECCGGG
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCc-eeEEEecCCC
Confidence 3799999999999999986533 339999999999999999999999999999999999998 555 5799999999
Q ss_pred ccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCc----hHHHHHHHHhh
Q 025244 76 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS----NLQAAYAAAFK 151 (255)
Q Consensus 76 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~----~~~~~~~~~~~ 151 (255)
++............||+.|+|||++............++.++|||||||++|||++|+.||.... ..+........
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 98766555556678999999999885421111112356779999999999999999999996432 22333333322
Q ss_pred cCC--------------------CCC----CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 152 NVR--------------------PSA----ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 152 ~~~--------------------~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
... +.. ..++..+.++|.+||+.||++||++.++++.+.+.+..
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 211 111 22456788999999999999999999999999887754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=258.87 Aligned_cols=185 Identities=25% Similarity=0.479 Sum_probs=149.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~-~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLP 196 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTT-SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEECC
T ss_pred eEEEEECCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCC-CcEEEecCcchhhcc
Confidence 4799999999999999987543 39999999999999999999999999999999999999988 799999999998643
Q ss_pred ccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH-----------H--
Q 025244 81 LTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL-----------Q-- 143 (255)
Q Consensus 81 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-----------~-- 143 (255)
... ......++..|+|||++.+ ..++.++||||||+++|||++|..||...... .
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTE--------SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred ccccccccccCCCCceeEECchhhcC--------CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence 322 1233467888999999853 44678999999999999999999988642110 0
Q ss_pred --HHHH-HHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 144 --AAYA-AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 144 --~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
.... .......+.+..++.++.++|.+||+.||.+||++.++++.|+.+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0111 111223345677899999999999999999999999999999877643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=262.67 Aligned_cols=176 Identities=29% Similarity=0.384 Sum_probs=145.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ |+|.+++.... +++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~~---~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECC
T ss_pred EEEEEcccC-cCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCC-CCEEEEeCcceEecC
Confidence 379999996 69999997643 9999999999999999999999999999999999999988 699999999998544
Q ss_pred ccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC-
Q 025244 81 LTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP- 155 (255)
Q Consensus 81 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~- 155 (255)
... ......||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+.+..+...........+
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 252 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHT-------BCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCC
T ss_pred CCCCccccccccccccCCCCCHHhcC-------CCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 322 1244589999999998753 3457889999999999999999999998876655444332211111
Q ss_pred -----------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 -----------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 -----------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....+++++.+||.+||+.||.+|||+.|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 024578999999999999999999999999987
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=266.73 Aligned_cols=176 Identities=27% Similarity=0.348 Sum_probs=134.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++.. .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 105 ~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 105 VYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAG 178 (371)
T ss_dssp EEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCCCC-----
T ss_pred eEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC-CCEEEEEeecccccc
Confidence 389999996 689998863 28999999999999999999999999999999999999988 799999999998655
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC----
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS---- 156 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 156 (255)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...........+.
T Consensus 179 ~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 179 TSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp -----------CTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred cccccCCceecCCccCHHHhcC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 4444556789999999999853 5678899999999999999999999998776655544432211110
Q ss_pred ----------------CC---------------------CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 157 ----------------AE---------------------NVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 157 ----------------~~---------------------~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
.. ..+.++.+||.+||..||.+|||+.|++++-+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 00 01567999999999999999999999999743
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=257.83 Aligned_cols=183 Identities=27% Similarity=0.388 Sum_probs=145.7
Q ss_pred CEEEEecCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMR-PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+++||||++|++|.+++.... ...+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+++..
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~ 183 (307)
T 2nru_A 105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA-FTAKISDFGLARAS 183 (307)
T ss_dssp CEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred eEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCC-CcEEEeeccccccc
Confidence 489999999999999998543 3459999999999999999999999999999999999999988 69999999999854
Q ss_pred ccc---cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHH---HHHHHhh--
Q 025244 80 SLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA---AYAAAFK-- 151 (255)
Q Consensus 80 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~---~~~~~~~-- 151 (255)
... .......||+.|+|||++. +.++.++||||||+++|+|++|..||......+. .......
T Consensus 184 ~~~~~~~~~~~~~g~~~y~aPE~~~---------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 254 (307)
T 2nru_A 184 EKFAQTVMTSRIVGTTAYMAPEALR---------GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEE 254 (307)
T ss_dssp CSCSSCEECSSCCSCGGGCCHHHHT---------TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTS
T ss_pred ccccccccccccCCCcCcCChHHhc---------CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhh
Confidence 322 1233457999999999874 2367899999999999999999999976543221 1111110
Q ss_pred ---------cCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 025244 152 ---------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 193 (255)
Q Consensus 152 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~ 193 (255)
.........+..+.+++.+||+.||.+||++.+++++|+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 255 KTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp CCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 011112334578999999999999999999999999998764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=258.07 Aligned_cols=182 Identities=28% Similarity=0.405 Sum_probs=143.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCeecCCCCCcEEEeCCCCceEEecCcc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSH---GIIHRDLKPENLLLTEDLKTIKLADFGL 75 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~i~HrDikp~Nill~~~~~~~kl~Dfg~ 75 (255)
.++||||++||+|.+++..... ..+++..++.++.|++.||+|||++ |++||||||+|||++.+ +.+||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~ 180 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGL 180 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT-CCEEECCCSS
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC-CCEEeccCcc
Confidence 4799999999999999987543 3499999999999999999999999 99999999999999988 6999999999
Q ss_pred cccccc--ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCc----hHHHHHHHH
Q 025244 76 AREESL--TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS----NLQAAYAAA 149 (255)
Q Consensus 76 a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~----~~~~~~~~~ 149 (255)
++.... ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.... .........
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLST--------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp CEECCSSSSCEECCCCSCGGGCCHHHHHH--------SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred ccccCcccccccccccCCcCccCHHHhcc--------CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 985432 222344569999999999853 457889999999999999999999995211 000001111
Q ss_pred hhcCCC--------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 150 FKNVRP--------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 150 ~~~~~~--------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
...... .....+..+.+++.+||+.||.+|||+.+++++|+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 110000 011224789999999999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=254.32 Aligned_cols=175 Identities=19% Similarity=0.290 Sum_probs=142.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--------------
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-------------- 64 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~-------------- 64 (255)
+++||||++|++|.+++..... ..+++..++.++.|++.||+|||++||+||||||+||+++.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 3799999999999999987521 349999999999999999999999999999999999999843
Q ss_pred ----CCceEEecCccccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCc
Q 025244 65 ----LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 140 (255)
Q Consensus 65 ----~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~ 140 (255)
...+||+|||++...... ....||+.|+|||++.+ ...++.++||||||+++|+|++|.+++....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQE-------NYTHLPKADIFALALTVVCAAGAEPLPRNGD 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTT-------CCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred ccCCceEEEEcccccccccCCc---cccCCCccccChhHhcC-------CCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence 137899999999865433 23469999999999853 2355679999999999999999998876543
Q ss_pred hHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 141 NLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
. ............+..+++++.++|.+||+.||.+||++.+++++
T Consensus 236 ~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 Q---WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp H---HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred H---HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 2 22233333344466789999999999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=253.70 Aligned_cols=178 Identities=29% Similarity=0.386 Sum_probs=145.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFR 156 (276)
T ss_dssp EEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECE
T ss_pred EEEEEEecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccC-CCEEEeeCCCccccC
Confidence 379999999999999997543 39999999999999999999999999999999999999988 799999999997543
Q ss_pred cc---cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC--CC
Q 025244 81 LT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--RP 155 (255)
Q Consensus 81 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~ 155 (255)
.. .......||+.|+|||++.+ ...++.++||||||+++|+|++|+.||................. .+
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (276)
T 2yex_A 157 YNNRERLLNKMCGTLPYVAPELLKR-------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229 (276)
T ss_dssp ETTEECCBCCCCSCGGGCCGGGGTC-------SSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTST
T ss_pred CCcchhcccCCccccCccChHHHhc-------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccC
Confidence 22 22345679999999999853 22346789999999999999999999987654433332222221 12
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....+++.+.++|.+||+.||.+||++.+++++
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 230 PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 234688999999999999999999999999886
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=259.44 Aligned_cols=176 Identities=22% Similarity=0.276 Sum_probs=143.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE-------------------
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL------------------- 61 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill------------------- 61 (255)
++|||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccc
Confidence 37999999 7888888887665569999999999999999999999999999999999999
Q ss_pred eCCCCceEEecCccccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCch
Q 025244 62 TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 141 (255)
Q Consensus 62 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~ 141 (255)
+.+ +.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+...
T Consensus 176 ~~~-~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 176 VKN-TSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILE--------LGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp ESC-CCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCC-CcEEEeecCcccccccc--ccCCcCCCcccCCeeeec--------CCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 445 68999999999864322 345689999999999853 5678899999999999999999999988766
Q ss_pred HHHHHHHHhhcCC-------------------------------------------CCCCCCcHHHHHHHHHhcccCCCC
Q 025244 142 LQAAYAAAFKNVR-------------------------------------------PSAENVPEELSIILTSCWKEDPNA 178 (255)
Q Consensus 142 ~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~l~~li~~~l~~~p~~ 178 (255)
.+........... ......+.++.+||.+||+.||.+
T Consensus 245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 5443332221110 001122458999999999999999
Q ss_pred CCCHHHHHHH
Q 025244 179 RPNFTQIIQM 188 (255)
Q Consensus 179 Rpt~~~vl~~ 188 (255)
|||+.|++++
T Consensus 325 Rpt~~e~l~h 334 (355)
T 2eu9_A 325 RITLAEALLH 334 (355)
T ss_dssp SCCHHHHTTS
T ss_pred CcCHHHHhcC
Confidence 9999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=257.56 Aligned_cols=181 Identities=29% Similarity=0.400 Sum_probs=145.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCC--CceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~--~~~kl~Dfg~a~~ 78 (255)
.++||||++|++|.+++..... +++..++.++.|++.||.|||++|++||||||+||+++.+. ..+||+|||+++.
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 3799999999999999976543 99999999999999999999999999999999999998652 2499999999986
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC--
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-- 156 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 156 (255)
...........||+.|+|||++... ....++.++||||||+++|+|++|..||....................
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T 2ycf_A 167 LGETSLMRTLCGTPTYLAPEVLVSV-----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241 (322)
T ss_dssp CCCCHHHHHHHSCCTTCCHHHHHHT-----TTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCH
T ss_pred cccccccccccCCcCccCchhhccC-----CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCc
Confidence 5544444456799999999987421 235678899999999999999999999976543322222222211111
Q ss_pred --CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 --AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...++..+.++|.+||+.||.+||++.+++++
T Consensus 242 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 24678999999999999999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=261.52 Aligned_cols=178 Identities=22% Similarity=0.401 Sum_probs=144.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~-~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+++||||++|++|.+++...+. +++..+..++.|++.||+|||++ ||+||||||+|||++.+ +.+||+|||+++..
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQL 182 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-CCEEECCCCCCHHH
T ss_pred EEEEEECCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCC-CCEEEEECCCCccc
Confidence 4799999999999999987654 99999999999999999999996 99999999999999988 69999999999754
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-----------
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA----------- 148 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~----------- 148 (255)
... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+.....
T Consensus 183 ~~~-~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3eqc_A 183 IDS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 253 (360)
T ss_dssp HHH-C----CCCCTTCCHHHHTT--------CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------
T ss_pred ccc-cccCCCCCCCeECHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCC
Confidence 322 2345689999999999853 56788999999999999999999999875543322111
Q ss_pred ------------------------------HhhcCCC--CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 149 ------------------------------AFKNVRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 149 ------------------------------~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
......+ ....++.++.+||.+||+.||.+|||+.++++|-+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 254 PPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp --------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred CCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 0111111 12347889999999999999999999999998754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=258.80 Aligned_cols=187 Identities=26% Similarity=0.366 Sum_probs=133.2
Q ss_pred CEEEEecCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNM-RPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~--i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
+++||||++ |+|.+++... ....+++..++.++.|++.||+|||++| |+||||||+|||++.+ +.+||+|||+++
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~ 186 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSAT 186 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT-SCEEBCCCTTCB
T ss_pred EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC-CCEEEecCccce
Confidence 379999995 7999999763 2334999999999999999999999999 9999999999999988 699999999998
Q ss_pred ccccccc-------------cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHH
Q 025244 78 EESLTEM-------------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 144 (255)
Q Consensus 78 ~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~ 144 (255)
....... .....||+.|+|||++... ....++.++||||||+++|+|++|+.||.+......
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY-----SNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp CCSSCC-------------------------------CC-----TTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred eccccCcccccccccccchhhccccCCCCcCChhhhhcc-----ccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 5433211 1245689999999988321 235678899999999999999999999976443322
Q ss_pred HHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcC
Q 025244 145 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 197 (255)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~ 197 (255)
.. .....+.....+..+.+||.+||+.||.+||++.+++++|+.......
T Consensus 262 ~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 262 VN---GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp -------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred hc---CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 11 122233455677889999999999999999999999999998876544
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=260.52 Aligned_cols=190 Identities=26% Similarity=0.420 Sum_probs=146.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCeecCCCCCcEEEeCCCCceEEec
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH--------SHGIIHRDLKPENLLLTEDLKTIKLAD 72 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH--------~~~i~HrDikp~Nill~~~~~~~kl~D 72 (255)
+++||||++||+|.+++.+.. +++..++.++.|++.||+||| ++|++||||||+|||++.+ +.+||+|
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~-~~~kL~D 190 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIAD 190 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT-SCEEECC
T ss_pred eEEEEeecCCCcHHHHHhccC---ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC-CCEEEEE
Confidence 379999999999999998643 999999999999999999999 8999999999999999988 6999999
Q ss_pred Ccccccccccc-----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhC----------CCCCC
Q 025244 73 FGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN----------KLPFE 137 (255)
Q Consensus 73 fg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g----------~~p~~ 137 (255)
||+++...... ......||+.|+|||++.+.... ....++.++||||||+++|||++| ..||.
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM--KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCT--TCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccc--cccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 99997543322 23455799999999998641100 000223689999999999999999 78886
Q ss_pred CCch----HHHHHHHH-hhcCCCCC------CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 025244 138 GMSN----LQAAYAAA-FKNVRPSA------ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 196 (255)
Q Consensus 138 ~~~~----~~~~~~~~-~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~ 196 (255)
.... ........ .....+.. ...+..+.++|.+||+.||.+||++.+++++|+.+....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 5432 22222222 22222221 133468999999999999999999999999999887643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=261.62 Aligned_cols=179 Identities=28% Similarity=0.436 Sum_probs=143.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... +++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLA 175 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCTTC----
T ss_pred EEEEEecCCcchHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCC-CcEEEEeCCCceeec
Confidence 3799999999999888775443 9999999999999999999999999999999999999988 699999999997543
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC-----
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR----- 154 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~----- 154 (255)
. ........||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+....+...........
T Consensus 176 ~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (331)
T 4aaa_A 176 APGEVYDDEVATRWYRAPELLVG-------DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH 248 (331)
T ss_dssp --------CCCCCTTCCHHHHTT-------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred CCccccCCCcCCccccCcccccC-------CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence 3 233345679999999999853 246788999999999999999999999987766555443321110
Q ss_pred ---------------C----------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 155 ---------------P----------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 155 ---------------~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
+ ....+++.+.+||.+||+.||.+|||+.|++++-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 308 (331)
T 4aaa_A 249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308 (331)
T ss_dssp HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0 0135789999999999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=255.16 Aligned_cols=179 Identities=26% Similarity=0.374 Sum_probs=148.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... .+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++....
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRNK-TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTE-GHAKLADFGVAGQLT 176 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECB
T ss_pred EEEEeecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCC-CCEEEeecccchhhh
Confidence 3799999999999999975432 39999999999999999999999999999999999999988 799999999997543
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC--CCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSA 157 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~ 157 (255)
.. .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.................. ...
T Consensus 177 ~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (314)
T 3com_A 177 DTMAKRNTVIGTPFWMAPEVIQE--------IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP 248 (314)
T ss_dssp TTBSCBCCCCSCGGGCCHHHHSS--------SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSG
T ss_pred hhccccCccCCCCCccChhhcCC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCc
Confidence 32 22345679999999999853 45788999999999999999999999887665554433322211 124
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
..++..+.++|.+||+.||.+||++.+++++-
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 45789999999999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=265.21 Aligned_cols=177 Identities=24% Similarity=0.293 Sum_probs=143.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCeecCCCCCcEEEeC-CCCceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH--SHGIIHRDLKPENLLLTE-DLKTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH--~~~i~HrDikp~Nill~~-~~~~~kl~Dfg~a~ 77 (255)
++|||||++ |+|.+++.......+++..+..++.|++.||.||| +.||+||||||+|||++. +.+.+||+|||+++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 379999995 69999999876556999999999999999999999 579999999999999964 22689999999998
Q ss_pred ccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC-
Q 025244 78 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS- 156 (255)
Q Consensus 78 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~- 156 (255)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+......+.
T Consensus 210 ~~~~~--~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 279 (382)
T 2vx3_A 210 QLGQR--IYQYIQSRFYRSPEVLLG--------MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA 279 (382)
T ss_dssp ETTCC--CCSSCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred ecccc--cccccCCccccChHHHcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 65432 345689999999999863 4688999999999999999999999998776665544432211110
Q ss_pred -------------------------------------CCC-------------------------CcHHHHHHHHHhccc
Q 025244 157 -------------------------------------AEN-------------------------VPEELSIILTSCWKE 174 (255)
Q Consensus 157 -------------------------------------~~~-------------------------~~~~l~~li~~~l~~ 174 (255)
... ..+++.+||.+||+.
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 359 (382)
T 2vx3_A 280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY 359 (382)
T ss_dssp HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence 000 014789999999999
Q ss_pred CCCCCCCHHHHHHH
Q 025244 175 DPNARPNFTQIIQM 188 (255)
Q Consensus 175 ~p~~Rpt~~~vl~~ 188 (255)
||.+|||+.|++++
T Consensus 360 dP~~Rpta~e~L~h 373 (382)
T 2vx3_A 360 DPKTRIQPYYALQH 373 (382)
T ss_dssp CTTTSCCHHHHTTS
T ss_pred ChhhCCCHHHHhcC
Confidence 99999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=254.65 Aligned_cols=180 Identities=26% Similarity=0.491 Sum_probs=144.1
Q ss_pred CEEEEecCCCCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCc
Q 025244 1 MVIVTELLSGGTLRKYLLNM------RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 74 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~------~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg 74 (255)
+++||||++|++|.+++... ....+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg 166 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED-GSVQIADFG 166 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-CCEEECCCH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCC-CCEEEEecc
Confidence 37999999999999999752 23349999999999999999999999999999999999999988 799999999
Q ss_pred cccccccc------cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHH
Q 025244 75 LAREESLT------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA 148 (255)
Q Consensus 75 ~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~ 148 (255)
++...... .......||+.|+|||++.. ...++.++||||||+++|+|++|+.||............
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 239 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ-------VRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT 239 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHH-------HHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhcc-------ccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH
Confidence 98753322 12234578999999998853 235788999999999999999999999887665554443
Q ss_pred HhhcCCC---------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 149 AFKNVRP---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 149 ~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....... ....++.++.++|.+||+.||.+||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 3322211 134678999999999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=251.41 Aligned_cols=178 Identities=26% Similarity=0.399 Sum_probs=149.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCC--CceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~--~~~kl~Dfg~a~~ 78 (255)
+++||||++|++|.+++..... +++..++.++.|++.||.|||++|++||||||+||+++.+. +.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEEEEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 3799999999999999987654 99999999999999999999999999999999999997542 3699999999986
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC---
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--- 155 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--- 155 (255)
...........||+.|+|||++. +.++.++||||||+++|+|++|..||.+....+............
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (287)
T 2wei_A 174 FQQNTKMKDRIGTAYYIAPEVLR---------GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP 244 (287)
T ss_dssp BCCCSSCSCHHHHHTTCCHHHHT---------TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG
T ss_pred ecCCCccccccCcccccChHHhc---------CCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCch
Confidence 55444444556899999999874 347889999999999999999999999877665554444433222
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
....+++++.++|.+||+.||.+||++.+++++-
T Consensus 245 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence 2356889999999999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=260.11 Aligned_cols=179 Identities=26% Similarity=0.321 Sum_probs=145.3
Q ss_pred EEEEecCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCeecCCCCCcEEEeCCCCceEEecCcccc
Q 025244 2 VIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLH--SHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 77 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~--~~~~~~~~~~~~~~~~~i~~~L~~lH--~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~ 77 (255)
++||||++| +|.+.+.. .....+++..+..++.|++.||.||| ++||+||||||+|||++...+.+||+|||+++
T Consensus 102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 689999975 66665543 23345899999999999999999999 99999999999999999733799999999998
Q ss_pred ccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC--
Q 025244 78 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-- 155 (255)
Q Consensus 78 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-- 155 (255)
............||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+.+..............+
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 181 KLSPSEPNVAYICSRYYRAPELIFG-------NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp CCCTTSCCCSTTSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ecCCCCCcccccCCcceeCHHHHcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 7665555566789999999998853 3457889999999999999999999999877665554443211111
Q ss_pred -----------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 -----------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 -----------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.....++++.+||.+||+.||.+|||+.|+++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 122357899999999999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=263.65 Aligned_cols=174 Identities=29% Similarity=0.360 Sum_probs=132.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+ |++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 109 ~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARHTA 183 (367)
T ss_dssp CEEEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECC--------
T ss_pred EEEEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCC-CCEEEeecccccccc
Confidence 48999999 79999999752 39999999999999999999999999999999999999988 699999999998643
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC-----
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP----- 155 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~----- 155 (255)
.. ....+||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..+....+......+
T Consensus 184 ~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 184 DE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ---------CCCTTCCHHHHTT-------CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cc--CCCcCcCcCccChHHHcC-------CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 32 345689999999999853 2567889999999999999999999999877665554433211111
Q ss_pred -------------------C------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 -------------------S------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 -------------------~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
. ....++.+.+||.+||..||.+|||+.++++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 13467889999999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=260.85 Aligned_cols=178 Identities=25% Similarity=0.338 Sum_probs=138.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ |+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||+++...
T Consensus 109 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~ 185 (362)
T 3pg1_A 109 LYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN-NDITICDFNLAREDT 185 (362)
T ss_dssp EEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCTTC-----
T ss_pred EEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC-CCEEEEecCcccccc
Confidence 379999996 79999988643 349999999999999999999999999999999999999988 699999999998655
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC-----
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP----- 155 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~----- 155 (255)
.........||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+....+...........+
T Consensus 186 ~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 258 (362)
T 3pg1_A 186 ADANKTHYVTHRWYRAPELVMQ-------FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV 258 (362)
T ss_dssp ----------CGGGCCHHHHTT-------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccceecccceecCcHHhcC-------CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHh
Confidence 5555556789999999998853 2457889999999999999999999999877655444332211111
Q ss_pred --------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 --------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 --------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.....++.+.+||.+||+.||.+|||+.+++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 123567889999999999999999999999987
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=254.77 Aligned_cols=183 Identities=27% Similarity=0.401 Sum_probs=146.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++....
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLE-GDIRLADFGVSAKNL 168 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-SCEEECCCHHHHHHH
T ss_pred EEEEEEeCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCC-CCEEEEECCCCcccc
Confidence 3799999999999999987433 39999999999999999999999999999999999999988 699999999986422
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC--CCC
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSA 157 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~ 157 (255)
. ........||+.|+|||++.... .....++.++||||||+++|+|++|..||...+.............. ...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAPEVVMCET---MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP 245 (302)
T ss_dssp HHHHC-----CCGGGCCHHHHHHHH---TTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSG
T ss_pred ccccccccccCChhhcCCeeecccc---CCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCc
Confidence 2 12234457999999999874211 01356788999999999999999999999987766555444433322 224
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..++..+.++|.+||+.||.+||++.+++++
T Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 246 SKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred cccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 5678999999999999999999999999886
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=252.10 Aligned_cols=182 Identities=25% Similarity=0.405 Sum_probs=146.0
Q ss_pred CEEEEecCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMR-PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+++||||++|++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++...+.+||+|||+++..
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 379999999999999998753 2347788999999999999999999999999999999999973379999999999854
Q ss_pred ccc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHH-HH-HhhcCCCC
Q 025244 80 SLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY-AA-AFKNVRPS 156 (255)
Q Consensus 80 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-~~-~~~~~~~~ 156 (255)
... .......||+.|+|||++.+ ....++.++||||||+++|+|++|+.||.......... .. ........
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (295)
T 2clq_A 174 AGINPCTETFTGTLQYMAPEIIDK------GPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEI 247 (295)
T ss_dssp CC-----CCCCCCGGGCCHHHHHH------GGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCC
T ss_pred CCCCCcccccCCCccccChhhhcC------CCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccc
Confidence 332 22345679999999999854 12336889999999999999999999997644333222 22 22222334
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+..++.++.++|.+||+.||++||++.+++++
T Consensus 248 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 248 PESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 56789999999999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=260.10 Aligned_cols=179 Identities=23% Similarity=0.390 Sum_probs=147.3
Q ss_pred CEEEEecCCCCCHHHH------HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCCCCceEEecC
Q 025244 1 MVIVTELLSGGTLRKY------LLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADF 73 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~------l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~-~~i~HrDikp~Nill~~~~~~~kl~Df 73 (255)
+++||||++||+|.++ +.......+++..++.++.|++.||.|||+ +|++||||||+||+++.+ +.+||+||
T Consensus 118 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~-~~~kl~df 196 (348)
T 2pml_X 118 VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN-GRVKLSDF 196 (348)
T ss_dssp EEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT-SCEEECCC
T ss_pred EEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC-CcEEEecc
Confidence 4799999999999999 665434569999999999999999999999 999999999999999988 69999999
Q ss_pred ccccccccccccccCCCccceecccccccccccccccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc
Q 025244 74 GLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH-KVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 152 (255)
Q Consensus 74 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 152 (255)
|++...... ......||..|+|||++.+ ...++. ++||||||+++|+|++|+.||................
T Consensus 197 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~ 268 (348)
T 2pml_X 197 GESEYMVDK-KIKGSRGTYEFMPPEFFSN-------ESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK 268 (348)
T ss_dssp TTCEECBTT-EECSSCSCGGGCCGGGGSS-------CCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSC
T ss_pred ccccccccc-cccCCCCCcCccCchhhcC-------CCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc
Confidence 999864433 3455689999999999863 123444 9999999999999999999998866633333333322
Q ss_pred CCCCC-------------------CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 153 VRPSA-------------------ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 153 ~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....+ ..++.++.++|.+||+.||.+||++.+++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 269 NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 22222 5688999999999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=263.63 Aligned_cols=177 Identities=23% Similarity=0.284 Sum_probs=139.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCCC--------------
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDL-------------- 65 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~-~i~HrDikp~Nill~~~~-------------- 65 (255)
++|||||+ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||++.+.
T Consensus 120 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~ 198 (397)
T 1wak_A 120 ICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQ 198 (397)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---
T ss_pred EEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHh
Confidence 47999999 67888888776555699999999999999999999999 999999999999998662
Q ss_pred ----------------------------------CceEEecCccccccccccccccCCCccceecccccccccccccccC
Q 025244 66 ----------------------------------KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 111 (255)
Q Consensus 66 ----------------------------------~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 111 (255)
..+||+|||+++..... .....||+.|+|||++.+ .
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~--------~ 268 (397)
T 1wak_A 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIG--------S 268 (397)
T ss_dssp ------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHT--------S
T ss_pred hcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcC--------C
Confidence 17999999999864432 345689999999999863 5
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCch------HHHHHHHHhhcCC-------------------------------
Q 025244 112 HYNHKVDSYSFAIVLWELLHNKLPFEGMSN------LQAAYAAAFKNVR------------------------------- 154 (255)
Q Consensus 112 ~~~~~~DvwslG~~l~el~~g~~p~~~~~~------~~~~~~~~~~~~~------------------------------- 154 (255)
.++.++|||||||++|||++|+.||...+. .............
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 578899999999999999999999976442 1111111110000
Q ss_pred ----------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 155 ----------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 155 ----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
......+..+.+||.+||+.||.+|||+.|+++|
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0012234678899999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=265.16 Aligned_cols=184 Identities=23% Similarity=0.288 Sum_probs=135.4
Q ss_pred CEEEEecCCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE----eCCCCceE
Q 025244 1 MVIVTELLSGGTLRKYLLNMR-------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL----TEDLKTIK 69 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~-------~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill----~~~~~~~k 69 (255)
++|||||++ |+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.+ +.+|
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~k 172 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER-GRVK 172 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT-TCEE
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC-CcEE
Confidence 479999995 68999887432 1239999999999999999999999999999999999999 444 6899
Q ss_pred EecCccccccccc----cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH---
Q 025244 70 LADFGLAREESLT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL--- 142 (255)
Q Consensus 70 l~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~--- 142 (255)
|+|||+++..... ......+||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+....
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 245 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 245 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTT-------CCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcC-------CCcccchhhhHHHHHHHHHHHhCCCCCCCccccccc
Confidence 9999999854322 22345689999999999853 245889999999999999999999999765431
Q ss_pred ------HHHHHHHhhcCCCCC-------------------------------------CCCcHHHHHHHHHhcccCCCCC
Q 025244 143 ------QAAYAAAFKNVRPSA-------------------------------------ENVPEELSIILTSCWKEDPNAR 179 (255)
Q Consensus 143 ------~~~~~~~~~~~~~~~-------------------------------------~~~~~~l~~li~~~l~~~p~~R 179 (255)
+....+......+.. ...+..+.+||.+||+.||.+|
T Consensus 246 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R 325 (405)
T 3rgf_A 246 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKR 325 (405)
T ss_dssp -CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGS
T ss_pred cccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccC
Confidence 222222211111111 1226788999999999999999
Q ss_pred CCHHHHHHHHHHhHhh
Q 025244 180 PNFTQIIQMLLNYLSA 195 (255)
Q Consensus 180 pt~~~vl~~l~~~~~~ 195 (255)
||+.|+++| .++..
T Consensus 326 ~ta~e~L~h--p~f~~ 339 (405)
T 3rgf_A 326 ITSEQAMQD--PYFLE 339 (405)
T ss_dssp CCHHHHHTS--GGGTS
T ss_pred CCHHHHhcC--hhhcc
Confidence 999999998 44443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=255.46 Aligned_cols=176 Identities=27% Similarity=0.319 Sum_probs=143.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++... .+++..+..++.|++.||+|||++|++||||||+|||++.+ +.+||+|||+++...
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSN-CDLKVCDFGLARIID 163 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECC
T ss_pred EEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCC-CcEEEEecccccccc
Confidence 379999996 7999999863 39999999999999999999999999999999999999988 699999999998543
Q ss_pred ccc-----------ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH
Q 025244 81 LTE-----------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA 149 (255)
Q Consensus 81 ~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 149 (255)
... ......||+.|+|||++.. ...++.++||||||+++|+|++|+.||.+.+..+......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 236 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT-------SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF 236 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHS-------CCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccccccCccccccchhhccccccccCCeeecc-------CCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 211 1223578999999998752 3567889999999999999999999999877554443322
Q ss_pred hhcCCC-------------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 150 FKNVRP-------------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 150 ~~~~~~-------------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.....+ ....+++++.++|.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 111110 023678999999999999999999999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=252.67 Aligned_cols=177 Identities=24% Similarity=0.303 Sum_probs=143.0
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
++||||++ |+|.+++.+. .+++..++.++.|++.||+|||++|++||||||+||+++.+.+.+||+|||+++....
T Consensus 98 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~ 173 (320)
T 2i6l_A 98 YIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173 (320)
T ss_dssp EEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--
T ss_pred eEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCC
Confidence 79999997 6999999653 3999999999999999999999999999999999999985546899999999985432
Q ss_pred c----cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC---
Q 025244 82 T----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--- 154 (255)
Q Consensus 82 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--- 154 (255)
. .......+|..|+|||++.. ...++.++||||||+++|||++|+.||.+....+...........
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (320)
T 2i6l_A 174 HYSHKGHLSEGLVTKWYRSPRLLLS-------PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246 (320)
T ss_dssp ------CCCGGGSCCTTCCHHHHHC-------TTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCH
T ss_pred CcccccccccccccccccCcHHhcC-------cccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence 1 22234567999999998753 356788999999999999999999999987765544333221110
Q ss_pred --------------------C------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 155 --------------------P------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 155 --------------------~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
+ ....++.++.++|.+||+.||.+||++.+++++-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (320)
T 2i6l_A 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP 307 (320)
T ss_dssp HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSH
T ss_pred hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCc
Confidence 0 1246789999999999999999999999999873
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=257.60 Aligned_cols=177 Identities=24% Similarity=0.316 Sum_probs=138.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCC-----CCceEEecCc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTED-----LKTIKLADFG 74 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~-~i~HrDikp~Nill~~~-----~~~~kl~Dfg 74 (255)
+++||||+ |++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||++.+ .+.+||+|||
T Consensus 105 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg 183 (373)
T 1q8y_A 105 VVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG 183 (373)
T ss_dssp EEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCT
T ss_pred EEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccc
Confidence 37999999 89999999986666699999999999999999999998 99999999999999532 1379999999
Q ss_pred cccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH------HHHHHH
Q 025244 75 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL------QAAYAA 148 (255)
Q Consensus 75 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~------~~~~~~ 148 (255)
+++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+.... ......
T Consensus 184 ~a~~~~~~--~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (373)
T 1q8y_A 184 NACWYDEH--YTNSIQTREYRSPEVLLG--------APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253 (373)
T ss_dssp TCEETTBC--CCSCCSCGGGCCHHHHHT--------CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred cccccCCC--CCCCCCCccccCcHHHhC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHH
Confidence 99864432 345689999999999853 55788999999999999999999999764421 111111
Q ss_pred Hhhc-----------------------------------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025244 149 AFKN-----------------------------------------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 187 (255)
Q Consensus 149 ~~~~-----------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~ 187 (255)
.... .......++.++.+||.+||+.||.+|||+.|+++
T Consensus 254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 1100 00112234578999999999999999999999998
Q ss_pred H
Q 025244 188 M 188 (255)
Q Consensus 188 ~ 188 (255)
+
T Consensus 334 h 334 (373)
T 1q8y_A 334 H 334 (373)
T ss_dssp C
T ss_pred C
Confidence 7
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=252.89 Aligned_cols=171 Identities=24% Similarity=0.381 Sum_probs=143.0
Q ss_pred CEEEEecCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~g-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+++||||+.+ ++|.+++..... +++..++.++.|++.||+|||++||+||||||+|||++.+.+.+||+|||+++..
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEcCCCCccHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence 3799999976 899999987654 9999999999999999999999999999999999999944379999999999865
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
... ......||+.|+|||++.+ ...++.++||||||+++|||++|+.||..... ...........
T Consensus 201 ~~~-~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------~~~~~~~~~~~ 265 (320)
T 3a99_A 201 KDT-VYTDFDGTRVYSPPEWIRY-------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------IIRGQVFFRQR 265 (320)
T ss_dssp CSS-CBCCCCSCGGGSCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHCCCCCSSC
T ss_pred ccc-cccCCCCCccCCChHHhcc-------CCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------hhccccccccc
Confidence 433 2345679999999998853 23346789999999999999999999975321 12223334567
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+++++.++|.+||+.||.+||++.+++++
T Consensus 266 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 266 VSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=247.95 Aligned_cols=176 Identities=28% Similarity=0.420 Sum_probs=134.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~ 167 (303)
T 1zy4_A 90 LFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDES-RNVKIGDFGLAKNVH 167 (303)
T ss_dssp EEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCCCCCSCTT
T ss_pred eEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCC-CCEEEeeCcchhhcc
Confidence 379999999999999998644 338889999999999999999999999999999999999988 699999999997543
Q ss_pred cc---------------cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHH
Q 025244 81 LT---------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 145 (255)
Q Consensus 81 ~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~ 145 (255)
.. .......||+.|+|||++.+ ...++.++||||||+++|+|++ ||.........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 168 RSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG-------TGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp C-------------------------CTTSCHHHHTS-------CSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cccchhccccccccccccccccCCCcccccCcccccC-------CCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 21 12234578999999999853 2467889999999999999998 55432222222
Q ss_pred HHHHhhcCC----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 146 YAAAFKNVR----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 146 ~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
......... ......+..+.++|.+||+.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 222222111 1234567889999999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=255.68 Aligned_cols=172 Identities=27% Similarity=0.358 Sum_probs=140.3
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
++||||++ ++|.+++.. .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 123 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-CELKILDFGLARHADA 196 (371)
T ss_dssp EEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECSTTCC-----
T ss_pred EEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCC-CCEEEEecCccccccc
Confidence 89999996 789888742 29999999999999999999999999999999999999988 7999999999986433
Q ss_pred ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC------
Q 025244 82 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP------ 155 (255)
Q Consensus 82 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~------ 155 (255)
. .....||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+.+..+...........+
T Consensus 197 ~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 197 E--MTGYVVTRWYRAPEVILS-------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp -----CTTCCCTTSCHHHHSC-------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred C--cCCcccCccccCHHHhcC-------CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 2 345678999999998853 2567889999999999999999999999877665554443211111
Q ss_pred ------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 ------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....+++.+.+||.+||+.||.+|||+.|++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 023568999999999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=261.82 Aligned_cols=177 Identities=16% Similarity=0.265 Sum_probs=139.4
Q ss_pred EEEEecCCCCCHHHHHHh-----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccc
Q 025244 2 VIVTELLSGGTLRKYLLN-----MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 76 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~-----~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a 76 (255)
+++|+++ +++|.+++.. .....+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 181 ~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~-~~~kL~DFG~a 258 (413)
T 3dzo_A 181 FFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR-GGVFLTGFEHL 258 (413)
T ss_dssp EEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCGGGC
T ss_pred EEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecC-CeEEEEeccce
Confidence 6778877 7999999952 223347888999999999999999999999999999999999998 68999999999
Q ss_pred cccccccccccCCCccceeccccccccccccc--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC
Q 025244 77 REESLTEMMTAETGTYRWMAPELYSTVTLRQG--EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 154 (255)
Q Consensus 77 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 154 (255)
+..... ....+| +.|+|||++.......+ ....++.++|||||||++|||++|+.||.+........ ...
T Consensus 259 ~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~-----~~~ 330 (413)
T 3dzo_A 259 VRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE-----WIF 330 (413)
T ss_dssp EETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG-----GGG
T ss_pred eecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH-----HHH
Confidence 864433 455678 99999999842110000 23457789999999999999999999998754332211 112
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 155 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 155 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.....+|+++.+||.+||+.||.+||++.+++++
T Consensus 331 ~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 331 RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 2234788999999999999999999999888654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=248.92 Aligned_cols=183 Identities=25% Similarity=0.433 Sum_probs=135.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~-~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+++||||+ ++.+..+..... ..+++..++.++.|++.||.|||++ |++||||||+||+++.+ +.+||+|||++...
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER-GQIKLCDFGISGRL 175 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTT-SCEEECCCTTC---
T ss_pred EEEEEecc-CCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCC-CCEEEEECCCchhc
Confidence 47999999 666766665433 3499999999999999999999996 99999999999999988 69999999999865
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC---C
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---S 156 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~ 156 (255)
..........||+.|+|||++.... .....++.++||||||+++|+|++|+.||..................+ .
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (318)
T 2dyl_A 176 VDDKAKDRSAGCAAYMAPERIDPPD---PTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG 252 (318)
T ss_dssp -----------CCTTCCHHHHC-----------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCS
T ss_pred cCCccccccCCCccccChhhccccc---ccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCc
Confidence 5444445567999999999985311 013457889999999999999999999998754433333333332222 2
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQML 189 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l 189 (255)
...+++++.++|.+||+.||.+||++.+++++-
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (318)
T 2dyl_A 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285 (318)
T ss_dssp SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence 346889999999999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=252.64 Aligned_cols=184 Identities=24% Similarity=0.439 Sum_probs=124.3
Q ss_pred CEEEEecCCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCCCCceEEecCccc
Q 025244 1 MVIVTELLSGGTLRKYLLN---MRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLA 76 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~---~~~~~~~~~~~~~~~~~i~~~L~~lH~~-~i~HrDikp~Nill~~~~~~~kl~Dfg~a 76 (255)
+++||||++ |+|.+++.. .....+++..+..++.|++.||.|||++ |++||||||+||+++.+ +.+||+|||++
T Consensus 96 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~~ 173 (327)
T 3aln_A 96 CWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS-GNIKLCDFGIS 173 (327)
T ss_dssp EEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETT-TEEEECCCSSS
T ss_pred eEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCC-CCEEEccCCCc
Confidence 379999997 588888864 2234599999999999999999999999 99999999999999988 79999999999
Q ss_pred cccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC
Q 025244 77 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 156 (255)
Q Consensus 77 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 156 (255)
+............||+.|+|||++.... ....++.++||||||+++|+|++|+.||.+................+.
T Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (327)
T 3aln_A 174 GQLVDSIAKTRDAGCRPYMAPERIDPSA----SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ 249 (327)
T ss_dssp CC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCC
T ss_pred eecccccccccCCCCccccCceeecccc----CcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCC
Confidence 8655444444557999999999984210 134578899999999999999999999987543222211111111111
Q ss_pred -----CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 157 -----AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 157 -----~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
...+++.+.++|.+||+.||.+||++.+++++-+
T Consensus 250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence 2357899999999999999999999999998643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=251.49 Aligned_cols=173 Identities=26% Similarity=0.352 Sum_probs=139.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++ ++|.+++.. .+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 104 ~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-CELKILDFGLARHAD 177 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT-CCEEECSTTCTTC--
T ss_pred EEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCC-CcEEEeecccccCCC
Confidence 389999996 688888743 29999999999999999999999999999999999999988 699999999998643
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc--------
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN-------- 152 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-------- 152 (255)
.. .....||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+.+..+.........
T Consensus 178 ~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 178 AE--MTGYVVTRWYRAPEVILS-------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp --------CCSBCCSCHHHHSC-------CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred CC--ccccccCcCcCCHHHHhC-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 22 345678999999998853 2567889999999999999999999998877655443332210
Q ss_pred ----------------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 153 ----------------------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 153 ----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.......+++++.++|.+||+.||.+||++.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 011134678999999999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=245.59 Aligned_cols=185 Identities=25% Similarity=0.430 Sum_probs=139.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++|||+. +++|.+++..... +++..++.++.|++.||.|||++|++||||||+||++++ +.+||+|||+++...
T Consensus 103 ~~lv~e~~-~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~--~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 103 IYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEEECCC-SEEHHHHHHHCSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--TEEEECCCSSSCC--
T ss_pred EEEEEecC-CCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC--CeEEEeecccccccc
Confidence 47999954 8999999987654 899999999999999999999999999999999999975 589999999998543
Q ss_pred ccc---ccccCCCccceecccccccccccc---cccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-hcC
Q 025244 81 LTE---MMTAETGTYRWMAPELYSTVTLRQ---GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF-KNV 153 (255)
Q Consensus 81 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~---~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~ 153 (255)
... ......||+.|+|||++.+..... .....++.++||||||+++|+|++|+.||.............. ...
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 257 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 257 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc
Confidence 322 223457899999999985421100 0124678899999999999999999999987554333322222 222
Q ss_pred C-CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 154 R-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 154 ~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
. ..+...+.++.++|.+||+.||.+||++.+++++-+
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 2 234566899999999999999999999999998743
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=247.05 Aligned_cols=171 Identities=25% Similarity=0.387 Sum_probs=142.9
Q ss_pred CEEEEec-CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTEL-LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey-~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
.++|||| ++|++|.+++.+... +++..++.++.|++.||.|||++|++||||||+||+++.+.+.+||+|||+++..
T Consensus 113 ~~~v~e~~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~ 190 (312)
T 2iwi_A 113 FMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190 (312)
T ss_dssp CEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEEC
T ss_pred EEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhc
Confidence 4799999 789999999987654 9999999999999999999999999999999999999933379999999999865
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
... ......||..|+|||++.+ ....+.++||||||+++|+|++|+.||..... ...........
T Consensus 191 ~~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~ 255 (312)
T 2iwi_A 191 HDE-PYTDFDGTRVYSPPEWISR-------HQYHALPATVWSLGILLYDMVCGDIPFERDQE-------ILEAELHFPAH 255 (312)
T ss_dssp CSS-CBCCCCSCTTTSCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHTCCCCCTT
T ss_pred ccC-cccccCCcccccCceeeec-------CCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------HhhhccCCccc
Confidence 433 2345679999999998853 22334589999999999999999999975321 11223334567
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
++..+.++|.+||+.||.+||++.+++++
T Consensus 256 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 256 VSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=257.61 Aligned_cols=181 Identities=24% Similarity=0.326 Sum_probs=132.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC----CCceEEecCccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED----LKTIKLADFGLA 76 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~----~~~~kl~Dfg~a 76 (255)
++|||||++ |+|.+++...... ..+..++.++.||+.||.|||++||+||||||+|||++.+ ...+||+|||++
T Consensus 93 ~~lv~E~~~-g~L~~~l~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQKDFA-HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSSCC-CCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEEECCC-CCHHHHHHhcCCC-ccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 479999995 6999999875432 5555677899999999999999999999999999999532 125789999999
Q ss_pred cccccc----cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhh
Q 025244 77 REESLT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFK 151 (255)
Q Consensus 77 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 151 (255)
+..... .......||+.|+|||++... ....++.++|||||||++|||++ |..||...............
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~ 245 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSED-----CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC 245 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC--------CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCC
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcc-----cccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccC
Confidence 864432 223456799999999998531 13456779999999999999999 99999764433322211111
Q ss_pred cCCC--CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 152 NVRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 152 ~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.... .....+..+.+||.+||+.||.+||++.++++|
T Consensus 246 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 246 SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 1111 122335668999999999999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=258.24 Aligned_cols=184 Identities=24% Similarity=0.368 Sum_probs=131.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-----------
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRC-----LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED----------- 64 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~-----~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~----------- 64 (255)
++|||||++ |+|.+++....... .++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence 479999995 69999998754311 1233457799999999999999999999999999999753
Q ss_pred -CCceEEecCcccccccccc-----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 025244 65 -LKTIKLADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFE 137 (255)
Q Consensus 65 -~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~ 137 (255)
...+||+|||+++...... ......||+.|+|||++.+.... .....++.++|||||||++|||++ |+.||.
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL-QTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTT-SCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccccc-ccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 1379999999998644322 12345799999999998542100 012567889999999999999999 999997
Q ss_pred CCchHHHHHHHHhhcCC-CC-----CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 138 GMSNLQAAYAAAFKNVR-PS-----AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 138 ~~~~~~~~~~~~~~~~~-~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+...... ........ +. ...+++++.++|.+||+.||.+||++.+++++
T Consensus 242 ~~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 242 DKYSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp STTTHHH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CchhhHH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 6544332 22222111 11 11345789999999999999999999999975
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=239.02 Aligned_cols=161 Identities=29% Similarity=0.440 Sum_probs=127.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--CCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~--~~~~kl~Dfg~a~~ 78 (255)
+++||||++||+|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.+ .+.+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 4799999999999999998766669999999999999999999999999999999999999872 26899999999864
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC---CC
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV---RP 155 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~~ 155 (255)
... ..++.++||||||+++|||++|+.||.+............... ..
T Consensus 170 ~~~-----------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 220 (299)
T 3m2w_A 170 TTG-----------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 220 (299)
T ss_dssp CTT-----------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCS
T ss_pred ccc-----------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcccc
Confidence 221 2356699999999999999999999976543322111000000 01
Q ss_pred CC----CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025244 156 SA----ENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 190 (255)
Q Consensus 156 ~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~ 190 (255)
.+ ..+++++.++|.+||+.||.+||++.+++++-+
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 11 467899999999999999999999999999754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=260.01 Aligned_cols=178 Identities=30% Similarity=0.369 Sum_probs=138.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC--ceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK--TIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~--~~kl~Dfg~a~ 77 (255)
.++||||++||+|.+++..... ..+++..++.++.|++.||+|||++||+||||||+||+++.+.+ .+||+|||+++
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 3689999999999999987542 34899999999999999999999999999999999999997622 38999999998
Q ss_pred ccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHH-------HHh
Q 025244 78 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA-------AAF 150 (255)
Q Consensus 78 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-------~~~ 150 (255)
............||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+......... ...
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQ--------KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCC--------SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred ccccccccccccCCcccCChHHhcc--------CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence 7665555566789999999999853 5678899999999999999999999976433221100 000
Q ss_pred ------------hcCCC----CCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 025244 151 ------------KNVRP----SAENVPEELSIILTSCWKEDPNARPNFTQII 186 (255)
Q Consensus 151 ------------~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl 186 (255)
....+ ....++..+.++|.+||..||.+|||+.+++
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 00001 1123568999999999999999999998854
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=252.07 Aligned_cols=167 Identities=28% Similarity=0.315 Sum_probs=130.0
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
+|||||++|++|.+++.. .+++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++....
T Consensus 160 ~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~--~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS--CEEECCCTTCEETTC
T ss_pred EEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC--cEEEEecccchhccc
Confidence 899999999999998864 39999999999999999999999999999999999999875 799999999986443
Q ss_pred ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCCc
Q 025244 82 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP 161 (255)
Q Consensus 82 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
. ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+...... .........+
T Consensus 234 ~---~~~~gt~~y~aPE~~~~---------~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-------~~~~~~~~~~ 294 (681)
T 2pzi_A 234 F---GYLYGTPGFQAPEIVRT---------GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-------PEDDPVLKTY 294 (681)
T ss_dssp C---SCCCCCTTTSCTTHHHH---------CSCHHHHHHHHHHHHHHHHSCCCEETTEECSSC-------CTTCHHHHHC
T ss_pred C---CccCCCccccCHHHHcC---------CCCCceehhhhHHHHHHHHhCCCCCcccccccc-------cccccccccC
Confidence 3 45679999999998853 247899999999999999999998865221000 0000001134
Q ss_pred HHHHHHHHHhcccCCCCCCC-HHHHHHHHHHhH
Q 025244 162 EELSIILTSCWKEDPNARPN-FTQIIQMLLNYL 193 (255)
Q Consensus 162 ~~l~~li~~~l~~~p~~Rpt-~~~vl~~l~~~~ 193 (255)
+.+.++|.+||+.||.+||+ ++++...|...+
T Consensus 295 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 295 DSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 78999999999999999996 455555555443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=225.93 Aligned_cols=155 Identities=17% Similarity=0.195 Sum_probs=123.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+++.+. ....++..++.|++.||+|||++||+||||||+|||++.+ +.+||+++|
T Consensus 106 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~-g~~kl~~~~------ 174 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID-GDVVLAYPA------ 174 (286)
T ss_dssp EEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETT-SCEEECSCC------
T ss_pred EEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCC-CCEEEEecc------
Confidence 47999999999999999542 4566788999999999999999999999999999999988 789988543
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHH---HHHhhcCCC--
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY---AAAFKNVRP-- 155 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---~~~~~~~~~-- 155 (255)
|++| ++.++||||||+++|||++|+.||.+.+...... ........+
T Consensus 175 -------------~~~~---------------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T 3uqc_A 175 -------------TMPD---------------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA 226 (286)
T ss_dssp -------------CCTT---------------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHH
T ss_pred -------------ccCC---------------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChh
Confidence 2232 4679999999999999999999998755422110 000111110
Q ss_pred -CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 156 -SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 156 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
....+++++.++|.+||+.||++| |+.++++.|......
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 135688999999999999999999 999999999876543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=230.97 Aligned_cols=166 Identities=16% Similarity=0.158 Sum_probs=128.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCeecCCCCCcEEEeCCCC-------------
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-SHGIIHRDLKPENLLLTEDLK------------- 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH-~~~i~HrDikp~Nill~~~~~------------- 66 (255)
++|||||++||++.+.+.+ ..+++..++.++.||+.||+||| ++||+||||||+|||++.+ +
T Consensus 137 ~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~-~~~~~~~~~~~~~~ 212 (336)
T 2vuw_A 137 LFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT-SLKKLHYTLNGKSS 212 (336)
T ss_dssp EEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEEC-SCSEEEEEETTEEE
T ss_pred EEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEecc-CCcceeeeccCccc
Confidence 4899999999987777744 33899999999999999999999 9999999999999999987 4
Q ss_pred -------ceEEecCccccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHH-HHHHHhCCCCCCC
Q 025244 67 -------TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIV-LWELLHNKLPFEG 138 (255)
Q Consensus 67 -------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~-l~el~~g~~p~~~ 138 (255)
.+||+|||+++..... ..+||+.|+|||++.+ ..+.++|||||+++ .+++++|..||.+
T Consensus 213 ~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g---------~~~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 213 TIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG---------DGDYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp EEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC---------CSSHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred cccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC---------CCccceehhhhhCCCCcccccccCCCcc
Confidence 8999999999864432 3479999999999853 22779999998777 7788999999854
Q ss_pred CchHHHHHHHHh-hcCCC-C-----CCCCcHHHHHHHHHhcccCCCCCCCHHHHH-HH
Q 025244 139 MSNLQAAYAAAF-KNVRP-S-----AENVPEELSIILTSCWKEDPNARPNFTQII-QM 188 (255)
Q Consensus 139 ~~~~~~~~~~~~-~~~~~-~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl-~~ 188 (255)
............ ..... . ...+++++.+||.+||+.| |+.|++ +|
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 280 VLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred hhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 211111111111 11111 1 1246789999999999976 999998 65
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-30 Score=233.20 Aligned_cols=118 Identities=19% Similarity=0.223 Sum_probs=85.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+||||||++|++|.++|.+.+. +++. +|+.||+.||+|+|++||+||||||+|||++.+ |.+||+|||+|+...
T Consensus 317 ~yLVMEyv~G~~L~d~i~~~~~--l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d-g~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAAGEE--IDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR-QHARLIDFGSIVTTP 390 (569)
T ss_dssp EEEEEECCCSEEHHHHHHTTCC--CCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT-SCEEECCCTTEESCC
T ss_pred EEEEEecCCCCcHHHHHHhCCC--CCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCC-CCEEEeecccCeeCC
Confidence 4899999999999999987654 6664 478999999999999999999999999999988 799999999998644
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNK 133 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~ 133 (255)
.. ....+.+||+.|||||++.+ .+..++|+||+|++++++.++.
T Consensus 391 ~~~~~~~t~vGTp~YmAPE~l~g---------~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 391 QDCSWPTNLVQSFFVFVNELFAE---------NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC--------------------------CCCCTTH
T ss_pred CCCccccCceechhhccHHHhCC---------CCCCcccccccccchhhhcccc
Confidence 32 33456789999999999853 4566899999999988776553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=5.2e-23 Score=184.58 Aligned_cols=118 Identities=19% Similarity=0.338 Sum_probs=98.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.+|||||++|++|.+++.+ +..++.|+++||.|||++||+||||||+|||++. .+||+|||+++...
T Consensus 414 ~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~ 480 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISN 480 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECC
T ss_pred cEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECC
Confidence 4899999999999999975 4578999999999999999999999999999987 79999999999654
Q ss_pred cccc--------cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 025244 81 LTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 137 (255)
Q Consensus 81 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~ 137 (255)
.... ..+..||+.|+|||++... ...|+...|+||..+-..+-+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~------~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERF------LEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHH------HHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHH------HHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 4321 2356899999999998641 1345667899999999988888777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=3.1e-18 Score=141.49 Aligned_cols=78 Identities=21% Similarity=0.207 Sum_probs=65.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|++|.+ +. . .....++.|++.||.|||++||+||||||+|||++ + +.+||+|||+++.
T Consensus 175 ~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~-~~vkl~DFG~a~~-- 241 (282)
T 1zar_A 175 NAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E-EGIWIIDFPQSVE-- 241 (282)
T ss_dssp TEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T-TEEEECCCTTCEE--
T ss_pred eEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C-CcEEEEECCCCeE--
Confidence 489999999999998 42 1 12446899999999999999999999999999999 6 7999999999974
Q ss_pred cccccccCCCccceecccccc
Q 025244 81 LTEMMTAETGTYRWMAPELYS 101 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~ 101 (255)
+..++|||.+.
T Consensus 242 ----------~~~~~a~e~l~ 252 (282)
T 1zar_A 242 ----------VGEEGWREILE 252 (282)
T ss_dssp ----------TTSTTHHHHHH
T ss_pred ----------CCCCCHHHHHH
Confidence 23467888763
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=4.1e-15 Score=121.17 Aligned_cols=71 Identities=21% Similarity=0.278 Sum_probs=59.0
Q ss_pred CEEEEecCCC-C----CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCeecCCCCCcEEEeCCCCceEEecCc
Q 025244 1 MVIVTELLSG-G----TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-SHGIIHRDLKPENLLLTEDLKTIKLADFG 74 (255)
Q Consensus 1 l~lV~Ey~~g-g----sL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH-~~~i~HrDikp~Nill~~~~~~~kl~Dfg 74 (255)
.+|||||+.+ | +|.+++.. .++..+..++.|++.||.||| +.||+||||||+|||++. .++|+|||
T Consensus 143 ~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~---~~~liDFG 214 (258)
T 1zth_A 143 NVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID---KVYFIDMG 214 (258)
T ss_dssp TEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS---SEEECCCT
T ss_pred CEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC---cEEEEECc
Confidence 3799999932 3 78776543 234567789999999999999 999999999999999987 79999999
Q ss_pred ccccc
Q 025244 75 LAREE 79 (255)
Q Consensus 75 ~a~~~ 79 (255)
+|...
T Consensus 215 ~a~~~ 219 (258)
T 1zth_A 215 QAVTL 219 (258)
T ss_dssp TCEET
T ss_pred ccccC
Confidence 99753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.34 E-value=3.2e-13 Score=115.36 Aligned_cols=68 Identities=25% Similarity=0.320 Sum_probs=56.3
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC----------ceEEe
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK----------TIKLA 71 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~----------~~kl~ 71 (255)
+|||||++|++|.++.. . ..+..++.|++.+|.+||+.||+||||||.|||++++ + .+.|+
T Consensus 187 ~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d-gd~~d~~~~~~~~~iI 257 (397)
T 4gyi_A 187 TIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE-KDAEDPSSITLTPIII 257 (397)
T ss_dssp EEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE-ECSSCTTSEEEEEEEC
T ss_pred eEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC-CCcccccccccceEEE
Confidence 69999999998866432 2 2345678999999999999999999999999999876 3 37899
Q ss_pred cCccccc
Q 025244 72 DFGLARE 78 (255)
Q Consensus 72 Dfg~a~~ 78 (255)
||+-+..
T Consensus 258 D~~Q~V~ 264 (397)
T 4gyi_A 258 XFPQMVS 264 (397)
T ss_dssp CCTTCEE
T ss_pred EeCCccc
Confidence 9998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.81 E-value=1.6e-09 Score=89.96 Aligned_cols=121 Identities=23% Similarity=0.322 Sum_probs=81.9
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS----------------------------------- 46 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~----------------------------------- 46 (255)
|+||||++|.+|.+.... .++..+...++.+++..|+.||+
T Consensus 92 ~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (304)
T 3sg8_A 92 FAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG 167 (304)
T ss_dssp CEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred eEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence 689999999999865432 17777888888888888888886
Q ss_pred -----------------------CCCeecCCCCCcEEEeCC-CCceEEecCccccccccccccc---cC---CC------
Q 025244 47 -----------------------HGIIHRDLKPENLLLTED-LKTIKLADFGLAREESLTEMMT---AE---TG------ 90 (255)
Q Consensus 47 -----------------------~~i~HrDikp~Nill~~~-~~~~kl~Dfg~a~~~~~~~~~~---~~---~g------ 90 (255)
..++|+|++|.||+++.+ .+.+.|+||+.+.......... .. .+
T Consensus 168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHH
T ss_pred ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHH
Confidence 136999999999999974 2567899999887432211000 00 00
Q ss_pred ---ccceec-ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 025244 91 ---TYRWMA-PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 136 (255)
Q Consensus 91 ---t~~y~a-PE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~ 136 (255)
...... |+... ......+.|+++.++|.+.+|..+|
T Consensus 248 ~l~~Y~~~~~~~~~~----------r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLE----------KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHH----------HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHH----------HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 001111 22221 1122468999999999999998776
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.79 E-value=3.4e-09 Score=85.88 Aligned_cols=69 Identities=16% Similarity=0.137 Sum_probs=54.5
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS----------------------------------- 46 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~----------------------------------- 46 (255)
|+||||++|.+|.+.+.. ......++.++..+|+.||+
T Consensus 86 ~lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 799999999999886421 12234678899999999998
Q ss_pred ------------------------CCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 47 ------------------------HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 47 ------------------------~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
..++|+|++|.||+++++ +.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-cEEEEEEchhccc
Confidence 448999999999999865 4567999987753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.64 E-value=2.2e-08 Score=84.94 Aligned_cols=73 Identities=19% Similarity=0.345 Sum_probs=59.3
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS----------------------------------- 46 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~----------------------------------- 46 (255)
|+||||++|.++.+... ..++..+...++.+++..|+.||+
T Consensus 117 ~~vme~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEEECCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEEecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 79999999988754211 127788888899999999999997
Q ss_pred -----------------------CCCeecCCCCCcEEEeCCCCc-eEEecCccccc
Q 025244 47 -----------------------HGIIHRDLKPENLLLTEDLKT-IKLADFGLARE 78 (255)
Q Consensus 47 -----------------------~~i~HrDikp~Nill~~~~~~-~kl~Dfg~a~~ 78 (255)
.+++|+|+++.||+++.+.+. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 358999999999999876323 58999999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.53 E-value=5.2e-08 Score=78.39 Aligned_cols=29 Identities=17% Similarity=0.237 Sum_probs=24.7
Q ss_pred CeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 49 IIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 49 i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
++|+|++|.||+++++ +.+.|+|||.+..
T Consensus 186 l~HgDl~~~Nil~~~~-~~~~liD~~~a~~ 214 (264)
T 1nd4_A 186 VTHGDACLPNIMVENG-RFSGFIDCGRLGV 214 (264)
T ss_dssp EECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred EECCCCCCCcEEEECC-cEEEEEcchhccc
Confidence 9999999999999875 4566999998753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.35 E-value=1.3e-05 Score=62.36 Aligned_cols=141 Identities=13% Similarity=0.109 Sum_probs=92.9
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCCCCceEEecCccccccccccccccCCC
Q 025244 12 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 90 (255)
Q Consensus 12 sL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~-~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g 90 (255)
||.+.|+..+. +++++++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+ |.|.+.+ +.+. ..
T Consensus 34 SL~eIL~~~~~-PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~d-G~V~f~~-~~s~-----------~~ 99 (229)
T 2yle_A 34 SLEEILRLYNQ-PINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRD-GAVTLAP-AADD-----------AG 99 (229)
T ss_dssp EHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETT-SCEEECC-C----------------
T ss_pred cHHHHHHHcCC-CcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecC-Cceeccc-cccc-----------cc
Confidence 69999987654 49999999999999999877632 221233345688999888 6776653 1110 11
Q ss_pred ccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCCcHHHHHHHHH
Q 025244 91 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 170 (255)
Q Consensus 91 t~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 170 (255)
...+.+||... ...+.+.-|||||+++|..+--..|- .....+|++|.+||..
T Consensus 100 ~~~~~~pe~~~---------~~~te~~~IysLG~tLY~ALDygL~e------------------~eE~eLS~~LE~LL~~ 152 (229)
T 2yle_A 100 EPPPVAGKLGY---------SQCMETEVIESLGIIIYKALDYGLKE------------------NEERELSPPLEQLIDH 152 (229)
T ss_dssp -------CCSS---------SSSCHHHHHHHHHHHHHHHHTTTCCT------------------TEEECCCHHHHHHHHH
T ss_pred ccCCCChhhcc---------ccchHHHHHHHHHHHHHHHhhcCCCc------------------ccchhhCHHHHHHHHH
Confidence 23456888652 23456889999999999987533331 1245688999999999
Q ss_pred hccc-------------------------CCCCCCCHHHHHHHHHHhH
Q 025244 171 CWKE-------------------------DPNARPNFTQIIQMLLNYL 193 (255)
Q Consensus 171 ~l~~-------------------------~p~~Rpt~~~vl~~l~~~~ 193 (255)
|... .+..|.+.++|++.....+
T Consensus 153 Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl 200 (229)
T 2yle_A 153 MANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHL 200 (229)
T ss_dssp HTTCCC--------------------CCSCCCCCCSHHHHHHHHHTTS
T ss_pred HHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhhc
Confidence 8766 2467889999988765443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=9.4e-06 Score=67.22 Aligned_cols=31 Identities=32% Similarity=0.484 Sum_probs=24.8
Q ss_pred CCeecCCCCCcEEEeC---CCCceEEecCccccc
Q 025244 48 GIIHRDLKPENLLLTE---DLKTIKLADFGLARE 78 (255)
Q Consensus 48 ~i~HrDikp~Nill~~---~~~~~kl~Dfg~a~~ 78 (255)
.++|+|+++.||+++. +...+.|+||+.+..
T Consensus 191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999987 323458999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=2.2e-05 Score=63.46 Aligned_cols=29 Identities=31% Similarity=0.450 Sum_probs=24.6
Q ss_pred CeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 49 IIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 49 i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
++|+|+.+.|||++.+ +.+-|+||+.+..
T Consensus 195 l~HGDl~~~Nil~~~~-~~~~viDwe~a~~ 223 (272)
T 4gkh_A 195 VTHGDFSLDNLIFDEG-KLIGCIDVGRVGI 223 (272)
T ss_dssp EECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred EEcCCCCCCeEEEECC-eEEEEEECccccc
Confidence 6899999999999876 4567999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.53 E-value=5.6e-05 Score=63.70 Aligned_cols=31 Identities=13% Similarity=0.244 Sum_probs=25.7
Q ss_pred CCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 47 ~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
..++|+|+.+.||+++++ +.+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~-~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDF-QPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETT-EEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCC-cEEEEEccccccc
Confidence 468999999999999853 4578999988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0025 Score=53.00 Aligned_cols=32 Identities=31% Similarity=0.489 Sum_probs=26.6
Q ss_pred CCCeecCCCCCcEEEeCC---CCceEEecCccccc
Q 025244 47 HGIIHRDLKPENLLLTED---LKTIKLADFGLARE 78 (255)
Q Consensus 47 ~~i~HrDikp~Nill~~~---~~~~kl~Dfg~a~~ 78 (255)
..++|+|+.+.|||++.+ .+.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999863 14689999998874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0019 Score=53.55 Aligned_cols=31 Identities=26% Similarity=0.333 Sum_probs=26.8
Q ss_pred CCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 47 ~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
.+++|+|+++.||+++.+ +.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~-~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGEN-EQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGG-GCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCC-CcEEEEehhhccc
Confidence 579999999999999766 5799999997753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0015 Score=53.54 Aligned_cols=29 Identities=21% Similarity=0.203 Sum_probs=24.1
Q ss_pred CCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 48 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 48 ~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
.++|+|+.+.||+. .+ +.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil~-~~-~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFLD-TG-ERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEEE-CS-SCEEECCCTTCEE
T ss_pred eeeccCCCcCCEEE-CC-CCEEEEecccccC
Confidence 38999999999994 44 5789999998864
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.05 E-value=0.0042 Score=53.44 Aligned_cols=81 Identities=19% Similarity=0.231 Sum_probs=47.3
Q ss_pred HhCCCeecCCCCCcEEEeCCCCceEEecCccccccccccccccCCC--ccceecccccccccccccccCCCCchhhHHHH
Q 025244 45 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG--TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 122 (255)
Q Consensus 45 H~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~~~~~~~~Dvwsl 122 (255)
+...++|+|+++.|||++.+ + ++|+||+.+.......-...... ...|++|+..... .........++...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~-~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 302 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQD-S-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQ-----ENDRKEYKQWILRT 302 (420)
T ss_dssp BCCEEECSCCSGGGEEECSS-C-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCS-----SCCSHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCC-C-CEEEeCcccccCchHHHHHHHHHHHHHHHHhccccccc-----ccchHHHHHHHHHH
Confidence 35679999999999999876 4 99999999875332211111111 2345666544210 00111224555677
Q ss_pred HHHHHHHHhC
Q 025244 123 AIVLWELLHN 132 (255)
Q Consensus 123 G~~l~el~~g 132 (255)
...+|+..++
T Consensus 303 ~~~~~~~y~~ 312 (420)
T 2pyw_A 303 IEQTWNLFNK 312 (420)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 7777776653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.02 E-value=0.01 Score=48.90 Aligned_cols=30 Identities=37% Similarity=0.558 Sum_probs=25.3
Q ss_pred CCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 48 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 48 ~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++|+|+++.|||++.+ +.+.|+||+.+..
T Consensus 188 ~liHgDl~~~Nil~~~~-~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGD-ELSGLIDFYFACN 217 (322)
T ss_dssp EEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred ccCCCCCCccCEEEeCC-ceEEEecchhccC
Confidence 68999999999999876 4457999987753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.40 E-value=0.029 Score=46.15 Aligned_cols=29 Identities=28% Similarity=0.283 Sum_probs=24.7
Q ss_pred CCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 47 ~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
..++|+|+++.||+++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D--GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S--SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C--CCEEEECCCCCc
Confidence 3589999999999998 4 689999988764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=93.21 E-value=0.067 Score=44.94 Aligned_cols=29 Identities=28% Similarity=0.450 Sum_probs=24.5
Q ss_pred CCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 48 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 48 ~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
.++|+|+++.|||++.+ .+.|+||+.+..
T Consensus 213 ~l~HgDl~~~Nil~~~~--~~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNK--CLRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC---CEEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCC--cEEEEEecCCCC
Confidence 58999999999999765 489999998863
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=93.04 E-value=0.054 Score=45.12 Aligned_cols=31 Identities=19% Similarity=0.340 Sum_probs=26.7
Q ss_pred CCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 47 ~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
..++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~-~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNE-ESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGG-GCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCC-CeEEEEECCCCee
Confidence 368999999999999876 5789999987764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=92.52 E-value=0.05 Score=46.20 Aligned_cols=30 Identities=27% Similarity=0.355 Sum_probs=25.9
Q ss_pred CCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 47 ~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
..++|+|+.+.|||++.+ .++++||..+..
T Consensus 227 ~~L~HGDl~~~Nil~~~~--~~~lID~e~a~~ 256 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH--ETKVIDPEFAFY 256 (397)
T ss_dssp CEEECSCCSGGGEEECSS--CEEECCCTTCEE
T ss_pred CceeeCCCCcCcEEEeCC--CeEEEeCccccc
Confidence 569999999999999875 489999988764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=91.32 E-value=0.088 Score=45.84 Aligned_cols=15 Identities=33% Similarity=0.408 Sum_probs=14.0
Q ss_pred CCeecCCCCCcEEEe
Q 025244 48 GIIHRDLKPENLLLT 62 (255)
Q Consensus 48 ~i~HrDikp~Nill~ 62 (255)
.++|+|+.+.|||++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 489999999999998
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=91.23 E-value=0.08 Score=45.67 Aligned_cols=31 Identities=32% Similarity=0.426 Sum_probs=24.4
Q ss_pred CCeecCCCCCcEEEeCC---------------------------CCceEEecCccccc
Q 025244 48 GIIHRDLKPENLLLTED---------------------------LKTIKLADFGLARE 78 (255)
Q Consensus 48 ~i~HrDikp~Nill~~~---------------------------~~~~kl~Dfg~a~~ 78 (255)
.++|+|+.+.|||++.+ .+.+.|+||..+..
T Consensus 250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 48999999999999874 14688999988763
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=90.45 E-value=0.13 Score=43.66 Aligned_cols=31 Identities=26% Similarity=0.455 Sum_probs=25.9
Q ss_pred CCeecCCCCCcEEEeCC---CCceEEecCccccc
Q 025244 48 GIIHRDLKPENLLLTED---LKTIKLADFGLARE 78 (255)
Q Consensus 48 ~i~HrDikp~Nill~~~---~~~~kl~Dfg~a~~ 78 (255)
.++|+|+.+.||+++.+ .+.+.++||..+..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 48999999999999875 24789999998863
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.40 E-value=0.21 Score=42.55 Aligned_cols=30 Identities=30% Similarity=0.472 Sum_probs=24.5
Q ss_pred CeecCCCCCcEEEeC-----CCCceEEecCccccc
Q 025244 49 IIHRDLKPENLLLTE-----DLKTIKLADFGLARE 78 (255)
Q Consensus 49 i~HrDikp~Nill~~-----~~~~~kl~Dfg~a~~ 78 (255)
++|+|+.+.|||+.. +.+.+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 679999999999942 225799999998864
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=86.02 E-value=0.32 Score=41.84 Aligned_cols=29 Identities=28% Similarity=0.497 Sum_probs=24.9
Q ss_pred CCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 48 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 48 ~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
.++|+|+.+.||+ +.+ +.+.++||..+..
T Consensus 263 ~~~H~D~~~~N~l-~~~-~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQ-NNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECS-SCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCC-CcEEEEecccCCc
Confidence 4899999999999 555 6899999998864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=83.94 E-value=0.69 Score=37.12 Aligned_cols=24 Identities=33% Similarity=0.352 Sum_probs=19.8
Q ss_pred CCeecCCCCCcEEEeCCCCceEEecC
Q 025244 48 GIIHRDLKPENLLLTEDLKTIKLADF 73 (255)
Q Consensus 48 ~i~HrDikp~Nill~~~~~~~kl~Df 73 (255)
.++|+|+.+.||+++.+ + ..++|-
T Consensus 189 ~LvHGDlw~gNvl~~~~-g-~~~iDp 212 (288)
T 3f7w_A 189 ARIHGDLWNGNVLWQDD-G-AVVIDP 212 (288)
T ss_dssp EEECSCCSGGGEEEETT-E-EEECSC
T ss_pred eeeecCCCCCcEEEcCC-C-eEEEec
Confidence 58999999999999987 4 456663
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=81.60 E-value=0.55 Score=38.54 Aligned_cols=25 Identities=32% Similarity=0.427 Sum_probs=22.2
Q ss_pred CCeecCCCCCcEEEeCCCCceEEecCc
Q 025244 48 GIIHRDLKPENLLLTEDLKTIKLADFG 74 (255)
Q Consensus 48 ~i~HrDikp~Nill~~~~~~~kl~Dfg 74 (255)
.++|+|+.+.|++++.+ + +.|+|++
T Consensus 208 ~l~HgD~~~~N~l~~~~-~-~~~iD~~ 232 (312)
T 3jr1_A 208 SILHGNLWIENCIQVDD-K-IFVCNPA 232 (312)
T ss_dssp EEECSSCSGGGEEEETT-E-EEECSCC
T ss_pred eeEeCCCCcCcEeecCC-C-eEEEcCc
Confidence 58999999999999987 5 8899984
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 255 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-45 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-44 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-42 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-41 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-40 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-40 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-40 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-40 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-40 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-39 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-38 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-37 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-36 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-36 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-36 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-36 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-36 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-34 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-32 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-30 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-26 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-26 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-25 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-24 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-19 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-19 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-17 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-14 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-12 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 4e-54
Identities = 61/197 (30%), Positives = 99/197 (50%), Gaps = 15/197 (7%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ IVT+ G +L +L + + ++ I A A+ M+ LH+ IIHRDLK N+
Sbjct: 78 LAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIF 136
Query: 61 LTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKV 117
L EDL T+K+ DFGLA S + +G+ WMAPE+ +R +K Y+ +
Sbjct: 137 LHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV-----IRMQDKNPYSFQS 190
Query: 118 DSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-----ENVPEELSIILTSCW 172
D Y+F IVL+EL+ +LP+ ++N + N P+ + ++ C
Sbjct: 191 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECL 250
Query: 173 KEDPNARPNFTQIIQML 189
K+ + RP F QI+ +
Sbjct: 251 KKKRDERPLFPQILASI 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 6e-48
Identities = 51/191 (26%), Positives = 96/191 (50%), Gaps = 16/191 (8%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPEN 58
+V+VTEL++ GTL+ YL + + + V + I + ++ LH+ IIHRDLK +N
Sbjct: 87 IVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDN 144
Query: 59 LLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
+ +T ++K+ D GLA + A GT +MAPE+Y ++ Y+ VD
Sbjct: 145 IFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMY---------EEKYDESVD 194
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA--ENVPEELSIILTSCWKEDP 176
Y+F + + E+ ++ P+ N Y V+P++ + E+ I+ C +++
Sbjct: 195 VYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNK 254
Query: 177 NARPNFTQIIQ 187
+ R + ++
Sbjct: 255 DERYSIKDLLN 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 3e-45
Identities = 48/187 (25%), Positives = 85/187 (45%), Gaps = 13/187 (6%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ ++ E GT+ + L + D + ++A A+ HS +IHRD+KPENLL
Sbjct: 81 VYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKRVIHRDIKPENLL 138
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
L +K+ADFG + + T GT ++ PE+ + ++ KVD +
Sbjct: 139 LGSA-GELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIEG--------RMHDEKVDLW 188
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
S ++ +E L K PFE Q Y + + V E +++ K +P+ RP
Sbjct: 189 SLGVLCYEFLVGKPPFEAN-TYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRP 247
Query: 181 NFTQIIQ 187
++++
Sbjct: 248 MLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 6e-45
Identities = 52/190 (27%), Positives = 85/190 (44%), Gaps = 8/190 (4%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ I+ E +GG + +L + R L A+ LH + IIHRDLK N+L
Sbjct: 84 LWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNIL 142
Query: 61 LTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
T D IKLADFG++ + + + GT WMAPE+ T + + Y++K D
Sbjct: 143 FTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD---RPYDYKADV 198
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA--ENVPEELSIILTSCWKEDPN 177
+S I L E+ + P ++ ++ A A L C +++ +
Sbjct: 199 WSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVD 258
Query: 178 ARPNFTQIIQ 187
AR +Q++Q
Sbjct: 259 ARWTTSQLLQ 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 7e-45
Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I+TE + G+L +L L + + A IA M + IHRDL+ N+L++
Sbjct: 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 143
Query: 63 EDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
+ L + K+ADFGLAR E++ +W APE + + K D +
Sbjct: 144 DTL-SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVW 194
Query: 121 SFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 179
SF I+L E++ H ++P+ GM+N + +N PEEL ++ CWKE P R
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDR 254
Query: 180 PNFTQIIQMLLNYLSA 195
P F + +L ++ +A
Sbjct: 255 PTFDYLRSVLEDFFTA 270
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 9e-45
Identities = 53/190 (27%), Positives = 89/190 (46%), Gaps = 12/190 (6%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ IVTE ++ G+L YL + L + F+LD+ AME L + +HRDL N+L
Sbjct: 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL 135
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
++ED K++DFGL +E + +W APE K ++ K D +
Sbjct: 136 VSEDN-VAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALRE--------KKFSTKSDVW 184
Query: 121 SFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 179
SF I+LWE+ ++P+ + + + P + ++ +CW D R
Sbjct: 185 SFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMR 244
Query: 180 PNFTQIIQML 189
P+F Q+ + L
Sbjct: 245 PSFLQLREQL 254
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 7e-44
Identities = 54/195 (27%), Positives = 79/195 (40%), Gaps = 17/195 (8%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPR--CLDVCVAIGFALDIARAMECLH-----SHGIIHRD 53
+ IV E GG L + LD + + A++ H H ++HRD
Sbjct: 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 139
Query: 54 LKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 112
LKP N+ L + +KL DFGLAR T A GT +M+PE +
Sbjct: 140 LKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR--------MS 190
Query: 113 YNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCW 172
YN K D +S +L+EL PF S + A R +EL+ I+T
Sbjct: 191 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRML 250
Query: 173 KEDPNARPNFTQIIQ 187
RP+ +I++
Sbjct: 251 NLKDYHRPSVEEILE 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 3e-43
Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IVTE +S G+L +L + L + + A IA M + +HRDL+ N+L+
Sbjct: 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 147
Query: 63 EDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
E+L K+ADFGLAR E++ +W APE + K D +
Sbjct: 148 ENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVW 198
Query: 121 SFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 179
SF I+L EL ++P+ GM N + P PE L ++ CW+++P R
Sbjct: 199 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 258
Query: 180 PNFTQIIQMLLNYLSAIAPP 199
P F + L +Y ++ P
Sbjct: 259 PTFEYLQAFLEDYFTSTEPQ 278
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 5e-43
Identities = 46/202 (22%), Positives = 88/202 (43%), Gaps = 15/202 (7%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+++V E+ GG L K+L+ R + V ++ M+ L +HRDL N+L
Sbjct: 83 LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL 141
Query: 61 LTEDLKTIKLADFGLAR----EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 116
L K++DFGL++ ++S +A +W APE + + ++ +
Sbjct: 142 LVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSR 192
Query: 117 VDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKED 175
D +S+ + +WE L + + P++ M + P EL +++ CW
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 252
Query: 176 PNARPNFTQIIQMLLNYLSAIA 197
RP+F + Q + ++A
Sbjct: 253 WEDRPDFLTVEQRMRACYYSLA 274
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 145 bits (366), Expect = 5e-43
Identities = 45/190 (23%), Positives = 76/190 (40%), Gaps = 8/190 (4%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+V +L+ G L YL L + + LH I+HRDLKPEN+L
Sbjct: 85 FFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL 142
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
L +D IKL DFG + + E + GT ++APE+ Y +VD +
Sbjct: 143 LDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE--CSMNDNHPGYGKEVDMW 199
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR---PSAENVPEELSIILTSCWKEDPN 177
S ++++ LL PF + N + P ++ + + +++ P
Sbjct: 200 STGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQ 259
Query: 178 ARPNFTQIIQ 187
R + +
Sbjct: 260 KRYTAEEALA 269
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-42
Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 13/192 (6%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I+TE ++ G L YL MR R + D+ AME L S +HRDL N L+
Sbjct: 76 IITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN 134
Query: 63 EDLKTIKLADFGLARE--ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
+ +K++DFGL+R + RW PE+ ++ K D +
Sbjct: 135 DQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY--------SKFSSKSDIW 185
Query: 121 SFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 179
+F +++WE+ K+P+E +N + A A E++ I+ SCW E + R
Sbjct: 186 AFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADER 245
Query: 180 PNFTQIIQMLLN 191
P F ++ +L+
Sbjct: 246 PTFKILLSNILD 257
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (365), Expect = 2e-42
Identities = 51/186 (27%), Positives = 80/186 (43%), Gaps = 12/186 (6%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E G ++ +P L + + LHSH +IHRD+K N+LL+
Sbjct: 92 LVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS 149
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 122
E +KL DFG A + + GT WMAPE+ + ++ Y+ KVD +S
Sbjct: 150 EPG-LVKLGDFGSAS---IMAPANSFVGTPYWMAPEV-----ILAMDEGQYDGKVDVWSL 200
Query: 123 AIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPN 181
I EL K P M+ + A Y A + + E + SC ++ P RP
Sbjct: 201 GITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT 260
Query: 182 FTQIIQ 187
+++
Sbjct: 261 SEVLLK 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (358), Expect = 1e-41
Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 35/215 (16%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRC----------------------LDVCVAIGFALDIA 38
M ++ E ++ G L ++L +M P L + A +A
Sbjct: 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 150
Query: 39 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWM 95
M L +HRDL N L+ E++ +K+ADFGL+R + + RWM
Sbjct: 151 AGMAYLSERKFVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWM 209
Query: 96 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVR 154
PE Y + D +++ +VLWE+ P+ GM++ + Y N+
Sbjct: 210 PPESIFY--------NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL 261
Query: 155 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189
EN P EL ++ CW + P RP+F I ++L
Sbjct: 262 ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-41
Identities = 49/197 (24%), Positives = 82/197 (41%), Gaps = 16/197 (8%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
++V E+ G L KYL + R + I ++ M+ L +HRDL N+L
Sbjct: 82 WMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVL 139
Query: 61 LTEDLKTIKLADFGLAR----EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 116
L K++DFGL++ +E+ + T +W APE + ++ K
Sbjct: 140 LVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--------YKFSSK 190
Query: 117 VDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKED 175
D +SF +++WE + + P+ GM + P E+ ++ CW D
Sbjct: 191 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYD 250
Query: 176 PNARPNFTQIIQMLLNY 192
RP F + L NY
Sbjct: 251 VENRPGFAAVELRLRNY 267
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-41
Identities = 57/215 (26%), Positives = 84/215 (39%), Gaps = 35/215 (16%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPR---------------------CLDVCVAIGFALDIAR 39
+ ++ E G L YL + R + L + FA +A+
Sbjct: 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 175
Query: 40 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMA 96
ME L +HRDL N+L+T K +K+ DFGLAR +S + +WMA
Sbjct: 176 GMEFLEFKSCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMA 234
Query: 97 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRP 155
PE Y K D +S+ I+LWE+ P+ G+ Y +
Sbjct: 235 PESLFE--------GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM 286
Query: 156 SA-ENVPEELSIILTSCWKEDPNARPNFTQIIQML 189
EE+ II+ SCW D RP+F + L
Sbjct: 287 DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-40
Identities = 63/255 (24%), Positives = 106/255 (41%), Gaps = 22/255 (8%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
++IV E L GG L + + + A I A++ LHS I HRD+KPENLL
Sbjct: 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 143
Query: 61 LTE--DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
T +KL DFG A+E + +T T ++APE+ + Y+ D
Sbjct: 144 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG--------PEKYDKSCD 195
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAYA-------AAFKNVRPSAENVPEELSIILTSC 171
+S ++++ LL PF L + ++ P V EE+ +++ +
Sbjct: 196 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 255
Query: 172 WKEDPNARPNFTQIIQM--LLNYLSAIAPPEPMIPHRIFNSENTILPP-ESPGTSSLMTV 228
K +P R T+ + ++ P P+ R+ + + TS+L T+
Sbjct: 256 LKTEPTQRMTITEFMNHPWIMQSTK--VPQTPLHTSRVLKEDKERWEDVKEEMTSALATM 313
Query: 229 RDDIGETPKAKMGDK 243
R D + K+ D
Sbjct: 314 RVDYEQIKIKKIEDA 328
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (351), Expect = 1e-40
Identities = 51/188 (27%), Positives = 84/188 (44%), Gaps = 5/188 (2%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I+TE + G+L +L + V +G IA M+ L +HRDL N+L+
Sbjct: 104 IITEFMENGSLDSFLRQNDGQF-TVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN 162
Query: 63 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 122
+L K++DFGL+R T P ++ Q + + D +S+
Sbjct: 163 SNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSY 219
Query: 123 AIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN 181
IV+WE++ + + P+ M+N A P + P L ++ CW++D N RP
Sbjct: 220 GIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPK 279
Query: 182 FTQIIQML 189
F QI+ L
Sbjct: 280 FGQIVNTL 287
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 3e-40
Identities = 51/190 (26%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+ E SGG L + + A F + + LH GI HRD+KPENLLL
Sbjct: 80 LFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 137
Query: 63 EDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
E +K++DFGLA + ++ GT ++APEL ++ + VD
Sbjct: 138 ER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-------REFHAEPVDV 189
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN--VRPSAENVPEELSIILTSCWKEDPN 177
+S IVL +L +LP++ S+ Y+ + + + +L E+P+
Sbjct: 190 WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPS 249
Query: 178 ARPNFTQIIQ 187
AR I +
Sbjct: 250 ARITIPDIKK 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 4e-40
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 17/214 (7%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
+V E L+GG+L + C+D + +A+E LHS+ +IHRD+K +N+LL
Sbjct: 94 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150
Query: 63 EDLKTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
D ++KL DFG + + + + GT WMAPE+ + K Y KVD +S
Sbjct: 151 MD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWS 201
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSAENVPEELSIILTSCWKEDPNAR 179
I+ E++ + P+ + L+A Y A + E + L C D R
Sbjct: 202 LGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR 261
Query: 180 PNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENT 213
+ +++Q +L P + P E T
Sbjct: 262 GSAKELLQH--QFLKIAKPLSSLTPLIAAAKEAT 293
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 139 bits (352), Expect = 4e-40
Identities = 41/191 (21%), Positives = 84/191 (43%), Gaps = 13/191 (6%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
MV++ E LSGG L + + + I + ++ +H H I+H D+KPEN++
Sbjct: 101 MVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIM 159
Query: 61 LT-EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
+ ++K+ DFGLA + + E++ T T + APE+ +++ D
Sbjct: 160 CETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV--------DREPVGFYTDM 211
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE---NVPEELSIILTSCWKEDP 176
++ ++ + LL PF G +L+ + + +V E + + +++P
Sbjct: 212 WAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEP 271
Query: 177 NARPNFTQIIQ 187
R ++
Sbjct: 272 RKRLTVHDALE 282
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 139 bits (351), Expect = 5e-40
Identities = 47/219 (21%), Positives = 87/219 (39%), Gaps = 14/219 (6%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
MV++ E +SGG L + + + + A+ + + + + +H + +H DLKPEN++
Sbjct: 98 MVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIM 156
Query: 61 LTEDLK-TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
T +KL DFGL + + TGT + APE+ K + D
Sbjct: 157 FTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG--------KPVGYYTDM 208
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE---NVPEELSIILTSCWKEDP 176
+S ++ + LL PF G ++ + + + E+ + DP
Sbjct: 209 WSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADP 268
Query: 177 NARPNFTQIIQM-LLNYLSAIAPPEPMIPHRIFNSENTI 214
N R Q ++ L +A + R ++I
Sbjct: 269 NTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSI 307
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (347), Expect = 5e-40
Identities = 54/192 (28%), Positives = 88/192 (45%), Gaps = 12/192 (6%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
I+TE ++ G L YL + + V + A I+ AME L IHRDL N L
Sbjct: 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 147
Query: 61 LTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
+ E+ +K+ADFGL+R +W APE + ++ K D
Sbjct: 148 VGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSD 198
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSIILTSCWKEDPN 177
++F ++LWE+ + +L Y K+ R E PE++ ++ +CW+ +P+
Sbjct: 199 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS 258
Query: 178 ARPNFTQIIQML 189
RP+F +I Q
Sbjct: 259 DRPSFAEIHQAF 270
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 9e-40
Identities = 55/196 (28%), Positives = 87/196 (44%), Gaps = 16/196 (8%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
M +VTEL G+L L + + +A+ +A M L S IHRDL NLL
Sbjct: 85 MKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 143
Query: 61 LTEDLKTIKLADFGLAR----EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 116
L +K+ DFGL R + M + W APE T + ++H
Sbjct: 144 LATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--------RTFSHA 194
Query: 117 VDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKE 174
D++ F + LWE+ + + P+ G++ Q + + R P E+ P+++ ++ CW
Sbjct: 195 SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAH 254
Query: 175 DPNARPNFTQIIQMLL 190
P RP F + LL
Sbjct: 255 KPEDRPTFVALRDFLL 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-39
Identities = 57/226 (25%), Positives = 87/226 (38%), Gaps = 24/226 (10%)
Query: 3 IVTELLSGGTLRKYLLNMRPRC--------------LDVCVAIGFALDIARAMECLHSHG 48
+ E G L +L R L + FA D+AR M+ L
Sbjct: 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 147
Query: 49 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 108
IHRDL N+L+ E+ K+ADFGL+R + + T RWMA E +
Sbjct: 148 FIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY------ 200
Query: 109 EKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII 167
Y D +S+ ++LWE++ P+ GM+ + N +E+ +
Sbjct: 201 --SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDL 258
Query: 168 LTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENT 213
+ CW+E P RP+F QI+ L L + F
Sbjct: 259 MRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGI 304
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-39
Identities = 56/206 (27%), Positives = 85/206 (41%), Gaps = 16/206 (7%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
++V + G LR ++ V IGF L +A+ M+ L S +HRDL N +
Sbjct: 104 PLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM 162
Query: 61 LTEDLKTIKLADFGLAR-----EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 115
L E T+K+ADFGLAR E T +WMA E T + +
Sbjct: 163 LDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT--------QKFTT 213
Query: 116 KVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSIILTSCWKE 174
K D +SF ++LWEL+ P N + R E P+ L ++ CW
Sbjct: 214 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHP 273
Query: 175 DPNARPNFTQIIQMLLNYLSAIAPPE 200
RP+F++++ + S
Sbjct: 274 KAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 6e-39
Identities = 50/232 (21%), Positives = 94/232 (40%), Gaps = 17/232 (7%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
++T+L+ G L Y+ + + + + IA+ M L ++HRDL N+L+
Sbjct: 87 LITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK 145
Query: 63 EDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
+K+ DFGLA+ E +WMA E + Y H+ D
Sbjct: 146 TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDV 196
Query: 120 YSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNA 178
+S+ + +WEL+ P++G+ + + P ++ +I+ CW D ++
Sbjct: 197 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADS 256
Query: 179 RPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRD 230
RP F ++I P+ + + + P +S +LM D
Sbjct: 257 RPKFRELIIEFSKMAR---DPQRYLVIQGDERMHLPSPTDSNFYRALMDEED 305
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-38
Identities = 57/190 (30%), Positives = 91/190 (47%), Gaps = 13/190 (6%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
I+ EL + G LR +L + LD+ I +A ++ A+ L S +HRD+ N+L++
Sbjct: 84 IIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 142
Query: 63 EDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
+ +KL DFGL+R E+S + +WMAPE + + + D +
Sbjct: 143 SND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVW 193
Query: 121 SFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 179
F + +WE+L H PF+G+ N P N P L ++T CW DP+ R
Sbjct: 194 MFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 253
Query: 180 PNFTQIIQML 189
P FT++ L
Sbjct: 254 PRFTELKAQL 263
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 2e-38
Identities = 49/192 (25%), Positives = 79/192 (41%), Gaps = 13/192 (6%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V E + G L YL R +G LD+ M L +IHRDL N L
Sbjct: 75 ICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL 133
Query: 61 LTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
+ E+ IK++DFG+ R + T +W +PE++S Y+ K D
Sbjct: 134 VGENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSD 184
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSIILTSCWKEDPN 177
+SF +++WE+ + R + I+ CWKE P
Sbjct: 185 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPE 244
Query: 178 ARPNFTQIIQML 189
RP F+++++ L
Sbjct: 245 DRPAFSRLLRQL 256
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 5e-38
Identities = 39/191 (20%), Positives = 78/191 (40%), Gaps = 13/191 (6%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+V++ E +SG + + + N L+ + + + A++ LHSH I H D++PEN++
Sbjct: 76 LVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENII 134
Query: 61 LTED-LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
TIK+ +FG AR+ + + APE++ + + D
Sbjct: 135 YQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH--------QHDVVSTATDM 186
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE---NVPEELSIILTSCWKEDP 176
+S +++ LL PF +N Q E + E + ++
Sbjct: 187 WSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKER 246
Query: 177 NARPNFTQIIQ 187
+R ++ +Q
Sbjct: 247 KSRMTASEALQ 257
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 1e-37
Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRC--------LDVCVAIGFALDIARAMECLHSHGIIHR 52
+++ EL++ G L+ YL ++RP + I A +IA M L+++ +HR
Sbjct: 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR 157
Query: 53 DLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLRQGE 109
DL N ++ ED T+K+ DFG+ R E RWM+PE
Sbjct: 158 DLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD------- 209
Query: 110 KKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIIL 168
+ D +SF +VLWE+ + P++G+SN Q + +N P+ L ++
Sbjct: 210 -GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELM 268
Query: 169 TSCWKEDPNARPNFTQIIQML 189
CW+ +P RP+F +II +
Sbjct: 269 RMCWQYNPKMRPSFLEIISSI 289
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-37
Identities = 52/194 (26%), Positives = 86/194 (44%), Gaps = 15/194 (7%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
M+I+TE + G L K+L + V +G IA M+ L + +HRDL N+L
Sbjct: 84 MMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNIL 142
Query: 61 LTEDLKTIKLADFGLAR----EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 116
+ +L K++DFGL+R + T + RW APE S + +
Sbjct: 143 VNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY--------RKFTSA 193
Query: 117 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKED 175
D +SF IV+WE++ + A R P+ + P + ++ CW+++
Sbjct: 194 SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQE 253
Query: 176 PNARPNFTQIIQML 189
RP F I+ +L
Sbjct: 254 RARRPKFADIVSIL 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (324), Expect = 2e-36
Identities = 48/192 (25%), Positives = 89/192 (46%), Gaps = 15/192 (7%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ ++ +L+SGG L + + A + A++ LH GI+HRDLKPENLL
Sbjct: 82 LYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLL 139
Query: 61 LTEDLK--TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
+ I ++DFGL++ E +++ GT ++APE+ + K Y+ VD
Sbjct: 140 YYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ--------KPYSKAVD 191
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAYA---AAFKNVRPSAENVPEELSIILTSCWKED 175
+S ++ + LL PF ++ + A ++ P +++ + + ++D
Sbjct: 192 CWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKD 251
Query: 176 PNARPNFTQIIQ 187
P R Q +Q
Sbjct: 252 PEKRFTCEQALQ 263
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-36
Identities = 47/190 (24%), Positives = 76/190 (40%), Gaps = 15/190 (7%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ G L KY+ + D + +I A+E LH GIIHRDLKPEN+L
Sbjct: 83 LYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENIL 140
Query: 61 LTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKV 117
L ED I++ DFG A+ ES + GT ++++PEL + K
Sbjct: 141 LNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE--------KSACKSS 191
Query: 118 DSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPN 177
D ++ ++++L+ PF N + K E + ++ D
Sbjct: 192 DLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDAT 250
Query: 178 ARPNFTQIIQ 187
R ++
Sbjct: 251 KRLGCEEMEG 260
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 3e-36
Identities = 50/223 (22%), Positives = 84/223 (37%), Gaps = 40/223 (17%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--------GIIHR 52
+ +V++ G+L YL + V I AL A + LH I HR
Sbjct: 76 LWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 132
Query: 53 DLKPENLLLTEDLKTIKLADFGLAR-----EESLTEMMTAETGTYRWMAPELYSTVTLRQ 107
DLK +N+L+ ++ T +AD GLA +++ GT R+MAPE+ +
Sbjct: 133 DLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 191
Query: 108 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY---------------AAAFKN 152
+ + D Y+ +V WE+ + Q Y +
Sbjct: 192 HFE--SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK 249
Query: 153 VRPSAEN------VPEELSIILTSCWKEDPNARPNFTQIIQML 189
+RP+ N ++ I+ CW + AR +I + L
Sbjct: 250 LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 5e-36
Identities = 44/200 (22%), Positives = 79/200 (39%), Gaps = 15/200 (7%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLL 61
I E + GG+L + L + + + ++ + + + L H I+HRD+KP N+L+
Sbjct: 81 ICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 138
Query: 62 TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 121
IKL DFG++ + M + GT +M+PE HY+ + D +S
Sbjct: 139 NSR-GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQG--------THYSVQSDIWS 188
Query: 122 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN 181
+ L E+ + P + + V A P ++RP
Sbjct: 189 MGLSLVEMAVGRYPIPP-PDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPP 247
Query: 182 FTQIIQMLLNYLSAIAPPEP 201
I ++L ++ P P
Sbjct: 248 M-AIFELLDYIVNEPPPKLP 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 5e-36
Identities = 63/213 (29%), Positives = 90/213 (42%), Gaps = 30/213 (14%)
Query: 3 IVTELLSGGTLRKYLLNMRPRC----------------LDVCVAIGFALDIARAMECLHS 46
++TE G L +L R LD+ + F+ +A+ M L S
Sbjct: 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS 163
Query: 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTV 103
IHRDL N+LLT + K+ DFGLAR +S + +WMAPE
Sbjct: 164 KNCIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN- 221
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP-FEGMSNLQAAYAAAFKNVRP-SAENVP 161
Y + D +S+ I LWEL + GM Y + R S E+ P
Sbjct: 222 -------CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAP 274
Query: 162 EELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194
E+ I+ +CW DP RP F QI+Q++ +S
Sbjct: 275 AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 7e-36
Identities = 62/207 (29%), Positives = 91/207 (43%), Gaps = 27/207 (13%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRC--------------LDVCVAIGFALDIARAMECLHS 46
+ ++ E S G LR+YL RP L + A +AR ME L S
Sbjct: 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 153
Query: 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTV 103
IHRDL N+L+TED +K+ADFGLAR + T +WMAPE
Sbjct: 154 KKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD- 211
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSAENVPE 162
+ Y H+ D +SF ++LWE+ P+ G+ + + N
Sbjct: 212 -------RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTN 264
Query: 163 ELSIILTSCWKEDPNARPNFTQIIQML 189
EL +++ CW P+ RP F Q+++ L
Sbjct: 265 ELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 1e-35
Identities = 40/187 (21%), Positives = 73/187 (39%), Gaps = 16/187 (8%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
V++ E + R L +A F + A+ H+ G++HRD+K EN+L
Sbjct: 84 FVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENIL 142
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
+ + +KL DFG + T GT + PE +++ +
Sbjct: 143 IDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRY-------HRYHGRSAAVW 194
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
S I+L++++ +PFE + + + V E ++ C P+ RP
Sbjct: 195 SLGILLYDMVCGDIPFEHDEEII-------RGQVFFRQRVSSECQHLIRWCLALRPSDRP 247
Query: 181 NFTQIIQ 187
F +I
Sbjct: 248 TFEEIQN 254
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-35
Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 28/214 (13%)
Query: 1 MVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHS 46
++++ E G L YL + R L + I ++ +A+ ME L S
Sbjct: 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 152
Query: 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GTYRWMAPELYSTV 103
IHRDL N+LL+E +K+ DFGLAR+ + +WMAPE
Sbjct: 153 RKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD- 210
Query: 104 TLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA-ENVP 161
+ Y + D +SF ++LWE+ P+ G+ + + R A +
Sbjct: 211 -------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT 263
Query: 162 EELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195
E+ + CW +P+ RP F+++++ L N L A
Sbjct: 264 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 5e-35
Identities = 55/187 (29%), Positives = 92/187 (49%), Gaps = 13/187 (6%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ V E L+GG L ++ + D+ A +A +I ++ LHS GI++RDLK +N+L
Sbjct: 78 LFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL 135
Query: 61 LTEDLKTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
L +D IK+ADFG+ +E L + GT ++APE+ + YNH VD
Sbjct: 136 LDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG--------QKYNHSVDW 186
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 179
+SF ++L+E+L + PF G + ++ N + +E +L + +P R
Sbjct: 187 WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP-RWLEKEAKDLLVKLFVREPEKR 245
Query: 180 PNFTQII 186
I
Sbjct: 246 LGVRGDI 252
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 121 bits (305), Expect = 7e-34
Identities = 40/212 (18%), Positives = 76/212 (35%), Gaps = 29/212 (13%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
V+V +LL G + LL++ R V A + ++ +H +++RD+KP+N L
Sbjct: 76 NVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFL 133
Query: 61 LTEDLK----TIKLADFGLAR--------EESLTEMMTAETGTYRWMAPELYSTVTLRQG 108
+ I + DFG+ + + +GT R+M+ +
Sbjct: 134 IGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH-------- 185
Query: 109 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA----AAFKNVRPSAE---NVP 161
+ + + D + V L LP++G+ K P E P
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFP 245
Query: 162 EELSIILTSCWKEDPNARPNFTQIIQMLLNYL 193
EE + +A P++ + + L
Sbjct: 246 EEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 119 bits (298), Expect = 7e-33
Identities = 47/199 (23%), Positives = 83/199 (41%), Gaps = 17/199 (8%)
Query: 3 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 62
IV E + G TLR + P + AI D +A+ H +GIIHRD+KP N++++
Sbjct: 88 IVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 145
Query: 63 EDLK---TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
+A + A GT ++++PE + + D
Sbjct: 146 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG--------DSVDARSDV 197
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA---ENVPEELSIILTSCWKEDP 176
YS VL+E+L + PF G S + AY ++ P + E + +L ++ ++P
Sbjct: 198 YSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNP 257
Query: 177 NARP-NFTQIIQMLLNYLS 194
R ++ L+ +
Sbjct: 258 ENRYQTAAEMRADLVRVHN 276
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 9e-33
Identities = 47/193 (24%), Positives = 75/193 (38%), Gaps = 16/193 (8%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
++++ EL++GG L + L A F I + LHS I H DLKPEN++
Sbjct: 88 VILILELVAGGELFDF--LAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM 145
Query: 61 LTED---LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKV 117
L + IK+ DFGLA + GT ++APE+ + +
Sbjct: 146 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV--------NYEPLGLEA 197
Query: 118 DSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE---NVPEELSIILTSCWKE 174
D +S ++ + LL PF G + + + N E N + +
Sbjct: 198 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 257
Query: 175 DPNARPNFTQIIQ 187
DP R +Q
Sbjct: 258 DPKKRMTIQDSLQ 270
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 119 bits (299), Expect = 2e-32
Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 13/182 (7%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ + +L++GG L +L A +I +E +H+ +++RDLKP N+L
Sbjct: 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFY--AAEIILGLEHMHNRFVVYRDLKPANIL 139
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
L E ++++D GLA + S + A GT+ +MAPE+ Y+ D +
Sbjct: 140 LDEH-GHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQK-------GVAYDSSADWF 190
Query: 121 SFAIVLWELLHNKLPFEGMS--NLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNA 178
S +L++LL PF + ++ EL +L + D N
Sbjct: 191 SLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNR 250
Query: 179 RP 180
R
Sbjct: 251 RL 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 116 bits (291), Expect = 9e-32
Identities = 42/210 (20%), Positives = 75/210 (35%), Gaps = 27/210 (12%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
V+V ELL + R + + A + +E +HS IHRD+KP+N L
Sbjct: 78 NVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFL 135
Query: 61 --LTEDLKTIKLADFGLAR--------EESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 110
L + + + DFGLA+ + TGT R+ + +
Sbjct: 136 MGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-------- 187
Query: 111 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN-------VRPSAENVPEE 163
+ + D S VL LP++G+ + + + P E
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE 247
Query: 164 LSIILTSCWKEDPNARPNFTQIIQMLLNYL 193
+ L C + +P+++ + Q+ N
Sbjct: 248 FATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (286), Expect = 7e-31
Identities = 53/184 (28%), Positives = 87/184 (47%), Gaps = 14/184 (7%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ ++ + + GG L + + VA +A ++ A+E LHS II+RDLKPEN+L
Sbjct: 79 IFMIMDYIEGGELFSL--LRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL 136
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
L ++ IK+ DFG A+ + ++ GT ++APE+ ST K YN +D +
Sbjct: 137 LDKNG-HIKITDFGFAKY--VPDVTYTLCGTPDYIAPEVVST--------KPYNKSIDWW 185
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
SF I+++E+L PF N Y E++ +L+ D + R
Sbjct: 186 SFGILIYEMLAGYTPFYDS-NTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRL 244
Query: 181 NFTQ 184
Q
Sbjct: 245 GNLQ 248
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 7e-31
Identities = 52/182 (28%), Positives = 83/182 (45%), Gaps = 13/182 (7%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ V E +GG L +L R R A + +I A+E LHS +++RD+K ENL+
Sbjct: 80 LCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137
Query: 61 LTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
L +D IK+ DFGL +E S M GT ++APE+ Y VD
Sbjct: 138 LDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDW 188
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 179
+ +V++E++ +LPF + + + +R + E +L K+DP R
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP-RTLSPEAKSLLAGLLKKDPKQR 247
Query: 180 PN 181
Sbjct: 248 LG 249
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 5e-30
Identities = 50/213 (23%), Positives = 81/213 (38%), Gaps = 36/213 (16%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V E + YL + + + R ++ LHSH ++HRDLKP+N+L
Sbjct: 90 LTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNIL 148
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
+T IKLADFGLAR S +T+ T + APE+ Y VD +
Sbjct: 149 VTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLW 199
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI-------------- 166
S + E+ K F G S++ P E+ P ++++
Sbjct: 200 SVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIE 259
Query: 167 ------------ILTSCWKEDPNARPNFTQIIQ 187
+L C +P R + +
Sbjct: 260 KFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 3e-29
Identities = 51/234 (21%), Positives = 83/234 (35%), Gaps = 38/234 (16%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPR-CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 59
+ +V + + R R + L V + + R++ +HS GI HRD+KP+NL
Sbjct: 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153
Query: 60 LLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
LL D +KL DFG A++ E + + + APEL Y +D
Sbjct: 154 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF-------GATDYTSSIDV 206
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE--------------------- 158
+S VL ELL + F G S + P+ E
Sbjct: 207 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 266
Query: 159 -------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPH 205
P E + + + P AR + ++ + P +P+
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH--SFFDELRDPNVKLPN 318
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 103 bits (257), Expect = 1e-26
Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 14/171 (8%)
Query: 11 GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 70
G + +L R A +A I E LHS +I+RDLKPENLL+ + I++
Sbjct: 126 GEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQV 182
Query: 71 ADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 130
DFG A+ GT +APE+ + K YN VD ++ ++++E+
Sbjct: 183 TDFGFAKRV--KGRTWTLCGTPEALAPEIILS--------KGYNKAVDWWALGVLIYEMA 232
Query: 131 HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN 181
PF +Q VR + +L +L + + D R
Sbjct: 233 AGYPPFFADQPIQIYEKIVSGKVRFP-SHFSSDLKDLLRNLLQVDLTKRFG 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 3e-26
Identities = 45/185 (24%), Positives = 83/185 (44%), Gaps = 14/185 (7%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ ++ + ++GG L +L + +I A+E LH GII+RD+K EN+L
Sbjct: 104 LHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 161
Query: 61 LTEDLKTIKLADFGLARE--ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 118
L + + L DFGL++E TE GT +MAP++ +G ++ VD
Sbjct: 162 LDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV------RGGDSGHDKAVD 214
Query: 119 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR---PSAENVPEELSIILTSCWKED 175
+S ++++ELL PF + + + ++ P + + ++ +D
Sbjct: 215 WWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKD 274
Query: 176 PNARP 180
P R
Sbjct: 275 PKKRL 279
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 4e-26
Identities = 59/229 (25%), Positives = 85/229 (37%), Gaps = 40/229 (17%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V + + N A L + +E LH H I+HRDLKP NLL
Sbjct: 75 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAY--MLMTLQGLEYLHQHWILHRDLKPNNLL 132
Query: 61 LTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
L E+ +KLADFGLA+ S T + T + APEL + Y VD
Sbjct: 133 LDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG-------ARMYGVGVDM 184
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI------------- 166
++ +L ELL G S+L P+ E P+ S+
Sbjct: 185 WAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIP 244
Query: 167 --------------ILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 201
++ + +P AR TQ ++M Y S P P
Sbjct: 245 LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM--KYFSNRPGPTP 291
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.2 bits (246), Expect = 4e-25
Identities = 37/223 (16%), Positives = 69/223 (30%), Gaps = 46/223 (20%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V + + L + + + +H + I+HRD+K N+L
Sbjct: 92 IYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYIHRNKILHRDMKAANVL 149
Query: 61 LTEDLKTIKLADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 115
+T D +KLADFGLAR SL + T T + PEL ++ Y
Sbjct: 150 ITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-------ERDYGP 201
Query: 116 KVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI--------- 166
+D + ++ E+ +G + + + E P +
Sbjct: 202 PIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV 261
Query: 167 ----------------------ILTSCWKEDPNARPNFTQIIQ 187
++ DP R + +
Sbjct: 262 KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 7e-25
Identities = 64/255 (25%), Positives = 90/255 (35%), Gaps = 50/255 (19%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
V + L G L K L + + L F I R ++ +HS ++HRDLKP NLL
Sbjct: 85 DVYLVTHLMGADLYKLL---KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL 141
Query: 61 LTEDLKTIKLADFGLAR----EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 116
L +K+ DFGLAR + T +T T + APE+ K Y
Sbjct: 142 LNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKS 193
Query: 117 VDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE------------------ 158
+D +S +L E+L N+ F G L PS E
Sbjct: 194 IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLP 253
Query: 159 ------------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP--EPMIP 204
N + +L +P+ R Q + YL P EP+
Sbjct: 254 HKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH--PYLEQYYDPSDEPIAE 311
Query: 205 HRI-FNSENTILPPE 218
F+ E LP E
Sbjct: 312 APFKFDMELDDLPKE 326
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 98.4 bits (244), Expect = 7e-25
Identities = 36/224 (16%), Positives = 77/224 (34%), Gaps = 49/224 (21%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+V E ++ ++ + L + +I +A++ HS GI+HRD+KP N++
Sbjct: 107 PALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 161
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
+ + + ++L D+GLA + + + PEL + + Y++ +D +
Sbjct: 162 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV-------DYQMYDYSLDMW 214
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--------------------------- 153
S +L ++ K PF + K +
Sbjct: 215 SLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRH 274
Query: 154 ----------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 187
+ V E L + D +R + ++
Sbjct: 275 SRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.9 bits (240), Expect = 2e-24
Identities = 52/234 (22%), Positives = 90/234 (38%), Gaps = 43/234 (18%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V E L L+K++ + + + + + + + HSH ++HRDLKP+NLL
Sbjct: 76 LYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 134
Query: 61 LTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
+ + IKLADFGLAR + T E T + APE+ K+Y+ VD
Sbjct: 135 INTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL-------GCKYYSTAVDI 186
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE--------------------- 158
+S + E++ + F G S + + P
Sbjct: 187 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 246
Query: 159 -------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPH 205
+ E+ +L+ DPN R + + + + P +PH
Sbjct: 247 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH--PFFQDVTKP---VPH 295
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 96.1 bits (238), Expect = 4e-24
Identities = 49/216 (22%), Positives = 82/216 (37%), Gaps = 39/216 (18%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+V+V E L LL++ L+ A F L + + H ++HRDLKP+NLL
Sbjct: 75 LVLVFEHLDQDLK--KLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL 132
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRW-MAPELYSTVTLRQGEKKHYNHKVDS 119
+ + +K+ADFGLAR + W AP++ K Y+ +D
Sbjct: 133 INRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM-------GSKKYSTTIDI 184
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN-------------------- 159
+S + E+++ F G+S P+++N
Sbjct: 185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPL 244
Query: 160 --------VPEELSIILTSCWKEDPNARPNFTQIIQ 187
+ E +L+ K DPN R Q ++
Sbjct: 245 PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.2 bits (225), Expect = 3e-22
Identities = 43/229 (18%), Positives = 82/229 (35%), Gaps = 42/229 (18%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V E + + ++ + + + + HS ++HRDLKP+NLL
Sbjct: 76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF--LFQLLKGLGFCHSRNVLHRDLKPQNLL 133
Query: 61 LTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 119
+ + +KLA+FGLAR + +AE T + P++ K Y+ +D
Sbjct: 134 INRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDM 185
Query: 120 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE--------------------- 158
+S + EL + P +++ F+ + E
Sbjct: 186 WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPAT 245
Query: 159 --------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 199
+ +L + K +P R + + +Q Y S PP
Sbjct: 246 TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH--PYFSDFCPP 292
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.2 bits (207), Expect = 1e-19
Identities = 44/186 (23%), Positives = 75/186 (40%), Gaps = 14/186 (7%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+ +V EL+ + + + + ++ LHS GIIHRDLKP N++
Sbjct: 97 VYLVMELMDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
+ D T+K+ DFGLAR + MMT T + APE+ Y VD +
Sbjct: 152 VKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL--------GMGYKENVDIW 202
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 180
S ++ E++ +K+ F G + + P E + + + A
Sbjct: 203 SVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGL 262
Query: 181 NFTQII 186
F ++
Sbjct: 263 TFPKLF 268
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.7 bits (206), Expect = 2e-19
Identities = 51/250 (20%), Positives = 83/250 (33%), Gaps = 48/250 (19%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
+V + GT L+ L + + + +H+ GIIHRDLKP NL
Sbjct: 98 FYLVMPFM--GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA 153
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
+ ED + +K+ DFGLAR+ MT T + APE+ Y VD +
Sbjct: 154 VNEDCE-LKILDFGLARQ--ADSEMTGYVVTRWYRAPEVIL-------NWMRYTQTVDIW 203
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE---------------------- 158
S ++ E++ K F+G +L P AE
Sbjct: 204 SVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEK 263
Query: 159 --------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI--APPEPMIPHRIF 208
N +L D R + + Y ++ EP +
Sbjct: 264 KDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH--PYFESLHDTEDEPQVQKYDD 321
Query: 209 NSENTILPPE 218
+ ++ +
Sbjct: 322 SFDDVDRTLD 331
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.8 bits (193), Expect = 1e-17
Identities = 58/250 (23%), Positives = 85/250 (34%), Gaps = 47/250 (18%)
Query: 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 60
V + L G L ++ + L I R ++ +HS IIHRDLKP NL
Sbjct: 97 DVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA 153
Query: 61 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 120
+ ED +K+ DFGLAR + MT T + APE+ HYN VD +
Sbjct: 154 VNED-CELKILDFGLARHTD--DEMTGYVATRWYRAPEIML-------NWMHYNQTVDIW 203
Query: 121 SFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE---------------------- 158
S ++ ELL + F G ++ P AE
Sbjct: 204 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 263
Query: 159 --------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP--EPMIPHRIF 208
+L D + R Q + Y + P EP+
Sbjct: 264 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH--AYFAQYHDPDDEPVADPYDQ 321
Query: 209 NSENTILPPE 218
+ E+ L +
Sbjct: 322 SFESRDLLID 331
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 68.9 bits (167), Expect = 4e-14
Identities = 33/198 (16%), Positives = 62/198 (31%), Gaps = 16/198 (8%)
Query: 16 YLLNMRPRCLDVCVAIGFALDIARAMECLH-SHGIIHRDLKPENLLLTED-----LKTIK 69
+ R + + + + ++ +H GIIH D+KPEN+L+ L IK
Sbjct: 113 LIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 172
Query: 70 LADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 129
+AD G A + T + +PE+ + D +S A +++EL
Sbjct: 173 IADLGNACWYDEHYTNS--IQTREYRSPEVLLG--------APWGCGADIWSTACLIFEL 222
Query: 130 LHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 189
+ FE + + N+R I ++
Sbjct: 223 ITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLK 282
Query: 190 LNYLSAIAPPEPMIPHRI 207
L + +
Sbjct: 283 FWPLEDVLTEKYKFSKDE 300
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 60.2 bits (145), Expect = 8e-12
Identities = 18/108 (16%), Positives = 33/108 (30%), Gaps = 16/108 (14%)
Query: 16 YLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 75
+ + V I + + GI+H DL N+L++E+ I + DF
Sbjct: 91 LIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFPQ 148
Query: 76 AREESLTEMMTAETGTYRWMAPELY--STVTLRQGEKKHYNHKVDSYS 121
+ E E+ + + Y + D S
Sbjct: 149 SVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 255 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.98 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.69 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.55 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.71 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.55 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 94.4 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 93.83 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 85.03 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=317.66 Aligned_cols=188 Identities=32% Similarity=0.553 Sum_probs=155.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.++|...+. .+++..++.++.||++||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~-~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED-LTVKIGDFGLATVKS 155 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-SSEEECCCCCSCC--
T ss_pred EEEEEecCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCC-CCEEEccccceeecc
Confidence 5899999999999999986543 39999999999999999999999999999999999999998 699999999998543
Q ss_pred cc---cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcC-CC-
Q 025244 81 LT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-RP- 155 (255)
Q Consensus 81 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~- 155 (255)
.. ....+..||+.|||||++.+. ....++.++|||||||++|||++|+.||.+.+............. .+
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~ 230 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQ-----DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTC-----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC
T ss_pred ccCCcccccccccCcccCCHHHHhcc-----cCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc
Confidence 22 233556899999999998541 234578999999999999999999999998776665555444332 22
Q ss_pred ---CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 156 ---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 156 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
....+|+++.+||.+||+.||.+|||+.+++++|+.+.++
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 2567899999999999999999999999999999887654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=312.16 Aligned_cols=175 Identities=26% Similarity=0.433 Sum_probs=152.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.++|.+.+. +++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~~--l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~-~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAP 157 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCSCSCCC
T ss_pred EEEEEeecCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCC-CCEeecccceeeecC
Confidence 4799999999999999987655 9999999999999999999999999999999999999988 799999999998644
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+...... ......+..+
T Consensus 158 ~~-~~~~~~Gt~~Y~APE~~~~--------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~-~~~~~~p~~~ 227 (263)
T d2j4za1 158 SS-RRTTLCGTLDYLPPEMIEG--------RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-RVEFTFPDFV 227 (263)
T ss_dssp CC-CCEETTEEGGGCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-TTCCCCCTTS
T ss_pred CC-cccccCCCCcccCHHHHcC--------CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCccC
Confidence 33 2345689999999999853 567899999999999999999999998876655544433 3333446678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
++++.+||.+||+.||.+|||+.|+++|
T Consensus 228 s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 228 TEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 9999999999999999999999999987
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-46 Score=312.72 Aligned_cols=185 Identities=28% Similarity=0.523 Sum_probs=151.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++|||||+||+|.+++....+ .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLE 179 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC-------
T ss_pred EEEEEEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCC-CcEEECCcccceEcc
Confidence 5899999999999999987543 49999999999999999999999999999999999999998 699999999998543
Q ss_pred cccc------cccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcC
Q 025244 81 LTEM------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNV 153 (255)
Q Consensus 81 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 153 (255)
.... .....||+.|+|||++. ...++.++|||||||++|||++ |+.||.+....+..........
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 251 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQ--------YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251 (299)
T ss_dssp ----------------CGGGSCHHHHH--------SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred CCCCcceeeecccccCCccccCHHHHh--------cCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 3211 12245789999999985 3678999999999999999998 8999998887776666666656
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 154 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 154 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
.+.+..+++++.+||.+||+.||.+|||+.|+++.|+.+++.
T Consensus 252 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 252 LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 667788999999999999999999999999999999887753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-47 Score=309.15 Aligned_cols=176 Identities=29% Similarity=0.577 Sum_probs=150.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
++|||||++||+|.+++.+... +++..+..++.||+.||+|||+++ |+||||||+|||++.+.+.+||+|||+++.
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEeCCCCCcHHHHHhcccc--ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 4799999999999999987654 999999999999999999999999 999999999999975437999999999985
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC--
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-- 156 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 156 (255)
.... ...+.+||+.|+|||++. +.++.++|||||||++|||++|+.||.+................+.
T Consensus 165 ~~~~-~~~~~~GT~~Y~aPE~~~---------~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~ 234 (270)
T d1t4ha_ 165 KRAS-FAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 234 (270)
T ss_dssp CCTT-SBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG
T ss_pred ccCC-ccCCcccCccccCHHHhC---------CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCccc
Confidence 4332 345678999999999884 3488999999999999999999999987776666655555444332
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...+++++.+||.+||+.||++|||+.|+++|
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 45678999999999999999999999999886
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-47 Score=312.27 Aligned_cols=176 Identities=30% Similarity=0.515 Sum_probs=152.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++.+. .+++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 92 ~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~~vkl~DFG~a~~~~ 167 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQIT 167 (293)
T ss_dssp EEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECC
T ss_pred EEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCC-CcEeeccchhheeec
Confidence 48999999999999988764 39999999999999999999999999999999999999988 799999999998654
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC--CCC
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSA 157 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~ 157 (255)
. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+........... +.+
T Consensus 168 ~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T d1yhwa1 168 PEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239 (293)
T ss_dssp STTCCBCCCCSCGGGCCHHHHSS--------SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSG
T ss_pred cccccccccccCCCccChhhhcC--------CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCc
Confidence 3 334456789999999999853 56788999999999999999999999987777666655544332 234
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..+++++++||.+||+.||.+|||+.|+++|
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 6789999999999999999999999999987
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=312.73 Aligned_cols=179 Identities=29% Similarity=0.413 Sum_probs=145.7
Q ss_pred CEEEEecCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CeecCCCCCcEEEeCCCCceEEecC
Q 025244 1 MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHG-----IIHRDLKPENLLLTEDLKTIKLADF 73 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~~-----i~HrDikp~Nill~~~~~~~kl~Df 73 (255)
++|||||++||+|.+++.+. .+..+++..++.++.|++.||+|||++| |+||||||+|||++.+ +.+||+||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~-~~vkl~DF 158 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDF 158 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT-SCEEECCH
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC-CcEEEeec
Confidence 47999999999999999753 2345999999999999999999999976 9999999999999988 79999999
Q ss_pred ccccccccc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc
Q 025244 74 GLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 152 (255)
Q Consensus 74 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 152 (255)
|+++..... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+....
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~ 230 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNR--------MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 230 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcC--------CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence 999865433 33456789999999999853 568899999999999999999999999887776666665555
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 153 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 153 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..+.+..+|+++.+||.+||+.||.+|||+.|+++|
T Consensus 231 ~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 231 FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 556677899999999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=308.53 Aligned_cols=183 Identities=26% Similarity=0.479 Sum_probs=156.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
.+|||||++||+|.+++.+... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 82 ~~lvmE~~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~-~~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 82 WMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALR 158 (277)
T ss_dssp EEEEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHhhccC--CCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc-Ccccccchhhhhhcc
Confidence 3799999999999999987654 9999999999999999999999999999999999999988 799999999998543
Q ss_pred cc----cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCC
Q 025244 81 LT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+...........+
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~ 230 (277)
T d1xbba_ 159 ADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG 230 (277)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred ccccccccccccCCCceecCchhhcC--------CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 22 12234578999999999864 557889999999999999998 899999887776665555555556
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
.+..+|+++.+||.+||+.||.+|||+++|++.|+..+.
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 678899999999999999999999999999998887653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=312.22 Aligned_cols=178 Identities=29% Similarity=0.388 Sum_probs=147.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.++|...+ .+++.++..++.|+++||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~-~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFR 154 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECE
T ss_pred eEEEEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCC-CCEEEccchhheeec
Confidence 479999999999999997644 39999999999999999999999999999999999999988 699999999998543
Q ss_pred c---ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC--C
Q 025244 81 L---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--P 155 (255)
Q Consensus 81 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~ 155 (255)
. .......+||+.|||||++.+ ...++.++|||||||++|||++|+.||.................. +
T Consensus 155 ~~~~~~~~~~~~GT~~Y~APE~~~~-------~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~ 227 (271)
T d1nvra_ 155 YNNRERLLNKMCGTLPYVAPELLKR-------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 227 (271)
T ss_dssp ETTEECCBCCCCSCGGGSCTHHHHC-------SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTST
T ss_pred cCCccccccceeeCcCccCHhHhcC-------CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Confidence 2 233456789999999999863 233467899999999999999999999876554444333332222 2
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....+++++.+||.+||+.||++|||++|+++|
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 228 PWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 245688999999999999999999999999876
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=314.99 Aligned_cols=182 Identities=31% Similarity=0.520 Sum_probs=154.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcE
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP---------------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 59 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~---------------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Ni 59 (255)
++||||||+||+|.++|..... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence 5899999999999999986532 2488999999999999999999999999999999999
Q ss_pred EEeCCCCceEEecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCC
Q 025244 60 LLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLP 135 (255)
Q Consensus 60 ll~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p 135 (255)
|++.+ +.+||+|||+|+...... ...+..||+.|||||++.+ ..++.++|||||||++|||++ |+.|
T Consensus 196 ll~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 196 LVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--------GIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp EEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred ccccC-CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC--------CCCCcceeccchhHHHHHHHhCCCCC
Confidence 99998 799999999998543322 2234568999999999853 678999999999999999997 8999
Q ss_pred CCCCchHHHHHHHHhhcCC-CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 136 FEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
|.+.+..+........... +.+..+|+++.+||.+||+.||++|||++||+++|..
T Consensus 267 f~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 9987766665555544443 4467899999999999999999999999999999853
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=309.50 Aligned_cols=185 Identities=24% Similarity=0.486 Sum_probs=158.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++...+. .+++.+++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDFGLSKALG 160 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTT-TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCCTTCEECT
T ss_pred EEEEEEeCCCCcHHHHhhcccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccC-Cceeeccchhhhccc
Confidence 4799999999999999875433 49999999999999999999999999999999999999988 699999999998543
Q ss_pred ccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCC
Q 025244 81 LTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
... ......||+.|+|||++.. ..++.++|||||||++|||++ |+.||.+.+..+....+......+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~ 232 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 232 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC
T ss_pred ccccccccccccccCccccChHHHhC--------CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 322 2234568999999999853 567889999999999999998 999999887776665555555556
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
.+..+|+++.+||.+||+.||++|||+.++++.|+.....
T Consensus 233 ~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 6788999999999999999999999999999998876543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=310.07 Aligned_cols=186 Identities=29% Similarity=0.535 Sum_probs=150.5
Q ss_pred CEEEEecCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
+++|||||+||+|.++|.... ...+++.+++.++.||+.||+|||++||+||||||+|||++.+ +
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~-~ 171 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-N 171 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG-G
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC-C
Confidence 589999999999999997642 2348899999999999999999999999999999999999988 6
Q ss_pred ceEEecCccccccccc---cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCchH
Q 025244 67 TIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNL 142 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g-~~p~~~~~~~ 142 (255)
.+||+|||+|+..... .......||+.|+|||++.+ ..++.++|||||||++|||++| .+||.+....
T Consensus 172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred cEEEccCcchhhccccccccccCceeeCccccchhHhhc--------CCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999853322 22345679999999999863 6689999999999999999986 5688876655
Q ss_pred HHHHHHHhhc-CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 143 QAAYAAAFKN-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 143 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
+......... ..+.+..+++++.++|.+||+.||.+|||+.|++++|++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 5544444433 3344667899999999999999999999999999999988765
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-46 Score=311.85 Aligned_cols=178 Identities=26% Similarity=0.411 Sum_probs=140.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC--CCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE--DLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~--~~~~~kl~Dfg~a~~ 78 (255)
++||||||+||+|.++|.+.+. +++.++..++.||+.||+|||++||+||||||+|||+.. +.+.+||+|||+++.
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred EEEEEeccCCCcHHHhhhcccC--CCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 4899999999999999987544 999999999999999999999999999999999999963 236899999999987
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC---
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--- 155 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--- 155 (255)
........+.+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+............
T Consensus 160 ~~~~~~~~~~~GT~~y~APE~~~~--------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 231 (307)
T d1a06a_ 160 EDPGSVLSTACGTPGYVAPEVLAQ--------KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 231 (307)
T ss_dssp -------------CTTSCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTT
T ss_pred ccCCCeeeeeeeCccccCcHHHcC--------CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCc
Confidence 665555667889999999999853 568899999999999999999999999877766655555444332
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....+|+++.+||.+||+.||.+|||+.|+++|
T Consensus 232 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 232 YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 346789999999999999999999999999987
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=303.20 Aligned_cols=184 Identities=29% Similarity=0.549 Sum_probs=146.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||+++|+|.+++..... .+++..++.++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||+++...
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVL 152 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGG-GCEEECSCC------
T ss_pred eEEEEEecCCCcHHHHhhcccc-CCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCC-CCeEecccchheecc
Confidence 5899999999999999986543 48999999999999999999999999999999999999998 699999999998544
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
... ......||+.|+|||++.+ ..++.++|||||||++|||++ |.+||...+..+...........+.+
T Consensus 153 ~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p 224 (263)
T d1sm2a_ 153 DDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 224 (263)
T ss_dssp ------------CTTSCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCC
T ss_pred CCCceeecceecCcccCChHHhcC--------CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence 332 2234578999999999853 568999999999999999999 56677666655555555454445556
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
..+++++.+||.+||+.||.+|||+++++++|++..+
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 7789999999999999999999999999999988754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=310.31 Aligned_cols=183 Identities=28% Similarity=0.420 Sum_probs=154.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++.+..+ .+++.++..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 84 ~~lvmEy~~~g~L~~~~~~~~~-~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~-~~~Kl~DFG~a~~~~ 161 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNT 161 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECH
T ss_pred EEEEEecCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC-CCEEEEechhhhccC
Confidence 4799999999999999876533 49999999999999999999999999999999999999988 799999999998543
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC--CCC
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSA 157 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~ 157 (255)
.. ....+.+||+.|+|||++.... .....++.++|||||||++|||++|+.||.+.+..+........... ..+
T Consensus 162 ~~~~~~~~~~Gt~~y~APE~l~~~~---~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (288)
T d2jfla1 162 RTIQRRDSFIGTPYWMAPEVVMCET---SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 238 (288)
T ss_dssp HHHHHHTCCCSCCTTCCHHHHTTCS---TTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSG
T ss_pred CCcccccccccccccCCHHHHhhcc---cCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 32 2345678999999999985321 12356789999999999999999999999988777766665554332 224
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..+++++.+||.+||+.||.+|||+.|+++|
T Consensus 239 ~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 239 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 5789999999999999999999999999886
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=306.63 Aligned_cols=186 Identities=30% Similarity=0.529 Sum_probs=156.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||+++|+|.+++.......+++.+++.++.||+.||+|||++||+||||||+|||++++ +.+||+|||+|+...
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~-~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLARLIE 160 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECS
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecc-cceeeccccceEEcc
Confidence 5899999999999998876554459999999999999999999999999999999999999998 699999999998644
Q ss_pred cc--cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
.. .......||+.|+|||++.. ..++.++|||||||++|||+|| .+||...+..+...........+.+
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~--------~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p 232 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred CCccccccccCCcccccChHHHhC--------CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence 32 22345678999999999853 5578899999999999999995 5556655555554444444445557
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
..+++++.+||.+||+.||++|||+.++++.|++++.+
T Consensus 233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 78999999999999999999999999999999988754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-45 Score=303.09 Aligned_cols=185 Identities=29% Similarity=0.501 Sum_probs=154.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||+++|+|.+++.+.....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~-~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMT 166 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCCTTTCC
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCC-CcEEEccccceeecC
Confidence 5899999999999999988766679999999999999999999999999999999999999988 699999999998643
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhc-CCCCC
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN-VRPSA 157 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~ 157 (255)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||................ ..+.+
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~ 238 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP 238 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred CCCceeeccccccccccChHHHcC--------CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence 322 2233457899999999853 568999999999999999999766654444444444444333 34456
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
..+++++.+||.+||+.||++|||+.++++.|+.+..
T Consensus 239 ~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 7899999999999999999999999999999877643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=307.47 Aligned_cols=176 Identities=25% Similarity=0.359 Sum_probs=149.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.+++...+. +++..+..++.|++.||+|||++||+||||||+|||++++ +.+||+|||+|+...
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~--l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~-~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLS 159 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECC
T ss_pred EEEEEEccCCCCHHHhhhccCC--CCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCC-ceEEecccccceecc
Confidence 4899999999999999987655 9999999999999999999999999999999999999988 799999999998643
Q ss_pred cc---cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
.. ....+.+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+.... ...+
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~--------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-~~~p 230 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFP 230 (288)
T ss_dssp ----------CCCCGGGCCHHHHHT--------CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-CCCC
T ss_pred cCCcccccccccCCccccCceeecc--------CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC-CCCC
Confidence 22 23445689999999999863 568899999999999999999999999877666555544333 3345
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
..+++++++||.+||+.||.+|||++|++++
T Consensus 231 ~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 231 EKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 6789999999999999999999999998664
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-45 Score=307.05 Aligned_cols=176 Identities=28% Similarity=0.432 Sum_probs=152.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++.+.+. +++..+..++.||+.||+|||++||+||||||+|||++.+ |.+||+|||+|+...
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~-g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSC
T ss_pred cccceeccCCCchhhhhhcccC--CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCC-CCEEEeecccccccc
Confidence 4899999999999999998665 9999999999999999999999999999999999999998 799999999998643
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
. .....+.+||+.|+|||++.+ ..++.++|+|||||++|||++|++||.+.+..+..... .......+..
T Consensus 157 ~~~~~~~~~~GT~~Y~aPE~~~~--------~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i-~~~~~~~p~~ 227 (337)
T d1o6la_ 157 SDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI-LMEEIRFPRT 227 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSS--------SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHCCCCCCTT
T ss_pred cCCcccccceeCHHHhhhhhccC--------CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH-hcCCCCCCcc
Confidence 3 344566789999999999853 56789999999999999999999999987765544443 3334455678
Q ss_pred CcHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPN-----FTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt-----~~~vl~~ 188 (255)
+++++.+||.+||++||.+|++ +.++++|
T Consensus 228 ~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 9999999999999999999994 8888886
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-45 Score=306.42 Aligned_cols=177 Identities=29% Similarity=0.440 Sum_probs=151.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++||||||+||+|..++...+. +++.++..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~~--l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMA 166 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TEEEECCCTTCBSSS
T ss_pred EEEEEEecCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC-CCEEEeecccccccC
Confidence 4899999999999877766543 9999999999999999999999999999999999999988 799999999998643
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC-CCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-SAEN 159 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~ 159 (255)
. ....+||+.|+|||++.+. ....++.++|||||||++|||++|+.||.+....+............ ....
T Consensus 167 ~---~~~~~GT~~Y~APE~~~~~-----~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 238 (309)
T d1u5ra_ 167 P---ANSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238 (309)
T ss_dssp S---BCCCCSCGGGCCHHHHTTT-----TSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTT
T ss_pred C---CCccccCccccCHHHHhcc-----CCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCC
Confidence 3 3456899999999998531 13468889999999999999999999999877776666555444332 3556
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+|+++.+||.+||+.||.+|||+.|+++|
T Consensus 239 ~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 89999999999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-45 Score=299.60 Aligned_cols=185 Identities=30% Similarity=0.540 Sum_probs=151.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++..... .+++..++.++.||++||+|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~-~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYME 159 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTT-TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC--------
T ss_pred EEEEEEeccCCcHHhhhhccCC-CCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCC-CcEEEccchhheecc
Confidence 5899999999999999876543 49999999999999999999999999999999999999998 699999999998644
Q ss_pred cc--cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
.. .......||+.|+|||++.. ..++.++|||||||++|||++ |.+||.+.+..+...........+.+
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~--------~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~ 231 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 231 (273)
T ss_dssp -----------CCGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred CCcceeccceecCcccchhhHhcc--------CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 32 22344578999999999853 678899999999999999998 89999988877776666666666678
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
..+|+++.+||.+||+.||.+|||+.||+++|++.++.
T Consensus 232 ~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 88999999999999999999999999999999887653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=311.08 Aligned_cols=180 Identities=29% Similarity=0.453 Sum_probs=148.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--CCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~--~~~~kl~Dfg~a~~ 78 (255)
++||||||+||+|.++|.+.+...+++.++..++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+++.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence 4899999999999999988666669999999999999999999999999999999999999853 25799999999997
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC----
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR---- 154 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---- 154 (255)
..........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..............
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~ 235 (335)
T d2ozaa1 164 TTSHNSLTTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235 (335)
T ss_dssp CCCCCCCCCCSCCCSSCCCCCCCG--------GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS
T ss_pred ccCCCccccccCCcccCCcHHHcC--------CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence 666666677889999999999853 56789999999999999999999999875544333222211111
Q ss_pred -C--CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 155 -P--SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 155 -~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+ ....+|+++.+||.+||+.||++|||+.|+++|
T Consensus 236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1 112578999999999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.4e-45 Score=311.13 Aligned_cols=179 Identities=23% Similarity=0.391 Sum_probs=155.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC-CCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE-DLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~-~~~~~kl~Dfg~a~~~ 79 (255)
++||||||+||+|.+++...+. .+++.+++.++.||+.||+|||++||+||||||+|||++. +.+.+||+|||+|+..
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTTC-CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCChHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceec
Confidence 4899999999999998876433 4999999999999999999999999999999999999973 2368999999999977
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC---C
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---S 156 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~ 156 (255)
.......+..||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+....... .
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 251 (352)
T d1koba_ 180 NPDEIVKVTTATAEFAAPEIVDR--------EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 251 (352)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST
T ss_pred CCCCceeeccCcccccCHHHHcC--------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence 66666667789999999999853 568899999999999999999999999887777666655544332 2
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...+++++.+||.+||+.||.+|||+.|+++|
T Consensus 252 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 45789999999999999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.4e-45 Score=310.90 Aligned_cols=179 Identities=24% Similarity=0.370 Sum_probs=154.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-CCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-LKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~-~~~~kl~Dfg~a~~~ 79 (255)
++||||||+||+|.++|.+..+ .+++.++..++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+++..
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 4899999999999999975433 39999999999999999999999999999999999999743 368999999999976
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC---
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--- 156 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 156 (255)
.......+..||+.|||||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+........
T Consensus 177 ~~~~~~~~~~gT~~Y~aPEv~~~--------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 248 (350)
T d1koaa2 177 DPKQSVKVTTGTAEFAAPEVAEG--------KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA 248 (350)
T ss_dssp CTTSCEEEECSCTTTCCHHHHHT--------CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGG
T ss_pred ccccccceecCcccccCHHHHcC--------CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence 66666667899999999999853 5678899999999999999999999998777666666555444332
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...+++++++||.+||+.||.+|||++|+++|
T Consensus 249 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 34688999999999999999999999999997
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.2e-45 Score=298.74 Aligned_cols=183 Identities=24% Similarity=0.366 Sum_probs=157.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.++|...+. +++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 85 ~~ivmE~~~~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFSCQLD 161 (277)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECC
T ss_pred eEEEEEcCCCchHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCC-CCeEEccchheeEcc
Confidence 4899999999999999987654 9999999999999999999999999999999999999988 799999999999766
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC---CC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---SA 157 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~ 157 (255)
........+||+.|+|||.+.+.... ....++.++||||+||++|||++|+.||.+.+.......+....... ..
T Consensus 162 ~~~~~~~~~gt~~y~~PE~~~~~~~~--~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (277)
T d1phka_ 162 PGEKLREVCGTPSYLAPEIIECSMND--NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239 (277)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCT--TSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred CCCceeeeeccCCCCCHHHhhccccc--cCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 65556667899999999998643211 23456889999999999999999999999887766665555544332 23
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.++|+++.+||.+||+.||.+||++.|+++|
T Consensus 240 ~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 4789999999999999999999999999886
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=300.47 Aligned_cols=178 Identities=26% Similarity=0.378 Sum_probs=154.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCC---CceEEecCcccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL---KTIKLADFGLAR 77 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~---~~~kl~Dfg~a~ 77 (255)
++||||||+||+|.++|.+.+. +++..++.++.|++.||+|||++||+||||||+|||++.+. ..+|++|||+++
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~--l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEEcCCCccccchhccccc--cchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 4899999999999999987654 99999999999999999999999999999999999998662 159999999998
Q ss_pred ccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC-
Q 025244 78 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS- 156 (255)
Q Consensus 78 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~- 156 (255)
.........+..||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+........
T Consensus 166 ~~~~~~~~~~~~~t~~y~APE~~~~--------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1jksa_ 166 KIDFGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237 (293)
T ss_dssp ECTTSCBCSCCCCCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred hcCCCccccccCCCCcccCHHHHcC--------CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence 7666555667789999999999853 5678999999999999999999999998777666655544433322
Q ss_pred --CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 --AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...+|+++.+||.+||+.||.+|||++|+++|
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 238 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 35789999999999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=308.25 Aligned_cols=176 Identities=23% Similarity=0.403 Sum_probs=143.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~-~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
++|||||++||+|.+++.+.+. +++..+..++.|++.||.|||++ ||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~--l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQL 155 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-CCEEECCCCCCHHH
T ss_pred EEEEEEcCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCC-CCEEEeeCCCcccc
Confidence 4899999999999999987654 99999999999999999999974 99999999999999988 79999999999864
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-----------
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA----------- 148 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~----------- 148 (255)
... ...+.+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+.....
T Consensus 156 ~~~-~~~~~~GT~~Y~APEvl~~--------~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 226 (322)
T d1s9ja_ 156 IDS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226 (322)
T ss_dssp HHH-TC---CCSSCCCCHHHHHC--------SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------
T ss_pred CCC-ccccccCCccccCchHHcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccC
Confidence 332 3456799999999999963 56899999999999999999999999765433221100
Q ss_pred ------------------------------HhhcCCCC--CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 149 ------------------------------AFKNVRPS--AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 149 ------------------------------~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
......+. ...++.++.+||.+||..||.+|||++|+++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000111 12357899999999999999999999999997
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=293.26 Aligned_cols=181 Identities=29% Similarity=0.542 Sum_probs=157.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+++|+|.+++..... .+++..++.++.|+++||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 74 ~~iv~Ey~~~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~-~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 74 IFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVL 151 (258)
T ss_dssp EEEEEECCTTEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTT-CCEEECCCSSCCBCS
T ss_pred eEEEEEccCCCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCC-CcEEECcchhheecc
Confidence 4799999999999999876543 38999999999999999999999999999999999999988 699999999998543
Q ss_pred ccc--ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
... ......||+.|+|||++.. ..++.++|||||||++|||+| |+.||.+.+..+...........+.+
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 223 (258)
T d1k2pa_ 152 DDEYTSSVGSKFPVRWSPPEVLMY--------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 223 (258)
T ss_dssp SSSCCCCCCSCCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred CCCceeecccCCCCCcCCcHHhcC--------CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 322 2234678999999999863 568899999999999999998 89999998877776666655555667
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 191 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~ 191 (255)
..+++++.+||.+||+.||++|||+.+++++|.+
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 8899999999999999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-44 Score=294.45 Aligned_cols=185 Identities=29% Similarity=0.522 Sum_probs=148.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||+++...
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTT-CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC-----
T ss_pred eEEEEEecccCcchhhhhcccc-cccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCC-CeEEEcccchhhccc
Confidence 4799999999999998886543 49999999999999999999999999999999999999998 699999999998543
Q ss_pred ccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCchHHHHHHHHhhcCCC
Q 025244 81 LTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKL-PFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~-p~~~~~~~~~~~~~~~~~~~~ 155 (255)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|.. |+.+....+...........+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~ 233 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISY--------RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 233 (283)
T ss_dssp ------------CCCGGGSCHHHHHS--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred CCCccceEeccCCCCccccCHHHHcc--------CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC
Confidence 221 2233568999999999853 678899999999999999999654 555555544444444444455
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 156 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
.+..++.++.+||.+||+.||++|||+.++++.|+...+.
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 234 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 6778999999999999999999999999999999887653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.9e-44 Score=306.94 Aligned_cols=177 Identities=25% Similarity=0.379 Sum_probs=149.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.++|.+... +++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~-g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFS 158 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-SCEEECCCTTCEECS
T ss_pred EEEEEEecCCCcHHHHHHhccc--ccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCC-CcEEEeeeceeeecC
Confidence 4899999999999999987654 8999999999999999999999999999999999999988 799999999998654
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHHhhcCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA--YAAAFKNVRPSAE 158 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~ 158 (255)
.. .....+||+.|+|||++.. ...++.++|||||||++|||++|+.||.+....... ...........+.
T Consensus 159 ~~-~~~~~~GT~~y~APE~~~~-------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 230 (364)
T d1omwa3 159 KK-KPHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 230 (364)
T ss_dssp SS-CCCSCCSCGGGCCHHHHST-------TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCS
T ss_pred CC-cccccccccccchhHHhhc-------CCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Confidence 43 2455689999999999853 346789999999999999999999999875433222 2222222333456
Q ss_pred CCcHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 025244 159 NVPEELSIILTSCWKEDPNARPN-----FTQIIQM 188 (255)
Q Consensus 159 ~~~~~l~~li~~~l~~~p~~Rpt-----~~~vl~~ 188 (255)
.+++++.+||.+||+.||.+||| ++++++|
T Consensus 231 ~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 231 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 79999999999999999999999 6889887
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=297.03 Aligned_cols=186 Identities=30% Similarity=0.488 Sum_probs=151.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|..++.......+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~-~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIE 164 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC---
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCC-CcEEEcccchhhhcc
Confidence 5899999999999999987554559999999999999999999999999999999999999988 699999999998543
Q ss_pred cc--cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCchHHHHHHHHhhcCCCCC
Q 025244 81 LT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP-FEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 81 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p-~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
.. .......||+.|+|||++.. ..++.++||||||+++|||++|..| +.+....+...........+.+
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~ 236 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP 236 (285)
T ss_dssp -----------CCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred CCCceeeccccccccccChHHHhC--------CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 22 22344678999999999853 6788999999999999999996555 5554444444444445555678
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
..+++++.++|.+||+.||++||++.+|++.|++++..
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 88999999999999999999999999999999887654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.2e-44 Score=294.55 Aligned_cols=181 Identities=29% Similarity=0.475 Sum_probs=148.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+||||||++||+|.+++...+. +++.+++.++.||+.||+|||++||+||||||+|||++.+ +..+++|||.+....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~--l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~-~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-SCEEECCCTTCEECC
T ss_pred EEEEEECCCCCEehhhhcccCC--CCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcc-ccceeehhhhhhhhc
Confidence 3799999999999999987655 9999999999999999999999999999999999999988 689999999987433
Q ss_pred cc----cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC-
Q 025244 81 LT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP- 155 (255)
Q Consensus 81 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~- 155 (255)
.. ......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+...........+
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~ 234 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARG--------DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 234 (277)
T ss_dssp ----------------TTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG
T ss_pred cccccccccccccCcccccCHHHHcC--------CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC
Confidence 22 23445689999999999853 568899999999999999999999999888777766665554433
Q ss_pred --CCCCCcHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHh
Q 025244 156 --SAENVPEELSIILTSCWKEDPNARP-NFTQIIQMLLNY 192 (255)
Q Consensus 156 --~~~~~~~~l~~li~~~l~~~p~~Rp-t~~~vl~~l~~~ 192 (255)
....+|+++.++|.+||+.||.+|| ++++++..|.+.
T Consensus 235 ~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 235 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 2467899999999999999999999 789988877654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=293.88 Aligned_cols=185 Identities=34% Similarity=0.587 Sum_probs=158.5
Q ss_pred CEEEEecCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
+++||||++||+|.++|..... ..+++.+++.++.||+.||+|||+++|+||||||+|||++.+ +
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~-~ 172 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-N 172 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-C
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCC-C
Confidence 5899999999999999986532 348999999999999999999999999999999999999998 7
Q ss_pred ceEEecCcccccccccc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchH
Q 025244 67 TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 142 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~ 142 (255)
.+||+|||+++...... ......||+.|+|||.+.+ ..++.++||||||+++|||++ |.+||.+....
T Consensus 173 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~--------~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred CeEeccchhhccccccccccccccCCCChhhhhhhHhcC--------CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 99999999998544332 2344678999999999853 678999999999999999998 78999887766
Q ss_pred HHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 143 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
+...........+.+..+++++.+||.+||+.||.+|||+.||++.|+++.+
T Consensus 245 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 5554444444455677899999999999999999999999999999988764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.5e-44 Score=297.54 Aligned_cols=174 Identities=29% Similarity=0.423 Sum_probs=151.9
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ |.+||+|||+|+...
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~-g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVP 155 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT-SCEEECCCSSCEECS
T ss_pred eeeEeeecCCcccccccccccc--ccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCC-CCEEEecCccceEec
Confidence 4899999999999999987655 8899999999999999999999999999999999999988 799999999998654
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
.. ..+.+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+... ....+..+
T Consensus 156 ~~--~~~~~Gt~~Y~APE~l~~--------~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~ 224 (316)
T d1fota_ 156 DV--TYTLCGTPDYIAPEVVST--------KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-ELRFPPFF 224 (316)
T ss_dssp SC--BCCCCSCTTTCCHHHHTT--------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-CCCCCTTS
T ss_pred cc--cccccCcccccCHHHHcC--------CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC-CCCCCCCC
Confidence 33 356789999999999853 56788999999999999999999999987766665554443 33456788
Q ss_pred cHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARP-----NFTQIIQM 188 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~ 188 (255)
++++.++|.+||..||.+|+ +++++++|
T Consensus 225 s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 225 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 99999999999999999996 89999887
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-43 Score=297.14 Aligned_cols=174 Identities=26% Similarity=0.346 Sum_probs=151.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+.||+|.+++.+.+. +++.++..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~~--l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~-g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECS
T ss_pred cccccccccccchhhhHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCC-CCEEeeeceeeeecc
Confidence 4799999999999999987665 9999999999999999999999999999999999999988 799999999998654
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 160 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
.. ..+..||+.|||||++.+ ..++.++|||||||++|||++|+.||.+.+.......+... ....+..+
T Consensus 193 ~~--~~~~~Gt~~Y~APE~~~~--------~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~ 261 (350)
T d1rdqe_ 193 GR--TWTLCGTPEALAPEIILS--------KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-KVRFPSHF 261 (350)
T ss_dssp SC--BCCCEECGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCTTC
T ss_pred cc--cccccCccccCCHHHHcC--------CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC-CCCCCccC
Confidence 32 346789999999999863 56788999999999999999999999987665555544433 34446789
Q ss_pred cHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 025244 161 PEELSIILTSCWKEDPNARP-----NFTQIIQM 188 (255)
Q Consensus 161 ~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~ 188 (255)
++++.++|.+||+.||.+|+ +++++++|
T Consensus 262 s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 99999999999999999994 89999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-44 Score=295.77 Aligned_cols=184 Identities=29% Similarity=0.348 Sum_probs=150.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++|+++..++... ..+++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 75 ~~ivmE~~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~-~~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 75 ISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFG 151 (299)
T ss_dssp CEEEEECCSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCGGGSTTT
T ss_pred eeehhhhhcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC-CccccccCccccccC
Confidence 58999999887766665433 349999999999999999999999999999999999999988 799999999998644
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC---
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--- 156 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 156 (255)
.. ......+||+.|+|||++.. ...++.++|||||||++|||++|++||.+.+..+....+......+.
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~ 224 (299)
T d1ua2a_ 152 SPNRAYTHQVVTRWYRAPELLFG-------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 224 (299)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTT-------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CCcccccceecChhhccHHHHcc-------CCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 33 33455689999999999853 35678999999999999999999999998887776655543221111
Q ss_pred ------------------------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 025244 157 ------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 196 (255)
Q Consensus 157 ------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~ 196 (255)
...+++++.+||.+||+.||++|||+.|+++| .++...
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H--p~f~~~ 286 (299)
T d1ua2a_ 225 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM--KYFSNR 286 (299)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS--GGGTSS
T ss_pred ccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC--HhhCCC
Confidence 12467899999999999999999999999987 444443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-44 Score=299.71 Aligned_cols=176 Identities=31% Similarity=0.497 Sum_probs=152.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.++|..... +++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 78 ~yivmEy~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~-~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 78 LFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENM 154 (320)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCC
T ss_pred eeEEEeecCCCcHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCC-Cceeccccchhhhcc
Confidence 4899999999999999987665 9999999999999999999999999999999999999988 799999999998544
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+.. .....+..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-~~~~~p~~ 225 (320)
T d1xjda_ 155 LGDAKTNTFCGTPDYIAPEILLG--------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-DNPFYPRW 225 (320)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCCCTT
T ss_pred cccccccccCCCCCcCCHHHHcC--------CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCCCcc
Confidence 3 333455789999999999963 5688999999999999999999999998776665554443 33344667
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFT-QIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~-~vl~~ 188 (255)
+|+++.+||.+||+.||.+||++. ++++|
T Consensus 226 ~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 226 LEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp SCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 899999999999999999999985 78765
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-44 Score=289.89 Aligned_cols=183 Identities=30% Similarity=0.553 Sum_probs=151.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||++||+|.++|...+...+++..++.++.||+.||.|||+++|+||||||+|||++.+ +.+|++|||+++...
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEAS 154 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC-----
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCC-CCEeecccccceecC
Confidence 5899999999999999987654458999999999999999999999999999999999999998 799999999998644
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
.. .....+|..|+|||++.+ ..++.++||||||+++|||++ |++||......+....+......+.+..
T Consensus 155 ~~--~~~~~~~~~y~aPE~l~~--------~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~ 224 (262)
T d1byga_ 155 ST--QDTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 224 (262)
T ss_dssp ---------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTT
T ss_pred CC--CccccccccCCChHHHhC--------CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 33 344578999999999853 568999999999999999998 7889988776666555554555556778
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
+++++.+||.+||+.||.+|||+.+++++|+....
T Consensus 225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999999987643
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=294.87 Aligned_cols=183 Identities=24% Similarity=0.504 Sum_probs=154.3
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
++||||+.+|+|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~-~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCCSHHHHTTT
T ss_pred eEEEEeccCCccccccccccc-CCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCC-CCeEeeccccceeccc
Confidence 689999999999999887543 49999999999999999999999999999999999999998 6999999999985433
Q ss_pred cc---ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCCCCC
Q 025244 82 TE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 157 (255)
Q Consensus 82 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
.. ......||+.|+|||++.+ +.++.++|||||||++|||+| |.+||.+.+..+...........+.+
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p 235 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 235 (317)
T ss_dssp TCC--------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCC
T ss_pred ccccccccccccCccccChHHHhc--------CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 22 2234568999999999863 568999999999999999998 89999887766655555555555667
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 158 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 158 ~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
..+++++.+||.+||+.||.+|||+.|++++|.....
T Consensus 236 ~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 236 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 7899999999999999999999999999999887653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=293.81 Aligned_cols=186 Identities=30% Similarity=0.503 Sum_probs=155.9
Q ss_pred CEEEEecCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 66 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~ 66 (255)
+++||||++||+|.++|+... ...+++..++.++.||+.||.|||+++|+||||||+|||++.+ +
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~-~ 164 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-Y 164 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-G
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC-C
Confidence 489999999999999997541 2459999999999999999999999999999999999999988 6
Q ss_pred ceEEecCccccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCchHHHH
Q 025244 67 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNK-LPFEGMSNLQAA 145 (255)
Q Consensus 67 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~-~p~~~~~~~~~~ 145 (255)
.+||+|||+++............||..|+|||.+.. ..++.++|||||||++|||++|. +||.+.+..+..
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~ 236 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred ceEEccccccccccccccccceecCCcccchHHhcc--------CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999986555544456679999999999853 56789999999999999999965 578776665555
Q ss_pred HHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 146 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
..+......+.+..+++++.+||.+||+.||++|||+.+++++|++.+..
T Consensus 237 ~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 237 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 44444444445678899999999999999999999999999999988764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=297.01 Aligned_cols=179 Identities=21% Similarity=0.277 Sum_probs=154.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-CCceEEecCcccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-LKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~-~~~~kl~Dfg~a~~~ 79 (255)
+|||||||+||+|.++|.+.+. .+++.++..++.||+.||+|||++||+||||||+|||++.+ ...+||+|||+++..
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~~~-~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 4899999999999999986542 39999999999999999999999999999999999999853 247999999999876
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC---
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--- 156 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 156 (255)
.......+..||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 155 ~~~~~~~~~~~t~~y~ape~~~~--------~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 226 (321)
T d1tkia_ 155 KPGDNFRLLFTAPEYYAPEVHQH--------DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA 226 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTT--------CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred ccCCcccccccccccccchhccC--------CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhh
Confidence 65555666789999999998853 5678899999999999999999999998877766666555444332
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 157 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 157 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
...+++++.+||.+||..||.+|||+.|+++|
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 24689999999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-43 Score=290.75 Aligned_cols=183 Identities=30% Similarity=0.553 Sum_probs=155.3
Q ss_pred CEEEEecCCCCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCc
Q 025244 1 MVIVTELLSGGTLRKYLLNMR----------------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 58 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~----------------------~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~N 58 (255)
+++||||+++|+|.++|.... ...+++..++.++.|++.||+|||+++++||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 579999999999999997532 1238889999999999999999999999999999999
Q ss_pred EEEeCCCCceEEecCccccccccc---cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCC-C
Q 025244 59 LLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNK-L 134 (255)
Q Consensus 59 ill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~-~ 134 (255)
||++.+ +.+||+|||+++..... ....+..||+.|+|||.+.+ ..++.++|||||||++|||++|. +
T Consensus 171 ILld~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 171 CLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--------NRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp EEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred eEECCC-CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc--------CCCChhhhhccchhhHHHHHccCCC
Confidence 999998 69999999999853322 22345678999999999863 67899999999999999999985 6
Q ss_pred CCCCCchHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 135 PFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 135 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
||.+.+..+...........+.+..+++++.+||.+||+.||++|||+.||++.|+..
T Consensus 242 p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 242 PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 8888877777766666665566778999999999999999999999999999999865
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=288.63 Aligned_cols=182 Identities=30% Similarity=0.577 Sum_probs=153.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+++|+|.+++..+.. .+++..++.++.|++.||.|||++||+||||||+||+++.+ +.+||+|||+++...
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~-~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMRALP 162 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEECC
T ss_pred hheeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccc-cceeeccchhhhhcc
Confidence 4799999999999999887543 39999999999999999999999999999999999999998 699999999998643
Q ss_pred ccc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhhcCC-
Q 025244 81 LTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVR- 154 (255)
Q Consensus 81 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~- 154 (255)
... ......|+..|+|||++.+ ..++.++||||||+++|||++ |+.||.+.+..+...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~ 234 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKT--------RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 234 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred cCCCcceecCccccCcccCCHHHHhC--------CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC
Confidence 321 2234467889999999864 567889999999999999998 89999998877776666555443
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 025244 155 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 192 (255)
Q Consensus 155 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~ 192 (255)
+.+..+|+++.+||.+||+.||++|||+.+|++.|++.
T Consensus 235 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 34678999999999999999999999999999988753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=287.70 Aligned_cols=178 Identities=26% Similarity=0.343 Sum_probs=149.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++|+++..... .....+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 90 ~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~-~~~kl~dfg~~~~~~ 167 (305)
T d1blxa_ 90 LTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYS 167 (305)
T ss_dssp EEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECSCCSCCCCC
T ss_pred EEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCC-CCeeecchhhhhhhc
Confidence 479999998766654444 344559999999999999999999999999999999999999988 699999999998766
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC-----
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP----- 155 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~----- 155 (255)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+...........+
T Consensus 168 ~~~~~~~~~gT~~Y~APE~~~~--------~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 168 FQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp GGGGGCCCCCCCTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred ccccCCCcccChhhcCcchhcC--------CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 6666678899999999999853 668899999999999999999999999887766655543321111
Q ss_pred ---------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 ---------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....+++.+.+||.+||+.||++|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 134578899999999999999999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-43 Score=286.84 Aligned_cols=171 Identities=24% Similarity=0.379 Sum_probs=144.2
Q ss_pred CEEEEecCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccc
Q 025244 1 MVIVTELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 79 (255)
Q Consensus 1 l~lV~Ey~~g-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~ 79 (255)
+++||||+.| +++.+++..... +++.++..++.|++.||+|||++||+||||||+|||++.+.+.+||+|||+++..
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~--l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 4799999976 688888887654 9999999999999999999999999999999999999966578999999999864
Q ss_pred ccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCCCCC
Q 025244 80 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 159 (255)
Q Consensus 80 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
... ...+..||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+ ............
T Consensus 162 ~~~-~~~~~~GT~~y~aPE~~~~-------~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~~~~~~~~~ 226 (273)
T d1xwsa_ 162 KDT-VYTDFDGTRVYSPPEWIRY-------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQVFFRQR 226 (273)
T ss_dssp CSS-CBCCCCSCGGGSCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCCCCSSC
T ss_pred ccc-cccccccCCCcCCHHHHcC-------CCCCCcccccccceeeehhHhhCCCCCCCch-------HHhhcccCCCCC
Confidence 433 3456789999999999864 2334678999999999999999999997632 122223344667
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 160 VPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 160 ~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
+|+++.+||.+||+.||.+|||++|+++|
T Consensus 227 ~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 227 VSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 99999999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-42 Score=286.27 Aligned_cols=186 Identities=34% Similarity=0.582 Sum_probs=156.1
Q ss_pred CEEEEecCCCCCHHHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC
Q 025244 1 MVIVTELLSGGTLRKYLLNMRP----------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 64 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~----------------~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~ 64 (255)
++|||||++||+|.++|.+... ..+++..+..++.||+.||+|||++|++||||||+||+++.+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~ 181 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccccc
Confidence 5899999999999999986532 248999999999999999999999999999999999999988
Q ss_pred CCceEEecCccccccccc---cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCc
Q 025244 65 LKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMS 140 (255)
Q Consensus 65 ~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~ 140 (255)
+.+|++|||+++..... .......||+.|+|||++.. ..++.++||||||+++|||++ |.+||.+..
T Consensus 182 -~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 182 -RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp -TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred -CcccccccchheeccCCCcceEeeecccChHHcCHHHhcC--------CCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 79999999999854332 22334678999999999853 678999999999999999998 667777766
Q ss_pred hHHHHHHHHhhcCCC-CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 141 NLQAAYAAAFKNVRP-SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 141 ~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
..+...........+ .+..++.++.+||.+||+.||.+|||+.++++.|++.+..
T Consensus 253 ~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 655555554444443 4567899999999999999999999999999999887654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-42 Score=284.20 Aligned_cols=188 Identities=27% Similarity=0.431 Sum_probs=152.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+. +++.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 76 ~~iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~-~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 76 LYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFG 153 (298)
T ss_dssp EEEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSTTHHHHHC
T ss_pred eeEEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeeccc-CcceeccCCcceecc
Confidence 489999995 566677766555569999999999999999999999999999999999999988 699999999998644
Q ss_pred c-ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC---
Q 025244 81 L-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--- 156 (255)
Q Consensus 81 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 156 (255)
. ........||+.|+|||++.. ...++.++|+|||||++|+|++|+.||.+.+..+...........+.
T Consensus 154 ~~~~~~~~~~gt~~y~apE~~~~-------~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 226 (298)
T d1gz8a_ 154 VPVRTYTHEVVTLWYRAPEILLG-------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226 (298)
T ss_dssp CCSBCTTCCBCCCTTCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CCcccceeecccceeeehhhhcc-------ccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhh
Confidence 3 334456689999999998753 34567899999999999999999999998877766655433211110
Q ss_pred -------------------------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcCCC
Q 025244 157 -------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 199 (255)
Q Consensus 157 -------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~~~ 199 (255)
...+++++.+||.+||..||++|||+.|+++| .+++....|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H--~ff~~~~~p 292 (298)
T d1gz8a_ 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH--PFFQDVTKP 292 (298)
T ss_dssp STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS--GGGTTCCCC
T ss_pred ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC--HhhccCCCC
Confidence 12467899999999999999999999999997 455544433
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-42 Score=285.62 Aligned_cols=185 Identities=30% Similarity=0.486 Sum_probs=151.2
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++||+|.+++..... .+++..++.++.|++.||.|||+.+|+||||||+|||++++ +.+||+|||+++...
T Consensus 104 ~~lv~E~~~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~-~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 104 PLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMY 181 (311)
T ss_dssp EEEEEECCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECSSGGGCCTT
T ss_pred eEEEEEEeecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCC-CCEEEecccchhhcc
Confidence 3799999999999999886543 48888999999999999999999999999999999999988 699999999998533
Q ss_pred ccc-----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhhcCC
Q 025244 81 LTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ-AAYAAAFKNVR 154 (255)
Q Consensus 81 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~ 154 (255)
... ......||..|+|||.+.. ..++.++||||||+++|||++|..||....... ...........
T Consensus 182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~ 253 (311)
T d1r0pa_ 182 DKEFDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 253 (311)
T ss_dssp TTTCCCTTCTTCSSCCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC
T ss_pred ccccccceecccccccccccChHHHhc--------CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 221 2233568999999999853 568999999999999999999877776544333 33333344444
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 025244 155 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 195 (255)
Q Consensus 155 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~ 195 (255)
+.+..+++++.+||.+||+.||++||++.||+++|++....
T Consensus 254 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 254 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 45678899999999999999999999999999999988754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=283.36 Aligned_cols=184 Identities=30% Similarity=0.540 Sum_probs=156.9
Q ss_pred CEEEEecCCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEec
Q 025244 1 MVIVTELLSGGTLRKYLLNMR--------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 72 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~--------~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~D 72 (255)
+++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+|||++.+ +.+||+|
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~-~~~Kl~D 176 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIGD 176 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT-CCEEECC
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCC-ceEEEee
Confidence 479999999999999987532 1347889999999999999999999999999999999999988 6999999
Q ss_pred Cccccccccc---cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCchHHHHHHH
Q 025244 73 FGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAA 148 (255)
Q Consensus 73 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g-~~p~~~~~~~~~~~~~ 148 (255)
||+++..... .......||+.|+|||.+.+ ..++.++||||||+++|||++| ++||.+.+..+.....
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~--------~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHcc--------CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999854332 22344578999999999853 6688899999999999999998 5888887777766666
Q ss_pred HhhcCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 025244 149 AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 193 (255)
Q Consensus 149 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~ 193 (255)
......+.+..+++.+.++|.+||+.||++|||+.+|+++|++..
T Consensus 249 ~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 249 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 666666667889999999999999999999999999999987654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-41 Score=284.75 Aligned_cols=180 Identities=25% Similarity=0.294 Sum_probs=146.6
Q ss_pred CEEEEecCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 1 MVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~--~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
++|||||++|+ +.+.+.. .....+++.++..++.||+.||+|||++||+||||||+|||++.+...+||+|||+++.
T Consensus 94 ~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 94 LNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 37999999755 4444432 23345999999999999999999999999999999999999997745899999999987
Q ss_pred cccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC----
Q 025244 79 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR---- 154 (255)
Q Consensus 79 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---- 154 (255)
........+.+||+.|+|||.+.+ ...++.++||||+||++|||++|+.||.+.+..+....+......
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 173 LVRGEPNVSYICSRYYRAPELIFG-------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245 (350)
T ss_dssp CCTTSCCCSCCSCTTSCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccCCcccccccccccccChHHhhc-------ccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence 666666667889999999998753 356889999999999999999999999987766655443321100
Q ss_pred ------------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 155 ------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 155 ------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.....+++++.+||.+||..||++|||+.|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0123568899999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-40 Score=274.99 Aligned_cols=186 Identities=24% Similarity=0.329 Sum_probs=145.6
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--CCceEEecCcccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLAREE 79 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~--~~~~kl~Dfg~a~~~ 79 (255)
++||||+ |++|.+.+..... .+++..++.++.|++.||+|||++||+||||||+|||++.. ...++|+|||+|+..
T Consensus 79 ~ivme~~-~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 79 VMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEEEc-CCchhhhhhhccC-CCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 7899999 6788887766443 49999999999999999999999999999999999998632 247999999999854
Q ss_pred cccc--------ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH--
Q 025244 80 SLTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA-- 149 (255)
Q Consensus 80 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~-- 149 (255)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~ 228 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--------BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH
T ss_pred cccccccceeccccCCcCCCccccCHHHHhC--------CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh
Confidence 3221 2345679999999999853 568999999999999999999999998755443322211
Q ss_pred -hh-cCCC---CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcC
Q 025244 150 -FK-NVRP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 197 (255)
Q Consensus 150 -~~-~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~ 197 (255)
.. ...+ ....+|+++.++|.+||+.||.+||++.++.+.|+..+....
T Consensus 229 ~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 229 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 11 1111 245789999999999999999999999999988887765443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-41 Score=278.15 Aligned_cols=190 Identities=25% Similarity=0.358 Sum_probs=143.3
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCCeecCCCCCcEEEeCCCCceEEec
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS--------HGIIHRDLKPENLLLTEDLKTIKLAD 72 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~--------~~i~HrDikp~Nill~~~~~~~kl~D 72 (255)
++|||||+++|+|.++|++.. +++..++.++.|++.||+|||+ +||+||||||+|||++.+ +.+||+|
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~~---l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~-~~~Kl~D 151 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIAD 151 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECC
T ss_pred EEEEEecccCCCHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC-CCeEEEe
Confidence 479999999999999998753 9999999999999999999996 599999999999999988 6999999
Q ss_pred Ccccccccccc-----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCc-------
Q 025244 73 FGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS------- 140 (255)
Q Consensus 73 fg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~------- 140 (255)
||+++...... ......||+.|+|||++..... .....++.++|||||||++|||++|..||....
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~ 229 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN--MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSC--TTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred cCccccccCCCcceeccccceecccCcCChhhcccccc--ccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence 99998543221 2345679999999999854110 011235678999999999999999988763211
Q ss_pred -------hHHHHHHHH-hhcCCCCCC------CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 025244 141 -------NLQAAYAAA-FKNVRPSAE------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 196 (255)
Q Consensus 141 -------~~~~~~~~~-~~~~~~~~~------~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~ 196 (255)
..+...... ....+|... ..+..+.+|+.+||+.||.+|||+.||++.|+.+....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 112222222 222222211 12356999999999999999999999999998876543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-40 Score=274.82 Aligned_cols=179 Identities=26% Similarity=0.378 Sum_probs=147.4
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+.||+|.+++...+. +.+..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~-~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCC-CCEEEeeccchhhhc
Confidence 4799999999999999988765 8889999999999999999999999999999999999998 799999999998543
Q ss_pred c--ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHHhhcCCC
Q 025244 81 L--TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ---AAYAAAFKNVRP 155 (255)
Q Consensus 81 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~ 155 (255)
. .....+..|++.|++||.+.+ ....++.++|||||||+||||++|+.||.+....+ ...........+
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~------~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~ 254 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRG------GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 254 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTT------CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC
T ss_pred ccccccccccccccccchhHHhhc------CCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCC
Confidence 2 233456689999999999853 23457889999999999999999999997754332 222333333444
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 025244 156 SAENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 188 (255)
Q Consensus 156 ~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~vl~~ 188 (255)
.+..+++++.+||.+||+.||.+|| |++|+++|
T Consensus 255 ~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 255 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 5667999999999999999999999 47889876
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1e-39 Score=270.25 Aligned_cols=188 Identities=21% Similarity=0.303 Sum_probs=150.4
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC----CCceEEecCcccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED----LKTIKLADFGLAR 77 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~----~~~~kl~Dfg~a~ 77 (255)
++||||+ |++|.+++...+. .++..++..++.|++.||+|||++||+||||||+|||++.+ .+.+||+|||+|+
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEEec-CCCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 7999999 7999999987543 49999999999999999999999999999999999999742 3579999999998
Q ss_pred ccccc--------cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH---HHHH
Q 025244 78 EESLT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL---QAAY 146 (255)
Q Consensus 78 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~---~~~~ 146 (255)
..... ......+||+.|||||++.+ ..++.++|||||||++|||++|+.||.+.... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--------~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~ 226 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--------REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 226 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcC--------CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHH
Confidence 54321 12345679999999999853 56899999999999999999999999764432 2111
Q ss_pred HHHhhc-CCC---CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcCCC
Q 025244 147 AAAFKN-VRP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 199 (255)
Q Consensus 147 ~~~~~~-~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~~~~~~ 199 (255)
...... ..+ ....+|+++.+++..|++.+|++||++..+.+.|.+.+......
T Consensus 227 ~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~ 283 (293)
T d1csna_ 227 RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283 (293)
T ss_dssp HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence 111111 111 24578899999999999999999999999999998887665443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=275.28 Aligned_cols=176 Identities=29% Similarity=0.375 Sum_probs=143.9
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
+++|||+.||+|.+++.... +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 86 ~~l~~~~~~g~L~~~l~~~~---l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~-~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEEECCCEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCG
T ss_pred EEEEEeecCCchhhhhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCC-CCEEEcccCceeeccC
Confidence 35566677999999997642 9999999999999999999999999999999999999988 7999999999985433
Q ss_pred cc----ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC--
Q 025244 82 TE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-- 155 (255)
Q Consensus 82 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-- 155 (255)
.. .....+||+.|+|||++.. ...++.++||||+||++|+|++|+.||.+.+..+...........+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTT-------BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred CCccceeeccccccceechHHHhhc-------CCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCCh
Confidence 22 2345679999999999853 3567889999999999999999999998877655444332211111
Q ss_pred ----------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 ----------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ----------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....+++++.+||.+||+.||.+|||+.|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 123567899999999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.1e-40 Score=271.73 Aligned_cols=178 Identities=27% Similarity=0.376 Sum_probs=141.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+.|+.+..+.... +.+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+|++|||++....
T Consensus 75 ~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~-~~~kl~DfG~a~~~~ 151 (286)
T d1ob3a_ 75 LVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFG 151 (286)
T ss_dssp EEEEEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCTTHHHHHC
T ss_pred eeEEEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCC-CCEEecccccceecc
Confidence 47999999766666655443 349999999999999999999999999999999999999998 799999999998644
Q ss_pred cc-cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC----
Q 025244 81 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---- 155 (255)
Q Consensus 81 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---- 155 (255)
.. .......|++.|+|||.+.. ...++.++|||||||++|||++|+.||.+.+..+...+.......+
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~-------~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (286)
T d1ob3a_ 152 IPVRKYTHEIVTLWYRAPDVLMG-------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224 (286)
T ss_dssp C---------CCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cCccccceecccchhhhHHHHhC-------CCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhh
Confidence 32 22345578999999999853 3567899999999999999999999999877766655543211111
Q ss_pred ------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 ------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
....+++++.+||.+||+.||++|||+.|+++|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 124567899999999999999999999999876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=276.15 Aligned_cols=174 Identities=26% Similarity=0.350 Sum_probs=145.8
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
++|||||+ |.+|.++++... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+|++|||+++...
T Consensus 98 ~~lv~e~~-~~~l~~~~~~~~---l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~-~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKHEK---LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQAD 172 (346)
T ss_dssp CEEEEECC-SEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECC
T ss_pred EEEEEecc-cccHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccc-cccccccccceeccC
Confidence 48999999 788888876532 9999999999999999999999999999999999999998 799999999998654
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCC------
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR------ 154 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------ 154 (255)
.. ....+||+.|+|||++.+ ...++.++||||+||++|+|++|+.||.+.+..............
T Consensus 173 ~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 173 SE--MTGYVVTRWYRAPEVILN-------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp SS--CCSSCSCGGGCCTHHHHT-------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred Cc--cccccccccccCHHHHcC-------CCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 33 456789999999999853 345788999999999999999999999887765554333221111
Q ss_pred ------------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 155 ------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 155 ------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.....+++++.+||.+||..||.+|||+.|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0134578999999999999999999999999997
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=272.32 Aligned_cols=178 Identities=20% Similarity=0.219 Sum_probs=141.0
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||++++.+...... ...+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 92 ~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~-~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 92 IYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFS 168 (318)
T ss_dssp EEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCEECC
T ss_pred EEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCC-CcEEeeecceeeecc
Confidence 4799999976655544332 3349999999999999999999999999999999999999998 799999999997543
Q ss_pred cc-----cccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC
Q 025244 81 LT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 155 (255)
Q Consensus 81 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 155 (255)
.. ....+.+||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..............+
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~-------~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccccccccccceecCHHHhhHHHHcC-------CCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 22 22344579999999999853 3467889999999999999999999999877665554433322211
Q ss_pred CCC-------------------------------CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 SAE-------------------------------NVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ~~~-------------------------------~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
... ..++++.+||.+||+.||++|||+.|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 100 125677899999999999999999999997
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.2e-40 Score=275.29 Aligned_cols=176 Identities=22% Similarity=0.301 Sum_probs=142.7
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+++++|.++.+ .+++.++..++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+++...
T Consensus 107 ~~~v~e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EEEEEECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eeEEEeecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceecc
Confidence 478999999999977642 399999999999999999999999999999999999999764579999999998766
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHh---------
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA-YAAAF--------- 150 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-~~~~~--------- 150 (255)
.........||+.|+|||.+.+ ...++.++|+||+||++|||++|+.||......... .....
T Consensus 182 ~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~ 254 (328)
T d3bqca1 182 PGQEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254 (328)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred CCCcccccccCccccCcccccC-------CCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhh
Confidence 5555677789999999998763 345788999999999999999999999765432211 11110
Q ss_pred ---h-c-----------------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 151 ---K-N-----------------------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 151 ---~-~-----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
. . ..+....+++++.+||.+||..||.+|||++|+++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0 000113367899999999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-38 Score=268.94 Aligned_cols=178 Identities=29% Similarity=0.346 Sum_probs=143.4
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCcccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 81 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~~ 81 (255)
++||||+.||+|.+++... .+++.++..++.||+.||+|||++||+||||||+|||++.+ +.+|++|||++.....
T Consensus 98 ~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~-~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARHTDD 173 (348)
T ss_dssp CEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCC----CCTG
T ss_pred EEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccc-ccccccccchhcccCc
Confidence 4677788899999999643 39999999999999999999999999999999999999998 7999999999976433
Q ss_pred ccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCCC-----
Q 025244 82 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS----- 156 (255)
Q Consensus 82 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 156 (255)
...+..||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+.......+......+.
T Consensus 174 --~~~~~~g~~~y~apE~~~~-------~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 174 --EMTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp --GGSSSCHHHHTSCHHHHTT-------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred --ccccccccccccCchhhcC-------CccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 3456789999999998753 34568899999999999999999999998776655544432221110
Q ss_pred -------------------------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 025244 157 -------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 194 (255)
Q Consensus 157 -------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~l~~~~~ 194 (255)
...+++++.+||.+||..||.+|||+.|+++| .++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H--p~f~ 305 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH--AYFA 305 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGT
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC--HhhC
Confidence 23578899999999999999999999999987 4444
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-37 Score=257.17 Aligned_cols=178 Identities=22% Similarity=0.296 Sum_probs=142.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+++||||+.|++|..++...+. +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||.++...
T Consensus 76 ~~iv~~~~~~~~l~~~~~~~~~--~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~-~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 76 LTLVFEFCDQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFG 152 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTTTC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECC
T ss_pred eeEEeeeccccccccccccccc--cchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccC-Cceeeeecchhhccc
Confidence 3789999999999888876544 8999999999999999999999999999999999999988 699999999998654
Q ss_pred ccc-ccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhhcCC----
Q 025244 81 LTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA-YAAAFKNVR---- 154 (255)
Q Consensus 81 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~---- 154 (255)
... ......++..|+|||++.. ...++.++|||||||++|||++|+.||......... .........
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (292)
T d1unla_ 153 IPVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225 (292)
T ss_dssp SCCSCCCSCCSCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred CCCccceeeccccchhhhhHhcc-------CCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChh
Confidence 432 3344567889999998853 345688999999999999999999986544443333 222211110
Q ss_pred ------------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 155 ------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 155 ------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
.....+++.+.+||.+||+.||.+|||++|+++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0123567899999999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-38 Score=266.43 Aligned_cols=174 Identities=28% Similarity=0.369 Sum_probs=131.6
Q ss_pred CEEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 1 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 1 l~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|+||||+.| ++.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.++++|||+++...
T Consensus 97 ~~iv~Ey~~~-~l~~~~~~----~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~-~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC-----
T ss_pred eEEEEeccch-HHHHhhhc----CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccc-cceeeechhhhhccc
Confidence 4899999965 55555532 38999999999999999999999999999999999999988 689999999998766
Q ss_pred cccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhhcCCC-----
Q 025244 81 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP----- 155 (255)
Q Consensus 81 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~----- 155 (255)
........+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..............+
T Consensus 171 ~~~~~~~~~~t~~y~aPE~l~~--------~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 171 TSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ----------CCTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccccccccccccChhhhcC--------CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 6666677789999999999853 567889999999999999999999998876655443332111110
Q ss_pred ----------------C--------------------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025244 156 ----------------S--------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 188 (255)
Q Consensus 156 ----------------~--------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~~ 188 (255)
. ....++++.+||.+||..||++|||++|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 00135678999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.98 E-value=6.3e-33 Score=235.50 Aligned_cols=177 Identities=21% Similarity=0.260 Sum_probs=129.6
Q ss_pred EEEEecCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCCCC-----ceEEecCc
Q 025244 2 VIVTELLSGG-TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLK-----TIKLADFG 74 (255)
Q Consensus 2 ~lV~Ey~~gg-sL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~-~~i~HrDikp~Nill~~~~~-----~~kl~Dfg 74 (255)
++||+++.++ +............+++..+..++.|++.||+|||+ .||+||||||+|||++.+.. .++++|||
T Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg 177 (362)
T d1q8ya_ 98 HVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG 177 (362)
T ss_dssp EEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCT
T ss_pred eeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecc
Confidence 3556655444 44444444455569999999999999999999998 89999999999999986521 38999999
Q ss_pred cccccccccccccCCCccceecccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCchH------HHHHHH
Q 025244 75 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL------QAAYAA 148 (255)
Q Consensus 75 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~------~~~~~~ 148 (255)
.+..... .....+||+.|+|||++.. ..++.++|+||+||++++|++|+.||...+.. ......
T Consensus 178 ~s~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 178 NACWYDE--HYTNSIQTREYRSPEVLLG--------APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp TCEETTB--CCCSCCSCGGGCCHHHHHT--------CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred ccccccc--ccccccccccccChhhccc--------cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 9986443 2356789999999998863 56788999999999999999999999753321 111110
Q ss_pred Hhhc-----------------------------------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025244 149 AFKN-----------------------------------------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 187 (255)
Q Consensus 149 ~~~~-----------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~vl~ 187 (255)
.... ........++++.+||.+||..||.+|||++|+++
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 00001123578999999999999999999999998
Q ss_pred H
Q 025244 188 M 188 (255)
Q Consensus 188 ~ 188 (255)
|
T Consensus 328 H 328 (362)
T d1q8ya_ 328 H 328 (362)
T ss_dssp C
T ss_pred C
Confidence 6
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.69 E-value=1.1e-18 Score=134.30 Aligned_cols=68 Identities=25% Similarity=0.315 Sum_probs=57.0
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCCCceEEecCccccccc
Q 025244 2 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 80 (255)
Q Consensus 2 ~lV~Ey~~ggsL~~~l~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~~~ 80 (255)
+|||||++++.+.+ ++...+..++.|++.+|+|||++||+||||||+|||++++ .++|+|||+|+...
T Consensus 86 ~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~--~~~liDFG~a~~~~ 153 (191)
T d1zara2 86 AVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFPQSVEVG 153 (191)
T ss_dssp EEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT--EEEECCCTTCEETT
T ss_pred EEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC--CEEEEECCCcccCC
Confidence 58999998765433 3444566789999999999999999999999999999965 58999999997643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.55 E-value=3.8e-05 Score=59.78 Aligned_cols=29 Identities=24% Similarity=0.434 Sum_probs=24.4
Q ss_pred CeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 49 IIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 49 i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
++|+|+.|.|||++++ +.+-|+||+.+..
T Consensus 185 l~HgD~~~~Nil~~~~-~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDG-KVSGFIDLGRSGR 213 (263)
T ss_dssp EECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred EEEeeccCcceeecCC-ceEEEeechhccc
Confidence 7899999999999876 4556999987764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.71 E-value=0.00068 Score=55.95 Aligned_cols=29 Identities=28% Similarity=0.362 Sum_probs=25.6
Q ss_pred CCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 48 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 48 ~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
.++|+|+.+.|||++++ .++|+||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~--~~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH--ETKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSS--CEEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCC--ceEEechhhccc
Confidence 58999999999999876 589999998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.55 E-value=0.0018 Score=51.47 Aligned_cols=31 Identities=35% Similarity=0.532 Sum_probs=26.3
Q ss_pred CCCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 47 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 47 ~~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
.|++|+|+.++||+++.+ +..-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~-~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGD-ELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccc-cceeEeccccccc
Confidence 379999999999999987 4567999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=94.40 E-value=0.0068 Score=46.09 Aligned_cols=29 Identities=17% Similarity=0.237 Sum_probs=24.6
Q ss_pred CeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 49 IIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 49 i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
++|+|+.|.|||++++ +.+-|+||+.+..
T Consensus 177 liHgD~~~~Nvl~~~~-~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENG-RFSGFIDCGRLGV 205 (255)
T ss_dssp EECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred EEeCCCCCcceEEeCC-ceEEEEEchhccc
Confidence 7999999999999876 4567999987753
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=93.83 E-value=0.018 Score=45.78 Aligned_cols=28 Identities=25% Similarity=0.307 Sum_probs=23.2
Q ss_pred CCeecCCCCCcEEEeCCCCceEEecCccccc
Q 025244 48 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 78 (255)
Q Consensus 48 ~i~HrDikp~Nill~~~~~~~kl~Dfg~a~~ 78 (255)
+++|+|+.+.|||++++ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~---~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG---PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS---EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC---ceEEechhccc
Confidence 68999999999999643 45899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=85.03 E-value=0.17 Score=40.91 Aligned_cols=15 Identities=40% Similarity=0.689 Sum_probs=13.3
Q ss_pred CeecCCCCCcEEEeC
Q 025244 49 IIHRDLKPENLLLTE 63 (255)
Q Consensus 49 i~HrDikp~Nill~~ 63 (255)
++|.|+.+.||++.+
T Consensus 220 ~CHnDL~~~NiL~~~ 234 (395)
T d1nw1a_ 220 FCHNDLQEGNILLPK 234 (395)
T ss_dssp EECSCCCGGGEEEEC
T ss_pred EEecCCCcccEeecc
Confidence 579999999999864
|